{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "b5d99bb7",
   "metadata": {
    "colab_type": "text",
    "id": "view-in-github"
   },
   "source": [
    "<a href=\"https://colab.research.google.com/github/radxrad/radx-kg/blob/main/notebooks/visualization/ExampleQueries_colab.ipynb\" target=\"_parent\"><img src=\"https://colab.research.google.com/assets/colab-badge.svg\" alt=\"Open In Colab\"/></a>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "a16ef60a-ad28-435f-91d2-3b84b5da90cc",
   "metadata": {
    "id": "a16ef60a-ad28-435f-91d2-3b84b5da90cc"
   },
   "source": [
    "# RADx Knowledge Graph Queries\n",
    "This notebook runs queries on the radx-kg to explore the content and relationships among RADx-rad digital assets. Query results are displayed as tables, bar plots, and visualized as subgraphs.\n",
    "\n",
    "To run this notebook select ```Runtime -> Run all ``` from the menu.\n",
    "\n",
    "The radx-kg consists of nodes and their relationships that can be queries with the [Cypher graph query language](https://neo4j.com/docs/getting-started/cypher-intro/#_getting_started_with_cypher).\n",
    "\n",
    "<p align=\"center\">\n",
    "<img src=\"https://github.com/radxrad/radx-kg/blob/main/docs/Metagraph.png?raw=1\", width=\"100%\">\n",
    "</p>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "91e7ef48-6256-4581-9df3-24c1133e5d7a",
   "metadata": {
    "id": "91e7ef48-6256-4581-9df3-24c1133e5d7a"
   },
   "source": [
    "## Setup\n",
    "This notebook installs a Neo4j Graph Database and imports the RADx-KG data and metadata. The software setup may take 2 - 3 minutes."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "f5670553-4d90-47ff-a277-adca5684ea7a",
   "metadata": {
    "cellView": "form",
    "id": "f5670553-4d90-47ff-a277-adca5684ea7a",
    "jupyter": {
     "source_hidden": true
    }
   },
   "outputs": [],
   "source": [
    "#@title Check if Notebook is running in Google Colab\n",
    "in_colab = False\n",
    "try:\n",
    "    import google.colab\n",
    "    in_colab = True\n",
    "except:\n",
    "    pass"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "fc8051ba-0597-484b-b7f7-83c2d935b34f",
   "metadata": {
    "cellView": "form",
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 17
    },
    "id": "fc8051ba-0597-484b-b7f7-83c2d935b34f",
    "jupyter": {
     "source_hidden": true
    },
    "outputId": "f964f42d-93cd-4592-97cf-bc262815a56b"
   },
   "outputs": [],
   "source": [
    "#@title Install software\n",
    "if in_colab:\n",
    "    # enable third party widgets in Colab\n",
    "    from google.colab import output\n",
    "    output.enable_custom_widget_manager()\n",
    "    output.no_vertical_scroll()\n",
    "\n",
    "    # copy required files (temporary solution)\n",
    "    !wget -q https://raw.githubusercontent.com/pwrose/neo4j-ipycytoscape/master/notebooks/neo4j_utils.py\n",
    "    !wget -q https://raw.githubusercontent.com/sbl-sdsc/kg-import/master/notebooks/neo4j_bulk_importer.py\n",
    "    !wget -q https://raw.githubusercontent.com/sbl-sdsc/kg-import/master/notebooks/utils.py\n",
    "    !wget -q https://raw.githubusercontent.com/sbl-sdsc/kg-import/master/notebooks/PrepareNeo4jBulkImport.ipynb\n",
    "\n",
    "    !git clone --quiet https://github.com/radxrad/radx-kg.git\n",
    "\n",
    "    # install software\n",
    "    !apt -qq install openjdk-17-jre-headless 2>/dev/null > /dev/null\n",
    "    %pip install -q papermill > /dev/null\n",
    "    %pip install -q py2neo > /dev/null\n",
    "    %pip install -q ipycytoscape > /dev/null\n",
    "    %pip install -q python-dotenv > /dev/null\n",
    "\n",
    "    # set environment variables\n",
    "    from dotenv import load_dotenv\n",
    "    load_dotenv(\"/content/radx-kg/.env.colab\")\n",
    "else:\n",
    "    # copy required files (temporary solution)\n",
    "    !curl -s -O https://raw.githubusercontent.com/pwrose/neo4j-ipycytoscape/master/notebooks/neo4j_utils.py\n",
    "    !curl -s -O https://raw.githubusercontent.com/sbl-sdsc/kg-import/master/notebooks/neo4j_bulk_importer.py\n",
    "    !curl -s -O https://raw.githubusercontent.com/sbl-sdsc/kg-import/master/notebooks/utils.py\n",
    "    !curl -s -O https://raw.githubusercontent.com/sbl-sdsc/kg-import/master/notebooks/PrepareNeo4jBulkImport.ipynb\n",
    "    from dotenv import load_dotenv\n",
    "    load_dotenv(\"../../.env\", override=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "08c31e38-cb94-422d-b6e0-9ad7b351df87",
   "metadata": {
    "cellView": "form",
    "id": "08c31e38-cb94-422d-b6e0-9ad7b351df87"
   },
   "outputs": [],
   "source": [
    "#@title Imports\n",
    "import os\n",
    "import pandas as pd\n",
    "import seaborn as sns\n",
    "from py2neo import Graph\n",
    "import neo4j_utils\n",
    "import neo4j_bulk_importer\n",
    "\n",
    "\n",
    "pd.set_option('display.max_colwidth', None)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "57c5764c-33a5-4359-be0b-c5b7930c5ac9",
   "metadata": {
    "id": "57c5764c-33a5-4359-be0b-c5b7930c5ac9"
   },
   "source": [
    "### Download and install Neo4j Graph Database"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "5a995db5-fcea-4137-8847-565895d75e19",
   "metadata": {
    "id": "5a995db5-fcea-4137-8847-565895d75e19"
   },
   "outputs": [],
   "source": [
    "neo4j_utils.download_neo4j()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e6b136af-8ed7-407e-b02d-6c25a96cd755",
   "metadata": {
    "id": "e6b136af-8ed7-407e-b02d-6c25a96cd755"
   },
   "source": [
    "### Import the RADx-rad Knowledge Graph\n",
    "CSV data and metadata files are uploaded into the Neo4j Graph database from the [kg](https://github.com/radxrad/radx-kg/tree/main/kg) directory using the [kg-import](https://github.com/sbl-sdsc/kg-import) bulk upload scripts. For a description of the data organization and the specification of metadata [see](https://github.com/sbl-sdsc/kg-import/blob/main/README.md)."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "55ed42e2-fd25-45c5-ba9b-b0eac392bbed",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 66,
     "referenced_widgets": [
      "c23cd1f9602f4dfaa51e0ca2f20da079",
      "cef1ee8643ec4ed7b1772aa188593d5b",
      "54b07100d4c344acbc0e6e002f8943d3",
      "a9008d164b824628927319617506d950",
      "d1f50b0b62bf4a7cbb58b68ee2ff7576",
      "17397a8947894dc29c5ca2081c86e26e",
      "9eee0c072fc944f9b984557a1e30b844",
      "513496702e95450ab96af1a229168901",
      "6f2700447e5643a0a0659dfbc0a3ba92",
      "f2fd1f0a71de4179854f923448dfb0e0",
      "966cf9ca7c6a4a71936c85c6332a65af"
     ]
    },
    "id": "55ed42e2-fd25-45c5-ba9b-b0eac392bbed",
    "outputId": "bc6dc30e-3bb6-4a05-9532-28899840e8c5"
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a1aa3dbeed3d4326bcef405ff9e500c4",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "Executing:   0%|          | 0/85 [00:00<?, ?cell/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Neo4j is not running.\n",
      "Directories in use:\n",
      "home:         /Users/Peter/work/neo4j-community-5.15.0\n",
      "config:       /Users/Peter/work/neo4j-community-5.15.0/conf\n",
      "logs:         /Users/Peter/work/neo4j-community-5.15.0/logs\n",
      "plugins:      /Users/Peter/work/neo4j-community-5.15.0/plugins\n",
      "import:       /Users/Peter/work/neo4j-community-5.15.0/import\n",
      "data:         /Users/Peter/work/neo4j-community-5.15.0/data\n",
      "certificates: /Users/Peter/work/neo4j-community-5.15.0/certificates\n",
      "licenses:     /Users/Peter/work/neo4j-community-5.15.0/licenses\n",
      "run:          /Users/Peter/work/neo4j-community-5.15.0/run\n",
      "Starting Neo4j.\n",
      "Started neo4j (pid:3584). It is available at http://localhost:7474\n",
      "There may be a short delay until the server is ready.\n",
      "Launching server.... running.\n"
     ]
    }
   ],
   "source": [
    "neo4j_bulk_importer.import_from_csv();"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c3bc4783-38ff-47af-ab21-6a90eb3343ff",
   "metadata": {
    "id": "c3bc4783-38ff-47af-ab21-6a90eb3343ff"
   },
   "source": [
    "### Connect to the local Neo4j Graph database"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "37928585-7936-4e25-9108-eb33f73a512d",
   "metadata": {
    "id": "37928585-7936-4e25-9108-eb33f73a512d"
   },
   "outputs": [],
   "source": [
    "database = os.environ.get(\"NEO4J_DATABASE\")\n",
    "username = os.environ.get(\"NEO4J_USERNAME\")\n",
    "password = os.environ.get(\"NEO4J_PASSWORD\")\n",
    "stylesheet = os.environ.get(\"NEO4J_STYLESHEET\")\n",
    "\n",
    "graph = Graph(\"bolt://localhost:7687\", name=database, user=username, password=password)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fa7036b9-8f38-43e9-8d1f-62018a990512",
   "metadata": {
    "id": "fa7036b9-8f38-43e9-8d1f-62018a990512",
    "jp-MarkdownHeadingCollapsed": true
   },
   "source": [
    "## Table of Content\n",
    "* [Metadata](#Metadata)\n",
    "* [Subgraph](#Subgraph)\n",
    "* [Publications](#Publications)\n",
    "* [Patents](#Patents)\n",
    "* [Software](#Software)\n",
    "* [Presentations](#Presentations)\n",
    "* [Events](#Events)\n",
    "* [Organizations](#Organizations)\n",
    "* [Funding Opportunities](#FundingOpportunities)\n",
    "* [Grants](#Grants)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "eaa077ac-10a5-4537-a470-76e3b657feb6",
   "metadata": {
    "id": "eaa077ac-10a5-4537-a470-76e3b657feb6"
   },
   "source": [
    "## Metadata <a class=\"anchor\" id=\"Metadata\"></a>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3e53d63e-0477-4cc0-8594-caf9a446568f",
   "metadata": {
    "id": "3e53d63e-0477-4cc0-8594-caf9a446568f"
   },
   "source": [
    "### Node metadata\n",
    "radx-kg is a self-describing KG. The MetaNodes define the properties and their types of the Nodes in the KG."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "id": "6f5d1ac1-1e9c-440c-92fe-27b07266dd2e",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 1000
    },
    "id": "6f5d1ac1-1e9c-440c-92fe-27b07266dd2e",
    "outputId": "0633c4cf-7482-4469-ffaf-51942fa7f3d8",
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>nodeName</th>\n",
       "      <th>name</th>\n",
       "      <th>id</th>\n",
       "      <th>url</th>\n",
       "      <th>country</th>\n",
       "      <th>endDate</th>\n",
       "      <th>city</th>\n",
       "      <th>eventUrl</th>\n",
       "      <th>eventType</th>\n",
       "      <th>state</th>\n",
       "      <th>...</th>\n",
       "      <th>researchInitiativeUrl</th>\n",
       "      <th>description</th>\n",
       "      <th>websites</th>\n",
       "      <th>longName</th>\n",
       "      <th>firstName</th>\n",
       "      <th>lastName</th>\n",
       "      <th>profileId</th>\n",
       "      <th>fullName</th>\n",
       "      <th>middleName</th>\n",
       "      <th>orcid</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Dataset</td>\n",
       "      <td>Name of the dataset (string)</td>\n",
       "      <td>Unique identifier for the dataset (string)</td>\n",
       "      <td>URL to dataset landing page (string)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Event</td>\n",
       "      <td>Name of the event (string)</td>\n",
       "      <td>Unique identifier of the event (date and event number) (string)</td>\n",
       "      <td></td>\n",
       "      <td>Country of event location (string)</td>\n",
       "      <td>End data of event (date)</td>\n",
       "      <td>City of event location (string)</td>\n",
       "      <td>URL of the event website (string)</td>\n",
       "      <td>Type of event: webinar, virtual conference, in-person conference, hybrid conference, virtual workshop, in-person workshop, hybrid workshop (string)</td>\n",
       "      <td>State or province of the event location (string)</td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>FundingOpportunity</td>\n",
       "      <td>Name of the funding opportunity (string)</td>\n",
       "      <td>Unique identifier for the funding opportunity (Thesaurus:C20021) (string)</td>\n",
       "      <td>URL to funding opportunity description (string)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Grant</td>\n",
       "      <td>Title of the project (string)</td>\n",
       "      <td>Unique identifier for the grant (Thesaurus:C16644) (string)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Organization</td>\n",
       "      <td>Name of the organization (string)</td>\n",
       "      <td>Unique entity identifier: ror id if available, otherwise uei id (string)</td>\n",
       "      <td>Research Organization Registry landing page of the organization (string)</td>\n",
       "      <td>Country of the organization (string)</td>\n",
       "      <td></td>\n",
       "      <td>City of the organization (string)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>State of the organization (string)</td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Patent</td>\n",
       "      <td>Title of the patent (string)</td>\n",
       "      <td>Identifier of the patents (string)</td>\n",
       "      <td>URL of patent webpage (string)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Presentation</td>\n",
       "      <td>Title of the presentation (string)</td>\n",
       "      <td>Unique identifier of the presentation (hash of event id and name) (string)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>Publication</td>\n",
       "      <td>Title of the publication (string)</td>\n",
       "      <td>Unique identifier for the publication (string)</td>\n",
       "      <td>URL of publication (string)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>ResearchInitiative</td>\n",
       "      <td>Abbreviation of the research initiative (string)</td>\n",
       "      <td>Unique id of the research initiative (string)</td>\n",
       "      <td>URL of the research initiative website (string)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>...</td>\n",
       "      <td>Description of the research initiative that funded the research initiative (string)</td>\n",
       "      <td>Description of the research initiative (string)</td>\n",
       "      <td>URLs of related websites (string[])</td>\n",
       "      <td>Long name for research initiative (string)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>Researcher</td>\n",
       "      <td>Name of the researcher (lastname plus initials) (string)</td>\n",
       "      <td>Unique researcher identifier (orcid preferred or NIH profile id) (string)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>First name (string)</td>\n",
       "      <td>Last name (string)</td>\n",
       "      <td>Unique researcher identifier from NIH Reporter (https://api.reporter.nih.gov/) (string)</td>\n",
       "      <td>First middle and last name (string)</td>\n",
       "      <td>Middle name or middle initial (string)</td>\n",
       "      <td>Unique reseacher identifier from ORICD (https://orcid.org) (string)</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>Software</td>\n",
       "      <td>Name of the software application or software repository (string)</td>\n",
       "      <td>Identifier of the software application or software repository (string)</td>\n",
       "      <td>URL of the software application or software repository (string)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td>...</td>\n",
       "      <td></td>\n",
       "      <td>Description of the software or software repository (string)</td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "      <td></td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>11 rows × 45 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "              nodeName  \\\n",
       "0              Dataset   \n",
       "1                Event   \n",
       "2   FundingOpportunity   \n",
       "3                Grant   \n",
       "4         Organization   \n",
       "5               Patent   \n",
       "6         Presentation   \n",
       "7          Publication   \n",
       "8   ResearchInitiative   \n",
       "9           Researcher   \n",
       "10            Software   \n",
       "\n",
       "                                                                name  \\\n",
       "0                                       Name of the dataset (string)   \n",
       "1                                         Name of the event (string)   \n",
       "2                           Name of the funding opportunity (string)   \n",
       "3                                      Title of the project (string)   \n",
       "4                                  Name of the organization (string)   \n",
       "5                                       Title of the patent (string)   \n",
       "6                                 Title of the presentation (string)   \n",
       "7                                  Title of the publication (string)   \n",
       "8                   Abbreviation of the research initiative (string)   \n",
       "9           Name of the researcher (lastname plus initials) (string)   \n",
       "10  Name of the software application or software repository (string)   \n",
       "\n",
       "                                                                            id  \\\n",
       "0                                   Unique identifier for the dataset (string)   \n",
       "1              Unique identifier of the event (date and event number) (string)   \n",
       "2    Unique identifier for the funding opportunity (Thesaurus:C20021) (string)   \n",
       "3                  Unique identifier for the grant (Thesaurus:C16644) (string)   \n",
       "4     Unique entity identifier: ror id if available, otherwise uei id (string)   \n",
       "5                                           Identifier of the patents (string)   \n",
       "6   Unique identifier of the presentation (hash of event id and name) (string)   \n",
       "7                               Unique identifier for the publication (string)   \n",
       "8                                Unique id of the research initiative (string)   \n",
       "9    Unique researcher identifier (orcid preferred or NIH profile id) (string)   \n",
       "10      Identifier of the software application or software repository (string)   \n",
       "\n",
       "                                                                         url  \\\n",
       "0                                       URL to dataset landing page (string)   \n",
       "1                                                                              \n",
       "2                            URL to funding opportunity description (string)   \n",
       "3                                                                              \n",
       "4   Research Organization Registry landing page of the organization (string)   \n",
       "5                                             URL of patent webpage (string)   \n",
       "6                                                                              \n",
       "7                                                URL of publication (string)   \n",
       "8                            URL of the research initiative website (string)   \n",
       "9                                                                              \n",
       "10           URL of the software application or software repository (string)   \n",
       "\n",
       "                                 country                   endDate  \\\n",
       "0                                                                    \n",
       "1     Country of event location (string)  End data of event (date)   \n",
       "2                                                                    \n",
       "3                                                                    \n",
       "4   Country of the organization (string)                             \n",
       "5                                                                    \n",
       "6                                                                    \n",
       "7                                                                    \n",
       "8                                                                    \n",
       "9                                                                    \n",
       "10                                                                   \n",
       "\n",
       "                                 city                           eventUrl  \\\n",
       "0                                                                          \n",
       "1     City of event location (string)  URL of the event website (string)   \n",
       "2                                                                          \n",
       "3                                                                          \n",
       "4   City of the organization (string)                                      \n",
       "5                                                                          \n",
       "6                                                                          \n",
       "7                                                                          \n",
       "8                                                                          \n",
       "9                                                                          \n",
       "10                                                                         \n",
       "\n",
       "                                                                                                                                              eventType  \\\n",
       "0                                                                                                                                                         \n",
       "1   Type of event: webinar, virtual conference, in-person conference, hybrid conference, virtual workshop, in-person workshop, hybrid workshop (string)   \n",
       "2                                                                                                                                                         \n",
       "3                                                                                                                                                         \n",
       "4                                                                                                                                                         \n",
       "5                                                                                                                                                         \n",
       "6                                                                                                                                                         \n",
       "7                                                                                                                                                         \n",
       "8                                                                                                                                                         \n",
       "9                                                                                                                                                         \n",
       "10                                                                                                                                                        \n",
       "\n",
       "                                               state  ...  \\\n",
       "0                                                     ...   \n",
       "1   State or province of the event location (string)  ...   \n",
       "2                                                     ...   \n",
       "3                                                     ...   \n",
       "4                 State of the organization (string)  ...   \n",
       "5                                                     ...   \n",
       "6                                                     ...   \n",
       "7                                                     ...   \n",
       "8                                                     ...   \n",
       "9                                                     ...   \n",
       "10                                                    ...   \n",
       "\n",
       "                                                                  researchInitiativeUrl  \\\n",
       "0                                                                                         \n",
       "1                                                                                         \n",
       "2                                                                                         \n",
       "3                                                                                         \n",
       "4                                                                                         \n",
       "5                                                                                         \n",
       "6                                                                                         \n",
       "7                                                                                         \n",
       "8   Description of the research initiative that funded the research initiative (string)   \n",
       "9                                                                                         \n",
       "10                                                                                        \n",
       "\n",
       "                                                    description  \\\n",
       "0                                                                 \n",
       "1                                                                 \n",
       "2                                                                 \n",
       "3                                                                 \n",
       "4                                                                 \n",
       "5                                                                 \n",
       "6                                                                 \n",
       "7                                                                 \n",
       "8               Description of the research initiative (string)   \n",
       "9                                                                 \n",
       "10  Description of the software or software repository (string)   \n",
       "\n",
       "                               websites  \\\n",
       "0                                         \n",
       "1                                         \n",
       "2                                         \n",
       "3                                         \n",
       "4                                         \n",
       "5                                         \n",
       "6                                         \n",
       "7                                         \n",
       "8   URLs of related websites (string[])   \n",
       "9                                         \n",
       "10                                        \n",
       "\n",
       "                                      longName            firstName  \\\n",
       "0                                                                     \n",
       "1                                                                     \n",
       "2                                                                     \n",
       "3                                                                     \n",
       "4                                                                     \n",
       "5                                                                     \n",
       "6                                                                     \n",
       "7                                                                     \n",
       "8   Long name for research initiative (string)                        \n",
       "9                                               First name (string)   \n",
       "10                                                                    \n",
       "\n",
       "              lastName  \\\n",
       "0                        \n",
       "1                        \n",
       "2                        \n",
       "3                        \n",
       "4                        \n",
       "5                        \n",
       "6                        \n",
       "7                        \n",
       "8                        \n",
       "9   Last name (string)   \n",
       "10                       \n",
       "\n",
       "                                                                                  profileId  \\\n",
       "0                                                                                             \n",
       "1                                                                                             \n",
       "2                                                                                             \n",
       "3                                                                                             \n",
       "4                                                                                             \n",
       "5                                                                                             \n",
       "6                                                                                             \n",
       "7                                                                                             \n",
       "8                                                                                             \n",
       "9   Unique researcher identifier from NIH Reporter (https://api.reporter.nih.gov/) (string)   \n",
       "10                                                                                            \n",
       "\n",
       "                               fullName  \\\n",
       "0                                         \n",
       "1                                         \n",
       "2                                         \n",
       "3                                         \n",
       "4                                         \n",
       "5                                         \n",
       "6                                         \n",
       "7                                         \n",
       "8                                         \n",
       "9   First middle and last name (string)   \n",
       "10                                        \n",
       "\n",
       "                                middleName  \\\n",
       "0                                            \n",
       "1                                            \n",
       "2                                            \n",
       "3                                            \n",
       "4                                            \n",
       "5                                            \n",
       "6                                            \n",
       "7                                            \n",
       "8                                            \n",
       "9   Middle name or middle initial (string)   \n",
       "10                                           \n",
       "\n",
       "                                                                  orcid  \n",
       "0                                                                        \n",
       "1                                                                        \n",
       "2                                                                        \n",
       "3                                                                        \n",
       "4                                                                        \n",
       "5                                                                        \n",
       "6                                                                        \n",
       "7                                                                        \n",
       "8                                                                        \n",
       "9   Unique reseacher identifier from ORICD (https://orcid.org) (string)  \n",
       "10                                                                       \n",
       "\n",
       "[11 rows x 45 columns]"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "query = \"\"\"\n",
    "MATCH (n:MetaNode) RETURN n;\n",
    "\"\"\"\n",
    "df = graph.run(query).to_data_frame()\n",
    "metadata = df[\"n\"].tolist()\n",
    "metadata = pd.DataFrame(metadata)\n",
    "metadata.fillna(\"\", inplace=True)\n",
    "metadata"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "c4063e5c-8172-4c5b-a984-e03cdbc52e17",
   "metadata": {
    "id": "c4063e5c-8172-4c5b-a984-e03cdbc52e17"
   },
   "source": [
    "### Metagraph <a class=\"anchor\" id=\"Metagraph\"></a>\n",
    "The metagraph shows the node labels and relationship types of the KG. Click on a node to display the node metadata."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "id": "a49b3dfc-bd6e-4402-b093-59a56c1f737c",
   "metadata": {
    "id": "a49b3dfc-bd6e-4402-b093-59a56c1f737c"
   },
   "outputs": [],
   "source": [
    "query = \"\"\"\n",
    "MATCH p=(:MetaNode)-->(:MetaNode) RETURN p\n",
    "\"\"\"\n",
    "subgraph1 = graph.run(query).to_subgraph()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "id": "9c72b910-069d-46db-8ab6-beac15d48853",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 917,
     "referenced_widgets": [
      "893136566176445c9f86542b2b5309e5",
      "a2a8d91b390e4dc3ab2d7cef40eb8c4a",
      "9e16133687ed47008dc49145ca392524",
      "996e945365a64c87ae276d64f16b7510",
      "4b3f75c541b046ac999adbbaaaaba500",
      "9e4488242d6e43149f40fd6cd67269da",
      "559051d8e5b6441e87824177a6ddc88a",
      "f965957bbf894308b456294027365e30",
      "4a04d8006e984af19766e149c7656550",
      "4186599920924d84b5fee05210462b50",
      "9ebd3b36d8b24c28add1f7963f7ea619",
      "58d04ecf3e154dcbacc58778c0e5438f",
      "51e6ba3d23904185a8d8b9f03c8345f7",
      "4e87c4833a534506a142584de623a042",
      "02bf94bec34546548468f290c79d3704",
      "575659f4edb94164a130ed0e71f3c626",
      "114c94f4190d4f3ca773a68c55ba2669",
      "fa83d237a3ff4822ae90b2d6a98a5859",
      "ead7475f011d4f35b12cb77d80e2d0a7",
      "6552ee7875fd4136923ec85cd6f3fd02",
      "7f45e0fb9a6748ee80be61f1b4e56360",
      "993a9df3b3d4491584adad67719b8221",
      "93659fa346534dcaaac133e830bd763c",
      "0e8f0361b4e540698b70501cad5ab969",
      "20b3fee617064bb495e6fe183fd22602",
      "11b298b1df6a4080ade6986b7ea7f7b9",
      "582c8846ded648ea8d9d84db1d30ce95"
     ]
    },
    "id": "9c72b910-069d-46db-8ab6-beac15d48853",
    "outputId": "79d64956-37aa-4cf8-8155-f9c74c5f349e"
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "46dc2c0ad4d846f68d3823a0ef90bfc1",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "CytoscapeWidget(cytoscape_layout={'name': 'cola', 'padding': 40, 'nodeSpacing': 65, 'nodeDimensionsIncludeLabe…"
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "widget1 = neo4j_utils.draw_graph(subgraph1, stylesheet)\n",
    "widget1.layout.height = \"900px\"\n",
    "widget1.set_layout(name='cola', padding=40, nodeSpacing=65, nodeDimensionsIncludeLabels=True, unconstrIter=5000)\n",
    "widget1\n",
    "# Click in the left cell margin to select \"View output fullscreen\" for a fullscreen view.\n",
    "# Click in the left notebook margin to select \"Take Screenshot\" to save a screenshot.\n",
    "# To improve the initial rendering of the graph, rerun this cell."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "13eca098-2fd5-4c4a-8533-489dd5a9e0cc",
   "metadata": {
    "id": "13eca098-2fd5-4c4a-8533-489dd5a9e0cc"
   },
   "source": [
    "### Number of Nodes"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "id": "787283c7-114f-495f-ac74-ebd115e07f06",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "787283c7-114f-495f-ac74-ebd115e07f06",
    "outputId": "ddbb5349-d882-40f0-9d65-8dd9330d93d1"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Total number of nodes: 4674\n"
     ]
    }
   ],
   "source": [
    "query = \"\"\"\n",
    "MATCH (n) RETURN COUNT(n);\n",
    "\"\"\"\n",
    "print(f\"Total number of nodes: {graph.evaluate(query)}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "dc48a488-1987-4310-aa7f-020aa29810b9",
   "metadata": {
    "id": "dc48a488-1987-4310-aa7f-020aa29810b9"
   },
   "source": [
    "### Number of nodes by node label"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "id": "5b928985-9122-49f6-bd2c-ffb890dece42",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 426
    },
    "id": "5b928985-9122-49f6-bd2c-ffb890dece42",
    "outputId": "0d366471-0a6e-4be6-f832-eb0d26ccab3c"
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Node</th>\n",
       "      <th>Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>Researcher</td>\n",
       "      <td>2365</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>Publication</td>\n",
       "      <td>1997</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>Presentation</td>\n",
       "      <td>87</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>Organization</td>\n",
       "      <td>59</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>Dataset</td>\n",
       "      <td>50</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>Grant</td>\n",
       "      <td>48</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>Patent</td>\n",
       "      <td>17</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>FundingOpportunity</td>\n",
       "      <td>16</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>Event</td>\n",
       "      <td>14</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>MetaNode</td>\n",
       "      <td>11</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>ResearchInitiative</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Software</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                  Node  Count\n",
       "0           Researcher   2365\n",
       "1          Publication   1997\n",
       "2         Presentation     87\n",
       "3         Organization     59\n",
       "4              Dataset     50\n",
       "5                Grant     48\n",
       "6               Patent     17\n",
       "7   FundingOpportunity     16\n",
       "8                Event     14\n",
       "9             MetaNode     11\n",
       "10  ResearchInitiative      5\n",
       "11            Software      5"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "query = \"\"\"\n",
    "MATCH (n) RETURN labels(n)[0] AS Node, COUNT(n) AS Count\n",
    "ORDER BY Count DESC\n",
    "\"\"\"\n",
    "graph.run(query).to_data_frame()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "e7a1259d-11b9-4622-bfa3-efb83880365b",
   "metadata": {
    "id": "e7a1259d-11b9-4622-bfa3-efb83880365b"
   },
   "source": [
    "### Number of relationships by relationship type"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "id": "901c90ed-e377-46c7-99a1-b107bc7a10df",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 488
    },
    "id": "901c90ed-e377-46c7-99a1-b107bc7a10df",
    "outputId": "307c43ae-c151-42fe-c0f1-62bc4303839d"
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Relationship</th>\n",
       "      <th>Count</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>AUTHORED</td>\n",
       "      <td>6946</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>CITES</td>\n",
       "      <td>4400</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>PRESENTED</td>\n",
       "      <td>348</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>IS_INVESTIGATOR_OF</td>\n",
       "      <td>228</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>USED</td>\n",
       "      <td>200</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>PRESENTED_AT</td>\n",
       "      <td>174</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>EMPLOYED_AT</td>\n",
       "      <td>166</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>CREATED</td>\n",
       "      <td>106</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>PROVIDES</td>\n",
       "      <td>106</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>SUPPORTED</td>\n",
       "      <td>94</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>IS_INVENTOR</td>\n",
       "      <td>68</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>MetaRelationship</td>\n",
       "      <td>25</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>DEVELOPED</td>\n",
       "      <td>10</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>FUNDED</td>\n",
       "      <td>2</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          Relationship  Count\n",
       "0             AUTHORED   6946\n",
       "1                CITES   4400\n",
       "2            PRESENTED    348\n",
       "3   IS_INVESTIGATOR_OF    228\n",
       "4                 USED    200\n",
       "5         PRESENTED_AT    174\n",
       "6          EMPLOYED_AT    166\n",
       "7              CREATED    106\n",
       "8             PROVIDES    106\n",
       "9            SUPPORTED     94\n",
       "10         IS_INVENTOR     68\n",
       "11    MetaRelationship     25\n",
       "12           DEVELOPED     10\n",
       "13              FUNDED      2"
      ]
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "query = \"\"\"\n",
    "MATCH ()-[r]-() RETURN DISTINCT TYPE(r) AS Relationship, COUNT(r) AS Count\n",
    "ORDER BY Count DESC\n",
    "\"\"\"\n",
    "graph.run(query).to_data_frame()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d903af69-8ad2-4a3f-a40d-6e226f7edb36",
   "metadata": {
    "id": "d903af69-8ad2-4a3f-a40d-6e226f7edb36"
   },
   "source": [
    "## Subgraph for an investigator <a class=\"anchor\" id=\"Subgraph\"></a>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "627b4c87-d27c-45e6-894e-8b50a21d7cad",
   "metadata": {
    "id": "627b4c87-d27c-45e6-894e-8b50a21d7cad"
   },
   "source": [
    "#### First neighbors in KG"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "id": "c9f92b1e-1a65-4a91-ad57-a5c04d253d47",
   "metadata": {
    "id": "c9f92b1e-1a65-4a91-ad57-a5c04d253d47"
   },
   "outputs": [],
   "source": [
    "researcher = \"Cirrito\"\n",
    "query = \"\"\"\n",
    "MATCH p=(r:Researcher)--() WHERE r.lastName = $researcher RETURN p\n",
    "\"\"\"\n",
    "subgraph2 = graph.run(query, researcher=researcher).to_subgraph()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "id": "8f4b82de-69f2-4d6e-a5f3-9318e493f5ef",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 1000,
     "referenced_widgets": [
      "86bfea604843476c9b98ecc00e4a9574",
      "3e72943b52c44242bceb791e8b3e00d1",
      "c2c511441595421189d8fce8c87a56fd",
      "034931925ad04bb9b228dd3c03ac96e3",
      "00319f516ed24521ad8fbe403f1ffc1d",
      "597c1438260d4ebf84f034567e76c0d0",
      "34df3402d3394c1d87ba057890e58977",
      "b95d2bbeced749429f7fe407d7ae639b",
      "20c002a92efc4292a3749801b4f02c18",
      "d87069a9ece54df99d708684a3567458",
      "20dd6ed0c82640f384ed560af46a2e2c",
      "7b5311b47f0744728e55f94df8c92224",
      "366287609349423a9ea670ade93ee9a2",
      "eb659eed22c04ed794d312f7261a6dd8",
      "098f71e4e6a54124bb6491defc6c1556",
      "5e4be9cca3024dbdbceb2ce24df7e1e6",
      "b50f0e5ffc54422fac7e8eb978a98836",
      "30d40415a6d84a44a60c21c51529c573"
     ]
    },
    "id": "8f4b82de-69f2-4d6e-a5f3-9318e493f5ef",
    "outputId": "d00358c9-38bc-42b7-8db5-649c2037f200"
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "b3ef152edf414ed5823f5e950e41584d",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "CytoscapeWidget(cytoscape_layout={'name': 'cola', 'padding': 0, 'nodeSpacing': 40, 'nodeDimensionsIncludeLabel…"
      ]
     },
     "execution_count": 52,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "widget2 = neo4j_utils.draw_graph(subgraph2, stylesheet)\n",
    "widget2.layout.height = \"1000px\"\n",
    "widget2.set_layout(name=\"cola\", padding=0, nodeSpacing=40, nodeDimensionsIncludeLabels=True, unconstrIter=5000)\n",
    "widget2\n",
    "# Click in the left cell margin to select \"View output fullscreen\" for a fullscreen view.\n",
    "# Click in the left notebook margin to select \"Take Screenshot\" to save a screenshot.\n",
    "# To improve the initial rendering of the graph, rerun this cell."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5928d741-5489-417d-893e-32ddcf3276ee",
   "metadata": {
    "id": "5928d741-5489-417d-893e-32ddcf3276ee"
   },
   "source": [
    "#### First and second neighbors in KG"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "id": "2d428ab3-0dfc-4be7-b58d-4c18e3efbec1",
   "metadata": {
    "id": "2d428ab3-0dfc-4be7-b58d-4c18e3efbec1"
   },
   "outputs": [],
   "source": [
    "researcher = \"Cirrito\"\n",
    "query = \"\"\"\n",
    "MATCH p=(r:Researcher)--()--() WHERE r.lastName = $researcher RETURN p\n",
    "\"\"\"\n",
    "subgraph3 = graph.run(query, researcher=researcher).to_subgraph()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "id": "980f5a21-1f9a-4d97-89c0-ff47b11a19e7",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 1000,
     "referenced_widgets": [
      "8f525cc727fd45e49db6dbed70ef21c1",
      "989fbe6e10f74184b82d66be64b545bd",
      "993ca51c0aa54e199a3d79eecb3a0346",
      "5d51b8e0ba1e46e2babe9cb7373c8a74",
      "faeef149db124256ad839a59fc46c4fb",
      "ac95da440e714ec9ad28c84ac814d979",
      "1c419b7f7a0a4a038553bf7170876f7f",
      "d66e68fb3b97441b84d85ba8cbdbff8d",
      "be171e229d9f4c4ea77a396d4b799b62",
      "7ab8514dc43e4de2ba28d9c06033a5e2",
      "dbfd555cb5b64e85a8adc4c61118c74b",
      "063518c28c164b2bab5607579390a6f4",
      "8b3bd41cc8364edc946c46ca492b2031",
      "5add710aeac54abda329af59d866f997",
      "169e046a3d62433aad537627bbf067fd",
      "4061a973c34846fa913cb68293958205",
      "077e9bf897c64ab28fc1fac08bed3f29",
      "d264a8369dd74f20915941672773088c",
      "bf9e461a744a4d419332b3e2083801bb",
      "108f57595ae64e4b9b56ef1624c0ad29",
      "5790b81e4018451d85be882c5de7bd14",
      "3d392600f5ed4d658c079a9fbff12cc4",
      "3bc3833769e4453a875446483f2815e7",
      "0260dd3ad51d43cebabe70cce80a4ef5",
      "b1cbf6fa663d48159bff513d0f2a5b7a",
      "d776794e85f84e118a7760f98e2b5c45",
      "703ca325eb414436af10284d3f2d49d7",
      "87405a7b3f934a3f8fbf30b26bbede3d",
      "1891308cc5cc4a2a8d1426475b87c4af",
      "5038ea577fc64173884849d76e5f1861",
      "e5178d1b75d04049977ccbe0d80ab7ab",
      "6d97b9e05bb3451899876866233c47e8",
      "1db0bae3cf9e4cecae1d7a5949b975c6",
      "58c61b54a7f84ffcbdf29497785e0da9",
      "39efb44c6d034df1bf2a9beede65dcd7",
      "cf63ef9549844ad494816d6ccc8a250f",
      "8e1c44891d9241d391d32b25c7f82331",
      "eca41e573ede44788ee257c22d36ba48",
      "87828501353046f0963a057a994c6f15",
      "3fb66a7628e24163a9efc5a906855908",
      "0dc3601a14cb4178b485ec78033521e8",
      "5f3f11d913eb4ee5a322a9def50d2357",
      "d9816999e5db48e3bcda9e5a97907a53",
      "5b32e7fc1adf4348b83d715bf9cf65e4",
      "9998956a9572471c843ae01a5eda2f48",
      "b1aab0d262c9479a864a104a7f28d670",
      "5ae6ba1cf0cc4cb8b72009f8a25599c5",
      "5b4d6206fe6e4e0aa8b8789b5bfb5976",
      "bb2cb16c0d7b485cb0514fcbf21ee787",
      "018599547284425ebd4a84def59600e9",
      "bdeb81280125437aa161bc08af874140",
      "674e8515c5fe43469a78cd990999390d",
      "6adeb90365864bd7a583e910b2a71a6c",
      "6cb956a1d044452781bdbb029524d8c4",
      "2be1317ef9784c299b7c326dea315d68",
      "ed6495b4b290422cbfbb4a63976dfb55",
      "e9b6f768fe5147e28dfa700b4dea0e82",
      "fd31bbffcb2849fbb7e73801c93f2c2a",
      "763d340c255a408a8094c00166b3ffa7",
      "94e8124e310f42429aaaa6371342ed40",
      "148ae7b696fb442fb5b9e1fa0dcf2417",
      "316535e3b8f0426d819f97b6fead5798",
      "e3036984bde54baebf031c0c1d4d56df",
      "b12803efdde849cdaaf479772a2f264d",
      "de39e48f80f6480d926d2473b17a2540",
      "54b6dcfee41d4fd1b07e76c43e24193f",
      "e97b072c329d432e988fa52870119524",
      "253788284c34414d8a8af430e928fada",
      "112d8fb8c0bd40e5bb76dd8570518ab7",
      "32ca53f8735142c19a49f49fefe0707b",
      "6e431a5f60ae4cdb8a826aff9e27b65c",
      "8bfb375f42054b9da36d627b3835654c",
      "e3be20d7136d458bbfbac134eceec37b",
      "3c3e29ff37cf4247bccb9b8e87aa827d",
      "3e1aaed2c64b41c892d053dd2ac7954e",
      "bc4b2cfb7669413fb24867750636cc0c",
      "6f7315ce708e40bdb5af0b8f933537c8",
      "894856695b534ebb845e4f13cc18ac8b",
      "fc12a255026b430db99fb732e8fcf546",
      "10feeb8e23354d5099f57e58296fb406",
      "0dc89dccbd4e48a490f8a82f5df489aa",
      "faaffc2b8baa410dbedaddd2cccf31c5",
      "cb09a57c607d47c98814840b84db5895",
      "408fac2790024e04970af08a0511946f",
      "30e81483122843589816c44b4f629e37",
      "abeb8bb4c3ee4084aba8aec3f9d83427",
      "ce291557b0714708a96813d20128c922",
      "b2c58ba315ee47db84c043f590fb9153",
      "70e2aea88cdf4e21868061e868ec214c",
      "4dd16811bfd54a74bc25d70a70d20d10",
      "34802c8a934b449897a75bbd23e946f5",
      "1bc5623b2b384bf09ac4346e49d6494f",
      "1c176f8fbbe54bdab63ccacaf5082397",
      "98f6c81bb73f4824a64d6c5ef9738591",
      "ac2632d4452a42febd71fdc62c473c95",
      "3ffea9057c724afdb09380d32a2fee2e",
      "6b1da2ba401745ce8f2f23227980bbd9",
      "8c065a94d29346c5a69e84afe9055f0d"
     ]
    },
    "id": "980f5a21-1f9a-4d97-89c0-ff47b11a19e7",
    "outputId": "77433f74-6af5-418e-a724-b49a9ba9147f"
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "bb9f2e997f32403fabe982b7c0ce7221",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "CytoscapeWidget(cytoscape_layout={'name': 'cola', 'padding': 0, 'nodeSpacing': 40, 'nodeDimensionsIncludeLabel…"
      ]
     },
     "execution_count": 54,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "widget3 = neo4j_utils.draw_graph(subgraph3, stylesheet)\n",
    "widget3.layout.height = \"1000px\"\n",
    "widget3.set_layout(name=\"cola\", padding=0, nodeSpacing=40, nodeDimensionsIncludeLabels=True, unconstrIter=5000)\n",
    "widget3\n",
    "# Click in the left cell margin to select \"View output fullscreen\" for a fullscreen view.\n",
    "# Click in the left notebook margin to select \"Take Screenshot\" to save a screenshot.\n",
    "# To improve the initial rendering of the graph, rerun this cell."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "91533163-0d78-4a23-bbe2-e0309e778b80",
   "metadata": {
    "id": "91533163-0d78-4a23-bbe2-e0309e778b80"
   },
   "source": [
    "## Publications <a class=\"anchor\" id=\"Publications\"></a>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "14582b16-4db4-48f1-900c-eecea4697bb9",
   "metadata": {
    "id": "14582b16-4db4-48f1-900c-eecea4697bb9"
   },
   "source": [
    "### Number of primary publications"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 55,
   "id": "c2e54391-4730-427f-a137-bf50e7a2021b",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "c2e54391-4730-427f-a137-bf50e7a2021b",
    "outputId": "513c89f0-6b30-43e3-c750-04a6fedfa08a"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of primary publications: 205\n"
     ]
    }
   ],
   "source": [
    "query = \"\"\"\n",
    "MATCH (p:Publication) WHERE p.type = \"primary\" RETURN COUNT(p)\n",
    "\"\"\"\n",
    "print(f\"Number of primary publications: {graph.evaluate(query)}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "62717e46-f6be-443f-9437-26dcc31067dd",
   "metadata": {
    "id": "62717e46-f6be-443f-9437-26dcc31067dd"
   },
   "source": [
    "### Number of publication by RADx-rad subprojects"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "id": "5b2e3254-2117-4d41-85fc-fc65229145a9",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 449
    },
    "id": "5b2e3254-2117-4d41-85fc-fc65229145a9",
    "outputId": "02c77c60-2490-4c44-8c98-6caabc41de92"
   },
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "query = \"\"\"\n",
    "MATCH (:Publication)<-[:AUTHORED]-(r:Researcher)-[:IS_INVESTIGATOR_OF]->(g:Grant) RETURN COUNT(g) AS Publications, g.subProject AS Project\n",
    "ORDER BY Publications DESC\n",
    "\"\"\"\n",
    "publications = graph.run(query).to_data_frame()\n",
    "sns.barplot(publications, x=\"Publications\", y=\"Project\");"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "59866f8b-2955-43dc-8eaf-c4b663db4360",
   "metadata": {
    "id": "59866f8b-2955-43dc-8eaf-c4b663db4360"
   },
   "source": [
    "### Number of secondary publications (citations)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "id": "eca04bdc-122b-48d3-9b5a-0159983347cf",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "eca04bdc-122b-48d3-9b5a-0159983347cf",
    "outputId": "410b991f-4fe0-4f28-8c63-1e258359ab38"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of citations: 1792\n"
     ]
    }
   ],
   "source": [
    "query = \"\"\"\n",
    "MATCH (p:Publication) WHERE p.type = \"secondary\" RETURN COUNT(p)\n",
    "\"\"\"\n",
    "print(f\"Number of citations: {graph.evaluate(query)}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "123cc336-28e6-4951-9574-1210a37a8635",
   "metadata": {
    "id": "123cc336-28e6-4951-9574-1210a37a8635"
   },
   "source": [
    "### Number of citations of the primary publications by subprojects"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "id": "d40f7ae6-88df-400e-a1f0-da98423e8825",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 449
    },
    "id": "d40f7ae6-88df-400e-a1f0-da98423e8825",
    "outputId": "a6350f2b-ca92-4f67-a1d7-127548024fa5"
   },
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "query = \"\"\"\n",
    "MATCH (:Publication)-[CITES]-(p:Publication)<-[:AUTHORED]-(r:Researcher)-[:IS_INVESTIGATOR_OF]->(g:Grant) RETURN COUNT(g) AS Citations, g.subProject AS Project\n",
    "ORDER BY Citations DESC\n",
    "\"\"\"\n",
    "citations = graph.run(query).to_data_frame()\n",
    "sns.barplot(citations, x=\"Citations\", y=\"Project\");"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "f330c45b-7355-4052-a4a8-6de8fcaaa7ce",
   "metadata": {
    "id": "f330c45b-7355-4052-a4a8-6de8fcaaa7ce"
   },
   "source": [
    "### Publications authored by researcher from multiple RADx-rad grants"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "id": "6ba02310-b648-4600-9b8e-660f34551feb",
   "metadata": {
    "id": "6ba02310-b648-4600-9b8e-660f34551feb"
   },
   "outputs": [],
   "source": [
    "query = \"\"\"\n",
    "MATCH p=(g1:Grant)<-[:IS_INVESTIGATOR_OF]-(r1:Researcher)-[:AUTHORED]->(:Publication)<-[:AUTHORED]-(r2:Researcher)-[:IS_INVESTIGATOR_OF]-(g2:Grant) WHERE g1 <> g2 RETURN p\n",
    "\"\"\"\n",
    "subgraph4 = graph.run(query, researcher=researcher).to_subgraph()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "id": "c46b76ba-70aa-4fe7-bbf8-01c6ba882c1e",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 917,
     "referenced_widgets": [
      "3de566bd89f04262a08ecbfc67ea8df6",
      "1501df663ab64d65822a548071f0f9a5",
      "46d4e111fe884e1f99b3c3a47ff5090f",
      "739952c1cadc4227998d85aa1fedc6a5",
      "a0f849a8cb32481195e2f771899db7f2",
      "4efa73a5a7c34d76a0259db1669a213d",
      "82df09a66bfa4b8ab3ac1933d99e1b26",
      "ae763ecbe8064071a51f121b70f06f62",
      "590f817f8bb84b65aedb04c96a6f2fd4",
      "f11e723322244aac939cd25cedf3a752",
      "1430e8bfd38948848f1d18ca002068bc",
      "29811122aec847e5b2d9ac191481e7d2",
      "a408033a050f4d688eb9a32933a69abf",
      "1b7799daad3e42a485149ae5543a2895",
      "f5fdbc22415e4916a564e679f7c8c17e",
      "459e39d017d94cfb926426fbdccfa0fd",
      "9e336250e2444aec9773879d82b9baa7",
      "8b83b2e7483f40ffb57121557b511f77",
      "c20253de64b74f9982386981a4372edb",
      "9120e1fba8364e54b4d4ab7a955c37c2",
      "338b4fd609934c4aa1ae15546e62198c",
      "ba82b77a43b342a3994a285cb5f3996c",
      "8222b7bbdd094199ada49f63281c2ae6",
      "fd26172ca7c74d469a8da92c32838748",
      "9ba4fe703bbc4138b83dbd3513b40605",
      "49831c3462224e2d939aaf13cb48608d",
      "89d16019824946e98316c1edbdb30521",
      "f504608a5ff0456f8b26eae0abc21d2a",
      "232311bb0e964ee79856c7f22edbc62f",
      "762f8fecfbcf463c8345def89cbda4a6",
      "5a0728420ce14d76b5964df8cf81a2fd",
      "c8c6784aaa804690be624164a1d3f437",
      "1af63d596f7d4ff2b3a8f82825194e68",
      "407bb20b4ed641d989a9ec5ce9deb0ad",
      "b83a26882a824a6aa512375d490b8067",
      "b9dc064adc924b5d8c0ef6a26a6b28a9"
     ]
    },
    "id": "c46b76ba-70aa-4fe7-bbf8-01c6ba882c1e",
    "outputId": "a88915c5-07fe-486a-df10-604fa8eec0bf",
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "a1b20af525224badbe0eda50dd82d770",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "CytoscapeWidget(cytoscape_layout={'name': 'cola', 'padding': 0, 'nodeSpacing': 40, 'nodeDimensionsIncludeLabel…"
      ]
     },
     "execution_count": 60,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "widget4 = neo4j_utils.draw_graph(subgraph4, stylesheet)\n",
    "widget4.layout.height = \"900px\"\n",
    "widget4.set_layout(name=\"cola\", padding=0, nodeSpacing=40, nodeDimensionsIncludeLabels=True, unconstrIter=5000)\n",
    "widget4\n",
    "# Click in the left cell margin to select \"View output fullscreen\" for a fullscreen view.\n",
    "# Click in the left notebook margin to select \"Take Screenshot\" to save a screenshot.\n",
    "# To improve the initial rendering of the graph, rerun this cell."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9250d93f-edb9-47f3-91b5-ca7bde4f46af",
   "metadata": {
    "id": "9250d93f-edb9-47f3-91b5-ca7bde4f46af"
   },
   "source": [
    "## Patents <a class=\"anchor\" id=\"Patents\"></a>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ac83c8ee-eeef-43b4-b522-719385c624ab",
   "metadata": {
    "id": "ac83c8ee-eeef-43b4-b522-719385c624ab"
   },
   "source": [
    "### Number of patents"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "id": "d87de898-a901-4add-bdc8-8cb16368350f",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "d87de898-a901-4add-bdc8-8cb16368350f",
    "outputId": "69eba41f-b7b9-4a4e-e8a7-7aa097463284"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of patents: 17\n"
     ]
    }
   ],
   "source": [
    "query = \"\"\"\n",
    "MATCH (p:Patent) RETURN COUNT(p)\n",
    "\"\"\"\n",
    "print(f\"Number of patents: {graph.evaluate(query)}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1a74602b-5297-4bbb-a31a-8c314779efb4",
   "metadata": {
    "id": "1a74602b-5297-4bbb-a31a-8c314779efb4"
   },
   "source": [
    "### Number of patents by RADx-rad subprojects"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "id": "090d2095-87b9-43ff-b446-bfeab503be24",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 449
    },
    "id": "090d2095-87b9-43ff-b446-bfeab503be24",
    "outputId": "76756030-4118-4e59-801f-5dcf5da60986"
   },
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "query = \"\"\"\n",
    "MATCH (p:Patent)<-[:IS_INVENTOR]-(r:Researcher)-[:IS_INVESTIGATOR_OF]->(g:Grant) RETURN COUNT(p) AS Patents, g.subProject AS Project\n",
    "ORDER BY Patents DESC\n",
    "\"\"\"\n",
    "patents = graph.run(query).to_data_frame()\n",
    "sns.barplot(patents, x=\"Patents\", y=\"Project\");"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8620155c-b66b-40ac-9cf0-32850722f233",
   "metadata": {
    "id": "8620155c-b66b-40ac-9cf0-32850722f233"
   },
   "source": [
    "### Patents with inventors from multiple RADx-rad grants"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "id": "a1db72fd-4d1b-46eb-bada-59dfa7f7262b",
   "metadata": {
    "id": "a1db72fd-4d1b-46eb-bada-59dfa7f7262b"
   },
   "outputs": [],
   "source": [
    "query = \"\"\"\n",
    "MATCH p=(g1:Grant)<-[:IS_INVESTIGATOR_OF]-(r1:Researcher)-[:IS_INVENTOR]->(:Patent)<-[:IS_INVENTOR]-(r2:Researcher)-[:IS_INVESTIGATOR_OF]-(g2:Grant) WHERE g1 <> g2 RETURN p\n",
    "\"\"\"\n",
    "subgraph5 = graph.run(query, researcher=researcher).to_subgraph()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "id": "6637fe31-5acf-4d8b-b0ab-afbe33873d86",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 917,
     "referenced_widgets": [
      "3a425c9cfcbe41d3b83702c885737883",
      "8751edf84e354cc9881538d0fa6f20ec",
      "71f606250c084f35802f0b66334e4135",
      "1a9f632256e947d38d2ff48d7ff54023",
      "29b30f41d8a241bba1caf3c4dc0ed004",
      "f212675824ce475395ae3bc34b0c0a3d",
      "e078648af27b42fe9b63502c5fc8eefe",
      "672fb233629a4c60a6b35865ab510493",
      "947678ab544b4eff9000b69a620a8036",
      "c1f8c20f720c44a9819f6cd993e82f51",
      "9b6ddbc374444203be8e3efc54195e1a",
      "bf493b2fdf3f49ddbb86efaaec9ea331",
      "cdc5e150ec0340cf9a8248b409b2ce13",
      "89b85b6cfbb243bd9874809bff82fc5f",
      "cc94147b60cd4b158068bf04c5d31e30"
     ]
    },
    "id": "6637fe31-5acf-4d8b-b0ab-afbe33873d86",
    "outputId": "95896df4-1e2f-42b8-ed98-e81e1960ebb8"
   },
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "8fb6f2c84d40400ab2c93836f62497ef",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "CytoscapeWidget(cytoscape_layout={'name': 'cola', 'padding': 0, 'nodeSpacing': 40, 'nodeDimensionsIncludeLabel…"
      ]
     },
     "execution_count": 64,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "widget5 = neo4j_utils.draw_graph(subgraph5, stylesheet)\n",
    "widget5.layout.height = \"900px\"\n",
    "widget5.set_layout(name='cola', padding=0, nodeSpacing=40, nodeDimensionsIncludeLabels=True, unconstrIter=5000)\n",
    "widget5\n",
    "# Click in the left cell margin to select \"View output fullscreen\" for a fullscreen view.\n",
    "# Click in the left notebook margin to select \"Take Screenshot\" to save a screenshot.\n",
    "# To improve the initial rendering of the graph, rerun this cell."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fdad8ca6-cd86-4800-8e9c-686c1c24d683",
   "metadata": {
    "id": "fdad8ca6-cd86-4800-8e9c-686c1c24d683"
   },
   "source": [
    "## Software <a class=\"anchor\" id=\"Software\"></a>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "id": "c1d5823b-d516-4efe-9391-e8f9d9e26a1c",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 293
    },
    "id": "c1d5823b-d516-4efe-9391-e8f9d9e26a1c",
    "outputId": "d834b2ad-c031-4398-ff06-63a5985828cd",
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>software</th>\n",
       "      <th>description</th>\n",
       "      <th>url</th>\n",
       "      <th>developer</th>\n",
       "      <th>grant</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>dbgap-reporter</td>\n",
       "      <td>Jupyter Notebooks to analyze the number of data access requests for dbGaP datasets and publication including RADx datasets.</td>\n",
       "      <td>https://github.com/radxrad/dbgap-reporter</td>\n",
       "      <td>Peter W Rose</td>\n",
       "      <td>RADx-Rad Discoveries &amp; Data: Consortium Coordination Center Program Organization</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>radx-kg</td>\n",
       "      <td>Knowledge Graph of Digital Assets from the NIH Rapid Acceleration of Diagnostics (RADx) initiative.</td>\n",
       "      <td>https://github.com/radxrad/radx-kg</td>\n",
       "      <td>Peter W Rose</td>\n",
       "      <td>RADx-Rad Discoveries &amp; Data: Consortium Coordination Center Program Organization</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>covid-counter</td>\n",
       "      <td>Tools for counting covid sequences.</td>\n",
       "      <td>https://github.com/center4health/covid-counter</td>\n",
       "      <td>Rishi Graham</td>\n",
       "      <td>RADx-Rad Discoveries &amp; Data: Consortium Coordination Center Program Organization</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>auspice_radx</td>\n",
       "      <td>Web app for visualizing pathogen evolution.</td>\n",
       "      <td>https://github.com/DBMI/auspice_radx</td>\n",
       "      <td>Kai Post</td>\n",
       "      <td>RADx-Rad Discoveries &amp; Data: Consortium Coordination Center Program Organization</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>radx</td>\n",
       "      <td>RADx-rad pipeline for metagenomic data and analysis of SARS-CoV-2 from wastewater.</td>\n",
       "      <td>https://github.com/ZooPhy/radx</td>\n",
       "      <td>Matthew Scotch</td>\n",
       "      <td>Bioinformatics Framework for Wastewater-based Surveillance of Infectious Diseases</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         software  \\\n",
       "0  dbgap-reporter   \n",
       "1         radx-kg   \n",
       "2   covid-counter   \n",
       "3    auspice_radx   \n",
       "4            radx   \n",
       "\n",
       "                                                                                                                   description  \\\n",
       "0  Jupyter Notebooks to analyze the number of data access requests for dbGaP datasets and publication including RADx datasets.   \n",
       "1                          Knowledge Graph of Digital Assets from the NIH Rapid Acceleration of Diagnostics (RADx) initiative.   \n",
       "2                                                                                          Tools for counting covid sequences.   \n",
       "3                                                                                  Web app for visualizing pathogen evolution.   \n",
       "4                                           RADx-rad pipeline for metagenomic data and analysis of SARS-CoV-2 from wastewater.   \n",
       "\n",
       "                                              url       developer  \\\n",
       "0       https://github.com/radxrad/dbgap-reporter    Peter W Rose   \n",
       "1              https://github.com/radxrad/radx-kg    Peter W Rose   \n",
       "2  https://github.com/center4health/covid-counter    Rishi Graham   \n",
       "3            https://github.com/DBMI/auspice_radx        Kai Post   \n",
       "4                  https://github.com/ZooPhy/radx  Matthew Scotch   \n",
       "\n",
       "                                                                               grant  \n",
       "0   RADx-Rad Discoveries & Data: Consortium Coordination Center Program Organization  \n",
       "1   RADx-Rad Discoveries & Data: Consortium Coordination Center Program Organization  \n",
       "2   RADx-Rad Discoveries & Data: Consortium Coordination Center Program Organization  \n",
       "3   RADx-Rad Discoveries & Data: Consortium Coordination Center Program Organization  \n",
       "4  Bioinformatics Framework for Wastewater-based Surveillance of Infectious Diseases  "
      ]
     },
     "execution_count": 65,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "query = \"\"\"\n",
    "MATCH (s:Software)<-[:DEVELOPED]-(r:Researcher)-[:IS_INVESTIGATOR_OF]->(g:Grant) RETURN s.name AS software, s.description AS description, s.url AS url, r.fullName AS developer, g.name AS grant\n",
    "\"\"\"\n",
    "graph.run(query).to_data_frame()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d456a15c-d23b-4f5e-8b45-b3c744640489",
   "metadata": {
    "id": "d456a15c-d23b-4f5e-8b45-b3c744640489"
   },
   "source": [
    "## Presentations <a class=\"anchor\" id=\"Presentations\"></a>\n",
    "Presentations include poster presentations."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "id": "1b640979-c575-4bc2-b508-cd950235f0d8",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/"
    },
    "id": "1b640979-c575-4bc2-b508-cd950235f0d8",
    "outputId": "40e612cf-2fd8-4c8f-e59d-6168382ce8da"
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Number of presentations: 87\n"
     ]
    }
   ],
   "source": [
    "query = \"\"\"\n",
    "MATCH (p:Presentation) RETURN COUNT(p)\n",
    "\"\"\"\n",
    "print(f\"Number of presentations: {graph.evaluate(query)}\")"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "8232e7cf-dc0e-4890-9fbe-140d8d2572cf",
   "metadata": {
    "id": "8232e7cf-dc0e-4890-9fbe-140d8d2572cf"
   },
   "source": [
    "### Number of presentations by RADx-rad subprojects"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "id": "3444a1b5-857e-4f2d-8442-0fe703f7853c",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 449
    },
    "id": "3444a1b5-857e-4f2d-8442-0fe703f7853c",
    "outputId": "7354f692-4d90-4241-ab75-b8af464d0abd"
   },
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "query = \"\"\"\n",
    "MATCH (p:Presentation)<-[:PRESENTED]-(r:Researcher)-[:IS_INVESTIGATOR_OF]->(g:Grant) RETURN COUNT(p) AS Presentations, g.subProject AS Project\n",
    "ORDER BY Presentations DESC\n",
    "\"\"\"\n",
    "presentations = graph.run(query).to_data_frame()\n",
    "sns.barplot(presentations, x=\"Presentations\", y=\"Project\");"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "maf8_5h7balU",
   "metadata": {
    "id": "maf8_5h7balU"
   },
   "source": [
    "## Events <a class=\"anchor\" id=\"Events\"></a>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "hmCKewF7bfq7",
   "metadata": {
    "id": "hmCKewF7bfq7"
   },
   "source": [
    "### Number of grants that had presentations at an event"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 68,
   "id": "BX_PRs7yYsde",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 449
    },
    "id": "BX_PRs7yYsde",
    "outputId": "8868a44e-e76a-4744-c64d-7f5b8f2b8d0e",
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "query = \"\"\"\n",
    "MATCH (e:Event)<-[:PRESENTED_AT]-(:Presentation)<-[:PRESENTED]-(r:Researcher)-[:IS_INVESTIGATOR_OF]->(g:Grant) RETURN e.name + \" (\" + e.startDate + \")\" AS Event, COUNT(g) AS Grants\n",
    "ORDER BY Grants DESC\n",
    "\"\"\"\n",
    "events = graph.run(query).to_data_frame()\n",
    "sns.barplot(events, x=\"Grants\", y=\"Event\");"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "ZgQKxgknb3lm",
   "metadata": {
    "id": "ZgQKxgknb3lm"
   },
   "source": [
    "## Organizations <a class=\"anchor\" id=\"Organizations\"></a>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "FLKp9Lyxb7iS",
   "metadata": {
    "id": "FLKp9Lyxb7iS"
   },
   "source": [
    "### Grant PIs and their organizations"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "id": "CjvB04fKcJNo",
   "metadata": {
    "id": "CjvB04fKcJNo"
   },
   "outputs": [],
   "source": [
    "query = \"\"\"\n",
    "MATCH p=(o:Organization)<-[i:EMPLOYED_AT]-(r:Researcher)-[:IS_INVESTIGATOR_OF]->(g:Grant) RETURN p\n",
    "\"\"\"\n",
    "subgraph6 = graph.run(query).to_subgraph()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "SWaa0i1PdHEy",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 1000,
     "referenced_widgets": [
      "e553469e2cc64fa98f21cc0348bae46a",
      "b33a688eda9c41cf8df710985e83e18d",
      "baf558e380b8456e89873d6427cb3c6d",
      "7a9b641771ba43e88258d4cb6083736e",
      "a7e6b099883f4da28a9835c212e553f2",
      "e5c63fa2da76408f814d6f646dcf44fc",
      "3633e763499a4f6f806a48c8af45bbc5",
      "32f7b14aebb546d6bb8b91c475a21974",
      "60a57c8ee4bc46ac96993b0b5b9bb3c2",
      "893e474b000f441abda64045e33ff03b",
      "141fabf1b40a42a9bcb2f361b56d789f",
      "1834e62113624555a0d68a56fc891977",
      "11a8aa84448643eea3fa7b1d62d055ed",
      "52c9512e494d4a23943b4f8b8dfd2a4b",
      "55601f14d92f4637b9e5290060f85a65",
      "b9843769ba524c40a464eac97e5a5c3c",
      "ca27835ac6ef4db2b2f3b9733fe2bfc2",
      "0e1c77abb5c84aa0b586141410f94421",
      "08c968b21f654e47bdb3c33089b449e9",
      "5c266c4d293f428296a9118625a7ceb1",
      "00cf12231c8c4aefbeef31f02ae23924",
      "9e6cd49444794c3e886a2b0ddc282dc9",
      "a335219e425e4427a91b0cee958786ee",
      "ded7d45f6e6641989eb46c379fe1dfe0",
      "f2eaee0c45b84e7592c851816e2c0cfe",
      "6062e99ecc7a458f88bfde0ab9733114",
      "d3fe9b262fb94a159482691002b3e662",
      "c84c02a00e294c5c8f46ee07c4f01074",
      "3ce1dcf6ffed445fbeb8669d1148a278",
      "dde39af3e6814c86b610d7ed97ff3e2d",
      "6f6479c5241a48de88a495cc523181c6",
      "237dcb6cd55a48a092bb2ce096ea2684",
      "d7454e8d661841ffbf5693af760cd1f0",
      "0888f052942940a5b2bc91038b4332a2",
      "82757e9d877d47148702e1387212c806",
      "cbb72e96d5f342d4911c3709112e1ad5",
      "a8c3ea7ea6624294a0de0e8147d01264",
      "2bb1321999dd49339efab65309f38b19",
      "4fd2018ffdff46a495bd4297d433941c",
      "d9891ffaf3094fdeb79b322d46d19002",
      "fc43c828f1c4421493db965d2739dc5a",
      "dd0dfc06a1f74d8db5ae7e14de227535",
      "11bdc56bb4cf45009fbad33d2e1164bf",
      "cd5a52304460488d9c02b1a7b1375d9b",
      "d41b9de92987458ba057ea46f9ccbd9f",
      "85839bfe7dcd4826a69daca59fc66504",
      "ed5de39f86f4482487c9142812a27fe1",
      "412e0dbcef814cc3b2f5d2cf1ae29ed3",
      "5433f69777e6463a90be6e74a9c1dff3",
      "e045bb78855c415a984de28a9ecb7f60",
      "207100826c1b44cbbdab30b356ddd8ae",
      "26aaacc010e14066b37c239477f53f29",
      "5c85cee106fa4d9ca05b6333e5194df8",
      "4ee5eafc490f4b568501739b04bef4bf",
      "aca2c0308e50482ca6557c835dd50fd0",
      "8c55ec6387dc41f28be7f8dce6e005d7",
      "d6287c5f6928425aa5bed3c3216b4b0f",
      "a37e38f54e754b36856082fc24d617d2",
      "3198f8dd5f4f458b9b20a8a1a9a77396",
      "9214242b62854ba9b397fac83d94abe1",
      "0c9148b744cf42988159a1761cf53819",
      "409de1bc7341450d901cfa47619ce6fb",
      "b1fadcf15700472dbd898b1c50b59c38",
      "a99204b9354745e1b7c3e8a1baf76387",
      "415c0d90bd4941d9b8cc703d6455bbd9",
      "98a44bff2057401b999c607e3a1c0b88",
      "76af6419ff894a1cae908de40eae3ed2",
      "99e1e9d760ae4091b5a4502b0fa3510f",
      "77119576e1aa4a82a8eebc1d82ebad65",
      "485d6fb3fb9747a7b38edbf236839e31",
      "b581416fdd4a4a43b6a08b5503eeee06",
      "c793bfdfa5354c8aaecdeb62eb00fa55",
      "ba01ada40ede443aaf1e9d3178b860ad",
      "703368227ef04e80a95959844924d2eb",
      "f19ad7bd4f054812814f5a2c8571d32e",
      "b37cfadad4ed45f8853813fe2d8736bb",
      "dc72fa2b9359468faea89397a6c1fa67",
      "4ff488cb7f4d4e8b95ede40535e6948a",
      "2ce8df62941447bc9bad6be5adc1369d",
      "4bb6f1a5e7cd4c7381cbbef29a1e8efc",
      "dda49b6d522345d380226bb5338e275e",
      "c0afd95bb3d3423bafe5b64a376dba38",
      "6ad181d199524f7490a1e5b4492661f5",
      "1cdf9db0e85f421780975a3c60256dc7",
      "bdadcdb137464e63a36e0820d73088b4",
      "fb310da446fc4125a0773165f2c82a91",
      "04c8117c3597441a9d9fbf80740fa7ba",
      "74254dbd3d2a42008848c4d63ebe384a",
      "c26592d8201a4d26a08bd45529da6867",
      "d95e75ad59e44e1882a2947fe4716f5a",
      "f9f16919e10247bfa4c6c1fe04135bf3",
      "9b5cedc5bada4887ae1687c74934743a",
      "d61077757ab8431196de3b93d611623a",
      "62924b2e73c7403ebdee907b89d0e280",
      "800b5a40dbd04bc996664b5999797b95",
      "da3e7c28cb864b4387d273d4e554a244",
      "7357295139d34211b86f3ae417509f63",
      "f1a33c4d2d4a4301aa2cc5f23e56b54b",
      "424c68a20a2f4102854410b89701cf6f",
      "1fffe6e9e1f64ff4b9b9e8a5d47e5576",
      "23548ae34ce74aeb8c86b04357b28fab",
      "64e8cced9718463ab3af8f22dadfb9a6",
      "eb84494c22fd4edf88e09a58f72ae772",
      "ff42b2625fc1478ca707807a4a598e83",
      "85ebfe708e324154b851352872349416",
      "ef923a7c7bce4bb28c0e3fee270f9cdf",
      "d7c851a9284a41c2a8426cdee0986bf6",
      "e310e64666b6444d8987a0d56d2d4fc8",
      "d4d3fb0b1f2b4925981e889193ae5985",
      "50d53c7b3f7940fcb267c48bf649e122",
      "eda9ff5cf17741df89ef7bc63bfc076e",
      "fda404ba1fef4d01be4f42822d09b6cc",
      "47cf3bba69cf40cf9a1feed8e40c3a6c",
      "96e4007e116d4b608374d787cf93a469",
      "ff79ae5c1e8f4642a3d57941c5e247d7",
      "8c741ed6f6e24b15b576154c5852a356",
      "4d1a960c267d4960986599f9f440f739",
      "feca05b1593349279a716957b204af18",
      "4b530f294bce4e1784d7f5cfaed5e6a2",
      "a281780730c0412d876233ed27764ede",
      "037c33e4c41144f0a6fe4201bcdb8e36",
      "4f7ae767f3794eeea6d5036f07d73083",
      "aad7ec166c8d4934a9c98b7ba72a9eaf",
      "5d21914cd4154e9ca96c86fbff4ec53f",
      "18882e21898f42b6b50a5e63243d8b34",
      "48c64d5c2042466db3eb64bd83207df1",
      "3308cf6b352c429486f27df857d63057",
      "4db0a15547c046e4b77e01dde5e25995",
      "f8c5d315a2254cb69dd728e3ee28d89d",
      "594a95410c3f49c1923c365db327b696",
      "1d60908481af4b6cb2d38dc43ee0928c",
      "b9f5a5d011ab4769a5f9645ec7f78b33",
      "4a06eef08f884afeb994a75e0158d5fa",
      "3a2783123d724c63aeb596f566b694e1",
      "eade7fbd3b9a411a9a89da1d1f62ad4b",
      "442c9804630c4e889147e4d6c219dcaf",
      "0a286473b68c462e819ed8d09bd82e21",
      "16e4f26eb6e24e6086b993676ec08155",
      "9e5f82ac92de4a9ea94c91f45bdfd538",
      "61b855bab3f146959117db362b0409ea",
      "5697e1bea5364f449b8d4320735cd99b",
      "84b4a04080e2453ab70279f08a9bd44d",
      "b6532c02cc144dd1846c574f3e0ddaca",
      "8b5db1b883f84d0ea82bf3d1e302e01d",
      "72a0ed43e3fd4a33be7061ac6b5271b4",
      "011429e2729d4b04a80400064905d434",
      "8c21c54cf1634e6290548f7cd48a1ddc",
      "788bd1b871e74ff1873a4ea2632124c3",
      "93d34947740e4a9b9705c6539a4cc708",
      "d7c2ac80b1194a2ea747c91b43ae4b6f",
      "9a6c2d5b48f041f0987177e973be5184",
      "7f29a1cc3a9e4d9fa64a3d8890af5070",
      "a66222c957aa43c9aef1560833f5afa7",
      "12d812d34dec4a7eb3b109de40098a93",
      "3908f1887ff34db59985917ea4155361",
      "0a5e32b0cb6544d295814de3a5981300",
      "2ebb4fa54d7746f28599f73f01dd2665",
      "db58fcc3b28d45f694fcfa7e2918f805",
      "76bd0ba97dc44f3f95d9f08ff2828972",
      "0d5747b3337c415891102617790ad3d3",
      "8f5c50749d4d45c8af42b55b8efbae63",
      "3c27bb597a8e43d4be219d92dab56953",
      "5cb286764b4c41b1a835b6b81bda195f",
      "6937a395b29640479b78494849cf254a",
      "49d3f7ae0e4644a2b8a9bbada29b34e5",
      "98e8e69168874bab97248c03e1149028",
      "dfd9f3fac6b74747bcb75dc96fc9f3bb",
      "84ca6711d27c4712a1d53594ae529d72",
      "8a6343f0b72a458d83bba840a2ccf16b",
      "1a07fac7c1154c31a1961d09d64fff66",
      "eec1254869ca4f4a9d106d560cc938aa",
      "617f4777654348329d0d99958e44f1a1",
      "fc2aef5ccb7444cd956fc1a1c2c7c0b9",
      "31993384bc244d36a62064a43856e818",
      "7aad80129d2945fc858848e17ba95ee5",
      "dbd00dab449540c2a704be82cff4a1a6",
      "543ef5f99b824195a8dc790625a26649",
      "b73d73d97aa144c19705ae3b224c4c94",
      "658de15459cb48ae8aa4ac0a79bb2ccb",
      "c5cc29bfbc3e4da7989e99cdf983f09e",
      "cfece3ed91c944c3be43f5a490828782",
      "feb605097beb408fae30d4673275b044",
      "cdf0ad068d1f4ffdbdadd842fd64ae6d",
      "9ac80b6f143a4297ab96975351cb09b5",
      "5db68871f530459ba2075f9384ab7e7a",
      "2e7ee267ba51431f856fe65bd4028f6f",
      "75ac9c100a9f419185cb3f5b72ea3c82",
      "0be6071ed57349ae8aad37e4f01f9af6",
      "da3e500fe98d4ded89851a01662a0c03",
      "7cda1742ece14264a5d6ffd89a064e14",
      "da7de2b2d1bb42bf8a79f666d8f782d9",
      "f71ca59245d24c258c08765efde968d0",
      "8a2c178be4a3472d9c60111cfa71e1a3",
      "c5717d6f003f4d58a7567e3084270176",
      "fff54eaeda7f402aa15ba54112a1cde4",
      "27ef892186e94689886e8704a2dbca31",
      "388bb64576ef4d3abeca337562ae6a94",
      "4c39a9f6adea46a3b443e83dba9550db",
      "3f41d1b6819347e699280da0c639a672",
      "ba5c069c8aad4c9b9bc4bc7b017e8c14",
      "c77e29d723bc4acc9ae646abdfb1f089",
      "6dbce0bc0fdd4c14a17ceefc273a8eaa",
      "29833c22ca5a49beb35c01eaf048cc69",
      "0db5e9d2df0c49518873eec30cc70e9b",
      "e277f7e913394386b7037912d8a49ad8",
      "8944b3400fa14230bf527a34b0f4fbbe",
      "78fe7dd68c844358aa22b5d95ea73254",
      "4067115d9254407e963de6eccef4eea8",
      "d03e84a2edb241189e25c19a5398aa58",
      "531783059b65433f8d3adda7b6fb4561",
      "b8b23ecf236c4f54ae77afad289637ec",
      "d400ad1471474656964038013f39ad88",
      "c6ed0f9fd5024080b657d165ab252c5c",
      "5da542ab2eb7444a90fc7e4c8edbd53f",
      "de8272ebb0404ebbab3c03a8658ca93a",
      "c049a979b5ef498e8b9105de81567c33",
      "eb51efe97dfa404b9e32ade6e01159e3",
      "4c7b76e6b7ee4592b1d7299dc96e0a54",
      "624096d498e04a35bb94c0b3fb735c08",
      "9e297218b93044c88c283dd164031858",
      "05e46279b713445eb67d7d67067f87ec",
      "ad0e2258663b466794b87b2727df9e08",
      "a9db4a3cc0ad42d6a42f8e162c38631c",
      "35400ef814654591833a05153f87be60",
      "6a12176566ce4d3fad6e308144b46305",
      "c680918223f84435b44d71eeb833bab2",
      "e7fb906f13624acb835d1164f1cea470",
      "06886727aeb3473d80b77c2ec4e5ab6a",
      "e8a40c87bdea422ba83f5696268e112a",
      "fb134e02e5964bd9a957416eaf8b9116",
      "12fcd1c29d8e4e5882bad438f27cd2ae",
      "8d79dd74babd4fe7b2e4e8b59d77e97a",
      "20f497ec387b48899616812f93822275",
      "abe5a1fa9c8f407c8047e91181d159ca",
      "4a01b0e23f28482a951321eb0f411915",
      "0a6a03df00ce40a1ab41aa89b9196556",
      "9ccd9f5f2ca14991bd863973412a6106",
      "4d8b211038dc47c38026c9a9180a832f",
      "e46fb05b8d664c53ab1863ae37d191a9",
      "f1b603b469de4449a44c79a6cb7fef89",
      "e0344b8805b541ff9cda6a5b65e92153",
      "63e3e5e1f38c47b29063b7fbd3036c60",
      "64db2c89b9ef4225b9bee921b63a3fd4",
      "2bca1441c11f42468ee132695d6dc462",
      "ce755e7a9ed941f99e2f2b791370f4c0",
      "5e77622878b041c8aa0305f54d8f9b29",
      "fbea21b09ac14d5eabb61176bd87d7e5",
      "d8d03169bd74488c84491f8f09e12fab",
      "14688fb88db444428b3a44ef12aff913",
      "221824a0b9d0415eba39d1c4e781a029",
      "10daead9e9ed4a669ab9404a44332142",
      "60f98c26be15478387419ae24591b406",
      "2125845b5d4f4b57b726a777ca273203",
      "1628c5b4deba42c2a5a4c5f82d26723a",
      "6f83d13463d242f0a08cfc265b592710",
      "86e4c84334fa45479da5914b8f08514f",
      "eed56dd822d6499e891834ea1eb35d44",
      "82950e2f33594911ae76ea77d55ca1c8",
      "3b03839d36e84a789700a36f7b74dae2",
      "a6128e64075b4ba69013c62cb3fb37ce",
      "f56721e7678b496791d5f2c685dc87c7",
      "262c29a5d5ca44a39a23b832eb0bcce5",
      "8f8b609b8d44440286670bae5188aee7",
      "21ce7314a96d49cab6455bc6f5520ab9",
      "12cee346c2694aaea7e2b3698cc81fd1",
      "33cfed3fceb446a790243268b3839887",
      "4949a7add02b4839b0c3da1ae4d3070e",
      "71360d44e3ac4e5b95385bc14fe9b9dd",
      "de6841351305438fb8a46da9fd6171e4",
      "d1c30c898b7a4765b3959d68795d245c",
      "11e9c892b29d49d29a7a7ae61e14f6ab",
      "fd880dc4f3344957bf47d8d46b1b94f6",
      "89e26da092c44387a25064ff9468e02f",
      "35cc5a19576044019ded467afe827486",
      "c610d95235074478acc1312cb717a94f",
      "6b5b523ad8ff4507973037b785b8525a",
      "f73ce55c934844c4a7902ec953e7078b",
      "620cb08a8e854e65a71cf52b0d183b84",
      "46f540d502a44db4acfeb3ed789b1a5b",
      "6ebed678670a4da79d1dd4bef73d5d27",
      "480c0c44b4ae4ba8aca9b9409ec817fc",
      "75cbf4cc8f574af597653a7a819f1fc9",
      "427703da5fec42a0a91226eaa9671e76",
      "0caa3a29db4e4d4bb6e47b3d1c251eb3",
      "d54e55fd859147bbad7fb0c3e8863a4e",
      "c76889d0de584e4b844982ad37083bbc",
      "6252f853f1f54556beedd0750a651423",
      "cbad7eca01984ba9a415a43247d87394",
      "088aff68ba3741179db0026867487d0a",
      "d5618f50fb5a4128a398340d3db76e65",
      "59494326f9fb4488a9c2c721223c9b04",
      "2f0e2975fc98450e93e00f12ea2e4dae",
      "69798cfa85fe4df99a49ea8272342468",
      "8b29a65692b94f938c56318c0f205479",
      "637559e8f35c463293bbd9b98df551ef",
      "b97da88f891f47dcaec2df5b2bdea92a",
      "8917f075488b408da5a49a4c5425389c",
      "4c7e4ea208c34e70a35906d9098bacb4",
      "0f9f7925d53546d9bb6a73a973ebb2c2",
      "89b6a63e5ac94c5cac9d63a5c53e536f",
      "71b5185343d440d19c1761c7aeb86b80",
      "eb540ecb7c6b4dc88b97c763ae3218f7",
      "aa679fd5330d4227a354b03a5c2f6d8a",
      "32077933642f4a5fa329134e9bc33368",
      "850eb7e9fc6a4c26948d11cf10ad789e",
      "47e702a1c6714029bb6d8cea694f1653",
      "71ef27307e074c2ba1f44b16ec632529",
      "12f76ef59fb44c1daeadbdcb7ff2c24d",
      "14008564563144498ff70087c1cee680",
      "11fd07d11f6e42669330bf5c5184c727",
      "62da5eb5b59d4489bbda7915c58b2e7e",
      "1cba806b5945468ca13482f04717cf64",
      "5c7d76b21b01471980087ab1953cf68b",
      "c787ddb5552542368423117788900006",
      "053b4bd0888f42708e1c180ede4a932c",
      "224028fcf90a409f89a3a77c03806ebc",
      "a6528203745e4789843202c04f52c65d",
      "adbf5469a60a4f3a9a416170807a7e39",
      "e1885e9a6f80441eb8ae6bfa410a85b1",
      "7508fb4ed6834fccb508dab6fdf7769e",
      "d89ec995cdb148c88524e2599a8da049",
      "940602eec24c469b90d0dfa46397abbf",
      "adf214c2ae644af096bf77d635d7d8c1",
      "43bd243d5ee34296bd3d10b535bb2c7d",
      "63c542f7f57c48fda6b10885ce866f08",
      "4d2b63b086c64cc88723affc5b5bc791",
      "f7a6637c47454d349f991487540e7417",
      "1608b6547f364109a3f1d5da1823d0dc",
      "53b91e723b3e4a67a0a3324377250953",
      "a0657a5d34ed4b55be2c3592768950c8",
      "820d58a8882c41768aa6b0f13f091e37",
      "84cc9bcce4cc49f2a3870f9d760854e0",
      "813df8c9618544959d83cc5a8b3ee45f",
      "87b574955b6f4d5995d08d5b9aa76cd1",
      "964ff70063c4427183ebca314257c07e",
      "3ceec56c34f640b9845e08a9912022f5",
      "cb37789e22c045bdb76667a85656da8f",
      "a34e981a93c74af9bbd3d33dff0fefba",
      "e2f9c18f7b704a7a9899a67b03de2d07",
      "0e8750e80948471482d620466a72d25c",
      "fec0627f01804f4fa2be300f78f1ac40",
      "0e1a08cc87a44b6da57b3d677577359e",
      "a2b19046a58440f29dbfe36aa4852c85",
      "efda262f928d45c3a1812c141244a2b2",
      "8408044d485544fba3b13a6f03d8d687",
      "a20f66b23a5a48b5830f0a89d7faea37",
      "82df30c73c1f4803b4fc0ffcbab9028f",
      "2e878a250c024ab38cb864576b8fba28",
      "e0e8ac190c3743e3a94a77caaeac7f1e",
      "aaf9e860fc1f4c489bff24d592e6ac71",
      "faa0cd4ec2fb48119c2a6f1699eec2b1",
      "a6aa91d8315642a89fd29f2db3892b72",
      "9074eeb2da4e474abc0f65c6885891bc",
      "e777c8d0d56048e7a31fbd2d5799d12c",
      "280a9d092b504e40a5ece81141b5ff80",
      "3458991d87fc49d19351014b04c27c65",
      "9ee3615bb2c449ddabc43ec40577758a",
      "3639c4f735d74774a247a0dff1a4dc5f",
      "6618e9ae950046328aa3c5fcf197f1bd"
     ]
    },
    "id": "SWaa0i1PdHEy",
    "outputId": "f54731c1-6bf3-4b0b-c0af-16d647b6f12a"
   },
   "outputs": [],
   "source": [
    "widget6 = neo4j_utils.draw_graph(subgraph6, stylesheet)\n",
    "widget6.layout.height = \"1000px\"\n",
    "widget6.set_layout(name='cola', padding=0, nodeSpacing=40, nodeDimensionsIncludeLabels=True, unconstrIter=5000)\n",
    "widget6\n",
    "# Click in the left cell margin to select \"View output fullscreen\" for a fullscreen view.\n",
    "# Click in the left notebook margin to select \"Take Screenshot\" to save a screenshot.\n",
    "# To improve the initial rendering of the graph, rerun this cell."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "dYsBKlF5ihe7",
   "metadata": {
    "id": "dYsBKlF5ihe7"
   },
   "source": [
    "## Funding Opportunities <a class=\"anchor\" id=\"FundingOpportunities\"></a>"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "YvwljvVsgB-5",
   "metadata": {
    "id": "YvwljvVsgB-5"
   },
   "outputs": [],
   "source": [
    "query = \"\"\"\n",
    "MATCH p=(f:FundingOpportunity)-[:PROVIDES]->(g:Grant) RETURN p\n",
    "\"\"\"\n",
    "subgraph7 = graph.run(query).to_subgraph()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "8-X491LNgf9l",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 1000,
     "referenced_widgets": [
      "4f8bc5f63abc44de9016f68e77ca9068",
      "bff50d396acc4dc89676f6b5d9b9db81",
      "a6e59a8c6d9e456db08fafb84898dbe8",
      "e02bdd20b233481e80d2dd89a3c95c08",
      "5210b05d066748a98998cd359b851fa7",
      "cb39a338672847069ae38ceff479a83e",
      "0781f4e63aaf4ce4ba3e811ea6db0f15",
      "6b438fd2c1c04ec2b1329cd6d935e6b4",
      "a750b5d72277492eb261dea02ab193b7",
      "710b1c06ebbf4cd1bdfb28dc9c505064",
      "8609b22c68154d7c864e3c88221e1362",
      "a2300cf72e814b57afb53710786ef9bb",
      "fa771f2a57eb4582916d612877677820",
      "6545e007005d42908c4151e5b3b03706",
      "260932de672941838e1ba550c1905aee",
      "cf3732029b3c4b838cbef7e3e25df749",
      "162dfabf3a9c4c2590297ad583f0290f",
      "0aba3c9a00e9439a8874a60244b1e6c1",
      "e1e226c8eb934022b2ab763e29231f7c",
      "bf36fda6ba0446aca415156cbb30351f",
      "d31693c77441460bb19ef4cccf7bf451",
      "55c9d3a5095c4755953eab3c033c9aed",
      "efc631d1ff66437bbb39bcd7c6eb4f75",
      "b996802ced8d488eba3d931d53ff07bd",
      "a24be9e94ac44db591fc2063638d2a97",
      "0f73cec4f0944a58b2fc73b80a2fe1ff",
      "00809169217d4075979e6a39d54fc5de",
      "6d1a9221321f470baf4cd2d1f3b8f525",
      "177f961967144fb0996aa52eda050bef",
      "b4e1216477674d58a042f43cfd6bfd0d",
      "403e95d7218649ca94f61fbd0d2f5ab7",
      "df8fbee325c741c98d6bfefe7cc3df85",
      "332f60fc81484a509b4004db830e0c3a",
      "f134cc9509c64b5c9a7472d9d7bb745a",
      "503ee802172b40abbdbc64e8d3e7f5be",
      "392ccd0cb70f4534aa317b28f546d3ec",
      "78c5ffa0ce81463b8f43df35f273b08c",
      "34cb75bf96de49b4940498b486f72cc4",
      "d6aef18847f247f8a37cac9450879e76",
      "610c98e6bd8849c3ab65cb5de6108ca5",
      "9dc7be13aff54f6aa31c350bed79d81a",
      "9cba3bb711624416a0531eca7cbe82b8",
      "d18d4e1e926445f697e97575a83593ad",
      "6af6a5d62668414ea57a099d8f8a4c0c",
      "44efcb185c1a428fa7c6c260accb6559",
      "ae9b29f2b1f84a18b0786edd7bef93dc",
      "9bad284206f3492ba038477dd2c9bb30",
      "f3e13c14a1d246ceb784929efbb95cb1",
      "85f9415be7b64f8eaf384db47c1e92b1",
      "9dbcf7edfaa641ea97ae570f06cc2904",
      "addf182acf504f31b435aef6567fe114",
      "da0085b114b748ce97ed5f009493773e",
      "ec77499e249d4e679cb3d8a9bf2bf3af",
      "a47e2a6ab1f14029bbe60314171790cc",
      "095285a5783e42fc9b25863470a74da7",
      "15f9786339474ffc9a3647eb7c4c45c0",
      "0537bb6129f445d19a11df95053327d5",
      "4776239192e64fb696a483e6932e858d",
      "b4b8114c7d354cca82b9a7c9876e75b5",
      "e44992a9bd664907b594a5267faff114",
      "13e73a5359b245898faa12ca92a7f650",
      "f69d39fc979a400fa092eda07b91141a",
      "ceafb536e4504d91a8429e6c1d0477a1",
      "c0ee0f2337334a32b4cc86167e099308",
      "27ab51974c714eb1a053f248f309f9e4",
      "e0f6d0dd8cf44185a320d996428c864b",
      "c5f10c29d7814955993ff52237901df1",
      "1ca3066361054234bf3c3941e917df53",
      "1541ee25c33f4a0e9e943f042865e368",
      "5b9504dfcb534b76b0a5633bbc1ef94a",
      "e7449fc4515140c68056a95efd44b3d7",
      "0c9512d4bdee44cfa55f7d8f9c209341",
      "763cf66684c94965824f1455a4a564e9",
      "173e15349f964bb1967748066c70c9eb",
      "ad7ce2a04faf4b839a0eb9c9b62aa299",
      "155562df1fb34cbbbf93153c59977321",
      "084674816fa64339a4ef9934920ccf28",
      "3e1e6cfe0bed46e094105960b5344301",
      "3816f93ad4034181978a907d95561820",
      "774ae19b061f486c94e89b44ecfd38b3",
      "9d893a603f844e7c803a7b449f1bd918",
      "9788c70579e340fbbc64cadf07b8f8c8",
      "5a49d55c63ca475fa524f87ad6210b5d",
      "f7f97e828f8a4149a8a7818abf7088e3",
      "30a6c41d28af4aab83d7497502f04414",
      "c047074f123042c2b0dfccb45a9b122e",
      "d66284811ba748c2bd7d879b1d7dbc71",
      "b182aa0efe584e7fa162fe395f2ee94c",
      "9530610dfd864a0f84cb1965b8f28086",
      "344df15d60944c9fb93d627eede7ff9c",
      "715902625a3f421ba44a76783db07191",
      "c3842b8a552d4961a3fc6b71cec4438a",
      "caf5ebd4f0ca4b8b97b9719142e2a782",
      "9eb20933d511449cb9686fdc2a553ba6",
      "f49e98e4331245e9b86a95b849c432b9",
      "254507028a684e45aa18b9233d45d4eb",
      "2c638d505e2542b5ac926f9c7e57796a",
      "a5a7b008120f46eebe7415f69de0981a",
      "d7844c6096f74218a755bc39bc7a5594",
      "e43f215a1b9c4ac09a856034b5a0f51e",
      "c30bd8ca75a0426083b475d77caed828",
      "5cebde752ef946b98cd3984d310109c1",
      "520c4348d9264dc4a5b0dec1177d897c",
      "fdfbe7585dfb40f6a35cd3f70ff47c2b",
      "95de76b5a9644e73a335a61d9c74588a",
      "5002a394e15c45cb87eab4d4a04db62b",
      "98584bb631f24f98ac553fda05dfb07b",
      "6a85553c6d11421ea2fd89701a16c349",
      "308222f895b440a083e99238b7ff5f4e",
      "8d5b898fe3614182a61273e394402e06",
      "817af41834d548c09750b337c7ca8ce2",
      "ca6c7af7239a4d3db3fc426e35e9c0bc",
      "bd9dc884dbd24e3c88f83f34712c34f2",
      "f5430260dcc44d4caab0fa323a6dcda5",
      "a918d31d1c89400984a873d4f108437c",
      "f799df5e1c22467ab9e0a3f3847b9825",
      "1790cbbc6b3f44e2a564c185b973d483",
      "27da58b9d88a4b0b85af43831f0cd420",
      "52d03d2ec9b848e5b869842dab2d0e99"
     ]
    },
    "id": "8-X491LNgf9l",
    "outputId": "ddaba5c5-1f1e-490e-e700-7a224f17ca81"
   },
   "outputs": [],
   "source": [
    "widget7 = neo4j_utils.draw_graph(subgraph7, stylesheet)\n",
    "widget7.layout.height = \"1000px\"\n",
    "widget7.set_layout(name='cola', padding=0, nodeSpacing=40, nodeDimensionsIncludeLabels=True, unconstrIter=5000)\n",
    "widget7\n",
    "# Click in the left cell margin to select \"View output fullscreen\" for a fullscreen view.\n",
    "# Click in the left notebook margin to select \"Take Screenshot\" to save a screenshot.\n",
    "# To improve the initial rendering of the graph, rerun this cell."
   ]
  },
  {
   "cell_type": "markdown",
   "id": "rvUjukkQjCUm",
   "metadata": {
    "id": "rvUjukkQjCUm"
   },
   "source": [
    "## Grants <a class=\"anchor\" id=\"Grants\"></a>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7JMj0sZMjGHs",
   "metadata": {
    "id": "7JMj0sZMjGHs"
   },
   "source": [
    "### Type of Grants"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "S3oTAevEjKLJ",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 449
    },
    "id": "S3oTAevEjKLJ",
    "outputId": "9a3c49cd-b4ec-465e-9da3-cd17d612deb4"
   },
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 640x480 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "query = \"\"\"\n",
    "MATCH (g:Grant) RETURN DISTINCT g.awardCode AS `Award Code`, COUNT(g) AS Grants\n",
    "ORDER BY Grants DESC, `Award Code`\n",
    "\"\"\"\n",
    "grants = graph.run(query).to_data_frame()\n",
    "sns.barplot(grants, x=\"Grants\", y=\"Award Code\");"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "2Qcmp_gIizxc",
   "metadata": {
    "id": "2Qcmp_gIizxc"
   },
   "source": [
    "## Fulltext Search <a class=\"anchor\" id=\"Fulltext Search\"></a>"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "76726091-e244-49bb-a659-7d98cb5abfeb",
   "metadata": {
    "id": "76726091-e244-49bb-a659-7d98cb5abfeb"
   },
   "source": [
    "## Full text query by keyword\n",
    "A full text query returns all nodes that match the text query ([Query Syntax](https://lucene.apache.org/core/5_5_0/queryparser/org/apache/lucene/queryparser/classic/package-summary.html#Overview)). For exact matches, enclose the phrase in double quotes, e.g., ```'\"aptamer\"'```.\n",
    "\n",
    "[Learn more about full-text searches.](https://graphaware.com/neo4j/2019/01/11/neo4j-full-text-search-deep-dive.html)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "id": "afa6352a-5a26-432c-ab15-570de57cad1c",
   "metadata": {
    "id": "afa6352a-5a26-432c-ab15-570de57cad1c"
   },
   "outputs": [],
   "source": [
    "phrase = '\"aptamer\"'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "id": "04fae75e-8f9a-4fde-b2ef-864d44972c0b",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 520
    },
    "id": "04fae75e-8f9a-4fde-b2ef-864d44972c0b",
    "outputId": "1caa1fa3-1bc2-4777-c6b1-ae938829675c"
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>type</th>\n",
       "      <th>title</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>dbgap:phs002702.v1.p1</td>\n",
       "      <td>Dataset</td>\n",
       "      <td>A Scalable Aptamer-based Electrochemical Biosensor For Rapid Detection of SARS-CoV-2 From Saliva</td>\n",
       "      <td>1.623665</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>R44DE030852</td>\n",
       "      <td>Grant</td>\n",
       "      <td>Designer DNA Nanostructure Based Biosensing for Rapid COVID19 Detection and Monitoring using Saliva Sample</td>\n",
       "      <td>3.178712</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>R44DE030842</td>\n",
       "      <td>Grant</td>\n",
       "      <td>A scalable aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2 from saliva</td>\n",
       "      <td>2.955715</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>R61HD105590</td>\n",
       "      <td>Grant</td>\n",
       "      <td>Diagnosing and predicting risk in children with SARS-CoV-2- related illness</td>\n",
       "      <td>1.709620</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>U01AA029316</td>\n",
       "      <td>Grant</td>\n",
       "      <td>Touchscreen-compatible, real-time electrochemical sensing of SARS-CoV-2</td>\n",
       "      <td>1.514202</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>U01AA029328</td>\n",
       "      <td>Grant</td>\n",
       "      <td>Development of an Automated Diagnostic Platform for SARS-CoV-2 Monitoring in Vulnerable Areas</td>\n",
       "      <td>1.472854</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>U01AA029348</td>\n",
       "      <td>Grant</td>\n",
       "      <td>Detection and Automatic Privacy-Protected Contact Tracing System Designed for COVID-19</td>\n",
       "      <td>1.132639</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>982f2b070830a8bb88ace0042d0100db</td>\n",
       "      <td>Presentation</td>\n",
       "      <td>A Novel Aptamer-based Lateral Flow Assay to Detect SARS-CoV-2</td>\n",
       "      <td>1.828435</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>f10c31d02026ef92e1edd49fbd367226</td>\n",
       "      <td>Presentation</td>\n",
       "      <td>A scalable aptamer-based electrochemical biosensor for rapid detection of SARS--Cov-2 from Saliva</td>\n",
       "      <td>1.623665</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>doi:10.24425/pjvs.2023.145056</td>\n",
       "      <td>Publication</td>\n",
       "      <td>Application of aptamer-based viral detection in animals.</td>\n",
       "      <td>5.151329</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>doi:10.1021/acs.chemrev.3c00377</td>\n",
       "      <td>Publication</td>\n",
       "      <td>Aptamer-Protein Interactions: From Regulation to Biomolecular Detection.</td>\n",
       "      <td>5.112577</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>doi:10.1101/2023.11.24.568626</td>\n",
       "      <td>Publication</td>\n",
       "      <td>AptaBERT: Predicting aptamer binding interactions</td>\n",
       "      <td>4.982814</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>doi:10.1039/d3sc00439b</td>\n",
       "      <td>Publication</td>\n",
       "      <td>Aptamers 101: aptamer discovery and in vitro applications in biosensors and separations.</td>\n",
       "      <td>4.885930</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>doi:10.3390/bios14010056</td>\n",
       "      <td>Publication</td>\n",
       "      <td>Sensing Levofloxacin with an RNA Aptamer as a Bioreceptor</td>\n",
       "      <td>4.856410</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>doi:10.1021/acsptsci.3c00258</td>\n",
       "      <td>Publication</td>\n",
       "      <td>A Universal Aptamer for Influenza A Viruses: Selection, Recognition, and Infection Inhibition.</td>\n",
       "      <td>4.774807</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                  id          type  \\\n",
       "0              dbgap:phs002702.v1.p1       Dataset   \n",
       "1                        R44DE030852         Grant   \n",
       "2                        R44DE030842         Grant   \n",
       "3                        R61HD105590         Grant   \n",
       "4                        U01AA029316         Grant   \n",
       "5                        U01AA029328         Grant   \n",
       "6                        U01AA029348         Grant   \n",
       "7   982f2b070830a8bb88ace0042d0100db  Presentation   \n",
       "8   f10c31d02026ef92e1edd49fbd367226  Presentation   \n",
       "9      doi:10.24425/pjvs.2023.145056   Publication   \n",
       "10   doi:10.1021/acs.chemrev.3c00377   Publication   \n",
       "11     doi:10.1101/2023.11.24.568626   Publication   \n",
       "12            doi:10.1039/d3sc00439b   Publication   \n",
       "13          doi:10.3390/bios14010056   Publication   \n",
       "14      doi:10.1021/acsptsci.3c00258   Publication   \n",
       "\n",
       "                                                                                                         title  \\\n",
       "0             A Scalable Aptamer-based Electrochemical Biosensor For Rapid Detection of SARS-CoV-2 From Saliva   \n",
       "1   Designer DNA Nanostructure Based Biosensing for Rapid COVID19 Detection and Monitoring using Saliva Sample   \n",
       "2             A scalable aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2 from saliva   \n",
       "3                                  Diagnosing and predicting risk in children with SARS-CoV-2- related illness   \n",
       "4                                      Touchscreen-compatible, real-time electrochemical sensing of SARS-CoV-2   \n",
       "5                Development of an Automated Diagnostic Platform for SARS-CoV-2 Monitoring in Vulnerable Areas   \n",
       "6                       Detection and Automatic Privacy-Protected Contact Tracing System Designed for COVID-19   \n",
       "7                                               A Novel Aptamer-based Lateral Flow Assay to Detect SARS-CoV-2    \n",
       "8            A scalable aptamer-based electrochemical biosensor for rapid detection of SARS--Cov-2 from Saliva   \n",
       "9                                                     Application of aptamer-based viral detection in animals.   \n",
       "10                                    Aptamer-Protein Interactions: From Regulation to Biomolecular Detection.   \n",
       "11                                                           AptaBERT: Predicting aptamer binding interactions   \n",
       "12                    Aptamers 101: aptamer discovery and in vitro applications in biosensors and separations.   \n",
       "13                                                   Sensing Levofloxacin with an RNA Aptamer as a Bioreceptor   \n",
       "14              A Universal Aptamer for Influenza A Viruses: Selection, Recognition, and Infection Inhibition.   \n",
       "\n",
       "       score  \n",
       "0   1.623665  \n",
       "1   3.178712  \n",
       "2   2.955715  \n",
       "3   1.709620  \n",
       "4   1.514202  \n",
       "5   1.472854  \n",
       "6   1.132639  \n",
       "7   1.828435  \n",
       "8   1.623665  \n",
       "9   5.151329  \n",
       "10  5.112577  \n",
       "11  4.982814  \n",
       "12  4.885930  \n",
       "13  4.856410  \n",
       "14  4.774807  "
      ]
     },
     "execution_count": 37,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "query = \"\"\"\n",
    "CALL db.index.fulltext.queryNodes(\"fulltext\", $phrase) YIELD node, score\n",
    "RETURN node.id AS id, LABELS(node)[0] AS type, node.name AS title, score\n",
    "ORDER BY type\n",
    "\"\"\"\n",
    "graph.run(query, phrase=phrase).to_data_frame().head(15)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "1ab781a4-170e-4549-a745-e7ecae6d8e31",
   "metadata": {
    "id": "1ab781a4-170e-4549-a745-e7ecae6d8e31"
   },
   "source": [
    "## Full text query using boolean operators\n",
    "The full text query supports a variety of query types, including fuzzy, proximity, and range queries, as well as boolean operators ([Query Syntax](https://lucene.apache.org/core/5_5_0/queryparser/org/apache/lucene/queryparser/classic/package-summary.html#Overview)). The following example uses a query with an ```AND``` operator."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "82d1eb18-eeec-4a5e-b40d-46f0e3c5e802",
   "metadata": {
    "id": "82d1eb18-eeec-4a5e-b40d-46f0e3c5e802"
   },
   "outputs": [],
   "source": [
    "phrase = 'aptamer AND biosensor'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "8167ccde-a6fd-4a55-818b-bde2e6309cad",
   "metadata": {
    "colab": {
     "base_uri": "https://localhost:8080/",
     "height": 426
    },
    "id": "8167ccde-a6fd-4a55-818b-bde2e6309cad",
    "outputId": "5578d1aa-8a0b-4f7f-b29f-d07bd64762b6"
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>id</th>\n",
       "      <th>type</th>\n",
       "      <th>title</th>\n",
       "      <th>score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>dbgap:phs002702.v1.p1</td>\n",
       "      <td>Dataset</td>\n",
       "      <td>A Scalable Aptamer-based Electrochemical Biosensor For Rapid Detection of SARS-CoV-2 From Saliva</td>\n",
       "      <td>3.460658</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>R44DE030842</td>\n",
       "      <td>Grant</td>\n",
       "      <td>A scalable aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2 from saliva</td>\n",
       "      <td>7.035230</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>U01AA029328</td>\n",
       "      <td>Grant</td>\n",
       "      <td>Development of an Automated Diagnostic Platform for SARS-CoV-2 Monitoring in Vulnerable Areas</td>\n",
       "      <td>5.802171</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>U01AA029316</td>\n",
       "      <td>Grant</td>\n",
       "      <td>Touchscreen-compatible, real-time electrochemical sensing of SARS-CoV-2</td>\n",
       "      <td>4.922408</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>R44DE030852</td>\n",
       "      <td>Grant</td>\n",
       "      <td>Designer DNA Nanostructure Based Biosensing for Rapid COVID19 Detection and Monitoring using Saliva Sample</td>\n",
       "      <td>4.354153</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>f10c31d02026ef92e1edd49fbd367226</td>\n",
       "      <td>Presentation</td>\n",
       "      <td>A scalable aptamer-based electrochemical biosensor for rapid detection of SARS--Cov-2 from Saliva</td>\n",
       "      <td>3.460658</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>doi:10.1021/acs.analchem.2c04709</td>\n",
       "      <td>Publication</td>\n",
       "      <td>T-Shaped Aptamer-Based LSPR Biosensor Using Ω-Shaped Fiber Optic for Rapid Detection of SARS-CoV-2</td>\n",
       "      <td>8.385915</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>doi:10.3390/bios13121027</td>\n",
       "      <td>Publication</td>\n",
       "      <td>A Novel Aptamer Biosensor Based on a Localized Surface Plasmon Resonance Sensing Chip for High-Sensitivity and Rapid Enrofloxacin Detection</td>\n",
       "      <td>7.886760</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>doi:10.3390/s23229139</td>\n",
       "      <td>Publication</td>\n",
       "      <td>Divalent Aptamer-Functionalized Nanochannels for Facile Detection of Cancer Cell-Derived Exosomes</td>\n",
       "      <td>7.106586</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>doi:10.3390/bios14010056</td>\n",
       "      <td>Publication</td>\n",
       "      <td>Sensing Levofloxacin with an RNA Aptamer as a Bioreceptor</td>\n",
       "      <td>6.700958</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>doi:10.1117/12.2669355</td>\n",
       "      <td>Publication</td>\n",
       "      <td>Diagnostic and neutralizing aptamers technology against Sars-Cov-2</td>\n",
       "      <td>4.346510</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>doi:10.1371/journal.pone.0290256</td>\n",
       "      <td>Publication</td>\n",
       "      <td>A capacitive laser-induced graphene based aptasensor for SARS-CoV-2 detection in human saliva</td>\n",
       "      <td>3.764834</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>doi:10.1101/2023.04.26.538490</td>\n",
       "      <td>Publication</td>\n",
       "      <td>Designer DNA NanoGripper</td>\n",
       "      <td>3.663291</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                  id          type  \\\n",
       "0              dbgap:phs002702.v1.p1       Dataset   \n",
       "1                        R44DE030842         Grant   \n",
       "2                        U01AA029328         Grant   \n",
       "3                        U01AA029316         Grant   \n",
       "4                        R44DE030852         Grant   \n",
       "5   f10c31d02026ef92e1edd49fbd367226  Presentation   \n",
       "6   doi:10.1021/acs.analchem.2c04709   Publication   \n",
       "7           doi:10.3390/bios13121027   Publication   \n",
       "8              doi:10.3390/s23229139   Publication   \n",
       "9           doi:10.3390/bios14010056   Publication   \n",
       "10            doi:10.1117/12.2669355   Publication   \n",
       "11  doi:10.1371/journal.pone.0290256   Publication   \n",
       "12     doi:10.1101/2023.04.26.538490   Publication   \n",
       "\n",
       "                                                                                                                                          title  \\\n",
       "0                                              A Scalable Aptamer-based Electrochemical Biosensor For Rapid Detection of SARS-CoV-2 From Saliva   \n",
       "1                                              A scalable aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2 from saliva   \n",
       "2                                                 Development of an Automated Diagnostic Platform for SARS-CoV-2 Monitoring in Vulnerable Areas   \n",
       "3                                                                       Touchscreen-compatible, real-time electrochemical sensing of SARS-CoV-2   \n",
       "4                                    Designer DNA Nanostructure Based Biosensing for Rapid COVID19 Detection and Monitoring using Saliva Sample   \n",
       "5                                             A scalable aptamer-based electrochemical biosensor for rapid detection of SARS--Cov-2 from Saliva   \n",
       "6                                            T-Shaped Aptamer-Based LSPR Biosensor Using Ω-Shaped Fiber Optic for Rapid Detection of SARS-CoV-2   \n",
       "7   A Novel Aptamer Biosensor Based on a Localized Surface Plasmon Resonance Sensing Chip for High-Sensitivity and Rapid Enrofloxacin Detection   \n",
       "8                                             Divalent Aptamer-Functionalized Nanochannels for Facile Detection of Cancer Cell-Derived Exosomes   \n",
       "9                                                                                     Sensing Levofloxacin with an RNA Aptamer as a Bioreceptor   \n",
       "10                                                                           Diagnostic and neutralizing aptamers technology against Sars-Cov-2   \n",
       "11                                                A capacitive laser-induced graphene based aptasensor for SARS-CoV-2 detection in human saliva   \n",
       "12                                                                                                                     Designer DNA NanoGripper   \n",
       "\n",
       "       score  \n",
       "0   3.460658  \n",
       "1   7.035230  \n",
       "2   5.802171  \n",
       "3   4.922408  \n",
       "4   4.354153  \n",
       "5   3.460658  \n",
       "6   8.385915  \n",
       "7   7.886760  \n",
       "8   7.106586  \n",
       "9   6.700958  \n",
       "10  4.346510  \n",
       "11  3.764834  \n",
       "12  3.663291  "
      ]
     },
     "execution_count": 39,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "query = \"\"\"\n",
    "CALL db.index.fulltext.queryNodes(\"fulltext\", $phrase) YIELD node, score\n",
    "RETURN node.id AS id, LABELS(node)[0] AS type, node.name AS title, score\n",
    "ORDER BY type\n",
    "\"\"\"\n",
    "graph.run(query, phrase=phrase).to_data_frame()"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d04ad0f6-a8e4-409e-972c-429e195aefcc",
   "metadata": {
    "id": "d04ad0f6-a8e4-409e-972c-429e195aefcc"
   },
   "source": [
    "### Shutdown Neo4j before closing this notebook.\n",
    "If you run this notebook locally, uncomment the last line and run neo4j_utils.stop() to stop the database. Otherwise, the database server will keep running."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "11eb5bb3-634b-47f2-b61e-5aea7e990934",
   "metadata": {
    "id": "11eb5bb3-634b-47f2-b61e-5aea7e990934"
   },
   "outputs": [],
   "source": [
    "#neo4j_utils.stop()"
   ]
  }
 ],
 "metadata": {
  "colab": {
   "include_colab_link": true,
   "provenance": []
  },
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.13"
  },
  "widgets": {
   "application/vnd.jupyter.widget-state+json": {
    "00319f516ed24521ad8fbe403f1ffc1d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PRESENTED",
       "source": 677,
       "target": 4360
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "00809169217d4075979e6a39d54fc5de": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4385,
       "target": 46
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "00cf12231c8c4aefbeef31f02ae23924": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 694,
       "target": 27
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "011429e2729d4b04a80400064905d434": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 689,
       "target": 24
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "018599547284425ebd4a84def59600e9": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1101,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0260dd3ad51d43cebabe70cce80a4ef5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1186,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "02bf94bec34546548468f290c79d3704": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "from": "Unique identifier for the researcher (string)",
       "isContactPi": "True if researcher is the contact PI (boolean)",
       "isPi": "True if researcher is a PI for the grant (boolean)",
       "isStudyInvestigator": "True if research is the dbGaP study investigator (boolean)",
       "name": "MetaRelationship",
       "relationshipName": "IS_INVESTIGATOR_OF",
       "source": 2755,
       "target": 2760,
       "to": "Unique identifier for the grant without prefix or suffix (string)"
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "034931925ad04bb9b228dd3c03ac96e3": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 677,
       "target": 36
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "037c33e4c41144f0a6fe4201bcdb8e36": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 705,
       "target": 18
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "04c8117c3597441a9d9fbf80740fa7ba": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 674,
       "target": 30
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0537bb6129f445d19a11df95053327d5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "When faced with a pandemic such as SARS-Coronavirus-2 (SAR-CoV-2), the virus responsible for COVID-19,\ntimely risk assessment and action are required to prevent public health impacts to entire communities.\nBecause infected individuals may not have access to testing or may be asymptomatic and contraction can\nmean death, a proactive approach to detect the virus is needed to develop public health strategy to mitigate\nvirus spread. Recent studies have detected SAR-CoV-2 genetic material in sewage and demonstrate a\npositive correlation between the concentration of viral markers and reported cases1-5. The Coronavirus\nSewershed Surveillance Project (CSSP) is a collaborative effort to monitor sewersheds for genetic indicators of\nCOVID-19 in wastewater to provide additional, population-level information about virus circulation that is not\ncaptured by clinical testing. Untreated wastewater (influent) samples are screened weekly from select\nsewersheds and targeted micro-sewersheds for detection and “true” prevalence. Congregate facilities provide\nunique opportunities for study because they are controlled populations where the precise number and timing of\ninfections can be defined. Our team will utilize detailed monitoring of congregate facilities to define the precise\nper patient contribution and longevity of SARS-COV-2 RNA to wastewater by 1) increasing the number of\nfacilities tested, 2) altering the frequency at which samples are collected, and 3) comparing sewershed data\ncollected to clinical patient case data.\nAlthough SARS-COV-2 contribution/patient varies among communities, there have been clear outlier\ncommunities that produce little or no genetic material in the wastewater despite the presence of known\noutbreaks. The reason for this lost signal is not known, so our team will define factors that contribute to SARS-\nCOV-2 signal suppression in wastewater by 1) defining the physical nature of the genetic material in the\nsewershed to better understand the types of factors that could suppress signal, 2) expanding testing within\nsewersheds with suppressed signal as well as from additional facilities with similar population and industry\ndemographics as those with suppressed signal to narrow the sources of signal suppression, 3) performing\nexhaustive chemical characterization comparing wastewater from locations that are suppressed to those that\nare not to identify candidate compounds that could be causing suppression, and 4) obtaining or generating\ncandidate inhibitors and test their ability to suppress signal from viral genetic material in a controlled\nexperimental setting.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 46,
       "label": "Grant",
       "name": "Wastewater Detection of COVID-19",
       "narrative": "Testing of wastewater for genetic traces of SARS-COV-2, a novel Coronavirus that has\ncaused a destructive worldwide pandemic, has been shown to be an effective method\nfor gaining population-level data about viral prevalence and infectivity trends. However,\nbecause we lack critical knowledge about the factors that contribute to SARS-COV-2\ndetection in wastewater, these measurements currently cannot be used to accurately\npredict how many infected patients exist in a population. With a better understanding of\nthe individual patient contribution and duration of SARS-COV-2 signal in wastewater as\nwell as a better understanding of factors that affect signal detection, it will be possible to\nmore accurately predict the severity of outbreaks in populations using this powerful\ntechnique.",
       "researchInitiative": "RADx-rad",
       "subProject": "Wastewater",
       "tooltip": "Grant\nabstract:When faced with a pandemic such as SARS-Coronavirus-2 (SAR-CoV-2), the virus responsible for COVID-19,\ntimely risk assessment and action are required to prevent public health impacts to entire communities.\nBecause infected individuals may not have access to testing or may be asymptomatic and contraction can\nmean death, a proactive approach to detect the virus is needed to develop public health strategy to mitigate\nvirus spread. Recent studies have detected SAR-CoV-2 genetic material in sewage and demonstrate a\npositive correlation between the concentration of viral markers and reported cases1-5. The Coronavirus\nSewershed Surveillance Project (CSSP) is a collaborative effort to monitor sewersheds for genetic indicators of\nCOVID-19 in wastewater to provide additional, population-level information about virus circulation that is not\ncaptured by clinical testing. Untreated wastewater (influent) samples are screened weekly from select\nsewersheds and targeted micro-sewersheds for detection and “true” prevalence. Congregate facilities provide\nunique opportunities for study because they are controlled populations where the precise number and timing of\ninfections can be defined. Our team will utilize detailed monitoring of congregate facilities to define the precise\nper patient contribution and longevity of SARS-COV-2 RNA to wastewater by 1) increasing the number of\nfacilities tested, 2) altering the frequency at which samples are collected, and 3) comparing sewershed data\ncollected to clinical patient case data.\nAlthough SARS-COV-2 contribution/patient varies among communities, there have been clear outlier\ncommunities that produce little or no genetic material in the wastewater despite the presence of known\noutbreaks. The reason for this lost signal is not known, so our team will define factors that contribute to SARS-\nCOV-2 signal suppression in wastewater by 1) defining the physical nature of the genetic material in the\nsewershed to better understand the types of factors that could suppress signal, 2) expanding testing within\nsewersheds with suppressed signal as well as from additional facilities with similar population and industry\ndemographics as those with suppressed signal to narrow the sources of signal suppression, 3) performing\nexhaustive chemical characterization comparing wastewater from locations that are suppressed to those that\nare not to identify candidate compounds that could be causing suppression, and 4) obtaining or generating\ncandidate inhibitors and test their ability to suppress signal from viral genetic material in a controlled\nexperimental setting.\nid:U01DA053893\nnarrative:Testing of wastewater for genetic traces of SARS-COV-2, a novel Coronavirus that has\ncaused a destructive worldwide pandemic, has been shown to be an effective method\nfor gaining population-level data about viral prevalence and infectivity trends. However,\nbecause we lack critical knowledge about the factors that contribute to SARS-COV-2\ndetection in wastewater, these measurements currently cannot be used to accurately\npredict how many infected patients exist in a population. With a better understanding of\nthe individual patient contribution and duration of SARS-COV-2 signal in wastewater as\nwell as a better understanding of factors that affect signal detection, it will be possible to\nmore accurately predict the severity of outbreaks in populations using this powerful\ntechnique.\nname:Wastewater Detection of COVID-19\nsubProject:Wastewater\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "053b4bd0888f42708e1c180ede4a932c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "COVID-19 Diagnostics. Our proposed screening approach, if adopted by CLIA-compliant testing facilities with robotics, next generation sequencing and bioinformatics capability, would meet one important need among testing alternatives. It would provide the capability for testing tens of thousands of patient samples in a large bolus. It could allow accurate and fast-turnaround SARS-CoV-2 testing capacity at population scale, permitting massive scale monitoring of at-risk individuals with minimal processing delay. This method exploits the indexing of poly-adenylated RNA from both virus and host cells and allows the possibility of extracting many metrics at once (more flags = easier to detect) with the same upstream processing routine. This added information will be useful for interpreting variation in response to viral exposure for both positive and negative tests. Looking ahead, the technical improvements embodied by a successful NGS-based viral gRNA screening platform could reveal new means to establish strategic preparedness roadmaps for future pandemics. It would be a model for how new infectious disease screening platforms might be rapidly jump-started and developed.\nWe are working to develop a method to analyze  nasopharyngeal, oropharyngeal, saliva, and/or blood samples from COVID-19 patients collected very early in the COVID-19 disease course (e.g. at diagnosis of infection) and prospectively determine or predict  COVID-19 disease severity (e.g. asymptomatic, mild, severe, long COVID, etc).  The method seeks to both quantify the viral content in the biological sample and to also obtain an informative gene expression profile from patient cells.  These profiles will be compared with patient symptoms and clinical data using machine learning to identify biomarkers that are prognostic for COVID-19 disease severity.",
       "awardCode": "ZIA",
       "fundingMechanism": "Intramural Research",
       "id": 11,
       "label": "Grant",
       "name": "SARS-CoV-2 Diagnostic/Prognostic Sequencing Method",
       "researchInitiative": "RADx-rad",
       "subProject": "Diagnostic-Prognostic RNAseq",
       "tooltip": "Grant\nabstract:COVID-19 Diagnostics. Our proposed screening approach, if adopted by CLIA-compliant testing facilities with robotics, next generation sequencing and bioinformatics capability, would meet one important need among testing alternatives. It would provide the capability for testing tens of thousands of patient samples in a large bolus. It could allow accurate and fast-turnaround SARS-CoV-2 testing capacity at population scale, permitting massive scale monitoring of at-risk individuals with minimal processing delay. This method exploits the indexing of poly-adenylated RNA from both virus and host cells and allows the possibility of extracting many metrics at once (more flags = easier to detect) with the same upstream processing routine. This added information will be useful for interpreting variation in response to viral exposure for both positive and negative tests. Looking ahead, the technical improvements embodied by a successful NGS-based viral gRNA screening platform could reveal new means to establish strategic preparedness roadmaps for future pandemics. It would be a model for how new infectious disease screening platforms might be rapidly jump-started and developed.\nWe are working to develop a method to analyze  nasopharyngeal, oropharyngeal, saliva, and/or blood samples from COVID-19 patients collected very early in the COVID-19 disease course (e.g. at diagnosis of infection) and prospectively determine or predict  COVID-19 disease severity (e.g. asymptomatic, mild, severe, long COVID, etc).  The method seeks to both quantify the viral content in the biological sample and to also obtain an informative gene expression profile from patient cells.  These profiles will be compared with patient symptoms and clinical data using machine learning to identify biomarkers that are prognostic for COVID-19 disease severity.\nid:ZIAES103366\nname:SARS-CoV-2 Diagnostic/Prognostic Sequencing Method\nsubProject:Diagnostic-Prognostic RNAseq\nresearchInitiative:RADx-rad\nfundingMechanism:Intramural Research\nawardCode:ZIA"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "05e46279b713445eb67d7d67067f87ec": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Wensheng",
       "fullName": "Wensheng Guo",
       "id": 691,
       "label": "Researcher",
       "lastName": "Guo",
       "name": "Guo W",
       "profileId": "profileid:1862771",
       "tooltip": "Researcher\nid:profileid:1862771\nlastName:Guo\nprofileId:profileid:1862771\nname:Guo W\nfullName:Wensheng Guo\nfirstName:Wensheng"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "063518c28c164b2bab5607579390a6f4": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1513,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "06886727aeb3473d80b77c2ec4e5ab6a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "CHAMPAIGN",
       "country": "UNITED STATES",
       "duns": "duns:041544081",
       "geonames": "geonames:4914570",
       "id": 584,
       "label": "Organization",
       "name": "University of Illinois Urbana-Champaign",
       "ror": "ror:047426m28",
       "state": "IL",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4914570\nror:ror:047426m28\ncity:CHAMPAIGN\nname:University of Illinois Urbana-Champaign\nuei:uei:Y8CWNJRCNN91\nduns:duns:041544081\nstate:IL\nid:ror:047426m28\nurl:https://ror.org/047426m28",
       "uei": "uei:Y8CWNJRCNN91",
       "url": "https://ror.org/047426m28"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "077e9bf897c64ab28fc1fac08bed3f29": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "CREATED",
       "source": 677,
       "target": 2741
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0781f4e63aaf4ce4ba3e811ea6db0f15": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4387,
       "target": 27
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "084674816fa64339a4ef9934920ccf28": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The devastation caused by emerging pathogens with fast transmission capacity, such as SARS-CoV-2, has\ndemonstrated the importance of preparedness for future viral outbreaks; this includes the ability for fast\ndeployment of in-situ testing tools and epidemiological surveillance with high temporal and spatial\nresolution; particularly in places that are most vulnerable to becoming reservoirs of infectious agents.\nWe propose to develop a versatile multiplexing detection platform for SARS-CoV-2 in saliva. The proposed\nsystem will integrate signals from different biorecognition elements. Aptamer, antibody, and ACE2 will be\nimmobilized onto laser inscribed graphene electrodes, and detection mechanisms targeting SARS-CoV-2\nspike protein will be studied under varying testing conditions (pH, temperature, ionic strength). After\ndetermining the operating conditions for enhanced performance of each biosensor, a self-referencing\napproach will be used between complementary recognition elements (i.e., possible combinations of\naptamers, antibodies, and ACE2 enzyme biosensors) to evaluate the effects on test results accuracy (i.e.,\nrisk of false-positive and false-negative results). A saliva pre-treatment protocol will be developed to\nfacilitate SARS-CoV-2 testing in human saliva using the multiplex biosensor platform. An open channel\nmicrofluidics system will be designed to automatically split and channel a single saliva sample into multiple\nstreams to the biosensors without saturation, biofouling, and pump requirement. The development of a\nfunctional and reliable multiplex biosensor system will be useful for addressing longstanding needs in public\nhealth as the respiratory Coronavirus family continues its seasonal visits, which may repeat over several\ndecades, much like the occasional visits from the influenza virus, with varying degrees of virulence.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 25,
       "label": "Grant",
       "name": "Development of an Automated Diagnostic Platform for SARS-CoV-2 Monitoring in Vulnerable Areas",
       "narrative": "The proposed research aims to develop a multiplex biosensor platform to support increased\ntesting of SARS-CoV-2 with high accuracy and temporal resolution. A multiplex biosensor system\ncould help reduce testing gaps in vulnerable areas where access to standard laboratory testing is\nvery limited.",
       "researchInitiative": "RADx-rad",
       "subProject": "Automatic Detection & Tracing",
       "tooltip": "Grant\nabstract:The devastation caused by emerging pathogens with fast transmission capacity, such as SARS-CoV-2, has\ndemonstrated the importance of preparedness for future viral outbreaks; this includes the ability for fast\ndeployment of in-situ testing tools and epidemiological surveillance with high temporal and spatial\nresolution; particularly in places that are most vulnerable to becoming reservoirs of infectious agents.\nWe propose to develop a versatile multiplexing detection platform for SARS-CoV-2 in saliva. The proposed\nsystem will integrate signals from different biorecognition elements. Aptamer, antibody, and ACE2 will be\nimmobilized onto laser inscribed graphene electrodes, and detection mechanisms targeting SARS-CoV-2\nspike protein will be studied under varying testing conditions (pH, temperature, ionic strength). After\ndetermining the operating conditions for enhanced performance of each biosensor, a self-referencing\napproach will be used between complementary recognition elements (i.e., possible combinations of\naptamers, antibodies, and ACE2 enzyme biosensors) to evaluate the effects on test results accuracy (i.e.,\nrisk of false-positive and false-negative results). A saliva pre-treatment protocol will be developed to\nfacilitate SARS-CoV-2 testing in human saliva using the multiplex biosensor platform. An open channel\nmicrofluidics system will be designed to automatically split and channel a single saliva sample into multiple\nstreams to the biosensors without saturation, biofouling, and pump requirement. The development of a\nfunctional and reliable multiplex biosensor system will be useful for addressing longstanding needs in public\nhealth as the respiratory Coronavirus family continues its seasonal visits, which may repeat over several\ndecades, much like the occasional visits from the influenza virus, with varying degrees of virulence.\nid:U01AA029328\nnarrative:The proposed research aims to develop a multiplex biosensor platform to support increased\ntesting of SARS-CoV-2 with high accuracy and temporal resolution. A multiplex biosensor system\ncould help reduce testing gaps in vulnerable areas where access to standard laboratory testing is\nvery limited.\nname:Development of an Automated Diagnostic Platform for SARS-CoV-2 Monitoring in Vulnerable Areas\nsubProject:Automatic Detection & Tracing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0888f052942940a5b2bc91038b4332a2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2015,
       "name": "EMPLOYED_AT",
       "source": 715,
       "target": 575
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "088aff68ba3741179db0026867487d0a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "NEW HAVEN",
       "country": "UNITED STATES",
       "duns": "duns:043207562",
       "geonames": "geonames:4839366",
       "id": 555,
       "label": "Organization",
       "name": "Yale University",
       "ror": "ror:03v76x132",
       "state": "CT",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4839366\nror:ror:03v76x132\ncity:NEW HAVEN\nname:Yale University\nuei:uei:FL6GV84CKN57\nduns:duns:043207562\nstate:CT\nid:ror:03v76x132\nurl:https://ror.org/03v76x132",
       "uei": "uei:FL6GV84CKN57",
       "url": "https://ror.org/03v76x132"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "08c968b21f654e47bdb3c33089b449e9": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2017,
       "name": "EMPLOYED_AT",
       "source": 647,
       "target": 566
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "095285a5783e42fc9b25863470a74da7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4392,
       "target": 29
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "098f71e4e6a54124bb6491defc6c1556": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "John",
       "fullName": "John R Cirrito",
       "id": 677,
       "label": "Researcher",
       "lastName": "Cirrito",
       "middleName": "R",
       "name": "Cirrito JR",
       "orcid": "orcid:0000-0002-7196-8786",
       "profileId": "profileid:8553912",
       "tooltip": "Researcher\nfirstName:John\nlastName:Cirrito\nprofileId:profileid:8553912\nname:Cirrito JR\nfullName:John R Cirrito\nmiddleName:R\norcid:orcid:0000-0002-7196-8786\nid:profileid:8553912"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0a286473b68c462e819ed8d09bd82e21": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 651,
       "target": 16
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0a5e32b0cb6544d295814de3a5981300": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2024,
       "name": "EMPLOYED_AT",
       "source": 693,
       "target": 596
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0a6a03df00ce40a1ab41aa89b9196556": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "PHOENIX",
       "country": "UNITED STATES",
       "duns": "duns:089993752",
       "geonames": "geonames:5308655",
       "id": 576,
       "label": "Organization",
       "name": "Inter Tribal Council of Arizona",
       "ror": "ror:03v1z6488",
       "state": "AZ",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5308655\nror:ror:03v1z6488\ncity:PHOENIX\nname:Inter Tribal Council of Arizona\nuei:uei:QVBEM11FYF47\nduns:duns:089993752\nstate:AZ\nid:ror:03v1z6488\nurl:https://ror.org/03v1z6488",
       "uei": "uei:QVBEM11FYF47",
       "url": "https://ror.org/03v1z6488"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0aba3c9a00e9439a8874a60244b1e6c1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4388,
       "target": 7
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0be6071ed57349ae8aad37e4f01f9af6": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Xudong",
       "fullName": "Xudong Fan",
       "id": 667,
       "label": "Researcher",
       "lastName": "Fan",
       "name": "Fan X",
       "orcid": "orcid:0000-0003-0149-1326",
       "profileId": "profileid:8485696",
       "tooltip": "Researcher\nid:profileid:8485696\nlastName:Fan\norcid:orcid:0000-0003-0149-1326\nprofileId:profileid:8485696\nname:Fan X\nfullName:Xudong Fan\nfirstName:Xudong"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0c9148b744cf42988159a1761cf53819": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 682,
       "target": 597
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0c9512d4bdee44cfa55f7d8f9c209341": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The novel coronavirus SARS-CoV-2 is causing significant morbidity and mortality. Current approaches to SARS-\nCoV-2 testing are costly, inconsistently implemented, and fail to rapidly identify evolving outbreaks. Innovative\nsurveillance programs are urgently needed to better measure baseline transmission dynamics and anticipate\nnew localized outbreaks. Wastewater based testing (WBT) has the potential to enable population level\nsurveillance, trigger earlier regional responses to acute outbreaks, and overcome barriers to individual testing\nsuch as stigma and lack of access. WBT could therefore enable faster and cheaper pathogen detection and\nimprove population-level estimates of prevalence. Reliable capture approaches for this novel coronavirus using\nWBT are currently undefined. Viral dynamics during wastewater transport must be considered, and correlation\nof WBT with clinical testing must be systematically evaluated at multiple scales. Here, we propose to optimize\nWBT surveillance protocols of waste streams at an urban university campus encompassing dorms, research\nfacilities and a tertiary care hospital, surrounding sewershed and wastewater treatment plant. We will detect\nSARS-CoV-2 using qRT-PCR to estimate prevalence and viral panel-enriched metatranscriptomics to\ncharacterize viral diversity. We will model case counts using normalized WBT data and develop point-of-use\nmicrofluidics systems for WBT. Our team of investigators is uniquely positioned for this study, with expertise in\ninfectious diseases, epidemiology, microbial characterization using WBT at national scales, and point-of-care\ntesting. We will implement three complimentary specific aims. In Aim 1, we will optimize (1a) collection and\nprocessing to determine sensitivity and safety of WBT. This includes grab vs. composite sampling;) filtration- vs.\nprecipitation-based enrichment; and viral inactivation protocols. We will further optimize scale and frequency of\nsampling (1b) at the building/sewer pit, campus, sewershed, and WWTP, and across various frequencies.\nPresence of SARS-CoV-2 will be ascertained by qRT-PCR and long-read spiked-primer enriched\nmetatranscriptomics. WBT results will be integrated with clinical case-loads, existing surveillance cohorts and\nexpanded employee surveillance. In Aim 2. we will improve modeling of SARS-CoV-2 case dynamics using\nextrapolated WBT data and site-specific normalization factors. We will correlate modeled building-, campus- and\ncommunity-level case counts with existing clinical incidence data and campus surveillance using ensemble\nKalman filter (EnKF) dynamic modeling incorporating both qRT-PCR and metatranscriptomics data. We will\ncompare normalization methods factoring in wastewater residence time, per capita viral load equivalents\n(PCVLEs), and other waste flow parameters to reduce model error. Finally, in Aim 3, we will adapt point-of-use\ntesting capabilities using microfluidics based on optimized WBT protocols. We will apply existing RADx\ndevelopment of a photothermal amplification system for SARS-CoV-2 detection to optimized WBT practices. We\nwill develop a modular system for WBT samples and determine assay detection thresholds using viral controls.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 2,
       "label": "Grant",
       "name": "Optimizing SARS-CoV-2 wastewater based surveillance in urban and university campus settings.",
       "narrative": "Wastewater based testing (WBT) holds great promise for cost-effective population-level surveillance and\ntransmission tracking of SARS-CoV-2, but optimal sampling modalities and protocols are unknown. Taking\nadvantage of a diverse inner city urban campus encompassing undergraduate and postgraduate dorms,\nresearch buildings, and medical facilities, we will optimize WBT surveillance strategies of waste streams at the\nbuilding level, surrounding sewersheds and wastewater treatment plants and model case counts using\nnormalized WBT data. We will further leverage metatranscriptomics for rapid identification of SARS-CoV-2\ntransmission chains and develop point-of-use microfluidics systems for timely WBT.",
       "researchInitiative": "RADx-rad",
       "subProject": "Wastewater",
       "tooltip": "Grant\nabstract:The novel coronavirus SARS-CoV-2 is causing significant morbidity and mortality. Current approaches to SARS-\nCoV-2 testing are costly, inconsistently implemented, and fail to rapidly identify evolving outbreaks. Innovative\nsurveillance programs are urgently needed to better measure baseline transmission dynamics and anticipate\nnew localized outbreaks. Wastewater based testing (WBT) has the potential to enable population level\nsurveillance, trigger earlier regional responses to acute outbreaks, and overcome barriers to individual testing\nsuch as stigma and lack of access. WBT could therefore enable faster and cheaper pathogen detection and\nimprove population-level estimates of prevalence. Reliable capture approaches for this novel coronavirus using\nWBT are currently undefined. Viral dynamics during wastewater transport must be considered, and correlation\nof WBT with clinical testing must be systematically evaluated at multiple scales. Here, we propose to optimize\nWBT surveillance protocols of waste streams at an urban university campus encompassing dorms, research\nfacilities and a tertiary care hospital, surrounding sewershed and wastewater treatment plant. We will detect\nSARS-CoV-2 using qRT-PCR to estimate prevalence and viral panel-enriched metatranscriptomics to\ncharacterize viral diversity. We will model case counts using normalized WBT data and develop point-of-use\nmicrofluidics systems for WBT. Our team of investigators is uniquely positioned for this study, with expertise in\ninfectious diseases, epidemiology, microbial characterization using WBT at national scales, and point-of-care\ntesting. We will implement three complimentary specific aims. In Aim 1, we will optimize (1a) collection and\nprocessing to determine sensitivity and safety of WBT. This includes grab vs. composite sampling;) filtration- vs.\nprecipitation-based enrichment; and viral inactivation protocols. We will further optimize scale and frequency of\nsampling (1b) at the building/sewer pit, campus, sewershed, and WWTP, and across various frequencies.\nPresence of SARS-CoV-2 will be ascertained by qRT-PCR and long-read spiked-primer enriched\nmetatranscriptomics. WBT results will be integrated with clinical case-loads, existing surveillance cohorts and\nexpanded employee surveillance. In Aim 2. we will improve modeling of SARS-CoV-2 case dynamics using\nextrapolated WBT data and site-specific normalization factors. We will correlate modeled building-, campus- and\ncommunity-level case counts with existing clinical incidence data and campus surveillance using ensemble\nKalman filter (EnKF) dynamic modeling incorporating both qRT-PCR and metatranscriptomics data. We will\ncompare normalization methods factoring in wastewater residence time, per capita viral load equivalents\n(PCVLEs), and other waste flow parameters to reduce model error. Finally, in Aim 3, we will adapt point-of-use\ntesting capabilities using microfluidics based on optimized WBT protocols. We will apply existing RADx\ndevelopment of a photothermal amplification system for SARS-CoV-2 detection to optimized WBT practices. We\nwill develop a modular system for WBT samples and determine assay detection thresholds using viral controls.\nid:U01DA053949\nnarrative:Wastewater based testing (WBT) holds great promise for cost-effective population-level surveillance and\ntransmission tracking of SARS-CoV-2, but optimal sampling modalities and protocols are unknown. Taking\nadvantage of a diverse inner city urban campus encompassing undergraduate and postgraduate dorms,\nresearch buildings, and medical facilities, we will optimize WBT surveillance strategies of waste streams at the\nbuilding level, surrounding sewersheds and wastewater treatment plants and model case counts using\nnormalized WBT data. We will further leverage metatranscriptomics for rapid identification of SARS-CoV-2\ntransmission chains and develop point-of-use microfluidics systems for timely WBT.\nname:Optimizing SARS-CoV-2 wastewater based surveillance in urban and university campus settings.\nsubProject:Wastewater\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0caa3a29db4e4d4bb6e47b3d1c251eb3": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "William",
       "fullName": "William P Fay",
       "id": 629,
       "label": "Researcher",
       "lastName": "Fay",
       "middleName": "P",
       "name": "Fay WP",
       "orcid": "orcid:0000-0001-9102-4216",
       "profileId": "profileid:1897028",
       "tooltip": "Researcher\nmiddleName:P\nid:profileid:1897028\nlastName:Fay\norcid:orcid:0000-0001-9102-4216\nprofileId:profileid:1897028\nname:Fay WP\nfullName:William P Fay\nfirstName:William"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0d5747b3337c415891102617790ad3d3": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 676,
       "target": 559
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0db5e9d2df0c49518873eec30cc70e9b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Hamid",
       "fullName": "Hamid Bassiri",
       "id": 687,
       "label": "Researcher",
       "lastName": "Bassiri",
       "name": "Bassiri H",
       "orcid": "orcid:0000-0001-6532-8478",
       "profileId": "profileid:10320851",
       "tooltip": "Researcher\nid:profileid:10320851\nlastName:Bassiri\norcid:orcid:0000-0001-6532-8478\nprofileId:profileid:10320851\nname:Bassiri H\nfullName:Hamid Bassiri\nfirstName:Hamid"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0dc3601a14cb4178b485ec78033521e8": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1341,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0dc89dccbd4e48a490f8a82f5df489aa": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Kevin",
       "fullName": "Kevin R McBrearty",
       "id": 346,
       "label": "Researcher",
       "lastName": "McBrearty",
       "middleName": "R",
       "name": "McBrearty KR",
       "tooltip": "Researcher\nmiddleName:R\nid:s2authorid:71857371\nlastName:McBrearty\nname:McBrearty KR\nfullName:Kevin R McBrearty\nfirstName:Kevin"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0e1a08cc87a44b6da57b3d677577359e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "In the wake of COVID-19 pandemic, Multisystem Inflammatory Syndrome in Children (MIS-C) has evolved as a\nnew threat to children exposed to SARS-CoV-2. The emergence of MIS-C is so new and so rapidly evolving\nthat there are currently no diagnostic tests to identify these patients nor are there tools to predict disease\nprogression. Through established, funded, multi-center consortia in the U.S. (CHARMS: Characterization of\nMIS-C and its Relationship to Kawasaki Disease funded by PCORI) and the UK (DIAMONDS), we will collect\nclinical data and samples to support the proposed studies. First, we will generate transcript, protein and\nantibody datasets from children with COVID-19, MIS-C, and with other febrile illnesses. Next, we will use these\ndata to devise tests to distinguish children at risk of progression to severe COVID-19 or MIS-C and diagnostic\ntests to distinguish these conditions from other causes of fever in children. Continuing our established\ncollaboration with Columbia University, we will define the antibody repertoire against all known human\ncoronaviruses and determine how pre-existing antibody to other coronaviruses may shape the immune\nresponse in acute SARS-CoV-2 infection and MIS-C. The first two years (R61) will build on the expertise of the\nassembled teams to discover unique proteomic and transcriptomic patterns in MIS-C and SARS-CoV-2-\ninfected patients and relate clinical parameters to the antibody response to coronaviral antigens profiled on\npeptide arrays. This work will leverage already banked plasma, serum, and RNA samples from children with\nCOVID-19, MIS-C, Kawasaki disease and other inflammatory conditions. Rigorous Go/NoGo criteria have\nbeen established and will determine progression to the R33 phase. The final two years (R33) will focus on\nplatform development and multicenter and bi-national test validation to diagnose and predict severity in\nchildren with SARS-CoV-2 infection or MIS-C based on aptamer technology, lateral-flow protein detection,\npoint-of-service RNA or antibody profiling with commercial partners. De-identified clinical and molecular data\nwill be deposited in the RADx-rad hub to facilitate data sharing. Many potential hurdles in this type of research\nhave already been overcome: a) IRB-approved patient recruitment for data and samples is on-going, b) clinical\nsamples have been banked, c) strong preliminary data has been generated on RNAseq, aptamer proteomics,\nand coronaviral antibody responses, and d) the teams have a strong track record of previous collaboration and\nproductivity. The synergistic expertise of these investigative teams in this multi-center proposal provides a\nunique opportunity to create diagnostic and prognostic tools for children suffering from the spectrum of SARS-\nCoV-2 illnesses.\n1",
       "awardCode": "R61",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 23,
       "label": "Grant",
       "name": "Diagnosing and predicting risk in children with SARS-CoV-2- related illness",
       "narrative": "As the COVID-19 pandemic evolved in early 2020, case reports appeared describing children with unusual\nfebrile illnesses with elevated inflammatory markers and multi-system involvement that is now termed\nMultisystem Inflammatory Syndrome in Children (MIS-C). The illness occurs weeks following exposure to\nSARS-CoV-2 and these children have a wide spectrum of disease severity ranging from cardiogenic shock to\nmilder illness that can be self-limited. To address an urgent, unmet clinical need, investigative teams across\nthree countries will join forces to discover and validate a diagnostic test to identify children with MIS-C and\npredict progression of disease.",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nabstract:In the wake of COVID-19 pandemic, Multisystem Inflammatory Syndrome in Children (MIS-C) has evolved as a\nnew threat to children exposed to SARS-CoV-2. The emergence of MIS-C is so new and so rapidly evolving\nthat there are currently no diagnostic tests to identify these patients nor are there tools to predict disease\nprogression. Through established, funded, multi-center consortia in the U.S. (CHARMS: Characterization of\nMIS-C and its Relationship to Kawasaki Disease funded by PCORI) and the UK (DIAMONDS), we will collect\nclinical data and samples to support the proposed studies. First, we will generate transcript, protein and\nantibody datasets from children with COVID-19, MIS-C, and with other febrile illnesses. Next, we will use these\ndata to devise tests to distinguish children at risk of progression to severe COVID-19 or MIS-C and diagnostic\ntests to distinguish these conditions from other causes of fever in children. Continuing our established\ncollaboration with Columbia University, we will define the antibody repertoire against all known human\ncoronaviruses and determine how pre-existing antibody to other coronaviruses may shape the immune\nresponse in acute SARS-CoV-2 infection and MIS-C. The first two years (R61) will build on the expertise of the\nassembled teams to discover unique proteomic and transcriptomic patterns in MIS-C and SARS-CoV-2-\ninfected patients and relate clinical parameters to the antibody response to coronaviral antigens profiled on\npeptide arrays. This work will leverage already banked plasma, serum, and RNA samples from children with\nCOVID-19, MIS-C, Kawasaki disease and other inflammatory conditions. Rigorous Go/NoGo criteria have\nbeen established and will determine progression to the R33 phase. The final two years (R33) will focus on\nplatform development and multicenter and bi-national test validation to diagnose and predict severity in\nchildren with SARS-CoV-2 infection or MIS-C based on aptamer technology, lateral-flow protein detection,\npoint-of-service RNA or antibody profiling with commercial partners. De-identified clinical and molecular data\nwill be deposited in the RADx-rad hub to facilitate data sharing. Many potential hurdles in this type of research\nhave already been overcome: a) IRB-approved patient recruitment for data and samples is on-going, b) clinical\nsamples have been banked, c) strong preliminary data has been generated on RNAseq, aptamer proteomics,\nand coronaviral antibody responses, and d) the teams have a strong track record of previous collaboration and\nproductivity. The synergistic expertise of these investigative teams in this multi-center proposal provides a\nunique opportunity to create diagnostic and prognostic tools for children suffering from the spectrum of SARS-\nCoV-2 illnesses.\n1\nid:R61HD105590\nnarrative:As the COVID-19 pandemic evolved in early 2020, case reports appeared describing children with unusual\nfebrile illnesses with elevated inflammatory markers and multi-system involvement that is now termed\nMultisystem Inflammatory Syndrome in Children (MIS-C). The illness occurs weeks following exposure to\nSARS-CoV-2 and these children have a wide spectrum of disease severity ranging from cardiogenic shock to\nmilder illness that can be self-limited. To address an urgent, unmet clinical need, investigative teams across\nthree countries will join forces to discover and validate a diagnostic test to identify children with MIS-C and\npredict progression of disease.\nname:Diagnosing and predicting risk in children with SARS-CoV-2- related illness\nsubProject:PreVAIL kIds\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R61"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0e1c77abb5c84aa0b586141410f94421": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2024,
       "name": "EMPLOYED_AT",
       "source": 621,
       "target": 553
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0e8750e80948471482d620466a72d25c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Recent studies, including ours, have suggested that breath may allow us to diagnose COVID-19 infection\nand even monitor its progress. As compared to immunological and genetic based methods using sample media\nlike blood, nasopharyngeal swab, and saliva, breath analysis is non-invasive, simple, safe, and inexpensive; it\nallows a nearly infinite amount of sample volume and can be used at the point-of-care for rapid detection.\nFundamentally, breath also provides critical metabolomics information regarding how human body responds to\nvirus infection and medical intervention (such as drug treatment and mechanical ventilation). The objectives of\nthe proposed SCENT project are: (1) to refine automated, portable, high-performance micro-gas\nchromatography (GC) device and related data analysis / biomarker identification algorithms for rapid (5-6\nminutes), in-situ, and sensitive (down to ppt) breath analysis and (2) to conduct breath analysis on up to 760\npatients, and identify and validate the COVID-19 biomarkers in breath. Thus, in coordination with the RADx-rad\nData Coordination Center (DCC), we will complete the following specific aims.\n(1) Refine 5 automated micro-GC devices to achieve higher speed and better separation capability. We\nwill construct 5 new automated and portable one-dimensional micro-GC devices that require only ~6 minutes of\nassay time (improved from current 20 minutes) at the ppt level sensitivity (Sub-Aim 1a). Then the devices will be\nupgraded to 2-dimensional micro-GC to significantly increase the separation capability (Sub-Aim 1b). In the\nmeantime, we will optimize and automate our existing data processing and biomarker identification algorithms\nand codes to streamline the workflow so that the GC device can automatically process and analyze the data\nwithout human intervention (Sub-Aim 1c).\n(2) Identify breath biomarkers that distinguish COVID-19 positive (symptomatic and asymptomatic) and\nnegative patients. We will recruit a training cohort of 380 participants, including 190 COVID-19 positive patients\n(95 symptomatic and 95 asymptomatic) and 190 COVID-19 negative patients from two hospitals (Michigan\nMedicine – Ann Arbor and the Henry Ford Hospital – Detroit). We will conduct breath analysis using machine\nlearning to identify VOC patterns that match each COVID-19 diagnostic status.\n(3) Validate the COVID-19 biomarkers using our refined micro-GC devices. Using the refined 2-D micro-GC\ndevices from Sub-Aim 1b, we will recruit a new validation cohort of 380 participants (190 COVID-19 positive\npatients and 190 COVID-19 negative patients) to validate the biomarkers identified in Aim 2.\n We will leverage existing engineering, data science, clinical, regulatory, and commercialization resources\nthroughout the project to hit our milestones, ensuring a high likelihood of rapid patient impact. Upon completion\nof this work, we will have a portable micro-GC device and accompanying automated algorithms that can detect\nand monitor COVID-19 status for people in a variety of clinical and community settings.",
       "awardCode": "U18",
       "fundingMechanism": "Other Research-Related",
       "id": 21,
       "label": "Grant",
       "name": "COVID-19 detection through scent analysis with a compact GC device",
       "narrative": "Our team of engineers, clinicians, and data scientists has developed a portable, high\nperformance breath analyzer that can be used to detect certain diseases. In this project, we will\nadapt and refine our existing device and algorithms so they can be used for rapid, safe, and non-\ninvasive COVID-19 detection. People will simply breath into the device and it will quickly provide\nresults, meaning that it can be used in a variety of everyday settings to help fight against the\nCOVID-19 pandemic.",
       "researchInitiative": "RADx-rad",
       "subProject": "SCENT",
       "tooltip": "Grant\nabstract:Recent studies, including ours, have suggested that breath may allow us to diagnose COVID-19 infection\nand even monitor its progress. As compared to immunological and genetic based methods using sample media\nlike blood, nasopharyngeal swab, and saliva, breath analysis is non-invasive, simple, safe, and inexpensive; it\nallows a nearly infinite amount of sample volume and can be used at the point-of-care for rapid detection.\nFundamentally, breath also provides critical metabolomics information regarding how human body responds to\nvirus infection and medical intervention (such as drug treatment and mechanical ventilation). The objectives of\nthe proposed SCENT project are: (1) to refine automated, portable, high-performance micro-gas\nchromatography (GC) device and related data analysis / biomarker identification algorithms for rapid (5-6\nminutes), in-situ, and sensitive (down to ppt) breath analysis and (2) to conduct breath analysis on up to 760\npatients, and identify and validate the COVID-19 biomarkers in breath. Thus, in coordination with the RADx-rad\nData Coordination Center (DCC), we will complete the following specific aims.\n(1) Refine 5 automated micro-GC devices to achieve higher speed and better separation capability. We\nwill construct 5 new automated and portable one-dimensional micro-GC devices that require only ~6 minutes of\nassay time (improved from current 20 minutes) at the ppt level sensitivity (Sub-Aim 1a). Then the devices will be\nupgraded to 2-dimensional micro-GC to significantly increase the separation capability (Sub-Aim 1b). In the\nmeantime, we will optimize and automate our existing data processing and biomarker identification algorithms\nand codes to streamline the workflow so that the GC device can automatically process and analyze the data\nwithout human intervention (Sub-Aim 1c).\n(2) Identify breath biomarkers that distinguish COVID-19 positive (symptomatic and asymptomatic) and\nnegative patients. We will recruit a training cohort of 380 participants, including 190 COVID-19 positive patients\n(95 symptomatic and 95 asymptomatic) and 190 COVID-19 negative patients from two hospitals (Michigan\nMedicine – Ann Arbor and the Henry Ford Hospital – Detroit). We will conduct breath analysis using machine\nlearning to identify VOC patterns that match each COVID-19 diagnostic status.\n(3) Validate the COVID-19 biomarkers using our refined micro-GC devices. Using the refined 2-D micro-GC\ndevices from Sub-Aim 1b, we will recruit a new validation cohort of 380 participants (190 COVID-19 positive\npatients and 190 COVID-19 negative patients) to validate the biomarkers identified in Aim 2.\n We will leverage existing engineering, data science, clinical, regulatory, and commercialization resources\nthroughout the project to hit our milestones, ensuring a high likelihood of rapid patient impact. Upon completion\nof this work, we will have a portable micro-GC device and accompanying automated algorithms that can detect\nand monitor COVID-19 status for people in a variety of clinical and community settings.\nid:U18TR003812\nnarrative:Our team of engineers, clinicians, and data scientists has developed a portable, high\nperformance breath analyzer that can be used to detect certain diseases. In this project, we will\nadapt and refine our existing device and algorithms so they can be used for rapid, safe, and non-\ninvasive COVID-19 detection. People will simply breath into the device and it will quickly provide\nresults, meaning that it can be used in a variety of everyday settings to help fight against the\nCOVID-19 pandemic.\nname:COVID-19 detection through scent analysis with a compact GC device\nsubProject:SCENT\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U18"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0e8f0361b4e540698b70501cad5ab969": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "City of event location (string)",
       "country": "Country of event location (string)",
       "endDate": "End data of event (date)",
       "eventType": "Type of event: webinar, virtual conference, in-person conference, hybrid conference, virtual workshop, in-person workshop, hybrid workshop (string)",
       "eventUrl": "URL of the event website (string)",
       "id": 2757,
       "label": "MetaNode",
       "name": "Name of the event (string)",
       "nodeName": "Event",
       "startDate": "Start date of event (date)",
       "state": "State or province of the event location (string)",
       "tooltip": "MetaNode\nid:Unique identifier of the event (date and event number) (string)\nstartDate:Start date of event (date)\nname:Name of the event (string)\nnodeName:Event\nstate:State or province of the event location (string)\neventUrl:URL of the event website (string)\nendDate:End data of event (date)\neventType:Type of event: webinar, virtual conference, in-person conference, hybrid conference, virtual workshop, in-person workshop, hybrid workshop (string)\ncountry:Country of event location (string)\ncity:City of event location (string)"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0f73cec4f0944a58b2fc73b80a2fe1ff": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4389,
       "target": 15
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "0f9f7925d53546d9bb6a73a973ebb2c2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "SEATTLE",
       "country": "UNITED STATES",
       "duns": "duns:605799469",
       "geonames": "geonames:5809844",
       "id": 570,
       "label": "Organization",
       "name": "University of Washington",
       "ror": "ror:00cvxb145",
       "state": "WA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5809844\nror:ror:00cvxb145\ncity:SEATTLE\nname:University of Washington\nuei:uei:HD1WMN6945W6\nduns:duns:605799469\nstate:WA\nid:ror:00cvxb145\nurl:https://ror.org/00cvxb145",
       "uei": "uei:HD1WMN6945W6",
       "url": "https://ror.org/00cvxb145"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "108f57595ae64e4b9b56ef1624c0ad29": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1428,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "10daead9e9ed4a669ab9404a44332142": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "HARTFORD",
       "country": "UNITED STATES",
       "duns": "duns:077314268",
       "geonames": "geonames:4835797",
       "id": 593,
       "label": "Organization",
       "name": "Connecticut Children's Medical Center",
       "ror": "ror:01a1jjn24",
       "state": "CT",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4835797\nror:ror:01a1jjn24\ncity:HARTFORD\nname:Connecticut Children's Medical Center\nuei:uei:U1L2PRKYF9T3\nduns:duns:077314268\nstate:CT\nid:ror:01a1jjn24\nurl:https://ror.org/01a1jjn24",
       "uei": "uei:U1L2PRKYF9T3",
       "url": "https://ror.org/01a1jjn24"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "10feeb8e23354d5099f57e58296fb406": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Jane",
       "fullName": "Jane A O’Halloran",
       "id": 1101,
       "label": "Researcher",
       "lastName": "O’Halloran",
       "middleName": "A",
       "name": "O’Halloran JA",
       "tooltip": "Researcher\nmiddleName:A\nid:s2authorid:1401004949\nlastName:O’Halloran\nname:O’Halloran JA\nfullName:Jane A O’Halloran\nfirstName:Jane"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "112d8fb8c0bd40e5bb76dd8570518ab7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "A",
       "fullName": "A Boon",
       "id": 925,
       "label": "Researcher",
       "lastName": "Boon",
       "name": "Boon A",
       "tooltip": "Researcher\nid:s2authorid:1968280\nlastName:Boon\nname:Boon A\nfullName:A Boon\nfirstName:A"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "114c94f4190d4f3ca773a68c55ba2669": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "applicants": "Name of the organization(s) that filed the patent application (string[])",
       "filingDate": "Date the patent application was filed (date)",
       "grantedDate": "Date the patent was granted (date)",
       "id": 2761,
       "inventors": "Name of the inventors (string[])",
       "label": "MetaNode",
       "name": "Title of the patent (string)",
       "nodeName": "Patent",
       "status": "active or pending (string)",
       "tooltip": "MetaNode\nid:Identifier of the patents (string)\napplicants:Name of the organization(s) that filed the patent application (string[])\nstatus:active or pending (string)\nname:Title of the patent (string)\nnodeName:Patent\nfilingDate:Date the patent application was filed (date)\ninventors:Name of the inventors (string[])\ngrantedDate:Date the patent was granted (date)\nurl:URL of patent webpage (string)",
       "url": "URL of patent webpage (string)"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "11a8aa84448643eea3fa7b1d62d055ed": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 695,
       "target": 19
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "11b298b1df6a4080ade6986b7ea7f7b9": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "City of the organization (string)",
       "country": "Country of the organization (string)",
       "duns": "Data Universal Numbering System (DUNS) by Dun & Bradstreet (string)",
       "geonames": "Unique identifier for geolocation from https://www.geonames.org/ (string)",
       "id": 2759,
       "label": "MetaNode",
       "name": "Name of the organization (string)",
       "nodeName": "Organization",
       "ror": "Research Organization Registry id of the organization from https://ror.org/ (string)",
       "state": "State of the organization (string)",
       "tooltip": "MetaNode\nid:Unique entity identifier: ror id if available, otherwise uei id (string)\nror:Research Organization Registry id of the organization from https://ror.org/ (string)\nname:Name of the organization (string)\nnodeName:Organization\nduns:Data Universal Numbering System (DUNS) by Dun & Bradstreet (string)\nstate:State of the organization (string)\ngeonames:Unique identifier for geolocation from https://www.geonames.org/ (string)\nuei:US government-owned Unique Entity Identifier (UEI) for the organization (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-170.html) (string)\nurl:Research Organization Registry landing page of the organization (string)\ncountry:Country of the organization (string)\ncity:City of the organization (string)",
       "uei": "US government-owned Unique Entity Identifier (UEI) for the organization (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-21-170.html) (string)",
       "url": "Research Organization Registry landing page of the organization (string)"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "11bdc56bb4cf45009fbad33d2e1164bf": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 620,
       "target": 14
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "11e9c892b29d49d29a7a7ae61e14f6ab": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Iwijn",
       "fullName": "Iwijn De Vlaminck",
       "id": 613,
       "label": "Researcher",
       "lastName": "De Vlaminck",
       "name": "De Vlaminck I",
       "profileId": "profileid:14135419",
       "tooltip": "Researcher\nid:profileid:14135419\nlastName:De Vlaminck\nprofileId:profileid:14135419\nname:De Vlaminck I\nfullName:Iwijn De Vlaminck\nfirstName:Iwijn"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "11fd07d11f6e42669330bf5c5184c727": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "PHILADELPHIA",
       "country": "UNITED STATES",
       "duns": "duns:042250712",
       "geonames": "geonames:4560349",
       "id": 567,
       "label": "Organization",
       "name": "University of Pennsylvania",
       "ror": "ror:00b30xv10",
       "state": "PA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4560349\nror:ror:00b30xv10\ncity:PHILADELPHIA\nname:University of Pennsylvania\nuei:uei:GM1XX56LEP58\nduns:duns:042250712\nstate:PA\nid:ror:00b30xv10\nurl:https://ror.org/00b30xv10",
       "uei": "uei:GM1XX56LEP58",
       "url": "https://ror.org/00b30xv10"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "12cee346c2694aaea7e2b3698cc81fd1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Lu",
       "fullName": "Lu Peng",
       "id": 623,
       "label": "Researcher",
       "lastName": "Peng",
       "name": "Peng L",
       "profileId": "profileid:77827345",
       "tooltip": "Researcher\nid:profileid:77827345\nlastName:Peng\nprofileId:profileid:77827345\nname:Peng L\nfullName:Lu Peng\nfirstName:Lu"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "12d812d34dec4a7eb3b109de40098a93": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2010,
       "name": "EMPLOYED_AT",
       "source": 694,
       "target": 589
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "12f76ef59fb44c1daeadbdcb7ff2c24d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "DURHAM",
       "country": "UNITED STATES",
       "duns": "duns:044387793",
       "geonames": "geonames:4464368",
       "id": 565,
       "label": "Organization",
       "name": "Duke University",
       "ror": "ror:00py81415",
       "state": "NC",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4464368\nror:ror:00py81415\ncity:DURHAM\nname:Duke University\nuei:uei:TP7EK8DZV6N5\nduns:duns:044387793\nstate:NC\nid:ror:00py81415\nurl:https://ror.org/00py81415",
       "uei": "uei:TP7EK8DZV6N5",
       "url": "https://ror.org/00py81415"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "12fcd1c29d8e4e5882bad438f27cd2ae": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "WASHINGTON",
       "country": "UNITED STATES",
       "duns": "duns:143983562",
       "geonames": "geonames:4140963",
       "id": 589,
       "label": "Organization",
       "name": "CHILDREN'S NATIONAL RESEARCH INSTITUTE",
       "state": "DC",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4140963\ncity:WASHINGTON\nname:CHILDREN'S NATIONAL RESEARCH INSTITUTE\nuei:uei:M3KHEEYRM1S6\nduns:duns:143983562\nstate:DC\nid:uei:M3KHEEYRM1S6",
       "uei": "uei:M3KHEEYRM1S6"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "13e73a5359b245898faa12ca92a7f650": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4399,
       "label": "FundingOpportunity",
       "name": "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)",
       "tooltip": "FundingOpportunity\nname:Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)\nid:PA-20-135\nurl:https://grants.nih.gov/grants/guide/pa-files/PA-20-135.html",
       "url": "https://grants.nih.gov/grants/guide/pa-files/PA-20-135.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "14008564563144498ff70087c1cee680": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "BALTIMORE",
       "country": "UNITED STATES",
       "duns": "duns:001910777",
       "geonames": "geonames:4347778",
       "id": 564,
       "label": "Organization",
       "name": "Johns Hopkins University",
       "ror": "ror:00za53h95",
       "state": "MD",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4347778\nror:ror:00za53h95\ncity:BALTIMORE\nname:Johns Hopkins University\nuei:uei:FTMTDMBR29C7\nduns:duns:001910777\nstate:MD\nid:ror:00za53h95\nurl:https://ror.org/00za53h95",
       "uei": "uei:FTMTDMBR29C7",
       "url": "https://ror.org/00za53h95"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "141fabf1b40a42a9bcb2f361b56d789f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2024,
       "name": "EMPLOYED_AT",
       "source": 622,
       "target": 566
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1430e8bfd38948848f1d18ca002068bc": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 684,
       "target": 2816
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "14688fb88db444428b3a44ef12aff913": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "STANFORD",
       "country": "UNITED STATES",
       "duns": "duns:009214214",
       "geonames": "geonames:5398563",
       "id": 607,
       "label": "Organization",
       "name": "Stanford University",
       "ror": "ror:00f54p054",
       "state": "CA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5398563\nror:ror:00f54p054\ncity:STANFORD\nname:Stanford University\nuei:uei:HJD6G4D6TJY5\nduns:duns:009214214\nstate:CA\nid:ror:00f54p054\nurl:https://ror.org/00f54p054",
       "uei": "uei:HJD6G4D6TJY5",
       "url": "https://ror.org/00f54p054"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "148ae7b696fb442fb5b9e1fa0dcf2417": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The COVID-19 pandemic has underscored the critical need for rapid and accurate screening and diagnostic methods for potential respiratory viruses. Existing COVID-19 diagnostic approaches face limitations either in terms of turnaround time or accuracy. In this study, we present an electrochemical biosensor that offers nearly instantaneous and precise SARS-CoV-2 detection, suitable for point-of-care and environmental monitoring applications. The biosensor employs a stapled hACE-2 N-terminal alpha helix peptide to functionalize an in-situ grown polypyrrole conductive polymer on a nitrocellulose membrane backbone through a chemical process. We assessed the biosensor’s analytical performance using heat-inactivated omicron and delta variants of the SARS-CoV-2 virus in artificial saliva (AS) and nasal swabs (NS) samples diluted in a strong ionic solution. Virus identification was achieved through electrochemical impedance spectroscopy (EIS) and frequency analyses. The assay demonstrated a limit of detection of 40 TCID50/mL, with 95% sensitivity and 100% specificity. Notably, the biosensor exhibited no cross-reactivity when tested against the influenza virus. The entire testing process using the biosensor takes less than a minute. In summary, our biosensor exhibits promising potential in the battle against pandemic respiratory viruses, offering a platform for the creation of rapid, compact, portable, and point-of-care devices capable of multiplexing various viruses. This groundbreaking development has the capacity to significantly bolster our readiness and response to future viral outbreaks.",
       "doi": "doi:10.3390/s23188000",
       "id": 3288,
       "journal": "Sensors (Basel, Switzerland)",
       "label": "Publication",
       "name": "Development and Analytical Evaluation of a Point-of-Care Electrochemical Biosensor for Rapid and Accurate SARS-CoV-2 Detection",
       "pmId": "37766054",
       "pmcId": "10534802",
       "tooltip": "Publication\njournal:Sensors (Basel, Switzerland)\nabstract:The COVID-19 pandemic has underscored the critical need for rapid and accurate screening and diagnostic methods for potential respiratory viruses. Existing COVID-19 diagnostic approaches face limitations either in terms of turnaround time or accuracy. In this study, we present an electrochemical biosensor that offers nearly instantaneous and precise SARS-CoV-2 detection, suitable for point-of-care and environmental monitoring applications. The biosensor employs a stapled hACE-2 N-terminal alpha helix peptide to functionalize an in-situ grown polypyrrole conductive polymer on a nitrocellulose membrane backbone through a chemical process. We assessed the biosensor’s analytical performance using heat-inactivated omicron and delta variants of the SARS-CoV-2 virus in artificial saliva (AS) and nasal swabs (NS) samples diluted in a strong ionic solution. Virus identification was achieved through electrochemical impedance spectroscopy (EIS) and frequency analyses. The assay demonstrated a limit of detection of 40 TCID50/mL, with 95% sensitivity and 100% specificity. Notably, the biosensor exhibited no cross-reactivity when tested against the influenza virus. The entire testing process using the biosensor takes less than a minute. In summary, our biosensor exhibits promising potential in the battle against pandemic respiratory viruses, offering a platform for the creation of rapid, compact, portable, and point-of-care devices capable of multiplexing various viruses. This groundbreaking development has the capacity to significantly bolster our readiness and response to future viral outbreaks.\nid:doi:10.3390/s23188000\nname:Development and Analytical Evaluation of a Point-of-Care Electrochemical Biosensor for Rapid and Accurate SARS-CoV-2 Detection\npmId:37766054\nyear:2023\ntype:secondary\npmcId:10534802\nurl:https://doi.org/doi:10.3390/s23188000\ndoi:doi:10.3390/s23188000",
       "type": "secondary",
       "url": "https://doi.org/doi:10.3390/s23188000",
       "year": 2023
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1501df663ab64d65822a548071f0f9a5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "GraphModel",
     "state": {
      "_adj": {
       "1091": {},
       "18": {},
       "2811": {},
       "2816": {},
       "2817": {},
       "2821": {},
       "2846": {},
       "41": {},
       "43": {},
       "47": {},
       "665": {},
       "682": {},
       "684": {},
       "996": {}
      },
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "GraphModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": null,
      "edges": [
       "IPY_MODEL_739952c1cadc4227998d85aa1fedc6a5",
       "IPY_MODEL_a0f849a8cb32481195e2f771899db7f2",
       "IPY_MODEL_4efa73a5a7c34d76a0259db1669a213d",
       "IPY_MODEL_82df09a66bfa4b8ab3ac1933d99e1b26",
       "IPY_MODEL_ae763ecbe8064071a51f121b70f06f62",
       "IPY_MODEL_590f817f8bb84b65aedb04c96a6f2fd4",
       "IPY_MODEL_f11e723322244aac939cd25cedf3a752",
       "IPY_MODEL_1430e8bfd38948848f1d18ca002068bc",
       "IPY_MODEL_29811122aec847e5b2d9ac191481e7d2",
       "IPY_MODEL_a408033a050f4d688eb9a32933a69abf",
       "IPY_MODEL_1b7799daad3e42a485149ae5543a2895",
       "IPY_MODEL_f5fdbc22415e4916a564e679f7c8c17e",
       "IPY_MODEL_459e39d017d94cfb926426fbdccfa0fd",
       "IPY_MODEL_9e336250e2444aec9773879d82b9baa7",
       "IPY_MODEL_8b83b2e7483f40ffb57121557b511f77",
       "IPY_MODEL_c20253de64b74f9982386981a4372edb",
       "IPY_MODEL_9120e1fba8364e54b4d4ab7a955c37c2",
       "IPY_MODEL_338b4fd609934c4aa1ae15546e62198c",
       "IPY_MODEL_ba82b77a43b342a3994a285cb5f3996c"
      ],
      "nodes": [
       "IPY_MODEL_8222b7bbdd094199ada49f63281c2ae6",
       "IPY_MODEL_fd26172ca7c74d469a8da92c32838748",
       "IPY_MODEL_9ba4fe703bbc4138b83dbd3513b40605",
       "IPY_MODEL_49831c3462224e2d939aaf13cb48608d",
       "IPY_MODEL_89d16019824946e98316c1edbdb30521",
       "IPY_MODEL_f504608a5ff0456f8b26eae0abc21d2a",
       "IPY_MODEL_232311bb0e964ee79856c7f22edbc62f",
       "IPY_MODEL_762f8fecfbcf463c8345def89cbda4a6",
       "IPY_MODEL_5a0728420ce14d76b5964df8cf81a2fd",
       "IPY_MODEL_c8c6784aaa804690be624164a1d3f437",
       "IPY_MODEL_1af63d596f7d4ff2b3a8f82825194e68",
       "IPY_MODEL_407bb20b4ed641d989a9ec5ce9deb0ad",
       "IPY_MODEL_b83a26882a824a6aa512375d490b8067",
       "IPY_MODEL_b9dc064adc924b5d8c0ef6a26a6b28a9"
      ]
     }
    },
    "1541ee25c33f4a0e9e943f042865e368": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The development of a rapid and reliable sensor system from readily available oral specimens is crucial for\nthe screening and management of SARS-CoV-2 infection. Other than tests that require laboratory-scale\ninstrumentation, the development of rapid tests can play a timely role in the management of an outbreak.\nCurrent rapid tests often involve the antibodies in a lateral flow format to detect viral protein components\nand, depending on the implementation, can result in a relatively high degree of error. In partnership with\nMIT, InnoTech proposes the development of a multiplexed sensor platform based on nanomaterials capable\nof molecular binding and subsequent reporting. We will develop and commercialize a multiplexed sensor\nplatform using nanomaterial reporters capable of rapid simultaneous detection of multiple components of\nviral particles in a field applicable electrochemical device. For our Phase I- Aim 1 we will focus on the\ndevelopment and optimization of synthetic biosensors for accurate detection of SARS-CoV-2 viral proteins\nand nucleic acid. Our milestone is the discovery and validation an array of molecular recognition biosensors\nagainst both protein and nucleic acid segments of SARS-CoV-2. We will complete this phase in 4 months.\nIn Phase II-Aim 1, we will develop and validate the electrochemical detectors. We will utilize the synthetic\nbiosensors identified and validated in Aim 1 to an electrochemical platform for the rapid detection of an\nactive SARS-CoV-2 infection using multiple biomarkers of the infection. We will specifically employ\ncommercially-available, disposable electrode platforms and existing potentiostats from Metrohm DropSens\nto streamline scale-up and commercialization. Our milestone, to be completed in year 1 of Phase II, is to\nhave a multiplex biosensor chip and an alpha prototype with a multiplex biosensor chip and a potentiostat\nreader which we will benchmark for sensitivity and quantitative accuracy against existing COVID-19\ndiagnostics. In Phase II-Aim 2, we will validate the prototype chips and detectors with retrospective clinical\nspecimens in preparation for EUA-FDA submission. We will determine the LOD, clinical performance,\nand cross-reactivity with other respiratory pathogens and normal flora. The milestone for this Aim is to\ndocument a multiplex of at least two proteins and two nucleic acid biosensors for SARS-CoV-2 that will\nprovide a LOD of 5-20 viruses per microliter in an oral specimen and will be clinically validated with\ngreater than 95% concordance with RT-PCR in 30 positive and 30 negative specimens.",
       "awardCode": "R42",
       "fundingMechanism": "SBIR/STTR",
       "id": 14,
       "label": "Grant",
       "name": "A multimodal platform for Oral screening of COVID-19",
       "narrative": "The development of rapid tests can play a timely role in the management of an outbreak. The\nCOVID-19 pandemic has been especially devastating due to the ability of asymptomatic carriers\nto transmit the virus. Thus, accurate and low-cost detection of the active infection on-site from\neasily collectible oral specimens is essential for the successful management of this disease.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:The development of a rapid and reliable sensor system from readily available oral specimens is crucial for\nthe screening and management of SARS-CoV-2 infection. Other than tests that require laboratory-scale\ninstrumentation, the development of rapid tests can play a timely role in the management of an outbreak.\nCurrent rapid tests often involve the antibodies in a lateral flow format to detect viral protein components\nand, depending on the implementation, can result in a relatively high degree of error. In partnership with\nMIT, InnoTech proposes the development of a multiplexed sensor platform based on nanomaterials capable\nof molecular binding and subsequent reporting. We will develop and commercialize a multiplexed sensor\nplatform using nanomaterial reporters capable of rapid simultaneous detection of multiple components of\nviral particles in a field applicable electrochemical device. For our Phase I- Aim 1 we will focus on the\ndevelopment and optimization of synthetic biosensors for accurate detection of SARS-CoV-2 viral proteins\nand nucleic acid. Our milestone is the discovery and validation an array of molecular recognition biosensors\nagainst both protein and nucleic acid segments of SARS-CoV-2. We will complete this phase in 4 months.\nIn Phase II-Aim 1, we will develop and validate the electrochemical detectors. We will utilize the synthetic\nbiosensors identified and validated in Aim 1 to an electrochemical platform for the rapid detection of an\nactive SARS-CoV-2 infection using multiple biomarkers of the infection. We will specifically employ\ncommercially-available, disposable electrode platforms and existing potentiostats from Metrohm DropSens\nto streamline scale-up and commercialization. Our milestone, to be completed in year 1 of Phase II, is to\nhave a multiplex biosensor chip and an alpha prototype with a multiplex biosensor chip and a potentiostat\nreader which we will benchmark for sensitivity and quantitative accuracy against existing COVID-19\ndiagnostics. In Phase II-Aim 2, we will validate the prototype chips and detectors with retrospective clinical\nspecimens in preparation for EUA-FDA submission. We will determine the LOD, clinical performance,\nand cross-reactivity with other respiratory pathogens and normal flora. The milestone for this Aim is to\ndocument a multiplex of at least two proteins and two nucleic acid biosensors for SARS-CoV-2 that will\nprovide a LOD of 5-20 viruses per microliter in an oral specimen and will be clinically validated with\ngreater than 95% concordance with RT-PCR in 30 positive and 30 negative specimens.\nid:R42DE030829\nnarrative:The development of rapid tests can play a timely role in the management of an outbreak. The\nCOVID-19 pandemic has been especially devastating due to the ability of asymptomatic carriers\nto transmit the virus. Thus, accurate and low-cost detection of the active infection on-site from\neasily collectible oral specimens is essential for the successful management of this disease.\nname:A multimodal platform for Oral screening of COVID-19\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:SBIR/STTR\nawardCode:R42"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "155562df1fb34cbbbf93153c59977321": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The COVID-19 pandemic is a critical global public health emergency and many countries are failing to contain\nthe virus's spread due to slow and insufficient testing. While several diagnostic methods are now available, most\ntests are either reagent-intensive and must be done in CLIA-approved labs, making them expensive and slow to\nreport results, or rapid and inexpensive, but potentially lacking in sensitivity. In the U.S., seriously ill and high-\nrisk patients have been prioritized for testing, causing states to miss mild and asymptomatic cases, some of\nwhich are the most effective spreaders of the virus. However, expanding testing has been a challenge due to\nshortages of sampling swabs and key reagents for nucleic acid amplification-based tests, which are the most\npopular option. Testing capabilities must be expanded exponentially to enable mass population-level testing of\nall patients, healthcare workers and their families, other critical key workers, and the wider community in order\nto bring the pandemic under control. mPOD proposes to expand testing capabilities through a novel biosensor\nthat will use oligonucleotide molecules called aptamers to bind to unique sites on the SARS-CoV-2 virus.\nAptamers have similar binding affinities to antibodies, but due to their smaller size, they are more agile, making\nthem particularly suited for high-specificity binding. To complete the test, a saliva sample will be loaded onto a\ntest strip containing aptamers immobilized onto gold electrodes. The gold-electrode test strip will be inserted into\nthe mPOD DTCT, a proprietary electrochemical test platform where virus-bound aptamers will be detected via\ncyclic voltammetry, triggering a positive result. The result is sent wirelessly via a mobile app, which sends\nencrypted data on to the cloud for storage and to public health agencies for enhanced data collection, tracking,\nand tracing of COVID-19. The app will also include a backend database to help businesses, manufacturers,\nschools, and large institutions track tested individuals' results and tailor specific public health responses. In order\nto further develop this technology and enable rapid deployment for timely COVID-19 intervention, mPOD plans\nto 1) Select SARS-CoV-2-specific aptamers for use in electrode test strips with an optimized signal-to-noise ratio\nperformance, 2) Demonstrate sensitivity and specificity of a low-cost, miniaturized potentiostat test strip for use\nas a COVID-19 POC or OTC diagnostic, 3) Complete and test a fully-fledged digital infrastructure for data\ncollection, tracking, and tracing of COVID-19 test results via the mPOD mobile app. This non-traditional approach\nwill provide new testing capabilities with the potential to report results faster than standard RT-PCR tests and\nwith greater accuracy and sensitivity compared to existing antigen-based diagnostics. Furthermore, once the\nsystem is developed, test strips with customized aptamers can be developed for rapid diagnosis of other\npathogens, including future emerging pandemics, via routine POC and OTC testing.",
       "awardCode": "R44",
       "fundingMechanism": "SBIR/STTR",
       "id": 6,
       "label": "Grant",
       "name": "A scalable aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2 from saliva",
       "narrative": "Worldwide, healthcare systems are struggling to diagnose new COVID-19 cases in a timely manner and to\nperform effective contract tracing to contain the pandemic. New diagnostic methods that are rapid, affordable,\nsensitive, and don't draw from already overtaxed supply chains are necessary to meet the urgent need for point-\nof-care and over-the-counter testing. To help meet this need, mPOD aims to develop a low-cost, aptamer-based\nbiosensor platform to detect the SARS-CoV-2 virus in saliva, complete with an app that will facilitate data\ncollection, tracking, and tracing of COVID-19 cases.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:The COVID-19 pandemic is a critical global public health emergency and many countries are failing to contain\nthe virus's spread due to slow and insufficient testing. While several diagnostic methods are now available, most\ntests are either reagent-intensive and must be done in CLIA-approved labs, making them expensive and slow to\nreport results, or rapid and inexpensive, but potentially lacking in sensitivity. In the U.S., seriously ill and high-\nrisk patients have been prioritized for testing, causing states to miss mild and asymptomatic cases, some of\nwhich are the most effective spreaders of the virus. However, expanding testing has been a challenge due to\nshortages of sampling swabs and key reagents for nucleic acid amplification-based tests, which are the most\npopular option. Testing capabilities must be expanded exponentially to enable mass population-level testing of\nall patients, healthcare workers and their families, other critical key workers, and the wider community in order\nto bring the pandemic under control. mPOD proposes to expand testing capabilities through a novel biosensor\nthat will use oligonucleotide molecules called aptamers to bind to unique sites on the SARS-CoV-2 virus.\nAptamers have similar binding affinities to antibodies, but due to their smaller size, they are more agile, making\nthem particularly suited for high-specificity binding. To complete the test, a saliva sample will be loaded onto a\ntest strip containing aptamers immobilized onto gold electrodes. The gold-electrode test strip will be inserted into\nthe mPOD DTCT, a proprietary electrochemical test platform where virus-bound aptamers will be detected via\ncyclic voltammetry, triggering a positive result. The result is sent wirelessly via a mobile app, which sends\nencrypted data on to the cloud for storage and to public health agencies for enhanced data collection, tracking,\nand tracing of COVID-19. The app will also include a backend database to help businesses, manufacturers,\nschools, and large institutions track tested individuals' results and tailor specific public health responses. In order\nto further develop this technology and enable rapid deployment for timely COVID-19 intervention, mPOD plans\nto 1) Select SARS-CoV-2-specific aptamers for use in electrode test strips with an optimized signal-to-noise ratio\nperformance, 2) Demonstrate sensitivity and specificity of a low-cost, miniaturized potentiostat test strip for use\nas a COVID-19 POC or OTC diagnostic, 3) Complete and test a fully-fledged digital infrastructure for data\ncollection, tracking, and tracing of COVID-19 test results via the mPOD mobile app. This non-traditional approach\nwill provide new testing capabilities with the potential to report results faster than standard RT-PCR tests and\nwith greater accuracy and sensitivity compared to existing antigen-based diagnostics. Furthermore, once the\nsystem is developed, test strips with customized aptamers can be developed for rapid diagnosis of other\npathogens, including future emerging pandemics, via routine POC and OTC testing.\nid:R44DE030842\nnarrative:Worldwide, healthcare systems are struggling to diagnose new COVID-19 cases in a timely manner and to\nperform effective contract tracing to contain the pandemic. New diagnostic methods that are rapid, affordable,\nsensitive, and don't draw from already overtaxed supply chains are necessary to meet the urgent need for point-\nof-care and over-the-counter testing. To help meet this need, mPOD aims to develop a low-cost, aptamer-based\nbiosensor platform to detect the SARS-CoV-2 virus in saliva, complete with an app that will facilitate data\ncollection, tracking, and tracing of COVID-19 cases.\nname:A scalable aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2 from saliva\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:SBIR/STTR\nawardCode:R44"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "15f9786339474ffc9a3647eb7c4c45c0": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4396,
       "target": 36
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1608b6547f364109a3f1d5da1823d0dc": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The devastation caused by emerging pathogens with fast transmission capacity, such as SARS-CoV-2, has\ndemonstrated the importance of preparedness for future viral outbreaks; this includes the ability for fast\ndeployment of in-situ testing tools and epidemiological surveillance with high temporal and spatial\nresolution; particularly in places that are most vulnerable to becoming reservoirs of infectious agents.\nWe propose to develop a versatile multiplexing detection platform for SARS-CoV-2 in saliva. The proposed\nsystem will integrate signals from different biorecognition elements. Aptamer, antibody, and ACE2 will be\nimmobilized onto laser inscribed graphene electrodes, and detection mechanisms targeting SARS-CoV-2\nspike protein will be studied under varying testing conditions (pH, temperature, ionic strength). After\ndetermining the operating conditions for enhanced performance of each biosensor, a self-referencing\napproach will be used between complementary recognition elements (i.e., possible combinations of\naptamers, antibodies, and ACE2 enzyme biosensors) to evaluate the effects on test results accuracy (i.e.,\nrisk of false-positive and false-negative results). A saliva pre-treatment protocol will be developed to\nfacilitate SARS-CoV-2 testing in human saliva using the multiplex biosensor platform. An open channel\nmicrofluidics system will be designed to automatically split and channel a single saliva sample into multiple\nstreams to the biosensors without saturation, biofouling, and pump requirement. The development of a\nfunctional and reliable multiplex biosensor system will be useful for addressing longstanding needs in public\nhealth as the respiratory Coronavirus family continues its seasonal visits, which may repeat over several\ndecades, much like the occasional visits from the influenza virus, with varying degrees of virulence.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 25,
       "label": "Grant",
       "name": "Development of an Automated Diagnostic Platform for SARS-CoV-2 Monitoring in Vulnerable Areas",
       "narrative": "The proposed research aims to develop a multiplex biosensor platform to support increased\ntesting of SARS-CoV-2 with high accuracy and temporal resolution. A multiplex biosensor system\ncould help reduce testing gaps in vulnerable areas where access to standard laboratory testing is\nvery limited.",
       "researchInitiative": "RADx-rad",
       "subProject": "Automatic Detection & Tracing",
       "tooltip": "Grant\nabstract:The devastation caused by emerging pathogens with fast transmission capacity, such as SARS-CoV-2, has\ndemonstrated the importance of preparedness for future viral outbreaks; this includes the ability for fast\ndeployment of in-situ testing tools and epidemiological surveillance with high temporal and spatial\nresolution; particularly in places that are most vulnerable to becoming reservoirs of infectious agents.\nWe propose to develop a versatile multiplexing detection platform for SARS-CoV-2 in saliva. The proposed\nsystem will integrate signals from different biorecognition elements. Aptamer, antibody, and ACE2 will be\nimmobilized onto laser inscribed graphene electrodes, and detection mechanisms targeting SARS-CoV-2\nspike protein will be studied under varying testing conditions (pH, temperature, ionic strength). After\ndetermining the operating conditions for enhanced performance of each biosensor, a self-referencing\napproach will be used between complementary recognition elements (i.e., possible combinations of\naptamers, antibodies, and ACE2 enzyme biosensors) to evaluate the effects on test results accuracy (i.e.,\nrisk of false-positive and false-negative results). A saliva pre-treatment protocol will be developed to\nfacilitate SARS-CoV-2 testing in human saliva using the multiplex biosensor platform. An open channel\nmicrofluidics system will be designed to automatically split and channel a single saliva sample into multiple\nstreams to the biosensors without saturation, biofouling, and pump requirement. The development of a\nfunctional and reliable multiplex biosensor system will be useful for addressing longstanding needs in public\nhealth as the respiratory Coronavirus family continues its seasonal visits, which may repeat over several\ndecades, much like the occasional visits from the influenza virus, with varying degrees of virulence.\nid:U01AA029328\nnarrative:The proposed research aims to develop a multiplex biosensor platform to support increased\ntesting of SARS-CoV-2 with high accuracy and temporal resolution. A multiplex biosensor system\ncould help reduce testing gaps in vulnerable areas where access to standard laboratory testing is\nvery limited.\nname:Development of an Automated Diagnostic Platform for SARS-CoV-2 Monitoring in Vulnerable Areas\nsubProject:Automatic Detection & Tracing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1628c5b4deba42c2a5a4c5f82d26723a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "MENANDS",
       "country": "UNITED STATES",
       "duns": "duns:153695478",
       "geonames": "geonames:5106834",
       "id": 594,
       "label": "Organization",
       "name": "Wadsworth Center",
       "ror": "ror:050kf9c55",
       "state": "NY",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5106834\nror:ror:050kf9c55\ncity:MENANDS\nname:Wadsworth Center\nuei:uei:LQK1DD1EYZK9\nduns:duns:153695478\nstate:NY\nid:ror:050kf9c55\nurl:https://ror.org/050kf9c55",
       "uei": "uei:LQK1DD1EYZK9",
       "url": "https://ror.org/050kf9c55"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "162dfabf3a9c4c2590297ad583f0290f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4391,
       "target": 16
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "169e046a3d62433aad537627bbf067fd": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 299,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "16e4f26eb6e24e6086b993676ec08155": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 711,
       "target": 35
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "17397a8947894dc29c5ca2081c86e26e": {
     "model_module": "@jupyter-widgets/base",
     "model_module_version": "1.2.0",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "173e15349f964bb1967748066c70c9eb": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The recent emergence of SARS-CoV-2 and resultant pandemic of COVID-19 disease has overwhelmed global\nhealth systems and led to over 200,000 American deaths to date. While initial reports suggested that SARS-\nCoV-2 infection in children was generally benign, a novel post-inflammatory syndrome known as multisystem\ninflammatory syndrome in children (MIS-C) has now been described. MIS-C in children is characterized by fever,\nsystemic inflammation, and end-organ involvement, and the majority of patients are IgG seropositive for SARS-\nCoV-2. Because the clinical features of MIS-C overlap with other infections and inflammatory disorders, new\nstrategies for diagnosis of MIS-C in febrile children are urgently needed. Our immediate objective (during the\nR61 phase) is to determine the reproducible changes in breath, urine, and salivary volatile composition in chil-\ndren diagnosed with MIS-C. We will integrate these discovery studies with clinical and immunological profiling to\ndevelop (during R61 phase) and validate (during R33 phase) a novel and much-needed MIS-C diagnostic, which\nis expected to have a major impact on care of febrile children. Our long-term goal to develop a diagnostic strategy\nto distinguish children with MIS-C from children with other causes of fever. Supported by our strong preliminary\ndata that indicate our expertise and feasibility of this strategy, our objectives will be met through three specific\naims: 1) Characterize breath biomarkers in children with MIS-C (R61); 2) Relate breath VOC changes to virolog-\nical, disease severity, and immunological features of MIS-C (R61); and 3) Validate our novel MIS-C diagnostic\nfor clinical use (R33). The proposed research is significant, because we will progress in development of new,\nmuch-needed MIS-C rapid diagnostic tool.",
       "awardCode": "R33",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 4,
       "label": "Grant",
       "name": "Diagnosis of MIS-C in febrile children",
       "narrative": "This research is highly relevant to public health because there is no current validated\ndiagnostic tool for the post-SARS-CoV-2 inflammatory disorder in children, MIS-C. Our\nproposal will develop a new strategy to diagnose this disorder, which will directly\nimprove care of children with fever and help support future clinical studies.",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nabstract:The recent emergence of SARS-CoV-2 and resultant pandemic of COVID-19 disease has overwhelmed global\nhealth systems and led to over 200,000 American deaths to date. While initial reports suggested that SARS-\nCoV-2 infection in children was generally benign, a novel post-inflammatory syndrome known as multisystem\ninflammatory syndrome in children (MIS-C) has now been described. MIS-C in children is characterized by fever,\nsystemic inflammation, and end-organ involvement, and the majority of patients are IgG seropositive for SARS-\nCoV-2. Because the clinical features of MIS-C overlap with other infections and inflammatory disorders, new\nstrategies for diagnosis of MIS-C in febrile children are urgently needed. Our immediate objective (during the\nR61 phase) is to determine the reproducible changes in breath, urine, and salivary volatile composition in chil-\ndren diagnosed with MIS-C. We will integrate these discovery studies with clinical and immunological profiling to\ndevelop (during R61 phase) and validate (during R33 phase) a novel and much-needed MIS-C diagnostic, which\nis expected to have a major impact on care of febrile children. Our long-term goal to develop a diagnostic strategy\nto distinguish children with MIS-C from children with other causes of fever. Supported by our strong preliminary\ndata that indicate our expertise and feasibility of this strategy, our objectives will be met through three specific\naims: 1) Characterize breath biomarkers in children with MIS-C (R61); 2) Relate breath VOC changes to virolog-\nical, disease severity, and immunological features of MIS-C (R61); and 3) Validate our novel MIS-C diagnostic\nfor clinical use (R33). The proposed research is significant, because we will progress in development of new,\nmuch-needed MIS-C rapid diagnostic tool.\nid:R33HD105594\nnarrative:This research is highly relevant to public health because there is no current validated\ndiagnostic tool for the post-SARS-CoV-2 inflammatory disorder in children, MIS-C. Our\nproposal will develop a new strategy to diagnose this disorder, which will directly\nimprove care of children with fever and help support future clinical studies.\nname:Diagnosis of MIS-C in febrile children\nsubProject:PreVAIL kIds\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R33"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "177f961967144fb0996aa52eda050bef": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4388,
       "target": 6
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1790cbbc6b3f44e2a564c185b973d483": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Children have been disproportionately less impacted by the Corona Virus Disease 2019 (COVID-19) caused\nby the Severe Acute Respiratory Syndrome Corona Virus 2 (SAR-CoV-2) compared to adults. However,\nsevere illnesses including Multisystem Inflammatory Syndrome (MIS-C) and respiratory failure have occurred\nin a small proportion of children with SARS-CoV-2 infection. Nearly 80% of children with MIS-C are critically ill\nwith a 2-4% mortality rate. Currently there are no modalities to characterize the spectrum of disease severity\nand predict which child with SARS-CoV-2 exposure will likely develop severe illness including MIS-C. Thus\nthere is an urgent need to develop a diagnostic modality to distinguish the varying phenotypes of disease and\nrisk stratify disease. The epigenetic changes in microRNA (miRNA) profiles that occur due to an infection can\nimpact disease severity by altering immune response and cytokine regulation which may be detected in body\nfluids including saliva. Our long-term goal is to improve outcomes of children with SARS-CoV-2 by early\nidentification and treatment of those at risk for severe illness. Our central hypothesis is that a model that\nintegrates salivary biomarkers with social and clinical determinants of health will predict disease severity in\nchildren with SARS-CoV-2 infection. The central hypothesis will be pursued through phased four specific aims.\nThe first two aims will be pursued during the R61 phase and include: 1) Define and compare the salivary\nmolecular host response in children with varying phenotypes (severe and non severe) SARS-CoV-2 infections\nand 2) Develop and validate a sensitive and specific model to predict severe SARS-CoV-2 illness in children.\nDuring the R33 phase we will pursue the following two aims: 3) Develop a portable, rapid device that quantifies\nsalivary miRNAs with comparable accuracy to predicate technology (qRT-PCR), and 4) Develop an artificial\nintelligence (AI) assisted cloud and mobile system for early recognition of severe SARS-CoV-2 infection in\nchildren. We will pursue the above aims using an innovative combination of salivaomics and bioinformatics,\nanalytic techniques of AI and clinical informatics. The proposed research is significant because development of\na sensitive model to risk stratify disease is expected to improve outcomes of children with severe SARS-CoV-2\ninfection via early recognition and timely intervention. The proximate expected outcome of this proposal is\nbetter understanding of the epigenetic regulation of host immune response to the viral infection which we\nexpect to lead to personalized therapy in the future. The results will have a positive impact immediately as it\nwill lead to the creation of patient profiles based on individual risk factors which can enable early identification\nof severe disease and appropriate resource allocation during the pandemic.",
       "awardCode": "R61",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 41,
       "label": "Grant",
       "name": "Severity Predictors Integrating salivary Transcriptomics and proteomics with Multi neural network Intelligence in SARS-CoV2 infection in Children (SPITS MISC)",
       "narrative": "This project is relevant to public health as development of a predictive model that integrates salivary\nbiomarkers with clinical and social determinants into a bedside tool will enable early identification of\nsevere COVID-19 in children, ensure appropriate resource allocation and aid in targeted treatment.",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nabstract:Children have been disproportionately less impacted by the Corona Virus Disease 2019 (COVID-19) caused\nby the Severe Acute Respiratory Syndrome Corona Virus 2 (SAR-CoV-2) compared to adults. However,\nsevere illnesses including Multisystem Inflammatory Syndrome (MIS-C) and respiratory failure have occurred\nin a small proportion of children with SARS-CoV-2 infection. Nearly 80% of children with MIS-C are critically ill\nwith a 2-4% mortality rate. Currently there are no modalities to characterize the spectrum of disease severity\nand predict which child with SARS-CoV-2 exposure will likely develop severe illness including MIS-C. Thus\nthere is an urgent need to develop a diagnostic modality to distinguish the varying phenotypes of disease and\nrisk stratify disease. The epigenetic changes in microRNA (miRNA) profiles that occur due to an infection can\nimpact disease severity by altering immune response and cytokine regulation which may be detected in body\nfluids including saliva. Our long-term goal is to improve outcomes of children with SARS-CoV-2 by early\nidentification and treatment of those at risk for severe illness. Our central hypothesis is that a model that\nintegrates salivary biomarkers with social and clinical determinants of health will predict disease severity in\nchildren with SARS-CoV-2 infection. The central hypothesis will be pursued through phased four specific aims.\nThe first two aims will be pursued during the R61 phase and include: 1) Define and compare the salivary\nmolecular host response in children with varying phenotypes (severe and non severe) SARS-CoV-2 infections\nand 2) Develop and validate a sensitive and specific model to predict severe SARS-CoV-2 illness in children.\nDuring the R33 phase we will pursue the following two aims: 3) Develop a portable, rapid device that quantifies\nsalivary miRNAs with comparable accuracy to predicate technology (qRT-PCR), and 4) Develop an artificial\nintelligence (AI) assisted cloud and mobile system for early recognition of severe SARS-CoV-2 infection in\nchildren. We will pursue the above aims using an innovative combination of salivaomics and bioinformatics,\nanalytic techniques of AI and clinical informatics. The proposed research is significant because development of\na sensitive model to risk stratify disease is expected to improve outcomes of children with severe SARS-CoV-2\ninfection via early recognition and timely intervention. The proximate expected outcome of this proposal is\nbetter understanding of the epigenetic regulation of host immune response to the viral infection which we\nexpect to lead to personalized therapy in the future. The results will have a positive impact immediately as it\nwill lead to the creation of patient profiles based on individual risk factors which can enable early identification\nof severe disease and appropriate resource allocation during the pandemic.\nid:R61HD105610\nnarrative:This project is relevant to public health as development of a predictive model that integrates salivary\nbiomarkers with clinical and social determinants into a bedside tool will enable early identification of\nsevere COVID-19 in children, ensure appropriate resource allocation and aid in targeted treatment.\nname:Severity Predictors Integrating salivary Transcriptomics and proteomics with Multi neural network Intelligence in SARS-CoV2 infection in Children (SPITS MISC)\nsubProject:PreVAIL kIds\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R61"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1834e62113624555a0d68a56fc891977": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 666,
       "target": 19
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "18882e21898f42b6b50a5e63243d8b34": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 633,
       "target": 571
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1891308cc5cc4a2a8d1426475b87c4af": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "CITES",
       "source": 3070,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1a07fac7c1154c31a1961d09d64fff66": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Daniel",
       "fullName": "Daniel Benjamin Horton",
       "id": 713,
       "label": "Researcher",
       "lastName": "Horton",
       "middleName": "Benjamin",
       "name": "Horton DB",
       "orcid": "orcid:0000-0002-1831-1339",
       "profileId": "profileid:11457621",
       "tooltip": "Researcher\nmiddleName:Benjamin\nid:profileid:11457621\nlastName:Horton\norcid:orcid:0000-0002-1831-1339\nprofileId:profileid:11457621\nname:Horton DB\nfullName:Daniel Benjamin Horton\nfirstName:Daniel"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1a9f632256e947d38d2ff48d7ff54023": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "IS_INVENTOR",
       "source": 689,
       "target": 2412
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1af63d596f7d4ff2b3a8f82825194e68": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Jesse",
       "fullName": "Jesse Vincent Jokerst",
       "id": 684,
       "label": "Researcher",
       "lastName": "Jokerst",
       "middleName": "Vincent",
       "name": "Jokerst JV",
       "orcid": "orcid:0000-0003-2829-6408",
       "profileId": "profileid:11288941",
       "tooltip": "Researcher\nmiddleName:Vincent\nid:profileid:11288941\nlastName:Jokerst\norcid:orcid:0000-0003-2829-6408\nprofileId:profileid:11288941\nname:Jokerst JV\nfullName:Jesse Vincent Jokerst\nfirstName:Jesse"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1b7799daad3e42a485149ae5543a2895": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1091,
       "target": 2816
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1bc5623b2b384bf09ac4346e49d6494f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Jordan",
       "fullName": "Jordan P Magrecki",
       "id": 299,
       "label": "Researcher",
       "lastName": "Magrecki",
       "middleName": "P",
       "name": "Magrecki JP",
       "tooltip": "Researcher\nmiddleName:P\nid:s2authorid:2222427326\nlastName:Magrecki\nname:Magrecki JP\nfullName:Jordan P Magrecki\nfirstName:Jordan"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1c176f8fbbe54bdab63ccacaf5082397": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4396,
       "label": "FundingOpportunity",
       "name": "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)",
       "tooltip": "FundingOpportunity\nid:PA-20-272\nname:Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)\nurl:https://grants.nih.gov/grants/guide/pa-files/PA-20-272.html",
       "url": "https://grants.nih.gov/grants/guide/pa-files/PA-20-272.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1c419b7f7a0a4a038553bf7170876f7f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 951,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1ca3066361054234bf3c3941e917df53": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "A well-recognized gap exists in the path from biomedical discovery in academia to clinical application and \ncommercialization of therapeutic, device, and diagnostic technologies in cardiovascular, pulmonary, \nhematologic, and sleep disorders. This chasm is the result of inadequate funding for support of proof-of-concept \nor validation studies essential for early stage development; insufficient access to the resources and \nexpertise needed to develop new technologies; and a lack of knowledge and experience among academic \ninvestigators in bringing new ideas to commercial realization. Within the partnering institutions included in \nthis application, the essential elements exist with which to build the infrastructure needed to support and \nsustain the uninterrupted, durable flow of inventions from discovery through development and \ncommercialization. While these institutions have a clear track record of remarkably successful development \nof many biomedical technologies, most of these commercial successes have been achieved by the tenacity \nof individual inventors rather than with the help of committed institutional mechanisms. We proposed to \naddress these key shortcomings by establishing the regional Boston Center for Accelerated Innovation in \nTherapeutics, Devices, and Diagnostics for Heart, Lung, Blood, and Sleep Disorders (B-BIC, or the Boston \nBiomedical Innovation Center). The key objectives of this Center are to: 1) develop an integrated \ninfrastructure that would expand the universe of commercializable technologies for heart, lung, blood, and \nsleep disorders; 2) place these opportunities in the proper evaluative context through an engagement (\"seed \nit\"), solicitation (\"find it\"), and selection (\"pick it\") strategy; 3) efficiently and effectively bring those selected to \nan appropriate exit point from the development process; and 4) provide the educational and mentoring \ninfrastructure necessary for the development of the proper entrepreneurial skills among academic \ninnovators. By achieving these goals, B-BlC would change the culture of our academic environment, as \nwell as the relationship between the public and private sectors in facilitating successful development \nstrategies for technologies in heart, lung, blood, and sleep disorders for the ultimate benefit of patients and society.",
       "awardCode": "U54",
       "fundingMechanism": "Research Centers",
       "id": 15,
       "label": "Grant",
       "name": "Boston Biomedical Innovation Center",
       "narrative": "Translation of basic observations into clinical practice is limited by the resources needed for development, \ninadequate experience of academic investigators, and the discovery-focused academic culture. Building an \nacademic infrastructure that facilitates translation by promoting development is an important goal to ensure \nthe successful translation of research into benefit for patients and society.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:A well-recognized gap exists in the path from biomedical discovery in academia to clinical application and \ncommercialization of therapeutic, device, and diagnostic technologies in cardiovascular, pulmonary, \nhematologic, and sleep disorders. This chasm is the result of inadequate funding for support of proof-of-concept \nor validation studies essential for early stage development; insufficient access to the resources and \nexpertise needed to develop new technologies; and a lack of knowledge and experience among academic \ninvestigators in bringing new ideas to commercial realization. Within the partnering institutions included in \nthis application, the essential elements exist with which to build the infrastructure needed to support and \nsustain the uninterrupted, durable flow of inventions from discovery through development and \ncommercialization. While these institutions have a clear track record of remarkably successful development \nof many biomedical technologies, most of these commercial successes have been achieved by the tenacity \nof individual inventors rather than with the help of committed institutional mechanisms. We proposed to \naddress these key shortcomings by establishing the regional Boston Center for Accelerated Innovation in \nTherapeutics, Devices, and Diagnostics for Heart, Lung, Blood, and Sleep Disorders (B-BIC, or the Boston \nBiomedical Innovation Center). The key objectives of this Center are to: 1) develop an integrated \ninfrastructure that would expand the universe of commercializable technologies for heart, lung, blood, and \nsleep disorders; 2) place these opportunities in the proper evaluative context through an engagement (\"seed \nit\"), solicitation (\"find it\"), and selection (\"pick it\") strategy; 3) efficiently and effectively bring those selected to \nan appropriate exit point from the development process; and 4) provide the educational and mentoring \ninfrastructure necessary for the development of the proper entrepreneurial skills among academic \ninnovators. By achieving these goals, B-BlC would change the culture of our academic environment, as \nwell as the relationship between the public and private sectors in facilitating successful development \nstrategies for technologies in heart, lung, blood, and sleep disorders for the ultimate benefit of patients and society.\nid:U54HL119145\nnarrative:Translation of basic observations into clinical practice is limited by the resources needed for development, \ninadequate experience of academic investigators, and the discovery-focused academic culture. Building an \nacademic infrastructure that facilitates translation by promoting development is an important goal to ensure \nthe successful translation of research into benefit for patients and society.\nname:Boston Biomedical Innovation Center\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:Research Centers\nawardCode:U54"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1cba806b5945468ca13482f04717cf64": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The ultimate goal of this proposal is to develop a novel platform technology for automatic surveillance\nand tracing of airborne SARS-CoV-2 virus particles in real time. The centerpiece of this proposal is the\n“Rolosense” technology which leverages a DNA micromotor as the virus sensing and transduction\nmaterial (VSTM) that can be detected by a conventional smart phone camera. This provides both\ngeographical tracing and surveillance. Rolosense motor are comprised a DNA-coated spherical particle\n(5 micrometer diameter) that hybridizes to a surface modified with complementary RNA. The particle\nmoves at speeds of over 1 micron/minute upon the addition of RNase H, which selectively hydrolyses\nhybridized RNA but not single-stranded RNA. DNA motors coated with virus binding ligand (VBL) stall\nin presence of SARS-CoV-2 virus particles. Because motors move autonomously for distances up to\nmillimeters without intervention, the assay is fully automated, and conventional steps such as viral\ninactivation, RNA isolation and amplification are not required. The readout is performed using an\nautomated smart phone app for particle tracking without the need for a spectrophotometer or\nfluorometer. Preliminary data shows realtime SARS-CoV-2 pseudovirus particle sensing. Milestones\ninclude the screening and identification of high affinity and high specificity VBLs. Both aptamers and\nantibody VBLs will be screening and validated. Simulations and experiments will be used to understand\nthe role of temperature and environmental conditions in modulating Rolosense performance.\nMultivalent display of VBLs with DNA origami will enhance avidity. Finally, microfluidic chips with\nairborne droplet capture will be implemented and tested. The work will be performed by a highly\ninterdisciplinary team with complementary expertise and a track-record of co-publications. PI Salaita\ninvented the Rolosense technology and has past experience in developing cell phone diagnostics and\nsynthetic motors. Co-I Melikian is an expert virologist, Co-I Heemstra is an expert at developing\naptamers for novel targets, Co-I Ke has extensive experience in DNA origami structures for avid target\nbinding and has co-authored work on Rolosense, Co-I Rajaraman and Primordia are experts at\nmicrofluidic device development and commercialization. Our solution offers the potential to provide an\nimmediate solution to today’s urgent virus sensing and tracing needs.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 0,
       "label": "Grant",
       "name": "Rolosense: An innovative platform for automatic mobile phone readout of active SARS-CoV-2 particles",
       "narrative": "Public Health Statement/Narrative\nThe aim of this proposal is to help reduce the spread of SARS-CoV-2 virus by\ndeveloping a surveillance technology that allows for realtime and fully automated viral\nsensing. The approach uses a smart phone camera to detect the displacement of\nmotors that are highly sensitive to the SARS-CoV-2 virus.",
       "researchInitiative": "RADx-rad",
       "subProject": "Automatic Detection & Tracing",
       "tooltip": "Grant\nabstract:The ultimate goal of this proposal is to develop a novel platform technology for automatic surveillance\nand tracing of airborne SARS-CoV-2 virus particles in real time. The centerpiece of this proposal is the\n“Rolosense” technology which leverages a DNA micromotor as the virus sensing and transduction\nmaterial (VSTM) that can be detected by a conventional smart phone camera. This provides both\ngeographical tracing and surveillance. Rolosense motor are comprised a DNA-coated spherical particle\n(5 micrometer diameter) that hybridizes to a surface modified with complementary RNA. The particle\nmoves at speeds of over 1 micron/minute upon the addition of RNase H, which selectively hydrolyses\nhybridized RNA but not single-stranded RNA. DNA motors coated with virus binding ligand (VBL) stall\nin presence of SARS-CoV-2 virus particles. Because motors move autonomously for distances up to\nmillimeters without intervention, the assay is fully automated, and conventional steps such as viral\ninactivation, RNA isolation and amplification are not required. The readout is performed using an\nautomated smart phone app for particle tracking without the need for a spectrophotometer or\nfluorometer. Preliminary data shows realtime SARS-CoV-2 pseudovirus particle sensing. Milestones\ninclude the screening and identification of high affinity and high specificity VBLs. Both aptamers and\nantibody VBLs will be screening and validated. Simulations and experiments will be used to understand\nthe role of temperature and environmental conditions in modulating Rolosense performance.\nMultivalent display of VBLs with DNA origami will enhance avidity. Finally, microfluidic chips with\nairborne droplet capture will be implemented and tested. The work will be performed by a highly\ninterdisciplinary team with complementary expertise and a track-record of co-publications. PI Salaita\ninvented the Rolosense technology and has past experience in developing cell phone diagnostics and\nsynthetic motors. Co-I Melikian is an expert virologist, Co-I Heemstra is an expert at developing\naptamers for novel targets, Co-I Ke has extensive experience in DNA origami structures for avid target\nbinding and has co-authored work on Rolosense, Co-I Rajaraman and Primordia are experts at\nmicrofluidic device development and commercialization. Our solution offers the potential to provide an\nimmediate solution to today’s urgent virus sensing and tracing needs.\nid:U01AA029345\nnarrative:Public Health Statement/Narrative\nThe aim of this proposal is to help reduce the spread of SARS-CoV-2 virus by\ndeveloping a surveillance technology that allows for realtime and fully automated viral\nsensing. The approach uses a smart phone camera to detect the displacement of\nmotors that are highly sensitive to the SARS-CoV-2 virus.\nname:Rolosense: An innovative platform for automatic mobile phone readout of active SARS-CoV-2 particles\nsubProject:Automatic Detection & Tracing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1cdf9db0e85f421780975a3c60256dc7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 618,
       "target": 554
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1d60908481af4b6cb2d38dc43ee0928c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 685,
       "target": 46
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1db0bae3cf9e4cecae1d7a5949b975c6": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4386,
       "target": 36
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "1fffe6e9e1f64ff4b9b9e8a5d47e5576": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 677,
       "target": 586
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "207100826c1b44cbbdab30b356ddd8ae": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2008,
       "name": "EMPLOYED_AT",
       "source": 706,
       "target": 562
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "20b3fee617064bb495e6fe183fd22602": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 2756,
       "label": "MetaNode",
       "name": "Name of the funding opportunity (string)",
       "nodeName": "FundingOpportunity",
       "tooltip": "MetaNode\nnodeName:FundingOpportunity\nname:Name of the funding opportunity (string)\nid:Unique identifier for the funding opportunity (Thesaurus:C20021) (string)\nurl:URL to funding opportunity description (string)",
       "url": "URL to funding opportunity description (string)"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "20c002a92efc4292a3749801b4f02c18": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 677,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "20dd6ed0c82640f384ed560af46a2e2c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "applicants": [
        "Washington University"
       ],
       "filingDate": "2023-03-30",
       "id": 2409,
       "inventors": [
        "Benjamin Sumlin",
        "Rajan Charkrabarty",
        "Nishit Jaideep Shetty",
        "John Cirrito",
        "Carla Yuede"
       ],
       "label": "Patent",
       "name": "Rapid, single-use methods and systems for electrochemical analysis of pathogens in exhaled breath \n       ",
       "status": "pending",
       "tooltip": "Patent\nid:WO2023192433\napplicants:['Washington University']\nstatus:pending\nname:Rapid, single-use methods and systems for electrochemical analysis of pathogens in exhaled breath \n       \nfilingDate:2023-03-30\ninventors:['Benjamin Sumlin', 'Rajan Charkrabarty', 'Nishit Jaideep Shetty', 'John Cirrito', 'Carla Yuede']\nurl:https://patents.google.com/patent/WO2023192433A1",
       "url": "https://patents.google.com/patent/WO2023192433A1"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "20f497ec387b48899616812f93822275": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "SAN FRANCISCO",
       "country": "UNITED STATES",
       "duns": "duns:094878337",
       "geonames": "geonames:5391959",
       "id": 591,
       "label": "Organization",
       "name": "University of California, San Francisco",
       "ror": "ror:043mz5j54",
       "state": "CA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5391959\nror:ror:043mz5j54\ncity:SAN FRANCISCO\nname:University of California, San Francisco\nuei:uei:KMH5K9V7S518\nduns:duns:094878337\nstate:CA\nid:ror:043mz5j54\nurl:https://ror.org/043mz5j54",
       "uei": "uei:KMH5K9V7S518",
       "url": "https://ror.org/043mz5j54"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "2125845b5d4f4b57b726a777ca273203": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "DETROIT",
       "country": "UNITED STATES",
       "duns": "duns:001962224",
       "id": 595,
       "label": "Organization",
       "state": "MI",
       "tooltip": "Organization\ncountry:UNITED STATES\ncity:DETROIT\nuei:uei:M6K6NTJ2MNE5\nduns:duns:001962224\nstate:MI\nid:uei:M6K6NTJ2MNE5",
       "uei": "uei:M6K6NTJ2MNE5"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "21ce7314a96d49cab6455bc6f5520ab9": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Roya",
       "fullName": "Roya Khosravi-Far",
       "id": 620,
       "label": "Researcher",
       "lastName": "Khosravi-Far",
       "name": "Khosravi-Far R",
       "profileId": "profileid:2191319",
       "tooltip": "Researcher\nid:profileid:2191319\nlastName:Khosravi-Far\nprofileId:profileid:2191319\nname:Khosravi-Far R\nfullName:Roya Khosravi-Far\nfirstName:Roya"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "221824a0b9d0415eba39d1c4e781a029": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "PHILADELPHIA",
       "country": "UNITED STATES",
       "duns": "duns:073757627",
       "geonames": "geonames:4560349",
       "id": 606,
       "label": "Organization",
       "name": "Children's Hospital of Philadelphia",
       "ror": "ror:01z7r7q48",
       "state": "PA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4560349\nror:ror:01z7r7q48\ncity:PHILADELPHIA\nname:Children's Hospital of Philadelphia\nuei:uei:G7MQPLSUX1L4\nduns:duns:073757627\nstate:PA\nid:ror:01z7r7q48\nurl:https://ror.org/01z7r7q48",
       "uei": "uei:G7MQPLSUX1L4",
       "url": "https://ror.org/01z7r7q48"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "224028fcf90a409f89a3a77c03806ebc": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Self-report of sudden loss of smell or taste substantially increases the odds of being infected with SARS-CoV-2\n(10 – 37-fold). However, self-report of smell function is an unreliable predictor of smell loss. Based on our\nexperience developing smell tests with personalized algorithms for asymptomatic detection of Alzheimer's\ndisease, we created a self-administered easy to use “at home” 5-minute objective smell test to uncover\nalterations in smell function unbeknownst to many individuals, and confer increased risk of infection by SARS-\nCoV-2. Our new smell test consists of a physical smell card containing peel and sniff odor labels and a web-\nbased application. The disposable smell card reduces the risk that the smell test serves as a vector of\ntransmission to other patients, research staff, and to health care workers. Each participant accesses the web-\nbased app on their own smartphone, tablet, or computer. In our pilot studies, we validated each participant's\nCOVID status by extracting results of clinical SARS-CoV-2 RT PCR assays from electronic health records. The\nsmell test provides better area under the curve for SARS-CoV-2 infection (0.83 – 0.85) in both US and\nArgentinian symptomatic patients (ages 19 - 87) than symptom tracking alone (0.66). We are expanding the\nsmell test from one smell card with three odors to 6 smell cards, each with 3 different odors (18 odors total).\nHaving six different versions of the smell card will afford longitudinal screening several times per week and\nprovide data to construct personalized thresholds for changes in olfactory function - each person serving as\ntheir own control and monitoring for diminishment of their expected performance based on their personal\ntrajectory rather than being based on population norms. Here we propose to develop a native app to conduct\nlongitudinal COVID Smell Test (Aim 1), collect data on asymptomatic health care workers, symptomatic\npatients, and undergraduates (Aim 2) and develop algorithms for the longitudinal smell test for personalized\nthresholds, differentiate smell loss from COVID relative to influenza, and assess risk of developing pulmonary\ndisease in COVID infected patients (Aim 3). The Longitudinal COVID Smell Test is accessible, affordable, and\nreadily scalable. Effective screening with the COVID smell test will better inform students and employees if\nthey should not report to school or work, and seek an evaluation by a healthcare professional and molecular\ntesting at an early, often asymptomatic, stage of the disease.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 10,
       "label": "Grant",
       "name": "Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2",
       "narrative": "Disturbances of smell and taste is the predominant symptom of infection by the SARS-CoV-2 virus, which is\nthe cause of the COVID-19 pandemic.. To identifying individuals at risk for SARS-CoV-2, we have developed a\nnovel technology to assess smell function at home using disposable smell cards. Here we propose to detect\nsigns of olfactory dysfunction in asymptomatic and symptomatic individuals with instantaneous return of a risk\nscore based on algorithms derived from validated COVID patients, leading to earlier self-quarantine and\nevaluation by a healthcare professional.",
       "researchInitiative": "RADx-rad",
       "subProject": "Chemosensory Testing",
       "tooltip": "Grant\nabstract:Self-report of sudden loss of smell or taste substantially increases the odds of being infected with SARS-CoV-2\n(10 – 37-fold). However, self-report of smell function is an unreliable predictor of smell loss. Based on our\nexperience developing smell tests with personalized algorithms for asymptomatic detection of Alzheimer's\ndisease, we created a self-administered easy to use “at home” 5-minute objective smell test to uncover\nalterations in smell function unbeknownst to many individuals, and confer increased risk of infection by SARS-\nCoV-2. Our new smell test consists of a physical smell card containing peel and sniff odor labels and a web-\nbased application. The disposable smell card reduces the risk that the smell test serves as a vector of\ntransmission to other patients, research staff, and to health care workers. Each participant accesses the web-\nbased app on their own smartphone, tablet, or computer. In our pilot studies, we validated each participant's\nCOVID status by extracting results of clinical SARS-CoV-2 RT PCR assays from electronic health records. The\nsmell test provides better area under the curve for SARS-CoV-2 infection (0.83 – 0.85) in both US and\nArgentinian symptomatic patients (ages 19 - 87) than symptom tracking alone (0.66). We are expanding the\nsmell test from one smell card with three odors to 6 smell cards, each with 3 different odors (18 odors total).\nHaving six different versions of the smell card will afford longitudinal screening several times per week and\nprovide data to construct personalized thresholds for changes in olfactory function - each person serving as\ntheir own control and monitoring for diminishment of their expected performance based on their personal\ntrajectory rather than being based on population norms. Here we propose to develop a native app to conduct\nlongitudinal COVID Smell Test (Aim 1), collect data on asymptomatic health care workers, symptomatic\npatients, and undergraduates (Aim 2) and develop algorithms for the longitudinal smell test for personalized\nthresholds, differentiate smell loss from COVID relative to influenza, and assess risk of developing pulmonary\ndisease in COVID infected patients (Aim 3). The Longitudinal COVID Smell Test is accessible, affordable, and\nreadily scalable. Effective screening with the COVID smell test will better inform students and employees if\nthey should not report to school or work, and seek an evaluation by a healthcare professional and molecular\ntesting at an early, often asymptomatic, stage of the disease.\nid:U01DC019579\nnarrative:Disturbances of smell and taste is the predominant symptom of infection by the SARS-CoV-2 virus, which is\nthe cause of the COVID-19 pandemic.. To identifying individuals at risk for SARS-CoV-2, we have developed a\nnovel technology to assess smell function at home using disposable smell cards. Here we propose to detect\nsigns of olfactory dysfunction in asymptomatic and symptomatic individuals with instantaneous return of a risk\nscore based on algorithms derived from validated COVID patients, leading to earlier self-quarantine and\nevaluation by a healthcare professional.\nname:Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2\nsubProject:Chemosensory Testing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "232311bb0e964ee79856c7f22edbc62f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "This work is directed at characterizing pediatric COVID-19 and stratifying incoming patients by projected\n(future) disease severity. Such stratification has several implications: immediately improving treatment planning, and\nas disease mechanistic pathways are uncovered, directing treatment. Predicting future severity will inform the risks of\noutpatient treatment; to the patients themselves, their family, other caregivers/cohabitants, and to schools and\nemployers. As varying levels of “reopening” are adopted across the country (and the world), such prognostication will\ninform policy on the handling of pediatric carriers in the community. Based on our preliminary analysis we assert that\na combination of novel assays including quantitative serology inflammatory markers (cytokine/chemokine profiles,\nimmune profiles), transcriptomics, epigenomics, longitudinal physiological monitoring, time series analysis, imaging,\nradiomics and clinical observation including social determinants of health, contains adequate information even at early\nstages of infection to stratify the disease and predict disease severity. We propose an artificial intelligence/machine\nlearning approach to integrate this rich and heterogeneous dataset, characterize the spectrum of disease and identify\nbiosignatures that predict severity in progressive disease. To facilitate translation of the approaches developed in this\nwork to a wide user community, we incorporate a Translational Development function, to oversee the design-control\nprocess and ensure readiness of our methods for regulatory review. Incorporated into our timelines are appropriate\nregulatory milestones intended to conform with the Emergency Use Authorization (EUA) programs in effect for SARS-\nCoV-2 diagnostics.",
       "awardCode": "R61",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 18,
       "label": "Grant",
       "name": "AICORE-kids: Artificial Intelligence COVID-19 Risk AssEssment for kids",
       "narrative": "We propose an artificial intelligence/machine learning approach to integrate a rich and heterogeneous dataset\non COVID-19 in children, characterize the spectrum of disease and identify biosignatures that predict severity in\nprogressive disease. To facilitate translation of the approaches developed in this work to a wide user community, we\nincorporate a Translational Development function, to oversee the design-control process and ensure readiness of our\nmethods for regulatory review. Incorporated into our timelines are appropriate regulatory milestones intended to\nconform with the Emergency Use Authorization (EUA) programs in effect for SARS-CoV-2 diagnostics.",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nresearchInitiative:RADx-rad\nnarrative:We propose an artificial intelligence/machine learning approach to integrate a rich and heterogeneous dataset\non COVID-19 in children, characterize the spectrum of disease and identify biosignatures that predict severity in\nprogressive disease. To facilitate translation of the approaches developed in this work to a wide user community, we\nincorporate a Translational Development function, to oversee the design-control process and ensure readiness of our\nmethods for regulatory review. Incorporated into our timelines are appropriate regulatory milestones intended to\nconform with the Emergency Use Authorization (EUA) programs in effect for SARS-CoV-2 diagnostics.\nname:AICORE-kids: Artificial Intelligence COVID-19 Risk AssEssment for kids\nsubProject:PreVAIL kIds\nfundingMechanism:Non-SBIR/STTR\nawardCode:R61\nabstract:This work is directed at characterizing pediatric COVID-19 and stratifying incoming patients by projected\n(future) disease severity. Such stratification has several implications: immediately improving treatment planning, and\nas disease mechanistic pathways are uncovered, directing treatment. Predicting future severity will inform the risks of\noutpatient treatment; to the patients themselves, their family, other caregivers/cohabitants, and to schools and\nemployers. As varying levels of “reopening” are adopted across the country (and the world), such prognostication will\ninform policy on the handling of pediatric carriers in the community. Based on our preliminary analysis we assert that\na combination of novel assays including quantitative serology inflammatory markers (cytokine/chemokine profiles,\nimmune profiles), transcriptomics, epigenomics, longitudinal physiological monitoring, time series analysis, imaging,\nradiomics and clinical observation including social determinants of health, contains adequate information even at early\nstages of infection to stratify the disease and predict disease severity. We propose an artificial intelligence/machine\nlearning approach to integrate this rich and heterogeneous dataset, characterize the spectrum of disease and identify\nbiosignatures that predict severity in progressive disease. To facilitate translation of the approaches developed in this\nwork to a wide user community, we incorporate a Translational Development function, to oversee the design-control\nprocess and ensure readiness of our methods for regulatory review. Incorporated into our timelines are appropriate\nregulatory milestones intended to conform with the Emergency Use Authorization (EUA) programs in effect for SARS-\nCoV-2 diagnostics.\nid:R61HD105593"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "23548ae34ce74aeb8c86b04357b28fab": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2018,
       "name": "EMPLOYED_AT",
       "source": 711,
       "target": 560
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "237dcb6cd55a48a092bb2ce096ea2684": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 681,
       "target": 40
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "253788284c34414d8a8af430e928fada": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "In recent times, the global landscape of disease detection and monitoring has been profoundly influenced by the convergence of nanotechnology and biosensing techniques. Biosensors have enormous potential to monitor human health, with flexible or wearable variants, through monitoring of biomarkers in clinical and biological behaviors and applications related to health and disease, with increasing biorecognition, sensitivity, selectivity, and accuracy. The emergence of nanomaterial-based biosensors has ushered in a new era of rapid and sensitive diagnostic tools, offering unparalleled capabilities in the realm of disease identification. Even after the declaration of the end of the COVID-19 pandemic, the demand for efficient and accessible diagnostic methodologies has grown exponentially. In response, the integration of nanomaterial biosensors into breathalyzer devices has gained considerable attention as a promising avenue for low-cost, non-invasive, and early detection of COVID-19. This review delves into the forefront of scientific advancements, exploring the potential of emerging nanomaterial biosensors within breathalyzers to revolutionize the landscape of COVID-19 detection, providing a comprehensive overview of their principles, applications, and implications.",
       "doi": "doi:10.3390/inorganics11120483",
       "id": 3070,
       "journal": "Inorganics",
       "label": "Publication",
       "name": "Emerging Nanomaterials Biosensors in Breathalyzers for Detection of COVID-19: Future Prospects",
       "tooltip": "Publication\njournal:Inorganics\nabstract:In recent times, the global landscape of disease detection and monitoring has been profoundly influenced by the convergence of nanotechnology and biosensing techniques. Biosensors have enormous potential to monitor human health, with flexible or wearable variants, through monitoring of biomarkers in clinical and biological behaviors and applications related to health and disease, with increasing biorecognition, sensitivity, selectivity, and accuracy. The emergence of nanomaterial-based biosensors has ushered in a new era of rapid and sensitive diagnostic tools, offering unparalleled capabilities in the realm of disease identification. Even after the declaration of the end of the COVID-19 pandemic, the demand for efficient and accessible diagnostic methodologies has grown exponentially. In response, the integration of nanomaterial biosensors into breathalyzer devices has gained considerable attention as a promising avenue for low-cost, non-invasive, and early detection of COVID-19. This review delves into the forefront of scientific advancements, exploring the potential of emerging nanomaterial biosensors within breathalyzers to revolutionize the landscape of COVID-19 detection, providing a comprehensive overview of their principles, applications, and implications.\nid:doi:10.3390/inorganics11120483\nname:Emerging Nanomaterials Biosensors in Breathalyzers for Detection of COVID-19: Future Prospects\nyear:2023\ntype:secondary\nurl:https://doi.org/doi:10.3390/inorganics11120483\ndoi:doi:10.3390/inorganics11120483",
       "type": "secondary",
       "url": "https://doi.org/doi:10.3390/inorganics11120483",
       "year": 2023
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "254507028a684e45aa18b9233d45d4eb": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4395,
       "label": "FundingOpportunity",
       "name": "NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Not Allowed)",
       "tooltip": "FundingOpportunity\nname:NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Not Allowed)\nid:RFA-OD-19-014\nurl:https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-014.html",
       "url": "https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-19-014.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "260932de672941838e1ba550c1905aee": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4390,
       "target": 8
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "262c29a5d5ca44a39a23b832eb0bcce5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Mark",
       "fullName": "Mark W Albers",
       "id": 618,
       "label": "Researcher",
       "lastName": "Albers",
       "middleName": "W",
       "name": "Albers MW",
       "orcid": "orcid:0000-0001-7855-3455",
       "profileId": "profileid:6625336",
       "tooltip": "Researcher\nmiddleName:W\nid:profileid:6625336\nlastName:Albers\norcid:orcid:0000-0001-7855-3455\nprofileId:profileid:6625336\nname:Albers MW\nfullName:Mark W Albers\nfirstName:Mark"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "26aaacc010e14066b37c239477f53f29": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 716,
       "target": 38
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "27ab51974c714eb1a053f248f309f9e4": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Self-report of sudden loss of smell or taste substantially increases the odds of being infected with SARS-CoV-2\n(10 – 37-fold). However, self-report of smell function is an unreliable predictor of smell loss. Based on our\nexperience developing smell tests with personalized algorithms for asymptomatic detection of Alzheimer's\ndisease, we created a self-administered easy to use “at home” 5-minute objective smell test to uncover\nalterations in smell function unbeknownst to many individuals, and confer increased risk of infection by SARS-\nCoV-2. Our new smell test consists of a physical smell card containing peel and sniff odor labels and a web-\nbased application. The disposable smell card reduces the risk that the smell test serves as a vector of\ntransmission to other patients, research staff, and to health care workers. Each participant accesses the web-\nbased app on their own smartphone, tablet, or computer. In our pilot studies, we validated each participant's\nCOVID status by extracting results of clinical SARS-CoV-2 RT PCR assays from electronic health records. The\nsmell test provides better area under the curve for SARS-CoV-2 infection (0.83 – 0.85) in both US and\nArgentinian symptomatic patients (ages 19 - 87) than symptom tracking alone (0.66). We are expanding the\nsmell test from one smell card with three odors to 6 smell cards, each with 3 different odors (18 odors total).\nHaving six different versions of the smell card will afford longitudinal screening several times per week and\nprovide data to construct personalized thresholds for changes in olfactory function - each person serving as\ntheir own control and monitoring for diminishment of their expected performance based on their personal\ntrajectory rather than being based on population norms. Here we propose to develop a native app to conduct\nlongitudinal COVID Smell Test (Aim 1), collect data on asymptomatic health care workers, symptomatic\npatients, and undergraduates (Aim 2) and develop algorithms for the longitudinal smell test for personalized\nthresholds, differentiate smell loss from COVID relative to influenza, and assess risk of developing pulmonary\ndisease in COVID infected patients (Aim 3). The Longitudinal COVID Smell Test is accessible, affordable, and\nreadily scalable. Effective screening with the COVID smell test will better inform students and employees if\nthey should not report to school or work, and seek an evaluation by a healthcare professional and molecular\ntesting at an early, often asymptomatic, stage of the disease.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 10,
       "label": "Grant",
       "name": "Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2",
       "narrative": "Disturbances of smell and taste is the predominant symptom of infection by the SARS-CoV-2 virus, which is\nthe cause of the COVID-19 pandemic.. To identifying individuals at risk for SARS-CoV-2, we have developed a\nnovel technology to assess smell function at home using disposable smell cards. Here we propose to detect\nsigns of olfactory dysfunction in asymptomatic and symptomatic individuals with instantaneous return of a risk\nscore based on algorithms derived from validated COVID patients, leading to earlier self-quarantine and\nevaluation by a healthcare professional.",
       "researchInitiative": "RADx-rad",
       "subProject": "Chemosensory Testing",
       "tooltip": "Grant\nabstract:Self-report of sudden loss of smell or taste substantially increases the odds of being infected with SARS-CoV-2\n(10 – 37-fold). However, self-report of smell function is an unreliable predictor of smell loss. Based on our\nexperience developing smell tests with personalized algorithms for asymptomatic detection of Alzheimer's\ndisease, we created a self-administered easy to use “at home” 5-minute objective smell test to uncover\nalterations in smell function unbeknownst to many individuals, and confer increased risk of infection by SARS-\nCoV-2. Our new smell test consists of a physical smell card containing peel and sniff odor labels and a web-\nbased application. The disposable smell card reduces the risk that the smell test serves as a vector of\ntransmission to other patients, research staff, and to health care workers. Each participant accesses the web-\nbased app on their own smartphone, tablet, or computer. In our pilot studies, we validated each participant's\nCOVID status by extracting results of clinical SARS-CoV-2 RT PCR assays from electronic health records. The\nsmell test provides better area under the curve for SARS-CoV-2 infection (0.83 – 0.85) in both US and\nArgentinian symptomatic patients (ages 19 - 87) than symptom tracking alone (0.66). We are expanding the\nsmell test from one smell card with three odors to 6 smell cards, each with 3 different odors (18 odors total).\nHaving six different versions of the smell card will afford longitudinal screening several times per week and\nprovide data to construct personalized thresholds for changes in olfactory function - each person serving as\ntheir own control and monitoring for diminishment of their expected performance based on their personal\ntrajectory rather than being based on population norms. Here we propose to develop a native app to conduct\nlongitudinal COVID Smell Test (Aim 1), collect data on asymptomatic health care workers, symptomatic\npatients, and undergraduates (Aim 2) and develop algorithms for the longitudinal smell test for personalized\nthresholds, differentiate smell loss from COVID relative to influenza, and assess risk of developing pulmonary\ndisease in COVID infected patients (Aim 3). The Longitudinal COVID Smell Test is accessible, affordable, and\nreadily scalable. Effective screening with the COVID smell test will better inform students and employees if\nthey should not report to school or work, and seek an evaluation by a healthcare professional and molecular\ntesting at an early, often asymptomatic, stage of the disease.\nid:U01DC019579\nnarrative:Disturbances of smell and taste is the predominant symptom of infection by the SARS-CoV-2 virus, which is\nthe cause of the COVID-19 pandemic.. To identifying individuals at risk for SARS-CoV-2, we have developed a\nnovel technology to assess smell function at home using disposable smell cards. Here we propose to detect\nsigns of olfactory dysfunction in asymptomatic and symptomatic individuals with instantaneous return of a risk\nscore based on algorithms derived from validated COVID patients, leading to earlier self-quarantine and\nevaluation by a healthcare professional.\nname:Longitudinal At Home Smell Testing to Detect Infection by SARS-CoV-2\nsubProject:Chemosensory Testing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "27da58b9d88a4b0b85af43831f0cd420": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4400,
       "label": "FundingOpportunity",
       "name": "Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)",
       "tooltip": "FundingOpportunity\nname:Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)\nid:PA-21-268\nurl:https://grants.nih.gov/grants/guide/pa-files/PA-21-268.html",
       "url": "https://grants.nih.gov/grants/guide/pa-files/PA-21-268.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "27ef892186e94689886e8704a2dbca31": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Cedric",
       "fullName": "Cedric Manlhiot",
       "id": 663,
       "label": "Researcher",
       "lastName": "Manlhiot",
       "name": "Manlhiot C",
       "orcid": "orcid:0000-0001-9419-7681",
       "profileId": "profileid:16231045",
       "tooltip": "Researcher\nid:profileid:16231045\nlastName:Manlhiot\norcid:orcid:0000-0001-9419-7681\nprofileId:profileid:16231045\nname:Manlhiot C\nfullName:Cedric Manlhiot\nfirstName:Cedric"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "280a9d092b504e40a5ece81141b5ff80": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Multi-Modal Wireless COVID Monitoring & Infection Alerts for Concentrated Populations\nAbstract: The high aerosolized transmissibility of COVID, long asymptomatic incubation period,\nand highly variable presentation attributes of the COVID pandemic have proven challenging in\nmany settings where patchwork pandemic responses have disproportionately negatively\nimpacted vulnerable socioeconomic, minority, and disabled sub-populations. Unfortunately, these\ndire trends are only made more acute in settings that feature populations with limited mobility and\nlittle to no ability to self-isolate (dense concentrated populations [DCPs]), such as residential\nnursing homes, schools, drug rehabilitation services, prison and psychiatric facility populations,\nand high-frequency essential medical services, such as chemotherapy infusion clinics or dialysis\nunits. In these DCP settings, limited diagnostic testing, prolonged indoor contact, limitations in\ncleaning and filtration capacities, support staff shortages, pre-existing comorbidities, and lack of\neffective infectious disease surveillance systems all collude to drive an increased COVID burden\nin DCPs. From this, it is clear that alternative detection strategies for DCPs are urgently needed\nto improve local capacity to monitor COVID outbreaks, mitigate their spread, and thus reduce\ninequitable disease and mortality burdens in these under-resourced and often overcrowded\nsettings. In previous work, we developed a first generation detection system using heart rate data\nfrom commercially-available Fitbit Ionic wearable devices to detect the onset of COVID and other\ninfectious diseases up to 10 days before users self-reported symptom onset (overall sensitivity\n67% prior to symptom onset). Here, we propose to further develop this system for the improved\ndetection of COVID and other infectious diseases in DCPs using existing wearable fitness devices\nin a wireless and interoperable digital health framework that centralizes all wearable-derived data\non PHD while tailoring its presentation and health event alert system to the IT capabilities and\nneeds of each DCP setting. In this, not only will we adapt our existing infection detection\nalgorithms for each DCP’s particular baseline characteristics, IT infrastructure, and needs, but\nalso use incoming data to further optimize the performance of those algorithms for continuous\nimprovement in the sensitivity, specificity, and alert lead time for COVID onset. This will quickly\nenable under-resourced DCP support staff to access and use world-class COVID surveillance\ndata in identifying individual infection events, implementing isolation, cleaning, and testing\npolicies, and minimizing transmission, thus reducing the burden of COVID in DCP settings and\nreducing DCP morbidity and mortality overall.",
       "awardCode": "R01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 34,
       "label": "Grant",
       "name": "Multi-Modal Wireless COVID Monitoring & Infection Alerts for Concentrated Populations",
       "narrative": "Multi-Modal Wireless COVID Monitoring & Infection Alerts for Concentrated Populations\nNarrative: The myriad risks and health burdens accompanying the ongoing COVID pandemic\nhave disproportionately impacted under-resourced settings with dense, concentrated populations\nthat cannot readily transition to isolation or remote care. While diagnostic testing is increasingly\navailable, it remains inaccessible to too many and highlights an urgent unmet need for alternative\nmethods to detect COVID infection and spread. In previous work using online machine learning\nand commercially-available fitness wearables, we have demonstrated remote detection of COVID\nonset up to 7 days in advance of symptoms, which we here propose to optimize and extend to\ndiverse dense concentrated population settings for ongoing and effective COVID surveillance.",
       "researchInitiative": "RADx-rad",
       "subProject": "Multimodal Surveillance",
       "tooltip": "Grant\nabstract:Multi-Modal Wireless COVID Monitoring & Infection Alerts for Concentrated Populations\nAbstract: The high aerosolized transmissibility of COVID, long asymptomatic incubation period,\nand highly variable presentation attributes of the COVID pandemic have proven challenging in\nmany settings where patchwork pandemic responses have disproportionately negatively\nimpacted vulnerable socioeconomic, minority, and disabled sub-populations. Unfortunately, these\ndire trends are only made more acute in settings that feature populations with limited mobility and\nlittle to no ability to self-isolate (dense concentrated populations [DCPs]), such as residential\nnursing homes, schools, drug rehabilitation services, prison and psychiatric facility populations,\nand high-frequency essential medical services, such as chemotherapy infusion clinics or dialysis\nunits. In these DCP settings, limited diagnostic testing, prolonged indoor contact, limitations in\ncleaning and filtration capacities, support staff shortages, pre-existing comorbidities, and lack of\neffective infectious disease surveillance systems all collude to drive an increased COVID burden\nin DCPs. From this, it is clear that alternative detection strategies for DCPs are urgently needed\nto improve local capacity to monitor COVID outbreaks, mitigate their spread, and thus reduce\ninequitable disease and mortality burdens in these under-resourced and often overcrowded\nsettings. In previous work, we developed a first generation detection system using heart rate data\nfrom commercially-available Fitbit Ionic wearable devices to detect the onset of COVID and other\ninfectious diseases up to 10 days before users self-reported symptom onset (overall sensitivity\n67% prior to symptom onset). Here, we propose to further develop this system for the improved\ndetection of COVID and other infectious diseases in DCPs using existing wearable fitness devices\nin a wireless and interoperable digital health framework that centralizes all wearable-derived data\non PHD while tailoring its presentation and health event alert system to the IT capabilities and\nneeds of each DCP setting. In this, not only will we adapt our existing infection detection\nalgorithms for each DCP’s particular baseline characteristics, IT infrastructure, and needs, but\nalso use incoming data to further optimize the performance of those algorithms for continuous\nimprovement in the sensitivity, specificity, and alert lead time for COVID onset. This will quickly\nenable under-resourced DCP support staff to access and use world-class COVID surveillance\ndata in identifying individual infection events, implementing isolation, cleaning, and testing\npolicies, and minimizing transmission, thus reducing the burden of COVID in DCP settings and\nreducing DCP morbidity and mortality overall.\nid:R01NR020105\nnarrative:Multi-Modal Wireless COVID Monitoring & Infection Alerts for Concentrated Populations\nNarrative: The myriad risks and health burdens accompanying the ongoing COVID pandemic\nhave disproportionately impacted under-resourced settings with dense, concentrated populations\nthat cannot readily transition to isolation or remote care. While diagnostic testing is increasingly\navailable, it remains inaccessible to too many and highlights an urgent unmet need for alternative\nmethods to detect COVID infection and spread. In previous work using online machine learning\nand commercially-available fitness wearables, we have demonstrated remote detection of COVID\nonset up to 7 days in advance of symptoms, which we here propose to optimize and extend to\ndiverse dense concentrated population settings for ongoing and effective COVID surveillance.\nname:Multi-Modal Wireless COVID Monitoring & Infection Alerts for Concentrated Populations\nsubProject:Multimodal Surveillance\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "29811122aec847e5b2d9ac191481e7d2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 996,
       "target": 2817
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "29833c22ca5a49beb35c01eaf048cc69": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Jesse",
       "fullName": "Jesse Vincent Jokerst",
       "id": 684,
       "label": "Researcher",
       "lastName": "Jokerst",
       "middleName": "Vincent",
       "name": "Jokerst JV",
       "orcid": "orcid:0000-0003-2829-6408",
       "profileId": "profileid:11288941",
       "tooltip": "Researcher\nmiddleName:Vincent\nid:profileid:11288941\nlastName:Jokerst\norcid:orcid:0000-0003-2829-6408\nprofileId:profileid:11288941\nname:Jokerst JV\nfullName:Jesse Vincent Jokerst\nfirstName:Jesse"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "29b30f41d8a241bba1caf3c4dc0ed004": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "IS_INVENTOR",
       "source": 617,
       "target": 2408
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "2bb1321999dd49339efab65309f38b19": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 626,
       "target": 33
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "2bca1441c11f42468ee132695d6dc462": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "CARY",
       "country": "UNITED STATES",
       "duns": "duns:117302365",
       "geonames": "geonames:4459467",
       "id": 600,
       "label": "Organization",
       "name": "Atom Bioworks, Inc.",
       "state": "NC",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4459467\ncity:CARY\nname:Atom Bioworks, Inc.\nuei:uei:ZGKNGJMR7185\nduns:duns:117302365\nstate:NC\nid:uei:ZGKNGJMR7185",
       "uei": "uei:ZGKNGJMR7185"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "2be1317ef9784c299b7c326dea315d68": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 957,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "2c638d505e2542b5ac926f9c7e57796a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4394,
       "label": "FundingOpportunity",
       "name": "Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional)",
       "tooltip": "FundingOpportunity\nname:Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional)\nid:RFA-OD-20-022\nurl:https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-022.html",
       "url": "https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-022.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "2ce8df62941447bc9bad6be5adc1369d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 684,
       "target": 43
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "2e7ee267ba51431f856fe65bd4028f6f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Ananth",
       "fullName": "Ananth V Annapragada",
       "id": 665,
       "label": "Researcher",
       "lastName": "Annapragada",
       "middleName": "V",
       "name": "Annapragada AV",
       "orcid": "orcid:0000-0002-3156-9617",
       "profileId": "profileid:7039414",
       "tooltip": "Researcher\nmiddleName:V\nid:profileid:7039414\nlastName:Annapragada\norcid:orcid:0000-0002-3156-9617\nprofileId:profileid:7039414\nname:Annapragada AV\nfullName:Ananth V Annapragada\nfirstName:Ananth"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "2e878a250c024ab38cb864576b8fba28": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Wastewater Assessment for Coronavirus in Kentucky – Implementing Enhanced Surveillance\nTechnology\nSurveillance for SARS-CoV-2 is hindered by the availability of testing, particularly in remote and rural\nareas. Screening of wastewater for SARS-CoV-2 viral biomarkers offers a viable alternative to individual\ntesting and it can identify communities and facilities that are at risk of becoming hotspots.Wastewater\nsurveillance overcomes several limitations of clinical surveillance, such as the need for robust healthcare\nand laboratory infrastructure and the lack of representative and comprehensive testing within\ncommunities. Conventional wastewater surveillance takes samples from sewer systems or wastewater\ntreatment facilities and uses a series of extraction steps prior to advanced PCR technology to quantitate\nthe viral biomarker (RNA). This approach is time and resource-intensive, which limits its wide-scale\napplication. Developing next generation technology to simplify wastewater RNA extraction and\nquantitation will make it feasible to use more broadly at facilities and in rural communities. The limited\nclinical testing for COVID-19 in rural Southeastern Kentucky hampers disease surveillance and prevents\ninformed public action to mitigate and contain the spread of disease. Wastewater testing for SARS-CoV-\n2 in these communities using field-friendly technology will provide important information to local\nauthorities and citizens about the spread and trend of SARS-CoV-2 infection in their communities. Our\nproject will accomplish two aims: 1) Develop next generation wastewater assessment technology and 2)\nImplement and evaluate the next generation wastewater assay. For Aim 1 we adapt technology invented\nby our team termed exclusion-based sample preparation (ESP) to simplify and improve RNA extraction\nfrom wastewater. We will pair ESP with loop-mediated isothermal amplification (LAMP) technology for\nRNA detection to create a sensitive, robust, and field-friendly platform for testing wastewater for SARS-\nCoV-2 RNA. We will compare the next generation assay with established techniques on metrics of\nsensitivity, specificity, and usability (e.g., assay time, number of assay steps). For Aim 2 we will first\nvalidate the next generation assay in the field at congregate living facilities in a side-by-side comparison\nwith conventional wastewater surveillance. Next, building on existing relationships in Appalachian\nKentucky, we will recruit and train a purposive group of wastewater treatment plant operators, watershed\nwatch citizen scientists, and school science teachers to test wastewater in their communities and schools\nusing the field-friendly next generation wastewater assay. Field results will be validated in the lab. A\nrobust mixed methods evaluation using the RE-AIM framework will assess community perceptions of\nfeasibility, acceptability, and utility of wastewater surveillance for SARS-CoV-2 and identify community\nmeasures taken in response to test results.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 45,
       "label": "Grant",
       "name": "Wastewater Assessment for Coronavirus in Kentucky: Implementing Enhanced Surveillance Technology",
       "narrative": "The goal of this project is to develop a “next generation” assay for the identification of SARS-CoV-2 in\nwastewater, which serves as a biomarker of community infection in contrast to more expensive and labor-\nintensive clinical testing. Existing wastewater assays have several limitations that reduce their accuracy and\nprevent use in remote and rural settings where disease surveillance could inform public action. Thus, we plan to\ndevelop, optimize, and validate a new “point-of-acquisition” SARS-CoV-2 assay that enables us to rapidly\nquantify the amount of coronavirus RNA in a wastewater sample, such that additional precautions (e.g.\nindividual testing, infection prevention measures) can be taken when needed.",
       "researchInitiative": "RADx-rad",
       "subProject": "Wastewater",
       "tooltip": "Grant\nabstract:Wastewater Assessment for Coronavirus in Kentucky – Implementing Enhanced Surveillance\nTechnology\nSurveillance for SARS-CoV-2 is hindered by the availability of testing, particularly in remote and rural\nareas. Screening of wastewater for SARS-CoV-2 viral biomarkers offers a viable alternative to individual\ntesting and it can identify communities and facilities that are at risk of becoming hotspots.Wastewater\nsurveillance overcomes several limitations of clinical surveillance, such as the need for robust healthcare\nand laboratory infrastructure and the lack of representative and comprehensive testing within\ncommunities. Conventional wastewater surveillance takes samples from sewer systems or wastewater\ntreatment facilities and uses a series of extraction steps prior to advanced PCR technology to quantitate\nthe viral biomarker (RNA). This approach is time and resource-intensive, which limits its wide-scale\napplication. Developing next generation technology to simplify wastewater RNA extraction and\nquantitation will make it feasible to use more broadly at facilities and in rural communities. The limited\nclinical testing for COVID-19 in rural Southeastern Kentucky hampers disease surveillance and prevents\ninformed public action to mitigate and contain the spread of disease. Wastewater testing for SARS-CoV-\n2 in these communities using field-friendly technology will provide important information to local\nauthorities and citizens about the spread and trend of SARS-CoV-2 infection in their communities. Our\nproject will accomplish two aims: 1) Develop next generation wastewater assessment technology and 2)\nImplement and evaluate the next generation wastewater assay. For Aim 1 we adapt technology invented\nby our team termed exclusion-based sample preparation (ESP) to simplify and improve RNA extraction\nfrom wastewater. We will pair ESP with loop-mediated isothermal amplification (LAMP) technology for\nRNA detection to create a sensitive, robust, and field-friendly platform for testing wastewater for SARS-\nCoV-2 RNA. We will compare the next generation assay with established techniques on metrics of\nsensitivity, specificity, and usability (e.g., assay time, number of assay steps). For Aim 2 we will first\nvalidate the next generation assay in the field at congregate living facilities in a side-by-side comparison\nwith conventional wastewater surveillance. Next, building on existing relationships in Appalachian\nKentucky, we will recruit and train a purposive group of wastewater treatment plant operators, watershed\nwatch citizen scientists, and school science teachers to test wastewater in their communities and schools\nusing the field-friendly next generation wastewater assay. Field results will be validated in the lab. A\nrobust mixed methods evaluation using the RE-AIM framework will assess community perceptions of\nfeasibility, acceptability, and utility of wastewater surveillance for SARS-CoV-2 and identify community\nmeasures taken in response to test results.\nid:U01DA053903\nnarrative:The goal of this project is to develop a “next generation” assay for the identification of SARS-CoV-2 in\nwastewater, which serves as a biomarker of community infection in contrast to more expensive and labor-\nintensive clinical testing. Existing wastewater assays have several limitations that reduce their accuracy and\nprevent use in remote and rural settings where disease surveillance could inform public action. Thus, we plan to\ndevelop, optimize, and validate a new “point-of-acquisition” SARS-CoV-2 assay that enables us to rapidly\nquantify the amount of coronavirus RNA in a wastewater sample, such that additional precautions (e.g.\nindividual testing, infection prevention measures) can be taken when needed.\nname:Wastewater Assessment for Coronavirus in Kentucky: Implementing Enhanced Surveillance Technology\nsubProject:Wastewater\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "2ebb4fa54d7746f28599f73f01dd2665": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2021,
       "name": "EMPLOYED_AT",
       "source": 651,
       "target": 604
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "2f0e2975fc98450e93e00f12ea2e4dae": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "LA JOLLA",
       "country": "UNITED STATES",
       "duns": "duns:804355790",
       "geonames": "geonames:5391811",
       "id": 556,
       "label": "Organization",
       "name": "University of California, San Diego",
       "ror": "ror:0168r3w48",
       "state": "CA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5391811\nror:ror:0168r3w48\ncity:LA JOLLA\nname:University of California, San Diego\nuei:uei:UYTTZT6G9DT1\nduns:duns:804355790\nstate:CA\nid:ror:0168r3w48\nurl:https://ror.org/0168r3w48",
       "uei": "uei:UYTTZT6G9DT1",
       "url": "https://ror.org/0168r3w48"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "308222f895b440a083e99238b7ff5f4e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4387,
       "label": "FundingOpportunity",
       "name": "Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with  Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)",
       "tooltip": "FundingOpportunity\nname:Emergency Awards: RADx-rad Predicting Viral-Associated Inflammatory Disease Severity in Children with  Laboratory Diagnostics and Artificial Intelligence (PreVAIL kIds) (R61/R33 Clinical Trial Optional)\nid:RFA-OD-20-023\nurl:https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-023.html",
       "url": "https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-023.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "30a6c41d28af4aab83d7497502f04414": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "This U18 application is responsive to the NIH’s RADx-rad Emergency Responses to the COVID-\npandemic for new or non-traditional technologies developed for single extracellular vesicle, exosome and\nextracellular RNA (exRNA) isolation and analysis and reposition them for detection of SARS-CoV-2. The\napplicant’s group is a grantee in the NIH Common Fund “Extracellular RNA Communication (ERC)” Program\nadvancing a new and emerging technology of Acoustofluidic Separation (AFS) for label-free, high yield and purity\nexosomes from biofluids which is coupled to extracellular RNA characterization using Surface Enhanced Raman\nSpectroscopy (SERS) for single EV identification. This U18 application is to reposition the AFS EV technology\nand SERS for the non-invasive earliest detection of SARS-CoV-2 in saliva of infected patients. Host immunity to\nSARS-CoV-2 will also be assessed in the saliva samples, permitting the earliest detection of SARS-CoV-2\ninfection and host immunity non-invasively in a saliva sample.\n Five Specific Aims are in place to reposition the saliva-based AFS and SERS technologies, in a 2-year\nU18 proposal, to test the hypothesis that an integrated multi-parametric non-invasive saliva test for SARS-CoV-\n2 infection, viral load and host immunity test demonstrating clinical performance surpassing current saliva-based\nSARS-CoV-2 EUA tests.",
       "awardCode": "U18",
       "fundingMechanism": "Other Research-Related",
       "id": 17,
       "label": "Grant",
       "name": "AFS/SERS Saliva-based SARS-CoV-2 Earliest Infection and Antibodies Detection",
       "narrative": "This U18 application to develop exosome-based non-traditional technology for point-of-care sampling\nand non-invasive earliest detection of SARS-CoV-2 infection and COVID-19 antibodies detection, for population\nlevel testing for COVID-19 infection and immunity.",
       "researchInitiative": "RADx-rad",
       "subProject": "Exosome",
       "tooltip": "Grant\nabstract:This U18 application is responsive to the NIH’s RADx-rad Emergency Responses to the COVID-\npandemic for new or non-traditional technologies developed for single extracellular vesicle, exosome and\nextracellular RNA (exRNA) isolation and analysis and reposition them for detection of SARS-CoV-2. The\napplicant’s group is a grantee in the NIH Common Fund “Extracellular RNA Communication (ERC)” Program\nadvancing a new and emerging technology of Acoustofluidic Separation (AFS) for label-free, high yield and purity\nexosomes from biofluids which is coupled to extracellular RNA characterization using Surface Enhanced Raman\nSpectroscopy (SERS) for single EV identification. This U18 application is to reposition the AFS EV technology\nand SERS for the non-invasive earliest detection of SARS-CoV-2 in saliva of infected patients. Host immunity to\nSARS-CoV-2 will also be assessed in the saliva samples, permitting the earliest detection of SARS-CoV-2\ninfection and host immunity non-invasively in a saliva sample.\n Five Specific Aims are in place to reposition the saliva-based AFS and SERS technologies, in a 2-year\nU18 proposal, to test the hypothesis that an integrated multi-parametric non-invasive saliva test for SARS-CoV-\n2 infection, viral load and host immunity test demonstrating clinical performance surpassing current saliva-based\nSARS-CoV-2 EUA tests.\nid:U18TR003778\nnarrative:This U18 application to develop exosome-based non-traditional technology for point-of-care sampling\nand non-invasive earliest detection of SARS-CoV-2 infection and COVID-19 antibodies detection, for population\nlevel testing for COVID-19 infection and immunity.\nname:AFS/SERS Saliva-based SARS-CoV-2 Earliest Infection and Antibodies Detection\nsubProject:Exosome\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U18"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "30d40415a6d84a44a60c21c51529c573": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 2741,
       "label": "Dataset",
       "name": " Nanobody-based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2",
       "tooltip": "Dataset\nid:dbgap:phs002700.v1.p1\nname: Nanobody-based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2\nurl:https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs002700.v1.p1",
       "url": "https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs002700.v1.p1"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "30e81483122843589816c44b4f629e37": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Woodrow",
       "fullName": "Woodrow D Gardiner",
       "id": 1888,
       "label": "Researcher",
       "lastName": "Gardiner",
       "middleName": "D",
       "name": "Gardiner WD",
       "tooltip": "Researcher\nmiddleName:D\nid:s2authorid:1938742277\nlastName:Gardiner\nname:Gardiner WD\nfullName:Woodrow D Gardiner\nfirstName:Woodrow"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "316535e3b8f0426d819f97b6fead5798": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "doi": "doi:10.1016/j.biombioe.2023.107006",
       "id": 4056,
       "journal": "Biomass and Bioenergy",
       "label": "Publication",
       "name": "Electrocatalytic method to quantify the redox reactivity of agricultural byproducts",
       "tooltip": "Publication\njournal:Biomass and Bioenergy\nid:doi:10.1016/j.biombioe.2023.107006\nname:Electrocatalytic method to quantify the redox reactivity of agricultural byproducts\nyear:2024\ntype:secondary\nurl:https://doi.org/doi:10.1016/j.biombioe.2023.107006\ndoi:doi:10.1016/j.biombioe.2023.107006",
       "type": "secondary",
       "url": "https://doi.org/doi:10.1016/j.biombioe.2023.107006",
       "year": 2024
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3198f8dd5f4f458b9b20a8a1a9a77396": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 612,
       "target": 4
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "31993384bc244d36a62064a43856e818": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Richard",
       "fullName": "Richard C Gerkin",
       "id": 716,
       "label": "Researcher",
       "lastName": "Gerkin",
       "middleName": "C",
       "name": "Gerkin RC",
       "profileId": "profileid:7680168",
       "tooltip": "Researcher\nmiddleName:C\nid:profileid:7680168\nlastName:Gerkin\nprofileId:profileid:7680168\nname:Gerkin RC\nfullName:Richard C Gerkin\nfirstName:Richard"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "32077933642f4a5fa329134e9bc33368": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "MATHER",
       "country": "UNITED STATES",
       "duns": "duns:127349889",
       "id": 561,
       "label": "Organization",
       "state": "CA",
       "tooltip": "Organization\ncountry:UNITED STATES\ncity:MATHER\nuei:uei:MTB2MR9MAA99\nduns:duns:127349889\nstate:CA\nid:uei:MTB2MR9MAA99",
       "uei": "uei:MTB2MR9MAA99"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "32ca53f8735142c19a49f49fefe0707b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "doi": "doi:10.1016/j.trac.2024.117520",
       "id": 2716,
       "journal": "TrAC Trends in Analytical Chemistry",
       "label": "Publication",
       "name": "Recent advances in metal-organic frameworks as emerging platforms for immunoassays",
       "tooltip": "Publication\njournal:TrAC Trends in Analytical Chemistry\nid:doi:10.1016/j.trac.2024.117520\nname:Recent advances in metal-organic frameworks as emerging platforms for immunoassays\nyear:2024\ntype:secondary\nurl:https://doi.org/doi:10.1016/j.trac.2024.117520\ndoi:doi:10.1016/j.trac.2024.117520",
       "type": "secondary",
       "url": "https://doi.org/doi:10.1016/j.trac.2024.117520",
       "year": 2024
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "32f7b14aebb546d6bb8b91c475a21974": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 613,
       "target": 27
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3308cf6b352c429486f27df857d63057": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2024,
       "name": "EMPLOYED_AT",
       "source": 613,
       "target": 590
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "332f60fc81484a509b4004db830e0c3a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4386,
       "target": 36
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "338b4fd609934c4aa1ae15546e62198c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 996,
       "target": 2821
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "33cfed3fceb446a790243268b3839887": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "David",
       "fullName": "David T Wong",
       "id": 622,
       "label": "Researcher",
       "lastName": "Wong",
       "middleName": "T",
       "name": "Wong DT",
       "profileId": "profileid:6390810",
       "tooltip": "Researcher\nmiddleName:T\nid:profileid:6390810\nlastName:Wong\nprofileId:profileid:6390810\nname:Wong DT\nfullName:David T Wong\nfirstName:David"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "344df15d60944c9fb93d627eede7ff9c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The University of Washington and the entrepreneurial community seeks to partner with the National Institutes\nof Health to become a Research Evaluation and Commercialization Hub (REACH) to accelerate academic\nbiomedical discoveries into products helping ease the highest U.S. burden of disease and disability.\nThe UW is a powerhouse in health sciences, technology, and innovation in a city known for seeking solutions\nto the most pressing health problems around the world.\nThe University’s long-standing relationship with the entrepreneurial business community has helped in the\nformation of Boeing, Microsoft, Amazon, Immunex, Zymogenetics, Teblos, the Drug Interaction Database, and\nSeattle Genetics. It’s also led to well-recognized recombinant therapeutic and vaccine products such as growth\nhormone, insulin, RecombiVax HB®, and Gardasil®.\nMany of our graduates work at major health organizations in the city, including The Gates Foundation, Path,\nFred Hutchinson Cancer Research Center, the Infectious Disease Research Institute. The University’s Foster\nSchool of Business gathers business leaders to judge and mentor solutions to health problems, and major\nbusiness leaders are part of the governing board of these organizations and the networking hub The\nWashington Global Health Alliance and The Innovation Hub of Life Sciences Washington.\nIn this rich spirt of collaboration, a hub to accelerate promising biomedical discoveries would fit right in. A hub\nis needed to further energize the spirit of discovery and collaboration and overcome barriers in getting products\nto the public. A hub will leverage existing resources for translational research and support the journey to\nfruition to innovative products that change lives. With institutional co-funding commitments, strong support of\ncommunity leaders, and proven leadership in entrepreneurial startups, the four Aims of this proposal are to (1)\nDevelop an integrated infrastructure and implementation system; (2) Identify the most promising technologies,\nand increase their availability using milestone-driven gap funding and mentoring (in business, marketing, and\nnetworking) for market-driven proof-of-product concept and product definition; (3) Fuel the formation of new\nbiotechnology, pharmaceutical, and medical device companies, and assist in pathways to a self-sustaining\nstructure; (4) Train the next generation of biomedical entrepreneurs to lead these ventures.\nWith NIH support, this hub will accelerate the creation of small businesses using biomedical discoveries to\nlaunch products that impact health outcomes. An investment in the Pacific Northwest will amplify the returns\non this funding due to the critical mass of investigators, and the will of our institutions to make this happen.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 20,
       "label": "Grant",
       "name": "Washington Entrepreneurial Research Evaluation and Commercialization Hub",
       "narrative": "This proposal plans to create a hub to accelerate academic biomedical discoveries into products\nhelping ease the highest burden of disease and disability in the United States.\nThe University of Washington and the region is a powerhouse in health sciences, technology,\nand collaboration but many promising ideas never get to market because of barriers in funding,\nconnections to industry professionals or product development know-how. The Washington\nEntrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) program will\nbuild on strengths and integration of the entrepreneurial and translational environment in the\nregion to identify and accelerate promising products, foster milestone-driven project plans and\ntranslational teams, and then work with experts to overcome the barriers to create marketable\nhealth products.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:The University of Washington and the entrepreneurial community seeks to partner with the National Institutes\nof Health to become a Research Evaluation and Commercialization Hub (REACH) to accelerate academic\nbiomedical discoveries into products helping ease the highest U.S. burden of disease and disability.\nThe UW is a powerhouse in health sciences, technology, and innovation in a city known for seeking solutions\nto the most pressing health problems around the world.\nThe University’s long-standing relationship with the entrepreneurial business community has helped in the\nformation of Boeing, Microsoft, Amazon, Immunex, Zymogenetics, Teblos, the Drug Interaction Database, and\nSeattle Genetics. It’s also led to well-recognized recombinant therapeutic and vaccine products such as growth\nhormone, insulin, RecombiVax HB®, and Gardasil®.\nMany of our graduates work at major health organizations in the city, including The Gates Foundation, Path,\nFred Hutchinson Cancer Research Center, the Infectious Disease Research Institute. The University’s Foster\nSchool of Business gathers business leaders to judge and mentor solutions to health problems, and major\nbusiness leaders are part of the governing board of these organizations and the networking hub The\nWashington Global Health Alliance and The Innovation Hub of Life Sciences Washington.\nIn this rich spirt of collaboration, a hub to accelerate promising biomedical discoveries would fit right in. A hub\nis needed to further energize the spirit of discovery and collaboration and overcome barriers in getting products\nto the public. A hub will leverage existing resources for translational research and support the journey to\nfruition to innovative products that change lives. With institutional co-funding commitments, strong support of\ncommunity leaders, and proven leadership in entrepreneurial startups, the four Aims of this proposal are to (1)\nDevelop an integrated infrastructure and implementation system; (2) Identify the most promising technologies,\nand increase their availability using milestone-driven gap funding and mentoring (in business, marketing, and\nnetworking) for market-driven proof-of-product concept and product definition; (3) Fuel the formation of new\nbiotechnology, pharmaceutical, and medical device companies, and assist in pathways to a self-sustaining\nstructure; (4) Train the next generation of biomedical entrepreneurs to lead these ventures.\nWith NIH support, this hub will accelerate the creation of small businesses using biomedical discoveries to\nlaunch products that impact health outcomes. An investment in the Pacific Northwest will amplify the returns\non this funding due to the critical mass of investigators, and the will of our institutions to make this happen.\nid:U01HL152401\nnarrative:This proposal plans to create a hub to accelerate academic biomedical discoveries into products\nhelping ease the highest burden of disease and disability in the United States.\nThe University of Washington and the region is a powerhouse in health sciences, technology,\nand collaboration but many promising ideas never get to market because of barriers in funding,\nconnections to industry professionals or product development know-how. The Washington\nEntrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) program will\nbuild on strengths and integration of the entrepreneurial and translational environment in the\nregion to identify and accelerate promising products, foster milestone-driven project plans and\ntranslational teams, and then work with experts to overcome the barriers to create marketable\nhealth products.\nname:Washington Entrepreneurial Research Evaluation and Commercialization Hub\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3458991d87fc49d19351014b04c27c65": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "/Abstract: This proposal has two major goals: 1) Define signature exhaled breath volatile\norganic compounds (VOCs) to diagnose SARS-CoV-2 infections, and 2) Develop a portable chemical sensing\ndevice that can capture and detect exhaled VOCs and includes machine learning algorithms for automated\ndata processing and results interpretation. This project will bring a portable sensor forward into clinical use with\nthe aim of supplementing COVID-19 diagnostics with a reagentless alternative. Breath testing of exhaled VOC\nbiomarkers is a relatively new concept that has the potential to transform healthcare in the US and globally.\nOur overarching hypothesis is that a miniature breath analysis device can measure signatures of exhaled\nbreath VOCs in real-time and correlate their profile to viral upper respiratory infections such as SARS-CoV-2,\neven asymptomatically. In Aim #1, we propose a prospective, observational study to analyze breath samples\nfrom COVID-19 positive and negative subjects, solely for the purpose of analysis through gold standard GC-\nMS to define breath VOC biomarkers of infection. We will recruit subjects at two local sites, the UC Davis\nMedical Center (Sacramento, CA) and VA Northern California Health Care System (Mather, CA), where MPI\nDr. Kenyon and Co-Is Drs. Harper and Schivo have joint clinical appointments. Our group has a proven track\nrecord to conduct these types of clinical breath studies. In Aim #2, we will develop a portable breath analysis\ndevice using our novel miniature differential mobility spectrometry (DMS) detector, coupled with chip-based\ngas chromatography. DMS is a subset of ion mobility spectrometry and detects VOCs at ambient temperatures\nand pressures, making it highly appropriate for portable devices. This device would include our custom chip-\nbased preconcentrator, which is packed with a chemical sorbent for extraction of VOCs from breath, and will\ncompare functionality of a compact commercially available GC column to a micro-GC column chip from\nDeviant, a subcontractor in this work. Individual components of this device have already been developed, and\nunder direction of MPI Prof. Davis, Chair of Mechanical and Aerospace Engineering, a team of research\nengineers would integrate these pieces together into a single unit. Collaborator Prof. Chuah would guide\ndevelopment of a custom software package for the device with machine learning and artificial intelligence\ncapabilities for automated data processing and interpretation. The device would be placed in the hands of\nclinicians, who would provide feedback that engineers would immediately incorporate into the device and\nreturn to the clinicians for more testing. Under Aim #3, our team would process the GC-MS and GC-DMS data\ngenerated in this work, identifying a novel VOC profile for COVID-19 diagnostics. Aim #4 would initiate towards\nthe end of this study to develop both a regulatory pathway & contract manufacturing plan for large scale\nproduction and deployment of the device for clinical approval. These efforts are supported by collaborator Dr.\nNam Tran, Director of Clinical Pathology & Clinical Chemistry at the UC Davis Medical Center.",
       "awardCode": "U18",
       "fundingMechanism": "Other Research-Related",
       "id": 37,
       "label": "Grant",
       "name": "Portable GC detector for breath-based COVID diagnostics",
       "narrative": "In the United States and worldwide, public health experts agree that nations must increase\ntheir capacity to test for COVID-19, yet global supplies for testing materials remain scarce. This project would\nlead to the development of an entirely new type of COVID-19 test, one that could diagnose infections with only\na breath sample. Through this proposal, our team would develop a portable device that could identify people\nwith COVID-19 infections by analyzing volatile organic compounds (VOCs) found in exhaled breath.",
       "researchInitiative": "RADx-rad",
       "subProject": "SCENT",
       "tooltip": "Grant\nabstract:/Abstract: This proposal has two major goals: 1) Define signature exhaled breath volatile\norganic compounds (VOCs) to diagnose SARS-CoV-2 infections, and 2) Develop a portable chemical sensing\ndevice that can capture and detect exhaled VOCs and includes machine learning algorithms for automated\ndata processing and results interpretation. This project will bring a portable sensor forward into clinical use with\nthe aim of supplementing COVID-19 diagnostics with a reagentless alternative. Breath testing of exhaled VOC\nbiomarkers is a relatively new concept that has the potential to transform healthcare in the US and globally.\nOur overarching hypothesis is that a miniature breath analysis device can measure signatures of exhaled\nbreath VOCs in real-time and correlate their profile to viral upper respiratory infections such as SARS-CoV-2,\neven asymptomatically. In Aim #1, we propose a prospective, observational study to analyze breath samples\nfrom COVID-19 positive and negative subjects, solely for the purpose of analysis through gold standard GC-\nMS to define breath VOC biomarkers of infection. We will recruit subjects at two local sites, the UC Davis\nMedical Center (Sacramento, CA) and VA Northern California Health Care System (Mather, CA), where MPI\nDr. Kenyon and Co-Is Drs. Harper and Schivo have joint clinical appointments. Our group has a proven track\nrecord to conduct these types of clinical breath studies. In Aim #2, we will develop a portable breath analysis\ndevice using our novel miniature differential mobility spectrometry (DMS) detector, coupled with chip-based\ngas chromatography. DMS is a subset of ion mobility spectrometry and detects VOCs at ambient temperatures\nand pressures, making it highly appropriate for portable devices. This device would include our custom chip-\nbased preconcentrator, which is packed with a chemical sorbent for extraction of VOCs from breath, and will\ncompare functionality of a compact commercially available GC column to a micro-GC column chip from\nDeviant, a subcontractor in this work. Individual components of this device have already been developed, and\nunder direction of MPI Prof. Davis, Chair of Mechanical and Aerospace Engineering, a team of research\nengineers would integrate these pieces together into a single unit. Collaborator Prof. Chuah would guide\ndevelopment of a custom software package for the device with machine learning and artificial intelligence\ncapabilities for automated data processing and interpretation. The device would be placed in the hands of\nclinicians, who would provide feedback that engineers would immediately incorporate into the device and\nreturn to the clinicians for more testing. Under Aim #3, our team would process the GC-MS and GC-DMS data\ngenerated in this work, identifying a novel VOC profile for COVID-19 diagnostics. Aim #4 would initiate towards\nthe end of this study to develop both a regulatory pathway & contract manufacturing plan for large scale\nproduction and deployment of the device for clinical approval. These efforts are supported by collaborator Dr.\nNam Tran, Director of Clinical Pathology & Clinical Chemistry at the UC Davis Medical Center.\nid:U18TR003795\nnarrative:In the United States and worldwide, public health experts agree that nations must increase\ntheir capacity to test for COVID-19, yet global supplies for testing materials remain scarce. This project would\nlead to the development of an entirely new type of COVID-19 test, one that could diagnose infections with only\na breath sample. Through this proposal, our team would develop a portable device that could identify people\nwith COVID-19 infections by analyzing volatile organic compounds (VOCs) found in exhaled breath.\nname:Portable GC detector for breath-based COVID diagnostics\nsubProject:SCENT\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U18"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "34802c8a934b449897a75bbd23e946f5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Carla",
       "fullName": "Carla M Yuede",
       "id": 2347,
       "label": "Researcher",
       "lastName": "Yuede",
       "middleName": "M",
       "name": "Yuede CM",
       "tooltip": "Researcher\nmiddleName:M\nid:s2authorid:5375227\nlastName:Yuede\nname:Yuede CM\nfullName:Carla M Yuede\nfirstName:Carla"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "34cb75bf96de49b4940498b486f72cc4": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4385,
       "target": 44
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "34df3402d3394c1d87ba057890e58977": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 677,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "35400ef814654591833a05153f87be60": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Valentina",
       "fullName": "Valentina Parma",
       "id": 692,
       "label": "Researcher",
       "lastName": "Parma",
       "name": "Parma V",
       "orcid": "orcid:0000-0003-0276-7072",
       "profileId": "profileid:16392635",
       "tooltip": "Researcher\nid:profileid:16392635\nlastName:Parma\norcid:orcid:0000-0003-0276-7072\nprofileId:profileid:16392635\nname:Parma V\nfullName:Valentina Parma\nfirstName:Valentina"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "35cc5a19576044019ded467afe827486": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Steven",
       "fullName": "Steven K Libutti",
       "id": 633,
       "label": "Researcher",
       "lastName": "Libutti",
       "middleName": "K",
       "name": "Libutti SK",
       "orcid": "orcid:0000-0003-2313-9809",
       "profileId": "profileid:9845089",
       "tooltip": "Researcher\nmiddleName:K\nid:profileid:9845089\nlastName:Libutti\norcid:orcid:0000-0003-2313-9809\nprofileId:profileid:9845089\nname:Libutti SK\nfullName:Steven K Libutti\nfirstName:Steven"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3633e763499a4f6f806a48c8af45bbc5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 626,
       "target": 588
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3639c4f735d74774a247a0dff1a4dc5f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Smell loss is a predominant symptom of COVID-19, and initial evidence based on self-reports suggests that\nchemosensory loss is a sensitive predictor of COVID-19 in the general population, more so than fever.\nHowever, given the natural lack of awareness of chemosensory changes, self-reports underestimate the true\nprevalence of smell loss in patients with COVID-19 by 20% compared to an objective test. Therefore, we\npropose testing and deploying a rapid and objective measure of smell ability, the SCENTinel test, inspired by\nthe NIH Toolbox® Odor Identification Test that our team previously developed. SCENTinel is an inexpensive,\nand convenient smell test for COVID-19 surveillance of the population that quickly and easily assesses\nthree smell loss factors: odor detection, odor intensity, and odor identification. It is designed for practical use in\nseveral contexts, including high-density areas such as community medical sites, universities, subacute care\nfacilities, and both industrial and nonindustrial workplaces. Our multi-disciplinary team has expertise in\nunderstanding taste and smell, developing and validating chemosensory tests, as well as studying the broad\nsymptomatology of COVID-19. The group is led by MPI Dalton from the Monell Chemical Senses Center, an\nexpert in human olfaction and designing olfactory tests; MPI Parma from Temple University is an expert in\nCOVID-19 smell loss, is the Chair of the Global Consortium for Chemosensory Research, and has expertise in\nconducting research in rapidly changing situations; Dr. Schalet and his team at Northwestern University and\nDr. Chun and his team at Yale University, among the other established and interested partners (Fox subacute\nnursing homes, Hormel Food). Our team also includes the Director of Technology Transfer at the Monell\nCenter, Dr. O’Leary, to explore potential partners and expand SCENTinel deployment nationwide. Dr. Reed\nfrom the Monell Chemical Senses Center will work directly with the Data Coordination Center, drawing on her\nexperience in managing large shared NIH datasets. All will work closely with the NIH Project Scientist. This\nproposal aims to a) fine-tune SCENTinel’s ability to predict a positive COVID-19 diagnostic test; b) examine\nmarginal smell loss as a sign of the earliest phases of COVID-19, before a positive diagnostic test; and c)\nassess the test’s psychometric validity with test-retest reliability measures and validation against the NIH\nToolbox® Odor Identification Test. Together, these aims will establish a standardized protocol for use of\nSCENTinel as a rapid and objective smell test that can easily be incorporated into onsite COVID-19 testing\ncenters, schools, and workplaces nationwide. Furthermore, it will provide key insights into early-onset\nchemosensory symptoms in relation to a confirmed COVID-19 diagnosis, providing a crucially needed means\nto contain the spread of COVID-19.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 39,
       "label": "Grant",
       "name": "SCENTinel: A Rapid Smell Test for COVID-19 Surveillance",
       "narrative": "As COVID-19 continues to spread in concurrence with the reopening of activities and workplaces, there is an\nimmediate need to develop more robust screening tools to ensure everyone’s personal safety. Loss of the\nsense of smell is an early and sensitive predictor of COVID-19 infection. The goal of this project is to develop\nthe SCENTinel test, an inexpensive, rapid, and highly scalable objective smell test to use for COVID-19\nsurveillance.",
       "researchInitiative": "RADx-rad",
       "subProject": "Chemosensory Testing",
       "tooltip": "Grant\nabstract:Smell loss is a predominant symptom of COVID-19, and initial evidence based on self-reports suggests that\nchemosensory loss is a sensitive predictor of COVID-19 in the general population, more so than fever.\nHowever, given the natural lack of awareness of chemosensory changes, self-reports underestimate the true\nprevalence of smell loss in patients with COVID-19 by 20% compared to an objective test. Therefore, we\npropose testing and deploying a rapid and objective measure of smell ability, the SCENTinel test, inspired by\nthe NIH Toolbox® Odor Identification Test that our team previously developed. SCENTinel is an inexpensive,\nand convenient smell test for COVID-19 surveillance of the population that quickly and easily assesses\nthree smell loss factors: odor detection, odor intensity, and odor identification. It is designed for practical use in\nseveral contexts, including high-density areas such as community medical sites, universities, subacute care\nfacilities, and both industrial and nonindustrial workplaces. Our multi-disciplinary team has expertise in\nunderstanding taste and smell, developing and validating chemosensory tests, as well as studying the broad\nsymptomatology of COVID-19. The group is led by MPI Dalton from the Monell Chemical Senses Center, an\nexpert in human olfaction and designing olfactory tests; MPI Parma from Temple University is an expert in\nCOVID-19 smell loss, is the Chair of the Global Consortium for Chemosensory Research, and has expertise in\nconducting research in rapidly changing situations; Dr. Schalet and his team at Northwestern University and\nDr. Chun and his team at Yale University, among the other established and interested partners (Fox subacute\nnursing homes, Hormel Food). Our team also includes the Director of Technology Transfer at the Monell\nCenter, Dr. O’Leary, to explore potential partners and expand SCENTinel deployment nationwide. Dr. Reed\nfrom the Monell Chemical Senses Center will work directly with the Data Coordination Center, drawing on her\nexperience in managing large shared NIH datasets. All will work closely with the NIH Project Scientist. This\nproposal aims to a) fine-tune SCENTinel’s ability to predict a positive COVID-19 diagnostic test; b) examine\nmarginal smell loss as a sign of the earliest phases of COVID-19, before a positive diagnostic test; and c)\nassess the test’s psychometric validity with test-retest reliability measures and validation against the NIH\nToolbox® Odor Identification Test. Together, these aims will establish a standardized protocol for use of\nSCENTinel as a rapid and objective smell test that can easily be incorporated into onsite COVID-19 testing\ncenters, schools, and workplaces nationwide. Furthermore, it will provide key insights into early-onset\nchemosensory symptoms in relation to a confirmed COVID-19 diagnosis, providing a crucially needed means\nto contain the spread of COVID-19.\nid:U01DC019578\nnarrative:As COVID-19 continues to spread in concurrence with the reopening of activities and workplaces, there is an\nimmediate need to develop more robust screening tools to ensure everyone’s personal safety. Loss of the\nsense of smell is an early and sensitive predictor of COVID-19 infection. The goal of this project is to develop\nthe SCENTinel test, an inexpensive, rapid, and highly scalable objective smell test to use for COVID-19\nsurveillance.\nname:SCENTinel: A Rapid Smell Test for COVID-19 Surveillance\nsubProject:Chemosensory Testing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "366287609349423a9ea670ade93ee9a2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "SAINT LOUIS",
       "country": "UNITED STATES",
       "duns": "duns:068552207",
       "geonames": "geonames:4407066",
       "id": 586,
       "label": "Organization",
       "name": "Washington University in St. Louis",
       "ror": "ror:01yc7t268",
       "state": "MO",
       "tooltip": "Organization\nid:ror:01yc7t268\nror:ror:01yc7t268\nname:Washington University in St. Louis\nduns:duns:068552207\nstate:MO\ngeonames:geonames:4407066\nuei:uei:L6NFUM28LQM5\nurl:https://ror.org/01yc7t268\ncountry:UNITED STATES\ncity:SAINT LOUIS",
       "uei": "uei:L6NFUM28LQM5",
       "url": "https://ror.org/01yc7t268"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3816f93ad4034181978a907d95561820": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Novel approaches for early and accurate diagnosis of COVID-19 associated syndromes and\nevaluation of clinical severity and outcomes of COVID-19 disease in children are urgently needed.\nThe overarching goal of this grant proposal is to develop clinical assays that can evaluate and predict\nseverity of pediatric COVID-19 disease, ranging from asymptomatic or mildly symptomatic to severe\nmanifestations such as multisystem inflammatory syndrome (MIS-C). To date, we have collected and\nbiobanked clinical samples from more than 400 patients across 3 academic hospitals, including\napproximately 100 patients with MIS-C. In the first R61 phase of this project, we will continue to enroll\npatients with pediatric COVID-19 and MIS-C for sample collection and longitudinal chart review and\ntesting (Aim 1), leverage machine learning to identify diagnostic and prognostic “omics” host\nbiomarkers based on RNA transcriptome profiling from nasal swab and whole blood samples (Aim 2)\nand cell-free DNA analysis from plasma (Aim 3), and generate predictive models of clinical severity\nand outcomes by incorporating longitudinal clinical, laboratory, viral, and omics data (Aim 4). Our\nrationale for including these samples is that they are routinely obtained in hospitals and clinics and\npermit easy and noninvasive collection without any special processing or handling requirements,\nwhich will accelerate the development of omics-based clinical assays. Our Go/No-Go transition\nmilestones for transition to the R33 phase after 2 years include: (1) collection of longitudinal samples\nfrom a minimum of 120 patients for each identified presentation (mildly symptomatic outpatient,\nseverely ill in the ICU, and MIS-C) and a comparable number of matched controls, (2) generation of\npanels of candidate of severity and confirmation of a subset of biomarkers by qPCR, (3) development\nof classifier models using machine learning using the biomarkers alone (for clinical assay\ndevelopment), and (4) combining these omics biomarkers with additional clinical, viral, and laboratory\nbiomarkers into combined classifier models using machine learning. For the classifier models, the\nminimum/goal performance requirements would be 70%/>80% sensitivity and 80%/>90% specificity.\nIn the second R33 phase, we propose to develop host-based clinical assays for diagnosis and\nseverity prediction of COVID-19-associated syndromes, including MIS-C, in children from nasal\nswabs and blood (Aim 5) and validate these biomarker panels as a Laboratory Developed Test (LDT)\nin a CLIA (Clinical Laboratory Improvement Amendments) diagnostic laboratory (Aim 6). These\nassays will be evaluated for accuracy, precision, reproducibility, limits of detection (LOD), matrix\neffect, interference, among other performance characteristics. We will work closely with the RADx-rad\nData Coordination Center (DCC) on assay development, testing, and validation for submission to the\nFDA for Emergency Use Authorization (EUA) and timely deployment of these assays for clinical use.",
       "awardCode": "R61",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 27,
       "label": "Grant",
       "name": "Discovery and clinical validation of host  biomarkers of disease severity and multi-system inflammatory syndrome in children (MIS-C) with Covid-19",
       "narrative": "Novel approaches to accurately diagnose acute pediatric COVID-19 associated diseases,\nincluding the Multisystem Inflammatory Syndrome in Children (MIS-C), as well as predict clinical\nseverity and outcomes, are urgently needed. For this project, we will identify RNA transcriptomic\nand cell-free DNA omics biomarkers that will be used to develop and validate host-based\nassays from nasal swab and blood samples, with the goal of regulatory submission for FDA\nEmergency Use Authorization (EUA).",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nabstract:Novel approaches for early and accurate diagnosis of COVID-19 associated syndromes and\nevaluation of clinical severity and outcomes of COVID-19 disease in children are urgently needed.\nThe overarching goal of this grant proposal is to develop clinical assays that can evaluate and predict\nseverity of pediatric COVID-19 disease, ranging from asymptomatic or mildly symptomatic to severe\nmanifestations such as multisystem inflammatory syndrome (MIS-C). To date, we have collected and\nbiobanked clinical samples from more than 400 patients across 3 academic hospitals, including\napproximately 100 patients with MIS-C. In the first R61 phase of this project, we will continue to enroll\npatients with pediatric COVID-19 and MIS-C for sample collection and longitudinal chart review and\ntesting (Aim 1), leverage machine learning to identify diagnostic and prognostic “omics” host\nbiomarkers based on RNA transcriptome profiling from nasal swab and whole blood samples (Aim 2)\nand cell-free DNA analysis from plasma (Aim 3), and generate predictive models of clinical severity\nand outcomes by incorporating longitudinal clinical, laboratory, viral, and omics data (Aim 4). Our\nrationale for including these samples is that they are routinely obtained in hospitals and clinics and\npermit easy and noninvasive collection without any special processing or handling requirements,\nwhich will accelerate the development of omics-based clinical assays. Our Go/No-Go transition\nmilestones for transition to the R33 phase after 2 years include: (1) collection of longitudinal samples\nfrom a minimum of 120 patients for each identified presentation (mildly symptomatic outpatient,\nseverely ill in the ICU, and MIS-C) and a comparable number of matched controls, (2) generation of\npanels of candidate of severity and confirmation of a subset of biomarkers by qPCR, (3) development\nof classifier models using machine learning using the biomarkers alone (for clinical assay\ndevelopment), and (4) combining these omics biomarkers with additional clinical, viral, and laboratory\nbiomarkers into combined classifier models using machine learning. For the classifier models, the\nminimum/goal performance requirements would be 70%/>80% sensitivity and 80%/>90% specificity.\nIn the second R33 phase, we propose to develop host-based clinical assays for diagnosis and\nseverity prediction of COVID-19-associated syndromes, including MIS-C, in children from nasal\nswabs and blood (Aim 5) and validate these biomarker panels as a Laboratory Developed Test (LDT)\nin a CLIA (Clinical Laboratory Improvement Amendments) diagnostic laboratory (Aim 6). These\nassays will be evaluated for accuracy, precision, reproducibility, limits of detection (LOD), matrix\neffect, interference, among other performance characteristics. We will work closely with the RADx-rad\nData Coordination Center (DCC) on assay development, testing, and validation for submission to the\nFDA for Emergency Use Authorization (EUA) and timely deployment of these assays for clinical use.\nid:R61HD105618\nnarrative:Novel approaches to accurately diagnose acute pediatric COVID-19 associated diseases,\nincluding the Multisystem Inflammatory Syndrome in Children (MIS-C), as well as predict clinical\nseverity and outcomes, are urgently needed. For this project, we will identify RNA transcriptomic\nand cell-free DNA omics biomarkers that will be used to develop and validate host-based\nassays from nasal swab and blood samples, with the goal of regulatory submission for FDA\nEmergency Use Authorization (EUA).\nname:Discovery and clinical validation of host  biomarkers of disease severity and multi-system inflammatory syndrome in children (MIS-C) with Covid-19\nsubProject:PreVAIL kIds\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R61"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "388bb64576ef4d3abeca337562ae6a94": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Rachel",
       "fullName": "Rachel Todd Noble",
       "id": 662,
       "label": "Researcher",
       "lastName": "Noble",
       "middleName": "Todd",
       "name": "Noble RT",
       "orcid": "orcid:0000-0001-9071-8312",
       "profileId": "profileid:10129440",
       "tooltip": "Researcher\nmiddleName:Todd\nid:profileid:10129440\nlastName:Noble\norcid:orcid:0000-0001-9071-8312\nprofileId:profileid:10129440\nname:Noble RT\nfullName:Rachel Todd Noble\nfirstName:Rachel"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3908f1887ff34db59985917ea4155361": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 670,
       "target": 25
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "392ccd0cb70f4534aa317b28f546d3ec": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4392,
       "target": 13
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "39efb44c6d034df1bf2a9beede65dcd7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "IS_INVENTOR",
       "source": 677,
       "target": 2409
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3a2783123d724c63aeb596f566b694e1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 685,
       "target": 582
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3a425c9cfcbe41d3b83702c885737883": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "CytoscapeModel",
     "state": {
      "_dom_classes": [],
      "_interaction_handlers": {},
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "CytoscapeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "CytoscapeView",
      "auto_ungrabify": false,
      "auto_unselectify": true,
      "autolock": false,
      "box_selection_enabled": false,
      "cytoscape_layout": {
       "name": "cola",
       "nodeDimensionsIncludeLabels": true,
       "nodeSpacing": 40,
       "padding": 0,
       "unconstrIter": 5000
      },
      "cytoscape_style": [
       {
        "selector": "node",
        "style": {
         "background-color": "#A5ABB6",
         "border-color": "#9AA1AC",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "edge",
        "style": {
         "curve-style": "bezier",
         "font-size": "8px",
         "label": "data(name)",
         "line-color": "#A5ABB6",
         "target-arrow-color": "#A5ABB6",
         "target-arrow-shape": "triangle",
         "text-rotation": "autorotate",
         "width": "1px"
        }
       },
       {
        "selector": "node[label=\"*\"]",
        "style": {
         "background-color": "#C990C0",
         "border-color": "#b261a5",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"City\"]",
        "style": {
         "background-color": "#F79767",
         "border-color": "#f36924",
         "border-width": "2px",
         "font-size": "10px",
         "height": "65px",
         "label": "data(name)",
         "text-max-width": "65px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "65px"
        }
       },
       {
        "selector": "node[label=\"Disease\"]",
        "style": {
         "background-color": "#569480",
         "border-color": "#447666",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Symptom\"]",
        "style": {
         "background-color": "#8DCC93",
         "border-color": "#5db665",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"Patient\"]",
        "style": {
         "background-color": "#4C8EDA",
         "border-color": "#2870c2",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(firstName)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"State\"]",
        "style": {
         "background-color": "#FFC454",
         "border-color": "#d7a013",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"MetaNode\"]",
        "style": {
         "background-color": "#D9C8AE",
         "border-color": "#c0a378",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(nodeName)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Grant\"]",
        "style": {
         "background-color": "#4C8EDA",
         "border-color": "#2870c2",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Researcher\"]",
        "style": {
         "background-color": "#FFC454",
         "border-color": "#d7a013",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"FundingOpportunity\"]",
        "style": {
         "background-color": "#DA7194",
         "border-color": "#cc3c6c",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Organization\"]",
        "style": {
         "background-color": "#569480",
         "border-color": "#447666",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Dataset\"]",
        "style": {
         "background-color": "#F79767",
         "border-color": "#f36924",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"CoordinationCenter\"]",
        "style": {
         "background-color": "#57C7E3",
         "border-color": "#23b3d7",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Event\"]",
        "style": {
         "background-color": "#8DCC93",
         "border-color": "#5db665",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Publication\"]",
        "style": {
         "background-color": "#AA7942",
         "border-color": "#8D6429",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Patent\"]",
        "style": {
         "background-color": "#C990C0",
         "border-color": "#b261a5",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Presentation\"]",
        "style": {
         "background-color": "#F16667",
         "border-color": "#eb2728",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Software\"]",
        "style": {
         "background-color": "#ECB5C9",
         "border-color": "#da7298",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"ResearchInitiative\"]",
        "style": {
         "background-color": "#57C7E3",
         "border-color": "#23b3d7",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "edge[name=\"MetaRelationship\"]",
        "style": {
         "curve-style": "bezier",
         "font-size": "8px",
         "label": "data(relationshipName)",
         "line-color": "#A5ABB6",
         "target-arrow-color": "#A5ABB6",
         "target-arrow-shape": "triangle",
         "text-rotation": "autorotate",
         "width": "1px"
        }
       }
      ],
      "desktop_tap_threshold": 4,
      "graph": "IPY_MODEL_8751edf84e354cc9881538d0fa6f20ec",
      "headless": false,
      "hide_edges_on_viewport": false,
      "layout": "IPY_MODEL_71f606250c084f35802f0b66334e4135",
      "max_zoom": 1e+50,
      "min_zoom": 1e-50,
      "motion_blur": false,
      "motion_blur_opacity": 0.2,
      "panning_enabled": true,
      "pixel_ratio": "auto",
      "rendered_position": {
       "renderedPosition": {
        "x": 100,
        "y": 100
       }
      },
      "selection_type": "single",
      "style_enabled": true,
      "texture_on_viewport": false,
      "tooltip_source": "tooltip",
      "touch_tap_threshold": 8,
      "user_panning_enabled": true,
      "user_zooming_enabled": true,
      "wheel_sensitivity": 1,
      "zoom": 2,
      "zooming_enabled": true
     }
    },
    "3b03839d36e84a789700a36f7b74dae2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Xiaohu",
       "fullName": "Xiaohu Yao",
       "id": 617,
       "label": "Researcher",
       "lastName": "Yao",
       "name": "Yao X",
       "profileId": "profileid:77861758",
       "tooltip": "Researcher\nid:profileid:77861758\nlastName:Yao\nprofileId:profileid:77861758\nname:Yao X\nfullName:Xiaohu Yao\nfirstName:Xiaohu"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3bc3833769e4453a875446483f2815e7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1800,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3c27bb597a8e43d4be219d92dab56953": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 625,
       "target": 608
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3c3e29ff37cf4247bccb9b8e87aa827d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Immediate Past Chair, A&WMA Critical Review Committee, Retired from Bay Area Air Quality Management District, San Francisco, CA, USA; McGill University, Montreal, Quebec, Canada; RJ Lee Group, Monroeville, PA, USA; Division of Atmospheric Sciences, Desert Research Institute, Reno, NV, USA; Department of Environmental and Global Health of the College of Public Health and Health Professions, University of Florida, Gainesville, FL, USA",
       "doi": "doi:10.1080/10962247.2023.2253709",
       "id": 2977,
       "journal": "Journal of the Air & Waste Management Association",
       "label": "Publication",
       "name": "Environmental sampling for disease surveillance: Recent advances and recommendations for best practice",
       "pmId": "37729106",
       "tooltip": "Publication\njournal:Journal of the Air & Waste Management Association\nabstract:Immediate Past Chair, A&WMA Critical Review Committee, Retired from Bay Area Air Quality Management District, San Francisco, CA, USA; McGill University, Montreal, Quebec, Canada; RJ Lee Group, Monroeville, PA, USA; Division of Atmospheric Sciences, Desert Research Institute, Reno, NV, USA; Department of Environmental and Global Health of the College of Public Health and Health Professions, University of Florida, Gainesville, FL, USA\nid:doi:10.1080/10962247.2023.2253709\nname:Environmental sampling for disease surveillance: Recent advances and recommendations for best practice\npmId:37729106\nyear:2023\ntype:secondary\nurl:https://doi.org/doi:10.1080/10962247.2023.2253709\ndoi:doi:10.1080/10962247.2023.2253709",
       "type": "secondary",
       "url": "https://doi.org/doi:10.1080/10962247.2023.2253709",
       "year": 2023
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3ce1dcf6ffed445fbeb8669d1148a278": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 619,
       "target": 551
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3ceec56c34f640b9845e08a9912022f5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "This U18 application is responsive to the NIH’s RADx-rad Emergency Responses to the COVID-\npandemic for new or non-traditional technologies developed for single extracellular vesicle, exosome and\nextracellular RNA (exRNA) isolation and analysis and reposition them for detection of SARS-CoV-2. The\napplicant’s group is a grantee in the NIH Common Fund “Extracellular RNA Communication (ERC)” Program\nadvancing a new and emerging technology of Acoustofluidic Separation (AFS) for label-free, high yield and purity\nexosomes from biofluids which is coupled to extracellular RNA characterization using Surface Enhanced Raman\nSpectroscopy (SERS) for single EV identification. This U18 application is to reposition the AFS EV technology\nand SERS for the non-invasive earliest detection of SARS-CoV-2 in saliva of infected patients. Host immunity to\nSARS-CoV-2 will also be assessed in the saliva samples, permitting the earliest detection of SARS-CoV-2\ninfection and host immunity non-invasively in a saliva sample.\n Five Specific Aims are in place to reposition the saliva-based AFS and SERS technologies, in a 2-year\nU18 proposal, to test the hypothesis that an integrated multi-parametric non-invasive saliva test for SARS-CoV-\n2 infection, viral load and host immunity test demonstrating clinical performance surpassing current saliva-based\nSARS-CoV-2 EUA tests.",
       "awardCode": "U18",
       "fundingMechanism": "Other Research-Related",
       "id": 17,
       "label": "Grant",
       "name": "AFS/SERS Saliva-based SARS-CoV-2 Earliest Infection and Antibodies Detection",
       "narrative": "This U18 application to develop exosome-based non-traditional technology for point-of-care sampling\nand non-invasive earliest detection of SARS-CoV-2 infection and COVID-19 antibodies detection, for population\nlevel testing for COVID-19 infection and immunity.",
       "researchInitiative": "RADx-rad",
       "subProject": "Exosome",
       "tooltip": "Grant\nabstract:This U18 application is responsive to the NIH’s RADx-rad Emergency Responses to the COVID-\npandemic for new or non-traditional technologies developed for single extracellular vesicle, exosome and\nextracellular RNA (exRNA) isolation and analysis and reposition them for detection of SARS-CoV-2. The\napplicant’s group is a grantee in the NIH Common Fund “Extracellular RNA Communication (ERC)” Program\nadvancing a new and emerging technology of Acoustofluidic Separation (AFS) for label-free, high yield and purity\nexosomes from biofluids which is coupled to extracellular RNA characterization using Surface Enhanced Raman\nSpectroscopy (SERS) for single EV identification. This U18 application is to reposition the AFS EV technology\nand SERS for the non-invasive earliest detection of SARS-CoV-2 in saliva of infected patients. Host immunity to\nSARS-CoV-2 will also be assessed in the saliva samples, permitting the earliest detection of SARS-CoV-2\ninfection and host immunity non-invasively in a saliva sample.\n Five Specific Aims are in place to reposition the saliva-based AFS and SERS technologies, in a 2-year\nU18 proposal, to test the hypothesis that an integrated multi-parametric non-invasive saliva test for SARS-CoV-\n2 infection, viral load and host immunity test demonstrating clinical performance surpassing current saliva-based\nSARS-CoV-2 EUA tests.\nid:U18TR003778\nnarrative:This U18 application to develop exosome-based non-traditional technology for point-of-care sampling\nand non-invasive earliest detection of SARS-CoV-2 infection and COVID-19 antibodies detection, for population\nlevel testing for COVID-19 infection and immunity.\nname:AFS/SERS Saliva-based SARS-CoV-2 Earliest Infection and Antibodies Detection\nsubProject:Exosome\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U18"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3d392600f5ed4d658c079a9fbff12cc4": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 2347,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3de566bd89f04262a08ecbfc67ea8df6": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "CytoscapeModel",
     "state": {
      "_dom_classes": [],
      "_interaction_handlers": {},
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "CytoscapeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "CytoscapeView",
      "auto_ungrabify": false,
      "auto_unselectify": true,
      "autolock": false,
      "box_selection_enabled": false,
      "cytoscape_layout": {
       "name": "cola",
       "nodeDimensionsIncludeLabels": true,
       "nodeSpacing": 40,
       "padding": 0,
       "unconstrIter": 5000
      },
      "cytoscape_style": [
       {
        "selector": "node",
        "style": {
         "background-color": "#A5ABB6",
         "border-color": "#9AA1AC",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "edge",
        "style": {
         "curve-style": "bezier",
         "font-size": "8px",
         "label": "data(name)",
         "line-color": "#A5ABB6",
         "target-arrow-color": "#A5ABB6",
         "target-arrow-shape": "triangle",
         "text-rotation": "autorotate",
         "width": "1px"
        }
       },
       {
        "selector": "node[label=\"*\"]",
        "style": {
         "background-color": "#C990C0",
         "border-color": "#b261a5",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"City\"]",
        "style": {
         "background-color": "#F79767",
         "border-color": "#f36924",
         "border-width": "2px",
         "font-size": "10px",
         "height": "65px",
         "label": "data(name)",
         "text-max-width": "65px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "65px"
        }
       },
       {
        "selector": "node[label=\"Disease\"]",
        "style": {
         "background-color": "#569480",
         "border-color": "#447666",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Symptom\"]",
        "style": {
         "background-color": "#8DCC93",
         "border-color": "#5db665",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"Patient\"]",
        "style": {
         "background-color": "#4C8EDA",
         "border-color": "#2870c2",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(firstName)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"State\"]",
        "style": {
         "background-color": "#FFC454",
         "border-color": "#d7a013",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"MetaNode\"]",
        "style": {
         "background-color": "#D9C8AE",
         "border-color": "#c0a378",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(nodeName)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Grant\"]",
        "style": {
         "background-color": "#4C8EDA",
         "border-color": "#2870c2",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Researcher\"]",
        "style": {
         "background-color": "#FFC454",
         "border-color": "#d7a013",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"FundingOpportunity\"]",
        "style": {
         "background-color": "#DA7194",
         "border-color": "#cc3c6c",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Organization\"]",
        "style": {
         "background-color": "#569480",
         "border-color": "#447666",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Dataset\"]",
        "style": {
         "background-color": "#F79767",
         "border-color": "#f36924",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"CoordinationCenter\"]",
        "style": {
         "background-color": "#57C7E3",
         "border-color": "#23b3d7",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Event\"]",
        "style": {
         "background-color": "#8DCC93",
         "border-color": "#5db665",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Publication\"]",
        "style": {
         "background-color": "#AA7942",
         "border-color": "#8D6429",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Patent\"]",
        "style": {
         "background-color": "#C990C0",
         "border-color": "#b261a5",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Presentation\"]",
        "style": {
         "background-color": "#F16667",
         "border-color": "#eb2728",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Software\"]",
        "style": {
         "background-color": "#ECB5C9",
         "border-color": "#da7298",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"ResearchInitiative\"]",
        "style": {
         "background-color": "#57C7E3",
         "border-color": "#23b3d7",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "edge[name=\"MetaRelationship\"]",
        "style": {
         "curve-style": "bezier",
         "font-size": "8px",
         "label": "data(relationshipName)",
         "line-color": "#A5ABB6",
         "target-arrow-color": "#A5ABB6",
         "target-arrow-shape": "triangle",
         "text-rotation": "autorotate",
         "width": "1px"
        }
       }
      ],
      "desktop_tap_threshold": 4,
      "graph": "IPY_MODEL_1501df663ab64d65822a548071f0f9a5",
      "headless": false,
      "hide_edges_on_viewport": false,
      "layout": "IPY_MODEL_46d4e111fe884e1f99b3c3a47ff5090f",
      "max_zoom": 1e+50,
      "min_zoom": 1e-50,
      "motion_blur": false,
      "motion_blur_opacity": 0.2,
      "panning_enabled": true,
      "pixel_ratio": "auto",
      "rendered_position": {
       "renderedPosition": {
        "x": 100,
        "y": 100
       }
      },
      "selection_type": "single",
      "style_enabled": true,
      "texture_on_viewport": false,
      "tooltip_source": "tooltip",
      "touch_tap_threshold": 8,
      "user_panning_enabled": true,
      "user_zooming_enabled": true,
      "wheel_sensitivity": 1,
      "zoom": 2,
      "zooming_enabled": true
     }
    },
    "3e1aaed2c64b41c892d053dd2ac7954e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "R",
       "fullName": "R Presti",
       "id": 1186,
       "label": "Researcher",
       "lastName": "Presti",
       "name": "Presti R",
       "tooltip": "Researcher\nid:s2authorid:6813377\nlastName:Presti\nname:Presti R\nfullName:R Presti\nfirstName:R"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3e1e6cfe0bed46e094105960b5344301": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The COVID-19 pandemic has rapidly spread across the world, bringing death, illness, disruption to daily\nlife, and economic crisis to businesses and individuals. The situation has been exacerbated after the schools\nand companies reopened due to economic pressure. One of the key failures in COVID-19 containment is\nunderlined by the inability of our healthcare system in real-time detection in point-of-care (POC) and end-user\nsettings and precise tracing with privacy protection of active infections. The fundamental limitations of current\ngene-based assays stem from their reliance upon amplification and detection of the viral genetic materials\neven if there were no intact/infectious viruses. These tests require labor-intensive, laboratory-based sample\npreparation protocols for virus lysis, extraction of genetic materials, purification of the isolated materials,\nthermal cycling for enzymatic amplification of viral nucleic acid sequences, and interpretation of complex\nresults by professionals. To accurately determine the infectivity of the infected individuals, contaminated\nobjects and environments, and provide guidance for patients, public and authorities to better manage treatment\nand containment, we seek a new paradigm for rapid and direct pathogen detection and identification in which\nthe intact virions are directly recognized through their distinct surface epitope features, and the resultant\nfluorescent signal is immediately captured by an end-user smartphone, followed by automatic data transition\nand event tracing in a blockchain-encrypted manner. To achieve specific recognition of SARS-CoV-2 virions,\nwe customized a designer DNA nanostructure (DDN)-based capture probe that harbors a macromolecular\n“net” whose vertices precisely match the intra- and inter-spatial pattern of SARS-CoV-2 trimeric spike\nglycoprotein clusters, and integrates a net-shaped array of SARS-CoV-2 spike specific-targeting aptamers.\nThis aptamer-DDN is designed for maximum affinity and specificity binding with spikes on intact virions in a\npolyvalent and pattern-matching fashion. Once bound to intact virions, the DNA “nets” trigger the release of\nfluorescence. This fluorescent signal can be readily and automatically detected by a membrane-shaped and\nsmartphone-based fluorimeter attached to the end-users' phone cameras. The acquired results will be\nassociated with user device IDs that are cyber-protected before tracing. We propose to combine DDN capture\nprobes and a smartphone device to develop and demonstrate a rapid, room temperature, single-step, virus-\nspecific, and ultrasensitive detection of SARS-CoV-2 virus, in which the detection results can be acquired\nwithin 5 minutes upon exposure, at the user end, allowing tracing the presence of viruses without affecting user\nprivacy. The signal to result transition, result to ID association, individual track and interacting network tracing\nwill be blockchain-encrypted to ensure information security for individual privacy, while tracing information\nwould be available to health authority for public health benefits.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 24,
       "label": "Grant",
       "name": "Detection and Automatic Privacy-Protected Contact Tracing System Designed for COVID-19",
       "narrative": "The goal of the project is to develop a pipeline for automatic detection and tracing of active SARS-CoV-2\ninfection in a cost-effective, highly accurate, real-time, portable, and super-encrypted manner. Our integrated\napproach first captures viral particles from patient samples to activate fluorescence reporters, followed by\nsignal detection using a smartphone fluorimeter, along with blockchain-based data processing and tracing. We\ndeployed designer DNA “net” nanostructures that match the spatial pattern of trimeric spike glycoprotein\nclusters on the viral outer surface for specific and rapid SARS-CoV-2 virion detection, smartphone-based point-\nof-care device for portable signal reading, and blockchain encryption for privacy protection during result\nrecording and track tracing, therefore, our detection and tracing model allows a direct, automatic, and cost-\neffective detection, a highly flexible result acquisition process and a super-encrypted data transition and tracing\nsystem.",
       "researchInitiative": "RADx-rad",
       "subProject": "Automatic Detection & Tracing",
       "tooltip": "Grant\nabstract:The COVID-19 pandemic has rapidly spread across the world, bringing death, illness, disruption to daily\nlife, and economic crisis to businesses and individuals. The situation has been exacerbated after the schools\nand companies reopened due to economic pressure. One of the key failures in COVID-19 containment is\nunderlined by the inability of our healthcare system in real-time detection in point-of-care (POC) and end-user\nsettings and precise tracing with privacy protection of active infections. The fundamental limitations of current\ngene-based assays stem from their reliance upon amplification and detection of the viral genetic materials\neven if there were no intact/infectious viruses. These tests require labor-intensive, laboratory-based sample\npreparation protocols for virus lysis, extraction of genetic materials, purification of the isolated materials,\nthermal cycling for enzymatic amplification of viral nucleic acid sequences, and interpretation of complex\nresults by professionals. To accurately determine the infectivity of the infected individuals, contaminated\nobjects and environments, and provide guidance for patients, public and authorities to better manage treatment\nand containment, we seek a new paradigm for rapid and direct pathogen detection and identification in which\nthe intact virions are directly recognized through their distinct surface epitope features, and the resultant\nfluorescent signal is immediately captured by an end-user smartphone, followed by automatic data transition\nand event tracing in a blockchain-encrypted manner. To achieve specific recognition of SARS-CoV-2 virions,\nwe customized a designer DNA nanostructure (DDN)-based capture probe that harbors a macromolecular\n“net” whose vertices precisely match the intra- and inter-spatial pattern of SARS-CoV-2 trimeric spike\nglycoprotein clusters, and integrates a net-shaped array of SARS-CoV-2 spike specific-targeting aptamers.\nThis aptamer-DDN is designed for maximum affinity and specificity binding with spikes on intact virions in a\npolyvalent and pattern-matching fashion. Once bound to intact virions, the DNA “nets” trigger the release of\nfluorescence. This fluorescent signal can be readily and automatically detected by a membrane-shaped and\nsmartphone-based fluorimeter attached to the end-users' phone cameras. The acquired results will be\nassociated with user device IDs that are cyber-protected before tracing. We propose to combine DDN capture\nprobes and a smartphone device to develop and demonstrate a rapid, room temperature, single-step, virus-\nspecific, and ultrasensitive detection of SARS-CoV-2 virus, in which the detection results can be acquired\nwithin 5 minutes upon exposure, at the user end, allowing tracing the presence of viruses without affecting user\nprivacy. The signal to result transition, result to ID association, individual track and interacting network tracing\nwill be blockchain-encrypted to ensure information security for individual privacy, while tracing information\nwould be available to health authority for public health benefits.\nid:U01AA029348\nnarrative:The goal of the project is to develop a pipeline for automatic detection and tracing of active SARS-CoV-2\ninfection in a cost-effective, highly accurate, real-time, portable, and super-encrypted manner. Our integrated\napproach first captures viral particles from patient samples to activate fluorescence reporters, followed by\nsignal detection using a smartphone fluorimeter, along with blockchain-based data processing and tracing. We\ndeployed designer DNA “net” nanostructures that match the spatial pattern of trimeric spike glycoprotein\nclusters on the viral outer surface for specific and rapid SARS-CoV-2 virion detection, smartphone-based point-\nof-care device for portable signal reading, and blockchain encryption for privacy protection during result\nrecording and track tracing, therefore, our detection and tracing model allows a direct, automatic, and cost-\neffective detection, a highly flexible result acquisition process and a super-encrypted data transition and tracing\nsystem.\nname:Detection and Automatic Privacy-Protected Contact Tracing System Designed for COVID-19\nsubProject:Automatic Detection & Tracing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3e72943b52c44242bceb791e8b3e00d1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "GraphModel",
     "state": {
      "_adj": {
       "2409": {},
       "2741": {},
       "2767": {},
       "2768": {},
       "36": {},
       "4360": {},
       "586": {},
       "677": {}
      },
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "GraphModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": null,
      "edges": [
       "IPY_MODEL_034931925ad04bb9b228dd3c03ac96e3",
       "IPY_MODEL_00319f516ed24521ad8fbe403f1ffc1d",
       "IPY_MODEL_597c1438260d4ebf84f034567e76c0d0",
       "IPY_MODEL_34df3402d3394c1d87ba057890e58977",
       "IPY_MODEL_b95d2bbeced749429f7fe407d7ae639b",
       "IPY_MODEL_20c002a92efc4292a3749801b4f02c18",
       "IPY_MODEL_d87069a9ece54df99d708684a3567458"
      ],
      "nodes": [
       "IPY_MODEL_20dd6ed0c82640f384ed560af46a2e2c",
       "IPY_MODEL_7b5311b47f0744728e55f94df8c92224",
       "IPY_MODEL_366287609349423a9ea670ade93ee9a2",
       "IPY_MODEL_eb659eed22c04ed794d312f7261a6dd8",
       "IPY_MODEL_098f71e4e6a54124bb6491defc6c1556",
       "IPY_MODEL_5e4be9cca3024dbdbceb2ce24df7e1e6",
       "IPY_MODEL_b50f0e5ffc54422fac7e8eb978a98836",
       "IPY_MODEL_30d40415a6d84a44a60c21c51529c573"
      ]
     }
    },
    "3f41d1b6819347e699280da0c639a672": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Pamela",
       "fullName": "Pamela Helen Dalton",
       "id": 680,
       "label": "Researcher",
       "lastName": "Dalton",
       "middleName": "Helen",
       "name": "Dalton PH",
       "orcid": "orcid:0000-0003-2474-2888",
       "profileId": "profileid:1877373",
       "tooltip": "Researcher\nmiddleName:Helen\nid:profileid:1877373\nlastName:Dalton\norcid:orcid:0000-0003-2474-2888\nprofileId:profileid:1877373\nname:Dalton PH\nfullName:Pamela Helen Dalton\nfirstName:Pamela"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3fb66a7628e24163a9efc5a906855908": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "CITES",
       "source": 4056,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "3ffea9057c724afdb09380d32a2fee2e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "PROJECT SUMMARY\n Coronavirus 2019 (COVID-19) has afflicted 6.2 million Americans and killed 190,000 as of early September\n2020 (WHO website); a roughly 3% mortality. Between a shortage in testing and unidentified asymptomatic\nindividuals, the actual number of those infected could be 6 to 24-fold higher than that reported. SARS-CoV-2\n(CoV-2), the virus underlying the disease, results in a range of symptoms; in select cases a severe respiratory\nillness that impedes breathing that could lead to hospitalization and death. CoV-2 is transmitted person-to-\nperson via inhalation of the virus through mucosal membranes of the nose and throat from transfer after\ntouching a contaminated surface or by inhaling aerosolized virus. Unfortunately, COVID-19 is likely to be\nprevalent well into 2021 and beyond.\n We must increase our ability to test for CoV-2. First, testing is needed to diagnose individuals that are\nsymptomatic or asymptomatic to reduce community spread. And second, monitoring gathering areas for\nairborne virus that could inform the decision to shutdown a space or implement disinfection and mitigation of\nan area. We propose to use an electrochemical biosensor in two detection devices, 1) a diagnostic\nbreathalyzer for instant detection of CoV-2 and 2) an airborne detector for real-time, continuous surveillance of\na large space.\n We have developed a novel ultra-sensitive, antibody-based electrochemical biosensor to detect CoV-2\nrepeat binding domain (RBD) spike protein. The technology is based on a micro-immunoelectrode (MIE)\nbiosensor pioneered by the Cirrito laboratory to study protein dynamics in the setting of neurodegeneration (2,3).\nThe biosensor uses voltammetry to measure the oxidation of tyrosine amino acids; oxidation is the release of\nelectrons that the biosensor measures as a change in current. Antibodies are covalently attached to the\nelectrode surface to provide selectivity. Our prototype CoV-2 biosensor is sensitive to 2 femtogram/ml,\ncompared to several current CoV-2 antigen tests that are sensitive to the low picogram/ml range.\n The proposal will first (Aim 1) optimize our CoV-2 biosensor to detect CoV-2 viral particles, as well as test\nseveral parameters to increase sensitivity and longevity. Aim 2 will build a test breathalyzer that will utilize a\nnebulizer to generate virus laden air containing aerosol droplets similar to a breath that contain defined\nconcentrations of CoV-2 viral particles. Aim 3 will test the airborne biosensor in a realistic environment. Co-I\nChakrabarty’s laboratory has unique capabilities of mimicking real-world environmental conditions, especially\nin the context of atmospheric aerosols, necessary for testing and optimizing the biosensor’s performance for\nfield deployment. Atmospheric conditions include relative humidity (RH) and temperature, as well as common\nairborne pollutants found indoors.\n Finding novel means to detect the CoV-2, as well as create a platform to detect other and future\npathogens, would enable us to limit the viral spread throughout the community in the current and future\npandemics.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 36,
       "label": "Grant",
       "name": "Nanobody-Based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2",
       "narrative": "COVID-19 has afflicted millions of Americans with a roughly 3% mortality rate. We have developed an\nultra-sensitive electrochemical biosensor to detect CoV-2 which we will incorporate into a breathalyzer for\ndiagnostic purposes, as well as an airborne detector to monitor large gathering spaces.",
       "researchInitiative": "RADx-rad",
       "subProject": "Automatic Detection & Tracing",
       "tooltip": "Grant\nabstract:PROJECT SUMMARY\n Coronavirus 2019 (COVID-19) has afflicted 6.2 million Americans and killed 190,000 as of early September\n2020 (WHO website); a roughly 3% mortality. Between a shortage in testing and unidentified asymptomatic\nindividuals, the actual number of those infected could be 6 to 24-fold higher than that reported. SARS-CoV-2\n(CoV-2), the virus underlying the disease, results in a range of symptoms; in select cases a severe respiratory\nillness that impedes breathing that could lead to hospitalization and death. CoV-2 is transmitted person-to-\nperson via inhalation of the virus through mucosal membranes of the nose and throat from transfer after\ntouching a contaminated surface or by inhaling aerosolized virus. Unfortunately, COVID-19 is likely to be\nprevalent well into 2021 and beyond.\n We must increase our ability to test for CoV-2. First, testing is needed to diagnose individuals that are\nsymptomatic or asymptomatic to reduce community spread. And second, monitoring gathering areas for\nairborne virus that could inform the decision to shutdown a space or implement disinfection and mitigation of\nan area. We propose to use an electrochemical biosensor in two detection devices, 1) a diagnostic\nbreathalyzer for instant detection of CoV-2 and 2) an airborne detector for real-time, continuous surveillance of\na large space.\n We have developed a novel ultra-sensitive, antibody-based electrochemical biosensor to detect CoV-2\nrepeat binding domain (RBD) spike protein. The technology is based on a micro-immunoelectrode (MIE)\nbiosensor pioneered by the Cirrito laboratory to study protein dynamics in the setting of neurodegeneration (2,3).\nThe biosensor uses voltammetry to measure the oxidation of tyrosine amino acids; oxidation is the release of\nelectrons that the biosensor measures as a change in current. Antibodies are covalently attached to the\nelectrode surface to provide selectivity. Our prototype CoV-2 biosensor is sensitive to 2 femtogram/ml,\ncompared to several current CoV-2 antigen tests that are sensitive to the low picogram/ml range.\n The proposal will first (Aim 1) optimize our CoV-2 biosensor to detect CoV-2 viral particles, as well as test\nseveral parameters to increase sensitivity and longevity. Aim 2 will build a test breathalyzer that will utilize a\nnebulizer to generate virus laden air containing aerosol droplets similar to a breath that contain defined\nconcentrations of CoV-2 viral particles. Aim 3 will test the airborne biosensor in a realistic environment. Co-I\nChakrabarty’s laboratory has unique capabilities of mimicking real-world environmental conditions, especially\nin the context of atmospheric aerosols, necessary for testing and optimizing the biosensor’s performance for\nfield deployment. Atmospheric conditions include relative humidity (RH) and temperature, as well as common\nairborne pollutants found indoors.\n Finding novel means to detect the CoV-2, as well as create a platform to detect other and future\npathogens, would enable us to limit the viral spread throughout the community in the current and future\npandemics.\nid:U01AA029331\nnarrative:COVID-19 has afflicted millions of Americans with a roughly 3% mortality rate. We have developed an\nultra-sensitive electrochemical biosensor to detect CoV-2 which we will incorporate into a breathalyzer for\ndiagnostic purposes, as well as an airborne detector to monitor large gathering spaces.\nname:Nanobody-Based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2\nsubProject:Automatic Detection & Tracing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "403e95d7218649ca94f61fbd0d2f5ab7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4392,
       "target": 37
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4061a973c34846fa913cb68293958205": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1888,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4067115d9254407e963de6eccef4eea8": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Juan",
       "fullName": "Juan C Salazar",
       "id": 674,
       "label": "Researcher",
       "lastName": "Salazar",
       "middleName": "C",
       "name": "Salazar JC",
       "orcid": "orcid:0000-0003-4112-6067",
       "profileId": "profileid:6786579",
       "tooltip": "Researcher\nmiddleName:C\nid:profileid:6786579\nlastName:Salazar\norcid:orcid:0000-0003-4112-6067\nprofileId:profileid:6786579\nname:Salazar JC\nfullName:Juan C Salazar\nfirstName:Juan"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "407bb20b4ed641d989a9ec5ce9deb0ad": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Preparing SARS-­CoV-­2 testing data for reuse requires making the data syntactically and semantically equivalent. \nStandardization  of  terminologies  and  a  common  data  model  accomplish  the  former,  while  the  latter  is \naccomplished  through  understanding  the  data  and  making  it  comparable  across  RADx-­rad  awardees  by \nbenchmarking against known gold standards. The standardization of samples is as important as standardizing \nthe data, particularly in the highly innovative RADx-­rad program, where new technologies will be developed or \noptimized for deployment in various settings. Highly motivated RADx-­rad awardees will receive advice on how \ntheir diagnostics compare to FDA-­approved ones, with each other, how their diagnostic performs in independent \ntesting,  as  well as how  to ensure  the  tests  are usable  in  real  world  settings.  In  collaboration  with  University  of \nTexas  Health  Science  Center  at  Houston,  University  of  California San  Diego  researchers  in  informatics/data \nscience and infectious diseases with ample experience in leading large consortia have designed a unique RADx-­\nrad  Consortium  Data  and  Coordination  Center  (radCDCC).  This  center  is  based  on  three  pillars:  (1)  effective \nadministration and coordination among awardees, NIH, and other programs;; (2) innovative approaches and tools \nto  collect  and  standardize  data  and  metadata  to  promote  findability,  accessibility,  interoperability  and  reuse \n(FAIR)  for  data  sharing;;  and  (3)  principled  preparation  of  standardized  samples  with  known  quantities  of  viral \nloads, and standardized procedures for testing new diagnostics to allow comparison across tests and calibration \nof  new  technologies.  Backed  by  sophisticated  HIPAA-­compliant  cloud  services,  user  friendly  web-­tools,  and \nextensive  support  from  UCSD’s  facilities  for  computation and  for  clinical  research,  the  radCDCC will  interface \nwith other RADx programs and other COVID-­19 focused programs at NIH to ensure alignment of awardees, NIH \nand the public in the pursuit of effective, affordable, and deployable new technologies for testing.  ",
       "awardCode": "U24",
       "fundingMechanism": "Other Research-Related",
       "id": 47,
       "label": "Grant",
       "name": "RADx-Rad Discoveries & Data: Consortium Coordination Center Program Organization",
       "narrative": "The  RADx-­rad  Consortium  Data  and  Coordination  Center  (radCDCC)  will  use  advanced data  management  to \ncoordinate  a  consortium  of  innovative  COVID-­19  diagnostic  technology  developers.  The  partnership  between \nthe  University  of  California  San  Diego  and  the  University  of  Texas  Health  Science  Center  at  Houston  brings \ntogether informatics/data scientists and infectious diseases specialists who will standardize viral samples, testing \nand procedures, as well as data in order to integrate and share data in a meaningful manner. ",
       "researchInitiative": "RADx-rad",
       "subProject": "Data Coordinating Center",
       "tooltip": "Grant\nabstract:Preparing SARS-­CoV-­2 testing data for reuse requires making the data syntactically and semantically equivalent. \nStandardization  of  terminologies  and  a  common  data  model  accomplish  the  former,  while  the  latter  is \naccomplished  through  understanding  the  data  and  making  it  comparable  across  RADx-­rad  awardees  by \nbenchmarking against known gold standards. The standardization of samples is as important as standardizing \nthe data, particularly in the highly innovative RADx-­rad program, where new technologies will be developed or \noptimized for deployment in various settings. Highly motivated RADx-­rad awardees will receive advice on how \ntheir diagnostics compare to FDA-­approved ones, with each other, how their diagnostic performs in independent \ntesting,  as  well as how  to ensure  the  tests  are usable  in  real  world  settings.  In  collaboration  with  University  of \nTexas  Health  Science  Center  at  Houston,  University  of  California San  Diego  researchers  in  informatics/data \nscience and infectious diseases with ample experience in leading large consortia have designed a unique RADx-­\nrad  Consortium  Data  and  Coordination  Center  (radCDCC).  This  center  is  based  on  three  pillars:  (1)  effective \nadministration and coordination among awardees, NIH, and other programs;; (2) innovative approaches and tools \nto  collect  and  standardize  data  and  metadata  to  promote  findability,  accessibility,  interoperability  and  reuse \n(FAIR)  for  data  sharing;;  and  (3)  principled  preparation  of  standardized  samples  with  known  quantities  of  viral \nloads, and standardized procedures for testing new diagnostics to allow comparison across tests and calibration \nof  new  technologies.  Backed  by  sophisticated  HIPAA-­compliant  cloud  services,  user  friendly  web-­tools,  and \nextensive  support  from  UCSD’s  facilities  for  computation and  for  clinical  research,  the  radCDCC will  interface \nwith other RADx programs and other COVID-­19 focused programs at NIH to ensure alignment of awardees, NIH \nand the public in the pursuit of effective, affordable, and deployable new technologies for testing.  \nid:U24LM013755\nnarrative:The  RADx-­rad  Consortium  Data  and  Coordination  Center  (radCDCC)  will  use  advanced data  management  to \ncoordinate  a  consortium  of  innovative  COVID-­19  diagnostic  technology  developers.  The  partnership  between \nthe  University  of  California  San  Diego  and  the  University  of  Texas  Health  Science  Center  at  Houston  brings \ntogether informatics/data scientists and infectious diseases specialists who will standardize viral samples, testing \nand procedures, as well as data in order to integrate and share data in a meaningful manner. \nname:RADx-Rad Discoveries & Data: Consortium Coordination Center Program Organization\nsubProject:Data Coordinating Center\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U24"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "408fac2790024e04970af08a0511946f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "endDate": "2023-09-21",
       "eventType": "webinar",
       "eventUrl": "https://www.radxrad.org/event/radx-rad-2023-conference-final-conference/",
       "id": 2414,
       "label": "Event",
       "name": "RADx-rad 2023 Conference",
       "startDate": "2023-09-21",
       "tooltip": "Event\nid:2023-09-21_E1\nstartDate:2023-09-21\nname:RADx-rad 2023 Conference\neventUrl:https://www.radxrad.org/event/radx-rad-2023-conference-final-conference/\nendDate:2023-09-21\neventType:webinar"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "409de1bc7341450d901cfa47619ce6fb": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 625,
       "target": 32
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "412e0dbcef814cc3b2f5d2cf1ae29ed3": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2021,
       "name": "EMPLOYED_AT",
       "source": 615,
       "target": 559
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "415c0d90bd4941d9b8cc703d6455bbd9": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 705,
       "target": 598
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4186599920924d84b5fee05210462b50": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "from": "Unique identifier for the presentation (string)",
       "name": "MetaRelationship",
       "relationshipName": "PRESENTED_AT",
       "source": 2752,
       "target": 2757,
       "to": "Unique identifier for the event (string)"
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "424c68a20a2f4102854410b89701cf6f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 622,
       "target": 17
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "427703da5fec42a0a91226eaa9671e76": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Radislav",
       "fullName": "Radislav A Potyrailo",
       "id": 626,
       "label": "Researcher",
       "lastName": "Potyrailo",
       "middleName": "A",
       "name": "Potyrailo RA",
       "orcid": "orcid:0000-0002-4823-1962",
       "profileId": "profileid:8857241",
       "tooltip": "Researcher\nmiddleName:A\nid:profileid:8857241\nlastName:Potyrailo\norcid:orcid:0000-0002-4823-1962\nprofileId:profileid:8857241\nname:Potyrailo RA\nfullName:Radislav A Potyrailo\nfirstName:Radislav"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "43bd243d5ee34296bd3d10b535bb2c7d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The goals of this Emergency Competitive Revision are to develop (Aim 1) and deploy (Aim 2) a\nnovel, objective, psychophysical smell and taste screening test to detect the onset of COVID 19\nin at-risk populations. Complementary to the temperature screening procedures currently in use,\nthis tool is predicted to promote early identification of COVID onset leading to better prognoses\nand the early implementation of protocols to prevent community spread. Our specific plan is to\nuse a hard-candy containing different combinations of tastants and flavors that are easy to\ndistribute to a large population. During the development phase (Aim 1), this novel test will be\ncompared with the NIH toolbox to assess the acceptability and efficacy of the two methods. We\nexpect that the hard-candy assessment will be at least as efficacious in detecting chemosensory\nloss but more acceptable to subjects. Aim 2 will entail daily self-monitoring of chemosensory\nfunction in at-risk populations with data tracked through a secure online portal. The novelty of\nthis confectionary-based test is that it provides standard stimuli that can yield objective\nmeasures of both the qualitative and quantitative aspects of smell (aroma and flavor) and taste\n(sweet and sour). Moreover, both orthonasal and retronasal olfactory function will be\nindependently assessed. The test can be self-administered and the familiar, pleasant nature of\nthe stimuli should facilitate a high compliance rate, allowing for continuous monitoring over\nprolonged periods. Moreover, the test is rapid and inexpensive. Data will be incorporated into a\npredictive model for COVID 19 and assessed using AOC analyses of sensitivity and specificity.\nOSU is a leading large public land grant university with a varied population of students, faculty,\nand support staff that includes all health care specialties. These characteristics, along with the\nUniversity-mandated regular PCR testing of students and staff makes it a perfect site to perform\nthis urgent research.",
       "awardCode": "R01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 5,
       "label": "Grant",
       "name": "A confectionary-based screening tool for assessing chemosensory loss in COVID 19 patients.",
       "narrative": "This research will develop a novel screening tool for COVID 19 using chemosensory testing. Loss of smell\nand/or taste is a predictive symptom of COVID 19 but current tests are not optimal for routine\nassessment in large populations of individuals. The development of a confectionary-based test will allow\nroutine self-monitoring of chemosensory function using objective, sensitive, simple and inexpensive\nprocedures to identify potential cases of COVID 19.",
       "researchInitiative": "RADx-rad",
       "subProject": "Chemosensory Testing",
       "tooltip": "Grant\nabstract:The goals of this Emergency Competitive Revision are to develop (Aim 1) and deploy (Aim 2) a\nnovel, objective, psychophysical smell and taste screening test to detect the onset of COVID 19\nin at-risk populations. Complementary to the temperature screening procedures currently in use,\nthis tool is predicted to promote early identification of COVID onset leading to better prognoses\nand the early implementation of protocols to prevent community spread. Our specific plan is to\nuse a hard-candy containing different combinations of tastants and flavors that are easy to\ndistribute to a large population. During the development phase (Aim 1), this novel test will be\ncompared with the NIH toolbox to assess the acceptability and efficacy of the two methods. We\nexpect that the hard-candy assessment will be at least as efficacious in detecting chemosensory\nloss but more acceptable to subjects. Aim 2 will entail daily self-monitoring of chemosensory\nfunction in at-risk populations with data tracked through a secure online portal. The novelty of\nthis confectionary-based test is that it provides standard stimuli that can yield objective\nmeasures of both the qualitative and quantitative aspects of smell (aroma and flavor) and taste\n(sweet and sour). Moreover, both orthonasal and retronasal olfactory function will be\nindependently assessed. The test can be self-administered and the familiar, pleasant nature of\nthe stimuli should facilitate a high compliance rate, allowing for continuous monitoring over\nprolonged periods. Moreover, the test is rapid and inexpensive. Data will be incorporated into a\npredictive model for COVID 19 and assessed using AOC analyses of sensitivity and specificity.\nOSU is a leading large public land grant university with a varied population of students, faculty,\nand support staff that includes all health care specialties. These characteristics, along with the\nUniversity-mandated regular PCR testing of students and staff makes it a perfect site to perform\nthis urgent research.\nid:R01DC016112\nnarrative:This research will develop a novel screening tool for COVID 19 using chemosensory testing. Loss of smell\nand/or taste is a predictive symptom of COVID 19 but current tests are not optimal for routine\nassessment in large populations of individuals. The development of a confectionary-based test will allow\nroutine self-monitoring of chemosensory function using objective, sensitive, simple and inexpensive\nprocedures to identify potential cases of COVID 19.\nname:A confectionary-based screening tool for assessing chemosensory loss in COVID 19 patients.\nsubProject:Chemosensory Testing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "442c9804630c4e889147e4d6c219dcaf": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 675,
       "target": 34
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "44efcb185c1a428fa7c6c260accb6559": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4385,
       "target": 9
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "459e39d017d94cfb926426fbdccfa0fd": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 684,
       "target": 2811
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "46d4e111fe884e1f99b3c3a47ff5090f": {
     "model_module": "@jupyter-widgets/base",
     "model_module_version": "1.2.0",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": "900px",
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "46f540d502a44db4acfeb3ed789b1a5b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Otakuye",
       "fullName": "Otakuye Conroy-Ben",
       "id": 638,
       "label": "Researcher",
       "lastName": "Conroy-Ben",
       "name": "Conroy-Ben O",
       "orcid": "orcid:0000-0001-8086-1625",
       "profileId": "profileid:10833925",
       "tooltip": "Researcher\nid:profileid:10833925\nlastName:Conroy-Ben\norcid:orcid:0000-0001-8086-1625\nprofileId:profileid:10833925\nname:Conroy-Ben O\nfullName:Otakuye Conroy-Ben\nfirstName:Otakuye"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4776239192e64fb696a483e6932e858d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Marshallese Pacific Islanders bear a disproportionate burden of COVID-19 infection, hospitalization, and\ndeath, with rates 4 to 25 times higher than those of other US racial and ethnic groups in the Continental US.2,3\nFor example, in Northwest Arkansas Marshallese people represent less than 3% of the total population, but\nthey account for 1 out of 5 COVID-19 cases in this area.2 Similarly, Marshallese represent just 1% of the\npopulation in Spokane County, Washington, but were nearly 30% of COVID-19 cases between March and\nMay, 2020.4 Social determinants of health have powerful influences on community and individual risks for\nCOVID-19.18 Culturally, the Marshallese community is extremely tight-knit, self-contained, and highly clustered;\nthey often live in multi-generational households; and they traditionally value close contact and large social\nevents, all of which increase vulnerability to the COVID-19 pandemic.19,20Marshallese are important recipients\nof effective surveillance efforts given the disproportionate impact of COVID-19 on this population and the long-\nstanding disparities in health and health care.\n The MASC-UP study will generate novel data that reflect variation in risk of COVID-19 infection based on\none’s place in the highly clustered Marshallese community. For Specific Aim 1, bilingual Marshallese\nCommunity Health Workers will recruit and train a longitudinal cohort of 800 Marshallese adults, ages 18 and\nolder, in participatory disease surveillance methods that include using a wireless thermometer to continuously\ntrack body temperature; social media and text messaging in which participants (aka citizen scientists) can\nreport symptoms; and a CHW helpline to report symptoms and request COVID-19 information. Participatory\ndisease surveillance complements traditional surveillance systems by engaging communities in reporting\nCOVID-19 symptoms and events. Its strengths lie in the speed at which data can be made available, the ability\nto scale the technology to obtain data at low cost, and the ability to cover populations that might not otherwise\nbe tracked. For Specific Aim 2 participants will complete an ego-centric contact survey to characterize the\nsocial contact networks of members in the disease surveillance cohort from Aim 1. The networks will allow\nidentification of people at highest risk of COVID-19 infection and elucidate targets for high-impact preventive\nintervention. For Specific Aim 3 we will integrate findings from Aims 1 and 2 into the existing test-based\ndisease surveillance currently being performed at the state and local levels. This Aim will augment existing\nsurveillance systems that have proved insufficient to stem the pandemic in Marshallese people. The proposed\nstudy will be generalizable to other high risk, clustered underserved populations.",
       "awardCode": "R01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 32,
       "label": "Grant",
       "name": "Marshallese: Alternate Surveillance for COVID-19 in a Unique Population",
       "narrative": "The Marshallese: Alternate Surveillance for COVID-19 in a Unique Population (MASC UP) study will deploy\ninnovative, culturally tailored, multi-modal, multi-level participatory surveillance systems in 2 of the largest\nMarshallese communities in the US: Northwest Arkansas and Spokane County, Washington. MASC UP will\ndemonstrate the value of culturally tailored, participatory disease surveillance developed and tested in real-\nworld settings to mitigate COVID-19 disparities in a high-risk, clustered population that has been profoundly\nunderserved by public health efforts to date. Our findings can be rapidly adapted and disseminated for\nimproved surveillance and disease prevention in other high-risk minority groups across the US.",
       "researchInitiative": "RADx-rad",
       "subProject": "Multimodal Surveillance",
       "tooltip": "Grant\nabstract:Marshallese Pacific Islanders bear a disproportionate burden of COVID-19 infection, hospitalization, and\ndeath, with rates 4 to 25 times higher than those of other US racial and ethnic groups in the Continental US.2,3\nFor example, in Northwest Arkansas Marshallese people represent less than 3% of the total population, but\nthey account for 1 out of 5 COVID-19 cases in this area.2 Similarly, Marshallese represent just 1% of the\npopulation in Spokane County, Washington, but were nearly 30% of COVID-19 cases between March and\nMay, 2020.4 Social determinants of health have powerful influences on community and individual risks for\nCOVID-19.18 Culturally, the Marshallese community is extremely tight-knit, self-contained, and highly clustered;\nthey often live in multi-generational households; and they traditionally value close contact and large social\nevents, all of which increase vulnerability to the COVID-19 pandemic.19,20Marshallese are important recipients\nof effective surveillance efforts given the disproportionate impact of COVID-19 on this population and the long-\nstanding disparities in health and health care.\n The MASC-UP study will generate novel data that reflect variation in risk of COVID-19 infection based on\none’s place in the highly clustered Marshallese community. For Specific Aim 1, bilingual Marshallese\nCommunity Health Workers will recruit and train a longitudinal cohort of 800 Marshallese adults, ages 18 and\nolder, in participatory disease surveillance methods that include using a wireless thermometer to continuously\ntrack body temperature; social media and text messaging in which participants (aka citizen scientists) can\nreport symptoms; and a CHW helpline to report symptoms and request COVID-19 information. Participatory\ndisease surveillance complements traditional surveillance systems by engaging communities in reporting\nCOVID-19 symptoms and events. Its strengths lie in the speed at which data can be made available, the ability\nto scale the technology to obtain data at low cost, and the ability to cover populations that might not otherwise\nbe tracked. For Specific Aim 2 participants will complete an ego-centric contact survey to characterize the\nsocial contact networks of members in the disease surveillance cohort from Aim 1. The networks will allow\nidentification of people at highest risk of COVID-19 infection and elucidate targets for high-impact preventive\nintervention. For Specific Aim 3 we will integrate findings from Aims 1 and 2 into the existing test-based\ndisease surveillance currently being performed at the state and local levels. This Aim will augment existing\nsurveillance systems that have proved insufficient to stem the pandemic in Marshallese people. The proposed\nstudy will be generalizable to other high risk, clustered underserved populations.\nid:R01MD016526\nnarrative:The Marshallese: Alternate Surveillance for COVID-19 in a Unique Population (MASC UP) study will deploy\ninnovative, culturally tailored, multi-modal, multi-level participatory surveillance systems in 2 of the largest\nMarshallese communities in the US: Northwest Arkansas and Spokane County, Washington. MASC UP will\ndemonstrate the value of culturally tailored, participatory disease surveillance developed and tested in real-\nworld settings to mitigate COVID-19 disparities in a high-risk, clustered population that has been profoundly\nunderserved by public health efforts to date. Our findings can be rapidly adapted and disseminated for\nimproved surveillance and disease prevention in other high-risk minority groups across the US.\nname:Marshallese: Alternate Surveillance for COVID-19 in a Unique Population\nsubProject:Multimodal Surveillance\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "47cf3bba69cf40cf9a1feed8e40c3a6c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 633,
       "target": 3
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "47e702a1c6714029bb6d8cea694f1653": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "LOUISVILLE",
       "country": "UNITED STATES",
       "duns": "duns:057588857",
       "geonames": "geonames:4299276",
       "id": 563,
       "label": "Organization",
       "name": "University of Louisville",
       "ror": "ror:01ckdn478",
       "state": "KY",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4299276\nror:ror:01ckdn478\ncity:LOUISVILLE\nname:University of Louisville\nuei:uei:E1KJM4T54MK6\nduns:duns:057588857\nstate:KY\nid:ror:01ckdn478\nurl:https://ror.org/01ckdn478",
       "uei": "uei:E1KJM4T54MK6",
       "url": "https://ror.org/01ckdn478"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "480c0c44b4ae4ba8aca9b9409ec817fc": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Erik",
       "fullName": "Erik F Young",
       "id": 624,
       "label": "Researcher",
       "lastName": "Young",
       "middleName": "F",
       "name": "Young EF",
       "profileId": "profileid:9445541",
       "tooltip": "Researcher\nmiddleName:F\nid:profileid:9445541\nlastName:Young\nprofileId:profileid:9445541\nname:Young EF\nfullName:Erik F Young\nfirstName:Erik"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "485d6fb3fb9747a7b38edbf236839e31": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 688,
       "target": 47
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "48c64d5c2042466db3eb64bd83207df1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 616,
       "target": 6
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4949a7add02b4839b0c3da1ae4d3070e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "SANTA BARBARA",
       "country": "UNITED STATES",
       "duns": "duns:094878394",
       "geonames": "geonames:5392952",
       "id": 609,
       "label": "Organization",
       "name": "University of California, Santa Barbara",
       "ror": "ror:02t274463",
       "state": "CA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5392952\nror:ror:02t274463\ncity:SANTA BARBARA\nname:University of California, Santa Barbara\nuei:uei:G9QBQDH39DF4\nduns:duns:094878394\nstate:CA\nid:ror:02t274463\nurl:https://ror.org/02t274463",
       "uei": "uei:G9QBQDH39DF4",
       "url": "https://ror.org/02t274463"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "49831c3462224e2d939aaf13cb48608d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The main protease (Mpro ) and papain-like protease (PLpro ) play critical roles in SARS-CoV-2 replication and are promising targets for antiviral inhibitors. The simultaneous visualization of Mpro and PLpro is extremely valuable for SARS-CoV-2 detection and rapid inhibitor screening. However, such a crucial investigation has remained challenging because of the lack of suitable probes. We have now developed a dual-color probe (3MBP5) for the simultaneous detection of Mpro and PLpro by fluorescence (or Förster) resonance energy transfer (FRET). This probe produces fluorescence from both the Cy3 and Cy5 fluorophores that are cleaved by Mpro and PLpro . 3MBP5-activatable specificity was demonstrated with recombinant proteins, inhibitors, plasmid-transfected HEK 293T cells, and SARS-CoV-2-infected TMPRSS2-Vero cells. Results from the dual-color probe first verified the simultaneous detection and intracellular distribution of SARS-CoV-2 Mpro and PLpro . This is a powerful tool for the simultaneous detection of different proteases with value for the rapid screening of inhibitors.",
       "doi": "doi:10.1002/anie.202113617",
       "id": 2821,
       "journal": "Angewandte Chemie (International ed. in English)",
       "label": "Publication",
       "name": "A Dual-Color Fluorescent Probe Allows Simultaneous Imaging of Main and Papain-like Proteases of SARS-CoV-2-Infected Cells for Accurate Detection and Rapid Inhibitor Screening.",
       "pmId": "34889013",
       "pmcId": "PMC8854376",
       "tooltip": "Publication\njournal:Angewandte Chemie (International ed. in English)\nabstract:The main protease (Mpro ) and papain-like protease (PLpro ) play critical roles in SARS-CoV-2 replication and are promising targets for antiviral inhibitors. The simultaneous visualization of Mpro and PLpro is extremely valuable for SARS-CoV-2 detection and rapid inhibitor screening. However, such a crucial investigation has remained challenging because of the lack of suitable probes. We have now developed a dual-color probe (3MBP5) for the simultaneous detection of Mpro and PLpro by fluorescence (or Förster) resonance energy transfer (FRET). This probe produces fluorescence from both the Cy3 and Cy5 fluorophores that are cleaved by Mpro and PLpro . 3MBP5-activatable specificity was demonstrated with recombinant proteins, inhibitors, plasmid-transfected HEK 293T cells, and SARS-CoV-2-infected TMPRSS2-Vero cells. Results from the dual-color probe first verified the simultaneous detection and intracellular distribution of SARS-CoV-2 Mpro and PLpro . This is a powerful tool for the simultaneous detection of different proteases with value for the rapid screening of inhibitors.\nid:doi:10.1002/anie.202113617\nname:A Dual-Color Fluorescent Probe Allows Simultaneous Imaging of Main and Papain-like Proteases of SARS-CoV-2-Infected Cells for Accurate Detection and Rapid Inhibitor Screening.\npmId:34889013\nyear:2022\ntype:primary\npmcId:PMC8854376\nurl:https://doi.org/doi:10.1002/anie.202113617\ndoi:doi:10.1002/anie.202113617",
       "type": "primary",
       "url": "https://doi.org/doi:10.1002/anie.202113617",
       "year": 2022
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "49d3f7ae0e4644a2b8a9bbada29b34e5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 663,
       "target": 12
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4a01b0e23f28482a951321eb0f411915": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "NEW YORK",
       "country": "UNITED STATES",
       "duns": "duns:621889815",
       "geonames": "geonames:5128581",
       "id": 577,
       "label": "Organization",
       "name": "Columbia University Irving Medical Center",
       "ror": "ror:01esghr10",
       "state": "NY",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5128581\nror:ror:01esghr10\ncity:NEW YORK\nname:Columbia University Irving Medical Center\nuei:uei:QHF5ZZ114M72\nduns:duns:621889815\nstate:NY\nid:ror:01esghr10\nurl:https://ror.org/01esghr10",
       "uei": "uei:QHF5ZZ114M72",
       "url": "https://ror.org/01esghr10"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4a04d8006e984af19766e149c7656550": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "from": "Unique identifier for the researcher (string)",
       "name": "MetaRelationship",
       "relationshipName": "DEVELOPED",
       "source": 2755,
       "target": 2758,
       "to": "Unique identifier for the software application or software repository (string)"
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4a06eef08f884afeb994a75e0158d5fa": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 683,
       "target": 570
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4b3f75c541b046ac999adbbaaaaba500": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "from": "Unique identifier for the researcher (string)",
       "name": "MetaRelationship",
       "relationshipName": "USED",
       "source": 2755,
       "target": 2753,
       "to": "Unique identifier (CRUIE preferred) for the dataset (string)"
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4b530f294bce4e1784d7f5cfaed5e6a2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 704,
       "target": 13
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4bb6f1a5e7cd4c7381cbbef29a1e8efc": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 712,
       "target": 12
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4c39a9f6adea46a3b443e83dba9550db": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Helena",
       "fullName": "Helena Solo-Gabriele",
       "id": 681,
       "label": "Researcher",
       "lastName": "Solo-Gabriele",
       "name": "Solo-Gabriele H",
       "orcid": "orcid:0000-0003-3390-3823",
       "profileId": "profileid:11165737",
       "tooltip": "Researcher\nid:profileid:11165737\nlastName:Solo-Gabriele\norcid:orcid:0000-0003-3390-3823\nprofileId:profileid:11165737\nname:Solo-Gabriele H\nfullName:Helena Solo-Gabriele\nfirstName:Helena"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4c7b76e6b7ee4592b1d7299dc96e0a54": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Nicholas",
       "fullName": "Nicholas J Kenyon",
       "id": 703,
       "label": "Researcher",
       "lastName": "Kenyon",
       "middleName": "J",
       "name": "Kenyon NJ",
       "orcid": "orcid:0000-0001-8839-4400",
       "profileId": "profileid:7745756",
       "tooltip": "Researcher\nmiddleName:J\nid:profileid:7745756\nlastName:Kenyon\norcid:orcid:0000-0001-8839-4400\nprofileId:profileid:7745756\nname:Kenyon NJ\nfullName:Nicholas J Kenyon\nfirstName:Nicholas"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4c7e4ea208c34e70a35906d9098bacb4": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "Newark",
       "country": "UNITED STATES",
       "duns": "duns:090299830",
       "geonames": "geonames:5101717",
       "id": 571,
       "label": "Organization",
       "name": "Rutgers, The State University of New Jersey",
       "ror": "ror:05vt9qd57",
       "state": "NJ",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5101717\nror:ror:05vt9qd57\ncity:Newark\nname:Rutgers, The State University of New Jersey\nuei:uei:YVVTQD8CJC79\nduns:duns:090299830\nstate:NJ\nid:ror:05vt9qd57\nurl:https://ror.org/05vt9qd57",
       "uei": "uei:YVVTQD8CJC79",
       "url": "https://ror.org/05vt9qd57"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4d1a960c267d4960986599f9f440f739": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 714,
       "target": 571
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4d2b63b086c64cc88723affc5b5bc791": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "A Novel Saliva-Based Aptamer Detection Assay for SARS-CoV-2 Infection\n(RFA-OD-20-021 STTR Application)\nAutomated, rapid diagnostics with little sample collection and preparation are needed to identify\nand trace affected persons in times when hyper-infectious pathogens cause pandemics. Frequent,\nlow cost and highly scalable testing is the only way to gain visibility on the magnitude of the\npandemic and ultimately control the spread of the disease. We propose the development of a\nunique system that can cheaply and readily detect SARS-CoV-2 in saliva samples. The\ndevelopment of a system that uses saliva present an opportunity to readily test patients using a\nsample that is easily collected and harbors high concentration of viral particles.\nThe SARS-CoV-2 pandemic has predominantly affected individuals with pre-existing conditions\nsuch as clotting disorders, diabetes, hypertension or other chronic diseases. Patients with these\npre-existing conditions who then are infected have exacerbated symptoms and complications that\ncan lead to death. For example, many patients that have succumbed to SARS-CoV-2 infection\nhave developed blood clots that have impaired pulmonary or cardiac function and ultimately\ncardiac failure. A rapid diagnostic using easily collected samples (e.g. saliva) would allow for\ninfections to be identified sooner, therapies to be administered quicker, treatment to be monitored,\nand ultimately leading to fewer individuals that succumb to the infection.\nWe outline a novel DNA Star biosensing approach based on the fact that viruses, such as SARS-\nCoV-2, express unique spatial patterns of antigens on their surfaces, facilitating multivalent\nbinding to host cells for infection. These configurations of epitopes drive the high sensitivity and\nspecificity of our assay. Based on this naturally occurring binding mechanism, we developed a\nrational design approach producing pattern matching designer DNA architecture for viral sensing.\nA proof-of-concept Dengue virus (DENV) rapid diagnostics was developed to demonstrate its\npower: DENV surface antigens present the most complex geometric pattern among all known\npathogens, a DNA star linked 10-aptamers nanostructure that offers polyvalent, spatial DENV-\nepitope pattern matching interactions has provided high DENV-binding avidity and specificity,\nincreasing affinity by ~1,000× compared to the conventional aptamer approach which relies on\nmonovalent aptamer-epitope interactions. Our POCT diagnostics detected intact DENV virions in\npatient samples with PCR equivalent sensitivity in <2 mins at a cost <$0.15.\nCurrent RT-PCR molecular test are suited to large, centralized laboratories, and difficult to scale\nfor rapid testing of samples and delivery of results to clinicians and patients. Immunoassay tests\nhave lower sensitivity, and patients need to develop a response to the virus in order to detect the\nantibody response. Our “DNA star” biosensor-based rapid diagnostics will provide the\ninfrastructure for real time SARS-CoV-2 diagnostics that is easy to use (instrument-free), faster\n(sample to results in minutes) and cost effective (~$3 per test).",
       "awardCode": "R44",
       "fundingMechanism": "SBIR/STTR",
       "id": 7,
       "label": "Grant",
       "name": "Designer DNA Nanostructure Based Biosensing for Rapid COVID19 Detection and Monitoring using Saliva Sample",
       "narrative": "Direct detection of viral pathogens is needed to help limit the spread of extremely contagious and lethal infectious\nagents. Our aptamer-based detection assay and instrument will provide a mechanism to detect low levels of the\nSARS-CoV-2 viral pathogen with an automatic system requiring minimal effort for sample collection and no\nsample preparation and the system will be built to analyze at least 7 other sample types (plasma, whole blood,\nurine, nasopharyngeal samples, etc.) and the detection modalities will have additional detection aptamers in\norder to detect additional viral pathogens. This assay system can be deployed to monitor people not only in\nhospital and senior living facilities, but in schools, airports and other locations so that infected and asymptomatic\nindividuals can be identified, quarantined, and treated to limit the spread of the pathogen.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:A Novel Saliva-Based Aptamer Detection Assay for SARS-CoV-2 Infection\n(RFA-OD-20-021 STTR Application)\nAutomated, rapid diagnostics with little sample collection and preparation are needed to identify\nand trace affected persons in times when hyper-infectious pathogens cause pandemics. Frequent,\nlow cost and highly scalable testing is the only way to gain visibility on the magnitude of the\npandemic and ultimately control the spread of the disease. We propose the development of a\nunique system that can cheaply and readily detect SARS-CoV-2 in saliva samples. The\ndevelopment of a system that uses saliva present an opportunity to readily test patients using a\nsample that is easily collected and harbors high concentration of viral particles.\nThe SARS-CoV-2 pandemic has predominantly affected individuals with pre-existing conditions\nsuch as clotting disorders, diabetes, hypertension or other chronic diseases. Patients with these\npre-existing conditions who then are infected have exacerbated symptoms and complications that\ncan lead to death. For example, many patients that have succumbed to SARS-CoV-2 infection\nhave developed blood clots that have impaired pulmonary or cardiac function and ultimately\ncardiac failure. A rapid diagnostic using easily collected samples (e.g. saliva) would allow for\ninfections to be identified sooner, therapies to be administered quicker, treatment to be monitored,\nand ultimately leading to fewer individuals that succumb to the infection.\nWe outline a novel DNA Star biosensing approach based on the fact that viruses, such as SARS-\nCoV-2, express unique spatial patterns of antigens on their surfaces, facilitating multivalent\nbinding to host cells for infection. These configurations of epitopes drive the high sensitivity and\nspecificity of our assay. Based on this naturally occurring binding mechanism, we developed a\nrational design approach producing pattern matching designer DNA architecture for viral sensing.\nA proof-of-concept Dengue virus (DENV) rapid diagnostics was developed to demonstrate its\npower: DENV surface antigens present the most complex geometric pattern among all known\npathogens, a DNA star linked 10-aptamers nanostructure that offers polyvalent, spatial DENV-\nepitope pattern matching interactions has provided high DENV-binding avidity and specificity,\nincreasing affinity by ~1,000× compared to the conventional aptamer approach which relies on\nmonovalent aptamer-epitope interactions. Our POCT diagnostics detected intact DENV virions in\npatient samples with PCR equivalent sensitivity in <2 mins at a cost <$0.15.\nCurrent RT-PCR molecular test are suited to large, centralized laboratories, and difficult to scale\nfor rapid testing of samples and delivery of results to clinicians and patients. Immunoassay tests\nhave lower sensitivity, and patients need to develop a response to the virus in order to detect the\nantibody response. Our “DNA star” biosensor-based rapid diagnostics will provide the\ninfrastructure for real time SARS-CoV-2 diagnostics that is easy to use (instrument-free), faster\n(sample to results in minutes) and cost effective (~$3 per test).\nid:R44DE030852\nnarrative:Direct detection of viral pathogens is needed to help limit the spread of extremely contagious and lethal infectious\nagents. Our aptamer-based detection assay and instrument will provide a mechanism to detect low levels of the\nSARS-CoV-2 viral pathogen with an automatic system requiring minimal effort for sample collection and no\nsample preparation and the system will be built to analyze at least 7 other sample types (plasma, whole blood,\nurine, nasopharyngeal samples, etc.) and the detection modalities will have additional detection aptamers in\norder to detect additional viral pathogens. This assay system can be deployed to monitor people not only in\nhospital and senior living facilities, but in schools, airports and other locations so that infected and asymptomatic\nindividuals can be identified, quarantined, and treated to limit the spread of the pathogen.\nname:Designer DNA Nanostructure Based Biosensing for Rapid COVID19 Detection and Monitoring using Saliva Sample\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:SBIR/STTR\nawardCode:R44"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4d8b211038dc47c38026c9a9180a832f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "CORAL GABLES",
       "country": "UNITED STATES",
       "duns": "duns:625174149",
       "geonames": "geonames:4151871",
       "id": 578,
       "label": "Organization",
       "name": "University of Miami",
       "ror": "ror:02dgjyy92",
       "state": "FL",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4151871\nror:ror:02dgjyy92\ncity:CORAL GABLES\nname:University of Miami\nuei:uei:RQMFJGDTQ5V3\nduns:duns:625174149\nstate:FL\nid:ror:02dgjyy92\nurl:https://ror.org/02dgjyy92",
       "uei": "uei:RQMFJGDTQ5V3",
       "url": "https://ror.org/02dgjyy92"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4db0a15547c046e4b77e01dde5e25995": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 661,
       "target": 8
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4dd16811bfd54a74bc25d70a70d20d10": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The transmission of SARS-CoV-2 coronavirus has led to the COVID-19 pandemic. Nucleic acid testing while specific has limitations for mass surveillance. One alternative is the main protease (Mpro ) due to its functional importance in mediating the viral life cycle. Here, we describe a combination of modular substrate and gold colloids to detect Mpro via visual readout. The strategy involves zwitterionic peptide that carries opposite charges at the C-/N-terminus to exploit the specific recognition by Mpro . Autolytic cleavage releases a positively charged moiety that assembles the nanoparticles with rapid color changes (t<10 min). We determine a limit of detection for Mpro in breath condensate matrices <10 nM. We further assayed ten COVID-negative subjects and found no false-positive result. In the light of simplicity, our test for viral protease is not limited to an equipped laboratory, but also is amenable to integrating as portable point-of-care devices including those on face-coverings.",
       "doi": "doi:10.1002/anie.202112995",
       "id": 2820,
       "journal": "Angewandte Chemie (International ed. in English)",
       "label": "Publication",
       "name": "A Charge-Switchable Zwitterionic Peptide for Rapid Detection of SARS-CoV-2 Main Protease.",
       "pmId": "34936725",
       "pmcId": "PMC8854333",
       "tooltip": "Publication\njournal:Angewandte Chemie (International ed. in English)\nabstract:The transmission of SARS-CoV-2 coronavirus has led to the COVID-19 pandemic. Nucleic acid testing while specific has limitations for mass surveillance. One alternative is the main protease (Mpro ) due to its functional importance in mediating the viral life cycle. Here, we describe a combination of modular substrate and gold colloids to detect Mpro via visual readout. The strategy involves zwitterionic peptide that carries opposite charges at the C-/N-terminus to exploit the specific recognition by Mpro . Autolytic cleavage releases a positively charged moiety that assembles the nanoparticles with rapid color changes (t<10 min). We determine a limit of detection for Mpro in breath condensate matrices <10 nM. We further assayed ten COVID-negative subjects and found no false-positive result. In the light of simplicity, our test for viral protease is not limited to an equipped laboratory, but also is amenable to integrating as portable point-of-care devices including those on face-coverings.\nid:doi:10.1002/anie.202112995\nname:A Charge-Switchable Zwitterionic Peptide for Rapid Detection of SARS-CoV-2 Main Protease.\npmId:34936725\nyear:2022\ntype:primary\npmcId:PMC8854333\nurl:https://doi.org/doi:10.1002/anie.202112995\ndoi:doi:10.1002/anie.202112995",
       "type": "primary",
       "url": "https://doi.org/doi:10.1002/anie.202112995",
       "year": 2022
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4e87c4833a534506a142584de623a042": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "from": "DOI of citing publication (string)",
       "name": "MetaRelationship",
       "relationshipName": "CITES",
       "source": 2754,
       "target": 2754,
       "to": "DOI of cited publication (string)"
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4ee5eafc490f4b568501739b04bef4bf": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 692,
       "target": 39
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4efa73a5a7c34d76a0259db1669a213d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 996,
       "target": 2811
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4f7ae767f3794eeea6d5036f07d73083": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 649,
       "target": 554
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4f8bc5f63abc44de9016f68e77ca9068": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "CytoscapeModel",
     "state": {
      "_dom_classes": [],
      "_interaction_handlers": {},
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "CytoscapeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "CytoscapeView",
      "auto_ungrabify": false,
      "auto_unselectify": true,
      "autolock": false,
      "box_selection_enabled": false,
      "cytoscape_layout": {
       "name": "cola",
       "nodeDimensionsIncludeLabels": true,
       "nodeSpacing": 40,
       "padding": 0,
       "unconstrIter": 5000
      },
      "cytoscape_style": [
       {
        "selector": "node",
        "style": {
         "background-color": "#A5ABB6",
         "border-color": "#9AA1AC",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "edge",
        "style": {
         "curve-style": "bezier",
         "font-size": "8px",
         "label": "data(name)",
         "line-color": "#A5ABB6",
         "target-arrow-color": "#A5ABB6",
         "target-arrow-shape": "triangle",
         "text-rotation": "autorotate",
         "width": "1px"
        }
       },
       {
        "selector": "node[label=\"*\"]",
        "style": {
         "background-color": "#C990C0",
         "border-color": "#b261a5",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"City\"]",
        "style": {
         "background-color": "#F79767",
         "border-color": "#f36924",
         "border-width": "2px",
         "font-size": "10px",
         "height": "65px",
         "label": "data(name)",
         "text-max-width": "65px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "65px"
        }
       },
       {
        "selector": "node[label=\"Disease\"]",
        "style": {
         "background-color": "#569480",
         "border-color": "#447666",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Symptom\"]",
        "style": {
         "background-color": "#8DCC93",
         "border-color": "#5db665",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"Patient\"]",
        "style": {
         "background-color": "#4C8EDA",
         "border-color": "#2870c2",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(firstName)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"State\"]",
        "style": {
         "background-color": "#FFC454",
         "border-color": "#d7a013",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"MetaNode\"]",
        "style": {
         "background-color": "#D9C8AE",
         "border-color": "#c0a378",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(nodeName)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Grant\"]",
        "style": {
         "background-color": "#4C8EDA",
         "border-color": "#2870c2",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Researcher\"]",
        "style": {
         "background-color": "#FFC454",
         "border-color": "#d7a013",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"FundingOpportunity\"]",
        "style": {
         "background-color": "#DA7194",
         "border-color": "#cc3c6c",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Organization\"]",
        "style": {
         "background-color": "#569480",
         "border-color": "#447666",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Dataset\"]",
        "style": {
         "background-color": "#F79767",
         "border-color": "#f36924",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"CoordinationCenter\"]",
        "style": {
         "background-color": "#57C7E3",
         "border-color": "#23b3d7",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Event\"]",
        "style": {
         "background-color": "#8DCC93",
         "border-color": "#5db665",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Publication\"]",
        "style": {
         "background-color": "#AA7942",
         "border-color": "#8D6429",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Patent\"]",
        "style": {
         "background-color": "#C990C0",
         "border-color": "#b261a5",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Presentation\"]",
        "style": {
         "background-color": "#F16667",
         "border-color": "#eb2728",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Software\"]",
        "style": {
         "background-color": "#ECB5C9",
         "border-color": "#da7298",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"ResearchInitiative\"]",
        "style": {
         "background-color": "#57C7E3",
         "border-color": "#23b3d7",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "edge[name=\"MetaRelationship\"]",
        "style": {
         "curve-style": "bezier",
         "font-size": "8px",
         "label": "data(relationshipName)",
         "line-color": "#A5ABB6",
         "target-arrow-color": "#A5ABB6",
         "target-arrow-shape": "triangle",
         "text-rotation": "autorotate",
         "width": "1px"
        }
       }
      ],
      "desktop_tap_threshold": 4,
      "graph": "IPY_MODEL_bff50d396acc4dc89676f6b5d9b9db81",
      "headless": false,
      "hide_edges_on_viewport": false,
      "layout": "IPY_MODEL_a6e59a8c6d9e456db08fafb84898dbe8",
      "max_zoom": 1e+50,
      "min_zoom": 1e-50,
      "motion_blur": false,
      "motion_blur_opacity": 0.2,
      "panning_enabled": true,
      "pixel_ratio": "auto",
      "rendered_position": {
       "renderedPosition": {
        "x": 100,
        "y": 100
       }
      },
      "selection_type": "single",
      "style_enabled": true,
      "texture_on_viewport": false,
      "tooltip_source": "tooltip",
      "touch_tap_threshold": 8,
      "user_panning_enabled": true,
      "user_zooming_enabled": true,
      "wheel_sensitivity": 1,
      "zoom": 2,
      "zooming_enabled": true
     }
    },
    "4fd2018ffdff46a495bd4297d433941c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 671,
       "target": 27
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "4ff488cb7f4d4e8b95ede40535e6948a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 649,
       "target": 15
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5002a394e15c45cb87eab4d4a04db62b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4388,
       "label": "FundingOpportunity",
       "name": "Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed)",
       "tooltip": "FundingOpportunity\nname:Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed)\nid:RFA-OD-20-020\nurl:https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-020.html",
       "url": "https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-020.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5038ea577fc64173884849d76e5f1861": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PRESENTED",
       "source": 677,
       "target": 4360
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "503ee802172b40abbdbc64e8d3e7f5be": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4398,
       "target": 19
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "50d53c7b3f7940fcb267c48bf649e122": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 690,
       "target": 47
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "513496702e95450ab96af1a229168901": {
     "model_module": "@jupyter-widgets/base",
     "model_module_version": "1.2.0",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "51e6ba3d23904185a8d8b9f03c8345f7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "from": "Unique identifier for the researcher (string)",
       "name": "MetaRelationship",
       "relationshipName": "IS_INVENTOR",
       "source": 2755,
       "target": 2761,
       "to": "Unique identifier for the patent (string)"
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "520c4348d9264dc4a5b0dec1177d897c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Preparing SARS-­CoV-­2 testing data for reuse requires making the data syntactically and semantically equivalent. \nStandardization  of  terminologies  and  a  common  data  model  accomplish  the  former,  while  the  latter  is \naccomplished  through  understanding  the  data  and  making  it  comparable  across  RADx-­rad  awardees  by \nbenchmarking against known gold standards. The standardization of samples is as important as standardizing \nthe data, particularly in the highly innovative RADx-­rad program, where new technologies will be developed or \noptimized for deployment in various settings. Highly motivated RADx-­rad awardees will receive advice on how \ntheir diagnostics compare to FDA-­approved ones, with each other, how their diagnostic performs in independent \ntesting,  as  well as how  to ensure  the  tests  are usable  in  real  world  settings.  In  collaboration  with  University  of \nTexas  Health  Science  Center  at  Houston,  University  of  California San  Diego  researchers  in  informatics/data \nscience and infectious diseases with ample experience in leading large consortia have designed a unique RADx-­\nrad  Consortium  Data  and  Coordination  Center  (radCDCC).  This  center  is  based  on  three  pillars:  (1)  effective \nadministration and coordination among awardees, NIH, and other programs;; (2) innovative approaches and tools \nto  collect  and  standardize  data  and  metadata  to  promote  findability,  accessibility,  interoperability  and  reuse \n(FAIR)  for  data  sharing;;  and  (3)  principled  preparation  of  standardized  samples  with  known  quantities  of  viral \nloads, and standardized procedures for testing new diagnostics to allow comparison across tests and calibration \nof  new  technologies.  Backed  by  sophisticated  HIPAA-­compliant  cloud  services,  user  friendly  web-­tools,  and \nextensive  support  from  UCSD’s  facilities  for  computation and  for  clinical  research,  the  radCDCC will  interface \nwith other RADx programs and other COVID-­19 focused programs at NIH to ensure alignment of awardees, NIH \nand the public in the pursuit of effective, affordable, and deployable new technologies for testing.  ",
       "awardCode": "U24",
       "fundingMechanism": "Other Research-Related",
       "id": 47,
       "label": "Grant",
       "name": "RADx-Rad Discoveries & Data: Consortium Coordination Center Program Organization",
       "narrative": "The  RADx-­rad  Consortium  Data  and  Coordination  Center  (radCDCC)  will  use  advanced data  management  to \ncoordinate  a  consortium  of  innovative  COVID-­19  diagnostic  technology  developers.  The  partnership  between \nthe  University  of  California  San  Diego  and  the  University  of  Texas  Health  Science  Center  at  Houston  brings \ntogether informatics/data scientists and infectious diseases specialists who will standardize viral samples, testing \nand procedures, as well as data in order to integrate and share data in a meaningful manner. ",
       "researchInitiative": "RADx-rad",
       "subProject": "Data Coordinating Center",
       "tooltip": "Grant\nabstract:Preparing SARS-­CoV-­2 testing data for reuse requires making the data syntactically and semantically equivalent. \nStandardization  of  terminologies  and  a  common  data  model  accomplish  the  former,  while  the  latter  is \naccomplished  through  understanding  the  data  and  making  it  comparable  across  RADx-­rad  awardees  by \nbenchmarking against known gold standards. The standardization of samples is as important as standardizing \nthe data, particularly in the highly innovative RADx-­rad program, where new technologies will be developed or \noptimized for deployment in various settings. Highly motivated RADx-­rad awardees will receive advice on how \ntheir diagnostics compare to FDA-­approved ones, with each other, how their diagnostic performs in independent \ntesting,  as  well as how  to ensure  the  tests  are usable  in  real  world  settings.  In  collaboration  with  University  of \nTexas  Health  Science  Center  at  Houston,  University  of  California San  Diego  researchers  in  informatics/data \nscience and infectious diseases with ample experience in leading large consortia have designed a unique RADx-­\nrad  Consortium  Data  and  Coordination  Center  (radCDCC).  This  center  is  based  on  three  pillars:  (1)  effective \nadministration and coordination among awardees, NIH, and other programs;; (2) innovative approaches and tools \nto  collect  and  standardize  data  and  metadata  to  promote  findability,  accessibility,  interoperability  and  reuse \n(FAIR)  for  data  sharing;;  and  (3)  principled  preparation  of  standardized  samples  with  known  quantities  of  viral \nloads, and standardized procedures for testing new diagnostics to allow comparison across tests and calibration \nof  new  technologies.  Backed  by  sophisticated  HIPAA-­compliant  cloud  services,  user  friendly  web-­tools,  and \nextensive  support  from  UCSD’s  facilities  for  computation and  for  clinical  research,  the  radCDCC will  interface \nwith other RADx programs and other COVID-­19 focused programs at NIH to ensure alignment of awardees, NIH \nand the public in the pursuit of effective, affordable, and deployable new technologies for testing.  \nid:U24LM013755\nnarrative:The  RADx-­rad  Consortium  Data  and  Coordination  Center  (radCDCC)  will  use  advanced data  management  to \ncoordinate  a  consortium  of  innovative  COVID-­19  diagnostic  technology  developers.  The  partnership  between \nthe  University  of  California  San  Diego  and  the  University  of  Texas  Health  Science  Center  at  Houston  brings \ntogether informatics/data scientists and infectious diseases specialists who will standardize viral samples, testing \nand procedures, as well as data in order to integrate and share data in a meaningful manner. \nname:RADx-Rad Discoveries & Data: Consortium Coordination Center Program Organization\nsubProject:Data Coordinating Center\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U24"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5210b05d066748a98998cd359b851fa7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4397,
       "target": 47
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "52c9512e494d4a23943b4f8b8dfd2a4b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 678,
       "target": 37
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "52d03d2ec9b848e5b869842dab2d0e99": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The University of Miami (UM), with three primary campuses in Miami, Florida, is geographically spread within\none of the worst current COVID-19 hotbeds. UM has deployed an elaborate human surveillance testing, tracking\nand tracing (3T) system to monitor the student body, faculty, and staff. This 3T system includes a major hospital\nthat is part of UM and that treats COVID-19 patients. To augment this COVID-19 monitoring system, UM has\ndeployed a pilot wastewater surveillance program for detecting SARS-CoV-2 from clusters of buildings on\ncampus. Weill Cornell Medicine (WCM) is located in New York City, NY, an area that until recently had one of\nthe worst outbreaks of COVID-19. WCM has established an international consortium for SARS-CoV-2\nenvironmental surveillance, including in NYC and globally with the MetaSUB Consortium, which is creating\nmetagenomic and metatranscriptomic maps of the world’s sewage. Based on this work at both UM and WCM,\nthis proposal aims to develop, implement, and demonstrate effective and predictive wastewater surveillance by\noptimizing sampling, concentration, and detection strategies. Working closely with the RADx-rad Data\nCoordination Center (DCC), this application (SF-RAD) will develop and implement data standards and\ninformatics infrastructure and perform integrative analyses to make all data, results, and models available to the\ncommunity, thus providing a critical contribution to the national SARS-COV-2 RADx-rad Wastewater Detection\nConsortium. Our objectives will be addressed through three aims. Aim 1: Data Standardization, focuses on\ndeveloping and implementing data standards and quality metrics, and establishing the operational infrastructure\nto manage SARS-CoV-2 wastewater-based surveillance datasets and metadata. Aim 2: Wastewater\nCharacterization, focuses on optimizing wastewater surveillance protocols and parameters for wastewater\nsampling, sample concentration, and viral detection technologies. Aim 3: Integration with Human Health\nSurveillance, focuses on metatranscriptomic analyses and on the integration of wastewater quantification data\nwith community and hospital COVID-19 prevalence, to develop predictive models to detect local and community\nlevel spread of COVID-19. All data will be made Findable, Accessible, Interoperable and Reusable (FAIR) in\nclose collaboration with the DCC, and will be collected and managed with attention to ethical issues in\nsurveillance and data management, including efforts to ensure research rigor and reproducibility. The results\nfrom this proposal will develop and deploy experimental and informatics infrastructure and operations as part of\nthe national RADx-rad SARS-CoV-2 wastewater surveillance network and will provide a proof-of-concept\nimplementation to use wastewater for infectious disease surveillance for early detection of localized COVID-19\noutbreaks.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 40,
       "label": "Grant",
       "name": "Development and Proof-of-Concept Implementation of the South Florida Miami RADx-rad SARS-CoV-2 Wastewater-Based Surveillance Infrastructure",
       "narrative": "Through this collaborative study between the University of Miami in Florida and Weill Cornell Medicine in New\nYork, we will generate, standardize, integrate, compare and make available to the RADx-rad Data Coordination\nCenter (DCC), SARS-CoV-2 human surveillance and wastewater quantification data with various sampling,\nprocessing, detection, and analysis approaches. We hypothesize that sensitivity (enhanced detection and\nrecovery) can be improved by optimizing sampling and concentration strategies, and that specificity (viral strain\nidentification for epidemiologic tracking) can be improved by optimizing wastewater detection methods. The\nresults from this proposal will develop and deploy experimental and informatics infrastructure and operations,\nprovide a proof-of-concept implementation to use wastewater for infectious disease surveillance, and advance\nwork towards a model capable of predicting local and community level spread of COVID-19 and emerging\npathogens based upon measurements of SARS-CoV-2 and other viruses from wastewater.",
       "researchInitiative": "RADx-rad",
       "subProject": "Wastewater",
       "tooltip": "Grant\nabstract:The University of Miami (UM), with three primary campuses in Miami, Florida, is geographically spread within\none of the worst current COVID-19 hotbeds. UM has deployed an elaborate human surveillance testing, tracking\nand tracing (3T) system to monitor the student body, faculty, and staff. This 3T system includes a major hospital\nthat is part of UM and that treats COVID-19 patients. To augment this COVID-19 monitoring system, UM has\ndeployed a pilot wastewater surveillance program for detecting SARS-CoV-2 from clusters of buildings on\ncampus. Weill Cornell Medicine (WCM) is located in New York City, NY, an area that until recently had one of\nthe worst outbreaks of COVID-19. WCM has established an international consortium for SARS-CoV-2\nenvironmental surveillance, including in NYC and globally with the MetaSUB Consortium, which is creating\nmetagenomic and metatranscriptomic maps of the world’s sewage. Based on this work at both UM and WCM,\nthis proposal aims to develop, implement, and demonstrate effective and predictive wastewater surveillance by\noptimizing sampling, concentration, and detection strategies. Working closely with the RADx-rad Data\nCoordination Center (DCC), this application (SF-RAD) will develop and implement data standards and\ninformatics infrastructure and perform integrative analyses to make all data, results, and models available to the\ncommunity, thus providing a critical contribution to the national SARS-COV-2 RADx-rad Wastewater Detection\nConsortium. Our objectives will be addressed through three aims. Aim 1: Data Standardization, focuses on\ndeveloping and implementing data standards and quality metrics, and establishing the operational infrastructure\nto manage SARS-CoV-2 wastewater-based surveillance datasets and metadata. Aim 2: Wastewater\nCharacterization, focuses on optimizing wastewater surveillance protocols and parameters for wastewater\nsampling, sample concentration, and viral detection technologies. Aim 3: Integration with Human Health\nSurveillance, focuses on metatranscriptomic analyses and on the integration of wastewater quantification data\nwith community and hospital COVID-19 prevalence, to develop predictive models to detect local and community\nlevel spread of COVID-19. All data will be made Findable, Accessible, Interoperable and Reusable (FAIR) in\nclose collaboration with the DCC, and will be collected and managed with attention to ethical issues in\nsurveillance and data management, including efforts to ensure research rigor and reproducibility. The results\nfrom this proposal will develop and deploy experimental and informatics infrastructure and operations as part of\nthe national RADx-rad SARS-CoV-2 wastewater surveillance network and will provide a proof-of-concept\nimplementation to use wastewater for infectious disease surveillance for early detection of localized COVID-19\noutbreaks.\nid:U01DA053941\nnarrative:Through this collaborative study between the University of Miami in Florida and Weill Cornell Medicine in New\nYork, we will generate, standardize, integrate, compare and make available to the RADx-rad Data Coordination\nCenter (DCC), SARS-CoV-2 human surveillance and wastewater quantification data with various sampling,\nprocessing, detection, and analysis approaches. We hypothesize that sensitivity (enhanced detection and\nrecovery) can be improved by optimizing sampling and concentration strategies, and that specificity (viral strain\nidentification for epidemiologic tracking) can be improved by optimizing wastewater detection methods. The\nresults from this proposal will develop and deploy experimental and informatics infrastructure and operations,\nprovide a proof-of-concept implementation to use wastewater for infectious disease surveillance, and advance\nwork towards a model capable of predicting local and community level spread of COVID-19 and emerging\npathogens based upon measurements of SARS-CoV-2 and other viruses from wastewater.\nname:Development and Proof-of-Concept Implementation of the South Florida Miami RADx-rad SARS-CoV-2 Wastewater-Based Surveillance Infrastructure\nsubProject:Wastewater\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "531783059b65433f8d3adda7b6fb4561": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Eduardo",
       "fullName": "Eduardo Reategui",
       "id": 676,
       "label": "Researcher",
       "lastName": "Reategui",
       "name": "Reategui E",
       "orcid": "orcid:0000-0002-8271-8205",
       "profileId": "profileid:12364332",
       "tooltip": "Researcher\nid:profileid:12364332\nlastName:Reategui\norcid:orcid:0000-0002-8271-8205\nprofileId:profileid:12364332\nname:Reategui E\nfullName:Eduardo Reategui\nfirstName:Eduardo"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "53b91e723b3e4a67a0a3324377250953": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The COVID-19 pandemic has rapidly spread across the world, bringing death, illness, disruption to daily\nlife, and economic crisis to businesses and individuals. The situation has been exacerbated after the schools\nand companies reopened due to economic pressure. One of the key failures in COVID-19 containment is\nunderlined by the inability of our healthcare system in real-time detection in point-of-care (POC) and end-user\nsettings and precise tracing with privacy protection of active infections. The fundamental limitations of current\ngene-based assays stem from their reliance upon amplification and detection of the viral genetic materials\neven if there were no intact/infectious viruses. These tests require labor-intensive, laboratory-based sample\npreparation protocols for virus lysis, extraction of genetic materials, purification of the isolated materials,\nthermal cycling for enzymatic amplification of viral nucleic acid sequences, and interpretation of complex\nresults by professionals. To accurately determine the infectivity of the infected individuals, contaminated\nobjects and environments, and provide guidance for patients, public and authorities to better manage treatment\nand containment, we seek a new paradigm for rapid and direct pathogen detection and identification in which\nthe intact virions are directly recognized through their distinct surface epitope features, and the resultant\nfluorescent signal is immediately captured by an end-user smartphone, followed by automatic data transition\nand event tracing in a blockchain-encrypted manner. To achieve specific recognition of SARS-CoV-2 virions,\nwe customized a designer DNA nanostructure (DDN)-based capture probe that harbors a macromolecular\n“net” whose vertices precisely match the intra- and inter-spatial pattern of SARS-CoV-2 trimeric spike\nglycoprotein clusters, and integrates a net-shaped array of SARS-CoV-2 spike specific-targeting aptamers.\nThis aptamer-DDN is designed for maximum affinity and specificity binding with spikes on intact virions in a\npolyvalent and pattern-matching fashion. Once bound to intact virions, the DNA “nets” trigger the release of\nfluorescence. This fluorescent signal can be readily and automatically detected by a membrane-shaped and\nsmartphone-based fluorimeter attached to the end-users' phone cameras. The acquired results will be\nassociated with user device IDs that are cyber-protected before tracing. We propose to combine DDN capture\nprobes and a smartphone device to develop and demonstrate a rapid, room temperature, single-step, virus-\nspecific, and ultrasensitive detection of SARS-CoV-2 virus, in which the detection results can be acquired\nwithin 5 minutes upon exposure, at the user end, allowing tracing the presence of viruses without affecting user\nprivacy. The signal to result transition, result to ID association, individual track and interacting network tracing\nwill be blockchain-encrypted to ensure information security for individual privacy, while tracing information\nwould be available to health authority for public health benefits.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 24,
       "label": "Grant",
       "name": "Detection and Automatic Privacy-Protected Contact Tracing System Designed for COVID-19",
       "narrative": "The goal of the project is to develop a pipeline for automatic detection and tracing of active SARS-CoV-2\ninfection in a cost-effective, highly accurate, real-time, portable, and super-encrypted manner. Our integrated\napproach first captures viral particles from patient samples to activate fluorescence reporters, followed by\nsignal detection using a smartphone fluorimeter, along with blockchain-based data processing and tracing. We\ndeployed designer DNA “net” nanostructures that match the spatial pattern of trimeric spike glycoprotein\nclusters on the viral outer surface for specific and rapid SARS-CoV-2 virion detection, smartphone-based point-\nof-care device for portable signal reading, and blockchain encryption for privacy protection during result\nrecording and track tracing, therefore, our detection and tracing model allows a direct, automatic, and cost-\neffective detection, a highly flexible result acquisition process and a super-encrypted data transition and tracing\nsystem.",
       "researchInitiative": "RADx-rad",
       "subProject": "Automatic Detection & Tracing",
       "tooltip": "Grant\nabstract:The COVID-19 pandemic has rapidly spread across the world, bringing death, illness, disruption to daily\nlife, and economic crisis to businesses and individuals. The situation has been exacerbated after the schools\nand companies reopened due to economic pressure. One of the key failures in COVID-19 containment is\nunderlined by the inability of our healthcare system in real-time detection in point-of-care (POC) and end-user\nsettings and precise tracing with privacy protection of active infections. The fundamental limitations of current\ngene-based assays stem from their reliance upon amplification and detection of the viral genetic materials\neven if there were no intact/infectious viruses. These tests require labor-intensive, laboratory-based sample\npreparation protocols for virus lysis, extraction of genetic materials, purification of the isolated materials,\nthermal cycling for enzymatic amplification of viral nucleic acid sequences, and interpretation of complex\nresults by professionals. To accurately determine the infectivity of the infected individuals, contaminated\nobjects and environments, and provide guidance for patients, public and authorities to better manage treatment\nand containment, we seek a new paradigm for rapid and direct pathogen detection and identification in which\nthe intact virions are directly recognized through their distinct surface epitope features, and the resultant\nfluorescent signal is immediately captured by an end-user smartphone, followed by automatic data transition\nand event tracing in a blockchain-encrypted manner. To achieve specific recognition of SARS-CoV-2 virions,\nwe customized a designer DNA nanostructure (DDN)-based capture probe that harbors a macromolecular\n“net” whose vertices precisely match the intra- and inter-spatial pattern of SARS-CoV-2 trimeric spike\nglycoprotein clusters, and integrates a net-shaped array of SARS-CoV-2 spike specific-targeting aptamers.\nThis aptamer-DDN is designed for maximum affinity and specificity binding with spikes on intact virions in a\npolyvalent and pattern-matching fashion. Once bound to intact virions, the DNA “nets” trigger the release of\nfluorescence. This fluorescent signal can be readily and automatically detected by a membrane-shaped and\nsmartphone-based fluorimeter attached to the end-users' phone cameras. The acquired results will be\nassociated with user device IDs that are cyber-protected before tracing. We propose to combine DDN capture\nprobes and a smartphone device to develop and demonstrate a rapid, room temperature, single-step, virus-\nspecific, and ultrasensitive detection of SARS-CoV-2 virus, in which the detection results can be acquired\nwithin 5 minutes upon exposure, at the user end, allowing tracing the presence of viruses without affecting user\nprivacy. The signal to result transition, result to ID association, individual track and interacting network tracing\nwill be blockchain-encrypted to ensure information security for individual privacy, while tracing information\nwould be available to health authority for public health benefits.\nid:U01AA029348\nnarrative:The goal of the project is to develop a pipeline for automatic detection and tracing of active SARS-CoV-2\ninfection in a cost-effective, highly accurate, real-time, portable, and super-encrypted manner. Our integrated\napproach first captures viral particles from patient samples to activate fluorescence reporters, followed by\nsignal detection using a smartphone fluorimeter, along with blockchain-based data processing and tracing. We\ndeployed designer DNA “net” nanostructures that match the spatial pattern of trimeric spike glycoprotein\nclusters on the viral outer surface for specific and rapid SARS-CoV-2 virion detection, smartphone-based point-\nof-care device for portable signal reading, and blockchain encryption for privacy protection during result\nrecording and track tracing, therefore, our detection and tracing model allows a direct, automatic, and cost-\neffective detection, a highly flexible result acquisition process and a super-encrypted data transition and tracing\nsystem.\nname:Detection and Automatic Privacy-Protected Contact Tracing System Designed for COVID-19\nsubProject:Automatic Detection & Tracing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5433f69777e6463a90be6e74a9c1dff3": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 650,
       "target": 552
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "543ef5f99b824195a8dc790625a26649": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Carl",
       "fullName": "Carl E Allen",
       "id": 707,
       "label": "Researcher",
       "lastName": "Allen",
       "middleName": "E",
       "name": "Allen CE",
       "orcid": "orcid:0000-0002-6625-739X",
       "profileId": "profileid:2563052",
       "tooltip": "Researcher\nmiddleName:E\nid:profileid:2563052\nlastName:Allen\norcid:orcid:0000-0002-6625-739X\nprofileId:profileid:2563052\nname:Allen CE\nfullName:Carl E Allen\nfirstName:Carl"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "54b07100d4c344acbc0e6e002f8943d3": {
     "model_module": "@jupyter-widgets/controls",
     "model_module_version": "1.5.0",
     "model_name": "FloatProgressModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "FloatProgressModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "ProgressView",
      "bar_style": "success",
      "description": "",
      "description_tooltip": null,
      "layout": "IPY_MODEL_513496702e95450ab96af1a229168901",
      "max": 85,
      "min": 0,
      "orientation": "horizontal",
      "style": "IPY_MODEL_6f2700447e5643a0a0659dfbc0a3ba92",
      "value": 85
     }
    },
    "54b6dcfee41d4fd1b07e76c43e24193f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Human-infecting pathogens that transmit through the air pose a significant threat to public health. As a prominent instance, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused the COVID-19 pandemic has affected the world in an unprecedented manner over the past few years. Despite the dissipating pandemic gloom, the lessons we have learned in dealing with pathogen-laden aerosols should be thoroughly reviewed because the airborne transmission risk may have been grossly underestimated. From a bioanalytical chemistry perspective, on-site airborne pathogen detection can be an effective non-pharmaceutic intervention (NPI) strategy, with on-site airborne pathogen detection and early-stage infection risk evaluation reducing the spread of disease and enabling life-saving decisions to be made. In light of this, we summarize the recent advances in highly efficient pathogen-laden aerosol sampling approaches, bioanalytical sensing technologies, and the prospects for airborne pathogen exposure measurement and evidence-based transmission interventions. We also discuss open challenges facing general bioaerosols detection, such as handling complex aerosol samples, improving sensitivity for airborne pathogen quantification, and establishing a risk assessment system with high spatiotemporal resolution for mitigating airborne transmission risks. This review provides a multidisciplinary outlook for future opportunities to improve the on-site airborne pathogen detection techniques, thereby enhancing the preparedness for more on-site bioaerosols measurement scenarios, such as monitoring high-risk pathogens on airplanes, weaponized pathogen aerosols, influenza variants at the workplace, and pollutant correlated with sick building syndromes.",
       "doi": "doi:10.1039/d3cs00417a",
       "id": 3301,
       "journal": "Chemical Society Reviews",
       "label": "Publication",
       "name": "On-site airborne pathogen detection for infection risk mitigation",
       "pmId": "37882143",
       "pmcId": "10712221",
       "tooltip": "Publication\njournal:Chemical Society Reviews\nabstract:Human-infecting pathogens that transmit through the air pose a significant threat to public health. As a prominent instance, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that caused the COVID-19 pandemic has affected the world in an unprecedented manner over the past few years. Despite the dissipating pandemic gloom, the lessons we have learned in dealing with pathogen-laden aerosols should be thoroughly reviewed because the airborne transmission risk may have been grossly underestimated. From a bioanalytical chemistry perspective, on-site airborne pathogen detection can be an effective non-pharmaceutic intervention (NPI) strategy, with on-site airborne pathogen detection and early-stage infection risk evaluation reducing the spread of disease and enabling life-saving decisions to be made. In light of this, we summarize the recent advances in highly efficient pathogen-laden aerosol sampling approaches, bioanalytical sensing technologies, and the prospects for airborne pathogen exposure measurement and evidence-based transmission interventions. We also discuss open challenges facing general bioaerosols detection, such as handling complex aerosol samples, improving sensitivity for airborne pathogen quantification, and establishing a risk assessment system with high spatiotemporal resolution for mitigating airborne transmission risks. This review provides a multidisciplinary outlook for future opportunities to improve the on-site airborne pathogen detection techniques, thereby enhancing the preparedness for more on-site bioaerosols measurement scenarios, such as monitoring high-risk pathogens on airplanes, weaponized pathogen aerosols, influenza variants at the workplace, and pollutant correlated with sick building syndromes.\nid:doi:10.1039/d3cs00417a\nname:On-site airborne pathogen detection for infection risk mitigation\npmId:37882143\nyear:2023\ntype:secondary\npmcId:10712221\nurl:https://doi.org/doi:10.1039/d3cs00417a\ndoi:doi:10.1039/d3cs00417a",
       "type": "secondary",
       "url": "https://doi.org/doi:10.1039/d3cs00417a",
       "year": 2023
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "55601f14d92f4637b9e5290060f85a65": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 669,
       "target": 556
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "559051d8e5b6441e87824177a6ddc88a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "from": "Unique identifier for the grant (Thesaurus:C16644) (string)",
       "name": "MetaRelationship",
       "relationshipName": "FUNDED",
       "source": 2760,
       "target": 2762,
       "to": "Unique identifier for the research initiative (string)"
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "55c9d3a5095c4755953eab3c033c9aed": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4394,
       "target": 39
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5697e1bea5364f449b8d4320735cd99b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 617,
       "target": 600
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "575659f4edb94164a130ed0e71f3c626": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "from": "Unique identifier for the researcher (string)",
       "lastUpdated": "NIH fiscal year this information was last updated (int)",
       "name": "MetaRelationship",
       "relationshipName": "EMPLOYED_AT",
       "source": 2755,
       "target": 2759,
       "to": "Unique entity identifier: ror id if available, otherwise uei id (string)"
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5790b81e4018451d85be882c5de7bd14": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 925,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "582c8846ded648ea8d9d84db1d30ce95": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "description": "Description of the software or software repository (string)",
       "id": 2758,
       "label": "MetaNode",
       "name": "Name of the software application or software repository (string)",
       "nodeName": "Software",
       "tooltip": "MetaNode\nid:Identifier of the software application or software repository (string)\ndescription:Description of the software or software repository (string)\nname:Name of the software application or software repository (string)\nnodeName:Software\nurl:URL of the software application or software repository (string)",
       "url": "URL of the software application or software repository (string)"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "58c61b54a7f84ffcbdf29497785e0da9": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "USED",
       "source": 721,
       "target": 2741
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "58d04ecf3e154dcbacc58778c0e5438f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "from": "Unique identifier for the research initiative (string)",
       "name": "MetaRelationship",
       "relationshipName": "SUPPORTED",
       "source": 2762,
       "target": 2760,
       "to": "Unique identifier for the grant (Thesaurus:C16644) (string)"
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "590f817f8bb84b65aedb04c96a6f2fd4": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 684,
       "target": 2821
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "59494326f9fb4488a9c2c721223c9b04": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "ANN ARBOR",
       "country": "UNITED STATES",
       "duns": "duns:073133571",
       "geonames": "geonames:4984247",
       "id": 557,
       "label": "Organization",
       "name": "University of Michigan–Ann Arbor",
       "ror": "ror:00jmfr291",
       "state": "MI",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4984247\nror:ror:00jmfr291\ncity:ANN ARBOR\nname:University of Michigan–Ann Arbor\nuei:uei:GNJ7BBP73WE9\nduns:duns:073133571\nstate:MI\nid:ror:00jmfr291\nurl:https://ror.org/00jmfr291",
       "uei": "uei:GNJ7BBP73WE9",
       "url": "https://ror.org/00jmfr291"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "594a95410c3f49c1923c365db327b696": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 703,
       "target": 37
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "597c1438260d4ebf84f034567e76c0d0": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "CREATED",
       "source": 677,
       "target": 2741
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5a0728420ce14d76b5964df8cf81a2fd": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Vulnerable populations do not just need testing—they need surveillance. The ideal surveillance tool would\noperate in the background with minimal involvement of the population to be tested; it would be simple,\naffordable, reliable, and accurate. Unfortunately, no such surveillance system yet exists. Here, we propose\na “smart mask” that changes colors when the wearer has been exposed to biomarkers (proteases) of\nCOVID-19. These proteases are known to be in saliva, and the smart mask will concentrate the proteases\nfrom aerosolized saliva when the subject breathes and speaks through the smart mask. This is a simple\nyet novel approach to surveillance because most people are already wearing masks—especially in high-\nrisk settings. Our first goal is to optimize the reagents that will monitor the proteases. We will customize\nthe peptide sequences such that the reagents change color only when two key SARS proteases are\npresent. After characterizing the colorimetric reagents, Aim 2 will integrate these reagents into an adhesive\nstrip (i.e., a sticker) that can be affixed to any existing cloth or surgical mask. Aim 3 is validation with human\nsubjects. First, we will use biobanked saliva samples that are confirmed to be either COVID-19-positive or\nCOVID-19-negative. Next, we will evaluate how long people infected with SARS-CoV-2 must breathe\nthrough the smart mask before it changes colors. Finally, we will use the smart mask for surveillance of a\npopulation that is concurrently being tested regularly via PCR. We will calculate the sensitivity and\nspecificity of the smart masks through comparison to PCR. We will measure true positives, true negatives,\nfalse positives, and false negatives and estimate needing 800 subjects, which is very feasible at our\ninstitution. Our team is well-suited to conduct this research because of Dr. Jokerst’s training colorimetric\nsensing; Drs. Penny, Knight, and Laurent have decades of human subjects research experience, and Dr.\nTu offers biostatistical experience to confirm study design. This work could have a significant impact on\nthe pandemic because our proposed design combines the simplicity of the home pregnancy test with the\nspecificity of expensive viral-based assays. It is practical because it uses the masks that are already\ncommon in daily life and reports the presence of SARS viruses via a simple color change. While a vaccine\nwill hopefully be deployed during the course of this work, the proteases evaluated here have been\nimplicated in a variety of SARS viruses. Thus, this work will be useful should future pandemics emerge.",
       "awardCode": "R01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 43,
       "label": "Grant",
       "name": "Validation of Smart Masks for Surveillance of COVID-19",
       "narrative": "We propose to build a mask that changes color when the wearer has COVID-19 or has been\nexposed to COVID-19. Mask-wearing is currently widespread and thus adding this colorimetric\nsensing approach is a simple yet innovative way to perform surveillance especially among\nvulnerable groups. After building and characterizing this mask, we will validate it in group of at-risk\nindividuals.",
       "researchInitiative": "RADx-rad",
       "subProject": "Multimodal Surveillance",
       "tooltip": "Grant\nresearchInitiative:RADx-rad\nnarrative:We propose to build a mask that changes color when the wearer has COVID-19 or has been\nexposed to COVID-19. Mask-wearing is currently widespread and thus adding this colorimetric\nsensing approach is a simple yet innovative way to perform surveillance especially among\nvulnerable groups. After building and characterizing this mask, we will validate it in group of at-risk\nindividuals.\nname:Validation of Smart Masks for Surveillance of COVID-19\nsubProject:Multimodal Surveillance\nfundingMechanism:Non-SBIR/STTR\nawardCode:R01\nabstract:Vulnerable populations do not just need testing—they need surveillance. The ideal surveillance tool would\noperate in the background with minimal involvement of the population to be tested; it would be simple,\naffordable, reliable, and accurate. Unfortunately, no such surveillance system yet exists. Here, we propose\na “smart mask” that changes colors when the wearer has been exposed to biomarkers (proteases) of\nCOVID-19. These proteases are known to be in saliva, and the smart mask will concentrate the proteases\nfrom aerosolized saliva when the subject breathes and speaks through the smart mask. This is a simple\nyet novel approach to surveillance because most people are already wearing masks—especially in high-\nrisk settings. Our first goal is to optimize the reagents that will monitor the proteases. We will customize\nthe peptide sequences such that the reagents change color only when two key SARS proteases are\npresent. After characterizing the colorimetric reagents, Aim 2 will integrate these reagents into an adhesive\nstrip (i.e., a sticker) that can be affixed to any existing cloth or surgical mask. Aim 3 is validation with human\nsubjects. First, we will use biobanked saliva samples that are confirmed to be either COVID-19-positive or\nCOVID-19-negative. Next, we will evaluate how long people infected with SARS-CoV-2 must breathe\nthrough the smart mask before it changes colors. Finally, we will use the smart mask for surveillance of a\npopulation that is concurrently being tested regularly via PCR. We will calculate the sensitivity and\nspecificity of the smart masks through comparison to PCR. We will measure true positives, true negatives,\nfalse positives, and false negatives and estimate needing 800 subjects, which is very feasible at our\ninstitution. Our team is well-suited to conduct this research because of Dr. Jokerst’s training colorimetric\nsensing; Drs. Penny, Knight, and Laurent have decades of human subjects research experience, and Dr.\nTu offers biostatistical experience to confirm study design. This work could have a significant impact on\nthe pandemic because our proposed design combines the simplicity of the home pregnancy test with the\nspecificity of expensive viral-based assays. It is practical because it uses the masks that are already\ncommon in daily life and reports the presence of SARS viruses via a simple color change. While a vaccine\nwill hopefully be deployed during the course of this work, the proteases evaluated here have been\nimplicated in a variety of SARS viruses. Thus, this work will be useful should future pandemics emerge.\nid:R01DE031114"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5a49d55c63ca475fa524f87ad6210b5d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The goal of this project is to establish robust, proof-of-concept feasibility for an innovative E-nose system,\ntermed the MOF-SCENT system, for real-time and non-invasive screening for asymptomatic and symptomatic\nCOVID-19 patients, with high accuracy based on the detection of VOCs emanating from exhaled breath. The\nproposed OE-HCCR-MOF based E-nose sensor is a novel biosensing and chemical sensing technology that\nwill fundamentally advance E-nose sensing technologies due to the improved sensitivity and selectivity.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 31,
       "label": "Grant",
       "name": "Midwest Biomedical Accelerator Consortium: MBArC",
       "narrative": "This proposal describes the design, fabrication, and proof-of-concept testing of a novel MOF-SCENT system\n(Metal-Organic Frameworks for Screening COVID-19 by Electronic-Nose Technology) that features the\nfollowing advantages: (1) Highly selective and sensitive detection of a panel of VOCs that indicate COVID-19\ndisease; (2) fast response and recovery time; (3) portable, lowcost, robust, easy-to-use, and deployable in any\nclinical, community, and everyday setting. The proposed accurate, sensitive, lowcost, robust, and portable\nMOF-SCENT system provides a realistic approach to dramatically increase testing capacity for COVID-\n19 because it can be rapidly integrated into and adopted by the public and healthcare systems by deploying a\nlarge number of such systems at central facilities (e.g., airports, shopping malls), point-of-care sites (e.g.,\nhospitals, pharmacies, urgent care centers), and workplaces, and even homes. The manufacturing of the\nMOF-SCENT system can be easily scaled to > 50,000 units because the simple design can be fabricated out\nof stainless steel in common machine shops, and the MOF materials are commercially available. The detector\nof the MOF-SCENT system could be manufactured based on existing portable vector network analyzer (VNA)\ninterrogators (new VNA technology called MN7021A RF Sensor., Keysight Technologies, Santa Rosa, CA).\nCommercially-available VNAs would be stripped down to increase production output and reduce costs\n(Keysight Technologies can head up the effort to massproduce the interrogators). Capital costs for the\nproduction ramp-up of large numbers of MOF-SCENT systems are minimal because existing machine shops\nand Keysight Technologies’ electronic assembly infrastructure would be used. Installation of the MOFSCENT\nsystem at homes, businesses, grocery stores, pharmacies, and medical clinics will significantly increase daily\naccessibility to on-demand accurate testing and thereby mitigate the second wave of infections of SARS-CoV-\n2. Keysight Technologies is the world’s largest test and measurement manufacturer, with a well-established\nsupply chain, superior logistics and technical support infrastructure, and a commitment to quality control.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:The goal of this project is to establish robust, proof-of-concept feasibility for an innovative E-nose system,\ntermed the MOF-SCENT system, for real-time and non-invasive screening for asymptomatic and symptomatic\nCOVID-19 patients, with high accuracy based on the detection of VOCs emanating from exhaled breath. The\nproposed OE-HCCR-MOF based E-nose sensor is a novel biosensing and chemical sensing technology that\nwill fundamentally advance E-nose sensing technologies due to the improved sensitivity and selectivity.\nid:U01HL152410\nnarrative:This proposal describes the design, fabrication, and proof-of-concept testing of a novel MOF-SCENT system\n(Metal-Organic Frameworks for Screening COVID-19 by Electronic-Nose Technology) that features the\nfollowing advantages: (1) Highly selective and sensitive detection of a panel of VOCs that indicate COVID-19\ndisease; (2) fast response and recovery time; (3) portable, lowcost, robust, easy-to-use, and deployable in any\nclinical, community, and everyday setting. The proposed accurate, sensitive, lowcost, robust, and portable\nMOF-SCENT system provides a realistic approach to dramatically increase testing capacity for COVID-\n19 because it can be rapidly integrated into and adopted by the public and healthcare systems by deploying a\nlarge number of such systems at central facilities (e.g., airports, shopping malls), point-of-care sites (e.g.,\nhospitals, pharmacies, urgent care centers), and workplaces, and even homes. The manufacturing of the\nMOF-SCENT system can be easily scaled to > 50,000 units because the simple design can be fabricated out\nof stainless steel in common machine shops, and the MOF materials are commercially available. The detector\nof the MOF-SCENT system could be manufactured based on existing portable vector network analyzer (VNA)\ninterrogators (new VNA technology called MN7021A RF Sensor., Keysight Technologies, Santa Rosa, CA).\nCommercially-available VNAs would be stripped down to increase production output and reduce costs\n(Keysight Technologies can head up the effort to massproduce the interrogators). Capital costs for the\nproduction ramp-up of large numbers of MOF-SCENT systems are minimal because existing machine shops\nand Keysight Technologies’ electronic assembly infrastructure would be used. Installation of the MOFSCENT\nsystem at homes, businesses, grocery stores, pharmacies, and medical clinics will significantly increase daily\naccessibility to on-demand accurate testing and thereby mitigate the second wave of infections of SARS-CoV-\n2. Keysight Technologies is the world’s largest test and measurement manufacturer, with a well-established\nsupply chain, superior logistics and technical support infrastructure, and a commitment to quality control.\nname:Midwest Biomedical Accelerator Consortium: MBArC\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5add710aeac54abda329af59d866f997": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "CITES",
       "source": 2716,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5ae6ba1cf0cc4cb8b72009f8a25599c5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "CITES",
       "source": 3288,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5b32e7fc1adf4348b83d715bf9cf65e4": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 2347,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5b4d6206fe6e4e0aa8b8789b5bfb5976": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 951,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5b9504dfcb534b76b0a5633bbc1ef94a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Robust, efficient and reliable testing for SARS-CoV-2 is extraordinarily challenging due to our lack of ultra-\nsensitive assays and ever evolving knowledge of the virus. Standard PCR based assays still result in very high\nfalse negative rates in the earliest days of infection. Microfluidic processing of clinical samples is low cost and\nshows great promise for translating most liquid biopsy assay to the clinic. Our laboratory was one of the first to\napply microfluidic technologies for the isolation of both circulating tumor cells and exosomes in the blood of\npatients with cancer. For SARS-CoV-2 patients, saliva, stool, and plasma are all thought to be potential resources\nfor both virus detection as well as other clinical biomarkers that might inform us of infection. Thus, for this U18,\nwe will optimize our exosome capture technology, the EVHB-Chip, for the isolation of intact SARS-CoV-2 virus,\ntesting its utility for each of these biofluids. To complete this work, we will complete a full clinical validation and\nbenchmarking of the assay. Once fully optimized, our detection assay will be compared against existing EUA\nSARS-CoV-2 detection assay to determine detection sensitivity and specificity. Further, we plan to demonstrate\nthat the increased sensitivity and specificity enabled by our microfluidic device will result in earlier detection of\nSARS-CoV-2, reducing false negatives in this testing window. At the completion of this work, we will have\ncollected the data training sets and submitted a full EUA plan that would enable the FDA’s authorization of our\ntest to be used in the clinic.",
       "awardCode": "U18",
       "fundingMechanism": "Other Research-Related",
       "id": 1,
       "label": "Grant",
       "name": "Microfluidic Isolation and Characterization of SARS-CoV-2 and Virus Related Exosomes",
       "narrative": "We will develop a SARS-CoV-2 detection assay using our existing microfluidic exosome isolation technology,\nthe EVHB-Chip. The high sensitivity and specificity of our technology allows for the isolation of rare nanoscale\nvesicles from complex biofluids. Based on our early data, we believe it is ideally suited for the isolation of SARS-\nCoV-2 virus particles and have established a strong team of collaborators to rapidly and efficiently lead us\nthrough assay development, validation, and clinical integration.",
       "researchInitiative": "RADx-rad",
       "subProject": "Exosome",
       "tooltip": "Grant\nabstract:Robust, efficient and reliable testing for SARS-CoV-2 is extraordinarily challenging due to our lack of ultra-\nsensitive assays and ever evolving knowledge of the virus. Standard PCR based assays still result in very high\nfalse negative rates in the earliest days of infection. Microfluidic processing of clinical samples is low cost and\nshows great promise for translating most liquid biopsy assay to the clinic. Our laboratory was one of the first to\napply microfluidic technologies for the isolation of both circulating tumor cells and exosomes in the blood of\npatients with cancer. For SARS-CoV-2 patients, saliva, stool, and plasma are all thought to be potential resources\nfor both virus detection as well as other clinical biomarkers that might inform us of infection. Thus, for this U18,\nwe will optimize our exosome capture technology, the EVHB-Chip, for the isolation of intact SARS-CoV-2 virus,\ntesting its utility for each of these biofluids. To complete this work, we will complete a full clinical validation and\nbenchmarking of the assay. Once fully optimized, our detection assay will be compared against existing EUA\nSARS-CoV-2 detection assay to determine detection sensitivity and specificity. Further, we plan to demonstrate\nthat the increased sensitivity and specificity enabled by our microfluidic device will result in earlier detection of\nSARS-CoV-2, reducing false negatives in this testing window. At the completion of this work, we will have\ncollected the data training sets and submitted a full EUA plan that would enable the FDA’s authorization of our\ntest to be used in the clinic.\nid:U18TR003793\nnarrative:We will develop a SARS-CoV-2 detection assay using our existing microfluidic exosome isolation technology,\nthe EVHB-Chip. The high sensitivity and specificity of our technology allows for the isolation of rare nanoscale\nvesicles from complex biofluids. Based on our early data, we believe it is ideally suited for the isolation of SARS-\nCoV-2 virus particles and have established a strong team of collaborators to rapidly and efficiently lead us\nthrough assay development, validation, and clinical integration.\nname:Microfluidic Isolation and Characterization of SARS-CoV-2 and Virus Related Exosomes\nsubProject:Exosome\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U18"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5c266c4d293f428296a9118625a7ceb1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 670,
       "target": 587
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5c7d76b21b01471980087ab1953cf68b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Presently, the application of molecular technology such as RT-qPCR and digital PCR (dPCR) to quantify\nSARS-CoV-2 and related targets in wastewater is cumbersome, time consuming, and costly. While\nprogress has been made on the development of methods and the interpretation of data, much remains to\nbe improved for the technology to be used as a public health management tool. A major drawback in the\ncurrent approaches are 1) the lack of streamlined and consistent pre-analytical processing steps, 2)\ncoverage across the relevant targets requires a high number of reactions (>20) from any single sample to\nprovide quantitative information, and 3) a lack of vision on the development of a pathogen/marker panel,\nmuch like those used in clinical arenas, for interpretation of the data across different states, regions and\nnations. The goal of this project will be to successfully navigate these three limitations toward\ndevelopment of a public health warning system that is not dependent on clinical testing and has the ability\nto rapidly address novel pathogen threats in the future.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 9,
       "label": "Grant",
       "name": "Improved scalability, sensitivity, and interpretability of pathogen detection, including SARS-CoV-2, in wastewater using high-throughput, highly multiplexed digital array PCR technology",
       "narrative": "The proposed research will enhance the usefulness of wastewater monitoring for pathogens to address\npublic health responses to the COVID-19 pandemic as well as future pandemics. We will demonstrate\nhighly multiplexed digital PCR assays on wastewater collected from multiple diverse geographical regions\nthat will be comprehensive, rapid, low cost, and quantitative for monitoring the circulation of disease.\nMoreover, the assay system will be able to address novel pathogens by allowing rapid aggregation of\ngenetic tests for these new targets.",
       "researchInitiative": "RADx-rad",
       "subProject": "Wastewater",
       "tooltip": "Grant\nabstract:Presently, the application of molecular technology such as RT-qPCR and digital PCR (dPCR) to quantify\nSARS-CoV-2 and related targets in wastewater is cumbersome, time consuming, and costly. While\nprogress has been made on the development of methods and the interpretation of data, much remains to\nbe improved for the technology to be used as a public health management tool. A major drawback in the\ncurrent approaches are 1) the lack of streamlined and consistent pre-analytical processing steps, 2)\ncoverage across the relevant targets requires a high number of reactions (>20) from any single sample to\nprovide quantitative information, and 3) a lack of vision on the development of a pathogen/marker panel,\nmuch like those used in clinical arenas, for interpretation of the data across different states, regions and\nnations. The goal of this project will be to successfully navigate these three limitations toward\ndevelopment of a public health warning system that is not dependent on clinical testing and has the ability\nto rapidly address novel pathogen threats in the future.\nid:U01DA053899\nnarrative:The proposed research will enhance the usefulness of wastewater monitoring for pathogens to address\npublic health responses to the COVID-19 pandemic as well as future pandemics. We will demonstrate\nhighly multiplexed digital PCR assays on wastewater collected from multiple diverse geographical regions\nthat will be comprehensive, rapid, low cost, and quantitative for monitoring the circulation of disease.\nMoreover, the assay system will be able to address novel pathogens by allowing rapid aggregation of\ngenetic tests for these new targets.\nname:Improved scalability, sensitivity, and interpretability of pathogen detection, including SARS-CoV-2, in wastewater using high-throughput, highly multiplexed digital array PCR technology\nsubProject:Wastewater\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5c85cee106fa4d9ca05b6333e5194df8": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 610,
       "target": 0
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5cb286764b4c41b1a835b6b81bda195f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 638,
       "target": 44
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5cebde752ef946b98cd3984d310109c1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4385,
       "label": "FundingOpportunity",
       "name": "Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 - Clinical Trials Not Allowed)",
       "tooltip": "FundingOpportunity\nname:Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 - Clinical Trials Not Allowed)\nid:RFA-OD-20-015\nurl:https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-015.html",
       "url": "https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-015.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5d21914cd4154e9ca96c86fbff4ec53f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 611,
       "target": 554
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5d51b8e0ba1e46e2babe9cb7373c8a74": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PRESENTED_AT",
       "source": 4360,
       "target": 2414
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5da542ab2eb7444a90fc7e4c8edbd53f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Christopher",
       "fullName": "Christopher Edward Mason",
       "id": 699,
       "label": "Researcher",
       "lastName": "Mason",
       "middleName": "Edward",
       "name": "Mason CE",
       "orcid": "orcid:0000-0002-1850-1642",
       "profileId": "profileid:10379550",
       "tooltip": "Researcher\nmiddleName:Edward\nid:profileid:10379550\nlastName:Mason\norcid:orcid:0000-0002-1850-1642\nprofileId:profileid:10379550\nname:Mason CE\nfullName:Christopher Edward Mason\nfirstName:Christopher"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5db68871f530459ba2075f9384ab7e7a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Yong",
       "fullName": "Yong Kim",
       "id": 647,
       "label": "Researcher",
       "lastName": "Kim",
       "name": "Kim Y",
       "orcid": "orcid:0000-0001-7224-0503",
       "profileId": "profileid:6951767",
       "tooltip": "Researcher\nid:profileid:6951767\nlastName:Kim\norcid:orcid:0000-0001-7224-0503\nprofileId:profileid:6951767\nname:Kim Y\nfullName:Yong Kim\nfirstName:Yong"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5e4be9cca3024dbdbceb2ce24df7e1e6": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "PROJECT SUMMARY\n Coronavirus 2019 (COVID-19) has afflicted 6.2 million Americans and killed 190,000 as of early September\n2020 (WHO website); a roughly 3% mortality. Between a shortage in testing and unidentified asymptomatic\nindividuals, the actual number of those infected could be 6 to 24-fold higher than that reported. SARS-CoV-2\n(CoV-2), the virus underlying the disease, results in a range of symptoms; in select cases a severe respiratory\nillness that impedes breathing that could lead to hospitalization and death. CoV-2 is transmitted person-to-\nperson via inhalation of the virus through mucosal membranes of the nose and throat from transfer after\ntouching a contaminated surface or by inhaling aerosolized virus. Unfortunately, COVID-19 is likely to be\nprevalent well into 2021 and beyond.\n We must increase our ability to test for CoV-2. First, testing is needed to diagnose individuals that are\nsymptomatic or asymptomatic to reduce community spread. And second, monitoring gathering areas for\nairborne virus that could inform the decision to shutdown a space or implement disinfection and mitigation of\nan area. We propose to use an electrochemical biosensor in two detection devices, 1) a diagnostic\nbreathalyzer for instant detection of CoV-2 and 2) an airborne detector for real-time, continuous surveillance of\na large space.\n We have developed a novel ultra-sensitive, antibody-based electrochemical biosensor to detect CoV-2\nrepeat binding domain (RBD) spike protein. The technology is based on a micro-immunoelectrode (MIE)\nbiosensor pioneered by the Cirrito laboratory to study protein dynamics in the setting of neurodegeneration (2,3).\nThe biosensor uses voltammetry to measure the oxidation of tyrosine amino acids; oxidation is the release of\nelectrons that the biosensor measures as a change in current. Antibodies are covalently attached to the\nelectrode surface to provide selectivity. Our prototype CoV-2 biosensor is sensitive to 2 femtogram/ml,\ncompared to several current CoV-2 antigen tests that are sensitive to the low picogram/ml range.\n The proposal will first (Aim 1) optimize our CoV-2 biosensor to detect CoV-2 viral particles, as well as test\nseveral parameters to increase sensitivity and longevity. Aim 2 will build a test breathalyzer that will utilize a\nnebulizer to generate virus laden air containing aerosol droplets similar to a breath that contain defined\nconcentrations of CoV-2 viral particles. Aim 3 will test the airborne biosensor in a realistic environment. Co-I\nChakrabarty’s laboratory has unique capabilities of mimicking real-world environmental conditions, especially\nin the context of atmospheric aerosols, necessary for testing and optimizing the biosensor’s performance for\nfield deployment. Atmospheric conditions include relative humidity (RH) and temperature, as well as common\nairborne pollutants found indoors.\n Finding novel means to detect the CoV-2, as well as create a platform to detect other and future\npathogens, would enable us to limit the viral spread throughout the community in the current and future\npandemics.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 36,
       "label": "Grant",
       "name": "Nanobody-Based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2",
       "narrative": "COVID-19 has afflicted millions of Americans with a roughly 3% mortality rate. We have developed an\nultra-sensitive electrochemical biosensor to detect CoV-2 which we will incorporate into a breathalyzer for\ndiagnostic purposes, as well as an airborne detector to monitor large gathering spaces.",
       "researchInitiative": "RADx-rad",
       "subProject": "Automatic Detection & Tracing",
       "tooltip": "Grant\nabstract:PROJECT SUMMARY\n Coronavirus 2019 (COVID-19) has afflicted 6.2 million Americans and killed 190,000 as of early September\n2020 (WHO website); a roughly 3% mortality. Between a shortage in testing and unidentified asymptomatic\nindividuals, the actual number of those infected could be 6 to 24-fold higher than that reported. SARS-CoV-2\n(CoV-2), the virus underlying the disease, results in a range of symptoms; in select cases a severe respiratory\nillness that impedes breathing that could lead to hospitalization and death. CoV-2 is transmitted person-to-\nperson via inhalation of the virus through mucosal membranes of the nose and throat from transfer after\ntouching a contaminated surface or by inhaling aerosolized virus. Unfortunately, COVID-19 is likely to be\nprevalent well into 2021 and beyond.\n We must increase our ability to test for CoV-2. First, testing is needed to diagnose individuals that are\nsymptomatic or asymptomatic to reduce community spread. And second, monitoring gathering areas for\nairborne virus that could inform the decision to shutdown a space or implement disinfection and mitigation of\nan area. We propose to use an electrochemical biosensor in two detection devices, 1) a diagnostic\nbreathalyzer for instant detection of CoV-2 and 2) an airborne detector for real-time, continuous surveillance of\na large space.\n We have developed a novel ultra-sensitive, antibody-based electrochemical biosensor to detect CoV-2\nrepeat binding domain (RBD) spike protein. The technology is based on a micro-immunoelectrode (MIE)\nbiosensor pioneered by the Cirrito laboratory to study protein dynamics in the setting of neurodegeneration (2,3).\nThe biosensor uses voltammetry to measure the oxidation of tyrosine amino acids; oxidation is the release of\nelectrons that the biosensor measures as a change in current. Antibodies are covalently attached to the\nelectrode surface to provide selectivity. Our prototype CoV-2 biosensor is sensitive to 2 femtogram/ml,\ncompared to several current CoV-2 antigen tests that are sensitive to the low picogram/ml range.\n The proposal will first (Aim 1) optimize our CoV-2 biosensor to detect CoV-2 viral particles, as well as test\nseveral parameters to increase sensitivity and longevity. Aim 2 will build a test breathalyzer that will utilize a\nnebulizer to generate virus laden air containing aerosol droplets similar to a breath that contain defined\nconcentrations of CoV-2 viral particles. Aim 3 will test the airborne biosensor in a realistic environment. Co-I\nChakrabarty’s laboratory has unique capabilities of mimicking real-world environmental conditions, especially\nin the context of atmospheric aerosols, necessary for testing and optimizing the biosensor’s performance for\nfield deployment. Atmospheric conditions include relative humidity (RH) and temperature, as well as common\nairborne pollutants found indoors.\n Finding novel means to detect the CoV-2, as well as create a platform to detect other and future\npathogens, would enable us to limit the viral spread throughout the community in the current and future\npandemics.\nid:U01AA029331\nnarrative:COVID-19 has afflicted millions of Americans with a roughly 3% mortality rate. We have developed an\nultra-sensitive electrochemical biosensor to detect CoV-2 which we will incorporate into a breathalyzer for\ndiagnostic purposes, as well as an airborne detector to monitor large gathering spaces.\nname:Nanobody-Based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2\nsubProject:Automatic Detection & Tracing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5e77622878b041c8aa0305f54d8f9b29": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "NEW YORK",
       "country": "UNITED STATES",
       "duns": "duns:049179401",
       "geonames": "geonames:5128581",
       "id": 602,
       "label": "Organization",
       "name": "Columbia University",
       "ror": "ror:00hj8s172",
       "state": "NY",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5128581\nror:ror:00hj8s172\ncity:NEW YORK\nname:Columbia University\nuei:uei:F4N1QNPB95M4\nduns:duns:049179401\nstate:NY\nid:ror:00hj8s172\nurl:https://ror.org/00hj8s172",
       "uei": "uei:F4N1QNPB95M4",
       "url": "https://ror.org/00hj8s172"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "5f3f11d913eb4ee5a322a9def50d2357": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1901,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6062e99ecc7a458f88bfde0ab9733114": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 684,
       "target": 556
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "60a57c8ee4bc46ac96993b0b5b9bb3c2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 683,
       "target": 42
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "60f98c26be15478387419ae24591b406": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "STORRS-MANSFIELD",
       "country": "UNITED STATES",
       "duns": "duns:614209054",
       "geonames": "geonames:4843786",
       "id": 592,
       "label": "Organization",
       "name": "University of Connecticut",
       "ror": "ror:02der9h97",
       "state": "CT",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4843786\nror:ror:02der9h97\ncity:STORRS-MANSFIELD\nname:University of Connecticut\nuei:uei:WNTPS995QBM7\nduns:duns:614209054\nstate:CT\nid:ror:02der9h97\nurl:https://ror.org/02der9h97",
       "uei": "uei:WNTPS995QBM7",
       "url": "https://ror.org/02der9h97"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "610c98e6bd8849c3ab65cb5de6108ca5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4387,
       "target": 4
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "617f4777654348329d0d99958e44f1a1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "John",
       "fullName": "John Edward Hayes",
       "id": 715,
       "label": "Researcher",
       "lastName": "Hayes",
       "middleName": "Edward",
       "name": "Hayes JE",
       "profileId": "profileid:9451051",
       "tooltip": "Researcher\nmiddleName:Edward\nid:profileid:9451051\nlastName:Hayes\nprofileId:profileid:9451051\nname:Hayes JE\nfullName:John Edward Hayes\nfirstName:John"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "61b855bab3f146959117db362b0409ea": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 616,
       "target": 601
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "620cb08a8e854e65a71cf52b0d183b84": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Kenneth",
       "fullName": "Kenneth L Shepard",
       "id": 639,
       "label": "Researcher",
       "lastName": "Shepard",
       "middleName": "L",
       "name": "Shepard KL",
       "orcid": "orcid:0000-0003-0665-6775",
       "profileId": "profileid:8656449",
       "tooltip": "Researcher\nmiddleName:L\nid:profileid:8656449\nlastName:Shepard\norcid:orcid:0000-0003-0665-6775\nprofileId:profileid:8656449\nname:Shepard KL\nfullName:Kenneth L Shepard\nfirstName:Kenneth"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "624096d498e04a35bb94c0b3fb735c08": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Xing",
       "fullName": "Xing Wang",
       "id": 689,
       "label": "Researcher",
       "lastName": "Wang",
       "name": "Wang X",
       "orcid": "orcid:0000-0001-9930-3287",
       "profileId": "profileid:12225947",
       "tooltip": "Researcher\nid:profileid:12225947\nlastName:Wang\norcid:orcid:0000-0001-9930-3287\nprofileId:profileid:12225947\nname:Wang X\nfullName:Xing Wang\nfirstName:Xing"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6252f853f1f54556beedd0750a651423": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "BOSTON",
       "country": "UNITED STATES",
       "duns": "duns:030811269",
       "geonames": "geonames:4930956",
       "id": 553,
       "label": "Organization",
       "name": "Brigham and Women's Hospital",
       "ror": "ror:04b6nzv94",
       "state": "MA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4930956\nror:ror:04b6nzv94\ncity:BOSTON\nname:Brigham and Women's Hospital\nuei:uei:QN6MS4VN7BD1\nduns:duns:030811269\nstate:MA\nid:ror:04b6nzv94\nurl:https://ror.org/04b6nzv94",
       "uei": "uei:QN6MS4VN7BD1",
       "url": "https://ror.org/04b6nzv94"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "62924b2e73c7403ebdee907b89d0e280": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 681,
       "target": 578
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "62da5eb5b59d4489bbda7915c58b2e7e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "LOS ANGELES",
       "country": "UNITED STATES",
       "duns": "duns:092530369",
       "geonames": "geonames:5368361",
       "id": 566,
       "label": "Organization",
       "name": "University of California, Los Angeles",
       "ror": "ror:046rm7j60",
       "state": "CA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5368361\nror:ror:046rm7j60\ncity:LOS ANGELES\nname:University of California, Los Angeles\nuei:uei:RN64EPNH8JC6\nduns:duns:092530369\nstate:CA\nid:ror:046rm7j60\nurl:https://ror.org/046rm7j60",
       "uei": "uei:RN64EPNH8JC6",
       "url": "https://ror.org/046rm7j60"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "637559e8f35c463293bbd9b98df551ef": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "country": "UNITED STATES",
       "geonames": "geonames:4464368",
       "id": 551,
       "label": "Organization",
       "name": "National Institute of Environmental Health Sciences",
       "ror": "ror:00j4k1h63",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4464368\nror:ror:00j4k1h63\nname:National Institute of Environmental Health Sciences\nid:ror:00j4k1h63\nurl:https://ror.org/00j4k1h63",
       "url": "https://ror.org/00j4k1h63"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "63c542f7f57c48fda6b10885ce866f08": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The recent emergence of SARS-CoV-2 and resultant pandemic of COVID-19 disease has overwhelmed global\nhealth systems and led to over 200,000 American deaths to date. While initial reports suggested that SARS-\nCoV-2 infection in children was generally benign, a novel post-inflammatory syndrome known as multisystem\ninflammatory syndrome in children (MIS-C) has now been described. MIS-C in children is characterized by fever,\nsystemic inflammation, and end-organ involvement, and the majority of patients are IgG seropositive for SARS-\nCoV-2. Because the clinical features of MIS-C overlap with other infections and inflammatory disorders, new\nstrategies for diagnosis of MIS-C in febrile children are urgently needed. Our immediate objective (during the\nR61 phase) is to determine the reproducible changes in breath, urine, and salivary volatile composition in chil-\ndren diagnosed with MIS-C. We will integrate these discovery studies with clinical and immunological profiling to\ndevelop (during R61 phase) and validate (during R33 phase) a novel and much-needed MIS-C diagnostic, which\nis expected to have a major impact on care of febrile children. Our long-term goal to develop a diagnostic strategy\nto distinguish children with MIS-C from children with other causes of fever. Supported by our strong preliminary\ndata that indicate our expertise and feasibility of this strategy, our objectives will be met through three specific\naims: 1) Characterize breath biomarkers in children with MIS-C (R61); 2) Relate breath VOC changes to virolog-\nical, disease severity, and immunological features of MIS-C (R61); and 3) Validate our novel MIS-C diagnostic\nfor clinical use (R33). The proposed research is significant, because we will progress in development of new,\nmuch-needed MIS-C rapid diagnostic tool.",
       "awardCode": "R33",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 4,
       "label": "Grant",
       "name": "Diagnosis of MIS-C in febrile children",
       "narrative": "This research is highly relevant to public health because there is no current validated\ndiagnostic tool for the post-SARS-CoV-2 inflammatory disorder in children, MIS-C. Our\nproposal will develop a new strategy to diagnose this disorder, which will directly\nimprove care of children with fever and help support future clinical studies.",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nabstract:The recent emergence of SARS-CoV-2 and resultant pandemic of COVID-19 disease has overwhelmed global\nhealth systems and led to over 200,000 American deaths to date. While initial reports suggested that SARS-\nCoV-2 infection in children was generally benign, a novel post-inflammatory syndrome known as multisystem\ninflammatory syndrome in children (MIS-C) has now been described. MIS-C in children is characterized by fever,\nsystemic inflammation, and end-organ involvement, and the majority of patients are IgG seropositive for SARS-\nCoV-2. Because the clinical features of MIS-C overlap with other infections and inflammatory disorders, new\nstrategies for diagnosis of MIS-C in febrile children are urgently needed. Our immediate objective (during the\nR61 phase) is to determine the reproducible changes in breath, urine, and salivary volatile composition in chil-\ndren diagnosed with MIS-C. We will integrate these discovery studies with clinical and immunological profiling to\ndevelop (during R61 phase) and validate (during R33 phase) a novel and much-needed MIS-C diagnostic, which\nis expected to have a major impact on care of febrile children. Our long-term goal to develop a diagnostic strategy\nto distinguish children with MIS-C from children with other causes of fever. Supported by our strong preliminary\ndata that indicate our expertise and feasibility of this strategy, our objectives will be met through three specific\naims: 1) Characterize breath biomarkers in children with MIS-C (R61); 2) Relate breath VOC changes to virolog-\nical, disease severity, and immunological features of MIS-C (R61); and 3) Validate our novel MIS-C diagnostic\nfor clinical use (R33). The proposed research is significant, because we will progress in development of new,\nmuch-needed MIS-C rapid diagnostic tool.\nid:R33HD105594\nnarrative:This research is highly relevant to public health because there is no current validated\ndiagnostic tool for the post-SARS-CoV-2 inflammatory disorder in children, MIS-C. Our\nproposal will develop a new strategy to diagnose this disorder, which will directly\nimprove care of children with fever and help support future clinical studies.\nname:Diagnosis of MIS-C in febrile children\nsubProject:PreVAIL kIds\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R33"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "63e3e5e1f38c47b29063b7fbd3036c60": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "JEFFERSON CITY",
       "country": "UNITED STATES",
       "duns": "duns:878092600",
       "geonames": "geonames:4392388",
       "id": 582,
       "label": "Organization",
       "name": "Missouri Department of Health and Senior Services",
       "ror": "ror:041qkag73",
       "state": "MO",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4392388\nror:ror:041qkag73\ncity:JEFFERSON CITY\nname:Missouri Department of Health and Senior Services\nuei:uei:UETLXV8NG8F4\nduns:duns:878092600\nstate:MO\nid:ror:041qkag73\nurl:https://ror.org/041qkag73",
       "uei": "uei:UETLXV8NG8F4",
       "url": "https://ror.org/041qkag73"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "64db2c89b9ef4225b9bee921b63a3fd4": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "LAUREL",
       "country": "UNITED STATES",
       "duns": "duns:117475118",
       "geonames": "geonames:4360369",
       "id": 601,
       "label": "Organization",
       "name": "MPOD, Inc",
       "state": "MD",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4360369\ncity:LAUREL\nname:MPOD, Inc\nuei:uei:JELTXBVC4DZ1\nduns:duns:117475118\nstate:MD\nid:uei:JELTXBVC4DZ1",
       "uei": "uei:JELTXBVC4DZ1"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "64e8cced9718463ab3af8f22dadfb9a6": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 677,
       "target": 36
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6545e007005d42908c4151e5b3b03706": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4388,
       "target": 26
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6552ee7875fd4136923ec85cd6f3fd02": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 2753,
       "label": "MetaNode",
       "name": "Name of the dataset (string)",
       "nodeName": "Dataset",
       "tooltip": "MetaNode\nid:Unique identifier for the dataset (string)\nname:Name of the dataset (string)\nnodeName:Dataset\nurl:URL to dataset landing page (string)",
       "url": "URL to dataset landing page (string)"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "658de15459cb48ae8aa4ac0a79bb2ccb": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Kevin",
       "fullName": "Kevin Ward",
       "id": 708,
       "label": "Researcher",
       "lastName": "Ward",
       "name": "Ward K",
       "profileId": "profileid:8485057",
       "tooltip": "Researcher\nid:profileid:8485057\nlastName:Ward\nprofileId:profileid:8485057\nname:Ward K\nfullName:Kevin Ward\nfirstName:Kevin"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6618e9ae950046328aa3c5fcf197f1bd": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The COVID-19 pandemic is the most devastating infectious disease outbreak in a century, particularly in\nunderserved and minoritized communities. In 2020 alone, it will cost a million lives. It continues to wreak\neconomic havoc worldwide. Therefore, it is critical to develop new tools that can mitigate the spread of SARS-\nCoV-2, the virus that causes COVID-19. Rapid screening tools can identify potentially infected individuals who\ncan then be isolated/quarantined from the uninfected and directed towards further testing and treatment.\nUnfortunately, definitive viral testing for SARS-CoV-2 has proven difficult to implement in many countries,\nincluding the US, due to technical, financial and governmental hurdles to universal access and timely\nprocessing. Symptom-based screening offers a valuable, albeit imperfect, complement to viral testing that can\nhelp identify many individuals with the disease for isolation as well as treatment. A major challenge with\nsymptomatic testing is that COVID-19 is highly protean: the heterogeneity of symptoms means no single\nsymptom or constellation of symptoms is definitive diagnostically. Still, there is growing evidence that sudden\npartial or complete olfactory loss – even more than other symptoms such as fever or dry cough – is the single\nbest predictor of COVID-19. In this proposal, we will develop and implement objective, self-administered smell\ntests for the purpose of identifying individuals with COVID-19 prior to, or in the absence of, viral testing, as well\nas for use in population-level surveillance of COVID-19 spread. Several kinds of objective tests have been\nused in clinical or laboratory settings to assess an individual's olfactory ability, including those that test the\nability to identify or discriminate odors as well as procedures to determine the lowest concentration an\nindividual can reliably perceive (i.e., odor detection threshold). Each approach has technical and logistical\nadvantages and disadvantages, and each captures different aspects of olfactory dysfunction. Regarding\nCOVID-19, it is unknown what type of measure has the highest specificity or sensitivity. In Aim 1, we will use\nself-administered objective testing of odor identification and odor detection threshold in SARS-CoV-2-tested\nindividuals to determine which olfactory measure is the best predictor of COVID-19. In Aim 2, we will use\nobjective smell testing to assess whether population monitoring of olfactory loss in university, municipal or\nother community settings can serve as a sentinel of COVID-19 community spread. Together, our studies will\nprovide a rapid, remote-friendly, cost-effective, scalable, non-intrusive method to screen for COVID-19 at the\nindividual level and to assess prevalence in communities, especially those that have been traditionally\nunderserved by the health care system and public health infrastructure.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 38,
       "label": "Grant",
       "name": "Rapid olfactory tools for telemedicine-friendly COVID-19 screening and surveillance",
       "narrative": "Olfactory loss (anosmia or hyposmia) is the single best symptomatic predictor of COVID-19. Objective, self-\nadministered smell testing can accelerate identification of COVID-19 in individuals and communities –\nparticularly when timely viral testing is not readily available – and help mitigate community spread of this\ndangerous disease.",
       "researchInitiative": "RADx-rad",
       "subProject": "Chemosensory Testing",
       "tooltip": "Grant\nabstract:The COVID-19 pandemic is the most devastating infectious disease outbreak in a century, particularly in\nunderserved and minoritized communities. In 2020 alone, it will cost a million lives. It continues to wreak\neconomic havoc worldwide. Therefore, it is critical to develop new tools that can mitigate the spread of SARS-\nCoV-2, the virus that causes COVID-19. Rapid screening tools can identify potentially infected individuals who\ncan then be isolated/quarantined from the uninfected and directed towards further testing and treatment.\nUnfortunately, definitive viral testing for SARS-CoV-2 has proven difficult to implement in many countries,\nincluding the US, due to technical, financial and governmental hurdles to universal access and timely\nprocessing. Symptom-based screening offers a valuable, albeit imperfect, complement to viral testing that can\nhelp identify many individuals with the disease for isolation as well as treatment. A major challenge with\nsymptomatic testing is that COVID-19 is highly protean: the heterogeneity of symptoms means no single\nsymptom or constellation of symptoms is definitive diagnostically. Still, there is growing evidence that sudden\npartial or complete olfactory loss – even more than other symptoms such as fever or dry cough – is the single\nbest predictor of COVID-19. In this proposal, we will develop and implement objective, self-administered smell\ntests for the purpose of identifying individuals with COVID-19 prior to, or in the absence of, viral testing, as well\nas for use in population-level surveillance of COVID-19 spread. Several kinds of objective tests have been\nused in clinical or laboratory settings to assess an individual's olfactory ability, including those that test the\nability to identify or discriminate odors as well as procedures to determine the lowest concentration an\nindividual can reliably perceive (i.e., odor detection threshold). Each approach has technical and logistical\nadvantages and disadvantages, and each captures different aspects of olfactory dysfunction. Regarding\nCOVID-19, it is unknown what type of measure has the highest specificity or sensitivity. In Aim 1, we will use\nself-administered objective testing of odor identification and odor detection threshold in SARS-CoV-2-tested\nindividuals to determine which olfactory measure is the best predictor of COVID-19. In Aim 2, we will use\nobjective smell testing to assess whether population monitoring of olfactory loss in university, municipal or\nother community settings can serve as a sentinel of COVID-19 community spread. Together, our studies will\nprovide a rapid, remote-friendly, cost-effective, scalable, non-intrusive method to screen for COVID-19 at the\nindividual level and to assess prevalence in communities, especially those that have been traditionally\nunderserved by the health care system and public health infrastructure.\nid:U01DC019573\nnarrative:Olfactory loss (anosmia or hyposmia) is the single best symptomatic predictor of COVID-19. Objective, self-\nadministered smell testing can accelerate identification of COVID-19 in individuals and communities –\nparticularly when timely viral testing is not readily available – and help mitigate community spread of this\ndangerous disease.\nname:Rapid olfactory tools for telemedicine-friendly COVID-19 screening and surveillance\nsubProject:Chemosensory Testing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "672fb233629a4c60a6b35865ab510493": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 689,
       "target": 24
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "674e8515c5fe43469a78cd990999390d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4396,
       "target": 36
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6937a395b29640479b78494849cf254a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 691,
       "target": 28
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "69798cfa85fe4df99a49ea8272342468": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "COLUMBUS",
       "country": "UNITED STATES",
       "duns": "duns:832127323",
       "geonames": "geonames:4509177",
       "id": 559,
       "label": "Organization",
       "name": "The Ohio State University",
       "ror": "ror:00rs6vg23",
       "state": "OH",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4509177\nror:ror:00rs6vg23\ncity:COLUMBUS\nname:The Ohio State University\nuei:uei:DLWBSLWAJWR1\nduns:duns:832127323\nstate:OH\nid:ror:00rs6vg23\nurl:https://ror.org/00rs6vg23",
       "uei": "uei:DLWBSLWAJWR1",
       "url": "https://ror.org/00rs6vg23"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6a12176566ce4d3fad6e308144b46305": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Rolf",
       "fullName": "Rolf U Halden",
       "id": 695,
       "label": "Researcher",
       "lastName": "Halden",
       "middleName": "U",
       "name": "Halden RU",
       "orcid": "orcid:0000-0001-5232-7361",
       "profileId": "profileid:7698522",
       "tooltip": "Researcher\nmiddleName:U\nid:profileid:7698522\nlastName:Halden\norcid:orcid:0000-0001-5232-7361\nprofileId:profileid:7698522\nname:Halden RU\nfullName:Rolf U Halden\nfirstName:Rolf"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6a85553c6d11421ea2fd89701a16c349": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The COVID-19 pandemic is the most devastating infectious disease outbreak in a century, particularly in\nunderserved and minoritized communities. In 2020 alone, it will cost a million lives. It continues to wreak\neconomic havoc worldwide. Therefore, it is critical to develop new tools that can mitigate the spread of SARS-\nCoV-2, the virus that causes COVID-19. Rapid screening tools can identify potentially infected individuals who\ncan then be isolated/quarantined from the uninfected and directed towards further testing and treatment.\nUnfortunately, definitive viral testing for SARS-CoV-2 has proven difficult to implement in many countries,\nincluding the US, due to technical, financial and governmental hurdles to universal access and timely\nprocessing. Symptom-based screening offers a valuable, albeit imperfect, complement to viral testing that can\nhelp identify many individuals with the disease for isolation as well as treatment. A major challenge with\nsymptomatic testing is that COVID-19 is highly protean: the heterogeneity of symptoms means no single\nsymptom or constellation of symptoms is definitive diagnostically. Still, there is growing evidence that sudden\npartial or complete olfactory loss – even more than other symptoms such as fever or dry cough – is the single\nbest predictor of COVID-19. In this proposal, we will develop and implement objective, self-administered smell\ntests for the purpose of identifying individuals with COVID-19 prior to, or in the absence of, viral testing, as well\nas for use in population-level surveillance of COVID-19 spread. Several kinds of objective tests have been\nused in clinical or laboratory settings to assess an individual's olfactory ability, including those that test the\nability to identify or discriminate odors as well as procedures to determine the lowest concentration an\nindividual can reliably perceive (i.e., odor detection threshold). Each approach has technical and logistical\nadvantages and disadvantages, and each captures different aspects of olfactory dysfunction. Regarding\nCOVID-19, it is unknown what type of measure has the highest specificity or sensitivity. In Aim 1, we will use\nself-administered objective testing of odor identification and odor detection threshold in SARS-CoV-2-tested\nindividuals to determine which olfactory measure is the best predictor of COVID-19. In Aim 2, we will use\nobjective smell testing to assess whether population monitoring of olfactory loss in university, municipal or\nother community settings can serve as a sentinel of COVID-19 community spread. Together, our studies will\nprovide a rapid, remote-friendly, cost-effective, scalable, non-intrusive method to screen for COVID-19 at the\nindividual level and to assess prevalence in communities, especially those that have been traditionally\nunderserved by the health care system and public health infrastructure.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 38,
       "label": "Grant",
       "name": "Rapid olfactory tools for telemedicine-friendly COVID-19 screening and surveillance",
       "narrative": "Olfactory loss (anosmia or hyposmia) is the single best symptomatic predictor of COVID-19. Objective, self-\nadministered smell testing can accelerate identification of COVID-19 in individuals and communities –\nparticularly when timely viral testing is not readily available – and help mitigate community spread of this\ndangerous disease.",
       "researchInitiative": "RADx-rad",
       "subProject": "Chemosensory Testing",
       "tooltip": "Grant\nabstract:The COVID-19 pandemic is the most devastating infectious disease outbreak in a century, particularly in\nunderserved and minoritized communities. In 2020 alone, it will cost a million lives. It continues to wreak\neconomic havoc worldwide. Therefore, it is critical to develop new tools that can mitigate the spread of SARS-\nCoV-2, the virus that causes COVID-19. Rapid screening tools can identify potentially infected individuals who\ncan then be isolated/quarantined from the uninfected and directed towards further testing and treatment.\nUnfortunately, definitive viral testing for SARS-CoV-2 has proven difficult to implement in many countries,\nincluding the US, due to technical, financial and governmental hurdles to universal access and timely\nprocessing. Symptom-based screening offers a valuable, albeit imperfect, complement to viral testing that can\nhelp identify many individuals with the disease for isolation as well as treatment. A major challenge with\nsymptomatic testing is that COVID-19 is highly protean: the heterogeneity of symptoms means no single\nsymptom or constellation of symptoms is definitive diagnostically. Still, there is growing evidence that sudden\npartial or complete olfactory loss – even more than other symptoms such as fever or dry cough – is the single\nbest predictor of COVID-19. In this proposal, we will develop and implement objective, self-administered smell\ntests for the purpose of identifying individuals with COVID-19 prior to, or in the absence of, viral testing, as well\nas for use in population-level surveillance of COVID-19 spread. Several kinds of objective tests have been\nused in clinical or laboratory settings to assess an individual's olfactory ability, including those that test the\nability to identify or discriminate odors as well as procedures to determine the lowest concentration an\nindividual can reliably perceive (i.e., odor detection threshold). Each approach has technical and logistical\nadvantages and disadvantages, and each captures different aspects of olfactory dysfunction. Regarding\nCOVID-19, it is unknown what type of measure has the highest specificity or sensitivity. In Aim 1, we will use\nself-administered objective testing of odor identification and odor detection threshold in SARS-CoV-2-tested\nindividuals to determine which olfactory measure is the best predictor of COVID-19. In Aim 2, we will use\nobjective smell testing to assess whether population monitoring of olfactory loss in university, municipal or\nother community settings can serve as a sentinel of COVID-19 community spread. Together, our studies will\nprovide a rapid, remote-friendly, cost-effective, scalable, non-intrusive method to screen for COVID-19 at the\nindividual level and to assess prevalence in communities, especially those that have been traditionally\nunderserved by the health care system and public health infrastructure.\nid:U01DC019573\nnarrative:Olfactory loss (anosmia or hyposmia) is the single best symptomatic predictor of COVID-19. Objective, self-\nadministered smell testing can accelerate identification of COVID-19 in individuals and communities –\nparticularly when timely viral testing is not readily available – and help mitigate community spread of this\ndangerous disease.\nname:Rapid olfactory tools for telemedicine-friendly COVID-19 screening and surveillance\nsubProject:Chemosensory Testing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6ad181d199524f7490a1e5b4492661f5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 636,
       "target": 45
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6adeb90365864bd7a583e910b2a71a6c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 346,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6af6a5d62668414ea57a099d8f8a4c0c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4390,
       "target": 35
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6b1da2ba401745ce8f2f23227980bbd9": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Anushka",
       "fullName": "Anushka Garg Mandal",
       "id": 315,
       "label": "Researcher",
       "lastName": "Mandal",
       "middleName": "Garg",
       "name": "Mandal AG",
       "tooltip": "Researcher\nmiddleName:Garg\nid:s2authorid:2222408568\nlastName:Mandal\nname:Mandal AG\nfullName:Anushka Garg Mandal\nfirstName:Anushka"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6b438fd2c1c04ec2b1329cd6d935e6b4": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4394,
       "target": 10
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6b5b523ad8ff4507973037b785b8525a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Rodney",
       "fullName": "Rodney Jy Ho",
       "id": 635,
       "label": "Researcher",
       "lastName": "Ho",
       "middleName": "Jy",
       "name": "Ho RJ",
       "orcid": "orcid:0000-0001-5960-4288",
       "profileId": "profileid:6417303",
       "tooltip": "Researcher\nmiddleName:Jy\nid:profileid:6417303\nlastName:Ho\norcid:orcid:0000-0001-5960-4288\nprofileId:profileid:6417303\nname:Ho RJ\nfullName:Rodney Jy Ho\nfirstName:Rodney"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6cb956a1d044452781bdbb029524d8c4": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 677,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6d1a9221321f470baf4cd2d1f3b8f525": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4396,
       "target": 31
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6d97b9e05bb3451899876866233c47e8": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "CITES",
       "source": 2708,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6dbce0bc0fdd4c14a17ceefc273a8eaa": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Jeff",
       "fullName": "Jeff Wenzel",
       "id": 685,
       "label": "Researcher",
       "lastName": "Wenzel",
       "name": "Wenzel J",
       "profileId": "profileid:77820001",
       "tooltip": "Researcher\nid:profileid:77820001\nlastName:Wenzel\nprofileId:profileid:77820001\nname:Wenzel J\nfullName:Jeff Wenzel\nfirstName:Jeff"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6e431a5f60ae4cdb8a826aff9e27b65c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Nishit",
       "fullName": "Nishit Shetty",
       "id": 1428,
       "label": "Researcher",
       "lastName": "Shetty",
       "name": "Shetty N",
       "tooltip": "Researcher\nid:s2authorid:34450801\nlastName:Shetty\nname:Shetty N\nfullName:Nishit Shetty\nfirstName:Nishit"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6ebed678670a4da79d1dd4bef73d5d27": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Ka'Imi",
       "fullName": "Ka'Imi Alohilani Sinclair",
       "id": 625,
       "label": "Researcher",
       "lastName": "Sinclair",
       "middleName": "Alohilani",
       "name": "Sinclair KA",
       "profileId": "profileid:9717053",
       "tooltip": "Researcher\nmiddleName:Alohilani\nid:profileid:9717053\nlastName:Sinclair\nprofileId:profileid:9717053\nname:Sinclair KA\nfullName:Ka'Imi Alohilani Sinclair\nfirstName:Ka'Imi"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6f2700447e5643a0a0659dfbc0a3ba92": {
     "model_module": "@jupyter-widgets/controls",
     "model_module_version": "1.5.0",
     "model_name": "ProgressStyleModel",
     "state": {
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "ProgressStyleModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "StyleView",
      "bar_color": null,
      "description_width": ""
     }
    },
    "6f6479c5241a48de88a495cc523181c6": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 689,
       "target": 584
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6f7315ce708e40bdb5af0b8f933537c8": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "D",
       "fullName": "D Brody",
       "id": 957,
       "label": "Researcher",
       "lastName": "Brody",
       "name": "Brody D",
       "tooltip": "Researcher\nid:s2authorid:40644627\nlastName:Brody\nname:Brody D\nfullName:D Brody\nfirstName:D"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "6f83d13463d242f0a08cfc265b592710": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "MOUNT PLEASANT",
       "country": "UNITED STATES",
       "duns": "duns:624134037",
       "geonames": "geonames:5002714",
       "id": 597,
       "label": "Organization",
       "name": "Central Michigan University",
       "ror": "ror:02xawj266",
       "state": "MI",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5002714\nror:ror:02xawj266\ncity:MOUNT PLEASANT\nname:Central Michigan University\nuei:uei:JJDYK36PRTL5\nduns:duns:624134037\nstate:MI\nid:ror:02xawj266\nurl:https://ror.org/02xawj266",
       "uei": "uei:JJDYK36PRTL5",
       "url": "https://ror.org/02xawj266"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "703368227ef04e80a95959844924d2eb": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 635,
       "target": 570
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "703ca325eb414436af10284d3f2d49d7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "CITES",
       "source": 3301,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "70e2aea88cdf4e21868061e868ec214c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "A fundamental question of any program focused on the testing and timely diagnosis of a communicable disease is its effectiveness in reducing community transmission. Unfortunately, direct estimation of this effectiveness is difficult in practice, elevating the value of mathematical modeling that can predict it from first principles. Here, we introduce testing effectiveness (TE), defined as the fraction by which transmission is reduced via testing and post-diagnosis isolation at the population scale, and develop a mathematical model that estimates it from the interactions of tests, within-host pathogen dynamics, and arbitrarily complex testing behaviors. While our model generalizes across pathogens, we demonstrate its flexibility through an analysis of three respiratory pathogens, influenza A, respiratory syncytial virus (RSV), and both pre-vaccine and post-vaccine era SARS-CoV-2, quantifying TE across post-exposure, post-symptom, and routine testing scenarios. We show that TE varies considerably by strategy and pathogen, with optimal testing depending on the number of tests available and when they are used. This work quantifies tradeoffs about when and how to test, providing a flexible framework to guide the use and development of current and future diagnostic tests to control transmission of infectious diseases.",
       "doi": "doi:10.1101/2023.09.22.23295983",
       "id": 4110,
       "journal": "medRxiv",
       "label": "Publication",
       "name": "Modeling the Transmission Mitigation Impact of Testing for Infectious Diseases",
       "pmId": "37808825",
       "pmcId": "10557819",
       "tooltip": "Publication\njournal:medRxiv\nabstract:A fundamental question of any program focused on the testing and timely diagnosis of a communicable disease is its effectiveness in reducing community transmission. Unfortunately, direct estimation of this effectiveness is difficult in practice, elevating the value of mathematical modeling that can predict it from first principles. Here, we introduce testing effectiveness (TE), defined as the fraction by which transmission is reduced via testing and post-diagnosis isolation at the population scale, and develop a mathematical model that estimates it from the interactions of tests, within-host pathogen dynamics, and arbitrarily complex testing behaviors. While our model generalizes across pathogens, we demonstrate its flexibility through an analysis of three respiratory pathogens, influenza A, respiratory syncytial virus (RSV), and both pre-vaccine and post-vaccine era SARS-CoV-2, quantifying TE across post-exposure, post-symptom, and routine testing scenarios. We show that TE varies considerably by strategy and pathogen, with optimal testing depending on the number of tests available and when they are used. This work quantifies tradeoffs about when and how to test, providing a flexible framework to guide the use and development of current and future diagnostic tests to control transmission of infectious diseases.\nid:doi:10.1101/2023.09.22.23295983\nname:Modeling the Transmission Mitigation Impact of Testing for Infectious Diseases\npmId:37808825\nyear:2023\ntype:secondary\npmcId:10557819\nurl:https://doi.org/doi:10.1101/2023.09.22.23295983\ndoi:doi:10.1101/2023.09.22.23295983",
       "type": "secondary",
       "url": "https://doi.org/doi:10.1101/2023.09.22.23295983",
       "year": 2023
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "710b1c06ebbf4cd1bdfb28dc9c505064": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4387,
       "target": 23
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "71360d44e3ac4e5b95385bc14fe9b9dd": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "PULLMAN",
       "country": "UNITED STATES",
       "duns": "duns:041485301",
       "geonames": "geonames:5807540",
       "id": 608,
       "label": "Organization",
       "name": "Washington State University",
       "ror": "ror:05dk0ce17",
       "state": "WA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5807540\nror:ror:05dk0ce17\ncity:PULLMAN\nname:Washington State University\nuei:uei:XRJSGX384TD6\nduns:duns:041485301\nstate:WA\nid:ror:05dk0ce17\nurl:https://ror.org/05dk0ce17",
       "uei": "uei:XRJSGX384TD6",
       "url": "https://ror.org/05dk0ce17"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "715902625a3f421ba44a76783db07191": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "In the wake of COVID-19 pandemic, Multisystem Inflammatory Syndrome in Children (MIS-C) has evolved as a\nnew threat to children exposed to SARS-CoV-2. The emergence of MIS-C is so new and so rapidly evolving\nthat there are currently no diagnostic tests to identify these patients nor are there tools to predict disease\nprogression. Through established, funded, multi-center consortia in the U.S. (CHARMS: Characterization of\nMIS-C and its Relationship to Kawasaki Disease funded by PCORI) and the UK (DIAMONDS), we will collect\nclinical data and samples to support the proposed studies. First, we will generate transcript, protein and\nantibody datasets from children with COVID-19, MIS-C, and with other febrile illnesses. Next, we will use these\ndata to devise tests to distinguish children at risk of progression to severe COVID-19 or MIS-C and diagnostic\ntests to distinguish these conditions from other causes of fever in children. Continuing our established\ncollaboration with Columbia University, we will define the antibody repertoire against all known human\ncoronaviruses and determine how pre-existing antibody to other coronaviruses may shape the immune\nresponse in acute SARS-CoV-2 infection and MIS-C. The first two years (R61) will build on the expertise of the\nassembled teams to discover unique proteomic and transcriptomic patterns in MIS-C and SARS-CoV-2-\ninfected patients and relate clinical parameters to the antibody response to coronaviral antigens profiled on\npeptide arrays. This work will leverage already banked plasma, serum, and RNA samples from children with\nCOVID-19, MIS-C, Kawasaki disease and other inflammatory conditions. Rigorous Go/NoGo criteria have\nbeen established and will determine progression to the R33 phase. The final two years (R33) will focus on\nplatform development and multicenter and bi-national test validation to diagnose and predict severity in\nchildren with SARS-CoV-2 infection or MIS-C based on aptamer technology, lateral-flow protein detection,\npoint-of-service RNA or antibody profiling with commercial partners. De-identified clinical and molecular data\nwill be deposited in the RADx-rad hub to facilitate data sharing. Many potential hurdles in this type of research\nhave already been overcome: a) IRB-approved patient recruitment for data and samples is on-going, b) clinical\nsamples have been banked, c) strong preliminary data has been generated on RNAseq, aptamer proteomics,\nand coronaviral antibody responses, and d) the teams have a strong track record of previous collaboration and\nproductivity. The synergistic expertise of these investigative teams in this multi-center proposal provides a\nunique opportunity to create diagnostic and prognostic tools for children suffering from the spectrum of SARS-\nCoV-2 illnesses.\n1",
       "awardCode": "R61",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 23,
       "label": "Grant",
       "name": "Diagnosing and predicting risk in children with SARS-CoV-2- related illness",
       "narrative": "As the COVID-19 pandemic evolved in early 2020, case reports appeared describing children with unusual\nfebrile illnesses with elevated inflammatory markers and multi-system involvement that is now termed\nMultisystem Inflammatory Syndrome in Children (MIS-C). The illness occurs weeks following exposure to\nSARS-CoV-2 and these children have a wide spectrum of disease severity ranging from cardiogenic shock to\nmilder illness that can be self-limited. To address an urgent, unmet clinical need, investigative teams across\nthree countries will join forces to discover and validate a diagnostic test to identify children with MIS-C and\npredict progression of disease.",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nabstract:In the wake of COVID-19 pandemic, Multisystem Inflammatory Syndrome in Children (MIS-C) has evolved as a\nnew threat to children exposed to SARS-CoV-2. The emergence of MIS-C is so new and so rapidly evolving\nthat there are currently no diagnostic tests to identify these patients nor are there tools to predict disease\nprogression. Through established, funded, multi-center consortia in the U.S. (CHARMS: Characterization of\nMIS-C and its Relationship to Kawasaki Disease funded by PCORI) and the UK (DIAMONDS), we will collect\nclinical data and samples to support the proposed studies. First, we will generate transcript, protein and\nantibody datasets from children with COVID-19, MIS-C, and with other febrile illnesses. Next, we will use these\ndata to devise tests to distinguish children at risk of progression to severe COVID-19 or MIS-C and diagnostic\ntests to distinguish these conditions from other causes of fever in children. Continuing our established\ncollaboration with Columbia University, we will define the antibody repertoire against all known human\ncoronaviruses and determine how pre-existing antibody to other coronaviruses may shape the immune\nresponse in acute SARS-CoV-2 infection and MIS-C. The first two years (R61) will build on the expertise of the\nassembled teams to discover unique proteomic and transcriptomic patterns in MIS-C and SARS-CoV-2-\ninfected patients and relate clinical parameters to the antibody response to coronaviral antigens profiled on\npeptide arrays. This work will leverage already banked plasma, serum, and RNA samples from children with\nCOVID-19, MIS-C, Kawasaki disease and other inflammatory conditions. Rigorous Go/NoGo criteria have\nbeen established and will determine progression to the R33 phase. The final two years (R33) will focus on\nplatform development and multicenter and bi-national test validation to diagnose and predict severity in\nchildren with SARS-CoV-2 infection or MIS-C based on aptamer technology, lateral-flow protein detection,\npoint-of-service RNA or antibody profiling with commercial partners. De-identified clinical and molecular data\nwill be deposited in the RADx-rad hub to facilitate data sharing. Many potential hurdles in this type of research\nhave already been overcome: a) IRB-approved patient recruitment for data and samples is on-going, b) clinical\nsamples have been banked, c) strong preliminary data has been generated on RNAseq, aptamer proteomics,\nand coronaviral antibody responses, and d) the teams have a strong track record of previous collaboration and\nproductivity. The synergistic expertise of these investigative teams in this multi-center proposal provides a\nunique opportunity to create diagnostic and prognostic tools for children suffering from the spectrum of SARS-\nCoV-2 illnesses.\n1\nid:R61HD105590\nnarrative:As the COVID-19 pandemic evolved in early 2020, case reports appeared describing children with unusual\nfebrile illnesses with elevated inflammatory markers and multi-system involvement that is now termed\nMultisystem Inflammatory Syndrome in Children (MIS-C). The illness occurs weeks following exposure to\nSARS-CoV-2 and these children have a wide spectrum of disease severity ranging from cardiogenic shock to\nmilder illness that can be self-limited. To address an urgent, unmet clinical need, investigative teams across\nthree countries will join forces to discover and validate a diagnostic test to identify children with MIS-C and\npredict progression of disease.\nname:Diagnosing and predicting risk in children with SARS-CoV-2- related illness\nsubProject:PreVAIL kIds\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R61"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "71b5185343d440d19c1761c7aeb86b80": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "PHILADELPHIA",
       "country": "UNITED STATES",
       "duns": "duns:088812565",
       "geonames": "geonames:4560349",
       "id": 572,
       "label": "Organization",
       "name": "Monell Chemical Senses Center",
       "ror": "ror:01mdfdm06",
       "state": "PA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4560349\nror:ror:01mdfdm06\ncity:PHILADELPHIA\nname:Monell Chemical Senses Center\nuei:uei:DJCTQA1PR7Q4\nduns:duns:088812565\nstate:PA\nid:ror:01mdfdm06\nurl:https://ror.org/01mdfdm06",
       "uei": "uei:DJCTQA1PR7Q4",
       "url": "https://ror.org/01mdfdm06"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "71ef27307e074c2ba1f44b16ec632529": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "DAVIS",
       "country": "UNITED STATES",
       "duns": "duns:047120084",
       "geonames": "geonames:5341704",
       "id": 562,
       "label": "Organization",
       "name": "University of California, Davis",
       "ror": "ror:05rrcem69",
       "state": "CA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5341704\nror:ror:05rrcem69\ncity:DAVIS\nname:University of California, Davis\nuei:uei:TX2DAGQPENZ5\nduns:duns:047120084\nstate:CA\nid:ror:05rrcem69\nurl:https://ror.org/05rrcem69",
       "uei": "uei:TX2DAGQPENZ5",
       "url": "https://ror.org/05rrcem69"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "71f606250c084f35802f0b66334e4135": {
     "model_module": "@jupyter-widgets/base",
     "model_module_version": "1.2.0",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": "900px",
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "72a0ed43e3fd4a33be7061ac6b5271b4": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 669,
       "target": 23
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "7357295139d34211b86f3ae417509f63": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2024,
       "name": "EMPLOYED_AT",
       "source": 629,
       "target": 569
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "739952c1cadc4227998d85aa1fedc6a5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1091,
       "target": 2817
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "74254dbd3d2a42008848c4d63ebe384a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 611,
       "target": 1
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "7508fb4ed6834fccb508dab6fdf7769e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The development of a rapid and reliable sensor system from readily available oral specimens is crucial for\nthe screening and management of SARS-CoV-2 infection. Other than tests that require laboratory-scale\ninstrumentation, the development of rapid tests can play a timely role in the management of an outbreak.\nCurrent rapid tests often involve the antibodies in a lateral flow format to detect viral protein components\nand, depending on the implementation, can result in a relatively high degree of error. In partnership with\nMIT, InnoTech proposes the development of a multiplexed sensor platform based on nanomaterials capable\nof molecular binding and subsequent reporting. We will develop and commercialize a multiplexed sensor\nplatform using nanomaterial reporters capable of rapid simultaneous detection of multiple components of\nviral particles in a field applicable electrochemical device. For our Phase I- Aim 1 we will focus on the\ndevelopment and optimization of synthetic biosensors for accurate detection of SARS-CoV-2 viral proteins\nand nucleic acid. Our milestone is the discovery and validation an array of molecular recognition biosensors\nagainst both protein and nucleic acid segments of SARS-CoV-2. We will complete this phase in 4 months.\nIn Phase II-Aim 1, we will develop and validate the electrochemical detectors. We will utilize the synthetic\nbiosensors identified and validated in Aim 1 to an electrochemical platform for the rapid detection of an\nactive SARS-CoV-2 infection using multiple biomarkers of the infection. We will specifically employ\ncommercially-available, disposable electrode platforms and existing potentiostats from Metrohm DropSens\nto streamline scale-up and commercialization. Our milestone, to be completed in year 1 of Phase II, is to\nhave a multiplex biosensor chip and an alpha prototype with a multiplex biosensor chip and a potentiostat\nreader which we will benchmark for sensitivity and quantitative accuracy against existing COVID-19\ndiagnostics. In Phase II-Aim 2, we will validate the prototype chips and detectors with retrospective clinical\nspecimens in preparation for EUA-FDA submission. We will determine the LOD, clinical performance,\nand cross-reactivity with other respiratory pathogens and normal flora. The milestone for this Aim is to\ndocument a multiplex of at least two proteins and two nucleic acid biosensors for SARS-CoV-2 that will\nprovide a LOD of 5-20 viruses per microliter in an oral specimen and will be clinically validated with\ngreater than 95% concordance with RT-PCR in 30 positive and 30 negative specimens.",
       "awardCode": "R42",
       "fundingMechanism": "SBIR/STTR",
       "id": 14,
       "label": "Grant",
       "name": "A multimodal platform for Oral screening of COVID-19",
       "narrative": "The development of rapid tests can play a timely role in the management of an outbreak. The\nCOVID-19 pandemic has been especially devastating due to the ability of asymptomatic carriers\nto transmit the virus. Thus, accurate and low-cost detection of the active infection on-site from\neasily collectible oral specimens is essential for the successful management of this disease.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:The development of a rapid and reliable sensor system from readily available oral specimens is crucial for\nthe screening and management of SARS-CoV-2 infection. Other than tests that require laboratory-scale\ninstrumentation, the development of rapid tests can play a timely role in the management of an outbreak.\nCurrent rapid tests often involve the antibodies in a lateral flow format to detect viral protein components\nand, depending on the implementation, can result in a relatively high degree of error. In partnership with\nMIT, InnoTech proposes the development of a multiplexed sensor platform based on nanomaterials capable\nof molecular binding and subsequent reporting. We will develop and commercialize a multiplexed sensor\nplatform using nanomaterial reporters capable of rapid simultaneous detection of multiple components of\nviral particles in a field applicable electrochemical device. For our Phase I- Aim 1 we will focus on the\ndevelopment and optimization of synthetic biosensors for accurate detection of SARS-CoV-2 viral proteins\nand nucleic acid. Our milestone is the discovery and validation an array of molecular recognition biosensors\nagainst both protein and nucleic acid segments of SARS-CoV-2. We will complete this phase in 4 months.\nIn Phase II-Aim 1, we will develop and validate the electrochemical detectors. We will utilize the synthetic\nbiosensors identified and validated in Aim 1 to an electrochemical platform for the rapid detection of an\nactive SARS-CoV-2 infection using multiple biomarkers of the infection. We will specifically employ\ncommercially-available, disposable electrode platforms and existing potentiostats from Metrohm DropSens\nto streamline scale-up and commercialization. Our milestone, to be completed in year 1 of Phase II, is to\nhave a multiplex biosensor chip and an alpha prototype with a multiplex biosensor chip and a potentiostat\nreader which we will benchmark for sensitivity and quantitative accuracy against existing COVID-19\ndiagnostics. In Phase II-Aim 2, we will validate the prototype chips and detectors with retrospective clinical\nspecimens in preparation for EUA-FDA submission. We will determine the LOD, clinical performance,\nand cross-reactivity with other respiratory pathogens and normal flora. The milestone for this Aim is to\ndocument a multiplex of at least two proteins and two nucleic acid biosensors for SARS-CoV-2 that will\nprovide a LOD of 5-20 viruses per microliter in an oral specimen and will be clinically validated with\ngreater than 95% concordance with RT-PCR in 30 positive and 30 negative specimens.\nid:R42DE030829\nnarrative:The development of rapid tests can play a timely role in the management of an outbreak. The\nCOVID-19 pandemic has been especially devastating due to the ability of asymptomatic carriers\nto transmit the virus. Thus, accurate and low-cost detection of the active infection on-site from\neasily collectible oral specimens is essential for the successful management of this disease.\nname:A multimodal platform for Oral screening of COVID-19\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:SBIR/STTR\nawardCode:R42"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "75ac9c100a9f419185cb3f5b72ea3c82": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Xiao-An",
       "fullName": "Xiao-An Fu",
       "id": 664,
       "label": "Researcher",
       "lastName": "Fu",
       "name": "Fu X",
       "profileId": "profileid:10807170",
       "tooltip": "Researcher\nid:profileid:10807170\nlastName:Fu\nprofileId:profileid:10807170\nname:Fu X\nfullName:Xiao-An Fu\nfirstName:Xiao-An"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "75cbf4cc8f574af597653a7a819f1fc9": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Denise",
       "fullName": "Denise A Dillard",
       "id": 627,
       "label": "Researcher",
       "lastName": "Dillard",
       "middleName": "A",
       "name": "Dillard DA",
       "orcid": "orcid:0000-0003-2969-7385",
       "profileId": "profileid:9436729",
       "tooltip": "Researcher\nmiddleName:A\nid:profileid:9436729\nlastName:Dillard\norcid:orcid:0000-0003-2969-7385\nprofileId:profileid:9436729\nname:Dillard DA\nfullName:Denise A Dillard\nfirstName:Denise"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "762f8fecfbcf463c8345def89cbda4a6": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Children have been disproportionately less impacted by the Corona Virus Disease 2019 (COVID-19) caused\nby the Severe Acute Respiratory Syndrome Corona Virus 2 (SAR-CoV-2) compared to adults. However,\nsevere illnesses including Multisystem Inflammatory Syndrome (MIS-C) and respiratory failure have occurred\nin a small proportion of children with SARS-CoV-2 infection. Nearly 80% of children with MIS-C are critically ill\nwith a 2-4% mortality rate. Currently there are no modalities to characterize the spectrum of disease severity\nand predict which child with SARS-CoV-2 exposure will likely develop severe illness including MIS-C. Thus\nthere is an urgent need to develop a diagnostic modality to distinguish the varying phenotypes of disease and\nrisk stratify disease. The epigenetic changes in microRNA (miRNA) profiles that occur due to an infection can\nimpact disease severity by altering immune response and cytokine regulation which may be detected in body\nfluids including saliva. Our long-term goal is to improve outcomes of children with SARS-CoV-2 by early\nidentification and treatment of those at risk for severe illness. Our central hypothesis is that a model that\nintegrates salivary biomarkers with social and clinical determinants of health will predict disease severity in\nchildren with SARS-CoV-2 infection. The central hypothesis will be pursued through phased four specific aims.\nThe first two aims will be pursued during the R61 phase and include: 1) Define and compare the salivary\nmolecular host response in children with varying phenotypes (severe and non severe) SARS-CoV-2 infections\nand 2) Develop and validate a sensitive and specific model to predict severe SARS-CoV-2 illness in children.\nDuring the R33 phase we will pursue the following two aims: 3) Develop a portable, rapid device that quantifies\nsalivary miRNAs with comparable accuracy to predicate technology (qRT-PCR), and 4) Develop an artificial\nintelligence (AI) assisted cloud and mobile system for early recognition of severe SARS-CoV-2 infection in\nchildren. We will pursue the above aims using an innovative combination of salivaomics and bioinformatics,\nanalytic techniques of AI and clinical informatics. The proposed research is significant because development of\na sensitive model to risk stratify disease is expected to improve outcomes of children with severe SARS-CoV-2\ninfection via early recognition and timely intervention. The proximate expected outcome of this proposal is\nbetter understanding of the epigenetic regulation of host immune response to the viral infection which we\nexpect to lead to personalized therapy in the future. The results will have a positive impact immediately as it\nwill lead to the creation of patient profiles based on individual risk factors which can enable early identification\nof severe disease and appropriate resource allocation during the pandemic.",
       "awardCode": "R61",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 41,
       "label": "Grant",
       "name": "Severity Predictors Integrating salivary Transcriptomics and proteomics with Multi neural network Intelligence in SARS-CoV2 infection in Children (SPITS MISC)",
       "narrative": "This project is relevant to public health as development of a predictive model that integrates salivary\nbiomarkers with clinical and social determinants into a bedside tool will enable early identification of\nsevere COVID-19 in children, ensure appropriate resource allocation and aid in targeted treatment.",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nabstract:Children have been disproportionately less impacted by the Corona Virus Disease 2019 (COVID-19) caused\nby the Severe Acute Respiratory Syndrome Corona Virus 2 (SAR-CoV-2) compared to adults. However,\nsevere illnesses including Multisystem Inflammatory Syndrome (MIS-C) and respiratory failure have occurred\nin a small proportion of children with SARS-CoV-2 infection. Nearly 80% of children with MIS-C are critically ill\nwith a 2-4% mortality rate. Currently there are no modalities to characterize the spectrum of disease severity\nand predict which child with SARS-CoV-2 exposure will likely develop severe illness including MIS-C. Thus\nthere is an urgent need to develop a diagnostic modality to distinguish the varying phenotypes of disease and\nrisk stratify disease. The epigenetic changes in microRNA (miRNA) profiles that occur due to an infection can\nimpact disease severity by altering immune response and cytokine regulation which may be detected in body\nfluids including saliva. Our long-term goal is to improve outcomes of children with SARS-CoV-2 by early\nidentification and treatment of those at risk for severe illness. Our central hypothesis is that a model that\nintegrates salivary biomarkers with social and clinical determinants of health will predict disease severity in\nchildren with SARS-CoV-2 infection. The central hypothesis will be pursued through phased four specific aims.\nThe first two aims will be pursued during the R61 phase and include: 1) Define and compare the salivary\nmolecular host response in children with varying phenotypes (severe and non severe) SARS-CoV-2 infections\nand 2) Develop and validate a sensitive and specific model to predict severe SARS-CoV-2 illness in children.\nDuring the R33 phase we will pursue the following two aims: 3) Develop a portable, rapid device that quantifies\nsalivary miRNAs with comparable accuracy to predicate technology (qRT-PCR), and 4) Develop an artificial\nintelligence (AI) assisted cloud and mobile system for early recognition of severe SARS-CoV-2 infection in\nchildren. We will pursue the above aims using an innovative combination of salivaomics and bioinformatics,\nanalytic techniques of AI and clinical informatics. The proposed research is significant because development of\na sensitive model to risk stratify disease is expected to improve outcomes of children with severe SARS-CoV-2\ninfection via early recognition and timely intervention. The proximate expected outcome of this proposal is\nbetter understanding of the epigenetic regulation of host immune response to the viral infection which we\nexpect to lead to personalized therapy in the future. The results will have a positive impact immediately as it\nwill lead to the creation of patient profiles based on individual risk factors which can enable early identification\nof severe disease and appropriate resource allocation during the pandemic.\nid:R61HD105610\nnarrative:This project is relevant to public health as development of a predictive model that integrates salivary\nbiomarkers with clinical and social determinants into a bedside tool will enable early identification of\nsevere COVID-19 in children, ensure appropriate resource allocation and aid in targeted treatment.\nname:Severity Predictors Integrating salivary Transcriptomics and proteomics with Multi neural network Intelligence in SARS-CoV2 infection in Children (SPITS MISC)\nsubProject:PreVAIL kIds\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R61"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "763cf66684c94965824f1455a4a564e9": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The goals of this Emergency Competitive Revision are to develop (Aim 1) and deploy (Aim 2) a\nnovel, objective, psychophysical smell and taste screening test to detect the onset of COVID 19\nin at-risk populations. Complementary to the temperature screening procedures currently in use,\nthis tool is predicted to promote early identification of COVID onset leading to better prognoses\nand the early implementation of protocols to prevent community spread. Our specific plan is to\nuse a hard-candy containing different combinations of tastants and flavors that are easy to\ndistribute to a large population. During the development phase (Aim 1), this novel test will be\ncompared with the NIH toolbox to assess the acceptability and efficacy of the two methods. We\nexpect that the hard-candy assessment will be at least as efficacious in detecting chemosensory\nloss but more acceptable to subjects. Aim 2 will entail daily self-monitoring of chemosensory\nfunction in at-risk populations with data tracked through a secure online portal. The novelty of\nthis confectionary-based test is that it provides standard stimuli that can yield objective\nmeasures of both the qualitative and quantitative aspects of smell (aroma and flavor) and taste\n(sweet and sour). Moreover, both orthonasal and retronasal olfactory function will be\nindependently assessed. The test can be self-administered and the familiar, pleasant nature of\nthe stimuli should facilitate a high compliance rate, allowing for continuous monitoring over\nprolonged periods. Moreover, the test is rapid and inexpensive. Data will be incorporated into a\npredictive model for COVID 19 and assessed using AOC analyses of sensitivity and specificity.\nOSU is a leading large public land grant university with a varied population of students, faculty,\nand support staff that includes all health care specialties. These characteristics, along with the\nUniversity-mandated regular PCR testing of students and staff makes it a perfect site to perform\nthis urgent research.",
       "awardCode": "R01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 5,
       "label": "Grant",
       "name": "A confectionary-based screening tool for assessing chemosensory loss in COVID 19 patients.",
       "narrative": "This research will develop a novel screening tool for COVID 19 using chemosensory testing. Loss of smell\nand/or taste is a predictive symptom of COVID 19 but current tests are not optimal for routine\nassessment in large populations of individuals. The development of a confectionary-based test will allow\nroutine self-monitoring of chemosensory function using objective, sensitive, simple and inexpensive\nprocedures to identify potential cases of COVID 19.",
       "researchInitiative": "RADx-rad",
       "subProject": "Chemosensory Testing",
       "tooltip": "Grant\nabstract:The goals of this Emergency Competitive Revision are to develop (Aim 1) and deploy (Aim 2) a\nnovel, objective, psychophysical smell and taste screening test to detect the onset of COVID 19\nin at-risk populations. Complementary to the temperature screening procedures currently in use,\nthis tool is predicted to promote early identification of COVID onset leading to better prognoses\nand the early implementation of protocols to prevent community spread. Our specific plan is to\nuse a hard-candy containing different combinations of tastants and flavors that are easy to\ndistribute to a large population. During the development phase (Aim 1), this novel test will be\ncompared with the NIH toolbox to assess the acceptability and efficacy of the two methods. We\nexpect that the hard-candy assessment will be at least as efficacious in detecting chemosensory\nloss but more acceptable to subjects. Aim 2 will entail daily self-monitoring of chemosensory\nfunction in at-risk populations with data tracked through a secure online portal. The novelty of\nthis confectionary-based test is that it provides standard stimuli that can yield objective\nmeasures of both the qualitative and quantitative aspects of smell (aroma and flavor) and taste\n(sweet and sour). Moreover, both orthonasal and retronasal olfactory function will be\nindependently assessed. The test can be self-administered and the familiar, pleasant nature of\nthe stimuli should facilitate a high compliance rate, allowing for continuous monitoring over\nprolonged periods. Moreover, the test is rapid and inexpensive. Data will be incorporated into a\npredictive model for COVID 19 and assessed using AOC analyses of sensitivity and specificity.\nOSU is a leading large public land grant university with a varied population of students, faculty,\nand support staff that includes all health care specialties. These characteristics, along with the\nUniversity-mandated regular PCR testing of students and staff makes it a perfect site to perform\nthis urgent research.\nid:R01DC016112\nnarrative:This research will develop a novel screening tool for COVID 19 using chemosensory testing. Loss of smell\nand/or taste is a predictive symptom of COVID 19 but current tests are not optimal for routine\nassessment in large populations of individuals. The development of a confectionary-based test will allow\nroutine self-monitoring of chemosensory function using objective, sensitive, simple and inexpensive\nprocedures to identify potential cases of COVID 19.\nname:A confectionary-based screening tool for assessing chemosensory loss in COVID 19 patients.\nsubProject:Chemosensory Testing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "763d340c255a408a8094c00166b3ffa7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Brookelyn",
       "fullName": "Brookelyn M Doherty",
       "id": 1740,
       "label": "Researcher",
       "lastName": "Doherty",
       "middleName": "M",
       "name": "Doherty BM",
       "tooltip": "Researcher\nmiddleName:M\nid:s2authorid:1938270813\nlastName:Doherty\nname:Doherty BM\nfullName:Brookelyn M Doherty\nfirstName:Brookelyn"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "76af6419ff894a1cae908de40eae3ed2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 639,
       "target": 602
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "76bd0ba97dc44f3f95d9f08ff2828972": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2015,
       "name": "EMPLOYED_AT",
       "source": 687,
       "target": 606
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "77119576e1aa4a82a8eebc1d82ebad65": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 624,
       "target": 26
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "774ae19b061f486c94e89b44ecfd38b3": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Direct bioelectronic detection of SARS-CoV-2 from saliva\n using single-molecule field-effect transistor array\n Nucleic acid tests have become the gold-standard for diagnostic testing for COVID-19, usually performed\nin specialized laboratories. Most are based on reverse-transcription quantitative polymerase chain reaction\n(qRT-PCR). The time required for specimen transport and processing results in a turnaround time that is typi-\ncally several days. The few rapid (<1 hour) point-of-care (POC) tests are more expensive, still require sample\npreparation and specialized reagents, and do not have the throughput needed for population surveillance. Di-\nrect testing for the virus, which also reduces requirements for multiple reagents, is a necessary step to improv-\ning diagnostic testing. While four such antigen tests have been approved for detection of SARS-CoV-2 based\non immunoassays to the N protein, sensitivity is limited and no quantitation of viral load is possible.\n We will address this gap by using DiagnostikosTM, an in-development rapid POC platform for direct, real-\ntime, multiplexed, quantitative bioelectronic detection of biomolecules that employs an all-electronic detection\ndevice that functions at the single-molecule level. These single-molecule field-effect transistors (smFETs) are\narrayed on a complementary metal-oxide-semiconductor (CMOS) integrated circuit chip. Chips will interface\nwith an envisioned USB-stick-form-factor reader device. Robust single-domain antibodies, known as nanobod-\nies and immobilized on these devices, are used for sensitive detection of viral particles and viral debris. The\nuse of multiple nanobodies for a single protein and nanobodies for different proteins in a single assay allows\nfor significant improvements in specificity. Nanobodies will be specific for one or more of the four major struc-\ntural proteins in SARS-CoV-2; the nucleocapsid (N) protein engulfing the viral RNA, the spike (S) protein, the\nmembrane (M) protein and the envelope (E) protein. No sample preparation or specialized reagents are re-\nquired for detection, and the device will be designed to operate with saliva, which has very recently been\nshown to be a reliable medium for detecting SARS-CoV-2. Individual sensor chips can be manufactured at a\ncost of $35. With the addition of other nanobodies, these large dense arrays can also allow detection of many\npathogens in a single test.\n In this Direct-To-Phase-2 SBIR program we will pursue several key innovations that are required to make\nsuch a platform possible, including isolation of nanobodies for key structure proteins of SARS-CoV-2 (Specific\nAim 1), development of the smFET platform for antigen detection (Specific Aim 2), development of large\nCMOS arrays of these smFET devices (Specific Aim 3), and verification of detection in increasingly complex\nsamples up to and including clinical samples (Specific Aim 4). This project is a partnership between university\nresearchers who developed the smFET technology and a venture-based start-up venture, Quicksilver Biosci-\nences, spun out to commercialize smFET technology and develop smFET/CMOS arrays for molecular diag-\nnostic applications.",
       "awardCode": "R44",
       "fundingMechanism": "SBIR/STTR",
       "id": 26,
       "label": "Grant",
       "name": "Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array",
       "narrative": "The proposal seeks to provide a new bioelectronic approach for antigen testing for infectious diseases. Low-\ncost and pervasive antigen testing would be an essential new tool for the control of the COVID-19 pandemic.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:Direct bioelectronic detection of SARS-CoV-2 from saliva\n using single-molecule field-effect transistor array\n Nucleic acid tests have become the gold-standard for diagnostic testing for COVID-19, usually performed\nin specialized laboratories. Most are based on reverse-transcription quantitative polymerase chain reaction\n(qRT-PCR). The time required for specimen transport and processing results in a turnaround time that is typi-\ncally several days. The few rapid (<1 hour) point-of-care (POC) tests are more expensive, still require sample\npreparation and specialized reagents, and do not have the throughput needed for population surveillance. Di-\nrect testing for the virus, which also reduces requirements for multiple reagents, is a necessary step to improv-\ning diagnostic testing. While four such antigen tests have been approved for detection of SARS-CoV-2 based\non immunoassays to the N protein, sensitivity is limited and no quantitation of viral load is possible.\n We will address this gap by using DiagnostikosTM, an in-development rapid POC platform for direct, real-\ntime, multiplexed, quantitative bioelectronic detection of biomolecules that employs an all-electronic detection\ndevice that functions at the single-molecule level. These single-molecule field-effect transistors (smFETs) are\narrayed on a complementary metal-oxide-semiconductor (CMOS) integrated circuit chip. Chips will interface\nwith an envisioned USB-stick-form-factor reader device. Robust single-domain antibodies, known as nanobod-\nies and immobilized on these devices, are used for sensitive detection of viral particles and viral debris. The\nuse of multiple nanobodies for a single protein and nanobodies for different proteins in a single assay allows\nfor significant improvements in specificity. Nanobodies will be specific for one or more of the four major struc-\ntural proteins in SARS-CoV-2; the nucleocapsid (N) protein engulfing the viral RNA, the spike (S) protein, the\nmembrane (M) protein and the envelope (E) protein. No sample preparation or specialized reagents are re-\nquired for detection, and the device will be designed to operate with saliva, which has very recently been\nshown to be a reliable medium for detecting SARS-CoV-2. Individual sensor chips can be manufactured at a\ncost of $35. With the addition of other nanobodies, these large dense arrays can also allow detection of many\npathogens in a single test.\n In this Direct-To-Phase-2 SBIR program we will pursue several key innovations that are required to make\nsuch a platform possible, including isolation of nanobodies for key structure proteins of SARS-CoV-2 (Specific\nAim 1), development of the smFET platform for antigen detection (Specific Aim 2), development of large\nCMOS arrays of these smFET devices (Specific Aim 3), and verification of detection in increasingly complex\nsamples up to and including clinical samples (Specific Aim 4). This project is a partnership between university\nresearchers who developed the smFET technology and a venture-based start-up venture, Quicksilver Biosci-\nences, spun out to commercialize smFET technology and develop smFET/CMOS arrays for molecular diag-\nnostic applications.\nid:R44DE030841\nnarrative:The proposal seeks to provide a new bioelectronic approach for antigen testing for infectious diseases. Low-\ncost and pervasive antigen testing would be an essential new tool for the control of the COVID-19 pandemic.\nname:Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:SBIR/STTR\nawardCode:R44"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "788bd1b871e74ff1873a4ea2632124c3": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2024,
       "name": "EMPLOYED_AT",
       "source": 667,
       "target": 557
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "78c5ffa0ce81463b8f43df35f273b08c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4399,
       "target": 5
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "78fe7dd68c844358aa22b5d95ea73254": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Michael",
       "fullName": "Michael P Snyder",
       "id": 675,
       "label": "Researcher",
       "lastName": "Snyder",
       "middleName": "P",
       "name": "Snyder MP",
       "orcid": "orcid:0000-0003-0784-7987",
       "profileId": "profileid:1862128",
       "tooltip": "Researcher\nmiddleName:P\nid:profileid:1862128\nlastName:Snyder\norcid:orcid:0000-0003-0784-7987\nprofileId:profileid:1862128\nname:Snyder MP\nfullName:Michael P Snyder\nfirstName:Michael"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "7a9b641771ba43e88258d4cb6083736e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 673,
       "target": 567
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "7aad80129d2945fc858848e17ba95ee5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Craig",
       "fullName": "Craig G Rusin",
       "id": 705,
       "label": "Researcher",
       "lastName": "Rusin",
       "middleName": "G",
       "name": "Rusin CG",
       "orcid": "orcid:0000-0003-3812-8133",
       "profileId": "profileid:10046004",
       "tooltip": "Researcher\nmiddleName:G\nid:profileid:10046004\nlastName:Rusin\norcid:orcid:0000-0003-3812-8133\nprofileId:profileid:10046004\nname:Rusin CG\nfullName:Craig G Rusin\nfirstName:Craig"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "7ab8514dc43e4de2ba28d9c06033a5e2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1428,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "7b5311b47f0744728e55f94df8c92224": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4360,
       "label": "Presentation",
       "name": "Detecting aerosolized SARS-CoV-2 in breath",
       "presenters": "John Cirrito",
       "tooltip": "Presentation\nid:526cb764deeea462872ecb79eeaafc58\npresenters:John Cirrito\nname:Detecting aerosolized SARS-CoV-2 in breath"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "7cda1742ece14264a5d6ffd89a064e14": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Jane",
       "fullName": "Jane C Burns",
       "id": 669,
       "label": "Researcher",
       "lastName": "Burns",
       "middleName": "C",
       "name": "Burns JC",
       "orcid": "orcid:0000-0001-5679-1217",
       "profileId": "profileid:7989301",
       "tooltip": "Researcher\nmiddleName:C\nid:profileid:7989301\nlastName:Burns\norcid:orcid:0000-0001-5679-1217\nprofileId:profileid:7989301\nname:Burns JC\nfullName:Jane C Burns\nfirstName:Jane"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "7f29a1cc3a9e4d9fa64a3d8890af5070": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2024,
       "name": "EMPLOYED_AT",
       "source": 690,
       "target": 555
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "7f45e0fb9a6748ee80be61f1b4e56360": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 2752,
       "label": "MetaNode",
       "name": "Title of the presentation (string)",
       "nodeName": "Presentation",
       "presentationUrl": "URL of the presentation link (string)",
       "presenters": "List of presenters separated by the vertical bar \"|\" (string)",
       "tooltip": "MetaNode\nnodeName:Presentation\nvideoUrl:URL of the presentation recording (string)\npresenters:List of presenters separated by the vertical bar \"|\" (string)\nname:Title of the presentation (string)\npresentationUrl:URL of the presentation link (string)\nid:Unique identifier of the presentation (hash of event id and name) (string)",
       "videoUrl": "URL of the presentation recording (string)"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "800b5a40dbd04bc996664b5999797b95": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 662,
       "target": 581
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "813df8c9618544959d83cc5a8b3ee45f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "With older age and multiple comorbidities, dialysis patients are at high risk for serious complications, even death,\nfrom COVID-19. There is a large disproportionate representation of minorities, especially Blacks and Hispanics.\nOver 85% of hemodialysis patients travel three times a week to dialysis facilities to receive life-sustaining\ntreatments and cannot shelter in place. There is a critical need to characterize COVID-19 transmission pathways\nin dialysis patients and clinics, identify potential coronavirus carriers, and develop procedures to curb the spread.\nWith regular medical encounters, a large amount of data has been collected for each patient over time. These\ndata have not been fully utilized for COVID-19 prediction and control in dialysis clinics. In this proposal, we seek\nto leverage demographic, clinical, treatment, laboratory, socioeconomic, serological, metabolomic, wearable and\nmachine-integrated sensors, and COVID-19 surveillance data to develop mathematical and statistical models\nand implement them in a large number of dialysis clinics. The mathematical and statistical modeling using\nmultiple data resources will help us understand how COVID-19 spread in dialysis facilities, identify potential\nCOVID-19 patients before symptoms appear, and identify potential asymptomatic COVID-19 patients. We will\ndevelop novel mathematical and statistical models that fully utilize the high dimensional multimodal data\navailable to us and other dialysis providers. We capitalize on the intrinsic advantages of hemodialysis clinics to\nimplement and validate the proposed prediction models. We firmly believe that this cross-disciplinary effort will\nimprove patients’ and staff’s safety while delivering high-quality, individualized care to a high-risk population.",
       "awardCode": "R01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 28,
       "label": "Grant",
       "name": "Early detection, containment, and management of COVID-19 in dialysis facilities using multi-modal data sources",
       "narrative": "Dialysis patients are at high risk for serious complications, even death, from COVID-19. We aim to leverage\nmultimodal data to develop mathematical and statistical models and implement them in a large number of\ndialysis clinics. Our cross-disciplinary effort will improve patients' and staff's safety while delivering high-quality,\nindividualized care to a high-risk population.",
       "researchInitiative": "RADx-rad",
       "subProject": "Multimodal Surveillance",
       "tooltip": "Grant\nabstract:With older age and multiple comorbidities, dialysis patients are at high risk for serious complications, even death,\nfrom COVID-19. There is a large disproportionate representation of minorities, especially Blacks and Hispanics.\nOver 85% of hemodialysis patients travel three times a week to dialysis facilities to receive life-sustaining\ntreatments and cannot shelter in place. There is a critical need to characterize COVID-19 transmission pathways\nin dialysis patients and clinics, identify potential coronavirus carriers, and develop procedures to curb the spread.\nWith regular medical encounters, a large amount of data has been collected for each patient over time. These\ndata have not been fully utilized for COVID-19 prediction and control in dialysis clinics. In this proposal, we seek\nto leverage demographic, clinical, treatment, laboratory, socioeconomic, serological, metabolomic, wearable and\nmachine-integrated sensors, and COVID-19 surveillance data to develop mathematical and statistical models\nand implement them in a large number of dialysis clinics. The mathematical and statistical modeling using\nmultiple data resources will help us understand how COVID-19 spread in dialysis facilities, identify potential\nCOVID-19 patients before symptoms appear, and identify potential asymptomatic COVID-19 patients. We will\ndevelop novel mathematical and statistical models that fully utilize the high dimensional multimodal data\navailable to us and other dialysis providers. We capitalize on the intrinsic advantages of hemodialysis clinics to\nimplement and validate the proposed prediction models. We firmly believe that this cross-disciplinary effort will\nimprove patients’ and staff’s safety while delivering high-quality, individualized care to a high-risk population.\nid:R01DK130067\nnarrative:Dialysis patients are at high risk for serious complications, even death, from COVID-19. We aim to leverage\nmultimodal data to develop mathematical and statistical models and implement them in a large number of\ndialysis clinics. Our cross-disciplinary effort will improve patients' and staff's safety while delivering high-quality,\nindividualized care to a high-risk population.\nname:Early detection, containment, and management of COVID-19 in dialysis facilities using multi-modal data sources\nsubProject:Multimodal Surveillance\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "817af41834d548c09750b337c7ca8ce2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4389,
       "label": "FundingOpportunity",
       "name": "The NIH Centers for Accelerated Innovations (U54)",
       "tooltip": "FundingOpportunity\nname:The NIH Centers for Accelerated Innovations (U54)\nid:RFA-HL-13-008\nurl:https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-008.html",
       "url": "https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-13-008.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "820d58a8882c41768aa6b0f13f091e37": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Direct bioelectronic detection of SARS-CoV-2 from saliva\n using single-molecule field-effect transistor array\n Nucleic acid tests have become the gold-standard for diagnostic testing for COVID-19, usually performed\nin specialized laboratories. Most are based on reverse-transcription quantitative polymerase chain reaction\n(qRT-PCR). The time required for specimen transport and processing results in a turnaround time that is typi-\ncally several days. The few rapid (<1 hour) point-of-care (POC) tests are more expensive, still require sample\npreparation and specialized reagents, and do not have the throughput needed for population surveillance. Di-\nrect testing for the virus, which also reduces requirements for multiple reagents, is a necessary step to improv-\ning diagnostic testing. While four such antigen tests have been approved for detection of SARS-CoV-2 based\non immunoassays to the N protein, sensitivity is limited and no quantitation of viral load is possible.\n We will address this gap by using DiagnostikosTM, an in-development rapid POC platform for direct, real-\ntime, multiplexed, quantitative bioelectronic detection of biomolecules that employs an all-electronic detection\ndevice that functions at the single-molecule level. These single-molecule field-effect transistors (smFETs) are\narrayed on a complementary metal-oxide-semiconductor (CMOS) integrated circuit chip. Chips will interface\nwith an envisioned USB-stick-form-factor reader device. Robust single-domain antibodies, known as nanobod-\nies and immobilized on these devices, are used for sensitive detection of viral particles and viral debris. The\nuse of multiple nanobodies for a single protein and nanobodies for different proteins in a single assay allows\nfor significant improvements in specificity. Nanobodies will be specific for one or more of the four major struc-\ntural proteins in SARS-CoV-2; the nucleocapsid (N) protein engulfing the viral RNA, the spike (S) protein, the\nmembrane (M) protein and the envelope (E) protein. No sample preparation or specialized reagents are re-\nquired for detection, and the device will be designed to operate with saliva, which has very recently been\nshown to be a reliable medium for detecting SARS-CoV-2. Individual sensor chips can be manufactured at a\ncost of $35. With the addition of other nanobodies, these large dense arrays can also allow detection of many\npathogens in a single test.\n In this Direct-To-Phase-2 SBIR program we will pursue several key innovations that are required to make\nsuch a platform possible, including isolation of nanobodies for key structure proteins of SARS-CoV-2 (Specific\nAim 1), development of the smFET platform for antigen detection (Specific Aim 2), development of large\nCMOS arrays of these smFET devices (Specific Aim 3), and verification of detection in increasingly complex\nsamples up to and including clinical samples (Specific Aim 4). This project is a partnership between university\nresearchers who developed the smFET technology and a venture-based start-up venture, Quicksilver Biosci-\nences, spun out to commercialize smFET technology and develop smFET/CMOS arrays for molecular diag-\nnostic applications.",
       "awardCode": "R44",
       "fundingMechanism": "SBIR/STTR",
       "id": 26,
       "label": "Grant",
       "name": "Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array",
       "narrative": "The proposal seeks to provide a new bioelectronic approach for antigen testing for infectious diseases. Low-\ncost and pervasive antigen testing would be an essential new tool for the control of the COVID-19 pandemic.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:Direct bioelectronic detection of SARS-CoV-2 from saliva\n using single-molecule field-effect transistor array\n Nucleic acid tests have become the gold-standard for diagnostic testing for COVID-19, usually performed\nin specialized laboratories. Most are based on reverse-transcription quantitative polymerase chain reaction\n(qRT-PCR). The time required for specimen transport and processing results in a turnaround time that is typi-\ncally several days. The few rapid (<1 hour) point-of-care (POC) tests are more expensive, still require sample\npreparation and specialized reagents, and do not have the throughput needed for population surveillance. Di-\nrect testing for the virus, which also reduces requirements for multiple reagents, is a necessary step to improv-\ning diagnostic testing. While four such antigen tests have been approved for detection of SARS-CoV-2 based\non immunoassays to the N protein, sensitivity is limited and no quantitation of viral load is possible.\n We will address this gap by using DiagnostikosTM, an in-development rapid POC platform for direct, real-\ntime, multiplexed, quantitative bioelectronic detection of biomolecules that employs an all-electronic detection\ndevice that functions at the single-molecule level. These single-molecule field-effect transistors (smFETs) are\narrayed on a complementary metal-oxide-semiconductor (CMOS) integrated circuit chip. Chips will interface\nwith an envisioned USB-stick-form-factor reader device. Robust single-domain antibodies, known as nanobod-\nies and immobilized on these devices, are used for sensitive detection of viral particles and viral debris. The\nuse of multiple nanobodies for a single protein and nanobodies for different proteins in a single assay allows\nfor significant improvements in specificity. Nanobodies will be specific for one or more of the four major struc-\ntural proteins in SARS-CoV-2; the nucleocapsid (N) protein engulfing the viral RNA, the spike (S) protein, the\nmembrane (M) protein and the envelope (E) protein. No sample preparation or specialized reagents are re-\nquired for detection, and the device will be designed to operate with saliva, which has very recently been\nshown to be a reliable medium for detecting SARS-CoV-2. Individual sensor chips can be manufactured at a\ncost of $35. With the addition of other nanobodies, these large dense arrays can also allow detection of many\npathogens in a single test.\n In this Direct-To-Phase-2 SBIR program we will pursue several key innovations that are required to make\nsuch a platform possible, including isolation of nanobodies for key structure proteins of SARS-CoV-2 (Specific\nAim 1), development of the smFET platform for antigen detection (Specific Aim 2), development of large\nCMOS arrays of these smFET devices (Specific Aim 3), and verification of detection in increasingly complex\nsamples up to and including clinical samples (Specific Aim 4). This project is a partnership between university\nresearchers who developed the smFET technology and a venture-based start-up venture, Quicksilver Biosci-\nences, spun out to commercialize smFET technology and develop smFET/CMOS arrays for molecular diag-\nnostic applications.\nid:R44DE030841\nnarrative:The proposal seeks to provide a new bioelectronic approach for antigen testing for infectious diseases. Low-\ncost and pervasive antigen testing would be an essential new tool for the control of the COVID-19 pandemic.\nname:Direct bioelectronic detection of SARS-CoV-2 from saliva using single-molecule field-effect transistor array\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:SBIR/STTR\nawardCode:R44"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8222b7bbdd094199ada49f63281c2ae6": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a serious threat to human health and lacks an effective treatment. There is an urgent need for both real-time tracking and precise treatment of the SARS-CoV-2-infected cells to mitigate and ultimately prevent viral transmission. However, selective triggering and tracking of the therapeutic process in the infected cells remains challenging. Here, we report a main protease (Mpro)-responsive, mitochondrial-targeting, and modular-peptide-conjugated probe (PSGMR) for selective imaging and inhibition of SARS-CoV-2-infected cells via enzyme-instructed self-assembly and aggregation-induced emission (AIE) effect. The amphiphilic PSGMR was constructed with tunable structure and responsive efficiency and validated with recombinant proteins, cells transfected with Mpro plasmid or infected by SARS-CoV-2, and a Mpro inhibitor. By rational construction of AIE luminogen (AIEgen) with modular peptides and Mpro, we verified that the cleavage of PSGMR yielded gradual aggregation with bright fluorescence and enhanced cytotoxicity to induce mitochondrial interference of the infected cells. This strategy may have value for selective detection and treatment of SARS-CoV-2-infected cells.",
       "doi": "doi:10.1021/acsnano.2c03219",
       "id": 2817,
       "journal": "ACS nano",
       "label": "Publication",
       "name": "Protease-Responsive Peptide-Conjugated Mitochondrial-Targeting AIEgens for Selective Imaging and Inhibition of SARS-CoV-2-Infected Cells.",
       "pmId": "35878004",
       "pmcId": "PMC9344892",
       "tooltip": "Publication\njournal:ACS nano\nabstract:Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a serious threat to human health and lacks an effective treatment. There is an urgent need for both real-time tracking and precise treatment of the SARS-CoV-2-infected cells to mitigate and ultimately prevent viral transmission. However, selective triggering and tracking of the therapeutic process in the infected cells remains challenging. Here, we report a main protease (Mpro)-responsive, mitochondrial-targeting, and modular-peptide-conjugated probe (PSGMR) for selective imaging and inhibition of SARS-CoV-2-infected cells via enzyme-instructed self-assembly and aggregation-induced emission (AIE) effect. The amphiphilic PSGMR was constructed with tunable structure and responsive efficiency and validated with recombinant proteins, cells transfected with Mpro plasmid or infected by SARS-CoV-2, and a Mpro inhibitor. By rational construction of AIE luminogen (AIEgen) with modular peptides and Mpro, we verified that the cleavage of PSGMR yielded gradual aggregation with bright fluorescence and enhanced cytotoxicity to induce mitochondrial interference of the infected cells. This strategy may have value for selective detection and treatment of SARS-CoV-2-infected cells.\nid:doi:10.1021/acsnano.2c03219\nname:Protease-Responsive Peptide-Conjugated Mitochondrial-Targeting AIEgens for Selective Imaging and Inhibition of SARS-CoV-2-Infected Cells.\npmId:35878004\nyear:2022\ntype:primary\npmcId:PMC9344892\nurl:https://doi.org/doi:10.1021/acsnano.2c03219\ndoi:doi:10.1021/acsnano.2c03219",
       "type": "primary",
       "url": "https://doi.org/doi:10.1021/acsnano.2c03219",
       "year": 2022
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "82757e9d877d47148702e1387212c806": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 697,
       "target": 41
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "82950e2f33594911ae76ea77d55ca1c8": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "HOUSTON",
       "country": "UNITED STATES",
       "duns": "duns:051113330",
       "geonames": "geonames:4699066",
       "id": 598,
       "label": "Organization",
       "name": "Baylor College of Medicine",
       "ror": "ror:02pttbw34",
       "state": "TX",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4699066\nror:ror:02pttbw34\ncity:HOUSTON\nname:Baylor College of Medicine\nuei:uei:FXKMA43NTV21\nduns:duns:051113330\nstate:TX\nid:ror:02pttbw34\nurl:https://ror.org/02pttbw34",
       "uei": "uei:FXKMA43NTV21",
       "url": "https://ror.org/02pttbw34"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "82df09a66bfa4b8ab3ac1933d99e1b26": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 684,
       "target": 43
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "82df30c73c1f4803b4fc0ffcbab9028f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The SARS-CoV-2 coronavirus, the cause of the COVID-19 global pandemic, is efficiently spread\nand has reached over 27 million confirmed cases as of September 8, 2020. There is therefore an\nurgent need for new technologies that can provide early detection of virus, reducing the\ntransmission and infection rate. The goal of this proposal is to develop an integrated biosensor-\ntouchscreen that sensitivity reports surface contact with SARS-CoV-2. In our preliminary work,\nwe have identified several aptamers that bind specifically to the envelope-anchored trimeric spike\n(S) protein of SARS-CoV-2, but not of SARS-CoV or MERS. In comparison to antibodies,\naptamers are synthetic molecules that more thermally stable and lower cost while providing\nsimilar specificity and affinity of target binding. In this application, we propose to integrate\naptamer-based biosensing of SARS-CoV-2 into a touchscreen device. Our main objectives are to\n1) engineer conformation switching aptamers for electrochemical sensing of SARS-CoV-2\nbinding, 2) develop nanogap capacitive sensors as a uniquely complementary approach to\ncapacitive touchscreen technology and 3) build and test an integrated biosensor and touchscreen\narray that can detect SARS-CoV-2 from patient samples. Successful completion of these aims\nwill result in a novel automatic sensing platform for SARS-CoV-2. This technology could transform\npersonal device touchscreens as well as to multi-user touchscreen devices in hospitals, airports,\nlibraries, restaurants, for early detection, curbing transmission rates from secondary exposure.\nImportantly, the developed technology could be adapted for other electronic sensing platforms,\nand easily applied for future pathogen detection.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 42,
       "label": "Grant",
       "name": "Touchscreen-compatible, real-time electrochemical sensing of SARS-CoV-2",
       "narrative": "There is an urgent need for new and rapidly translatable technologies that can reduce SARS-CoV-2\ntransmission. The main goal of this proposal is to develop an integrated biosensor-touchscreen that sensitively\nreports surface contact with SARS-CoV-2. Successful completion of these aims will result in a novel automatic\nsensing platform for SARS-CoV-2 that could also applied to multi-user touchscreen devices such as those found\nin hospitals, airports, and restaurants, as well as single-user touchscreen such as mobile phones.",
       "researchInitiative": "RADx-rad",
       "subProject": "Automatic Detection & Tracing",
       "tooltip": "Grant\nabstract:The SARS-CoV-2 coronavirus, the cause of the COVID-19 global pandemic, is efficiently spread\nand has reached over 27 million confirmed cases as of September 8, 2020. There is therefore an\nurgent need for new technologies that can provide early detection of virus, reducing the\ntransmission and infection rate. The goal of this proposal is to develop an integrated biosensor-\ntouchscreen that sensitivity reports surface contact with SARS-CoV-2. In our preliminary work,\nwe have identified several aptamers that bind specifically to the envelope-anchored trimeric spike\n(S) protein of SARS-CoV-2, but not of SARS-CoV or MERS. In comparison to antibodies,\naptamers are synthetic molecules that more thermally stable and lower cost while providing\nsimilar specificity and affinity of target binding. In this application, we propose to integrate\naptamer-based biosensing of SARS-CoV-2 into a touchscreen device. Our main objectives are to\n1) engineer conformation switching aptamers for electrochemical sensing of SARS-CoV-2\nbinding, 2) develop nanogap capacitive sensors as a uniquely complementary approach to\ncapacitive touchscreen technology and 3) build and test an integrated biosensor and touchscreen\narray that can detect SARS-CoV-2 from patient samples. Successful completion of these aims\nwill result in a novel automatic sensing platform for SARS-CoV-2. This technology could transform\npersonal device touchscreens as well as to multi-user touchscreen devices in hospitals, airports,\nlibraries, restaurants, for early detection, curbing transmission rates from secondary exposure.\nImportantly, the developed technology could be adapted for other electronic sensing platforms,\nand easily applied for future pathogen detection.\nid:U01AA029316\nnarrative:There is an urgent need for new and rapidly translatable technologies that can reduce SARS-CoV-2\ntransmission. The main goal of this proposal is to develop an integrated biosensor-touchscreen that sensitively\nreports surface contact with SARS-CoV-2. Successful completion of these aims will result in a novel automatic\nsensing platform for SARS-CoV-2 that could also applied to multi-user touchscreen devices such as those found\nin hospitals, airports, and restaurants, as well as single-user touchscreen such as mobile phones.\nname:Touchscreen-compatible, real-time electrochemical sensing of SARS-CoV-2\nsubProject:Automatic Detection & Tracing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8408044d485544fba3b13a6f03d8d687": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The University of Miami (UM), with three primary campuses in Miami, Florida, is geographically spread within\none of the worst current COVID-19 hotbeds. UM has deployed an elaborate human surveillance testing, tracking\nand tracing (3T) system to monitor the student body, faculty, and staff. This 3T system includes a major hospital\nthat is part of UM and that treats COVID-19 patients. To augment this COVID-19 monitoring system, UM has\ndeployed a pilot wastewater surveillance program for detecting SARS-CoV-2 from clusters of buildings on\ncampus. Weill Cornell Medicine (WCM) is located in New York City, NY, an area that until recently had one of\nthe worst outbreaks of COVID-19. WCM has established an international consortium for SARS-CoV-2\nenvironmental surveillance, including in NYC and globally with the MetaSUB Consortium, which is creating\nmetagenomic and metatranscriptomic maps of the world’s sewage. Based on this work at both UM and WCM,\nthis proposal aims to develop, implement, and demonstrate effective and predictive wastewater surveillance by\noptimizing sampling, concentration, and detection strategies. Working closely with the RADx-rad Data\nCoordination Center (DCC), this application (SF-RAD) will develop and implement data standards and\ninformatics infrastructure and perform integrative analyses to make all data, results, and models available to the\ncommunity, thus providing a critical contribution to the national SARS-COV-2 RADx-rad Wastewater Detection\nConsortium. Our objectives will be addressed through three aims. Aim 1: Data Standardization, focuses on\ndeveloping and implementing data standards and quality metrics, and establishing the operational infrastructure\nto manage SARS-CoV-2 wastewater-based surveillance datasets and metadata. Aim 2: Wastewater\nCharacterization, focuses on optimizing wastewater surveillance protocols and parameters for wastewater\nsampling, sample concentration, and viral detection technologies. Aim 3: Integration with Human Health\nSurveillance, focuses on metatranscriptomic analyses and on the integration of wastewater quantification data\nwith community and hospital COVID-19 prevalence, to develop predictive models to detect local and community\nlevel spread of COVID-19. All data will be made Findable, Accessible, Interoperable and Reusable (FAIR) in\nclose collaboration with the DCC, and will be collected and managed with attention to ethical issues in\nsurveillance and data management, including efforts to ensure research rigor and reproducibility. The results\nfrom this proposal will develop and deploy experimental and informatics infrastructure and operations as part of\nthe national RADx-rad SARS-CoV-2 wastewater surveillance network and will provide a proof-of-concept\nimplementation to use wastewater for infectious disease surveillance for early detection of localized COVID-19\noutbreaks.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 40,
       "label": "Grant",
       "name": "Development and Proof-of-Concept Implementation of the South Florida Miami RADx-rad SARS-CoV-2 Wastewater-Based Surveillance Infrastructure",
       "narrative": "Through this collaborative study between the University of Miami in Florida and Weill Cornell Medicine in New\nYork, we will generate, standardize, integrate, compare and make available to the RADx-rad Data Coordination\nCenter (DCC), SARS-CoV-2 human surveillance and wastewater quantification data with various sampling,\nprocessing, detection, and analysis approaches. We hypothesize that sensitivity (enhanced detection and\nrecovery) can be improved by optimizing sampling and concentration strategies, and that specificity (viral strain\nidentification for epidemiologic tracking) can be improved by optimizing wastewater detection methods. The\nresults from this proposal will develop and deploy experimental and informatics infrastructure and operations,\nprovide a proof-of-concept implementation to use wastewater for infectious disease surveillance, and advance\nwork towards a model capable of predicting local and community level spread of COVID-19 and emerging\npathogens based upon measurements of SARS-CoV-2 and other viruses from wastewater.",
       "researchInitiative": "RADx-rad",
       "subProject": "Wastewater",
       "tooltip": "Grant\nabstract:The University of Miami (UM), with three primary campuses in Miami, Florida, is geographically spread within\none of the worst current COVID-19 hotbeds. UM has deployed an elaborate human surveillance testing, tracking\nand tracing (3T) system to monitor the student body, faculty, and staff. This 3T system includes a major hospital\nthat is part of UM and that treats COVID-19 patients. To augment this COVID-19 monitoring system, UM has\ndeployed a pilot wastewater surveillance program for detecting SARS-CoV-2 from clusters of buildings on\ncampus. Weill Cornell Medicine (WCM) is located in New York City, NY, an area that until recently had one of\nthe worst outbreaks of COVID-19. WCM has established an international consortium for SARS-CoV-2\nenvironmental surveillance, including in NYC and globally with the MetaSUB Consortium, which is creating\nmetagenomic and metatranscriptomic maps of the world’s sewage. Based on this work at both UM and WCM,\nthis proposal aims to develop, implement, and demonstrate effective and predictive wastewater surveillance by\noptimizing sampling, concentration, and detection strategies. Working closely with the RADx-rad Data\nCoordination Center (DCC), this application (SF-RAD) will develop and implement data standards and\ninformatics infrastructure and perform integrative analyses to make all data, results, and models available to the\ncommunity, thus providing a critical contribution to the national SARS-COV-2 RADx-rad Wastewater Detection\nConsortium. Our objectives will be addressed through three aims. Aim 1: Data Standardization, focuses on\ndeveloping and implementing data standards and quality metrics, and establishing the operational infrastructure\nto manage SARS-CoV-2 wastewater-based surveillance datasets and metadata. Aim 2: Wastewater\nCharacterization, focuses on optimizing wastewater surveillance protocols and parameters for wastewater\nsampling, sample concentration, and viral detection technologies. Aim 3: Integration with Human Health\nSurveillance, focuses on metatranscriptomic analyses and on the integration of wastewater quantification data\nwith community and hospital COVID-19 prevalence, to develop predictive models to detect local and community\nlevel spread of COVID-19. All data will be made Findable, Accessible, Interoperable and Reusable (FAIR) in\nclose collaboration with the DCC, and will be collected and managed with attention to ethical issues in\nsurveillance and data management, including efforts to ensure research rigor and reproducibility. The results\nfrom this proposal will develop and deploy experimental and informatics infrastructure and operations as part of\nthe national RADx-rad SARS-CoV-2 wastewater surveillance network and will provide a proof-of-concept\nimplementation to use wastewater for infectious disease surveillance for early detection of localized COVID-19\noutbreaks.\nid:U01DA053941\nnarrative:Through this collaborative study between the University of Miami in Florida and Weill Cornell Medicine in New\nYork, we will generate, standardize, integrate, compare and make available to the RADx-rad Data Coordination\nCenter (DCC), SARS-CoV-2 human surveillance and wastewater quantification data with various sampling,\nprocessing, detection, and analysis approaches. We hypothesize that sensitivity (enhanced detection and\nrecovery) can be improved by optimizing sampling and concentration strategies, and that specificity (viral strain\nidentification for epidemiologic tracking) can be improved by optimizing wastewater detection methods. The\nresults from this proposal will develop and deploy experimental and informatics infrastructure and operations,\nprovide a proof-of-concept implementation to use wastewater for infectious disease surveillance, and advance\nwork towards a model capable of predicting local and community level spread of COVID-19 and emerging\npathogens based upon measurements of SARS-CoV-2 and other viruses from wastewater.\nname:Development and Proof-of-Concept Implementation of the South Florida Miami RADx-rad SARS-CoV-2 Wastewater-Based Surveillance Infrastructure\nsubProject:Wastewater\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "84b4a04080e2453ab70279f08a9bd44d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 673,
       "target": 29
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "84ca6711d27c4712a1d53594ae529d72": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 635,
       "target": 20
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "84cc9bcce4cc49f2a3870f9d760854e0": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "COVID-19 presents a public health emergency: There is a critical need for rapid, not reagent intensive, non-\ninvasive testing technologies. This program will lead to the production of a prototype system to diagnose\nCOVID-19 infection using the body odor signature of the disease. Our goal is to maximize societal impact\nby creating a validated prototype that can be used in a community or workplace setting by minimally\ntrained personnel for low-cost, on-the-spot diagnosis within minutes. The system will be developed in a\nmanner that puts it on a pathway for rapid FDA approval. The Research Aims are:\nAim 1. Optimization, assembly, and integration of a prototype system with the ability to odor signature\nof COVID-19 in samples of body odor. The system will be simple to use, pose essentially zero risk to the\noperator and the test subject, and report a result within minutes. The production cost at scale will be\napproximately $9,000 for the complete measurement system, with a per test cost of approximately $0.50. The\ndesign and construction of the prototype will be conducted by Novo Engineering, a leading firm with extensive\nexperience in medical device development.\nAim 2. Software development. Software for the system from VOC sampling to final diagnostic result will be\ndeveloped to ensure error-free operation of the device. Our preliminary results suggest that simple linear\ndiscriminant analysis (LDA) does an excellent job of classifying VOCs from human body odor as COVID-19\npositive or negative (92% sensitivity and 87% specificity). Optimization of the sensor array (Aim 1) and use of\nricher feature sets in our classifier models will lead to further performance improvements in the prototype system.\nAim 3. System Benchmarking and Validation. We will benchmark the full prototype system against a number\nof VOC mixtures, with and without in vitro skin models. The system will undergo extensive testing against body\nodor samples from individuals with pathological conditions other than COVID-19 and other sources of potentially\nconfounding VOCs. The prototype will be validated against 1000 samples drawn from the COVID-SAFE program\nat Penn. The screening will include all members of the Penn community, and represents incredible racial and\nethnic diversity as well as a wide variance in age, sex, and gender.\nAim 4. Regulatory Approval Plan The plan will be developed under the direction of Sr/Key personnel John\nFuson, JD, an attorney at Crowell & Moring LLP and a former Associate Chief Counsel at FDA. Novo Engineering\nhas extensive experience in guiding prototype design in alignment with the requirements for FDA approval. The\nproposed COVID-19 VOC-based testing device will be regulated by the FDA, likely as a Class I or II medical\ndevice. Because there is no clear predicate device to reference in this case, we intend to submit a direct de novo\npetition to FDA asking the agency to categorize and clear the proposed COVID-19 testing device as Class I or\nClass II without reference to any predicate.",
       "awardCode": "U18",
       "fundingMechanism": "Other Research-Related",
       "id": 29,
       "label": "Grant",
       "name": "Effective, Reagent-free Detection of the Odor Signature of Covid-19 Infection Using a Nano-Enabled Sensor Array",
       "narrative": "This program addresses the critical unmet need of an effective means to screen for COVID-19 infection, and\npotentially other novel virus infections, in a community setting based upon the body odor signature of the\ndisease. The program will result in a validated prototype system, with a test time of minutes, a test cost of\napproximately $0.50, on a path to rapid FDA approval.",
       "researchInitiative": "RADx-rad",
       "subProject": "SCENT",
       "tooltip": "Grant\nabstract:COVID-19 presents a public health emergency: There is a critical need for rapid, not reagent intensive, non-\ninvasive testing technologies. This program will lead to the production of a prototype system to diagnose\nCOVID-19 infection using the body odor signature of the disease. Our goal is to maximize societal impact\nby creating a validated prototype that can be used in a community or workplace setting by minimally\ntrained personnel for low-cost, on-the-spot diagnosis within minutes. The system will be developed in a\nmanner that puts it on a pathway for rapid FDA approval. The Research Aims are:\nAim 1. Optimization, assembly, and integration of a prototype system with the ability to odor signature\nof COVID-19 in samples of body odor. The system will be simple to use, pose essentially zero risk to the\noperator and the test subject, and report a result within minutes. The production cost at scale will be\napproximately $9,000 for the complete measurement system, with a per test cost of approximately $0.50. The\ndesign and construction of the prototype will be conducted by Novo Engineering, a leading firm with extensive\nexperience in medical device development.\nAim 2. Software development. Software for the system from VOC sampling to final diagnostic result will be\ndeveloped to ensure error-free operation of the device. Our preliminary results suggest that simple linear\ndiscriminant analysis (LDA) does an excellent job of classifying VOCs from human body odor as COVID-19\npositive or negative (92% sensitivity and 87% specificity). Optimization of the sensor array (Aim 1) and use of\nricher feature sets in our classifier models will lead to further performance improvements in the prototype system.\nAim 3. System Benchmarking and Validation. We will benchmark the full prototype system against a number\nof VOC mixtures, with and without in vitro skin models. The system will undergo extensive testing against body\nodor samples from individuals with pathological conditions other than COVID-19 and other sources of potentially\nconfounding VOCs. The prototype will be validated against 1000 samples drawn from the COVID-SAFE program\nat Penn. The screening will include all members of the Penn community, and represents incredible racial and\nethnic diversity as well as a wide variance in age, sex, and gender.\nAim 4. Regulatory Approval Plan The plan will be developed under the direction of Sr/Key personnel John\nFuson, JD, an attorney at Crowell & Moring LLP and a former Associate Chief Counsel at FDA. Novo Engineering\nhas extensive experience in guiding prototype design in alignment with the requirements for FDA approval. The\nproposed COVID-19 VOC-based testing device will be regulated by the FDA, likely as a Class I or II medical\ndevice. Because there is no clear predicate device to reference in this case, we intend to submit a direct de novo\npetition to FDA asking the agency to categorize and clear the proposed COVID-19 testing device as Class I or\nClass II without reference to any predicate.\nid:U18TR003775\nnarrative:This program addresses the critical unmet need of an effective means to screen for COVID-19 infection, and\npotentially other novel virus infections, in a community setting based upon the body odor signature of the\ndisease. The program will result in a validated prototype system, with a test time of minutes, a test cost of\napproximately $0.50, on a path to rapid FDA approval.\nname:Effective, Reagent-free Detection of the Odor Signature of Covid-19 Infection Using a Nano-Enabled Sensor Array\nsubProject:SCENT\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U18"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "850eb7e9fc6a4c26948d11cf10ad789e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "COLUMBUS",
       "country": "UNITED STATES",
       "duns": "duns:167239057",
       "geonames": "geonames:4509177",
       "id": 560,
       "label": "Organization",
       "name": "Nanomaterial Innovation, Ltd",
       "state": "OH",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4509177\ncity:COLUMBUS\nname:Nanomaterial Innovation, Ltd\nuei:uei:N2KLACCRD6D5\nduns:duns:167239057\nstate:OH\nid:uei:N2KLACCRD6D5",
       "uei": "uei:N2KLACCRD6D5"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "85839bfe7dcd4826a69daca59fc66504": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 665,
       "target": 18
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "85ebfe708e324154b851352872349416": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 699,
       "target": 40
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "85f9415be7b64f8eaf384db47c1e92b1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4387,
       "target": 12
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8609b22c68154d7c864e3c88221e1362": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4385,
       "target": 2
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "86bfea604843476c9b98ecc00e4a9574": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "CytoscapeModel",
     "state": {
      "_dom_classes": [],
      "_interaction_handlers": {},
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "CytoscapeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "CytoscapeView",
      "auto_ungrabify": false,
      "auto_unselectify": true,
      "autolock": false,
      "box_selection_enabled": false,
      "cytoscape_layout": {
       "name": "cola",
       "nodeDimensionsIncludeLabels": true,
       "nodeSpacing": 40,
       "padding": 0,
       "unconstrIter": 5000
      },
      "cytoscape_style": [
       {
        "selector": "node",
        "style": {
         "background-color": "#A5ABB6",
         "border-color": "#9AA1AC",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "edge",
        "style": {
         "curve-style": "bezier",
         "font-size": "8px",
         "label": "data(name)",
         "line-color": "#A5ABB6",
         "target-arrow-color": "#A5ABB6",
         "target-arrow-shape": "triangle",
         "text-rotation": "autorotate",
         "width": "1px"
        }
       },
       {
        "selector": "node[label=\"*\"]",
        "style": {
         "background-color": "#C990C0",
         "border-color": "#b261a5",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"City\"]",
        "style": {
         "background-color": "#F79767",
         "border-color": "#f36924",
         "border-width": "2px",
         "font-size": "10px",
         "height": "65px",
         "label": "data(name)",
         "text-max-width": "65px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "65px"
        }
       },
       {
        "selector": "node[label=\"Disease\"]",
        "style": {
         "background-color": "#569480",
         "border-color": "#447666",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Symptom\"]",
        "style": {
         "background-color": "#8DCC93",
         "border-color": "#5db665",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"Patient\"]",
        "style": {
         "background-color": "#4C8EDA",
         "border-color": "#2870c2",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(firstName)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"State\"]",
        "style": {
         "background-color": "#FFC454",
         "border-color": "#d7a013",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"MetaNode\"]",
        "style": {
         "background-color": "#D9C8AE",
         "border-color": "#c0a378",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(nodeName)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Grant\"]",
        "style": {
         "background-color": "#4C8EDA",
         "border-color": "#2870c2",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Researcher\"]",
        "style": {
         "background-color": "#FFC454",
         "border-color": "#d7a013",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"FundingOpportunity\"]",
        "style": {
         "background-color": "#DA7194",
         "border-color": "#cc3c6c",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Organization\"]",
        "style": {
         "background-color": "#569480",
         "border-color": "#447666",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Dataset\"]",
        "style": {
         "background-color": "#F79767",
         "border-color": "#f36924",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"CoordinationCenter\"]",
        "style": {
         "background-color": "#57C7E3",
         "border-color": "#23b3d7",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Event\"]",
        "style": {
         "background-color": "#8DCC93",
         "border-color": "#5db665",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Publication\"]",
        "style": {
         "background-color": "#AA7942",
         "border-color": "#8D6429",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Patent\"]",
        "style": {
         "background-color": "#C990C0",
         "border-color": "#b261a5",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Presentation\"]",
        "style": {
         "background-color": "#F16667",
         "border-color": "#eb2728",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Software\"]",
        "style": {
         "background-color": "#ECB5C9",
         "border-color": "#da7298",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"ResearchInitiative\"]",
        "style": {
         "background-color": "#57C7E3",
         "border-color": "#23b3d7",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "edge[name=\"MetaRelationship\"]",
        "style": {
         "curve-style": "bezier",
         "font-size": "8px",
         "label": "data(relationshipName)",
         "line-color": "#A5ABB6",
         "target-arrow-color": "#A5ABB6",
         "target-arrow-shape": "triangle",
         "text-rotation": "autorotate",
         "width": "1px"
        }
       }
      ],
      "desktop_tap_threshold": 4,
      "graph": "IPY_MODEL_3e72943b52c44242bceb791e8b3e00d1",
      "headless": false,
      "hide_edges_on_viewport": false,
      "layout": "IPY_MODEL_c2c511441595421189d8fce8c87a56fd",
      "max_zoom": 1e+50,
      "min_zoom": 1e-50,
      "motion_blur": false,
      "motion_blur_opacity": 0.2,
      "panning_enabled": true,
      "pixel_ratio": "auto",
      "rendered_position": {
       "renderedPosition": {
        "x": 100,
        "y": 100
       }
      },
      "selection_type": "single",
      "style_enabled": true,
      "texture_on_viewport": false,
      "tooltip_source": "tooltip",
      "touch_tap_threshold": 8,
      "user_panning_enabled": true,
      "user_zooming_enabled": true,
      "wheel_sensitivity": 1,
      "zoom": 2,
      "zooming_enabled": true
     }
    },
    "86e4c84334fa45479da5914b8f08514f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "HERSHEY",
       "country": "UNITED STATES",
       "duns": "duns:129348186",
       "geonames": "geonames:5193342",
       "id": 596,
       "label": "Organization",
       "name": "Penn State Milton S. Hershey Medical Center",
       "ror": "ror:01h22ap11",
       "state": "PA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5193342\nror:ror:01h22ap11\ncity:HERSHEY\nname:Penn State Milton S. Hershey Medical Center\nuei:uei:TNKGNDAWB445\nduns:duns:129348186\nstate:PA\nid:ror:01h22ap11\nurl:https://ror.org/01h22ap11",
       "uei": "uei:TNKGNDAWB445",
       "url": "https://ror.org/01h22ap11"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "87405a7b3f934a3f8fbf30b26bbede3d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "SUPPORTED",
       "source": 546,
       "target": 36
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8751edf84e354cc9881538d0fa6f20ec": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "GraphModel",
     "state": {
      "_adj": {
       "24": {},
       "2408": {},
       "2412": {},
       "617": {},
       "689": {},
       "7": {}
      },
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "GraphModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": null,
      "edges": [
       "IPY_MODEL_1a9f632256e947d38d2ff48d7ff54023",
       "IPY_MODEL_29b30f41d8a241bba1caf3c4dc0ed004",
       "IPY_MODEL_f212675824ce475395ae3bc34b0c0a3d",
       "IPY_MODEL_e078648af27b42fe9b63502c5fc8eefe",
       "IPY_MODEL_672fb233629a4c60a6b35865ab510493",
       "IPY_MODEL_947678ab544b4eff9000b69a620a8036"
      ],
      "nodes": [
       "IPY_MODEL_c1f8c20f720c44a9819f6cd993e82f51",
       "IPY_MODEL_9b6ddbc374444203be8e3efc54195e1a",
       "IPY_MODEL_bf493b2fdf3f49ddbb86efaaec9ea331",
       "IPY_MODEL_cdc5e150ec0340cf9a8248b409b2ce13",
       "IPY_MODEL_89b85b6cfbb243bd9874809bff82fc5f",
       "IPY_MODEL_cc94147b60cd4b158068bf04c5d31e30"
      ]
     }
    },
    "87828501353046f0963a057a994c6f15": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 957,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "87b574955b6f4d5995d08d5b9aa76cd1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The goal of this project is to establish robust, proof-of-concept feasibility for an innovative E-nose system,\ntermed the MOF-SCENT system, for real-time and non-invasive screening for asymptomatic and symptomatic\nCOVID-19 patients, with high accuracy based on the detection of VOCs emanating from exhaled breath. The\nproposed OE-HCCR-MOF based E-nose sensor is a novel biosensing and chemical sensing technology that\nwill fundamentally advance E-nose sensing technologies due to the improved sensitivity and selectivity.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 31,
       "label": "Grant",
       "name": "Midwest Biomedical Accelerator Consortium: MBArC",
       "narrative": "This proposal describes the design, fabrication, and proof-of-concept testing of a novel MOF-SCENT system\n(Metal-Organic Frameworks for Screening COVID-19 by Electronic-Nose Technology) that features the\nfollowing advantages: (1) Highly selective and sensitive detection of a panel of VOCs that indicate COVID-19\ndisease; (2) fast response and recovery time; (3) portable, lowcost, robust, easy-to-use, and deployable in any\nclinical, community, and everyday setting. The proposed accurate, sensitive, lowcost, robust, and portable\nMOF-SCENT system provides a realistic approach to dramatically increase testing capacity for COVID-\n19 because it can be rapidly integrated into and adopted by the public and healthcare systems by deploying a\nlarge number of such systems at central facilities (e.g., airports, shopping malls), point-of-care sites (e.g.,\nhospitals, pharmacies, urgent care centers), and workplaces, and even homes. The manufacturing of the\nMOF-SCENT system can be easily scaled to > 50,000 units because the simple design can be fabricated out\nof stainless steel in common machine shops, and the MOF materials are commercially available. The detector\nof the MOF-SCENT system could be manufactured based on existing portable vector network analyzer (VNA)\ninterrogators (new VNA technology called MN7021A RF Sensor., Keysight Technologies, Santa Rosa, CA).\nCommercially-available VNAs would be stripped down to increase production output and reduce costs\n(Keysight Technologies can head up the effort to massproduce the interrogators). Capital costs for the\nproduction ramp-up of large numbers of MOF-SCENT systems are minimal because existing machine shops\nand Keysight Technologies’ electronic assembly infrastructure would be used. Installation of the MOFSCENT\nsystem at homes, businesses, grocery stores, pharmacies, and medical clinics will significantly increase daily\naccessibility to on-demand accurate testing and thereby mitigate the second wave of infections of SARS-CoV-\n2. Keysight Technologies is the world’s largest test and measurement manufacturer, with a well-established\nsupply chain, superior logistics and technical support infrastructure, and a commitment to quality control.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:The goal of this project is to establish robust, proof-of-concept feasibility for an innovative E-nose system,\ntermed the MOF-SCENT system, for real-time and non-invasive screening for asymptomatic and symptomatic\nCOVID-19 patients, with high accuracy based on the detection of VOCs emanating from exhaled breath. The\nproposed OE-HCCR-MOF based E-nose sensor is a novel biosensing and chemical sensing technology that\nwill fundamentally advance E-nose sensing technologies due to the improved sensitivity and selectivity.\nid:U01HL152410\nnarrative:This proposal describes the design, fabrication, and proof-of-concept testing of a novel MOF-SCENT system\n(Metal-Organic Frameworks for Screening COVID-19 by Electronic-Nose Technology) that features the\nfollowing advantages: (1) Highly selective and sensitive detection of a panel of VOCs that indicate COVID-19\ndisease; (2) fast response and recovery time; (3) portable, lowcost, robust, easy-to-use, and deployable in any\nclinical, community, and everyday setting. The proposed accurate, sensitive, lowcost, robust, and portable\nMOF-SCENT system provides a realistic approach to dramatically increase testing capacity for COVID-\n19 because it can be rapidly integrated into and adopted by the public and healthcare systems by deploying a\nlarge number of such systems at central facilities (e.g., airports, shopping malls), point-of-care sites (e.g.,\nhospitals, pharmacies, urgent care centers), and workplaces, and even homes. The manufacturing of the\nMOF-SCENT system can be easily scaled to > 50,000 units because the simple design can be fabricated out\nof stainless steel in common machine shops, and the MOF materials are commercially available. The detector\nof the MOF-SCENT system could be manufactured based on existing portable vector network analyzer (VNA)\ninterrogators (new VNA technology called MN7021A RF Sensor., Keysight Technologies, Santa Rosa, CA).\nCommercially-available VNAs would be stripped down to increase production output and reduce costs\n(Keysight Technologies can head up the effort to massproduce the interrogators). Capital costs for the\nproduction ramp-up of large numbers of MOF-SCENT systems are minimal because existing machine shops\nand Keysight Technologies’ electronic assembly infrastructure would be used. Installation of the MOFSCENT\nsystem at homes, businesses, grocery stores, pharmacies, and medical clinics will significantly increase daily\naccessibility to on-demand accurate testing and thereby mitigate the second wave of infections of SARS-CoV-\n2. Keysight Technologies is the world’s largest test and measurement manufacturer, with a well-established\nsupply chain, superior logistics and technical support infrastructure, and a commitment to quality control.\nname:Midwest Biomedical Accelerator Consortium: MBArC\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8917f075488b408da5a49a4c5425389c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "TEMPE",
       "country": "UNITED STATES",
       "duns": "duns:943360412",
       "geonames": "geonames:5317058",
       "id": 568,
       "label": "Organization",
       "name": "Arizona State University",
       "ror": "ror:03efmqc40",
       "state": "AZ",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5317058\nror:ror:03efmqc40\ncity:TEMPE\nname:Arizona State University\nuei:uei:NTLHJXM55KZ6\nduns:duns:943360412\nstate:AZ\nid:ror:03efmqc40\nurl:https://ror.org/03efmqc40",
       "uei": "uei:NTLHJXM55KZ6",
       "url": "https://ror.org/03efmqc40"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "893136566176445c9f86542b2b5309e5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "CytoscapeModel",
     "state": {
      "_dom_classes": [],
      "_interaction_handlers": {},
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "CytoscapeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "CytoscapeView",
      "auto_ungrabify": false,
      "auto_unselectify": true,
      "autolock": false,
      "box_selection_enabled": false,
      "cytoscape_layout": {
       "name": "cola",
       "nodeDimensionsIncludeLabels": true,
       "nodeSpacing": 65,
       "padding": 40,
       "unconstrIter": 5000
      },
      "cytoscape_style": [
       {
        "selector": "node",
        "style": {
         "background-color": "#A5ABB6",
         "border-color": "#9AA1AC",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "edge",
        "style": {
         "curve-style": "bezier",
         "font-size": "8px",
         "label": "data(name)",
         "line-color": "#A5ABB6",
         "target-arrow-color": "#A5ABB6",
         "target-arrow-shape": "triangle",
         "text-rotation": "autorotate",
         "width": "1px"
        }
       },
       {
        "selector": "node[label=\"*\"]",
        "style": {
         "background-color": "#C990C0",
         "border-color": "#b261a5",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"City\"]",
        "style": {
         "background-color": "#F79767",
         "border-color": "#f36924",
         "border-width": "2px",
         "font-size": "10px",
         "height": "65px",
         "label": "data(name)",
         "text-max-width": "65px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "65px"
        }
       },
       {
        "selector": "node[label=\"Disease\"]",
        "style": {
         "background-color": "#569480",
         "border-color": "#447666",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Symptom\"]",
        "style": {
         "background-color": "#8DCC93",
         "border-color": "#5db665",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"Patient\"]",
        "style": {
         "background-color": "#4C8EDA",
         "border-color": "#2870c2",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(firstName)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"State\"]",
        "style": {
         "background-color": "#FFC454",
         "border-color": "#d7a013",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"MetaNode\"]",
        "style": {
         "background-color": "#D9C8AE",
         "border-color": "#c0a378",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(nodeName)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Grant\"]",
        "style": {
         "background-color": "#4C8EDA",
         "border-color": "#2870c2",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Researcher\"]",
        "style": {
         "background-color": "#FFC454",
         "border-color": "#d7a013",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"FundingOpportunity\"]",
        "style": {
         "background-color": "#DA7194",
         "border-color": "#cc3c6c",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Organization\"]",
        "style": {
         "background-color": "#569480",
         "border-color": "#447666",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Dataset\"]",
        "style": {
         "background-color": "#F79767",
         "border-color": "#f36924",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"CoordinationCenter\"]",
        "style": {
         "background-color": "#57C7E3",
         "border-color": "#23b3d7",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Event\"]",
        "style": {
         "background-color": "#8DCC93",
         "border-color": "#5db665",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Publication\"]",
        "style": {
         "background-color": "#AA7942",
         "border-color": "#8D6429",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Patent\"]",
        "style": {
         "background-color": "#C990C0",
         "border-color": "#b261a5",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Presentation\"]",
        "style": {
         "background-color": "#F16667",
         "border-color": "#eb2728",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Software\"]",
        "style": {
         "background-color": "#ECB5C9",
         "border-color": "#da7298",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"ResearchInitiative\"]",
        "style": {
         "background-color": "#57C7E3",
         "border-color": "#23b3d7",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "edge[name=\"MetaRelationship\"]",
        "style": {
         "curve-style": "bezier",
         "font-size": "8px",
         "label": "data(relationshipName)",
         "line-color": "#A5ABB6",
         "target-arrow-color": "#A5ABB6",
         "target-arrow-shape": "triangle",
         "text-rotation": "autorotate",
         "width": "1px"
        }
       }
      ],
      "desktop_tap_threshold": 4,
      "graph": "IPY_MODEL_a2a8d91b390e4dc3ab2d7cef40eb8c4a",
      "headless": false,
      "hide_edges_on_viewport": false,
      "layout": "IPY_MODEL_9e16133687ed47008dc49145ca392524",
      "max_zoom": 1e+50,
      "min_zoom": 1e-50,
      "motion_blur": false,
      "motion_blur_opacity": 0.2,
      "panning_enabled": true,
      "pixel_ratio": "auto",
      "rendered_position": {
       "renderedPosition": {
        "x": 100,
        "y": 100
       }
      },
      "selection_type": "single",
      "style_enabled": true,
      "texture_on_viewport": false,
      "tooltip_source": "tooltip",
      "touch_tap_threshold": 8,
      "user_panning_enabled": true,
      "user_zooming_enabled": true,
      "wheel_sensitivity": 1,
      "zoom": 2,
      "zooming_enabled": true
     }
    },
    "893e474b000f441abda64045e33ff03b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 662,
       "target": 9
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8944b3400fa14230bf527a34b0f4fbbe": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Yuedong",
       "fullName": "Yuedong Wang",
       "id": 672,
       "label": "Researcher",
       "lastName": "Wang",
       "name": "Wang Y",
       "profileId": "profileid:2264716",
       "tooltip": "Researcher\nid:profileid:2264716\nlastName:Wang\nprofileId:profileid:2264716\nname:Wang Y\nfullName:Yuedong Wang\nfirstName:Yuedong"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "894856695b534ebb845e4f13cc18ac8b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 2741,
       "label": "Dataset",
       "name": " Nanobody-based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2",
       "tooltip": "Dataset\nid:dbgap:phs002700.v1.p1\nname: Nanobody-based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2\nurl:https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs002700.v1.p1",
       "url": "https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs002700.v1.p1"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "89b6a63e5ac94c5cac9d63a5c53e536f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "GAINESVILLE",
       "country": "UNITED STATES",
       "duns": "duns:969663814",
       "geonames": "geonames:4156404",
       "id": 573,
       "label": "Organization",
       "name": "University of Florida",
       "ror": "ror:02y3ad647",
       "state": "FL",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4156404\nror:ror:02y3ad647\ncity:GAINESVILLE\nname:University of Florida\nuei:uei:NNFQH1JAPEP3\nduns:duns:969663814\nstate:FL\nid:ror:02y3ad647\nurl:https://ror.org/02y3ad647",
       "uei": "uei:NNFQH1JAPEP3",
       "url": "https://ror.org/02y3ad647"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "89b85b6cfbb243bd9874809bff82fc5f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The COVID-19 pandemic has rapidly spread across the world, bringing death, illness, disruption to daily\nlife, and economic crisis to businesses and individuals. The situation has been exacerbated after the schools\nand companies reopened due to economic pressure. One of the key failures in COVID-19 containment is\nunderlined by the inability of our healthcare system in real-time detection in point-of-care (POC) and end-user\nsettings and precise tracing with privacy protection of active infections. The fundamental limitations of current\ngene-based assays stem from their reliance upon amplification and detection of the viral genetic materials\neven if there were no intact/infectious viruses. These tests require labor-intensive, laboratory-based sample\npreparation protocols for virus lysis, extraction of genetic materials, purification of the isolated materials,\nthermal cycling for enzymatic amplification of viral nucleic acid sequences, and interpretation of complex\nresults by professionals. To accurately determine the infectivity of the infected individuals, contaminated\nobjects and environments, and provide guidance for patients, public and authorities to better manage treatment\nand containment, we seek a new paradigm for rapid and direct pathogen detection and identification in which\nthe intact virions are directly recognized through their distinct surface epitope features, and the resultant\nfluorescent signal is immediately captured by an end-user smartphone, followed by automatic data transition\nand event tracing in a blockchain-encrypted manner. To achieve specific recognition of SARS-CoV-2 virions,\nwe customized a designer DNA nanostructure (DDN)-based capture probe that harbors a macromolecular\n“net” whose vertices precisely match the intra- and inter-spatial pattern of SARS-CoV-2 trimeric spike\nglycoprotein clusters, and integrates a net-shaped array of SARS-CoV-2 spike specific-targeting aptamers.\nThis aptamer-DDN is designed for maximum affinity and specificity binding with spikes on intact virions in a\npolyvalent and pattern-matching fashion. Once bound to intact virions, the DNA “nets” trigger the release of\nfluorescence. This fluorescent signal can be readily and automatically detected by a membrane-shaped and\nsmartphone-based fluorimeter attached to the end-users' phone cameras. The acquired results will be\nassociated with user device IDs that are cyber-protected before tracing. We propose to combine DDN capture\nprobes and a smartphone device to develop and demonstrate a rapid, room temperature, single-step, virus-\nspecific, and ultrasensitive detection of SARS-CoV-2 virus, in which the detection results can be acquired\nwithin 5 minutes upon exposure, at the user end, allowing tracing the presence of viruses without affecting user\nprivacy. The signal to result transition, result to ID association, individual track and interacting network tracing\nwill be blockchain-encrypted to ensure information security for individual privacy, while tracing information\nwould be available to health authority for public health benefits.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 24,
       "label": "Grant",
       "name": "Detection and Automatic Privacy-Protected Contact Tracing System Designed for COVID-19",
       "narrative": "The goal of the project is to develop a pipeline for automatic detection and tracing of active SARS-CoV-2\ninfection in a cost-effective, highly accurate, real-time, portable, and super-encrypted manner. Our integrated\napproach first captures viral particles from patient samples to activate fluorescence reporters, followed by\nsignal detection using a smartphone fluorimeter, along with blockchain-based data processing and tracing. We\ndeployed designer DNA “net” nanostructures that match the spatial pattern of trimeric spike glycoprotein\nclusters on the viral outer surface for specific and rapid SARS-CoV-2 virion detection, smartphone-based point-\nof-care device for portable signal reading, and blockchain encryption for privacy protection during result\nrecording and track tracing, therefore, our detection and tracing model allows a direct, automatic, and cost-\neffective detection, a highly flexible result acquisition process and a super-encrypted data transition and tracing\nsystem.",
       "researchInitiative": "RADx-rad",
       "subProject": "Automatic Detection & Tracing",
       "tooltip": "Grant\nabstract:The COVID-19 pandemic has rapidly spread across the world, bringing death, illness, disruption to daily\nlife, and economic crisis to businesses and individuals. The situation has been exacerbated after the schools\nand companies reopened due to economic pressure. One of the key failures in COVID-19 containment is\nunderlined by the inability of our healthcare system in real-time detection in point-of-care (POC) and end-user\nsettings and precise tracing with privacy protection of active infections. The fundamental limitations of current\ngene-based assays stem from their reliance upon amplification and detection of the viral genetic materials\neven if there were no intact/infectious viruses. These tests require labor-intensive, laboratory-based sample\npreparation protocols for virus lysis, extraction of genetic materials, purification of the isolated materials,\nthermal cycling for enzymatic amplification of viral nucleic acid sequences, and interpretation of complex\nresults by professionals. To accurately determine the infectivity of the infected individuals, contaminated\nobjects and environments, and provide guidance for patients, public and authorities to better manage treatment\nand containment, we seek a new paradigm for rapid and direct pathogen detection and identification in which\nthe intact virions are directly recognized through their distinct surface epitope features, and the resultant\nfluorescent signal is immediately captured by an end-user smartphone, followed by automatic data transition\nand event tracing in a blockchain-encrypted manner. To achieve specific recognition of SARS-CoV-2 virions,\nwe customized a designer DNA nanostructure (DDN)-based capture probe that harbors a macromolecular\n“net” whose vertices precisely match the intra- and inter-spatial pattern of SARS-CoV-2 trimeric spike\nglycoprotein clusters, and integrates a net-shaped array of SARS-CoV-2 spike specific-targeting aptamers.\nThis aptamer-DDN is designed for maximum affinity and specificity binding with spikes on intact virions in a\npolyvalent and pattern-matching fashion. Once bound to intact virions, the DNA “nets” trigger the release of\nfluorescence. This fluorescent signal can be readily and automatically detected by a membrane-shaped and\nsmartphone-based fluorimeter attached to the end-users' phone cameras. The acquired results will be\nassociated with user device IDs that are cyber-protected before tracing. We propose to combine DDN capture\nprobes and a smartphone device to develop and demonstrate a rapid, room temperature, single-step, virus-\nspecific, and ultrasensitive detection of SARS-CoV-2 virus, in which the detection results can be acquired\nwithin 5 minutes upon exposure, at the user end, allowing tracing the presence of viruses without affecting user\nprivacy. The signal to result transition, result to ID association, individual track and interacting network tracing\nwill be blockchain-encrypted to ensure information security for individual privacy, while tracing information\nwould be available to health authority for public health benefits.\nid:U01AA029348\nnarrative:The goal of the project is to develop a pipeline for automatic detection and tracing of active SARS-CoV-2\ninfection in a cost-effective, highly accurate, real-time, portable, and super-encrypted manner. Our integrated\napproach first captures viral particles from patient samples to activate fluorescence reporters, followed by\nsignal detection using a smartphone fluorimeter, along with blockchain-based data processing and tracing. We\ndeployed designer DNA “net” nanostructures that match the spatial pattern of trimeric spike glycoprotein\nclusters on the viral outer surface for specific and rapid SARS-CoV-2 virion detection, smartphone-based point-\nof-care device for portable signal reading, and blockchain encryption for privacy protection during result\nrecording and track tracing, therefore, our detection and tracing model allows a direct, automatic, and cost-\neffective detection, a highly flexible result acquisition process and a super-encrypted data transition and tracing\nsystem.\nname:Detection and Automatic Privacy-Protected Contact Tracing System Designed for COVID-19\nsubProject:Automatic Detection & Tracing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "89d16019824946e98316c1edbdb30521": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Ananth",
       "fullName": "Ananth V Annapragada",
       "id": 665,
       "label": "Researcher",
       "lastName": "Annapragada",
       "middleName": "V",
       "name": "Annapragada AV",
       "orcid": "orcid:0000-0002-3156-9617",
       "profileId": "profileid:7039414",
       "tooltip": "Researcher\nmiddleName:V\nid:profileid:7039414\nlastName:Annapragada\norcid:orcid:0000-0002-3156-9617\nprofileId:profileid:7039414\nname:Annapragada AV\nfullName:Ananth V Annapragada\nfirstName:Ananth"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "89e26da092c44387a25064ff9468e02f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Susan",
       "fullName": "Susan P Travers",
       "id": 615,
       "label": "Researcher",
       "lastName": "Travers",
       "middleName": "P",
       "name": "Travers SP",
       "orcid": "orcid:0000-0001-8730-3618",
       "profileId": "profileid:1896926",
       "tooltip": "Researcher\nmiddleName:P\nid:profileid:1896926\nlastName:Travers\norcid:orcid:0000-0001-8730-3618\nprofileId:profileid:1896926\nname:Travers SP\nfullName:Susan P Travers\nfirstName:Susan"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8a2c178be4a3472d9c60111cfa71e1a3": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Diana",
       "fullName": "Diana Carolina Vanegas-Gamboa",
       "id": 670,
       "label": "Researcher",
       "lastName": "Vanegas-Gamboa",
       "middleName": "Carolina",
       "name": "Vanegas-Gamboa DC",
       "orcid": "orcid:0000-0001-9858-0960",
       "profileId": "profileid:77816868",
       "tooltip": "Researcher\nmiddleName:Carolina\nid:profileid:77816868\nlastName:Vanegas-Gamboa\norcid:orcid:0000-0001-9858-0960\nprofileId:profileid:77816868\nname:Vanegas-Gamboa DC\nfullName:Diana Carolina Vanegas-Gamboa\nfirstName:Diana"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8a6343f0b72a458d83bba840a2ccf16b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 707,
       "target": 18
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8b29a65692b94f938c56318c0f205479": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "RICHMOND",
       "country": "UNITED STATES",
       "duns": "duns:105300446",
       "geonames": "geonames:4781708",
       "id": 558,
       "label": "Organization",
       "name": "Virginia Commonwealth University",
       "ror": "ror:02nkdxk79",
       "state": "VA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4781708\nror:ror:02nkdxk79\ncity:RICHMOND\nname:Virginia Commonwealth University\nuei:uei:MLQFL4JSSAA9\nduns:duns:105300446\nstate:VA\nid:ror:02nkdxk79\nurl:https://ror.org/02nkdxk79",
       "uei": "uei:MLQFL4JSSAA9",
       "url": "https://ror.org/02nkdxk79"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8b3bd41cc8364edc946c46ca492b2031": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 346,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8b5db1b883f84d0ea82bf3d1e302e01d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 671,
       "target": 591
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8b83b2e7483f40ffb57121557b511f77": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 684,
       "target": 2817
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8bfb375f42054b9da36d627b3835654c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "doi": "doi:10.1016/j.bios.2023.115946",
       "id": 2708,
       "journal": "Biosensors & bioelectronics",
       "label": "Publication",
       "name": "Machine learning-driven SERS fingerprinting of disintegrated viral components for rapid detection of SARS-CoV-2 in environmental dust.",
       "pmId": "38141443",
       "tooltip": "Publication\njournal:Biosensors & bioelectronics\nid:doi:10.1016/j.bios.2023.115946\nname:Machine learning-driven SERS fingerprinting of disintegrated viral components for rapid detection of SARS-CoV-2 in environmental dust.\npmId:38141443\nyear:2023\ntype:secondary\nurl:https://doi.org/doi:10.1016/j.bios.2023.115946\ndoi:doi:10.1016/j.bios.2023.115946",
       "type": "secondary",
       "url": "https://doi.org/doi:10.1016/j.bios.2023.115946",
       "year": 2023
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8c065a94d29346c5a69e84afe9055f0d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "A",
       "fullName": "A Sarabandi",
       "id": 1341,
       "label": "Researcher",
       "lastName": "Sarabandi",
       "name": "Sarabandi A",
       "tooltip": "Researcher\nid:s2authorid:31272705\nlastName:Sarabandi\nname:Sarabandi A\nfullName:A Sarabandi\nfirstName:A"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8c21c54cf1634e6290548f7cd48a1ddc": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 639,
       "target": 26
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8c55ec6387dc41f28be7f8dce6e005d7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 699,
       "target": 579
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8c741ed6f6e24b15b576154c5852a356": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 647,
       "target": 17
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8d5b898fe3614182a61273e394402e06": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The World Health Organization has recognized a global pandemic of novel coronavirus pneumonia (COVID-19)\nfrom exposure to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronaviruses (CoVs)\nare membrane-enveloped positive-sense, single-stranded RNA viruses decorated with membrane proteins. The\nspike (S) glycoprotein is implicated in the viral attachment and fusion to host cells via the human angiotensin-\nconverting enzyme 2 (hACE2). There are different assays to test for COVID-19, including nucleic acid, antigen,\nand serological tests that can be used in hospitals, point-of-care, and large-scale population testing. Nucleic acid\ntesting is the standard method for the detection of SARS-CoV-2, which consists of the amplification of viral RNA\nfrom nasopharyngeal swabs (NPS) by quantitative reverse-transcription polymerase chain reaction (qRT-PCR).\nFurthermore, given the invasive nature of NPS, saliva is being considered an alternative for detection. Methods\nthat bypass RNA extraction, as well as isothermal amplification such as loop-mediated isothermal amplification\n(LAMP), have been developed to improve the speed of viral RNA detection. However, viral protein expression\ncannot be detected by qRT-PCR. Serological tests, on the other hand, are based on host antibodies against the\nvirus (IgG/IgM). Although fast, these tests suffer from significant false negative/positive. Besides, they do not\ndetect a current infection. Therefore, to relieve the current healthcare crisis, new technologies capable of\nsimultaneous viral RNA/protein detection at the single virus level and host antibody response detection from a\nbody fluid in an integrated device would be highly valuable for enhanced COVID-19 diagnosis.\nRecently, our group, as part of Phase 2 of the Extracellular RNA Communication Consortium (ERCC2), has\nsuccessfully developed a microfluidics technology capable of capturing individual exosomes from biofluids and\nthen simultaneously quantify both exosomal surface proteins and RNA cargo. Given the resemblance in size\nand other characteristics between exosomes and coronaviruses, our technology can be adapted for COVID-19\ndiagnosis. Therefore, we propose to develop and validate a safe-to-use version of our microfluidics system for\ndirect detection of SARS-CoV-2. The integrated system is capable of multi-parametric detection for enhanced\nCOVID-19 diagnosis. The platform will be engineered to simultaneously quantify both viral protein, viral RNA,\nand host antibodies (IgG/IgM) in the same sample, enabling diagnosis, disease status, and prognostic\nassessment. Model systems, including host IgG/IgM from patient serum, standard synthetic vesicles (SVs), and\nheat-inactivated SARS-CoV-2 viral particles (SVVs), will be designed and spiked in biofluids to validate and\ncalibrate the system. To demonstrate the clinical utility, our biochip technology will be deployed and tested using\ndifferent biofluids from COVID-19 patients at two independent laboratories (Institute of Systems Biology in\nSeattle and The Ohio State University (OSU) Wexner Medical Center in Columbus). Measurements obtained\nfrom the biochips will be compared to standard qRT-PCR and ELISA methods. A transition plan will be prepared\nfor FDA Emergency Use Authorization (EUA) application of the biochip technology through a COVID-19 clinical\ntesting laboratory at OSU Wexner Medical Center. A commercialization plan will also be developed via licensing\nto a biotech company.\nWe have assembled a multi-disciplinary team with extensive knowledge and experience in nanobiotechnology,\nmicrofluidics, micro/nano-fabrication, infectious diseases, and clinical COVID-19 patient sample collection and\ntesting. The proposed aims and milestones are given as follows:\nSpecific Aim 1: Development of an integrated biochip to simultaneously capture, fix, and characterize\nsingle SARS-CoV-2 and IgG/IgM proteins. Milestones. (i) Sorting, capture, and quantitative analysis of\nselected proteins and viral RNA in single virus in spike experiments with >95% repeatability; (ii) A sensitivity of\nsingle virus detection with >90% repeatability and 5-fold better sensitivity than the current qRT-PCR and ELISA\nmethods. Specific Aim 2: Testing of single SARS-CoV-2 virus and associated IgG/IgM in biofluids from\nCOVID-19 patients. Milestones. (i) Quantitative analysis of clinical samples with >95% repeatability; (ii) 95%\nof concordance for the detection of SARS-CoV-2 between the biochip technology and the lab-based qRT-PCR\nand ELISA. Specific Aim 3: Biochip technology transition plan. Milestones. (i) Submission of documentation\nto the FDA Center for Devices and Radiological Health (CDRH) for EUA; (ii) Scale-up commercialization plan for\nGMP chip production.",
       "awardCode": "U18",
       "fundingMechanism": "Other Research-Related",
       "id": 35,
       "label": "Grant",
       "name": "Multi-parametric Integrated Molecular Detection of SARS-CoV-2 from Biofluids by Adapting Single Extracellular Vesicle Characterization Technologies",
       "narrative": "In this project, we propose to repurpose our single exosome-based characterization technology towards the\ndetection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection from biofluids. Our\napproach will enable the simultaneous detection of viral signals and host antibodies, including viral RNA, S-\nprotein, and associated IgG/IgM from the same sample on a single device, thus enabling enhanced diagnosis,\ndisease status, and prognostic assessment of COVID-19.",
       "researchInitiative": "RADx-rad",
       "subProject": "Exosome",
       "tooltip": "Grant\nabstract:The World Health Organization has recognized a global pandemic of novel coronavirus pneumonia (COVID-19)\nfrom exposure to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronaviruses (CoVs)\nare membrane-enveloped positive-sense, single-stranded RNA viruses decorated with membrane proteins. The\nspike (S) glycoprotein is implicated in the viral attachment and fusion to host cells via the human angiotensin-\nconverting enzyme 2 (hACE2). There are different assays to test for COVID-19, including nucleic acid, antigen,\nand serological tests that can be used in hospitals, point-of-care, and large-scale population testing. Nucleic acid\ntesting is the standard method for the detection of SARS-CoV-2, which consists of the amplification of viral RNA\nfrom nasopharyngeal swabs (NPS) by quantitative reverse-transcription polymerase chain reaction (qRT-PCR).\nFurthermore, given the invasive nature of NPS, saliva is being considered an alternative for detection. Methods\nthat bypass RNA extraction, as well as isothermal amplification such as loop-mediated isothermal amplification\n(LAMP), have been developed to improve the speed of viral RNA detection. However, viral protein expression\ncannot be detected by qRT-PCR. Serological tests, on the other hand, are based on host antibodies against the\nvirus (IgG/IgM). Although fast, these tests suffer from significant false negative/positive. Besides, they do not\ndetect a current infection. Therefore, to relieve the current healthcare crisis, new technologies capable of\nsimultaneous viral RNA/protein detection at the single virus level and host antibody response detection from a\nbody fluid in an integrated device would be highly valuable for enhanced COVID-19 diagnosis.\nRecently, our group, as part of Phase 2 of the Extracellular RNA Communication Consortium (ERCC2), has\nsuccessfully developed a microfluidics technology capable of capturing individual exosomes from biofluids and\nthen simultaneously quantify both exosomal surface proteins and RNA cargo. Given the resemblance in size\nand other characteristics between exosomes and coronaviruses, our technology can be adapted for COVID-19\ndiagnosis. Therefore, we propose to develop and validate a safe-to-use version of our microfluidics system for\ndirect detection of SARS-CoV-2. The integrated system is capable of multi-parametric detection for enhanced\nCOVID-19 diagnosis. The platform will be engineered to simultaneously quantify both viral protein, viral RNA,\nand host antibodies (IgG/IgM) in the same sample, enabling diagnosis, disease status, and prognostic\nassessment. Model systems, including host IgG/IgM from patient serum, standard synthetic vesicles (SVs), and\nheat-inactivated SARS-CoV-2 viral particles (SVVs), will be designed and spiked in biofluids to validate and\ncalibrate the system. To demonstrate the clinical utility, our biochip technology will be deployed and tested using\ndifferent biofluids from COVID-19 patients at two independent laboratories (Institute of Systems Biology in\nSeattle and The Ohio State University (OSU) Wexner Medical Center in Columbus). Measurements obtained\nfrom the biochips will be compared to standard qRT-PCR and ELISA methods. A transition plan will be prepared\nfor FDA Emergency Use Authorization (EUA) application of the biochip technology through a COVID-19 clinical\ntesting laboratory at OSU Wexner Medical Center. A commercialization plan will also be developed via licensing\nto a biotech company.\nWe have assembled a multi-disciplinary team with extensive knowledge and experience in nanobiotechnology,\nmicrofluidics, micro/nano-fabrication, infectious diseases, and clinical COVID-19 patient sample collection and\ntesting. The proposed aims and milestones are given as follows:\nSpecific Aim 1: Development of an integrated biochip to simultaneously capture, fix, and characterize\nsingle SARS-CoV-2 and IgG/IgM proteins. Milestones. (i) Sorting, capture, and quantitative analysis of\nselected proteins and viral RNA in single virus in spike experiments with >95% repeatability; (ii) A sensitivity of\nsingle virus detection with >90% repeatability and 5-fold better sensitivity than the current qRT-PCR and ELISA\nmethods. Specific Aim 2: Testing of single SARS-CoV-2 virus and associated IgG/IgM in biofluids from\nCOVID-19 patients. Milestones. (i) Quantitative analysis of clinical samples with >95% repeatability; (ii) 95%\nof concordance for the detection of SARS-CoV-2 between the biochip technology and the lab-based qRT-PCR\nand ELISA. Specific Aim 3: Biochip technology transition plan. Milestones. (i) Submission of documentation\nto the FDA Center for Devices and Radiological Health (CDRH) for EUA; (ii) Scale-up commercialization plan for\nGMP chip production.\nid:U18TR003807\nnarrative:In this project, we propose to repurpose our single exosome-based characterization technology towards the\ndetection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection from biofluids. Our\napproach will enable the simultaneous detection of viral signals and host antibodies, including viral RNA, S-\nprotein, and associated IgG/IgM from the same sample on a single device, thus enabling enhanced diagnosis,\ndisease status, and prognostic assessment of COVID-19.\nname:Multi-parametric Integrated Molecular Detection of SARS-CoV-2 from Biofluids by Adapting Single Extracellular Vesicle Characterization Technologies\nsubProject:Exosome\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U18"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8d79dd74babd4fe7b2e4e8b59d77e97a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "NISKAYUNA",
       "country": "UNITED STATES",
       "duns": "duns:086188401",
       "geonames": "geonames:4930956",
       "id": 588,
       "label": "Organization",
       "name": "General Electric (United States)",
       "ror": "ror:013msgt25",
       "state": "NY",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4930956\nror:ror:013msgt25\ncity:NISKAYUNA\nname:General Electric (United States)\nuei:uei:M2FYKG7HP723\nduns:duns:086188401\nstate:NY\nid:ror:013msgt25\nurl:https://ror.org/013msgt25",
       "uei": "uei:M2FYKG7HP723",
       "url": "https://ror.org/013msgt25"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8e1c44891d9241d391d32b25c7f82331": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 677,
       "target": 36
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8f525cc727fd45e49db6dbed70ef21c1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "CytoscapeModel",
     "state": {
      "_dom_classes": [],
      "_interaction_handlers": {},
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "CytoscapeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "CytoscapeView",
      "auto_ungrabify": false,
      "auto_unselectify": true,
      "autolock": false,
      "box_selection_enabled": false,
      "cytoscape_layout": {
       "name": "cola",
       "nodeDimensionsIncludeLabels": true,
       "nodeSpacing": 40,
       "padding": 0,
       "unconstrIter": 5000
      },
      "cytoscape_style": [
       {
        "selector": "node",
        "style": {
         "background-color": "#A5ABB6",
         "border-color": "#9AA1AC",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "edge",
        "style": {
         "curve-style": "bezier",
         "font-size": "8px",
         "label": "data(name)",
         "line-color": "#A5ABB6",
         "target-arrow-color": "#A5ABB6",
         "target-arrow-shape": "triangle",
         "text-rotation": "autorotate",
         "width": "1px"
        }
       },
       {
        "selector": "node[label=\"*\"]",
        "style": {
         "background-color": "#C990C0",
         "border-color": "#b261a5",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"City\"]",
        "style": {
         "background-color": "#F79767",
         "border-color": "#f36924",
         "border-width": "2px",
         "font-size": "10px",
         "height": "65px",
         "label": "data(name)",
         "text-max-width": "65px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "65px"
        }
       },
       {
        "selector": "node[label=\"Disease\"]",
        "style": {
         "background-color": "#569480",
         "border-color": "#447666",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Symptom\"]",
        "style": {
         "background-color": "#8DCC93",
         "border-color": "#5db665",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"Patient\"]",
        "style": {
         "background-color": "#4C8EDA",
         "border-color": "#2870c2",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(firstName)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"State\"]",
        "style": {
         "background-color": "#FFC454",
         "border-color": "#d7a013",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"MetaNode\"]",
        "style": {
         "background-color": "#D9C8AE",
         "border-color": "#c0a378",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(nodeName)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Grant\"]",
        "style": {
         "background-color": "#4C8EDA",
         "border-color": "#2870c2",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Researcher\"]",
        "style": {
         "background-color": "#FFC454",
         "border-color": "#d7a013",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"FundingOpportunity\"]",
        "style": {
         "background-color": "#DA7194",
         "border-color": "#cc3c6c",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Organization\"]",
        "style": {
         "background-color": "#569480",
         "border-color": "#447666",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Dataset\"]",
        "style": {
         "background-color": "#F79767",
         "border-color": "#f36924",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"CoordinationCenter\"]",
        "style": {
         "background-color": "#57C7E3",
         "border-color": "#23b3d7",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Event\"]",
        "style": {
         "background-color": "#8DCC93",
         "border-color": "#5db665",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Publication\"]",
        "style": {
         "background-color": "#AA7942",
         "border-color": "#8D6429",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Patent\"]",
        "style": {
         "background-color": "#C990C0",
         "border-color": "#b261a5",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Presentation\"]",
        "style": {
         "background-color": "#F16667",
         "border-color": "#eb2728",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Software\"]",
        "style": {
         "background-color": "#ECB5C9",
         "border-color": "#da7298",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"ResearchInitiative\"]",
        "style": {
         "background-color": "#57C7E3",
         "border-color": "#23b3d7",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "edge[name=\"MetaRelationship\"]",
        "style": {
         "curve-style": "bezier",
         "font-size": "8px",
         "label": "data(relationshipName)",
         "line-color": "#A5ABB6",
         "target-arrow-color": "#A5ABB6",
         "target-arrow-shape": "triangle",
         "text-rotation": "autorotate",
         "width": "1px"
        }
       }
      ],
      "desktop_tap_threshold": 4,
      "graph": "IPY_MODEL_989fbe6e10f74184b82d66be64b545bd",
      "headless": false,
      "hide_edges_on_viewport": false,
      "layout": "IPY_MODEL_993ca51c0aa54e199a3d79eecb3a0346",
      "max_zoom": 1e+50,
      "min_zoom": 1e-50,
      "motion_blur": false,
      "motion_blur_opacity": 0.2,
      "panning_enabled": true,
      "pixel_ratio": "auto",
      "rendered_position": {
       "renderedPosition": {
        "x": 100,
        "y": 100
       }
      },
      "selection_type": "single",
      "style_enabled": true,
      "texture_on_viewport": false,
      "tooltip_source": "tooltip",
      "touch_tap_threshold": 8,
      "user_panning_enabled": true,
      "user_zooming_enabled": true,
      "wheel_sensitivity": 1,
      "zoom": 2,
      "zooming_enabled": true
     }
    },
    "8f5c50749d4d45c8af42b55b8efbae63": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 672,
       "target": 609
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "8f8b609b8d44440286670bae5188aee7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Joseph",
       "fullName": "Joseph Loscalzo",
       "id": 621,
       "label": "Researcher",
       "lastName": "Loscalzo",
       "name": "Loscalzo J",
       "orcid": "orcid:0000-0002-1153-8047",
       "profileId": "profileid:1876423",
       "tooltip": "Researcher\nid:profileid:1876423\nlastName:Loscalzo\norcid:orcid:0000-0002-1153-8047\nprofileId:profileid:1876423\nname:Loscalzo J\nfullName:Joseph Loscalzo\nfirstName:Joseph"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9074eeb2da4e474abc0f65c6885891bc": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Marshallese Pacific Islanders bear a disproportionate burden of COVID-19 infection, hospitalization, and\ndeath, with rates 4 to 25 times higher than those of other US racial and ethnic groups in the Continental US.2,3\nFor example, in Northwest Arkansas Marshallese people represent less than 3% of the total population, but\nthey account for 1 out of 5 COVID-19 cases in this area.2 Similarly, Marshallese represent just 1% of the\npopulation in Spokane County, Washington, but were nearly 30% of COVID-19 cases between March and\nMay, 2020.4 Social determinants of health have powerful influences on community and individual risks for\nCOVID-19.18 Culturally, the Marshallese community is extremely tight-knit, self-contained, and highly clustered;\nthey often live in multi-generational households; and they traditionally value close contact and large social\nevents, all of which increase vulnerability to the COVID-19 pandemic.19,20Marshallese are important recipients\nof effective surveillance efforts given the disproportionate impact of COVID-19 on this population and the long-\nstanding disparities in health and health care.\n The MASC-UP study will generate novel data that reflect variation in risk of COVID-19 infection based on\none’s place in the highly clustered Marshallese community. For Specific Aim 1, bilingual Marshallese\nCommunity Health Workers will recruit and train a longitudinal cohort of 800 Marshallese adults, ages 18 and\nolder, in participatory disease surveillance methods that include using a wireless thermometer to continuously\ntrack body temperature; social media and text messaging in which participants (aka citizen scientists) can\nreport symptoms; and a CHW helpline to report symptoms and request COVID-19 information. Participatory\ndisease surveillance complements traditional surveillance systems by engaging communities in reporting\nCOVID-19 symptoms and events. Its strengths lie in the speed at which data can be made available, the ability\nto scale the technology to obtain data at low cost, and the ability to cover populations that might not otherwise\nbe tracked. For Specific Aim 2 participants will complete an ego-centric contact survey to characterize the\nsocial contact networks of members in the disease surveillance cohort from Aim 1. The networks will allow\nidentification of people at highest risk of COVID-19 infection and elucidate targets for high-impact preventive\nintervention. For Specific Aim 3 we will integrate findings from Aims 1 and 2 into the existing test-based\ndisease surveillance currently being performed at the state and local levels. This Aim will augment existing\nsurveillance systems that have proved insufficient to stem the pandemic in Marshallese people. The proposed\nstudy will be generalizable to other high risk, clustered underserved populations.",
       "awardCode": "R01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 32,
       "label": "Grant",
       "name": "Marshallese: Alternate Surveillance for COVID-19 in a Unique Population",
       "narrative": "The Marshallese: Alternate Surveillance for COVID-19 in a Unique Population (MASC UP) study will deploy\ninnovative, culturally tailored, multi-modal, multi-level participatory surveillance systems in 2 of the largest\nMarshallese communities in the US: Northwest Arkansas and Spokane County, Washington. MASC UP will\ndemonstrate the value of culturally tailored, participatory disease surveillance developed and tested in real-\nworld settings to mitigate COVID-19 disparities in a high-risk, clustered population that has been profoundly\nunderserved by public health efforts to date. Our findings can be rapidly adapted and disseminated for\nimproved surveillance and disease prevention in other high-risk minority groups across the US.",
       "researchInitiative": "RADx-rad",
       "subProject": "Multimodal Surveillance",
       "tooltip": "Grant\nabstract:Marshallese Pacific Islanders bear a disproportionate burden of COVID-19 infection, hospitalization, and\ndeath, with rates 4 to 25 times higher than those of other US racial and ethnic groups in the Continental US.2,3\nFor example, in Northwest Arkansas Marshallese people represent less than 3% of the total population, but\nthey account for 1 out of 5 COVID-19 cases in this area.2 Similarly, Marshallese represent just 1% of the\npopulation in Spokane County, Washington, but were nearly 30% of COVID-19 cases between March and\nMay, 2020.4 Social determinants of health have powerful influences on community and individual risks for\nCOVID-19.18 Culturally, the Marshallese community is extremely tight-knit, self-contained, and highly clustered;\nthey often live in multi-generational households; and they traditionally value close contact and large social\nevents, all of which increase vulnerability to the COVID-19 pandemic.19,20Marshallese are important recipients\nof effective surveillance efforts given the disproportionate impact of COVID-19 on this population and the long-\nstanding disparities in health and health care.\n The MASC-UP study will generate novel data that reflect variation in risk of COVID-19 infection based on\none’s place in the highly clustered Marshallese community. For Specific Aim 1, bilingual Marshallese\nCommunity Health Workers will recruit and train a longitudinal cohort of 800 Marshallese adults, ages 18 and\nolder, in participatory disease surveillance methods that include using a wireless thermometer to continuously\ntrack body temperature; social media and text messaging in which participants (aka citizen scientists) can\nreport symptoms; and a CHW helpline to report symptoms and request COVID-19 information. Participatory\ndisease surveillance complements traditional surveillance systems by engaging communities in reporting\nCOVID-19 symptoms and events. Its strengths lie in the speed at which data can be made available, the ability\nto scale the technology to obtain data at low cost, and the ability to cover populations that might not otherwise\nbe tracked. For Specific Aim 2 participants will complete an ego-centric contact survey to characterize the\nsocial contact networks of members in the disease surveillance cohort from Aim 1. The networks will allow\nidentification of people at highest risk of COVID-19 infection and elucidate targets for high-impact preventive\nintervention. For Specific Aim 3 we will integrate findings from Aims 1 and 2 into the existing test-based\ndisease surveillance currently being performed at the state and local levels. This Aim will augment existing\nsurveillance systems that have proved insufficient to stem the pandemic in Marshallese people. The proposed\nstudy will be generalizable to other high risk, clustered underserved populations.\nid:R01MD016526\nnarrative:The Marshallese: Alternate Surveillance for COVID-19 in a Unique Population (MASC UP) study will deploy\ninnovative, culturally tailored, multi-modal, multi-level participatory surveillance systems in 2 of the largest\nMarshallese communities in the US: Northwest Arkansas and Spokane County, Washington. MASC UP will\ndemonstrate the value of culturally tailored, participatory disease surveillance developed and tested in real-\nworld settings to mitigate COVID-19 disparities in a high-risk, clustered population that has been profoundly\nunderserved by public health efforts to date. Our findings can be rapidly adapted and disseminated for\nimproved surveillance and disease prevention in other high-risk minority groups across the US.\nname:Marshallese: Alternate Surveillance for COVID-19 in a Unique Population\nsubProject:Multimodal Surveillance\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9120e1fba8364e54b4d4ab7a955c37c2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1091,
       "target": 2811
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9214242b62854ba9b397fac83d94abe1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 612,
       "target": 606
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "93659fa346534dcaaac133e830bd763c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Abstract of the publication (string)",
       "doi": "Digital Object Identifier of the publication (string)",
       "id": 2754,
       "journal": "Name of the journal (string)",
       "label": "MetaNode",
       "name": "Title of the publication (string)",
       "nodeName": "Publication",
       "pmId": "PubMed identifier of the publication (string)",
       "pmcId": "PubMedCentral identifier of the publication full text entry (string)",
       "tooltip": "MetaNode\nnodeName:Publication\njournal:Name of the journal (string)\nyear:Year of publication (int)\nname:Title of the publication (string)\nid:Unique identifier for the publication (string)\nabstract:Abstract of the publication (string)\ntype:primary or secondary citation (string)\npmId:PubMed identifier of the publication (string)\npmcId:PubMedCentral identifier of the publication full text entry (string)\nurl:URL of publication (string)\ndoi:Digital Object Identifier of the publication (string)",
       "type": "primary or secondary citation (string)",
       "url": "URL of publication (string)",
       "year": "Year of publication (int)"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "93d34947740e4a9b9705c6539a4cc708": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 703,
       "target": 561
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "940602eec24c469b90d0dfa46397abbf": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The Rutgers Optimizes Innovation (ROI) Program will provide a vertically integrated mechanism to swiftly\nuncover promising biomedical product discoveries, and seamlessly guide the innovator through the\ncommercialization process with financial and regulatory, IP protection, mentoring, management, and educational\nresources. Drawing on the biomedical/bioengineering sciences across Rutgers and on the solid expertise of the\nOffice of Research Commercialization (ORC), we will integrate our strengths to uncover, develop and\ncommercialize discoveries that improve health and well-being, and train the next generation of innovators. The\nROI Program comprises a cooperative of Rutgers University and affiliates that includes the schools of\nengineering, arts and sciences, schools of medicine, nursing, dental science, public health, and research\ninstitutes and centers, industries, incubators, funders and policymakers.\n All entities provide significant resources to the ROI Program and have contributed to the planning, development,\nand leadership composition of the cooperative. Based in one of the most productive states with respect to\ncommercialization of health-related discoveries (assets), the ROI Program will serve as a platform for translating\nbiomedical discoveries into marketable products. Our REACH Hub will identify innovative health-related\ntechnologies by using the expertise of the NCI-funded Cancer Institute of NJ (CINJ), the Rutgers Institute for\nTranslational Medicine and Science (RITMS, lead of the NCATS-funded CTSA) and the Biomaterials Center,\nfunded by NSF and DOD. These technologies will be evaluated for commercialization feasibility, especially with\nrespect to providing precision therapy to tackle an unmet need created by the heterogeneity of disease\npathogenesis and response to treatment. Addressing such unmet needs will provide assets tailored to patients’\ntherapeutic responses that ultimately improves population health.\n The ROI Program will provide a streamlined and harmonized infrastructure that will enhance commercialization\nof academic discovery. The educational programs embedded in the ROI Program will provide our innovators\nwith hands-on, practical training in product development and start-up requirements, while also training a diverse\nworkforce in biomedical innovation by leveraging, coalescing and repurposing current resources, including I-\nCorps and iJOBS. Implementing a unique project management and mentoring program comprised of industry,\ndisease-state and content experts will also enhance innovators’ opportunity for success. Embracing a Fail Fast\nPhilosophy assures the technology will be developed in a cost-effective and market-conscious manner. Across\nall Aims, the ROI Program will collaborate with the REACH Consortium to build on their advances in platforms for\ncommercialization, technology review, and training, and provide the Consortium with our expertise and commitment to\nserve as an active participating member. Importantly, evaluation milestones and metrics are planned in all aspects\nof the ROI Program to assure continuous quality assessment, improvement and sustainability.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 3,
       "label": "Grant",
       "name": "Rutgers Optimizes Innovation (ROI) Program",
       "narrative": "The Rutgers Optimizes Innovation (ROI) Program will accelerate the transformation of the most promising\nresearch discoveries into marketed products designed to provide the right therapy to the right patient at\nthe right time. By identifying and advancing the most promising and transformative therapeutic and diagnostic\ntechnologies in precision medicine, ROI will impact the health and well-being of a diverse society.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:The Rutgers Optimizes Innovation (ROI) Program will provide a vertically integrated mechanism to swiftly\nuncover promising biomedical product discoveries, and seamlessly guide the innovator through the\ncommercialization process with financial and regulatory, IP protection, mentoring, management, and educational\nresources. Drawing on the biomedical/bioengineering sciences across Rutgers and on the solid expertise of the\nOffice of Research Commercialization (ORC), we will integrate our strengths to uncover, develop and\ncommercialize discoveries that improve health and well-being, and train the next generation of innovators. The\nROI Program comprises a cooperative of Rutgers University and affiliates that includes the schools of\nengineering, arts and sciences, schools of medicine, nursing, dental science, public health, and research\ninstitutes and centers, industries, incubators, funders and policymakers.\n All entities provide significant resources to the ROI Program and have contributed to the planning, development,\nand leadership composition of the cooperative. Based in one of the most productive states with respect to\ncommercialization of health-related discoveries (assets), the ROI Program will serve as a platform for translating\nbiomedical discoveries into marketable products. Our REACH Hub will identify innovative health-related\ntechnologies by using the expertise of the NCI-funded Cancer Institute of NJ (CINJ), the Rutgers Institute for\nTranslational Medicine and Science (RITMS, lead of the NCATS-funded CTSA) and the Biomaterials Center,\nfunded by NSF and DOD. These technologies will be evaluated for commercialization feasibility, especially with\nrespect to providing precision therapy to tackle an unmet need created by the heterogeneity of disease\npathogenesis and response to treatment. Addressing such unmet needs will provide assets tailored to patients’\ntherapeutic responses that ultimately improves population health.\n The ROI Program will provide a streamlined and harmonized infrastructure that will enhance commercialization\nof academic discovery. The educational programs embedded in the ROI Program will provide our innovators\nwith hands-on, practical training in product development and start-up requirements, while also training a diverse\nworkforce in biomedical innovation by leveraging, coalescing and repurposing current resources, including I-\nCorps and iJOBS. Implementing a unique project management and mentoring program comprised of industry,\ndisease-state and content experts will also enhance innovators’ opportunity for success. Embracing a Fail Fast\nPhilosophy assures the technology will be developed in a cost-effective and market-conscious manner. Across\nall Aims, the ROI Program will collaborate with the REACH Consortium to build on their advances in platforms for\ncommercialization, technology review, and training, and provide the Consortium with our expertise and commitment to\nserve as an active participating member. Importantly, evaluation milestones and metrics are planned in all aspects\nof the ROI Program to assure continuous quality assessment, improvement and sustainability.\nid:U01HL150852\nnarrative:The Rutgers Optimizes Innovation (ROI) Program will accelerate the transformation of the most promising\nresearch discoveries into marketed products designed to provide the right therapy to the right patient at\nthe right time. By identifying and advancing the most promising and transformative therapeutic and diagnostic\ntechnologies in precision medicine, ROI will impact the health and well-being of a diverse society.\nname:Rutgers Optimizes Innovation (ROI) Program\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "947678ab544b4eff9000b69a620a8036": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "IS_INVENTOR",
       "source": 617,
       "target": 2412
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "94e8124e310f42429aaaa6371342ed40": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Airborne transmission via virus-laden aerosols is a dominant route for the transmission of respiratory diseases, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Direct, non-invasive screening of respiratory virus aerosols in patients has been a long-standing technical challenge. Here, we introduce a point-of-care testing platform that directly detects SARS-CoV-2 aerosols in as little as two exhaled breaths of patients and provides results in under 60 s. It integrates a hand-held breath aerosol collector and a llama-derived, SARS-CoV-2 spike-protein specific nanobody bound to an ultrasensitive micro-immunoelectrode biosensor, which detects the oxidation of tyrosine amino acids present in SARS-CoV-2 viral particles. Laboratory and clinical trial results were within 20% of those obtained using standard testing methods. Importantly, the electrochemical biosensor directly detects the virus itself, as opposed to a surrogate or signature of the virus, and is sensitive to as little as 10 viral particles in a sample. Our platform holds the potential to be adapted for multiplexed detection of different respiratory viruses. It provides a rapid and non-invasive alternative to conventional viral diagnostics.",
       "doi": "doi:10.1021/acssensors.3c00512",
       "id": 2767,
       "journal": "ACS sensors",
       "label": "Publication",
       "name": "Rapid Direct Detection of SARS-CoV-2 Aerosols in Exhaled Breath at the Point of Care.",
       "pmId": "37498298",
       "pmcId": "PMC10463275",
       "tooltip": "Publication\njournal:ACS sensors\nabstract:Airborne transmission via virus-laden aerosols is a dominant route for the transmission of respiratory diseases, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Direct, non-invasive screening of respiratory virus aerosols in patients has been a long-standing technical challenge. Here, we introduce a point-of-care testing platform that directly detects SARS-CoV-2 aerosols in as little as two exhaled breaths of patients and provides results in under 60 s. It integrates a hand-held breath aerosol collector and a llama-derived, SARS-CoV-2 spike-protein specific nanobody bound to an ultrasensitive micro-immunoelectrode biosensor, which detects the oxidation of tyrosine amino acids present in SARS-CoV-2 viral particles. Laboratory and clinical trial results were within 20% of those obtained using standard testing methods. Importantly, the electrochemical biosensor directly detects the virus itself, as opposed to a surrogate or signature of the virus, and is sensitive to as little as 10 viral particles in a sample. Our platform holds the potential to be adapted for multiplexed detection of different respiratory viruses. It provides a rapid and non-invasive alternative to conventional viral diagnostics.\nid:doi:10.1021/acssensors.3c00512\nname:Rapid Direct Detection of SARS-CoV-2 Aerosols in Exhaled Breath at the Point of Care.\npmId:37498298\nyear:2023\ntype:primary\npmcId:PMC10463275\nurl:https://doi.org/doi:10.1021/acssensors.3c00512\ndoi:doi:10.1021/acssensors.3c00512",
       "type": "primary",
       "url": "https://doi.org/doi:10.1021/acssensors.3c00512",
       "year": 2023
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9530610dfd864a0f84cb1965b8f28086": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Recent studies, including ours, have suggested that breath may allow us to diagnose COVID-19 infection\nand even monitor its progress. As compared to immunological and genetic based methods using sample media\nlike blood, nasopharyngeal swab, and saliva, breath analysis is non-invasive, simple, safe, and inexpensive; it\nallows a nearly infinite amount of sample volume and can be used at the point-of-care for rapid detection.\nFundamentally, breath also provides critical metabolomics information regarding how human body responds to\nvirus infection and medical intervention (such as drug treatment and mechanical ventilation). The objectives of\nthe proposed SCENT project are: (1) to refine automated, portable, high-performance micro-gas\nchromatography (GC) device and related data analysis / biomarker identification algorithms for rapid (5-6\nminutes), in-situ, and sensitive (down to ppt) breath analysis and (2) to conduct breath analysis on up to 760\npatients, and identify and validate the COVID-19 biomarkers in breath. Thus, in coordination with the RADx-rad\nData Coordination Center (DCC), we will complete the following specific aims.\n(1) Refine 5 automated micro-GC devices to achieve higher speed and better separation capability. We\nwill construct 5 new automated and portable one-dimensional micro-GC devices that require only ~6 minutes of\nassay time (improved from current 20 minutes) at the ppt level sensitivity (Sub-Aim 1a). Then the devices will be\nupgraded to 2-dimensional micro-GC to significantly increase the separation capability (Sub-Aim 1b). In the\nmeantime, we will optimize and automate our existing data processing and biomarker identification algorithms\nand codes to streamline the workflow so that the GC device can automatically process and analyze the data\nwithout human intervention (Sub-Aim 1c).\n(2) Identify breath biomarkers that distinguish COVID-19 positive (symptomatic and asymptomatic) and\nnegative patients. We will recruit a training cohort of 380 participants, including 190 COVID-19 positive patients\n(95 symptomatic and 95 asymptomatic) and 190 COVID-19 negative patients from two hospitals (Michigan\nMedicine – Ann Arbor and the Henry Ford Hospital – Detroit). We will conduct breath analysis using machine\nlearning to identify VOC patterns that match each COVID-19 diagnostic status.\n(3) Validate the COVID-19 biomarkers using our refined micro-GC devices. Using the refined 2-D micro-GC\ndevices from Sub-Aim 1b, we will recruit a new validation cohort of 380 participants (190 COVID-19 positive\npatients and 190 COVID-19 negative patients) to validate the biomarkers identified in Aim 2.\n We will leverage existing engineering, data science, clinical, regulatory, and commercialization resources\nthroughout the project to hit our milestones, ensuring a high likelihood of rapid patient impact. Upon completion\nof this work, we will have a portable micro-GC device and accompanying automated algorithms that can detect\nand monitor COVID-19 status for people in a variety of clinical and community settings.",
       "awardCode": "U18",
       "fundingMechanism": "Other Research-Related",
       "id": 21,
       "label": "Grant",
       "name": "COVID-19 detection through scent analysis with a compact GC device",
       "narrative": "Our team of engineers, clinicians, and data scientists has developed a portable, high\nperformance breath analyzer that can be used to detect certain diseases. In this project, we will\nadapt and refine our existing device and algorithms so they can be used for rapid, safe, and non-\ninvasive COVID-19 detection. People will simply breath into the device and it will quickly provide\nresults, meaning that it can be used in a variety of everyday settings to help fight against the\nCOVID-19 pandemic.",
       "researchInitiative": "RADx-rad",
       "subProject": "SCENT",
       "tooltip": "Grant\nabstract:Recent studies, including ours, have suggested that breath may allow us to diagnose COVID-19 infection\nand even monitor its progress. As compared to immunological and genetic based methods using sample media\nlike blood, nasopharyngeal swab, and saliva, breath analysis is non-invasive, simple, safe, and inexpensive; it\nallows a nearly infinite amount of sample volume and can be used at the point-of-care for rapid detection.\nFundamentally, breath also provides critical metabolomics information regarding how human body responds to\nvirus infection and medical intervention (such as drug treatment and mechanical ventilation). The objectives of\nthe proposed SCENT project are: (1) to refine automated, portable, high-performance micro-gas\nchromatography (GC) device and related data analysis / biomarker identification algorithms for rapid (5-6\nminutes), in-situ, and sensitive (down to ppt) breath analysis and (2) to conduct breath analysis on up to 760\npatients, and identify and validate the COVID-19 biomarkers in breath. Thus, in coordination with the RADx-rad\nData Coordination Center (DCC), we will complete the following specific aims.\n(1) Refine 5 automated micro-GC devices to achieve higher speed and better separation capability. We\nwill construct 5 new automated and portable one-dimensional micro-GC devices that require only ~6 minutes of\nassay time (improved from current 20 minutes) at the ppt level sensitivity (Sub-Aim 1a). Then the devices will be\nupgraded to 2-dimensional micro-GC to significantly increase the separation capability (Sub-Aim 1b). In the\nmeantime, we will optimize and automate our existing data processing and biomarker identification algorithms\nand codes to streamline the workflow so that the GC device can automatically process and analyze the data\nwithout human intervention (Sub-Aim 1c).\n(2) Identify breath biomarkers that distinguish COVID-19 positive (symptomatic and asymptomatic) and\nnegative patients. We will recruit a training cohort of 380 participants, including 190 COVID-19 positive patients\n(95 symptomatic and 95 asymptomatic) and 190 COVID-19 negative patients from two hospitals (Michigan\nMedicine – Ann Arbor and the Henry Ford Hospital – Detroit). We will conduct breath analysis using machine\nlearning to identify VOC patterns that match each COVID-19 diagnostic status.\n(3) Validate the COVID-19 biomarkers using our refined micro-GC devices. Using the refined 2-D micro-GC\ndevices from Sub-Aim 1b, we will recruit a new validation cohort of 380 participants (190 COVID-19 positive\npatients and 190 COVID-19 negative patients) to validate the biomarkers identified in Aim 2.\n We will leverage existing engineering, data science, clinical, regulatory, and commercialization resources\nthroughout the project to hit our milestones, ensuring a high likelihood of rapid patient impact. Upon completion\nof this work, we will have a portable micro-GC device and accompanying automated algorithms that can detect\nand monitor COVID-19 status for people in a variety of clinical and community settings.\nid:U18TR003812\nnarrative:Our team of engineers, clinicians, and data scientists has developed a portable, high\nperformance breath analyzer that can be used to detect certain diseases. In this project, we will\nadapt and refine our existing device and algorithms so they can be used for rapid, safe, and non-\ninvasive COVID-19 detection. People will simply breath into the device and it will quickly provide\nresults, meaning that it can be used in a variety of everyday settings to help fight against the\nCOVID-19 pandemic.\nname:COVID-19 detection through scent analysis with a compact GC device\nsubProject:SCENT\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U18"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "95de76b5a9644e73a335a61d9c74588a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The rapid onset of the COVID-19 pandemic left many across the world unprepared to test, treat, and plan for\ncoronavirus morbidity and mortality. This was true for Tribal nations, whose sovereign status enabled swift and\npreventative measures such as lock-downs and border closures, yet whose culture contributed to additional\nunique risk factors. Among those are testing disparities, underlying health factors, and community infrastructure.\nHowever, clinical testing doesn’t capture the extent of positive cases, and without the collective efforts of this\nproject, Tribes will likely not be included in wastewater-based epidemiology (WBE) analysis, which has garnered\nwide-spread interest due to its ability to generate data in advance of community infectivity. In this project, we will\nshow that WBE is a non-invasive, culturally appropriate biomonitoring strategy that can be adopted and\nimplemented by Tribal communities to empower them with a practical, yet technologically advanced health\nsurveillance tool. Building upon a rigorous methodology of Tribal consultation and community-based participatory\nresearch, assessment of wastewater and community infrastructure, and training of Tribal wastewater operators\nand health administrators on WBE, we will form the WBE Tribal Coordination Center. Tribes will be recruited\nthrough the InterTribal Council of Arizona’s National Tribal Water and Wastewater Operator Training Program\nnetwork. We will measure coronavirus in wastewater across U.S. reservations using established RT-qPCR\ntechniques and a novel protein quantification method, and we will sequence viral RNA extracts to assess SARS-\nCoV-2 variants in Tribal communities. Risk factors contributing to elevated COVID-19 in Tribal communities will\nbe quantified with integration of geospatial analysis. Frameworks for risks from numerous environmentally-\ntransmitted pathogens have been developed by our team, setting a foundation to incorporate variability and\nuncertainty for Tribal settings with qualitative information from Tribes in order to appropriately scope our modeling\nefforts. Simulation results will help to target resources efficiently for monitoring and public health interventions\nby identifying specific sampling locations where it is most likely to detect SARS-CoV-2 given other community\nand scientific constraints. Information from the RADx Data Coordination Center will be used to the fullest extent\nto compare Tribal communities with their non-Tribal counterparts. Through the coronavirus pandemic and\nbeyond, Tribes will be better informed of their ability to use WBE to measure community health, thereby\nprotecting community health and building capacity for future applications and research translation.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 44,
       "label": "Grant",
       "name": "Wastewater Analysis of SARS CoV-2 in Tribal Communities",
       "narrative": "SARS-CoV-2 wastewater-based epidemiology is particularly applicable for Tribal communities who wish to\nimprove testing rates, are managing operational plans, or want to observe temporal trends within a defined\nsewershed. Our approach of analyzing wastewater for human metabolites and pathogens addresses known and\nwell-documented concerns of violation of cultural norms by avoiding the collection and analysis biospecimens of\nindividuals. By effectively working with Tribes, these efforts will culminate in a robust data stream to inform\nleadership, health administrators and wastewater utilities of coronavirus trends reflective of the population from\nwhich samples are collected.",
       "researchInitiative": "RADx-rad",
       "subProject": "Wastewater",
       "tooltip": "Grant\nabstract:The rapid onset of the COVID-19 pandemic left many across the world unprepared to test, treat, and plan for\ncoronavirus morbidity and mortality. This was true for Tribal nations, whose sovereign status enabled swift and\npreventative measures such as lock-downs and border closures, yet whose culture contributed to additional\nunique risk factors. Among those are testing disparities, underlying health factors, and community infrastructure.\nHowever, clinical testing doesn’t capture the extent of positive cases, and without the collective efforts of this\nproject, Tribes will likely not be included in wastewater-based epidemiology (WBE) analysis, which has garnered\nwide-spread interest due to its ability to generate data in advance of community infectivity. In this project, we will\nshow that WBE is a non-invasive, culturally appropriate biomonitoring strategy that can be adopted and\nimplemented by Tribal communities to empower them with a practical, yet technologically advanced health\nsurveillance tool. Building upon a rigorous methodology of Tribal consultation and community-based participatory\nresearch, assessment of wastewater and community infrastructure, and training of Tribal wastewater operators\nand health administrators on WBE, we will form the WBE Tribal Coordination Center. Tribes will be recruited\nthrough the InterTribal Council of Arizona’s National Tribal Water and Wastewater Operator Training Program\nnetwork. We will measure coronavirus in wastewater across U.S. reservations using established RT-qPCR\ntechniques and a novel protein quantification method, and we will sequence viral RNA extracts to assess SARS-\nCoV-2 variants in Tribal communities. Risk factors contributing to elevated COVID-19 in Tribal communities will\nbe quantified with integration of geospatial analysis. Frameworks for risks from numerous environmentally-\ntransmitted pathogens have been developed by our team, setting a foundation to incorporate variability and\nuncertainty for Tribal settings with qualitative information from Tribes in order to appropriately scope our modeling\nefforts. Simulation results will help to target resources efficiently for monitoring and public health interventions\nby identifying specific sampling locations where it is most likely to detect SARS-CoV-2 given other community\nand scientific constraints. Information from the RADx Data Coordination Center will be used to the fullest extent\nto compare Tribal communities with their non-Tribal counterparts. Through the coronavirus pandemic and\nbeyond, Tribes will be better informed of their ability to use WBE to measure community health, thereby\nprotecting community health and building capacity for future applications and research translation.\nid:U01DA053976\nnarrative:SARS-CoV-2 wastewater-based epidemiology is particularly applicable for Tribal communities who wish to\nimprove testing rates, are managing operational plans, or want to observe temporal trends within a defined\nsewershed. Our approach of analyzing wastewater for human metabolites and pathogens addresses known and\nwell-documented concerns of violation of cultural norms by avoiding the collection and analysis biospecimens of\nindividuals. By effectively working with Tribes, these efforts will culminate in a robust data stream to inform\nleadership, health administrators and wastewater utilities of coronavirus trends reflective of the population from\nwhich samples are collected.\nname:Wastewater Analysis of SARS CoV-2 in Tribal Communities\nsubProject:Wastewater\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "964ff70063c4427183ebca314257c07e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "In adults, SARS-CoV-2 infection exhibits a wide range of clinical outcomes, from asymptomatic and mild disease\nto severe viral pneumonia, respiratory distress, acute kidney injury, thrombotic disorders, and serious cardiac,\ncerebrovascular and vascular complications. Severe infection can also occur both in children and young adults\n(< 21), and a significant proportion of children admitted with Covid-19 require ICU support, frequently including\nmechanical ventilation. In addition, children and adolescents with initially asymptomatic SARS-CoV-2 infection\nhave presented with a rare, but very severe multisystem inflammatory syndrome (MIS-C). Epidemiologic, clinical\nand laboratory predictors of progression towards severe forms of acute infection with SARS-CoV-2 and MIS-C\nare thus urgently needed in the fight against Covid-19 in this population. As defined in the NIH Rapid\nAcceleration of Diagnostics (RADx) program, biomarker discovery can enable risk stratification and guide\ninterventional studies to target Covid-19 patients at enhanced risk of developing complications and/or severe\ndisease. To target this discovery initiative, herein we will use a battery of biological, immunological and molecular\ntests, including Grating-Coupled Fluorescence Plasmonic (GCFP) and advanced flow cytometry, to study\nchildren and young adults (<21 years) with mild, moderate or severe SARS-CoV-2 infection. GCFP allows the\nuse of disposable biosensor chips that can be mass-produced at low cost and spotted in microarray format to\ngreatly increase multiplexing capabilities. In addition, we will use a similar biomarker approach for rapid\ndifferentiation of patients with MIS-C versus other pediatric infectious or inflammatory conditions where the\nclinical presentation resembles MIS-C, most importantly Kawasaki disease. A child’s biologic and immunologic\nresponse to SARS-CoV-2 exposure is likely influenced by a variety of factors, including genetics, epigenetics\nand products of the mucosa/gut-brain axis, adipose tissue and neuroendocrine immune network, and further\nmodulated by environmental exposures. With these factors in mind, we hypothesize that a child’s biomarker\nprofile in response to SARS-CoV-2 infection enables a timely and accurate prediction of severity of Covid-19\nand diagnosis of MIS-C, and will help guide treatment strategies, and predict patient outcomes. To test this\nhypothesis, we will use a non-traditional diagnostic and comprehensive biomarker discovery to characterize the\nclinical and laboratory spectrum of children and adolescents with mild, moderate and severe SARS-CoV-2\ninfection, as well as MIS-C. We will then validate our newly developed diagnostic and prognostic algorithm to\ndistinguish MIS-C from other inflammatory disorders with overlapping clinical manifestations, including Kawasaki\ndisease, and predict the longitudinal risk of complications.",
       "awardCode": "R61",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 30,
       "label": "Grant",
       "name": "Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)",
       "narrative": "SARS-CoV-2 infection has harshly impacted health care outcomes in children and young adults. This\ngroundbreaking project will employ multiple state-of-the-art technologies and approaches to evaluate children\nand young adults (<21), enrolled in the United States and Colombia, across the spectrum of clinical\nmanifestations of Covid-19 to identify and validate biomolecules or bacterial signatures with diagnostic and\nprognostic value.",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nabstract:In adults, SARS-CoV-2 infection exhibits a wide range of clinical outcomes, from asymptomatic and mild disease\nto severe viral pneumonia, respiratory distress, acute kidney injury, thrombotic disorders, and serious cardiac,\ncerebrovascular and vascular complications. Severe infection can also occur both in children and young adults\n(< 21), and a significant proportion of children admitted with Covid-19 require ICU support, frequently including\nmechanical ventilation. In addition, children and adolescents with initially asymptomatic SARS-CoV-2 infection\nhave presented with a rare, but very severe multisystem inflammatory syndrome (MIS-C). Epidemiologic, clinical\nand laboratory predictors of progression towards severe forms of acute infection with SARS-CoV-2 and MIS-C\nare thus urgently needed in the fight against Covid-19 in this population. As defined in the NIH Rapid\nAcceleration of Diagnostics (RADx) program, biomarker discovery can enable risk stratification and guide\ninterventional studies to target Covid-19 patients at enhanced risk of developing complications and/or severe\ndisease. To target this discovery initiative, herein we will use a battery of biological, immunological and molecular\ntests, including Grating-Coupled Fluorescence Plasmonic (GCFP) and advanced flow cytometry, to study\nchildren and young adults (<21 years) with mild, moderate or severe SARS-CoV-2 infection. GCFP allows the\nuse of disposable biosensor chips that can be mass-produced at low cost and spotted in microarray format to\ngreatly increase multiplexing capabilities. In addition, we will use a similar biomarker approach for rapid\ndifferentiation of patients with MIS-C versus other pediatric infectious or inflammatory conditions where the\nclinical presentation resembles MIS-C, most importantly Kawasaki disease. A child’s biologic and immunologic\nresponse to SARS-CoV-2 exposure is likely influenced by a variety of factors, including genetics, epigenetics\nand products of the mucosa/gut-brain axis, adipose tissue and neuroendocrine immune network, and further\nmodulated by environmental exposures. With these factors in mind, we hypothesize that a child’s biomarker\nprofile in response to SARS-CoV-2 infection enables a timely and accurate prediction of severity of Covid-19\nand diagnosis of MIS-C, and will help guide treatment strategies, and predict patient outcomes. To test this\nhypothesis, we will use a non-traditional diagnostic and comprehensive biomarker discovery to characterize the\nclinical and laboratory spectrum of children and adolescents with mild, moderate and severe SARS-CoV-2\ninfection, as well as MIS-C. We will then validate our newly developed diagnostic and prognostic algorithm to\ndistinguish MIS-C from other inflammatory disorders with overlapping clinical manifestations, including Kawasaki\ndisease, and predict the longitudinal risk of complications.\nid:R61HD105613\nnarrative:SARS-CoV-2 infection has harshly impacted health care outcomes in children and young adults. This\ngroundbreaking project will employ multiple state-of-the-art technologies and approaches to evaluate children\nand young adults (<21), enrolled in the United States and Colombia, across the spectrum of clinical\nmanifestations of Covid-19 to identify and validate biomolecules or bacterial signatures with diagnostic and\nprognostic value.\nname:Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)\nsubProject:PreVAIL kIds\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R61"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "966cf9ca7c6a4a71936c85c6332a65af": {
     "model_module": "@jupyter-widgets/controls",
     "model_module_version": "1.5.0",
     "model_name": "DescriptionStyleModel",
     "state": {
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "DescriptionStyleModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "StyleView",
      "description_width": ""
     }
    },
    "96e4007e116d4b608374d787cf93a469": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 661,
       "target": 564
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9788c70579e340fbbc64cadf07b8f8c8": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "With older age and multiple comorbidities, dialysis patients are at high risk for serious complications, even death,\nfrom COVID-19. There is a large disproportionate representation of minorities, especially Blacks and Hispanics.\nOver 85% of hemodialysis patients travel three times a week to dialysis facilities to receive life-sustaining\ntreatments and cannot shelter in place. There is a critical need to characterize COVID-19 transmission pathways\nin dialysis patients and clinics, identify potential coronavirus carriers, and develop procedures to curb the spread.\nWith regular medical encounters, a large amount of data has been collected for each patient over time. These\ndata have not been fully utilized for COVID-19 prediction and control in dialysis clinics. In this proposal, we seek\nto leverage demographic, clinical, treatment, laboratory, socioeconomic, serological, metabolomic, wearable and\nmachine-integrated sensors, and COVID-19 surveillance data to develop mathematical and statistical models\nand implement them in a large number of dialysis clinics. The mathematical and statistical modeling using\nmultiple data resources will help us understand how COVID-19 spread in dialysis facilities, identify potential\nCOVID-19 patients before symptoms appear, and identify potential asymptomatic COVID-19 patients. We will\ndevelop novel mathematical and statistical models that fully utilize the high dimensional multimodal data\navailable to us and other dialysis providers. We capitalize on the intrinsic advantages of hemodialysis clinics to\nimplement and validate the proposed prediction models. We firmly believe that this cross-disciplinary effort will\nimprove patients’ and staff’s safety while delivering high-quality, individualized care to a high-risk population.",
       "awardCode": "R01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 28,
       "label": "Grant",
       "name": "Early detection, containment, and management of COVID-19 in dialysis facilities using multi-modal data sources",
       "narrative": "Dialysis patients are at high risk for serious complications, even death, from COVID-19. We aim to leverage\nmultimodal data to develop mathematical and statistical models and implement them in a large number of\ndialysis clinics. Our cross-disciplinary effort will improve patients' and staff's safety while delivering high-quality,\nindividualized care to a high-risk population.",
       "researchInitiative": "RADx-rad",
       "subProject": "Multimodal Surveillance",
       "tooltip": "Grant\nabstract:With older age and multiple comorbidities, dialysis patients are at high risk for serious complications, even death,\nfrom COVID-19. There is a large disproportionate representation of minorities, especially Blacks and Hispanics.\nOver 85% of hemodialysis patients travel three times a week to dialysis facilities to receive life-sustaining\ntreatments and cannot shelter in place. There is a critical need to characterize COVID-19 transmission pathways\nin dialysis patients and clinics, identify potential coronavirus carriers, and develop procedures to curb the spread.\nWith regular medical encounters, a large amount of data has been collected for each patient over time. These\ndata have not been fully utilized for COVID-19 prediction and control in dialysis clinics. In this proposal, we seek\nto leverage demographic, clinical, treatment, laboratory, socioeconomic, serological, metabolomic, wearable and\nmachine-integrated sensors, and COVID-19 surveillance data to develop mathematical and statistical models\nand implement them in a large number of dialysis clinics. The mathematical and statistical modeling using\nmultiple data resources will help us understand how COVID-19 spread in dialysis facilities, identify potential\nCOVID-19 patients before symptoms appear, and identify potential asymptomatic COVID-19 patients. We will\ndevelop novel mathematical and statistical models that fully utilize the high dimensional multimodal data\navailable to us and other dialysis providers. We capitalize on the intrinsic advantages of hemodialysis clinics to\nimplement and validate the proposed prediction models. We firmly believe that this cross-disciplinary effort will\nimprove patients’ and staff’s safety while delivering high-quality, individualized care to a high-risk population.\nid:R01DK130067\nnarrative:Dialysis patients are at high risk for serious complications, even death, from COVID-19. We aim to leverage\nmultimodal data to develop mathematical and statistical models and implement them in a large number of\ndialysis clinics. Our cross-disciplinary effort will improve patients' and staff's safety while delivering high-quality,\nindividualized care to a high-risk population.\nname:Early detection, containment, and management of COVID-19 in dialysis facilities using multi-modal data sources\nsubProject:Multimodal Surveillance\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "98584bb631f24f98ac553fda05dfb07b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4396,
       "label": "FundingOpportunity",
       "name": "Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)",
       "tooltip": "FundingOpportunity\nname:Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)\nid:PA-20-272\nurl:https://grants.nih.gov/grants/guide/pa-files/PA-20-272.html",
       "url": "https://grants.nih.gov/grants/guide/pa-files/PA-20-272.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "989fbe6e10f74184b82d66be64b545bd": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "GraphModel",
     "state": {
      "_adj": {
       "1022": {},
       "1101": {},
       "1186": {},
       "1196": {},
       "1290": {},
       "1341": {},
       "1428": {},
       "1513": {},
       "1740": {},
       "1800": {},
       "1888": {},
       "1901": {},
       "2347": {},
       "2409": {},
       "2414": {},
       "2708": {},
       "2716": {},
       "2741": {},
       "2767": {},
       "2768": {},
       "2820": {},
       "2977": {},
       "299": {},
       "3070": {},
       "315": {},
       "3288": {},
       "3301": {},
       "346": {},
       "36": {},
       "4056": {},
       "4110": {},
       "4360": {},
       "4386": {},
       "4396": {},
       "546": {},
       "677": {},
       "721": {},
       "925": {},
       "951": {},
       "957": {}
      },
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "GraphModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": null,
      "edges": [
       "IPY_MODEL_5d51b8e0ba1e46e2babe9cb7373c8a74",
       "IPY_MODEL_faeef149db124256ad839a59fc46c4fb",
       "IPY_MODEL_ac95da440e714ec9ad28c84ac814d979",
       "IPY_MODEL_1c419b7f7a0a4a038553bf7170876f7f",
       "IPY_MODEL_d66e68fb3b97441b84d85ba8cbdbff8d",
       "IPY_MODEL_be171e229d9f4c4ea77a396d4b799b62",
       "IPY_MODEL_7ab8514dc43e4de2ba28d9c06033a5e2",
       "IPY_MODEL_dbfd555cb5b64e85a8adc4c61118c74b",
       "IPY_MODEL_063518c28c164b2bab5607579390a6f4",
       "IPY_MODEL_8b3bd41cc8364edc946c46ca492b2031",
       "IPY_MODEL_5add710aeac54abda329af59d866f997",
       "IPY_MODEL_169e046a3d62433aad537627bbf067fd",
       "IPY_MODEL_4061a973c34846fa913cb68293958205",
       "IPY_MODEL_077e9bf897c64ab28fc1fac08bed3f29",
       "IPY_MODEL_d264a8369dd74f20915941672773088c",
       "IPY_MODEL_bf9e461a744a4d419332b3e2083801bb",
       "IPY_MODEL_108f57595ae64e4b9b56ef1624c0ad29",
       "IPY_MODEL_5790b81e4018451d85be882c5de7bd14",
       "IPY_MODEL_3d392600f5ed4d658c079a9fbff12cc4",
       "IPY_MODEL_3bc3833769e4453a875446483f2815e7",
       "IPY_MODEL_0260dd3ad51d43cebabe70cce80a4ef5",
       "IPY_MODEL_b1cbf6fa663d48159bff513d0f2a5b7a",
       "IPY_MODEL_d776794e85f84e118a7760f98e2b5c45",
       "IPY_MODEL_703ca325eb414436af10284d3f2d49d7",
       "IPY_MODEL_87405a7b3f934a3f8fbf30b26bbede3d",
       "IPY_MODEL_1891308cc5cc4a2a8d1426475b87c4af",
       "IPY_MODEL_5038ea577fc64173884849d76e5f1861",
       "IPY_MODEL_e5178d1b75d04049977ccbe0d80ab7ab",
       "IPY_MODEL_6d97b9e05bb3451899876866233c47e8",
       "IPY_MODEL_1db0bae3cf9e4cecae1d7a5949b975c6",
       "IPY_MODEL_58c61b54a7f84ffcbdf29497785e0da9",
       "IPY_MODEL_39efb44c6d034df1bf2a9beede65dcd7",
       "IPY_MODEL_cf63ef9549844ad494816d6ccc8a250f",
       "IPY_MODEL_8e1c44891d9241d391d32b25c7f82331",
       "IPY_MODEL_eca41e573ede44788ee257c22d36ba48",
       "IPY_MODEL_87828501353046f0963a057a994c6f15",
       "IPY_MODEL_3fb66a7628e24163a9efc5a906855908",
       "IPY_MODEL_0dc3601a14cb4178b485ec78033521e8",
       "IPY_MODEL_5f3f11d913eb4ee5a322a9def50d2357",
       "IPY_MODEL_d9816999e5db48e3bcda9e5a97907a53",
       "IPY_MODEL_5b32e7fc1adf4348b83d715bf9cf65e4",
       "IPY_MODEL_9998956a9572471c843ae01a5eda2f48",
       "IPY_MODEL_b1aab0d262c9479a864a104a7f28d670",
       "IPY_MODEL_5ae6ba1cf0cc4cb8b72009f8a25599c5",
       "IPY_MODEL_5b4d6206fe6e4e0aa8b8789b5bfb5976",
       "IPY_MODEL_bb2cb16c0d7b485cb0514fcbf21ee787",
       "IPY_MODEL_018599547284425ebd4a84def59600e9",
       "IPY_MODEL_bdeb81280125437aa161bc08af874140",
       "IPY_MODEL_674e8515c5fe43469a78cd990999390d",
       "IPY_MODEL_6adeb90365864bd7a583e910b2a71a6c",
       "IPY_MODEL_6cb956a1d044452781bdbb029524d8c4",
       "IPY_MODEL_2be1317ef9784c299b7c326dea315d68",
       "IPY_MODEL_ed6495b4b290422cbfbb4a63976dfb55",
       "IPY_MODEL_e9b6f768fe5147e28dfa700b4dea0e82",
       "IPY_MODEL_fd31bbffcb2849fbb7e73801c93f2c2a"
      ],
      "nodes": [
       "IPY_MODEL_763d340c255a408a8094c00166b3ffa7",
       "IPY_MODEL_94e8124e310f42429aaaa6371342ed40",
       "IPY_MODEL_148ae7b696fb442fb5b9e1fa0dcf2417",
       "IPY_MODEL_316535e3b8f0426d819f97b6fead5798",
       "IPY_MODEL_e3036984bde54baebf031c0c1d4d56df",
       "IPY_MODEL_b12803efdde849cdaaf479772a2f264d",
       "IPY_MODEL_de39e48f80f6480d926d2473b17a2540",
       "IPY_MODEL_54b6dcfee41d4fd1b07e76c43e24193f",
       "IPY_MODEL_e97b072c329d432e988fa52870119524",
       "IPY_MODEL_253788284c34414d8a8af430e928fada",
       "IPY_MODEL_112d8fb8c0bd40e5bb76dd8570518ab7",
       "IPY_MODEL_32ca53f8735142c19a49f49fefe0707b",
       "IPY_MODEL_6e431a5f60ae4cdb8a826aff9e27b65c",
       "IPY_MODEL_8bfb375f42054b9da36d627b3835654c",
       "IPY_MODEL_e3be20d7136d458bbfbac134eceec37b",
       "IPY_MODEL_3c3e29ff37cf4247bccb9b8e87aa827d",
       "IPY_MODEL_3e1aaed2c64b41c892d053dd2ac7954e",
       "IPY_MODEL_bc4b2cfb7669413fb24867750636cc0c",
       "IPY_MODEL_6f7315ce708e40bdb5af0b8f933537c8",
       "IPY_MODEL_894856695b534ebb845e4f13cc18ac8b",
       "IPY_MODEL_fc12a255026b430db99fb732e8fcf546",
       "IPY_MODEL_10feeb8e23354d5099f57e58296fb406",
       "IPY_MODEL_0dc89dccbd4e48a490f8a82f5df489aa",
       "IPY_MODEL_faaffc2b8baa410dbedaddd2cccf31c5",
       "IPY_MODEL_cb09a57c607d47c98814840b84db5895",
       "IPY_MODEL_408fac2790024e04970af08a0511946f",
       "IPY_MODEL_30e81483122843589816c44b4f629e37",
       "IPY_MODEL_abeb8bb4c3ee4084aba8aec3f9d83427",
       "IPY_MODEL_ce291557b0714708a96813d20128c922",
       "IPY_MODEL_b2c58ba315ee47db84c043f590fb9153",
       "IPY_MODEL_70e2aea88cdf4e21868061e868ec214c",
       "IPY_MODEL_4dd16811bfd54a74bc25d70a70d20d10",
       "IPY_MODEL_34802c8a934b449897a75bbd23e946f5",
       "IPY_MODEL_1bc5623b2b384bf09ac4346e49d6494f",
       "IPY_MODEL_1c176f8fbbe54bdab63ccacaf5082397",
       "IPY_MODEL_98f6c81bb73f4824a64d6c5ef9738591",
       "IPY_MODEL_ac2632d4452a42febd71fdc62c473c95",
       "IPY_MODEL_3ffea9057c724afdb09380d32a2fee2e",
       "IPY_MODEL_6b1da2ba401745ce8f2f23227980bbd9",
       "IPY_MODEL_8c065a94d29346c5a69e84afe9055f0d"
      ]
     }
    },
    "98a44bff2057401b999c607e3a1c0b88": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 627,
       "target": 608
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "98e8e69168874bab97248c03e1149028": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2009,
       "name": "EMPLOYED_AT",
       "source": 708,
       "target": 558
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "98f6c81bb73f4824a64d6c5ef9738591": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4386,
       "label": "FundingOpportunity",
       "name": "Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed)",
       "tooltip": "FundingOpportunity\nid:RFA-OD-20-014\nname:Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed)\nurl:https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-014.html",
       "url": "https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-014.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "993a9df3b3d4491584adad67719b8221": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "First name (string)",
       "fullName": "First middle and last name (string)",
       "id": 2755,
       "label": "MetaNode",
       "lastName": "Last name (string)",
       "middleName": "Middle name or middle initial (string)",
       "name": "Name of the researcher (lastname plus initials) (string)",
       "nodeName": "Researcher",
       "orcid": "Unique reseacher identifier from ORICD (https://orcid.org) (string)",
       "profileId": "Unique researcher identifier from NIH Reporter (https://api.reporter.nih.gov/) (string)",
       "tooltip": "MetaNode\nnodeName:Researcher\nfirstName:First name (string)\nlastName:Last name (string)\nprofileId:Unique researcher identifier from NIH Reporter (https://api.reporter.nih.gov/) (string)\nname:Name of the researcher (lastname plus initials) (string)\nfullName:First middle and last name (string)\nmiddleName:Middle name or middle initial (string)\norcid:Unique reseacher identifier from ORICD (https://orcid.org) (string)\nid:Unique researcher identifier (orcid preferred or NIH profile id) (string)"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "993ca51c0aa54e199a3d79eecb3a0346": {
     "model_module": "@jupyter-widgets/base",
     "model_module_version": "1.2.0",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": "1000px",
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "996e945365a64c87ae276d64f16b7510": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "from": "Unique identifier for the researcher (string)",
       "name": "MetaRelationship",
       "relationshipName": "CREATED",
       "source": 2755,
       "target": 2753,
       "to": "Unique identifier (CRUIE preferred) for the dataset (string)"
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9998956a9572471c843ae01a5eda2f48": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "CITES",
       "source": 2977,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "99e1e9d760ae4091b5a4502b0fa3510f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 678,
       "target": 562
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9a6c2d5b48f041f0987177e973be5184": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 692,
       "target": 572
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9ac80b6f143a4297ab96975351cb09b5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Tony Jun",
       "fullName": "Tony Jun Huang",
       "id": 645,
       "label": "Researcher",
       "lastName": "Huang",
       "name": "Huang T",
       "profileId": "profileid:9493483",
       "tooltip": "Researcher\nid:profileid:9493483\nlastName:Huang\nprofileId:profileid:9493483\nname:Huang T\nfullName:Tony Jun Huang\nfirstName:Tony Jun"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9b5cedc5bada4887ae1687c74934743a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 668,
       "target": 22
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9b6ddbc374444203be8e3efc54195e1a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "applicants": [
        "Atom Bioworks, Inc",
        "The Board Of Trustees Of The University Of Illinois"
       ],
       "filingDate": "2021-11-18",
       "id": 2408,
       "inventors": [
        "Xing Wang",
        "Xiaohu Yao",
        "Nicolas Letourneau"
       ],
       "label": "Patent",
       "name": "Polynucleotide nanostructures for detecting viral infections and other diseases \n       ",
       "status": "pending",
       "tooltip": "Patent\nid:WO2022109155\napplicants:['Atom Bioworks, Inc', 'The Board Of Trustees Of The University Of Illinois']\nstatus:pending\nname:Polynucleotide nanostructures for detecting viral infections and other diseases \n       \nfilingDate:2021-11-18\ninventors:['Xing Wang', 'Xiaohu Yao', 'Nicolas Letourneau']\nurl:https://patents.google.com/patent/WO2022109155A1",
       "url": "https://patents.google.com/patent/WO2022109155A1"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9ba4fe703bbc4138b83dbd3513b40605": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "A",
       "fullName": "A Clark",
       "id": 1091,
       "label": "Researcher",
       "lastName": "Clark",
       "name": "Clark A",
       "tooltip": "Researcher\nid:s2authorid:2168471616\nlastName:Clark\nname:Clark A\nfullName:A Clark\nfirstName:A"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9bad284206f3492ba038477dd2c9bb30": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4396,
       "target": 23
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9cba3bb711624416a0531eca7cbe82b8": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4387,
       "target": 22
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9ccd9f5f2ca14991bd863973412a6106": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "NEW YORK",
       "country": "UNITED STATES",
       "duns": "duns:060217502",
       "geonames": "geonames:5128581",
       "id": 579,
       "label": "Organization",
       "name": "Weill Cornell Medicine",
       "ror": "ror:02r109517",
       "state": "NY",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5128581\nror:ror:02r109517\ncity:NEW YORK\nname:Weill Cornell Medicine\nuei:uei:YNT8TCJH8FQ8\nduns:duns:060217502\nstate:NY\nid:ror:02r109517\nurl:https://ror.org/02r109517",
       "uei": "uei:YNT8TCJH8FQ8",
       "url": "https://ror.org/02r109517"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9d893a603f844e7c803a7b449f1bd918": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "COVID-19 presents a public health emergency: There is a critical need for rapid, not reagent intensive, non-\ninvasive testing technologies. This program will lead to the production of a prototype system to diagnose\nCOVID-19 infection using the body odor signature of the disease. Our goal is to maximize societal impact\nby creating a validated prototype that can be used in a community or workplace setting by minimally\ntrained personnel for low-cost, on-the-spot diagnosis within minutes. The system will be developed in a\nmanner that puts it on a pathway for rapid FDA approval. The Research Aims are:\nAim 1. Optimization, assembly, and integration of a prototype system with the ability to odor signature\nof COVID-19 in samples of body odor. The system will be simple to use, pose essentially zero risk to the\noperator and the test subject, and report a result within minutes. The production cost at scale will be\napproximately $9,000 for the complete measurement system, with a per test cost of approximately $0.50. The\ndesign and construction of the prototype will be conducted by Novo Engineering, a leading firm with extensive\nexperience in medical device development.\nAim 2. Software development. Software for the system from VOC sampling to final diagnostic result will be\ndeveloped to ensure error-free operation of the device. Our preliminary results suggest that simple linear\ndiscriminant analysis (LDA) does an excellent job of classifying VOCs from human body odor as COVID-19\npositive or negative (92% sensitivity and 87% specificity). Optimization of the sensor array (Aim 1) and use of\nricher feature sets in our classifier models will lead to further performance improvements in the prototype system.\nAim 3. System Benchmarking and Validation. We will benchmark the full prototype system against a number\nof VOC mixtures, with and without in vitro skin models. The system will undergo extensive testing against body\nodor samples from individuals with pathological conditions other than COVID-19 and other sources of potentially\nconfounding VOCs. The prototype will be validated against 1000 samples drawn from the COVID-SAFE program\nat Penn. The screening will include all members of the Penn community, and represents incredible racial and\nethnic diversity as well as a wide variance in age, sex, and gender.\nAim 4. Regulatory Approval Plan The plan will be developed under the direction of Sr/Key personnel John\nFuson, JD, an attorney at Crowell & Moring LLP and a former Associate Chief Counsel at FDA. Novo Engineering\nhas extensive experience in guiding prototype design in alignment with the requirements for FDA approval. The\nproposed COVID-19 VOC-based testing device will be regulated by the FDA, likely as a Class I or II medical\ndevice. Because there is no clear predicate device to reference in this case, we intend to submit a direct de novo\npetition to FDA asking the agency to categorize and clear the proposed COVID-19 testing device as Class I or\nClass II without reference to any predicate.",
       "awardCode": "U18",
       "fundingMechanism": "Other Research-Related",
       "id": 29,
       "label": "Grant",
       "name": "Effective, Reagent-free Detection of the Odor Signature of Covid-19 Infection Using a Nano-Enabled Sensor Array",
       "narrative": "This program addresses the critical unmet need of an effective means to screen for COVID-19 infection, and\npotentially other novel virus infections, in a community setting based upon the body odor signature of the\ndisease. The program will result in a validated prototype system, with a test time of minutes, a test cost of\napproximately $0.50, on a path to rapid FDA approval.",
       "researchInitiative": "RADx-rad",
       "subProject": "SCENT",
       "tooltip": "Grant\nabstract:COVID-19 presents a public health emergency: There is a critical need for rapid, not reagent intensive, non-\ninvasive testing technologies. This program will lead to the production of a prototype system to diagnose\nCOVID-19 infection using the body odor signature of the disease. Our goal is to maximize societal impact\nby creating a validated prototype that can be used in a community or workplace setting by minimally\ntrained personnel for low-cost, on-the-spot diagnosis within minutes. The system will be developed in a\nmanner that puts it on a pathway for rapid FDA approval. The Research Aims are:\nAim 1. Optimization, assembly, and integration of a prototype system with the ability to odor signature\nof COVID-19 in samples of body odor. The system will be simple to use, pose essentially zero risk to the\noperator and the test subject, and report a result within minutes. The production cost at scale will be\napproximately $9,000 for the complete measurement system, with a per test cost of approximately $0.50. The\ndesign and construction of the prototype will be conducted by Novo Engineering, a leading firm with extensive\nexperience in medical device development.\nAim 2. Software development. Software for the system from VOC sampling to final diagnostic result will be\ndeveloped to ensure error-free operation of the device. Our preliminary results suggest that simple linear\ndiscriminant analysis (LDA) does an excellent job of classifying VOCs from human body odor as COVID-19\npositive or negative (92% sensitivity and 87% specificity). Optimization of the sensor array (Aim 1) and use of\nricher feature sets in our classifier models will lead to further performance improvements in the prototype system.\nAim 3. System Benchmarking and Validation. We will benchmark the full prototype system against a number\nof VOC mixtures, with and without in vitro skin models. The system will undergo extensive testing against body\nodor samples from individuals with pathological conditions other than COVID-19 and other sources of potentially\nconfounding VOCs. The prototype will be validated against 1000 samples drawn from the COVID-SAFE program\nat Penn. The screening will include all members of the Penn community, and represents incredible racial and\nethnic diversity as well as a wide variance in age, sex, and gender.\nAim 4. Regulatory Approval Plan The plan will be developed under the direction of Sr/Key personnel John\nFuson, JD, an attorney at Crowell & Moring LLP and a former Associate Chief Counsel at FDA. Novo Engineering\nhas extensive experience in guiding prototype design in alignment with the requirements for FDA approval. The\nproposed COVID-19 VOC-based testing device will be regulated by the FDA, likely as a Class I or II medical\ndevice. Because there is no clear predicate device to reference in this case, we intend to submit a direct de novo\npetition to FDA asking the agency to categorize and clear the proposed COVID-19 testing device as Class I or\nClass II without reference to any predicate.\nid:U18TR003775\nnarrative:This program addresses the critical unmet need of an effective means to screen for COVID-19 infection, and\npotentially other novel virus infections, in a community setting based upon the body odor signature of the\ndisease. The program will result in a validated prototype system, with a test time of minutes, a test cost of\napproximately $0.50, on a path to rapid FDA approval.\nname:Effective, Reagent-free Detection of the Odor Signature of Covid-19 Infection Using a Nano-Enabled Sensor Array\nsubProject:SCENT\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U18"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9dbcf7edfaa641ea97ae570f06cc2904": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4386,
       "target": 0
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9dc7be13aff54f6aa31c350bed79d81a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4390,
       "target": 17
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9e16133687ed47008dc49145ca392524": {
     "model_module": "@jupyter-widgets/base",
     "model_module_version": "1.2.0",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": "900px",
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "9e297218b93044c88c283dd164031858": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Hua",
       "fullName": "Hua Xu",
       "id": 688,
       "label": "Researcher",
       "lastName": "Xu",
       "name": "Xu H",
       "orcid": "orcid:0000-0002-5274-4672",
       "profileId": "profileid:9603016",
       "tooltip": "Researcher\nid:profileid:9603016\nlastName:Xu\norcid:orcid:0000-0002-5274-4672\nprofileId:profileid:9603016\nname:Xu H\nfullName:Hua Xu\nfirstName:Hua"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9e336250e2444aec9773879d82b9baa7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 665,
       "target": 2846
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9e4488242d6e43149f40fd6cd67269da": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "from": "Unique identifier for the researcher (string)",
       "name": "MetaRelationship",
       "relationshipName": "AUTHORED",
       "source": 2755,
       "target": 2754,
       "to": "Unique identifier for publication (string)"
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9e5f82ac92de4a9ea94c91f45bdfd538": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2019,
       "name": "EMPLOYED_AT",
       "source": 695,
       "target": 568
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9e6cd49444794c3e886a2b0ddc282dc9": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 660,
       "target": 577
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9eb20933d511449cb9686fdc2a553ba6": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4392,
       "label": "FundingOpportunity",
       "name": "Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed)",
       "tooltip": "FundingOpportunity\nname:Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed)\nid:RFA-OD-20-017\nurl:https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-017.html",
       "url": "https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-017.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9ebd3b36d8b24c28add1f7963f7ea619": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "from": "Unique identifier for the funding opportunity (Thesaurus:C20021) (string)",
       "name": "MetaRelationship",
       "relationshipName": "PROVIDES",
       "source": 2756,
       "target": 2760,
       "to": "Unique identifier for the grant (Thesaurus:C16644) (string)"
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9ee3615bb2c449ddabc43ec40577758a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "PROJECT SUMMARY\n Coronavirus 2019 (COVID-19) has afflicted 6.2 million Americans and killed 190,000 as of early September\n2020 (WHO website); a roughly 3% mortality. Between a shortage in testing and unidentified asymptomatic\nindividuals, the actual number of those infected could be 6 to 24-fold higher than that reported. SARS-CoV-2\n(CoV-2), the virus underlying the disease, results in a range of symptoms; in select cases a severe respiratory\nillness that impedes breathing that could lead to hospitalization and death. CoV-2 is transmitted person-to-\nperson via inhalation of the virus through mucosal membranes of the nose and throat from transfer after\ntouching a contaminated surface or by inhaling aerosolized virus. Unfortunately, COVID-19 is likely to be\nprevalent well into 2021 and beyond.\n We must increase our ability to test for CoV-2. First, testing is needed to diagnose individuals that are\nsymptomatic or asymptomatic to reduce community spread. And second, monitoring gathering areas for\nairborne virus that could inform the decision to shutdown a space or implement disinfection and mitigation of\nan area. We propose to use an electrochemical biosensor in two detection devices, 1) a diagnostic\nbreathalyzer for instant detection of CoV-2 and 2) an airborne detector for real-time, continuous surveillance of\na large space.\n We have developed a novel ultra-sensitive, antibody-based electrochemical biosensor to detect CoV-2\nrepeat binding domain (RBD) spike protein. The technology is based on a micro-immunoelectrode (MIE)\nbiosensor pioneered by the Cirrito laboratory to study protein dynamics in the setting of neurodegeneration (2,3).\nThe biosensor uses voltammetry to measure the oxidation of tyrosine amino acids; oxidation is the release of\nelectrons that the biosensor measures as a change in current. Antibodies are covalently attached to the\nelectrode surface to provide selectivity. Our prototype CoV-2 biosensor is sensitive to 2 femtogram/ml,\ncompared to several current CoV-2 antigen tests that are sensitive to the low picogram/ml range.\n The proposal will first (Aim 1) optimize our CoV-2 biosensor to detect CoV-2 viral particles, as well as test\nseveral parameters to increase sensitivity and longevity. Aim 2 will build a test breathalyzer that will utilize a\nnebulizer to generate virus laden air containing aerosol droplets similar to a breath that contain defined\nconcentrations of CoV-2 viral particles. Aim 3 will test the airborne biosensor in a realistic environment. Co-I\nChakrabarty’s laboratory has unique capabilities of mimicking real-world environmental conditions, especially\nin the context of atmospheric aerosols, necessary for testing and optimizing the biosensor’s performance for\nfield deployment. Atmospheric conditions include relative humidity (RH) and temperature, as well as common\nairborne pollutants found indoors.\n Finding novel means to detect the CoV-2, as well as create a platform to detect other and future\npathogens, would enable us to limit the viral spread throughout the community in the current and future\npandemics.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 36,
       "label": "Grant",
       "name": "Nanobody-Based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2",
       "narrative": "COVID-19 has afflicted millions of Americans with a roughly 3% mortality rate. We have developed an\nultra-sensitive electrochemical biosensor to detect CoV-2 which we will incorporate into a breathalyzer for\ndiagnostic purposes, as well as an airborne detector to monitor large gathering spaces.",
       "researchInitiative": "RADx-rad",
       "subProject": "Automatic Detection & Tracing",
       "tooltip": "Grant\nabstract:PROJECT SUMMARY\n Coronavirus 2019 (COVID-19) has afflicted 6.2 million Americans and killed 190,000 as of early September\n2020 (WHO website); a roughly 3% mortality. Between a shortage in testing and unidentified asymptomatic\nindividuals, the actual number of those infected could be 6 to 24-fold higher than that reported. SARS-CoV-2\n(CoV-2), the virus underlying the disease, results in a range of symptoms; in select cases a severe respiratory\nillness that impedes breathing that could lead to hospitalization and death. CoV-2 is transmitted person-to-\nperson via inhalation of the virus through mucosal membranes of the nose and throat from transfer after\ntouching a contaminated surface or by inhaling aerosolized virus. Unfortunately, COVID-19 is likely to be\nprevalent well into 2021 and beyond.\n We must increase our ability to test for CoV-2. First, testing is needed to diagnose individuals that are\nsymptomatic or asymptomatic to reduce community spread. And second, monitoring gathering areas for\nairborne virus that could inform the decision to shutdown a space or implement disinfection and mitigation of\nan area. We propose to use an electrochemical biosensor in two detection devices, 1) a diagnostic\nbreathalyzer for instant detection of CoV-2 and 2) an airborne detector for real-time, continuous surveillance of\na large space.\n We have developed a novel ultra-sensitive, antibody-based electrochemical biosensor to detect CoV-2\nrepeat binding domain (RBD) spike protein. The technology is based on a micro-immunoelectrode (MIE)\nbiosensor pioneered by the Cirrito laboratory to study protein dynamics in the setting of neurodegeneration (2,3).\nThe biosensor uses voltammetry to measure the oxidation of tyrosine amino acids; oxidation is the release of\nelectrons that the biosensor measures as a change in current. Antibodies are covalently attached to the\nelectrode surface to provide selectivity. Our prototype CoV-2 biosensor is sensitive to 2 femtogram/ml,\ncompared to several current CoV-2 antigen tests that are sensitive to the low picogram/ml range.\n The proposal will first (Aim 1) optimize our CoV-2 biosensor to detect CoV-2 viral particles, as well as test\nseveral parameters to increase sensitivity and longevity. Aim 2 will build a test breathalyzer that will utilize a\nnebulizer to generate virus laden air containing aerosol droplets similar to a breath that contain defined\nconcentrations of CoV-2 viral particles. Aim 3 will test the airborne biosensor in a realistic environment. Co-I\nChakrabarty’s laboratory has unique capabilities of mimicking real-world environmental conditions, especially\nin the context of atmospheric aerosols, necessary for testing and optimizing the biosensor’s performance for\nfield deployment. Atmospheric conditions include relative humidity (RH) and temperature, as well as common\nairborne pollutants found indoors.\n Finding novel means to detect the CoV-2, as well as create a platform to detect other and future\npathogens, would enable us to limit the viral spread throughout the community in the current and future\npandemics.\nid:U01AA029331\nnarrative:COVID-19 has afflicted millions of Americans with a roughly 3% mortality rate. We have developed an\nultra-sensitive electrochemical biosensor to detect CoV-2 which we will incorporate into a breathalyzer for\ndiagnostic purposes, as well as an airborne detector to monitor large gathering spaces.\nname:Nanobody-Based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2\nsubProject:Automatic Detection & Tracing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "9eee0c072fc944f9b984557a1e30b844": {
     "model_module": "@jupyter-widgets/controls",
     "model_module_version": "1.5.0",
     "model_name": "DescriptionStyleModel",
     "state": {
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "DescriptionStyleModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "StyleView",
      "description_width": ""
     }
    },
    "a0657a5d34ed4b55be2c3592768950c8": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Novel approaches for early and accurate diagnosis of COVID-19 associated syndromes and\nevaluation of clinical severity and outcomes of COVID-19 disease in children are urgently needed.\nThe overarching goal of this grant proposal is to develop clinical assays that can evaluate and predict\nseverity of pediatric COVID-19 disease, ranging from asymptomatic or mildly symptomatic to severe\nmanifestations such as multisystem inflammatory syndrome (MIS-C). To date, we have collected and\nbiobanked clinical samples from more than 400 patients across 3 academic hospitals, including\napproximately 100 patients with MIS-C. In the first R61 phase of this project, we will continue to enroll\npatients with pediatric COVID-19 and MIS-C for sample collection and longitudinal chart review and\ntesting (Aim 1), leverage machine learning to identify diagnostic and prognostic “omics” host\nbiomarkers based on RNA transcriptome profiling from nasal swab and whole blood samples (Aim 2)\nand cell-free DNA analysis from plasma (Aim 3), and generate predictive models of clinical severity\nand outcomes by incorporating longitudinal clinical, laboratory, viral, and omics data (Aim 4). Our\nrationale for including these samples is that they are routinely obtained in hospitals and clinics and\npermit easy and noninvasive collection without any special processing or handling requirements,\nwhich will accelerate the development of omics-based clinical assays. Our Go/No-Go transition\nmilestones for transition to the R33 phase after 2 years include: (1) collection of longitudinal samples\nfrom a minimum of 120 patients for each identified presentation (mildly symptomatic outpatient,\nseverely ill in the ICU, and MIS-C) and a comparable number of matched controls, (2) generation of\npanels of candidate of severity and confirmation of a subset of biomarkers by qPCR, (3) development\nof classifier models using machine learning using the biomarkers alone (for clinical assay\ndevelopment), and (4) combining these omics biomarkers with additional clinical, viral, and laboratory\nbiomarkers into combined classifier models using machine learning. For the classifier models, the\nminimum/goal performance requirements would be 70%/>80% sensitivity and 80%/>90% specificity.\nIn the second R33 phase, we propose to develop host-based clinical assays for diagnosis and\nseverity prediction of COVID-19-associated syndromes, including MIS-C, in children from nasal\nswabs and blood (Aim 5) and validate these biomarker panels as a Laboratory Developed Test (LDT)\nin a CLIA (Clinical Laboratory Improvement Amendments) diagnostic laboratory (Aim 6). These\nassays will be evaluated for accuracy, precision, reproducibility, limits of detection (LOD), matrix\neffect, interference, among other performance characteristics. We will work closely with the RADx-rad\nData Coordination Center (DCC) on assay development, testing, and validation for submission to the\nFDA for Emergency Use Authorization (EUA) and timely deployment of these assays for clinical use.",
       "awardCode": "R61",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 27,
       "label": "Grant",
       "name": "Discovery and clinical validation of host  biomarkers of disease severity and multi-system inflammatory syndrome in children (MIS-C) with Covid-19",
       "narrative": "Novel approaches to accurately diagnose acute pediatric COVID-19 associated diseases,\nincluding the Multisystem Inflammatory Syndrome in Children (MIS-C), as well as predict clinical\nseverity and outcomes, are urgently needed. For this project, we will identify RNA transcriptomic\nand cell-free DNA omics biomarkers that will be used to develop and validate host-based\nassays from nasal swab and blood samples, with the goal of regulatory submission for FDA\nEmergency Use Authorization (EUA).",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nabstract:Novel approaches for early and accurate diagnosis of COVID-19 associated syndromes and\nevaluation of clinical severity and outcomes of COVID-19 disease in children are urgently needed.\nThe overarching goal of this grant proposal is to develop clinical assays that can evaluate and predict\nseverity of pediatric COVID-19 disease, ranging from asymptomatic or mildly symptomatic to severe\nmanifestations such as multisystem inflammatory syndrome (MIS-C). To date, we have collected and\nbiobanked clinical samples from more than 400 patients across 3 academic hospitals, including\napproximately 100 patients with MIS-C. In the first R61 phase of this project, we will continue to enroll\npatients with pediatric COVID-19 and MIS-C for sample collection and longitudinal chart review and\ntesting (Aim 1), leverage machine learning to identify diagnostic and prognostic “omics” host\nbiomarkers based on RNA transcriptome profiling from nasal swab and whole blood samples (Aim 2)\nand cell-free DNA analysis from plasma (Aim 3), and generate predictive models of clinical severity\nand outcomes by incorporating longitudinal clinical, laboratory, viral, and omics data (Aim 4). Our\nrationale for including these samples is that they are routinely obtained in hospitals and clinics and\npermit easy and noninvasive collection without any special processing or handling requirements,\nwhich will accelerate the development of omics-based clinical assays. Our Go/No-Go transition\nmilestones for transition to the R33 phase after 2 years include: (1) collection of longitudinal samples\nfrom a minimum of 120 patients for each identified presentation (mildly symptomatic outpatient,\nseverely ill in the ICU, and MIS-C) and a comparable number of matched controls, (2) generation of\npanels of candidate of severity and confirmation of a subset of biomarkers by qPCR, (3) development\nof classifier models using machine learning using the biomarkers alone (for clinical assay\ndevelopment), and (4) combining these omics biomarkers with additional clinical, viral, and laboratory\nbiomarkers into combined classifier models using machine learning. For the classifier models, the\nminimum/goal performance requirements would be 70%/>80% sensitivity and 80%/>90% specificity.\nIn the second R33 phase, we propose to develop host-based clinical assays for diagnosis and\nseverity prediction of COVID-19-associated syndromes, including MIS-C, in children from nasal\nswabs and blood (Aim 5) and validate these biomarker panels as a Laboratory Developed Test (LDT)\nin a CLIA (Clinical Laboratory Improvement Amendments) diagnostic laboratory (Aim 6). These\nassays will be evaluated for accuracy, precision, reproducibility, limits of detection (LOD), matrix\neffect, interference, among other performance characteristics. We will work closely with the RADx-rad\nData Coordination Center (DCC) on assay development, testing, and validation for submission to the\nFDA for Emergency Use Authorization (EUA) and timely deployment of these assays for clinical use.\nid:R61HD105618\nnarrative:Novel approaches to accurately diagnose acute pediatric COVID-19 associated diseases,\nincluding the Multisystem Inflammatory Syndrome in Children (MIS-C), as well as predict clinical\nseverity and outcomes, are urgently needed. For this project, we will identify RNA transcriptomic\nand cell-free DNA omics biomarkers that will be used to develop and validate host-based\nassays from nasal swab and blood samples, with the goal of regulatory submission for FDA\nEmergency Use Authorization (EUA).\nname:Discovery and clinical validation of host  biomarkers of disease severity and multi-system inflammatory syndrome in children (MIS-C) with Covid-19\nsubProject:PreVAIL kIds\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R61"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a0f849a8cb32481195e2f771899db7f2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 996,
       "target": 2816
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a20f66b23a5a48b5830f0a89d7faea37": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Vulnerable populations do not just need testing—they need surveillance. The ideal surveillance tool would\noperate in the background with minimal involvement of the population to be tested; it would be simple,\naffordable, reliable, and accurate. Unfortunately, no such surveillance system yet exists. Here, we propose\na “smart mask” that changes colors when the wearer has been exposed to biomarkers (proteases) of\nCOVID-19. These proteases are known to be in saliva, and the smart mask will concentrate the proteases\nfrom aerosolized saliva when the subject breathes and speaks through the smart mask. This is a simple\nyet novel approach to surveillance because most people are already wearing masks—especially in high-\nrisk settings. Our first goal is to optimize the reagents that will monitor the proteases. We will customize\nthe peptide sequences such that the reagents change color only when two key SARS proteases are\npresent. After characterizing the colorimetric reagents, Aim 2 will integrate these reagents into an adhesive\nstrip (i.e., a sticker) that can be affixed to any existing cloth or surgical mask. Aim 3 is validation with human\nsubjects. First, we will use biobanked saliva samples that are confirmed to be either COVID-19-positive or\nCOVID-19-negative. Next, we will evaluate how long people infected with SARS-CoV-2 must breathe\nthrough the smart mask before it changes colors. Finally, we will use the smart mask for surveillance of a\npopulation that is concurrently being tested regularly via PCR. We will calculate the sensitivity and\nspecificity of the smart masks through comparison to PCR. We will measure true positives, true negatives,\nfalse positives, and false negatives and estimate needing 800 subjects, which is very feasible at our\ninstitution. Our team is well-suited to conduct this research because of Dr. Jokerst’s training colorimetric\nsensing; Drs. Penny, Knight, and Laurent have decades of human subjects research experience, and Dr.\nTu offers biostatistical experience to confirm study design. This work could have a significant impact on\nthe pandemic because our proposed design combines the simplicity of the home pregnancy test with the\nspecificity of expensive viral-based assays. It is practical because it uses the masks that are already\ncommon in daily life and reports the presence of SARS viruses via a simple color change. While a vaccine\nwill hopefully be deployed during the course of this work, the proteases evaluated here have been\nimplicated in a variety of SARS viruses. Thus, this work will be useful should future pandemics emerge.",
       "awardCode": "R01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 43,
       "label": "Grant",
       "name": "Validation of Smart Masks for Surveillance of COVID-19",
       "narrative": "We propose to build a mask that changes color when the wearer has COVID-19 or has been\nexposed to COVID-19. Mask-wearing is currently widespread and thus adding this colorimetric\nsensing approach is a simple yet innovative way to perform surveillance especially among\nvulnerable groups. After building and characterizing this mask, we will validate it in group of at-risk\nindividuals.",
       "researchInitiative": "RADx-rad",
       "subProject": "Multimodal Surveillance",
       "tooltip": "Grant\nabstract:Vulnerable populations do not just need testing—they need surveillance. The ideal surveillance tool would\noperate in the background with minimal involvement of the population to be tested; it would be simple,\naffordable, reliable, and accurate. Unfortunately, no such surveillance system yet exists. Here, we propose\na “smart mask” that changes colors when the wearer has been exposed to biomarkers (proteases) of\nCOVID-19. These proteases are known to be in saliva, and the smart mask will concentrate the proteases\nfrom aerosolized saliva when the subject breathes and speaks through the smart mask. This is a simple\nyet novel approach to surveillance because most people are already wearing masks—especially in high-\nrisk settings. Our first goal is to optimize the reagents that will monitor the proteases. We will customize\nthe peptide sequences such that the reagents change color only when two key SARS proteases are\npresent. After characterizing the colorimetric reagents, Aim 2 will integrate these reagents into an adhesive\nstrip (i.e., a sticker) that can be affixed to any existing cloth or surgical mask. Aim 3 is validation with human\nsubjects. First, we will use biobanked saliva samples that are confirmed to be either COVID-19-positive or\nCOVID-19-negative. Next, we will evaluate how long people infected with SARS-CoV-2 must breathe\nthrough the smart mask before it changes colors. Finally, we will use the smart mask for surveillance of a\npopulation that is concurrently being tested regularly via PCR. We will calculate the sensitivity and\nspecificity of the smart masks through comparison to PCR. We will measure true positives, true negatives,\nfalse positives, and false negatives and estimate needing 800 subjects, which is very feasible at our\ninstitution. Our team is well-suited to conduct this research because of Dr. Jokerst’s training colorimetric\nsensing; Drs. Penny, Knight, and Laurent have decades of human subjects research experience, and Dr.\nTu offers biostatistical experience to confirm study design. This work could have a significant impact on\nthe pandemic because our proposed design combines the simplicity of the home pregnancy test with the\nspecificity of expensive viral-based assays. It is practical because it uses the masks that are already\ncommon in daily life and reports the presence of SARS viruses via a simple color change. While a vaccine\nwill hopefully be deployed during the course of this work, the proteases evaluated here have been\nimplicated in a variety of SARS viruses. Thus, this work will be useful should future pandemics emerge.\nid:R01DE031114\nnarrative:We propose to build a mask that changes color when the wearer has COVID-19 or has been\nexposed to COVID-19. Mask-wearing is currently widespread and thus adding this colorimetric\nsensing approach is a simple yet innovative way to perform surveillance especially among\nvulnerable groups. After building and characterizing this mask, we will validate it in group of at-risk\nindividuals.\nname:Validation of Smart Masks for Surveillance of COVID-19\nsubProject:Multimodal Surveillance\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a2300cf72e814b57afb53710786ef9bb": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4387,
       "target": 18
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a24be9e94ac44db591fc2063638d2a97": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4393,
       "target": 32
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a281780730c0412d876233ed27764ede": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 679,
       "target": 38
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a2a8d91b390e4dc3ab2d7cef40eb8c4a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "GraphModel",
     "state": {
      "_adj": {
       "2752": {},
       "2753": {},
       "2754": {},
       "2755": {},
       "2756": {},
       "2757": {},
       "2758": {},
       "2759": {},
       "2760": {},
       "2761": {},
       "2762": {}
      },
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "GraphModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": null,
      "edges": [
       "IPY_MODEL_996e945365a64c87ae276d64f16b7510",
       "IPY_MODEL_4b3f75c541b046ac999adbbaaaaba500",
       "IPY_MODEL_9e4488242d6e43149f40fd6cd67269da",
       "IPY_MODEL_559051d8e5b6441e87824177a6ddc88a",
       "IPY_MODEL_f965957bbf894308b456294027365e30",
       "IPY_MODEL_4a04d8006e984af19766e149c7656550",
       "IPY_MODEL_4186599920924d84b5fee05210462b50",
       "IPY_MODEL_9ebd3b36d8b24c28add1f7963f7ea619",
       "IPY_MODEL_58d04ecf3e154dcbacc58778c0e5438f",
       "IPY_MODEL_51e6ba3d23904185a8d8b9f03c8345f7",
       "IPY_MODEL_4e87c4833a534506a142584de623a042",
       "IPY_MODEL_02bf94bec34546548468f290c79d3704",
       "IPY_MODEL_575659f4edb94164a130ed0e71f3c626"
      ],
      "nodes": [
       "IPY_MODEL_114c94f4190d4f3ca773a68c55ba2669",
       "IPY_MODEL_fa83d237a3ff4822ae90b2d6a98a5859",
       "IPY_MODEL_ead7475f011d4f35b12cb77d80e2d0a7",
       "IPY_MODEL_6552ee7875fd4136923ec85cd6f3fd02",
       "IPY_MODEL_7f45e0fb9a6748ee80be61f1b4e56360",
       "IPY_MODEL_993a9df3b3d4491584adad67719b8221",
       "IPY_MODEL_93659fa346534dcaaac133e830bd763c",
       "IPY_MODEL_0e8f0361b4e540698b70501cad5ab969",
       "IPY_MODEL_20b3fee617064bb495e6fe183fd22602",
       "IPY_MODEL_11b298b1df6a4080ade6986b7ea7f7b9",
       "IPY_MODEL_582c8846ded648ea8d9d84db1d30ce95"
      ]
     }
    },
    "a2b19046a58440f29dbfe36aa4852c85": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The SARS-CoV-2 pandemic has manifested in children with a wide spectrum of clinical presentations ranging\nfrom asymptomatic infection to devastating acute respiratory symptoms, appendicitis (often with rupture), and\nMultisystem Inflammatory Syndrome in Children (MIS-C), a serious inflammatory condition presenting several\nweeks after exposure to or infection with the virus. These presentations overlap in their clinical severity while\nmaintaining distinct clinical profiles. Public health and clinical approaches will benefit from an improved\nunderstanding of the spectrum of illness associated with SARS CoV-2 and from the capacity to integrate data to\nachieve two goals: (i) to identify the clinical, social, and biological variables that predict severe COVID-19 and\nMIS-C, and (ii) to target those populations and individuals at greatest risk for harm from the virus. We propose\nthe COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness\nin Children (CONNECT to Predict SIck Children) comprising eight partners providing access to data on >15\nmillion children. Our network will systematically integrate social, epidemiological, genetic, immunological, and\ncomputational approaches to identify both population- and individual-level risk factors for severe illness. Our\nunderlying hypothesis is that a combination of multidimensional data – clinical, sociodemographic, epidemiologic,\nand biological -- can be integrated to predict which children are at greatest risk to have severe consequences\nfrom SARS-CoV-2 infection. To test our hypothesis, we will develop CONNECT to Predict SIck Children, a\nnetwork of networks that leverages inpatient, outpatient, community, and epidemiological data resources to\nsupport the analysis of large data using machine learning and model-based analyses. For the R61 phase, we\nwill develop and refine predictive models using data from our network of networks (Aim 1). We will also recruit\nparticipants previously diagnosed with either COVID-19 or MIS-C (along with appropriate controls who have had\nmild or asymptomatic infections with SARS-CoV2), who will provide survey data (including social determinants)\nand saliva and blood samples to identify persisting biological factors associated with severe disease (Aim 2). We\nwill iteratively assess our models using a knowledge management framework that considers the marginal value\nof data for improving models' predictive capacity over time. In the R33 phase, we will validate and further refine\npredictive models incorporating data from additional participants recruited throughout our network of networks,\nincluding newly infected children with severe COVID-19 or MIS-C identified through real-time surveillance (Aim\n3). We seek to develop predictive models for children and adolescents that are useful, sensitive to community\nand environmental contexts, and informed by the REASSURED framework specified by the RFA. The models\nand biomarkers developed through our nationwide network of networks will produce generalizable knowledge\nthat will improve our ability to predict which children are at greatest risk for severe complications of SARS-CoV-\n2 infection. This knowledge will facilitate interventions to prevent and treat severe pediatric illness.",
       "awardCode": "R61",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 22,
       "label": "Grant",
       "name": "COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)",
       "narrative": "COVID-19, the disease caused by SARS-CoV-2, is a world-wide public health problem. Pediatric disease has\nbeen particularly difficult to manage since children tend less frequently to get sick from SARS-CoV-2 infection\nas adults but, when they do become ill, can present with life-threatening pulmonary disease or a systemic\ninflammatory condition known as multisystem inflammatory syndrome. The proposed COVID-19 Network of\nNetworks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to\nPredict SIck Children) will develop models and biomarkers that predict risk for severe disease in children and\nadolescents by systematically integrating social science, epidemiological, genetic, biochemical, immunological,\nand computational approaches.",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nabstract:The SARS-CoV-2 pandemic has manifested in children with a wide spectrum of clinical presentations ranging\nfrom asymptomatic infection to devastating acute respiratory symptoms, appendicitis (often with rupture), and\nMultisystem Inflammatory Syndrome in Children (MIS-C), a serious inflammatory condition presenting several\nweeks after exposure to or infection with the virus. These presentations overlap in their clinical severity while\nmaintaining distinct clinical profiles. Public health and clinical approaches will benefit from an improved\nunderstanding of the spectrum of illness associated with SARS CoV-2 and from the capacity to integrate data to\nachieve two goals: (i) to identify the clinical, social, and biological variables that predict severe COVID-19 and\nMIS-C, and (ii) to target those populations and individuals at greatest risk for harm from the virus. We propose\nthe COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness\nin Children (CONNECT to Predict SIck Children) comprising eight partners providing access to data on >15\nmillion children. Our network will systematically integrate social, epidemiological, genetic, immunological, and\ncomputational approaches to identify both population- and individual-level risk factors for severe illness. Our\nunderlying hypothesis is that a combination of multidimensional data – clinical, sociodemographic, epidemiologic,\nand biological -- can be integrated to predict which children are at greatest risk to have severe consequences\nfrom SARS-CoV-2 infection. To test our hypothesis, we will develop CONNECT to Predict SIck Children, a\nnetwork of networks that leverages inpatient, outpatient, community, and epidemiological data resources to\nsupport the analysis of large data using machine learning and model-based analyses. For the R61 phase, we\nwill develop and refine predictive models using data from our network of networks (Aim 1). We will also recruit\nparticipants previously diagnosed with either COVID-19 or MIS-C (along with appropriate controls who have had\nmild or asymptomatic infections with SARS-CoV2), who will provide survey data (including social determinants)\nand saliva and blood samples to identify persisting biological factors associated with severe disease (Aim 2). We\nwill iteratively assess our models using a knowledge management framework that considers the marginal value\nof data for improving models' predictive capacity over time. In the R33 phase, we will validate and further refine\npredictive models incorporating data from additional participants recruited throughout our network of networks,\nincluding newly infected children with severe COVID-19 or MIS-C identified through real-time surveillance (Aim\n3). We seek to develop predictive models for children and adolescents that are useful, sensitive to community\nand environmental contexts, and informed by the REASSURED framework specified by the RFA. The models\nand biomarkers developed through our nationwide network of networks will produce generalizable knowledge\nthat will improve our ability to predict which children are at greatest risk for severe complications of SARS-CoV-\n2 infection. This knowledge will facilitate interventions to prevent and treat severe pediatric illness.\nid:R61HD105619\nnarrative:COVID-19, the disease caused by SARS-CoV-2, is a world-wide public health problem. Pediatric disease has\nbeen particularly difficult to manage since children tend less frequently to get sick from SARS-CoV-2 infection\nas adults but, when they do become ill, can present with life-threatening pulmonary disease or a systemic\ninflammatory condition known as multisystem inflammatory syndrome. The proposed COVID-19 Network of\nNetworks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to\nPredict SIck Children) will develop models and biomarkers that predict risk for severe disease in children and\nadolescents by systematically integrating social science, epidemiological, genetic, biochemical, immunological,\nand computational approaches.\nname:COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)\nsubProject:PreVAIL kIds\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R61"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a335219e425e4427a91b0cee958786ee": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 623,
       "target": 583
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a34e981a93c74af9bbd3d33dff0fefba": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Enabling access to comprehensive biomedical information is central to the mission of the National Library of\nMedicine and key to disease prevention for better health outcomes nationally and globally. In the area of\ninfectious disease prevention, real time and non-biased sequence data are essential for early detection of\nthreats to mitigate outbreaks, epidemics and pandemics. This proposed research project aims to innovate in\nthe creation and accessibility of metagenomic sequence data relating to infectious agents by leveraging the\npotentially transformative tool of wastewater-based epidemiology (WBE). The WBE approach employs analysis\nof community wastewater from large populations to enable non-invasive, near real-time monitoring of both\nsymptomatic and asymptomatic individuals. When combined with high-throughput metagenomic sequencing\n(HTS), the resulting WBE-HTS approach is promising for detecting a broad spectrum of infectious agents\nsimultaneously without any a priori assumptions about virus identity or presence. This project will test the\nhypothesis that the processing of aggregated metagenomic sequence data on viruses detectable in U.S.\nwastewater can serve to identify vulnerabilities, outbreaks and epidemics early, thereby creating a novel and\npotentially life-saving diagnostic approach for protecting public health.\n For hypothesis testing, the team will leverage Arizona State University's Human Health Observatory (HHO),\nthe largest sewage monitoring network and largest archive of sewage and sludge samples worldwide,\nrepresenting more than 200 U.S. cities and over 300 cities globally.\n The overall goal of this work is to develop a broadly applicable online bioinformatics framework and to\ndemonstrate its utility in a case study employing WBE and HTS.\n The three specific aims are to: (i) inventory viruses extant in the U.S. in a comprehensive database, using\nexisting database sources and WBE; (ii) generate a knowledge repository and online portal of metagenomic\ndata to support near real-time surveillance of the human–associated virome, and (iii) evaluate the utility of the\nWBE bioinformatics framework for tracking viral outbreaks and epidemics.\n Successful completion of this project will provide the U.S. with an early warning system for pathogen\ndetection and outbreak tracking that can serve to prevent epidemics, thereby reducing morbidity and mortality\nin the U.S. from contagious pathogens, first for viruses and potentially in the future for pathogenic bacteria and\nother biohazards.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 19,
       "label": "Grant",
       "name": "Bioinformatics Framework for Wastewater-based Surveillance of Infectious Diseases",
       "narrative": "This biomedical informatics project will leverage high-throughput sequencing (HTS) data from U.S. wastewater\nprocess flows collected over the past two decades to create an innovative early warning system for virus\nsurveillance and public health protection. It will furnish significantly expanded virome databases and an online\ntool enabling public health practitioners and researchers to rapidly detect characteristic sequences of\npathogenic human viruses in DNA and RNA sequence data from environmental and clinical specimens.",
       "researchInitiative": "RADx-rad",
       "subProject": "Wastewater",
       "tooltip": "Grant\nabstract:Enabling access to comprehensive biomedical information is central to the mission of the National Library of\nMedicine and key to disease prevention for better health outcomes nationally and globally. In the area of\ninfectious disease prevention, real time and non-biased sequence data are essential for early detection of\nthreats to mitigate outbreaks, epidemics and pandemics. This proposed research project aims to innovate in\nthe creation and accessibility of metagenomic sequence data relating to infectious agents by leveraging the\npotentially transformative tool of wastewater-based epidemiology (WBE). The WBE approach employs analysis\nof community wastewater from large populations to enable non-invasive, near real-time monitoring of both\nsymptomatic and asymptomatic individuals. When combined with high-throughput metagenomic sequencing\n(HTS), the resulting WBE-HTS approach is promising for detecting a broad spectrum of infectious agents\nsimultaneously without any a priori assumptions about virus identity or presence. This project will test the\nhypothesis that the processing of aggregated metagenomic sequence data on viruses detectable in U.S.\nwastewater can serve to identify vulnerabilities, outbreaks and epidemics early, thereby creating a novel and\npotentially life-saving diagnostic approach for protecting public health.\n For hypothesis testing, the team will leverage Arizona State University's Human Health Observatory (HHO),\nthe largest sewage monitoring network and largest archive of sewage and sludge samples worldwide,\nrepresenting more than 200 U.S. cities and over 300 cities globally.\n The overall goal of this work is to develop a broadly applicable online bioinformatics framework and to\ndemonstrate its utility in a case study employing WBE and HTS.\n The three specific aims are to: (i) inventory viruses extant in the U.S. in a comprehensive database, using\nexisting database sources and WBE; (ii) generate a knowledge repository and online portal of metagenomic\ndata to support near real-time surveillance of the human–associated virome, and (iii) evaluate the utility of the\nWBE bioinformatics framework for tracking viral outbreaks and epidemics.\n Successful completion of this project will provide the U.S. with an early warning system for pathogen\ndetection and outbreak tracking that can serve to prevent epidemics, thereby reducing morbidity and mortality\nin the U.S. from contagious pathogens, first for viruses and potentially in the future for pathogenic bacteria and\nother biohazards.\nid:U01LM013129\nnarrative:This biomedical informatics project will leverage high-throughput sequencing (HTS) data from U.S. wastewater\nprocess flows collected over the past two decades to create an innovative early warning system for virus\nsurveillance and public health protection. It will furnish significantly expanded virome databases and an online\ntool enabling public health practitioners and researchers to rapidly detect characteristic sequences of\npathogenic human viruses in DNA and RNA sequence data from environmental and clinical specimens.\nname:Bioinformatics Framework for Wastewater-based Surveillance of Infectious Diseases\nsubProject:Wastewater\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a37e38f54e754b36856082fc24d617d2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 623,
       "target": 24
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a408033a050f4d688eb9a32933a69abf": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1091,
       "target": 2821
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a47e2a6ab1f14029bbe60314171790cc": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4400,
       "target": 24
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a5a7b008120f46eebe7415f69de0981a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4397,
       "label": "FundingOpportunity",
       "name": "Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed)",
       "tooltip": "FundingOpportunity\nname:Emergency Awards: RADx-rad Data Coordination Center (DCC) (U24 Clinical Trial Not Allowed)\nid:RFA-OD-20-019\nurl:https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-019.html",
       "url": "https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-019.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a6128e64075b4ba69013c62cb3fb37ce": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Jeffrey",
       "fullName": "Jeffrey Ly",
       "id": 616,
       "label": "Researcher",
       "lastName": "Ly",
       "name": "Ly J",
       "profileId": "profileid:78421272",
       "tooltip": "Researcher\nid:profileid:78421272\nlastName:Ly\nprofileId:profileid:78421272\nname:Ly J\nfullName:Jeffrey Ly\nfirstName:Jeffrey"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a6528203745e4789843202c04f52c65d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The COVID-19 pandemic has caused unprecedented societal suffering and economic disruption. In the\nUnited States, more than six million people have contracted COVID-19 and more than one hundred ninety\nthousand patients have died of this disease to date. Although current COVID-19 diagnostic testing technologies\nare critical for slowing the spread of the virus and preventing future outbreaks, they are not practical for field use.\nCurrent diagnostic tests are cumbersome to perform because they use aqueous solutions, require multiple steps,\nand hours-to-days to obtain results. Since the US began to reopen the economy in May, there has been a\nsignificant increase in the number of COVID-19 cases. Therefore, there is an urgent need to develop a diagnostic\napproach that is non-invasive, portable, and can rapidly provide test results.\n The overall goal of the project is to develop a mobile breath analysis technology for rapid screening for\nCOVID-19 using a handheld breath collection tool and a portable GC with a photoionization detector (PID). The\nhandheld tool will be a closed system for trapping select volatile organic compounds (VOCs) on a microfabricated\nchip. The captured VOCs will be eluted with ethanol and then analyzed using a commercially available, portable\nGC-PID instrument. Artificial intelligence (AI) and machine learning algorithms will be applied to recognize the\nVOC pattern that correlates with COVID-19 infection. The central innovation is the microfabricated chip that\ncaptures carbonyl compounds in exhaled breath and thus serves as a preconcentrator, which enables analysis\nof carbonyl VOCs by the portable GC-PID. The hypothesis is that the carbonyl metabolome in exhaled breath is\ndirectly related to the body’s reaction to the novel coronavirus infection, and changes in the carbonyl VOC\ncomposition in exhaled breath relative to healthy controls can be used to detect both symptomatic and\nasymptomatic COVID-19 patients.\n Three specific aims are proposed to fulfill the overall goal. Aim 1 is to build a disposable handheld breath\nanalyzer tool for concentrating carbonyl VOCs. Aim 2 is to identify VOC patterns in the breath of COVID-19\npatients by machine learning algorithms. Aim 3 is to integrate portable GC technology with the breath sampling\ntool for COVID-19 screening guided by an AI system. The University of Louisville is uniquely suited to rapidly\ntransition the microchip technology to field use because of the PI and Co-PI’s experience in breath analysis and\ntranslational research, and the project team’s experience in virology, infectious diseases, biostatistics, and\nartificial intelligence as well as the state-of-the-art facilities that include a MicroNano Technology Center,\nBiosafety Level 3 Regional Biocontainment Lab, and an NIH-funded REACH program.",
       "awardCode": "U18",
       "fundingMechanism": "Other Research-Related",
       "id": 13,
       "label": "Grant",
       "name": "A Handheld Microchip for GC analysis of breath to screen for COVID-19",
       "narrative": "8. Project Narrative\n This project will develop a mobile breath analysis technology for rapid screening for COVID-19 using a\nhandheld breath collection tool and a portable GC with a photoionization detector (PID). Artificial intelligence and\nmachine learning algorithms will be used to analyze the detected signals of volatile organic compounds (VOCs)\nin exhaled breath by the portable GC for detection of COVID-19 patients. UofL is uniquely suited to develop this\napproach because of the PI’s expertise in breath analysis for detection of Tuberculosis and lung cancer and the\nteam’s experience in virology, infectious diseases, biostatistics, and artificial intelligence.",
       "researchInitiative": "RADx-rad",
       "subProject": "SCENT",
       "tooltip": "Grant\nabstract:The COVID-19 pandemic has caused unprecedented societal suffering and economic disruption. In the\nUnited States, more than six million people have contracted COVID-19 and more than one hundred ninety\nthousand patients have died of this disease to date. Although current COVID-19 diagnostic testing technologies\nare critical for slowing the spread of the virus and preventing future outbreaks, they are not practical for field use.\nCurrent diagnostic tests are cumbersome to perform because they use aqueous solutions, require multiple steps,\nand hours-to-days to obtain results. Since the US began to reopen the economy in May, there has been a\nsignificant increase in the number of COVID-19 cases. Therefore, there is an urgent need to develop a diagnostic\napproach that is non-invasive, portable, and can rapidly provide test results.\n The overall goal of the project is to develop a mobile breath analysis technology for rapid screening for\nCOVID-19 using a handheld breath collection tool and a portable GC with a photoionization detector (PID). The\nhandheld tool will be a closed system for trapping select volatile organic compounds (VOCs) on a microfabricated\nchip. The captured VOCs will be eluted with ethanol and then analyzed using a commercially available, portable\nGC-PID instrument. Artificial intelligence (AI) and machine learning algorithms will be applied to recognize the\nVOC pattern that correlates with COVID-19 infection. The central innovation is the microfabricated chip that\ncaptures carbonyl compounds in exhaled breath and thus serves as a preconcentrator, which enables analysis\nof carbonyl VOCs by the portable GC-PID. The hypothesis is that the carbonyl metabolome in exhaled breath is\ndirectly related to the body’s reaction to the novel coronavirus infection, and changes in the carbonyl VOC\ncomposition in exhaled breath relative to healthy controls can be used to detect both symptomatic and\nasymptomatic COVID-19 patients.\n Three specific aims are proposed to fulfill the overall goal. Aim 1 is to build a disposable handheld breath\nanalyzer tool for concentrating carbonyl VOCs. Aim 2 is to identify VOC patterns in the breath of COVID-19\npatients by machine learning algorithms. Aim 3 is to integrate portable GC technology with the breath sampling\ntool for COVID-19 screening guided by an AI system. The University of Louisville is uniquely suited to rapidly\ntransition the microchip technology to field use because of the PI and Co-PI’s experience in breath analysis and\ntranslational research, and the project team’s experience in virology, infectious diseases, biostatistics, and\nartificial intelligence as well as the state-of-the-art facilities that include a MicroNano Technology Center,\nBiosafety Level 3 Regional Biocontainment Lab, and an NIH-funded REACH program.\nid:U18TR003787\nnarrative:8. Project Narrative\n This project will develop a mobile breath analysis technology for rapid screening for COVID-19 using a\nhandheld breath collection tool and a portable GC with a photoionization detector (PID). Artificial intelligence and\nmachine learning algorithms will be used to analyze the detected signals of volatile organic compounds (VOCs)\nin exhaled breath by the portable GC for detection of COVID-19 patients. UofL is uniquely suited to develop this\napproach because of the PI’s expertise in breath analysis for detection of Tuberculosis and lung cancer and the\nteam’s experience in virology, infectious diseases, biostatistics, and artificial intelligence.\nname:A Handheld Microchip for GC analysis of breath to screen for COVID-19\nsubProject:SCENT\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U18"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a66222c957aa43c9aef1560833f5afa7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 714,
       "target": 22
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a6aa91d8315642a89fd29f2db3892b72": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Available tools for detection of SARS-CoV-2 virus require extensive sample preparation and/or expensive lab-\nbased equipment to obtain accurate results. The objective in this proposal is to build a touch-screen sensor array\nto directly capture, detect, and identify model SARS-CoV-2 virus particles with minimal false alarms. This ambi-\ntious goal will be achieved by the interdisciplinary team of GE Research scientists and engineers and will be a\nsynergistic combination of the proposed innovations and the prior scientific and engineering accomplishments\nof the team.\n Our proposed solution is based on several innovations driven by eliminating a need for a dedicated sam-\npling step and solving the problems of detection and reliable selective recognition of virus particles, performing\ndetection/recognition operation in a two-dimensional (2D) format of biosensors, e.g., as a touch-screen surface,\nand having this technical solution as a low-profile, low power, unobtrusive device that can be adapted to diverse\napplication scenarios.\n Innovations of the proposed proof-of-principle touch-screen detector are in three main areas. For virus\nrecognition, we will create new multifunctional bioreceptors. Our transduction principle will be based on our\nearlier reported transduction with the significantly enhanced performance. Our touch surface design will have a\n2D array of biosensors.\n The proposed proof-of-principle sensor will be developed in five aims. Aim 1 will focus on demonstration of\nnew multifunctional bioreceptors. Aim 2 will focus on validation of the functionality of these multifunctional\nbioreceptors upon their immobilization on sensor surface. Aim 3 will focus on demonstration of sensing of mod-\nel virus particles in a layout of 2D array of biosensors. Aim 4 will focus on demonstration of virus recognition\nwith immobilized multifunctional bioreceptors in variable ambient conditions. Aim 5 will focus on demonstra-\ntion of enhanced detection and recognition of model virus particles in the same layout of 2D array of biosensors\nas in Aim 3, but under variable ambient conditions. The findings in this proposed work will change the state-of-\nthe-art biosensing paradigm and will improve the scientific knowledge, technologies, and workflow practice for\nvirus detection.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 33,
       "label": "Grant",
       "name": "Minimal False-alarm Touch-based Detection of SARS-Cov-2 Virus Particles using Poly-aptamers",
       "narrative": "Reliable real-time detection of SARS-CoV-2 virus represents a considerable challenge, with available tools re-\nquiring extensive sample preparation and/or expensive lab-based equipment to obtain accurate results. The ob-\njective in this proposal is to build a touch-screen sensor array to directly capture, detect, and identify model\nSARS-CoV-2 virus particles with minimal false alarms. This ambitious goal will be achieved by the interdisci-\nplinary team of GE Research scientists and engineers and will be a synergistic combination of the proposed in-\nnovations and the prior scientific and engineering accomplishments of the team.",
       "researchInitiative": "RADx-rad",
       "subProject": "Automatic Detection & Tracing",
       "tooltip": "Grant\nabstract:Available tools for detection of SARS-CoV-2 virus require extensive sample preparation and/or expensive lab-\nbased equipment to obtain accurate results. The objective in this proposal is to build a touch-screen sensor array\nto directly capture, detect, and identify model SARS-CoV-2 virus particles with minimal false alarms. This ambi-\ntious goal will be achieved by the interdisciplinary team of GE Research scientists and engineers and will be a\nsynergistic combination of the proposed innovations and the prior scientific and engineering accomplishments\nof the team.\n Our proposed solution is based on several innovations driven by eliminating a need for a dedicated sam-\npling step and solving the problems of detection and reliable selective recognition of virus particles, performing\ndetection/recognition operation in a two-dimensional (2D) format of biosensors, e.g., as a touch-screen surface,\nand having this technical solution as a low-profile, low power, unobtrusive device that can be adapted to diverse\napplication scenarios.\n Innovations of the proposed proof-of-principle touch-screen detector are in three main areas. For virus\nrecognition, we will create new multifunctional bioreceptors. Our transduction principle will be based on our\nearlier reported transduction with the significantly enhanced performance. Our touch surface design will have a\n2D array of biosensors.\n The proposed proof-of-principle sensor will be developed in five aims. Aim 1 will focus on demonstration of\nnew multifunctional bioreceptors. Aim 2 will focus on validation of the functionality of these multifunctional\nbioreceptors upon their immobilization on sensor surface. Aim 3 will focus on demonstration of sensing of mod-\nel virus particles in a layout of 2D array of biosensors. Aim 4 will focus on demonstration of virus recognition\nwith immobilized multifunctional bioreceptors in variable ambient conditions. Aim 5 will focus on demonstra-\ntion of enhanced detection and recognition of model virus particles in the same layout of 2D array of biosensors\nas in Aim 3, but under variable ambient conditions. The findings in this proposed work will change the state-of-\nthe-art biosensing paradigm and will improve the scientific knowledge, technologies, and workflow practice for\nvirus detection.\nid:U01AA029324\nnarrative:Reliable real-time detection of SARS-CoV-2 virus represents a considerable challenge, with available tools re-\nquiring extensive sample preparation and/or expensive lab-based equipment to obtain accurate results. The ob-\njective in this proposal is to build a touch-screen sensor array to directly capture, detect, and identify model\nSARS-CoV-2 virus particles with minimal false alarms. This ambitious goal will be achieved by the interdisci-\nplinary team of GE Research scientists and engineers and will be a synergistic combination of the proposed in-\nnovations and the prior scientific and engineering accomplishments of the team.\nname:Minimal False-alarm Touch-based Detection of SARS-Cov-2 Virus Particles using Poly-aptamers\nsubProject:Automatic Detection & Tracing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a6e59a8c6d9e456db08fafb84898dbe8": {
     "model_module": "@jupyter-widgets/base",
     "model_module_version": "1.2.0",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": "1000px",
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "a750b5d72277492eb261dea02ab193b7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4395,
       "target": 31
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a7e6b099883f4da28a9835c212e553f2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 674,
       "target": 593
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a8c3ea7ea6624294a0de0e8147d01264": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 713,
       "target": 22
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a9008d164b824628927319617506d950": {
     "model_module": "@jupyter-widgets/controls",
     "model_module_version": "1.5.0",
     "model_name": "HTMLModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HTMLModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HTMLView",
      "description": "",
      "description_tooltip": null,
      "layout": "IPY_MODEL_f2fd1f0a71de4179854f923448dfb0e0",
      "placeholder": "​",
      "style": "IPY_MODEL_966cf9ca7c6a4a71936c85c6332a65af",
      "value": " 85/85 [00:13&lt;00:00, 14.09cell/s]"
     }
    },
    "a918d31d1c89400984a873d4f108437c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4391,
       "label": "FundingOpportunity",
       "name": "Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)",
       "tooltip": "FundingOpportunity\nname:Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)\nid:RFA-OD-20-021\nurl:https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-021.html",
       "url": "https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-021.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a99204b9354745e1b7c3e8a1baf76387": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 621,
       "target": 15
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "a9db4a3cc0ad42d6a42f8e162c38631c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Steven",
       "fullName": "Steven Daniel Hicks",
       "id": 693,
       "label": "Researcher",
       "lastName": "Hicks",
       "middleName": "Daniel",
       "name": "Hicks SD",
       "orcid": "orcid:0000-0002-9579-6798",
       "profileId": "profileid:14228211",
       "tooltip": "Researcher\nmiddleName:Daniel\nid:profileid:14228211\nlastName:Hicks\norcid:orcid:0000-0002-9579-6798\nprofileId:profileid:14228211\nname:Hicks SD\nfullName:Steven Daniel Hicks\nfirstName:Steven"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "aa679fd5330d4227a354b03a5c2f6d8a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "NEW YORK",
       "country": "UNITED STATES",
       "duns": "duns:121911077",
       "geonames": "geonames:5128581",
       "id": 574,
       "label": "Organization",
       "name": "New York University School of Medicine",
       "ror": "ror:05wthjx48",
       "state": "NY",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5128581\nror:ror:05wthjx48\ncity:NEW YORK\nname:New York University School of Medicine\nuei:uei:M5SZJ6VHUHN8\nduns:duns:121911077\nstate:NY\nid:ror:05wthjx48\nurl:https://ror.org/05wthjx48",
       "uei": "uei:M5SZJ6VHUHN8",
       "url": "https://ror.org/05wthjx48"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "aad7ec166c8d4934a9c98b7ba72a9eaf": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2024,
       "name": "EMPLOYED_AT",
       "source": 610,
       "target": 585
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "aaf9e860fc1f4c489bff24d592e6ac71": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Preparing SARS-­CoV-­2 testing data for reuse requires making the data syntactically and semantically equivalent. \nStandardization  of  terminologies  and  a  common  data  model  accomplish  the  former,  while  the  latter  is \naccomplished  through  understanding  the  data  and  making  it  comparable  across  RADx-­rad  awardees  by \nbenchmarking against known gold standards. The standardization of samples is as important as standardizing \nthe data, particularly in the highly innovative RADx-­rad program, where new technologies will be developed or \noptimized for deployment in various settings. Highly motivated RADx-­rad awardees will receive advice on how \ntheir diagnostics compare to FDA-­approved ones, with each other, how their diagnostic performs in independent \ntesting,  as  well as how  to ensure  the  tests  are usable  in  real  world  settings.  In  collaboration  with  University  of \nTexas  Health  Science  Center  at  Houston,  University  of  California San  Diego  researchers  in  informatics/data \nscience and infectious diseases with ample experience in leading large consortia have designed a unique RADx-­\nrad  Consortium  Data  and  Coordination  Center  (radCDCC).  This  center  is  based  on  three  pillars:  (1)  effective \nadministration and coordination among awardees, NIH, and other programs;; (2) innovative approaches and tools \nto  collect  and  standardize  data  and  metadata  to  promote  findability,  accessibility,  interoperability  and  reuse \n(FAIR)  for  data  sharing;;  and  (3)  principled  preparation  of  standardized  samples  with  known  quantities  of  viral \nloads, and standardized procedures for testing new diagnostics to allow comparison across tests and calibration \nof  new  technologies.  Backed  by  sophisticated  HIPAA-­compliant  cloud  services,  user  friendly  web-­tools,  and \nextensive  support  from  UCSD’s  facilities  for  computation and  for  clinical  research,  the  radCDCC will  interface \nwith other RADx programs and other COVID-­19 focused programs at NIH to ensure alignment of awardees, NIH \nand the public in the pursuit of effective, affordable, and deployable new technologies for testing.  ",
       "awardCode": "U24",
       "fundingMechanism": "Other Research-Related",
       "id": 47,
       "label": "Grant",
       "name": "RADx-Rad Discoveries & Data: Consortium Coordination Center Program Organization",
       "narrative": "The  RADx-­rad  Consortium  Data  and  Coordination  Center  (radCDCC)  will  use  advanced data  management  to \ncoordinate  a  consortium  of  innovative  COVID-­19  diagnostic  technology  developers.  The  partnership  between \nthe  University  of  California  San  Diego  and  the  University  of  Texas  Health  Science  Center  at  Houston  brings \ntogether informatics/data scientists and infectious diseases specialists who will standardize viral samples, testing \nand procedures, as well as data in order to integrate and share data in a meaningful manner. ",
       "researchInitiative": "RADx-rad",
       "subProject": "Data Coordinating Center",
       "tooltip": "Grant\nabstract:Preparing SARS-­CoV-­2 testing data for reuse requires making the data syntactically and semantically equivalent. \nStandardization  of  terminologies  and  a  common  data  model  accomplish  the  former,  while  the  latter  is \naccomplished  through  understanding  the  data  and  making  it  comparable  across  RADx-­rad  awardees  by \nbenchmarking against known gold standards. The standardization of samples is as important as standardizing \nthe data, particularly in the highly innovative RADx-­rad program, where new technologies will be developed or \noptimized for deployment in various settings. Highly motivated RADx-­rad awardees will receive advice on how \ntheir diagnostics compare to FDA-­approved ones, with each other, how their diagnostic performs in independent \ntesting,  as  well as how  to ensure  the  tests  are usable  in  real  world  settings.  In  collaboration  with  University  of \nTexas  Health  Science  Center  at  Houston,  University  of  California San  Diego  researchers  in  informatics/data \nscience and infectious diseases with ample experience in leading large consortia have designed a unique RADx-­\nrad  Consortium  Data  and  Coordination  Center  (radCDCC).  This  center  is  based  on  three  pillars:  (1)  effective \nadministration and coordination among awardees, NIH, and other programs;; (2) innovative approaches and tools \nto  collect  and  standardize  data  and  metadata  to  promote  findability,  accessibility,  interoperability  and  reuse \n(FAIR)  for  data  sharing;;  and  (3)  principled  preparation  of  standardized  samples  with  known  quantities  of  viral \nloads, and standardized procedures for testing new diagnostics to allow comparison across tests and calibration \nof  new  technologies.  Backed  by  sophisticated  HIPAA-­compliant  cloud  services,  user  friendly  web-­tools,  and \nextensive  support  from  UCSD’s  facilities  for  computation and  for  clinical  research,  the  radCDCC will  interface \nwith other RADx programs and other COVID-­19 focused programs at NIH to ensure alignment of awardees, NIH \nand the public in the pursuit of effective, affordable, and deployable new technologies for testing.  \nid:U24LM013755\nnarrative:The  RADx-­rad  Consortium  Data  and  Coordination  Center  (radCDCC)  will  use  advanced data  management  to \ncoordinate  a  consortium  of  innovative  COVID-­19  diagnostic  technology  developers.  The  partnership  between \nthe  University  of  California  San  Diego  and  the  University  of  Texas  Health  Science  Center  at  Houston  brings \ntogether informatics/data scientists and infectious diseases specialists who will standardize viral samples, testing \nand procedures, as well as data in order to integrate and share data in a meaningful manner. \nname:RADx-Rad Discoveries & Data: Consortium Coordination Center Program Organization\nsubProject:Data Coordinating Center\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U24"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "abe5a1fa9c8f407c8047e91181d159ca": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "ITHACA",
       "country": "UNITED STATES",
       "duns": "duns:872612445",
       "geonames": "geonames:5122432",
       "id": 590,
       "label": "Organization",
       "name": "Cornell University",
       "ror": "ror:05bnh6r87",
       "state": "NY",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5122432\nror:ror:05bnh6r87\ncity:ITHACA\nname:Cornell University\nuei:uei:G56PUALJ3KT5\nduns:duns:872612445\nstate:NY\nid:ror:05bnh6r87\nurl:https://ror.org/05bnh6r87",
       "uei": "uei:G56PUALJ3KT5",
       "url": "https://ror.org/05bnh6r87"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "abeb8bb4c3ee4084aba8aec3f9d83427": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4360,
       "label": "Presentation",
       "name": "Detecting aerosolized SARS-CoV-2 in breath",
       "presenters": "John Cirrito",
       "tooltip": "Presentation\nid:526cb764deeea462872ecb79eeaafc58\npresenters:John Cirrito\nname:Detecting aerosolized SARS-CoV-2 in breath"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ac2632d4452a42febd71fdc62c473c95": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "description": "RADx-rad will support new, non-traditional approaches, including rapid detection devices and home-based testing technologies, that address current gaps in COVID-19 testing. The program will also support new or non-traditional applications of existing approaches to make them more usable, accessible, or accurate. These may lead to new ways to identify the current SARS-CoV-2 virus as well as potential future viruses.",
       "id": 546,
       "label": "ResearchInitiative",
       "longName": "RADx-rad Discoveries and Data Coordinating Center (DCC)",
       "name": "RADx-rad",
       "researchInitiativeUrl": "https://www.nih.gov/research-training/medical-research-initiatives/radx/radx-programs#radx-rad",
       "tooltip": "ResearchInitiative\nresearchInitiativeUrl:https://www.nih.gov/research-training/medical-research-initiatives/radx/radx-programs#radx-rad\nid:RADx-rad\ndescription:RADx-rad will support new, non-traditional approaches, including rapid detection devices and home-based testing technologies, that address current gaps in COVID-19 testing. The program will also support new or non-traditional applications of existing approaches to make them more usable, accessible, or accurate. These may lead to new ways to identify the current SARS-CoV-2 virus as well as potential future viruses.\nname:RADx-rad\nlongName:RADx-rad Discoveries and Data Coordinating Center (DCC)\nwebsites:['https://radxlab.org', 'https://github.com/radxrad']\nurl:https://radxrad.org/",
       "url": "https://radxrad.org/",
       "websites": [
        "https://radxlab.org",
        "https://github.com/radxrad"
       ]
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ac95da440e714ec9ad28c84ac814d979": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "IS_INVENTOR",
       "source": 1428,
       "target": 2409
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "aca2c0308e50482ca6557c835dd50fd0": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 638,
       "target": 576
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ad0e2258663b466794b87b2727df9e08": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Lucila",
       "fullName": "Lucila Ohno-Machado",
       "id": 690,
       "label": "Researcher",
       "lastName": "Ohno-Machado",
       "name": "Ohno-Machado L",
       "orcid": "orcid:0000-0002-8005-7327",
       "profileId": "profileid:1900244",
       "tooltip": "Researcher\nid:profileid:1900244\nlastName:Ohno-Machado\norcid:orcid:0000-0002-8005-7327\nprofileId:profileid:1900244\nname:Ohno-Machado L\nfullName:Lucila Ohno-Machado\nfirstName:Lucila"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ad7ce2a04faf4b839a0eb9c9b62aa299": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "A Novel Saliva-Based Aptamer Detection Assay for SARS-CoV-2 Infection\n(RFA-OD-20-021 STTR Application)\nAutomated, rapid diagnostics with little sample collection and preparation are needed to identify\nand trace affected persons in times when hyper-infectious pathogens cause pandemics. Frequent,\nlow cost and highly scalable testing is the only way to gain visibility on the magnitude of the\npandemic and ultimately control the spread of the disease. We propose the development of a\nunique system that can cheaply and readily detect SARS-CoV-2 in saliva samples. The\ndevelopment of a system that uses saliva present an opportunity to readily test patients using a\nsample that is easily collected and harbors high concentration of viral particles.\nThe SARS-CoV-2 pandemic has predominantly affected individuals with pre-existing conditions\nsuch as clotting disorders, diabetes, hypertension or other chronic diseases. Patients with these\npre-existing conditions who then are infected have exacerbated symptoms and complications that\ncan lead to death. For example, many patients that have succumbed to SARS-CoV-2 infection\nhave developed blood clots that have impaired pulmonary or cardiac function and ultimately\ncardiac failure. A rapid diagnostic using easily collected samples (e.g. saliva) would allow for\ninfections to be identified sooner, therapies to be administered quicker, treatment to be monitored,\nand ultimately leading to fewer individuals that succumb to the infection.\nWe outline a novel DNA Star biosensing approach based on the fact that viruses, such as SARS-\nCoV-2, express unique spatial patterns of antigens on their surfaces, facilitating multivalent\nbinding to host cells for infection. These configurations of epitopes drive the high sensitivity and\nspecificity of our assay. Based on this naturally occurring binding mechanism, we developed a\nrational design approach producing pattern matching designer DNA architecture for viral sensing.\nA proof-of-concept Dengue virus (DENV) rapid diagnostics was developed to demonstrate its\npower: DENV surface antigens present the most complex geometric pattern among all known\npathogens, a DNA star linked 10-aptamers nanostructure that offers polyvalent, spatial DENV-\nepitope pattern matching interactions has provided high DENV-binding avidity and specificity,\nincreasing affinity by ~1,000× compared to the conventional aptamer approach which relies on\nmonovalent aptamer-epitope interactions. Our POCT diagnostics detected intact DENV virions in\npatient samples with PCR equivalent sensitivity in <2 mins at a cost <$0.15.\nCurrent RT-PCR molecular test are suited to large, centralized laboratories, and difficult to scale\nfor rapid testing of samples and delivery of results to clinicians and patients. Immunoassay tests\nhave lower sensitivity, and patients need to develop a response to the virus in order to detect the\nantibody response. Our “DNA star” biosensor-based rapid diagnostics will provide the\ninfrastructure for real time SARS-CoV-2 diagnostics that is easy to use (instrument-free), faster\n(sample to results in minutes) and cost effective (~$3 per test).",
       "awardCode": "R44",
       "fundingMechanism": "SBIR/STTR",
       "id": 7,
       "label": "Grant",
       "name": "Designer DNA Nanostructure Based Biosensing for Rapid COVID19 Detection and Monitoring using Saliva Sample",
       "narrative": "Direct detection of viral pathogens is needed to help limit the spread of extremely contagious and lethal infectious\nagents. Our aptamer-based detection assay and instrument will provide a mechanism to detect low levels of the\nSARS-CoV-2 viral pathogen with an automatic system requiring minimal effort for sample collection and no\nsample preparation and the system will be built to analyze at least 7 other sample types (plasma, whole blood,\nurine, nasopharyngeal samples, etc.) and the detection modalities will have additional detection aptamers in\norder to detect additional viral pathogens. This assay system can be deployed to monitor people not only in\nhospital and senior living facilities, but in schools, airports and other locations so that infected and asymptomatic\nindividuals can be identified, quarantined, and treated to limit the spread of the pathogen.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:A Novel Saliva-Based Aptamer Detection Assay for SARS-CoV-2 Infection\n(RFA-OD-20-021 STTR Application)\nAutomated, rapid diagnostics with little sample collection and preparation are needed to identify\nand trace affected persons in times when hyper-infectious pathogens cause pandemics. Frequent,\nlow cost and highly scalable testing is the only way to gain visibility on the magnitude of the\npandemic and ultimately control the spread of the disease. We propose the development of a\nunique system that can cheaply and readily detect SARS-CoV-2 in saliva samples. The\ndevelopment of a system that uses saliva present an opportunity to readily test patients using a\nsample that is easily collected and harbors high concentration of viral particles.\nThe SARS-CoV-2 pandemic has predominantly affected individuals with pre-existing conditions\nsuch as clotting disorders, diabetes, hypertension or other chronic diseases. Patients with these\npre-existing conditions who then are infected have exacerbated symptoms and complications that\ncan lead to death. For example, many patients that have succumbed to SARS-CoV-2 infection\nhave developed blood clots that have impaired pulmonary or cardiac function and ultimately\ncardiac failure. A rapid diagnostic using easily collected samples (e.g. saliva) would allow for\ninfections to be identified sooner, therapies to be administered quicker, treatment to be monitored,\nand ultimately leading to fewer individuals that succumb to the infection.\nWe outline a novel DNA Star biosensing approach based on the fact that viruses, such as SARS-\nCoV-2, express unique spatial patterns of antigens on their surfaces, facilitating multivalent\nbinding to host cells for infection. These configurations of epitopes drive the high sensitivity and\nspecificity of our assay. Based on this naturally occurring binding mechanism, we developed a\nrational design approach producing pattern matching designer DNA architecture for viral sensing.\nA proof-of-concept Dengue virus (DENV) rapid diagnostics was developed to demonstrate its\npower: DENV surface antigens present the most complex geometric pattern among all known\npathogens, a DNA star linked 10-aptamers nanostructure that offers polyvalent, spatial DENV-\nepitope pattern matching interactions has provided high DENV-binding avidity and specificity,\nincreasing affinity by ~1,000× compared to the conventional aptamer approach which relies on\nmonovalent aptamer-epitope interactions. Our POCT diagnostics detected intact DENV virions in\npatient samples with PCR equivalent sensitivity in <2 mins at a cost <$0.15.\nCurrent RT-PCR molecular test are suited to large, centralized laboratories, and difficult to scale\nfor rapid testing of samples and delivery of results to clinicians and patients. Immunoassay tests\nhave lower sensitivity, and patients need to develop a response to the virus in order to detect the\nantibody response. Our “DNA star” biosensor-based rapid diagnostics will provide the\ninfrastructure for real time SARS-CoV-2 diagnostics that is easy to use (instrument-free), faster\n(sample to results in minutes) and cost effective (~$3 per test).\nid:R44DE030852\nnarrative:Direct detection of viral pathogens is needed to help limit the spread of extremely contagious and lethal infectious\nagents. Our aptamer-based detection assay and instrument will provide a mechanism to detect low levels of the\nSARS-CoV-2 viral pathogen with an automatic system requiring minimal effort for sample collection and no\nsample preparation and the system will be built to analyze at least 7 other sample types (plasma, whole blood,\nurine, nasopharyngeal samples, etc.) and the detection modalities will have additional detection aptamers in\norder to detect additional viral pathogens. This assay system can be deployed to monitor people not only in\nhospital and senior living facilities, but in schools, airports and other locations so that infected and asymptomatic\nindividuals can be identified, quarantined, and treated to limit the spread of the pathogen.\nname:Designer DNA Nanostructure Based Biosensing for Rapid COVID19 Detection and Monitoring using Saliva Sample\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:SBIR/STTR\nawardCode:R44"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "adbf5469a60a4f3a9a416170807a7e39": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Since the SARS-CoV-2 pandemic began, the emergence of an associated novel multisystem\ninflammatory syndrome in children (MIS-C) has been reported. Interestingly, patients with MIS-C follow a\npresentation, management and clinical course that are somewhat similar to that of patients with Kawasaki\ndisease (KD). Currently, the reason for such an overlap in clinical features and management is unclear and\nwhether this overlap is the result of a partially shared etiology or pathophysiology is the subject of fierce\ndebates. The degree of overlap implies that some of the clinical prediction tools that we have developed in the\npast for KD could be repurposed to accelerate the development of clinical support decision tools for MIS-C. In\nthis study, we will first (R61 component) systematically address the overlap between KD and MIS-C and create\nsalient machine-learning based prediction models for diagnosis/identification (Aim #1), management (Aim #2),\nand short- and long-term outcomes (Aim #3) of MIS-C based on our previously developed predictive models for\nKD in a process akin to transfer learning. Secondly (R33 component), we will validate and evaluate the\nperformance and clinical utility of these models in a predictive clinical decision support system for the diagnosis\nand management of pediatric patients presenting with features indicative of either MIS-C or KD. In this study we\nwill include 3 groups of patients: 1) patients with SARS-CoV-2 infection with MIS-C (CDC criteria) regardless of\nwhether they have overlapping signs of KD, 2) patients with SARS-CoV-2 infection investigated for but\neventually not diagnosed with MIS-C, and 3) patients with KD but without SARS-CoV-2 infection. Targeted data\nwill be collected from enrolled patients (900 for training and 450 for validation) for deep phenotyping and\nbiomarker measurements. Physician feedback on the predictions generated by the algorithm will be used to\nestablish clinical utility. Data required for model training will be accrued in the first two years of activity (R61\nperiod of the grant); the development of algorithms and their internal validation will occur concurrently. In the\nfollowing 2 years (R33 period of the grant), we will perform external validation, establish clinical utility, add real-\ntime epidemiological surveillance data to the models and finally package, and certify the algorithms for future\ndeployment and for the integration in electronic health records. This project will be a collaboration with the\nInternational Kawasaki Disease Registry (IKDR) Consortium. The IKDR Consortium has an active KD and\npediatric COVID registry in 35 sites across the world and the number of sites is currently expanding to 60+ sites.\nMore than 600 MIS-C patients have already been identified at IKDR centers, making this project clearly feasible\nand perfectly positioning IKDR to perform this study. We strongly believe that the use of emerging data science\nmethods and of our previously developed algorithms in the context of KD, as opposed to focusing on MIS-C\npatients alone, will boost our understanding of the etiology and pathophysiology of both MIS-C and KD and will\nmore rapidly lead to the emergence of data-driven management protocols for patients with MIS-C.",
       "awardCode": "R61",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 12,
       "label": "Grant",
       "name": "A data science approach to identify and manage Multisystem Inflammatory Syndrome in Children (MIS-C) associated with SARS-CoV-2 infection and Kawasaki disease in pediatric patients",
       "narrative": "The primary objective of this study is to design and validate a predictive decision support\nsystem for the identification, treatment and management of SARS-CoV-2 associated with multisystem\ninflammatory syndrome in children (MIS-C). To develop this system, we will adapt and retrain machine learning\nalgorithms which we have previously trained in patients with Kawasaki Disease, a pediatric inflammatory\nvasculopathy with multiple similarities to MIS-C. This study, performed in collaboration with the International\nKawasaki Disease Registry (IKDR) consortium, will consist of two phases, first a large-scale data collection\nand algorithm development effort and second, the prospective evaluation of the performance and clinical utility\nof the algorithm ahead of large-scale deployment.",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nabstract:Since the SARS-CoV-2 pandemic began, the emergence of an associated novel multisystem\ninflammatory syndrome in children (MIS-C) has been reported. Interestingly, patients with MIS-C follow a\npresentation, management and clinical course that are somewhat similar to that of patients with Kawasaki\ndisease (KD). Currently, the reason for such an overlap in clinical features and management is unclear and\nwhether this overlap is the result of a partially shared etiology or pathophysiology is the subject of fierce\ndebates. The degree of overlap implies that some of the clinical prediction tools that we have developed in the\npast for KD could be repurposed to accelerate the development of clinical support decision tools for MIS-C. In\nthis study, we will first (R61 component) systematically address the overlap between KD and MIS-C and create\nsalient machine-learning based prediction models for diagnosis/identification (Aim #1), management (Aim #2),\nand short- and long-term outcomes (Aim #3) of MIS-C based on our previously developed predictive models for\nKD in a process akin to transfer learning. Secondly (R33 component), we will validate and evaluate the\nperformance and clinical utility of these models in a predictive clinical decision support system for the diagnosis\nand management of pediatric patients presenting with features indicative of either MIS-C or KD. In this study we\nwill include 3 groups of patients: 1) patients with SARS-CoV-2 infection with MIS-C (CDC criteria) regardless of\nwhether they have overlapping signs of KD, 2) patients with SARS-CoV-2 infection investigated for but\neventually not diagnosed with MIS-C, and 3) patients with KD but without SARS-CoV-2 infection. Targeted data\nwill be collected from enrolled patients (900 for training and 450 for validation) for deep phenotyping and\nbiomarker measurements. Physician feedback on the predictions generated by the algorithm will be used to\nestablish clinical utility. Data required for model training will be accrued in the first two years of activity (R61\nperiod of the grant); the development of algorithms and their internal validation will occur concurrently. In the\nfollowing 2 years (R33 period of the grant), we will perform external validation, establish clinical utility, add real-\ntime epidemiological surveillance data to the models and finally package, and certify the algorithms for future\ndeployment and for the integration in electronic health records. This project will be a collaboration with the\nInternational Kawasaki Disease Registry (IKDR) Consortium. The IKDR Consortium has an active KD and\npediatric COVID registry in 35 sites across the world and the number of sites is currently expanding to 60+ sites.\nMore than 600 MIS-C patients have already been identified at IKDR centers, making this project clearly feasible\nand perfectly positioning IKDR to perform this study. We strongly believe that the use of emerging data science\nmethods and of our previously developed algorithms in the context of KD, as opposed to focusing on MIS-C\npatients alone, will boost our understanding of the etiology and pathophysiology of both MIS-C and KD and will\nmore rapidly lead to the emergence of data-driven management protocols for patients with MIS-C.\nid:R61HD105591\nnarrative:The primary objective of this study is to design and validate a predictive decision support\nsystem for the identification, treatment and management of SARS-CoV-2 associated with multisystem\ninflammatory syndrome in children (MIS-C). To develop this system, we will adapt and retrain machine learning\nalgorithms which we have previously trained in patients with Kawasaki Disease, a pediatric inflammatory\nvasculopathy with multiple similarities to MIS-C. This study, performed in collaboration with the International\nKawasaki Disease Registry (IKDR) consortium, will consist of two phases, first a large-scale data collection\nand algorithm development effort and second, the prospective evaluation of the performance and clinical utility\nof the algorithm ahead of large-scale deployment.\nname:A data science approach to identify and manage Multisystem Inflammatory Syndrome in Children (MIS-C) associated with SARS-CoV-2 infection and Kawasaki disease in pediatric patients\nsubProject:PreVAIL kIds\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R61"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "addf182acf504f31b435aef6567fe114": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4387,
       "target": 30
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "adf214c2ae644af096bf77d635d7d8c1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The novel coronavirus SARS-CoV-2 is causing significant morbidity and mortality. Current approaches to SARS-\nCoV-2 testing are costly, inconsistently implemented, and fail to rapidly identify evolving outbreaks. Innovative\nsurveillance programs are urgently needed to better measure baseline transmission dynamics and anticipate\nnew localized outbreaks. Wastewater based testing (WBT) has the potential to enable population level\nsurveillance, trigger earlier regional responses to acute outbreaks, and overcome barriers to individual testing\nsuch as stigma and lack of access. WBT could therefore enable faster and cheaper pathogen detection and\nimprove population-level estimates of prevalence. Reliable capture approaches for this novel coronavirus using\nWBT are currently undefined. Viral dynamics during wastewater transport must be considered, and correlation\nof WBT with clinical testing must be systematically evaluated at multiple scales. Here, we propose to optimize\nWBT surveillance protocols of waste streams at an urban university campus encompassing dorms, research\nfacilities and a tertiary care hospital, surrounding sewershed and wastewater treatment plant. We will detect\nSARS-CoV-2 using qRT-PCR to estimate prevalence and viral panel-enriched metatranscriptomics to\ncharacterize viral diversity. We will model case counts using normalized WBT data and develop point-of-use\nmicrofluidics systems for WBT. Our team of investigators is uniquely positioned for this study, with expertise in\ninfectious diseases, epidemiology, microbial characterization using WBT at national scales, and point-of-care\ntesting. We will implement three complimentary specific aims. In Aim 1, we will optimize (1a) collection and\nprocessing to determine sensitivity and safety of WBT. This includes grab vs. composite sampling;) filtration- vs.\nprecipitation-based enrichment; and viral inactivation protocols. We will further optimize scale and frequency of\nsampling (1b) at the building/sewer pit, campus, sewershed, and WWTP, and across various frequencies.\nPresence of SARS-CoV-2 will be ascertained by qRT-PCR and long-read spiked-primer enriched\nmetatranscriptomics. WBT results will be integrated with clinical case-loads, existing surveillance cohorts and\nexpanded employee surveillance. In Aim 2. we will improve modeling of SARS-CoV-2 case dynamics using\nextrapolated WBT data and site-specific normalization factors. We will correlate modeled building-, campus- and\ncommunity-level case counts with existing clinical incidence data and campus surveillance using ensemble\nKalman filter (EnKF) dynamic modeling incorporating both qRT-PCR and metatranscriptomics data. We will\ncompare normalization methods factoring in wastewater residence time, per capita viral load equivalents\n(PCVLEs), and other waste flow parameters to reduce model error. Finally, in Aim 3, we will adapt point-of-use\ntesting capabilities using microfluidics based on optimized WBT protocols. We will apply existing RADx\ndevelopment of a photothermal amplification system for SARS-CoV-2 detection to optimized WBT practices. We\nwill develop a modular system for WBT samples and determine assay detection thresholds using viral controls.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 2,
       "label": "Grant",
       "name": "Optimizing SARS-CoV-2 wastewater based surveillance in urban and university campus settings.",
       "narrative": "Wastewater based testing (WBT) holds great promise for cost-effective population-level surveillance and\ntransmission tracking of SARS-CoV-2, but optimal sampling modalities and protocols are unknown. Taking\nadvantage of a diverse inner city urban campus encompassing undergraduate and postgraduate dorms,\nresearch buildings, and medical facilities, we will optimize WBT surveillance strategies of waste streams at the\nbuilding level, surrounding sewersheds and wastewater treatment plants and model case counts using\nnormalized WBT data. We will further leverage metatranscriptomics for rapid identification of SARS-CoV-2\ntransmission chains and develop point-of-use microfluidics systems for timely WBT.",
       "researchInitiative": "RADx-rad",
       "subProject": "Wastewater",
       "tooltip": "Grant\nabstract:The novel coronavirus SARS-CoV-2 is causing significant morbidity and mortality. Current approaches to SARS-\nCoV-2 testing are costly, inconsistently implemented, and fail to rapidly identify evolving outbreaks. Innovative\nsurveillance programs are urgently needed to better measure baseline transmission dynamics and anticipate\nnew localized outbreaks. Wastewater based testing (WBT) has the potential to enable population level\nsurveillance, trigger earlier regional responses to acute outbreaks, and overcome barriers to individual testing\nsuch as stigma and lack of access. WBT could therefore enable faster and cheaper pathogen detection and\nimprove population-level estimates of prevalence. Reliable capture approaches for this novel coronavirus using\nWBT are currently undefined. Viral dynamics during wastewater transport must be considered, and correlation\nof WBT with clinical testing must be systematically evaluated at multiple scales. Here, we propose to optimize\nWBT surveillance protocols of waste streams at an urban university campus encompassing dorms, research\nfacilities and a tertiary care hospital, surrounding sewershed and wastewater treatment plant. We will detect\nSARS-CoV-2 using qRT-PCR to estimate prevalence and viral panel-enriched metatranscriptomics to\ncharacterize viral diversity. We will model case counts using normalized WBT data and develop point-of-use\nmicrofluidics systems for WBT. Our team of investigators is uniquely positioned for this study, with expertise in\ninfectious diseases, epidemiology, microbial characterization using WBT at national scales, and point-of-care\ntesting. We will implement three complimentary specific aims. In Aim 1, we will optimize (1a) collection and\nprocessing to determine sensitivity and safety of WBT. This includes grab vs. composite sampling;) filtration- vs.\nprecipitation-based enrichment; and viral inactivation protocols. We will further optimize scale and frequency of\nsampling (1b) at the building/sewer pit, campus, sewershed, and WWTP, and across various frequencies.\nPresence of SARS-CoV-2 will be ascertained by qRT-PCR and long-read spiked-primer enriched\nmetatranscriptomics. WBT results will be integrated with clinical case-loads, existing surveillance cohorts and\nexpanded employee surveillance. In Aim 2. we will improve modeling of SARS-CoV-2 case dynamics using\nextrapolated WBT data and site-specific normalization factors. We will correlate modeled building-, campus- and\ncommunity-level case counts with existing clinical incidence data and campus surveillance using ensemble\nKalman filter (EnKF) dynamic modeling incorporating both qRT-PCR and metatranscriptomics data. We will\ncompare normalization methods factoring in wastewater residence time, per capita viral load equivalents\n(PCVLEs), and other waste flow parameters to reduce model error. Finally, in Aim 3, we will adapt point-of-use\ntesting capabilities using microfluidics based on optimized WBT protocols. We will apply existing RADx\ndevelopment of a photothermal amplification system for SARS-CoV-2 detection to optimized WBT practices. We\nwill develop a modular system for WBT samples and determine assay detection thresholds using viral controls.\nid:U01DA053949\nnarrative:Wastewater based testing (WBT) holds great promise for cost-effective population-level surveillance and\ntransmission tracking of SARS-CoV-2, but optimal sampling modalities and protocols are unknown. Taking\nadvantage of a diverse inner city urban campus encompassing undergraduate and postgraduate dorms,\nresearch buildings, and medical facilities, we will optimize WBT surveillance strategies of waste streams at the\nbuilding level, surrounding sewersheds and wastewater treatment plants and model case counts using\nnormalized WBT data. We will further leverage metatranscriptomics for rapid identification of SARS-CoV-2\ntransmission chains and develop point-of-use microfluidics systems for timely WBT.\nname:Optimizing SARS-CoV-2 wastewater based surveillance in urban and university campus settings.\nsubProject:Wastewater\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ae763ecbe8064071a51f121b70f06f62": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 665,
       "target": 18
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ae9b29f2b1f84a18b0786edd7bef93dc": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4386,
       "target": 24
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b12803efdde849cdaaf479772a2f264d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Real-time surveillance of airborne SARS-CoV-2 virus is a technological gap that has eluded the scientific community since the beginning of the COVID-19 pandemic. Offline air sampling techniques for SARS-CoV-2 detection suffer from longer turnaround times and require skilled labor. Here, we present a proof-of-concept pathogen Air Quality (pAQ) monitor for real-time (5 min time resolution) direct detection of SARS-CoV-2 aerosols. The system synergistically integrates a high flow (~1000 lpm) wet cyclone air sampler and a nanobody-based ultrasensitive micro-immunoelectrode biosensor. The wet cyclone showed comparable or better virus sampling performance than commercially available samplers. Laboratory experiments demonstrate a device sensitivity of 77-83% and a limit of detection of 7-35 viral RNA copies/m3 of air. Our pAQ monitor is suited for point-of-need surveillance of SARS-CoV-2 variants in indoor environments and can be adapted for multiplexed detection of other respiratory pathogens of interest. Widespread adoption of such technology could assist public health officials with implementing rapid disease control measures.",
       "doi": "doi:10.1038/s41467-023-39419-z",
       "id": 2768,
       "journal": "Nature communications",
       "label": "Publication",
       "name": "Real-time environmental surveillance of SARS-CoV-2 aerosols.",
       "pmId": "37429842",
       "pmcId": "PMC10333287",
       "tooltip": "Publication\njournal:Nature communications\nabstract:Real-time surveillance of airborne SARS-CoV-2 virus is a technological gap that has eluded the scientific community since the beginning of the COVID-19 pandemic. Offline air sampling techniques for SARS-CoV-2 detection suffer from longer turnaround times and require skilled labor. Here, we present a proof-of-concept pathogen Air Quality (pAQ) monitor for real-time (5 min time resolution) direct detection of SARS-CoV-2 aerosols. The system synergistically integrates a high flow (~1000 lpm) wet cyclone air sampler and a nanobody-based ultrasensitive micro-immunoelectrode biosensor. The wet cyclone showed comparable or better virus sampling performance than commercially available samplers. Laboratory experiments demonstrate a device sensitivity of 77-83% and a limit of detection of 7-35 viral RNA copies/m3 of air. Our pAQ monitor is suited for point-of-need surveillance of SARS-CoV-2 variants in indoor environments and can be adapted for multiplexed detection of other respiratory pathogens of interest. Widespread adoption of such technology could assist public health officials with implementing rapid disease control measures.\nid:doi:10.1038/s41467-023-39419-z\nname:Real-time environmental surveillance of SARS-CoV-2 aerosols.\npmId:37429842\nyear:2023\ntype:primary\npmcId:PMC10333287\nurl:https://doi.org/doi:10.1038/s41467-023-39419-z\ndoi:doi:10.1038/s41467-023-39419-z",
       "type": "primary",
       "url": "https://doi.org/doi:10.1038/s41467-023-39419-z",
       "year": 2023
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b182aa0efe584e7fa162fe395f2ee94c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "This work is directed at characterizing pediatric COVID-19 and stratifying incoming patients by projected\n(future) disease severity. Such stratification has several implications: immediately improving treatment planning, and\nas disease mechanistic pathways are uncovered, directing treatment. Predicting future severity will inform the risks of\noutpatient treatment; to the patients themselves, their family, other caregivers/cohabitants, and to schools and\nemployers. As varying levels of “reopening” are adopted across the country (and the world), such prognostication will\ninform policy on the handling of pediatric carriers in the community. Based on our preliminary analysis we assert that\na combination of novel assays including quantitative serology inflammatory markers (cytokine/chemokine profiles,\nimmune profiles), transcriptomics, epigenomics, longitudinal physiological monitoring, time series analysis, imaging,\nradiomics and clinical observation including social determinants of health, contains adequate information even at early\nstages of infection to stratify the disease and predict disease severity. We propose an artificial intelligence/machine\nlearning approach to integrate this rich and heterogeneous dataset, characterize the spectrum of disease and identify\nbiosignatures that predict severity in progressive disease. To facilitate translation of the approaches developed in this\nwork to a wide user community, we incorporate a Translational Development function, to oversee the design-control\nprocess and ensure readiness of our methods for regulatory review. Incorporated into our timelines are appropriate\nregulatory milestones intended to conform with the Emergency Use Authorization (EUA) programs in effect for SARS-\nCoV-2 diagnostics.",
       "awardCode": "R61",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 18,
       "label": "Grant",
       "name": "AICORE-kids: Artificial Intelligence COVID-19 Risk AssEssment for kids",
       "narrative": "We propose an artificial intelligence/machine learning approach to integrate a rich and heterogeneous dataset\non COVID-19 in children, characterize the spectrum of disease and identify biosignatures that predict severity in\nprogressive disease. To facilitate translation of the approaches developed in this work to a wide user community, we\nincorporate a Translational Development function, to oversee the design-control process and ensure readiness of our\nmethods for regulatory review. Incorporated into our timelines are appropriate regulatory milestones intended to\nconform with the Emergency Use Authorization (EUA) programs in effect for SARS-CoV-2 diagnostics.",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nabstract:This work is directed at characterizing pediatric COVID-19 and stratifying incoming patients by projected\n(future) disease severity. Such stratification has several implications: immediately improving treatment planning, and\nas disease mechanistic pathways are uncovered, directing treatment. Predicting future severity will inform the risks of\noutpatient treatment; to the patients themselves, their family, other caregivers/cohabitants, and to schools and\nemployers. As varying levels of “reopening” are adopted across the country (and the world), such prognostication will\ninform policy on the handling of pediatric carriers in the community. Based on our preliminary analysis we assert that\na combination of novel assays including quantitative serology inflammatory markers (cytokine/chemokine profiles,\nimmune profiles), transcriptomics, epigenomics, longitudinal physiological monitoring, time series analysis, imaging,\nradiomics and clinical observation including social determinants of health, contains adequate information even at early\nstages of infection to stratify the disease and predict disease severity. We propose an artificial intelligence/machine\nlearning approach to integrate this rich and heterogeneous dataset, characterize the spectrum of disease and identify\nbiosignatures that predict severity in progressive disease. To facilitate translation of the approaches developed in this\nwork to a wide user community, we incorporate a Translational Development function, to oversee the design-control\nprocess and ensure readiness of our methods for regulatory review. Incorporated into our timelines are appropriate\nregulatory milestones intended to conform with the Emergency Use Authorization (EUA) programs in effect for SARS-\nCoV-2 diagnostics.\nid:R61HD105593\nnarrative:We propose an artificial intelligence/machine learning approach to integrate a rich and heterogeneous dataset\non COVID-19 in children, characterize the spectrum of disease and identify biosignatures that predict severity in\nprogressive disease. To facilitate translation of the approaches developed in this work to a wide user community, we\nincorporate a Translational Development function, to oversee the design-control process and ensure readiness of our\nmethods for regulatory review. Incorporated into our timelines are appropriate regulatory milestones intended to\nconform with the Emergency Use Authorization (EUA) programs in effect for SARS-CoV-2 diagnostics.\nname:AICORE-kids: Artificial Intelligence COVID-19 Risk AssEssment for kids\nsubProject:PreVAIL kIds\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R61"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b1aab0d262c9479a864a104a7f28d670": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1196,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b1cbf6fa663d48159bff513d0f2a5b7a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 299,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b1fadcf15700472dbd898b1c50b59c38": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2021,
       "name": "EMPLOYED_AT",
       "source": 688,
       "target": 555
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b2c58ba315ee47db84c043f590fb9153": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Peter",
       "fullName": "Peter W Rose",
       "id": 1290,
       "label": "Researcher",
       "lastName": "Rose",
       "middleName": "W",
       "name": "Rose PW",
       "tooltip": "Researcher\nmiddleName:W\nid:s2authorid:2184494479\nlastName:Rose\nname:Rose PW\nfullName:Peter W Rose\nfirstName:Peter"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b33a688eda9c41cf8df710985e83e18d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "GraphModel",
     "state": {
      "_adj": {
       "0": {},
       "1": {},
       "10": {},
       "11": {},
       "12": {},
       "13": {},
       "14": {},
       "15": {},
       "16": {},
       "17": {},
       "18": {},
       "19": {},
       "2": {},
       "20": {},
       "21": {},
       "22": {},
       "23": {},
       "24": {},
       "25": {},
       "26": {},
       "27": {},
       "28": {},
       "29": {},
       "3": {},
       "30": {},
       "31": {},
       "32": {},
       "33": {},
       "34": {},
       "35": {},
       "36": {},
       "37": {},
       "38": {},
       "39": {},
       "4": {},
       "40": {},
       "41": {},
       "42": {},
       "43": {},
       "44": {},
       "45": {},
       "46": {},
       "47": {},
       "5": {},
       "551": {},
       "552": {},
       "553": {},
       "554": {},
       "555": {},
       "556": {},
       "557": {},
       "558": {},
       "559": {},
       "560": {},
       "561": {},
       "562": {},
       "563": {},
       "564": {},
       "565": {},
       "566": {},
       "567": {},
       "568": {},
       "569": {},
       "570": {},
       "571": {},
       "572": {},
       "573": {},
       "574": {},
       "575": {},
       "576": {},
       "577": {},
       "578": {},
       "579": {},
       "580": {},
       "581": {},
       "582": {},
       "583": {},
       "584": {},
       "585": {},
       "586": {},
       "587": {},
       "588": {},
       "589": {},
       "590": {},
       "591": {},
       "592": {},
       "593": {},
       "594": {},
       "595": {},
       "596": {},
       "597": {},
       "598": {},
       "599": {},
       "6": {},
       "600": {},
       "601": {},
       "602": {},
       "603": {},
       "604": {},
       "605": {},
       "606": {},
       "607": {},
       "608": {},
       "609": {},
       "610": {},
       "611": {},
       "612": {},
       "613": {},
       "615": {},
       "616": {},
       "617": {},
       "618": {},
       "619": {},
       "620": {},
       "621": {},
       "622": {},
       "623": {},
       "624": {},
       "625": {},
       "626": {},
       "627": {},
       "629": {},
       "630": {},
       "631": {},
       "632": {},
       "633": {},
       "635": {},
       "636": {},
       "638": {},
       "639": {},
       "645": {},
       "647": {},
       "649": {},
       "650": {},
       "651": {},
       "660": {},
       "661": {},
       "662": {},
       "663": {},
       "664": {},
       "665": {},
       "666": {},
       "667": {},
       "668": {},
       "669": {},
       "670": {},
       "671": {},
       "672": {},
       "673": {},
       "674": {},
       "675": {},
       "676": {},
       "677": {},
       "678": {},
       "679": {},
       "680": {},
       "681": {},
       "682": {},
       "683": {},
       "684": {},
       "685": {},
       "687": {},
       "688": {},
       "689": {},
       "690": {},
       "691": {},
       "692": {},
       "693": {},
       "694": {},
       "695": {},
       "697": {},
       "698": {},
       "699": {},
       "7": {},
       "700": {},
       "701": {},
       "703": {},
       "704": {},
       "705": {},
       "706": {},
       "707": {},
       "708": {},
       "711": {},
       "712": {},
       "713": {},
       "714": {},
       "715": {},
       "716": {},
       "8": {},
       "9": {}
      },
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "GraphModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": null,
      "edges": [
       "IPY_MODEL_7a9b641771ba43e88258d4cb6083736e",
       "IPY_MODEL_a7e6b099883f4da28a9835c212e553f2",
       "IPY_MODEL_e5c63fa2da76408f814d6f646dcf44fc",
       "IPY_MODEL_3633e763499a4f6f806a48c8af45bbc5",
       "IPY_MODEL_32f7b14aebb546d6bb8b91c475a21974",
       "IPY_MODEL_60a57c8ee4bc46ac96993b0b5b9bb3c2",
       "IPY_MODEL_893e474b000f441abda64045e33ff03b",
       "IPY_MODEL_141fabf1b40a42a9bcb2f361b56d789f",
       "IPY_MODEL_1834e62113624555a0d68a56fc891977",
       "IPY_MODEL_11a8aa84448643eea3fa7b1d62d055ed",
       "IPY_MODEL_52c9512e494d4a23943b4f8b8dfd2a4b",
       "IPY_MODEL_55601f14d92f4637b9e5290060f85a65",
       "IPY_MODEL_b9843769ba524c40a464eac97e5a5c3c",
       "IPY_MODEL_ca27835ac6ef4db2b2f3b9733fe2bfc2",
       "IPY_MODEL_0e1c77abb5c84aa0b586141410f94421",
       "IPY_MODEL_08c968b21f654e47bdb3c33089b449e9",
       "IPY_MODEL_5c266c4d293f428296a9118625a7ceb1",
       "IPY_MODEL_00cf12231c8c4aefbeef31f02ae23924",
       "IPY_MODEL_9e6cd49444794c3e886a2b0ddc282dc9",
       "IPY_MODEL_a335219e425e4427a91b0cee958786ee",
       "IPY_MODEL_ded7d45f6e6641989eb46c379fe1dfe0",
       "IPY_MODEL_f2eaee0c45b84e7592c851816e2c0cfe",
       "IPY_MODEL_6062e99ecc7a458f88bfde0ab9733114",
       "IPY_MODEL_d3fe9b262fb94a159482691002b3e662",
       "IPY_MODEL_c84c02a00e294c5c8f46ee07c4f01074",
       "IPY_MODEL_3ce1dcf6ffed445fbeb8669d1148a278",
       "IPY_MODEL_dde39af3e6814c86b610d7ed97ff3e2d",
       "IPY_MODEL_6f6479c5241a48de88a495cc523181c6",
       "IPY_MODEL_237dcb6cd55a48a092bb2ce096ea2684",
       "IPY_MODEL_d7454e8d661841ffbf5693af760cd1f0",
       "IPY_MODEL_0888f052942940a5b2bc91038b4332a2",
       "IPY_MODEL_82757e9d877d47148702e1387212c806",
       "IPY_MODEL_cbb72e96d5f342d4911c3709112e1ad5",
       "IPY_MODEL_a8c3ea7ea6624294a0de0e8147d01264",
       "IPY_MODEL_2bb1321999dd49339efab65309f38b19",
       "IPY_MODEL_4fd2018ffdff46a495bd4297d433941c",
       "IPY_MODEL_d9891ffaf3094fdeb79b322d46d19002",
       "IPY_MODEL_fc43c828f1c4421493db965d2739dc5a",
       "IPY_MODEL_dd0dfc06a1f74d8db5ae7e14de227535",
       "IPY_MODEL_11bdc56bb4cf45009fbad33d2e1164bf",
       "IPY_MODEL_cd5a52304460488d9c02b1a7b1375d9b",
       "IPY_MODEL_d41b9de92987458ba057ea46f9ccbd9f",
       "IPY_MODEL_85839bfe7dcd4826a69daca59fc66504",
       "IPY_MODEL_ed5de39f86f4482487c9142812a27fe1",
       "IPY_MODEL_412e0dbcef814cc3b2f5d2cf1ae29ed3",
       "IPY_MODEL_5433f69777e6463a90be6e74a9c1dff3",
       "IPY_MODEL_e045bb78855c415a984de28a9ecb7f60",
       "IPY_MODEL_207100826c1b44cbbdab30b356ddd8ae",
       "IPY_MODEL_26aaacc010e14066b37c239477f53f29",
       "IPY_MODEL_5c85cee106fa4d9ca05b6333e5194df8",
       "IPY_MODEL_4ee5eafc490f4b568501739b04bef4bf",
       "IPY_MODEL_aca2c0308e50482ca6557c835dd50fd0",
       "IPY_MODEL_8c55ec6387dc41f28be7f8dce6e005d7",
       "IPY_MODEL_d6287c5f6928425aa5bed3c3216b4b0f",
       "IPY_MODEL_a37e38f54e754b36856082fc24d617d2",
       "IPY_MODEL_3198f8dd5f4f458b9b20a8a1a9a77396",
       "IPY_MODEL_9214242b62854ba9b397fac83d94abe1",
       "IPY_MODEL_0c9148b744cf42988159a1761cf53819",
       "IPY_MODEL_409de1bc7341450d901cfa47619ce6fb",
       "IPY_MODEL_b1fadcf15700472dbd898b1c50b59c38",
       "IPY_MODEL_a99204b9354745e1b7c3e8a1baf76387",
       "IPY_MODEL_415c0d90bd4941d9b8cc703d6455bbd9",
       "IPY_MODEL_98a44bff2057401b999c607e3a1c0b88",
       "IPY_MODEL_76af6419ff894a1cae908de40eae3ed2",
       "IPY_MODEL_99e1e9d760ae4091b5a4502b0fa3510f",
       "IPY_MODEL_77119576e1aa4a82a8eebc1d82ebad65",
       "IPY_MODEL_485d6fb3fb9747a7b38edbf236839e31",
       "IPY_MODEL_b581416fdd4a4a43b6a08b5503eeee06",
       "IPY_MODEL_c793bfdfa5354c8aaecdeb62eb00fa55",
       "IPY_MODEL_ba01ada40ede443aaf1e9d3178b860ad",
       "IPY_MODEL_703368227ef04e80a95959844924d2eb",
       "IPY_MODEL_f19ad7bd4f054812814f5a2c8571d32e",
       "IPY_MODEL_b37cfadad4ed45f8853813fe2d8736bb",
       "IPY_MODEL_dc72fa2b9359468faea89397a6c1fa67",
       "IPY_MODEL_4ff488cb7f4d4e8b95ede40535e6948a",
       "IPY_MODEL_2ce8df62941447bc9bad6be5adc1369d",
       "IPY_MODEL_4bb6f1a5e7cd4c7381cbbef29a1e8efc",
       "IPY_MODEL_dda49b6d522345d380226bb5338e275e",
       "IPY_MODEL_c0afd95bb3d3423bafe5b64a376dba38",
       "IPY_MODEL_6ad181d199524f7490a1e5b4492661f5",
       "IPY_MODEL_1cdf9db0e85f421780975a3c60256dc7",
       "IPY_MODEL_bdadcdb137464e63a36e0820d73088b4",
       "IPY_MODEL_fb310da446fc4125a0773165f2c82a91",
       "IPY_MODEL_04c8117c3597441a9d9fbf80740fa7ba",
       "IPY_MODEL_74254dbd3d2a42008848c4d63ebe384a",
       "IPY_MODEL_c26592d8201a4d26a08bd45529da6867",
       "IPY_MODEL_d95e75ad59e44e1882a2947fe4716f5a",
       "IPY_MODEL_f9f16919e10247bfa4c6c1fe04135bf3",
       "IPY_MODEL_9b5cedc5bada4887ae1687c74934743a",
       "IPY_MODEL_d61077757ab8431196de3b93d611623a",
       "IPY_MODEL_62924b2e73c7403ebdee907b89d0e280",
       "IPY_MODEL_800b5a40dbd04bc996664b5999797b95",
       "IPY_MODEL_da3e7c28cb864b4387d273d4e554a244",
       "IPY_MODEL_7357295139d34211b86f3ae417509f63",
       "IPY_MODEL_f1a33c4d2d4a4301aa2cc5f23e56b54b",
       "IPY_MODEL_424c68a20a2f4102854410b89701cf6f",
       "IPY_MODEL_1fffe6e9e1f64ff4b9b9e8a5d47e5576",
       "IPY_MODEL_23548ae34ce74aeb8c86b04357b28fab",
       "IPY_MODEL_64e8cced9718463ab3af8f22dadfb9a6",
       "IPY_MODEL_eb84494c22fd4edf88e09a58f72ae772",
       "IPY_MODEL_ff42b2625fc1478ca707807a4a598e83",
       "IPY_MODEL_85ebfe708e324154b851352872349416",
       "IPY_MODEL_ef923a7c7bce4bb28c0e3fee270f9cdf",
       "IPY_MODEL_d7c851a9284a41c2a8426cdee0986bf6",
       "IPY_MODEL_e310e64666b6444d8987a0d56d2d4fc8",
       "IPY_MODEL_d4d3fb0b1f2b4925981e889193ae5985",
       "IPY_MODEL_50d53c7b3f7940fcb267c48bf649e122",
       "IPY_MODEL_eda9ff5cf17741df89ef7bc63bfc076e",
       "IPY_MODEL_fda404ba1fef4d01be4f42822d09b6cc",
       "IPY_MODEL_47cf3bba69cf40cf9a1feed8e40c3a6c",
       "IPY_MODEL_96e4007e116d4b608374d787cf93a469",
       "IPY_MODEL_ff79ae5c1e8f4642a3d57941c5e247d7",
       "IPY_MODEL_8c741ed6f6e24b15b576154c5852a356",
       "IPY_MODEL_4d1a960c267d4960986599f9f440f739",
       "IPY_MODEL_feca05b1593349279a716957b204af18",
       "IPY_MODEL_4b530f294bce4e1784d7f5cfaed5e6a2",
       "IPY_MODEL_a281780730c0412d876233ed27764ede",
       "IPY_MODEL_037c33e4c41144f0a6fe4201bcdb8e36",
       "IPY_MODEL_4f7ae767f3794eeea6d5036f07d73083",
       "IPY_MODEL_aad7ec166c8d4934a9c98b7ba72a9eaf",
       "IPY_MODEL_5d21914cd4154e9ca96c86fbff4ec53f",
       "IPY_MODEL_18882e21898f42b6b50a5e63243d8b34",
       "IPY_MODEL_48c64d5c2042466db3eb64bd83207df1",
       "IPY_MODEL_3308cf6b352c429486f27df857d63057",
       "IPY_MODEL_4db0a15547c046e4b77e01dde5e25995",
       "IPY_MODEL_f8c5d315a2254cb69dd728e3ee28d89d",
       "IPY_MODEL_594a95410c3f49c1923c365db327b696",
       "IPY_MODEL_1d60908481af4b6cb2d38dc43ee0928c",
       "IPY_MODEL_b9f5a5d011ab4769a5f9645ec7f78b33",
       "IPY_MODEL_4a06eef08f884afeb994a75e0158d5fa",
       "IPY_MODEL_3a2783123d724c63aeb596f566b694e1",
       "IPY_MODEL_eade7fbd3b9a411a9a89da1d1f62ad4b",
       "IPY_MODEL_442c9804630c4e889147e4d6c219dcaf",
       "IPY_MODEL_0a286473b68c462e819ed8d09bd82e21",
       "IPY_MODEL_16e4f26eb6e24e6086b993676ec08155",
       "IPY_MODEL_9e5f82ac92de4a9ea94c91f45bdfd538",
       "IPY_MODEL_61b855bab3f146959117db362b0409ea",
       "IPY_MODEL_5697e1bea5364f449b8d4320735cd99b",
       "IPY_MODEL_84b4a04080e2453ab70279f08a9bd44d",
       "IPY_MODEL_b6532c02cc144dd1846c574f3e0ddaca",
       "IPY_MODEL_8b5db1b883f84d0ea82bf3d1e302e01d",
       "IPY_MODEL_72a0ed43e3fd4a33be7061ac6b5271b4",
       "IPY_MODEL_011429e2729d4b04a80400064905d434",
       "IPY_MODEL_8c21c54cf1634e6290548f7cd48a1ddc",
       "IPY_MODEL_788bd1b871e74ff1873a4ea2632124c3",
       "IPY_MODEL_93d34947740e4a9b9705c6539a4cc708",
       "IPY_MODEL_d7c2ac80b1194a2ea747c91b43ae4b6f",
       "IPY_MODEL_9a6c2d5b48f041f0987177e973be5184",
       "IPY_MODEL_7f29a1cc3a9e4d9fa64a3d8890af5070",
       "IPY_MODEL_a66222c957aa43c9aef1560833f5afa7",
       "IPY_MODEL_12d812d34dec4a7eb3b109de40098a93",
       "IPY_MODEL_3908f1887ff34db59985917ea4155361",
       "IPY_MODEL_0a5e32b0cb6544d295814de3a5981300",
       "IPY_MODEL_2ebb4fa54d7746f28599f73f01dd2665",
       "IPY_MODEL_db58fcc3b28d45f694fcfa7e2918f805",
       "IPY_MODEL_76bd0ba97dc44f3f95d9f08ff2828972",
       "IPY_MODEL_0d5747b3337c415891102617790ad3d3",
       "IPY_MODEL_8f5c50749d4d45c8af42b55b8efbae63",
       "IPY_MODEL_3c27bb597a8e43d4be219d92dab56953",
       "IPY_MODEL_5cb286764b4c41b1a835b6b81bda195f",
       "IPY_MODEL_6937a395b29640479b78494849cf254a",
       "IPY_MODEL_49d3f7ae0e4644a2b8a9bbada29b34e5",
       "IPY_MODEL_98e8e69168874bab97248c03e1149028",
       "IPY_MODEL_dfd9f3fac6b74747bcb75dc96fc9f3bb",
       "IPY_MODEL_84ca6711d27c4712a1d53594ae529d72",
       "IPY_MODEL_8a6343f0b72a458d83bba840a2ccf16b"
      ],
      "nodes": [
       "IPY_MODEL_1a07fac7c1154c31a1961d09d64fff66",
       "IPY_MODEL_eec1254869ca4f4a9d106d560cc938aa",
       "IPY_MODEL_617f4777654348329d0d99958e44f1a1",
       "IPY_MODEL_fc2aef5ccb7444cd956fc1a1c2c7c0b9",
       "IPY_MODEL_31993384bc244d36a62064a43856e818",
       "IPY_MODEL_7aad80129d2945fc858848e17ba95ee5",
       "IPY_MODEL_dbd00dab449540c2a704be82cff4a1a6",
       "IPY_MODEL_543ef5f99b824195a8dc790625a26649",
       "IPY_MODEL_b73d73d97aa144c19705ae3b224c4c94",
       "IPY_MODEL_658de15459cb48ae8aa4ac0a79bb2ccb",
       "IPY_MODEL_c5cc29bfbc3e4da7989e99cdf983f09e",
       "IPY_MODEL_cfece3ed91c944c3be43f5a490828782",
       "IPY_MODEL_feb605097beb408fae30d4673275b044",
       "IPY_MODEL_cdf0ad068d1f4ffdbdadd842fd64ae6d",
       "IPY_MODEL_9ac80b6f143a4297ab96975351cb09b5",
       "IPY_MODEL_5db68871f530459ba2075f9384ab7e7a",
       "IPY_MODEL_2e7ee267ba51431f856fe65bd4028f6f",
       "IPY_MODEL_75ac9c100a9f419185cb3f5b72ea3c82",
       "IPY_MODEL_0be6071ed57349ae8aad37e4f01f9af6",
       "IPY_MODEL_da3e500fe98d4ded89851a01662a0c03",
       "IPY_MODEL_7cda1742ece14264a5d6ffd89a064e14",
       "IPY_MODEL_da7de2b2d1bb42bf8a79f666d8f782d9",
       "IPY_MODEL_f71ca59245d24c258c08765efde968d0",
       "IPY_MODEL_8a2c178be4a3472d9c60111cfa71e1a3",
       "IPY_MODEL_c5717d6f003f4d58a7567e3084270176",
       "IPY_MODEL_fff54eaeda7f402aa15ba54112a1cde4",
       "IPY_MODEL_27ef892186e94689886e8704a2dbca31",
       "IPY_MODEL_388bb64576ef4d3abeca337562ae6a94",
       "IPY_MODEL_4c39a9f6adea46a3b443e83dba9550db",
       "IPY_MODEL_3f41d1b6819347e699280da0c639a672",
       "IPY_MODEL_ba5c069c8aad4c9b9bc4bc7b017e8c14",
       "IPY_MODEL_c77e29d723bc4acc9ae646abdfb1f089",
       "IPY_MODEL_6dbce0bc0fdd4c14a17ceefc273a8eaa",
       "IPY_MODEL_29833c22ca5a49beb35c01eaf048cc69",
       "IPY_MODEL_0db5e9d2df0c49518873eec30cc70e9b",
       "IPY_MODEL_e277f7e913394386b7037912d8a49ad8",
       "IPY_MODEL_8944b3400fa14230bf527a34b0f4fbbe",
       "IPY_MODEL_78fe7dd68c844358aa22b5d95ea73254",
       "IPY_MODEL_4067115d9254407e963de6eccef4eea8",
       "IPY_MODEL_d03e84a2edb241189e25c19a5398aa58",
       "IPY_MODEL_531783059b65433f8d3adda7b6fb4561",
       "IPY_MODEL_b8b23ecf236c4f54ae77afad289637ec",
       "IPY_MODEL_d400ad1471474656964038013f39ad88",
       "IPY_MODEL_c6ed0f9fd5024080b657d165ab252c5c",
       "IPY_MODEL_5da542ab2eb7444a90fc7e4c8edbd53f",
       "IPY_MODEL_de8272ebb0404ebbab3c03a8658ca93a",
       "IPY_MODEL_c049a979b5ef498e8b9105de81567c33",
       "IPY_MODEL_eb51efe97dfa404b9e32ade6e01159e3",
       "IPY_MODEL_4c7b76e6b7ee4592b1d7299dc96e0a54",
       "IPY_MODEL_624096d498e04a35bb94c0b3fb735c08",
       "IPY_MODEL_9e297218b93044c88c283dd164031858",
       "IPY_MODEL_05e46279b713445eb67d7d67067f87ec",
       "IPY_MODEL_ad0e2258663b466794b87b2727df9e08",
       "IPY_MODEL_a9db4a3cc0ad42d6a42f8e162c38631c",
       "IPY_MODEL_35400ef814654591833a05153f87be60",
       "IPY_MODEL_6a12176566ce4d3fad6e308144b46305",
       "IPY_MODEL_c680918223f84435b44d71eeb833bab2",
       "IPY_MODEL_e7fb906f13624acb835d1164f1cea470",
       "IPY_MODEL_06886727aeb3473d80b77c2ec4e5ab6a",
       "IPY_MODEL_e8a40c87bdea422ba83f5696268e112a",
       "IPY_MODEL_fb134e02e5964bd9a957416eaf8b9116",
       "IPY_MODEL_12fcd1c29d8e4e5882bad438f27cd2ae",
       "IPY_MODEL_8d79dd74babd4fe7b2e4e8b59d77e97a",
       "IPY_MODEL_20f497ec387b48899616812f93822275",
       "IPY_MODEL_abe5a1fa9c8f407c8047e91181d159ca",
       "IPY_MODEL_4a01b0e23f28482a951321eb0f411915",
       "IPY_MODEL_0a6a03df00ce40a1ab41aa89b9196556",
       "IPY_MODEL_9ccd9f5f2ca14991bd863973412a6106",
       "IPY_MODEL_4d8b211038dc47c38026c9a9180a832f",
       "IPY_MODEL_e46fb05b8d664c53ab1863ae37d191a9",
       "IPY_MODEL_f1b603b469de4449a44c79a6cb7fef89",
       "IPY_MODEL_e0344b8805b541ff9cda6a5b65e92153",
       "IPY_MODEL_63e3e5e1f38c47b29063b7fbd3036c60",
       "IPY_MODEL_64db2c89b9ef4225b9bee921b63a3fd4",
       "IPY_MODEL_2bca1441c11f42468ee132695d6dc462",
       "IPY_MODEL_ce755e7a9ed941f99e2f2b791370f4c0",
       "IPY_MODEL_5e77622878b041c8aa0305f54d8f9b29",
       "IPY_MODEL_fbea21b09ac14d5eabb61176bd87d7e5",
       "IPY_MODEL_d8d03169bd74488c84491f8f09e12fab",
       "IPY_MODEL_14688fb88db444428b3a44ef12aff913",
       "IPY_MODEL_221824a0b9d0415eba39d1c4e781a029",
       "IPY_MODEL_10daead9e9ed4a669ab9404a44332142",
       "IPY_MODEL_60f98c26be15478387419ae24591b406",
       "IPY_MODEL_2125845b5d4f4b57b726a777ca273203",
       "IPY_MODEL_1628c5b4deba42c2a5a4c5f82d26723a",
       "IPY_MODEL_6f83d13463d242f0a08cfc265b592710",
       "IPY_MODEL_86e4c84334fa45479da5914b8f08514f",
       "IPY_MODEL_eed56dd822d6499e891834ea1eb35d44",
       "IPY_MODEL_82950e2f33594911ae76ea77d55ca1c8",
       "IPY_MODEL_3b03839d36e84a789700a36f7b74dae2",
       "IPY_MODEL_a6128e64075b4ba69013c62cb3fb37ce",
       "IPY_MODEL_f56721e7678b496791d5f2c685dc87c7",
       "IPY_MODEL_262c29a5d5ca44a39a23b832eb0bcce5",
       "IPY_MODEL_8f8b609b8d44440286670bae5188aee7",
       "IPY_MODEL_21ce7314a96d49cab6455bc6f5520ab9",
       "IPY_MODEL_12cee346c2694aaea7e2b3698cc81fd1",
       "IPY_MODEL_33cfed3fceb446a790243268b3839887",
       "IPY_MODEL_4949a7add02b4839b0c3da1ae4d3070e",
       "IPY_MODEL_71360d44e3ac4e5b95385bc14fe9b9dd",
       "IPY_MODEL_de6841351305438fb8a46da9fd6171e4",
       "IPY_MODEL_d1c30c898b7a4765b3959d68795d245c",
       "IPY_MODEL_11e9c892b29d49d29a7a7ae61e14f6ab",
       "IPY_MODEL_fd880dc4f3344957bf47d8d46b1b94f6",
       "IPY_MODEL_89e26da092c44387a25064ff9468e02f",
       "IPY_MODEL_35cc5a19576044019ded467afe827486",
       "IPY_MODEL_c610d95235074478acc1312cb717a94f",
       "IPY_MODEL_6b5b523ad8ff4507973037b785b8525a",
       "IPY_MODEL_f73ce55c934844c4a7902ec953e7078b",
       "IPY_MODEL_620cb08a8e854e65a71cf52b0d183b84",
       "IPY_MODEL_46f540d502a44db4acfeb3ed789b1a5b",
       "IPY_MODEL_6ebed678670a4da79d1dd4bef73d5d27",
       "IPY_MODEL_480c0c44b4ae4ba8aca9b9409ec817fc",
       "IPY_MODEL_75cbf4cc8f574af597653a7a819f1fc9",
       "IPY_MODEL_427703da5fec42a0a91226eaa9671e76",
       "IPY_MODEL_0caa3a29db4e4d4bb6e47b3d1c251eb3",
       "IPY_MODEL_d54e55fd859147bbad7fb0c3e8863a4e",
       "IPY_MODEL_c76889d0de584e4b844982ad37083bbc",
       "IPY_MODEL_6252f853f1f54556beedd0750a651423",
       "IPY_MODEL_cbad7eca01984ba9a415a43247d87394",
       "IPY_MODEL_088aff68ba3741179db0026867487d0a",
       "IPY_MODEL_d5618f50fb5a4128a398340d3db76e65",
       "IPY_MODEL_59494326f9fb4488a9c2c721223c9b04",
       "IPY_MODEL_2f0e2975fc98450e93e00f12ea2e4dae",
       "IPY_MODEL_69798cfa85fe4df99a49ea8272342468",
       "IPY_MODEL_8b29a65692b94f938c56318c0f205479",
       "IPY_MODEL_637559e8f35c463293bbd9b98df551ef",
       "IPY_MODEL_b97da88f891f47dcaec2df5b2bdea92a",
       "IPY_MODEL_8917f075488b408da5a49a4c5425389c",
       "IPY_MODEL_4c7e4ea208c34e70a35906d9098bacb4",
       "IPY_MODEL_0f9f7925d53546d9bb6a73a973ebb2c2",
       "IPY_MODEL_89b6a63e5ac94c5cac9d63a5c53e536f",
       "IPY_MODEL_71b5185343d440d19c1761c7aeb86b80",
       "IPY_MODEL_eb540ecb7c6b4dc88b97c763ae3218f7",
       "IPY_MODEL_aa679fd5330d4227a354b03a5c2f6d8a",
       "IPY_MODEL_32077933642f4a5fa329134e9bc33368",
       "IPY_MODEL_850eb7e9fc6a4c26948d11cf10ad789e",
       "IPY_MODEL_47e702a1c6714029bb6d8cea694f1653",
       "IPY_MODEL_71ef27307e074c2ba1f44b16ec632529",
       "IPY_MODEL_12f76ef59fb44c1daeadbdcb7ff2c24d",
       "IPY_MODEL_14008564563144498ff70087c1cee680",
       "IPY_MODEL_11fd07d11f6e42669330bf5c5184c727",
       "IPY_MODEL_62da5eb5b59d4489bbda7915c58b2e7e",
       "IPY_MODEL_1cba806b5945468ca13482f04717cf64",
       "IPY_MODEL_5c7d76b21b01471980087ab1953cf68b",
       "IPY_MODEL_c787ddb5552542368423117788900006",
       "IPY_MODEL_053b4bd0888f42708e1c180ede4a932c",
       "IPY_MODEL_224028fcf90a409f89a3a77c03806ebc",
       "IPY_MODEL_a6528203745e4789843202c04f52c65d",
       "IPY_MODEL_adbf5469a60a4f3a9a416170807a7e39",
       "IPY_MODEL_e1885e9a6f80441eb8ae6bfa410a85b1",
       "IPY_MODEL_7508fb4ed6834fccb508dab6fdf7769e",
       "IPY_MODEL_d89ec995cdb148c88524e2599a8da049",
       "IPY_MODEL_940602eec24c469b90d0dfa46397abbf",
       "IPY_MODEL_adf214c2ae644af096bf77d635d7d8c1",
       "IPY_MODEL_43bd243d5ee34296bd3d10b535bb2c7d",
       "IPY_MODEL_63c542f7f57c48fda6b10885ce866f08",
       "IPY_MODEL_4d2b63b086c64cc88723affc5b5bc791",
       "IPY_MODEL_f7a6637c47454d349f991487540e7417",
       "IPY_MODEL_1608b6547f364109a3f1d5da1823d0dc",
       "IPY_MODEL_53b91e723b3e4a67a0a3324377250953",
       "IPY_MODEL_a0657a5d34ed4b55be2c3592768950c8",
       "IPY_MODEL_820d58a8882c41768aa6b0f13f091e37",
       "IPY_MODEL_84cc9bcce4cc49f2a3870f9d760854e0",
       "IPY_MODEL_813df8c9618544959d83cc5a8b3ee45f",
       "IPY_MODEL_87b574955b6f4d5995d08d5b9aa76cd1",
       "IPY_MODEL_964ff70063c4427183ebca314257c07e",
       "IPY_MODEL_3ceec56c34f640b9845e08a9912022f5",
       "IPY_MODEL_cb37789e22c045bdb76667a85656da8f",
       "IPY_MODEL_a34e981a93c74af9bbd3d33dff0fefba",
       "IPY_MODEL_e2f9c18f7b704a7a9899a67b03de2d07",
       "IPY_MODEL_0e8750e80948471482d620466a72d25c",
       "IPY_MODEL_fec0627f01804f4fa2be300f78f1ac40",
       "IPY_MODEL_0e1a08cc87a44b6da57b3d677577359e",
       "IPY_MODEL_a2b19046a58440f29dbfe36aa4852c85",
       "IPY_MODEL_efda262f928d45c3a1812c141244a2b2",
       "IPY_MODEL_8408044d485544fba3b13a6f03d8d687",
       "IPY_MODEL_a20f66b23a5a48b5830f0a89d7faea37",
       "IPY_MODEL_82df30c73c1f4803b4fc0ffcbab9028f",
       "IPY_MODEL_2e878a250c024ab38cb864576b8fba28",
       "IPY_MODEL_e0e8ac190c3743e3a94a77caaeac7f1e",
       "IPY_MODEL_aaf9e860fc1f4c489bff24d592e6ac71",
       "IPY_MODEL_faa0cd4ec2fb48119c2a6f1699eec2b1",
       "IPY_MODEL_a6aa91d8315642a89fd29f2db3892b72",
       "IPY_MODEL_9074eeb2da4e474abc0f65c6885891bc",
       "IPY_MODEL_e777c8d0d56048e7a31fbd2d5799d12c",
       "IPY_MODEL_280a9d092b504e40a5ece81141b5ff80",
       "IPY_MODEL_3458991d87fc49d19351014b04c27c65",
       "IPY_MODEL_9ee3615bb2c449ddabc43ec40577758a",
       "IPY_MODEL_3639c4f735d74774a247a0dff1a4dc5f",
       "IPY_MODEL_6618e9ae950046328aa3c5fcf197f1bd"
      ]
     }
    },
    "b37cfadad4ed45f8853813fe2d8736bb": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 663,
       "target": 564
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b4b8114c7d354cca82b9a7c9876e75b5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Multi-Modal Wireless COVID Monitoring & Infection Alerts for Concentrated Populations\nAbstract: The high aerosolized transmissibility of COVID, long asymptomatic incubation period,\nand highly variable presentation attributes of the COVID pandemic have proven challenging in\nmany settings where patchwork pandemic responses have disproportionately negatively\nimpacted vulnerable socioeconomic, minority, and disabled sub-populations. Unfortunately, these\ndire trends are only made more acute in settings that feature populations with limited mobility and\nlittle to no ability to self-isolate (dense concentrated populations [DCPs]), such as residential\nnursing homes, schools, drug rehabilitation services, prison and psychiatric facility populations,\nand high-frequency essential medical services, such as chemotherapy infusion clinics or dialysis\nunits. In these DCP settings, limited diagnostic testing, prolonged indoor contact, limitations in\ncleaning and filtration capacities, support staff shortages, pre-existing comorbidities, and lack of\neffective infectious disease surveillance systems all collude to drive an increased COVID burden\nin DCPs. From this, it is clear that alternative detection strategies for DCPs are urgently needed\nto improve local capacity to monitor COVID outbreaks, mitigate their spread, and thus reduce\ninequitable disease and mortality burdens in these under-resourced and often overcrowded\nsettings. In previous work, we developed a first generation detection system using heart rate data\nfrom commercially-available Fitbit Ionic wearable devices to detect the onset of COVID and other\ninfectious diseases up to 10 days before users self-reported symptom onset (overall sensitivity\n67% prior to symptom onset). Here, we propose to further develop this system for the improved\ndetection of COVID and other infectious diseases in DCPs using existing wearable fitness devices\nin a wireless and interoperable digital health framework that centralizes all wearable-derived data\non PHD while tailoring its presentation and health event alert system to the IT capabilities and\nneeds of each DCP setting. In this, not only will we adapt our existing infection detection\nalgorithms for each DCP’s particular baseline characteristics, IT infrastructure, and needs, but\nalso use incoming data to further optimize the performance of those algorithms for continuous\nimprovement in the sensitivity, specificity, and alert lead time for COVID onset. This will quickly\nenable under-resourced DCP support staff to access and use world-class COVID surveillance\ndata in identifying individual infection events, implementing isolation, cleaning, and testing\npolicies, and minimizing transmission, thus reducing the burden of COVID in DCP settings and\nreducing DCP morbidity and mortality overall.",
       "awardCode": "R01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 34,
       "label": "Grant",
       "name": "Multi-Modal Wireless COVID Monitoring & Infection Alerts for Concentrated Populations",
       "narrative": "Multi-Modal Wireless COVID Monitoring & Infection Alerts for Concentrated Populations\nNarrative: The myriad risks and health burdens accompanying the ongoing COVID pandemic\nhave disproportionately impacted under-resourced settings with dense, concentrated populations\nthat cannot readily transition to isolation or remote care. While diagnostic testing is increasingly\navailable, it remains inaccessible to too many and highlights an urgent unmet need for alternative\nmethods to detect COVID infection and spread. In previous work using online machine learning\nand commercially-available fitness wearables, we have demonstrated remote detection of COVID\nonset up to 7 days in advance of symptoms, which we here propose to optimize and extend to\ndiverse dense concentrated population settings for ongoing and effective COVID surveillance.",
       "researchInitiative": "RADx-rad",
       "subProject": "Multimodal Surveillance",
       "tooltip": "Grant\nabstract:Multi-Modal Wireless COVID Monitoring & Infection Alerts for Concentrated Populations\nAbstract: The high aerosolized transmissibility of COVID, long asymptomatic incubation period,\nand highly variable presentation attributes of the COVID pandemic have proven challenging in\nmany settings where patchwork pandemic responses have disproportionately negatively\nimpacted vulnerable socioeconomic, minority, and disabled sub-populations. Unfortunately, these\ndire trends are only made more acute in settings that feature populations with limited mobility and\nlittle to no ability to self-isolate (dense concentrated populations [DCPs]), such as residential\nnursing homes, schools, drug rehabilitation services, prison and psychiatric facility populations,\nand high-frequency essential medical services, such as chemotherapy infusion clinics or dialysis\nunits. In these DCP settings, limited diagnostic testing, prolonged indoor contact, limitations in\ncleaning and filtration capacities, support staff shortages, pre-existing comorbidities, and lack of\neffective infectious disease surveillance systems all collude to drive an increased COVID burden\nin DCPs. From this, it is clear that alternative detection strategies for DCPs are urgently needed\nto improve local capacity to monitor COVID outbreaks, mitigate their spread, and thus reduce\ninequitable disease and mortality burdens in these under-resourced and often overcrowded\nsettings. In previous work, we developed a first generation detection system using heart rate data\nfrom commercially-available Fitbit Ionic wearable devices to detect the onset of COVID and other\ninfectious diseases up to 10 days before users self-reported symptom onset (overall sensitivity\n67% prior to symptom onset). Here, we propose to further develop this system for the improved\ndetection of COVID and other infectious diseases in DCPs using existing wearable fitness devices\nin a wireless and interoperable digital health framework that centralizes all wearable-derived data\non PHD while tailoring its presentation and health event alert system to the IT capabilities and\nneeds of each DCP setting. In this, not only will we adapt our existing infection detection\nalgorithms for each DCP’s particular baseline characteristics, IT infrastructure, and needs, but\nalso use incoming data to further optimize the performance of those algorithms for continuous\nimprovement in the sensitivity, specificity, and alert lead time for COVID onset. This will quickly\nenable under-resourced DCP support staff to access and use world-class COVID surveillance\ndata in identifying individual infection events, implementing isolation, cleaning, and testing\npolicies, and minimizing transmission, thus reducing the burden of COVID in DCP settings and\nreducing DCP morbidity and mortality overall.\nid:R01NR020105\nnarrative:Multi-Modal Wireless COVID Monitoring & Infection Alerts for Concentrated Populations\nNarrative: The myriad risks and health burdens accompanying the ongoing COVID pandemic\nhave disproportionately impacted under-resourced settings with dense, concentrated populations\nthat cannot readily transition to isolation or remote care. While diagnostic testing is increasingly\navailable, it remains inaccessible to too many and highlights an urgent unmet need for alternative\nmethods to detect COVID infection and spread. In previous work using online machine learning\nand commercially-available fitness wearables, we have demonstrated remote detection of COVID\nonset up to 7 days in advance of symptoms, which we here propose to optimize and extend to\ndiverse dense concentrated population settings for ongoing and effective COVID surveillance.\nname:Multi-Modal Wireless COVID Monitoring & Infection Alerts for Concentrated Populations\nsubProject:Multimodal Surveillance\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b4e1216477674d58a042f43cfd6bfd0d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4394,
       "target": 38
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b50f0e5ffc54422fac7e8eb978a98836": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Real-time surveillance of airborne SARS-CoV-2 virus is a technological gap that has eluded the scientific community since the beginning of the COVID-19 pandemic. Offline air sampling techniques for SARS-CoV-2 detection suffer from longer turnaround times and require skilled labor. Here, we present a proof-of-concept pathogen Air Quality (pAQ) monitor for real-time (5 min time resolution) direct detection of SARS-CoV-2 aerosols. The system synergistically integrates a high flow (~1000 lpm) wet cyclone air sampler and a nanobody-based ultrasensitive micro-immunoelectrode biosensor. The wet cyclone showed comparable or better virus sampling performance than commercially available samplers. Laboratory experiments demonstrate a device sensitivity of 77-83% and a limit of detection of 7-35 viral RNA copies/m3 of air. Our pAQ monitor is suited for point-of-need surveillance of SARS-CoV-2 variants in indoor environments and can be adapted for multiplexed detection of other respiratory pathogens of interest. Widespread adoption of such technology could assist public health officials with implementing rapid disease control measures.",
       "doi": "doi:10.1038/s41467-023-39419-z",
       "id": 2768,
       "journal": "Nature communications",
       "label": "Publication",
       "name": "Real-time environmental surveillance of SARS-CoV-2 aerosols.",
       "pmId": "37429842",
       "pmcId": "PMC10333287",
       "tooltip": "Publication\njournal:Nature communications\nabstract:Real-time surveillance of airborne SARS-CoV-2 virus is a technological gap that has eluded the scientific community since the beginning of the COVID-19 pandemic. Offline air sampling techniques for SARS-CoV-2 detection suffer from longer turnaround times and require skilled labor. Here, we present a proof-of-concept pathogen Air Quality (pAQ) monitor for real-time (5 min time resolution) direct detection of SARS-CoV-2 aerosols. The system synergistically integrates a high flow (~1000 lpm) wet cyclone air sampler and a nanobody-based ultrasensitive micro-immunoelectrode biosensor. The wet cyclone showed comparable or better virus sampling performance than commercially available samplers. Laboratory experiments demonstrate a device sensitivity of 77-83% and a limit of detection of 7-35 viral RNA copies/m3 of air. Our pAQ monitor is suited for point-of-need surveillance of SARS-CoV-2 variants in indoor environments and can be adapted for multiplexed detection of other respiratory pathogens of interest. Widespread adoption of such technology could assist public health officials with implementing rapid disease control measures.\nid:doi:10.1038/s41467-023-39419-z\nname:Real-time environmental surveillance of SARS-CoV-2 aerosols.\npmId:37429842\nyear:2023\ntype:primary\npmcId:PMC10333287\nurl:https://doi.org/doi:10.1038/s41467-023-39419-z\ndoi:doi:10.1038/s41467-023-39419-z",
       "type": "primary",
       "url": "https://doi.org/doi:10.1038/s41467-023-39419-z",
       "year": 2023
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b581416fdd4a4a43b6a08b5503eeee06": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 619,
       "target": 11
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b6532c02cc144dd1846c574f3e0ddaca": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 704,
       "target": 563
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b73d73d97aa144c19705ae3b224c4c94": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Sridevi",
       "fullName": "Sridevi Devaraj",
       "id": 706,
       "label": "Researcher",
       "lastName": "Devaraj",
       "name": "Devaraj S",
       "profileId": "profileid:6787050",
       "tooltip": "Researcher\nid:profileid:6787050\nlastName:Devaraj\nprofileId:profileid:6787050\nname:Devaraj S\nfullName:Sridevi Devaraj\nfirstName:Sridevi"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b83a26882a824a6aa512375d490b8067": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "A",
       "fullName": "A Carlin",
       "id": 996,
       "label": "Researcher",
       "lastName": "Carlin",
       "name": "Carlin A",
       "tooltip": "Researcher\nid:s2authorid:4193340\nlastName:Carlin\nname:Carlin A\nfullName:A Carlin\nfirstName:A"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b8b23ecf236c4f54ae77afad289637ec": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Steven",
       "fullName": "Steven D Munger",
       "id": 679,
       "label": "Researcher",
       "lastName": "Munger",
       "middleName": "D",
       "name": "Munger SD",
       "orcid": "orcid:0000-0001-5624-0925",
       "profileId": "profileid:6293772",
       "tooltip": "Researcher\nmiddleName:D\nid:profileid:6293772\nlastName:Munger\norcid:orcid:0000-0001-5624-0925\nprofileId:profileid:6293772\nname:Munger SD\nfullName:Steven D Munger\nfirstName:Steven"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b95d2bbeced749429f7fe407d7ae639b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 677,
       "target": 586
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b97da88f891f47dcaec2df5b2bdea92a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "COLUMBIA",
       "country": "UNITED STATES",
       "duns": "duns:082263013",
       "geonames": "geonames:4381982",
       "id": 569,
       "label": "Organization",
       "name": "Harry S. Truman Memorial Veterans' Hospital",
       "ror": "ror:01a4gqp27",
       "state": "MO",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4381982\nror:ror:01a4gqp27\ncity:COLUMBIA\nname:Harry S. Truman Memorial Veterans' Hospital\nuei:uei:LW3JC7WVEP78\nduns:duns:082263013\nstate:MO\nid:ror:01a4gqp27\nurl:https://ror.org/01a4gqp27",
       "uei": "uei:LW3JC7WVEP78",
       "url": "https://ror.org/01a4gqp27"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b9843769ba524c40a464eac97e5a5c3c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 679,
       "target": 573
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b996802ced8d488eba3d931d53ff07bd": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4390,
       "target": 1
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b9dc064adc924b5d8c0ef6a26a6b28a9": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Transmembrane protease serine 2 (TMPRSS2) is a plasma membrane protease that activates both spike protein of coronaviruses for cell entry and oncogenic signaling pathways for tumor progression. TMPRSS2 inhibition can reduce cancer invasion and metastasis and partially prevent the entry of SARS-CoV-2 into host cells. Thus, there is an urgent need for both TMPRSS2-selective imaging and precise screening of TMPRSS2 inhibitors. Here, we report a TMPRSS2-responsive surface-potential-tunable peptide-conjugated probe (EGTP) with aggregation-induced emission (AIE) features for TMPRSS2 selective imaging and accurate inhibitor screening. The amphiphilic EGTP was constructed with tunable surface potential and responsive efficiency with TMPRSS2 and its inhibitor. The rational construction of AIE luminogens (AIEgens) with modular peptides indicated that the cleavage of EGTP led to a gradual aggregation with bright fluorescence in high TMPRSS2-expressing cells. This strategy may have value for selective detection of cancer cells, SARS-CoV-2-target cells, and screening of protease inhibitors.",
       "doi": "doi:10.1021/acs.analchem.2c04988",
       "id": 2811,
       "journal": "Analytical chemistry",
       "label": "Publication",
       "name": "Protease-Responsive Potential-Tunable AIEgens for Cell Selective Imaging of TMPRSS2 and Accurate Inhibitor Screening.",
       "pmId": "36753444",
       "tooltip": "Publication\njournal:Analytical chemistry\nabstract:Transmembrane protease serine 2 (TMPRSS2) is a plasma membrane protease that activates both spike protein of coronaviruses for cell entry and oncogenic signaling pathways for tumor progression. TMPRSS2 inhibition can reduce cancer invasion and metastasis and partially prevent the entry of SARS-CoV-2 into host cells. Thus, there is an urgent need for both TMPRSS2-selective imaging and precise screening of TMPRSS2 inhibitors. Here, we report a TMPRSS2-responsive surface-potential-tunable peptide-conjugated probe (EGTP) with aggregation-induced emission (AIE) features for TMPRSS2 selective imaging and accurate inhibitor screening. The amphiphilic EGTP was constructed with tunable surface potential and responsive efficiency with TMPRSS2 and its inhibitor. The rational construction of AIE luminogens (AIEgens) with modular peptides indicated that the cleavage of EGTP led to a gradual aggregation with bright fluorescence in high TMPRSS2-expressing cells. This strategy may have value for selective detection of cancer cells, SARS-CoV-2-target cells, and screening of protease inhibitors.\nid:doi:10.1021/acs.analchem.2c04988\nname:Protease-Responsive Potential-Tunable AIEgens for Cell Selective Imaging of TMPRSS2 and Accurate Inhibitor Screening.\npmId:36753444\nyear:2023\ntype:primary\nurl:https://doi.org/doi:10.1021/acs.analchem.2c04988\ndoi:doi:10.1021/acs.analchem.2c04988",
       "type": "primary",
       "url": "https://doi.org/doi:10.1021/acs.analchem.2c04988",
       "year": 2023
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "b9f5a5d011ab4769a5f9645ec7f78b33": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 676,
       "target": 35
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ba01ada40ede443aaf1e9d3178b860ad": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2024,
       "name": "EMPLOYED_AT",
       "source": 631,
       "target": 571
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ba5c069c8aad4c9b9bc4bc7b017e8c14": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Suzie",
       "fullName": "Suzie H Pun",
       "id": 683,
       "label": "Researcher",
       "lastName": "Pun",
       "middleName": "H",
       "name": "Pun SH",
       "orcid": "orcid:0000-0003-1443-4996",
       "profileId": "profileid:8012149",
       "tooltip": "Researcher\nmiddleName:H\nid:profileid:8012149\nlastName:Pun\norcid:orcid:0000-0003-1443-4996\nprofileId:profileid:8012149\nname:Pun SH\nfullName:Suzie H Pun\nfirstName:Suzie"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ba82b77a43b342a3994a285cb5f3996c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 682,
       "target": 41
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "baf558e380b8456e89873d6427cb3c6d": {
     "model_module": "@jupyter-widgets/base",
     "model_module_version": "1.2.0",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": "1000px",
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "bb2cb16c0d7b485cb0514fcbf21ee787": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1740,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "bc4b2cfb7669413fb24867750636cc0c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "John",
       "fullName": "John R Cirrito",
       "id": 677,
       "label": "Researcher",
       "lastName": "Cirrito",
       "middleName": "R",
       "name": "Cirrito JR",
       "orcid": "orcid:0000-0002-7196-8786",
       "profileId": "profileid:8553912",
       "tooltip": "Researcher\nfirstName:John\nlastName:Cirrito\nprofileId:profileid:8553912\nname:Cirrito JR\nfullName:John R Cirrito\nmiddleName:R\norcid:orcid:0000-0002-7196-8786\nid:profileid:8553912"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "bd9dc884dbd24e3c88f83f34712c34f2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "PROJECT SUMMARY\n Coronavirus 2019 (COVID-19) has afflicted 6.2 million Americans and killed 190,000 as of early September\n2020 (WHO website); a roughly 3% mortality. Between a shortage in testing and unidentified asymptomatic\nindividuals, the actual number of those infected could be 6 to 24-fold higher than that reported. SARS-CoV-2\n(CoV-2), the virus underlying the disease, results in a range of symptoms; in select cases a severe respiratory\nillness that impedes breathing that could lead to hospitalization and death. CoV-2 is transmitted person-to-\nperson via inhalation of the virus through mucosal membranes of the nose and throat from transfer after\ntouching a contaminated surface or by inhaling aerosolized virus. Unfortunately, COVID-19 is likely to be\nprevalent well into 2021 and beyond.\n We must increase our ability to test for CoV-2. First, testing is needed to diagnose individuals that are\nsymptomatic or asymptomatic to reduce community spread. And second, monitoring gathering areas for\nairborne virus that could inform the decision to shutdown a space or implement disinfection and mitigation of\nan area. We propose to use an electrochemical biosensor in two detection devices, 1) a diagnostic\nbreathalyzer for instant detection of CoV-2 and 2) an airborne detector for real-time, continuous surveillance of\na large space.\n We have developed a novel ultra-sensitive, antibody-based electrochemical biosensor to detect CoV-2\nrepeat binding domain (RBD) spike protein. The technology is based on a micro-immunoelectrode (MIE)\nbiosensor pioneered by the Cirrito laboratory to study protein dynamics in the setting of neurodegeneration (2,3).\nThe biosensor uses voltammetry to measure the oxidation of tyrosine amino acids; oxidation is the release of\nelectrons that the biosensor measures as a change in current. Antibodies are covalently attached to the\nelectrode surface to provide selectivity. Our prototype CoV-2 biosensor is sensitive to 2 femtogram/ml,\ncompared to several current CoV-2 antigen tests that are sensitive to the low picogram/ml range.\n The proposal will first (Aim 1) optimize our CoV-2 biosensor to detect CoV-2 viral particles, as well as test\nseveral parameters to increase sensitivity and longevity. Aim 2 will build a test breathalyzer that will utilize a\nnebulizer to generate virus laden air containing aerosol droplets similar to a breath that contain defined\nconcentrations of CoV-2 viral particles. Aim 3 will test the airborne biosensor in a realistic environment. Co-I\nChakrabarty’s laboratory has unique capabilities of mimicking real-world environmental conditions, especially\nin the context of atmospheric aerosols, necessary for testing and optimizing the biosensor’s performance for\nfield deployment. Atmospheric conditions include relative humidity (RH) and temperature, as well as common\nairborne pollutants found indoors.\n Finding novel means to detect the CoV-2, as well as create a platform to detect other and future\npathogens, would enable us to limit the viral spread throughout the community in the current and future\npandemics.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 36,
       "label": "Grant",
       "name": "Nanobody-Based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2",
       "narrative": "COVID-19 has afflicted millions of Americans with a roughly 3% mortality rate. We have developed an\nultra-sensitive electrochemical biosensor to detect CoV-2 which we will incorporate into a breathalyzer for\ndiagnostic purposes, as well as an airborne detector to monitor large gathering spaces.",
       "researchInitiative": "RADx-rad",
       "subProject": "Automatic Detection & Tracing",
       "tooltip": "Grant\nabstract:PROJECT SUMMARY\n Coronavirus 2019 (COVID-19) has afflicted 6.2 million Americans and killed 190,000 as of early September\n2020 (WHO website); a roughly 3% mortality. Between a shortage in testing and unidentified asymptomatic\nindividuals, the actual number of those infected could be 6 to 24-fold higher than that reported. SARS-CoV-2\n(CoV-2), the virus underlying the disease, results in a range of symptoms; in select cases a severe respiratory\nillness that impedes breathing that could lead to hospitalization and death. CoV-2 is transmitted person-to-\nperson via inhalation of the virus through mucosal membranes of the nose and throat from transfer after\ntouching a contaminated surface or by inhaling aerosolized virus. Unfortunately, COVID-19 is likely to be\nprevalent well into 2021 and beyond.\n We must increase our ability to test for CoV-2. First, testing is needed to diagnose individuals that are\nsymptomatic or asymptomatic to reduce community spread. And second, monitoring gathering areas for\nairborne virus that could inform the decision to shutdown a space or implement disinfection and mitigation of\nan area. We propose to use an electrochemical biosensor in two detection devices, 1) a diagnostic\nbreathalyzer for instant detection of CoV-2 and 2) an airborne detector for real-time, continuous surveillance of\na large space.\n We have developed a novel ultra-sensitive, antibody-based electrochemical biosensor to detect CoV-2\nrepeat binding domain (RBD) spike protein. The technology is based on a micro-immunoelectrode (MIE)\nbiosensor pioneered by the Cirrito laboratory to study protein dynamics in the setting of neurodegeneration (2,3).\nThe biosensor uses voltammetry to measure the oxidation of tyrosine amino acids; oxidation is the release of\nelectrons that the biosensor measures as a change in current. Antibodies are covalently attached to the\nelectrode surface to provide selectivity. Our prototype CoV-2 biosensor is sensitive to 2 femtogram/ml,\ncompared to several current CoV-2 antigen tests that are sensitive to the low picogram/ml range.\n The proposal will first (Aim 1) optimize our CoV-2 biosensor to detect CoV-2 viral particles, as well as test\nseveral parameters to increase sensitivity and longevity. Aim 2 will build a test breathalyzer that will utilize a\nnebulizer to generate virus laden air containing aerosol droplets similar to a breath that contain defined\nconcentrations of CoV-2 viral particles. Aim 3 will test the airborne biosensor in a realistic environment. Co-I\nChakrabarty’s laboratory has unique capabilities of mimicking real-world environmental conditions, especially\nin the context of atmospheric aerosols, necessary for testing and optimizing the biosensor’s performance for\nfield deployment. Atmospheric conditions include relative humidity (RH) and temperature, as well as common\nairborne pollutants found indoors.\n Finding novel means to detect the CoV-2, as well as create a platform to detect other and future\npathogens, would enable us to limit the viral spread throughout the community in the current and future\npandemics.\nid:U01AA029331\nnarrative:COVID-19 has afflicted millions of Americans with a roughly 3% mortality rate. We have developed an\nultra-sensitive electrochemical biosensor to detect CoV-2 which we will incorporate into a breathalyzer for\ndiagnostic purposes, as well as an airborne detector to monitor large gathering spaces.\nname:Nanobody-Based Electrochemical Biosensor for Real-Time Detection of Aerosolized SARS-CoV2\nsubProject:Automatic Detection & Tracing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "bdadcdb137464e63a36e0820d73088b4": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2010,
       "name": "EMPLOYED_AT",
       "source": 697,
       "target": 595
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "bdeb81280125437aa161bc08af874140": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1513,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "be171e229d9f4c4ea77a396d4b799b62": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1740,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "bf36fda6ba0446aca415156cbb30351f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4395,
       "target": 20
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "bf493b2fdf3f49ddbb86efaaec9ea331": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "applicants": [
        "Atom Bioworks Inc",
        "University of Illinois"
       ],
       "filingDate": "2021-11-18",
       "id": 2412,
       "inventors": [
        "Xing Wang",
        "Xiaohu Yao",
        "Nicolas Letourneau"
       ],
       "label": "Patent",
       "name": "Polynucleotide nanostructures for detecting viral infections and other diseases",
       "status": "pending",
       "tooltip": "Patent\nid:EP4247971A1\napplicants:['Atom Bioworks Inc', 'University of Illinois']\nstatus:pending\nname:Polynucleotide nanostructures for detecting viral infections and other diseases\nfilingDate:2021-11-18\ninventors:['Xing Wang', 'Xiaohu Yao', 'Nicolas Letourneau']\nurl:https://patents.google.com/patent/EP4247971A1",
       "url": "https://patents.google.com/patent/EP4247971A1"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "bf9e461a744a4d419332b3e2083801bb": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1022,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "bff50d396acc4dc89676f6b5d9b9db81": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "GraphModel",
     "state": {
      "_adj": {
       "0": {},
       "1": {},
       "10": {},
       "12": {},
       "13": {},
       "14": {},
       "15": {},
       "16": {},
       "17": {},
       "18": {},
       "19": {},
       "2": {},
       "20": {},
       "21": {},
       "22": {},
       "23": {},
       "24": {},
       "25": {},
       "26": {},
       "27": {},
       "28": {},
       "29": {},
       "3": {},
       "30": {},
       "31": {},
       "32": {},
       "33": {},
       "34": {},
       "35": {},
       "36": {},
       "37": {},
       "38": {},
       "39": {},
       "4": {},
       "40": {},
       "41": {},
       "42": {},
       "43": {},
       "4385": {},
       "4386": {},
       "4387": {},
       "4388": {},
       "4389": {},
       "4390": {},
       "4391": {},
       "4392": {},
       "4393": {},
       "4394": {},
       "4395": {},
       "4396": {},
       "4397": {},
       "4398": {},
       "4399": {},
       "44": {},
       "4400": {},
       "45": {},
       "46": {},
       "47": {},
       "5": {},
       "6": {},
       "7": {},
       "8": {},
       "9": {}
      },
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "GraphModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": null,
      "edges": [
       "IPY_MODEL_e02bdd20b233481e80d2dd89a3c95c08",
       "IPY_MODEL_5210b05d066748a98998cd359b851fa7",
       "IPY_MODEL_cb39a338672847069ae38ceff479a83e",
       "IPY_MODEL_0781f4e63aaf4ce4ba3e811ea6db0f15",
       "IPY_MODEL_6b438fd2c1c04ec2b1329cd6d935e6b4",
       "IPY_MODEL_a750b5d72277492eb261dea02ab193b7",
       "IPY_MODEL_710b1c06ebbf4cd1bdfb28dc9c505064",
       "IPY_MODEL_8609b22c68154d7c864e3c88221e1362",
       "IPY_MODEL_a2300cf72e814b57afb53710786ef9bb",
       "IPY_MODEL_fa771f2a57eb4582916d612877677820",
       "IPY_MODEL_6545e007005d42908c4151e5b3b03706",
       "IPY_MODEL_260932de672941838e1ba550c1905aee",
       "IPY_MODEL_cf3732029b3c4b838cbef7e3e25df749",
       "IPY_MODEL_162dfabf3a9c4c2590297ad583f0290f",
       "IPY_MODEL_0aba3c9a00e9439a8874a60244b1e6c1",
       "IPY_MODEL_e1e226c8eb934022b2ab763e29231f7c",
       "IPY_MODEL_bf36fda6ba0446aca415156cbb30351f",
       "IPY_MODEL_d31693c77441460bb19ef4cccf7bf451",
       "IPY_MODEL_55c9d3a5095c4755953eab3c033c9aed",
       "IPY_MODEL_efc631d1ff66437bbb39bcd7c6eb4f75",
       "IPY_MODEL_b996802ced8d488eba3d931d53ff07bd",
       "IPY_MODEL_a24be9e94ac44db591fc2063638d2a97",
       "IPY_MODEL_0f73cec4f0944a58b2fc73b80a2fe1ff",
       "IPY_MODEL_00809169217d4075979e6a39d54fc5de",
       "IPY_MODEL_6d1a9221321f470baf4cd2d1f3b8f525",
       "IPY_MODEL_177f961967144fb0996aa52eda050bef",
       "IPY_MODEL_b4e1216477674d58a042f43cfd6bfd0d",
       "IPY_MODEL_403e95d7218649ca94f61fbd0d2f5ab7",
       "IPY_MODEL_df8fbee325c741c98d6bfefe7cc3df85",
       "IPY_MODEL_332f60fc81484a509b4004db830e0c3a",
       "IPY_MODEL_f134cc9509c64b5c9a7472d9d7bb745a",
       "IPY_MODEL_503ee802172b40abbdbc64e8d3e7f5be",
       "IPY_MODEL_392ccd0cb70f4534aa317b28f546d3ec",
       "IPY_MODEL_78c5ffa0ce81463b8f43df35f273b08c",
       "IPY_MODEL_34cb75bf96de49b4940498b486f72cc4",
       "IPY_MODEL_d6aef18847f247f8a37cac9450879e76",
       "IPY_MODEL_610c98e6bd8849c3ab65cb5de6108ca5",
       "IPY_MODEL_9dc7be13aff54f6aa31c350bed79d81a",
       "IPY_MODEL_9cba3bb711624416a0531eca7cbe82b8",
       "IPY_MODEL_d18d4e1e926445f697e97575a83593ad",
       "IPY_MODEL_6af6a5d62668414ea57a099d8f8a4c0c",
       "IPY_MODEL_44efcb185c1a428fa7c6c260accb6559",
       "IPY_MODEL_ae9b29f2b1f84a18b0786edd7bef93dc",
       "IPY_MODEL_9bad284206f3492ba038477dd2c9bb30",
       "IPY_MODEL_f3e13c14a1d246ceb784929efbb95cb1",
       "IPY_MODEL_85f9415be7b64f8eaf384db47c1e92b1",
       "IPY_MODEL_9dbcf7edfaa641ea97ae570f06cc2904",
       "IPY_MODEL_addf182acf504f31b435aef6567fe114",
       "IPY_MODEL_da0085b114b748ce97ed5f009493773e",
       "IPY_MODEL_ec77499e249d4e679cb3d8a9bf2bf3af",
       "IPY_MODEL_a47e2a6ab1f14029bbe60314171790cc",
       "IPY_MODEL_095285a5783e42fc9b25863470a74da7",
       "IPY_MODEL_15f9786339474ffc9a3647eb7c4c45c0"
      ],
      "nodes": [
       "IPY_MODEL_0537bb6129f445d19a11df95053327d5",
       "IPY_MODEL_4776239192e64fb696a483e6932e858d",
       "IPY_MODEL_b4b8114c7d354cca82b9a7c9876e75b5",
       "IPY_MODEL_e44992a9bd664907b594a5267faff114",
       "IPY_MODEL_13e73a5359b245898faa12ca92a7f650",
       "IPY_MODEL_f69d39fc979a400fa092eda07b91141a",
       "IPY_MODEL_ceafb536e4504d91a8429e6c1d0477a1",
       "IPY_MODEL_c0ee0f2337334a32b4cc86167e099308",
       "IPY_MODEL_27ab51974c714eb1a053f248f309f9e4",
       "IPY_MODEL_e0f6d0dd8cf44185a320d996428c864b",
       "IPY_MODEL_c5f10c29d7814955993ff52237901df1",
       "IPY_MODEL_1ca3066361054234bf3c3941e917df53",
       "IPY_MODEL_1541ee25c33f4a0e9e943f042865e368",
       "IPY_MODEL_5b9504dfcb534b76b0a5633bbc1ef94a",
       "IPY_MODEL_e7449fc4515140c68056a95efd44b3d7",
       "IPY_MODEL_0c9512d4bdee44cfa55f7d8f9c209341",
       "IPY_MODEL_763cf66684c94965824f1455a4a564e9",
       "IPY_MODEL_173e15349f964bb1967748066c70c9eb",
       "IPY_MODEL_ad7ce2a04faf4b839a0eb9c9b62aa299",
       "IPY_MODEL_155562df1fb34cbbbf93153c59977321",
       "IPY_MODEL_084674816fa64339a4ef9934920ccf28",
       "IPY_MODEL_3e1e6cfe0bed46e094105960b5344301",
       "IPY_MODEL_3816f93ad4034181978a907d95561820",
       "IPY_MODEL_774ae19b061f486c94e89b44ecfd38b3",
       "IPY_MODEL_9d893a603f844e7c803a7b449f1bd918",
       "IPY_MODEL_9788c70579e340fbbc64cadf07b8f8c8",
       "IPY_MODEL_5a49d55c63ca475fa524f87ad6210b5d",
       "IPY_MODEL_f7f97e828f8a4149a8a7818abf7088e3",
       "IPY_MODEL_30a6c41d28af4aab83d7497502f04414",
       "IPY_MODEL_c047074f123042c2b0dfccb45a9b122e",
       "IPY_MODEL_d66284811ba748c2bd7d879b1d7dbc71",
       "IPY_MODEL_b182aa0efe584e7fa162fe395f2ee94c",
       "IPY_MODEL_9530610dfd864a0f84cb1965b8f28086",
       "IPY_MODEL_344df15d60944c9fb93d627eede7ff9c",
       "IPY_MODEL_715902625a3f421ba44a76783db07191",
       "IPY_MODEL_c3842b8a552d4961a3fc6b71cec4438a",
       "IPY_MODEL_caf5ebd4f0ca4b8b97b9719142e2a782",
       "IPY_MODEL_9eb20933d511449cb9686fdc2a553ba6",
       "IPY_MODEL_f49e98e4331245e9b86a95b849c432b9",
       "IPY_MODEL_254507028a684e45aa18b9233d45d4eb",
       "IPY_MODEL_2c638d505e2542b5ac926f9c7e57796a",
       "IPY_MODEL_a5a7b008120f46eebe7415f69de0981a",
       "IPY_MODEL_d7844c6096f74218a755bc39bc7a5594",
       "IPY_MODEL_e43f215a1b9c4ac09a856034b5a0f51e",
       "IPY_MODEL_c30bd8ca75a0426083b475d77caed828",
       "IPY_MODEL_5cebde752ef946b98cd3984d310109c1",
       "IPY_MODEL_520c4348d9264dc4a5b0dec1177d897c",
       "IPY_MODEL_fdfbe7585dfb40f6a35cd3f70ff47c2b",
       "IPY_MODEL_95de76b5a9644e73a335a61d9c74588a",
       "IPY_MODEL_5002a394e15c45cb87eab4d4a04db62b",
       "IPY_MODEL_98584bb631f24f98ac553fda05dfb07b",
       "IPY_MODEL_6a85553c6d11421ea2fd89701a16c349",
       "IPY_MODEL_308222f895b440a083e99238b7ff5f4e",
       "IPY_MODEL_8d5b898fe3614182a61273e394402e06",
       "IPY_MODEL_817af41834d548c09750b337c7ca8ce2",
       "IPY_MODEL_ca6c7af7239a4d3db3fc426e35e9c0bc",
       "IPY_MODEL_bd9dc884dbd24e3c88f83f34712c34f2",
       "IPY_MODEL_f5430260dcc44d4caab0fa323a6dcda5",
       "IPY_MODEL_a918d31d1c89400984a873d4f108437c",
       "IPY_MODEL_f799df5e1c22467ab9e0a3f3847b9825",
       "IPY_MODEL_1790cbbc6b3f44e2a564c185b973d483",
       "IPY_MODEL_27da58b9d88a4b0b85af43831f0cd420",
       "IPY_MODEL_52d03d2ec9b848e5b869842dab2d0e99"
      ]
     }
    },
    "c047074f123042c2b0dfccb45a9b122e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "A substantial and growing body of evidence has demonstrated that COVID-19 is transmitted by human-emitted\nairborne particles; therefore, it is critical to rapidly screen individuals to determine whether they are at risk of\ntransmitting the disease to others before they enter large venues (e.g., airports, schools) and smaller ones\nwhere extended exposure or close proximity is expected (e.g., dental offices, hair salons). Given the large\nnumber of asymptomatic cases of the disease, the infrared thermometers and health questionnaires frequently\nused to screen individuals are plainly inadequate. Existing SARS-CoV-2 detection technology is time consum-\ning and complicated to use, expensive and not portable and therefore ill-suited to use as point of care (POC)\nscreening tools. Tests recently approved by the FDA under the Emergency Use Authorization face some of\nthe same challenges.\nThe goal of this project is to develop and test a novel breathalyzer for detecting aerosolized SARS-CoV-2 di-\nrectly from exhaled breath in near real-time by marrying a proven, cutting-edge aerosol sampling technology\nwith a novel and inexpensive virus detector. The innovation is directly detecting virus in the breath, while other\nbreathalyzers depend on indirect detection (VOCs and AI algorithms) to infer the presence of the virus.\nIn this Fast-track STTR project, Aersol Devices Inc (ADev) will modify its commercial bioaerosol collector,\nwhich is used to sample from the ambient environment, to enable it to collect viruses from breath samples into\na concentrated liquid sample. The University of Minnesota (UMN) will modify its Magnetic Particle Spectrome-\nter (MPS), a version of which has previously been used to detect Influenza A H1N1 virus, so that the liquid\nsamples from the collector can be analyzed to detect SARS-CoV-2.\nSpecific aims include developing the hardware for transforming an ambient sampler into a breath sampler, de-\nsigning a rapid means of decontaminating the collector between tests, integrating the collector and the detector\ninto a robust package, functionalizing magnetic nanoparticles with SARS-CoV-2 antibodies, increasing the sig-\nnal/noise ratio of the MPS electronics, reducing the assay time, improving the analytical sensitivity/specificity,\nmeasuring the clinical sensitivity/specificity and comparing to RT-qPCR in pre-clinical testing.\nThe technology platform proposed is flexible and extensible and could be tailored to detect other pathogens\n(e.g., rhinoviruses, respiratory syncytial virus, parainfluenza virus other coronaviruses, etc.). This flexibility is\nvaluable since (1) this will not be the last pandemic (new pathogens in the future) and (2) development could\npivot to a different pathogen if a vaccine or other control measures bring the current COVID-19 pandemic un-\nder control before this SARS-CoV-2 breathalyzer is commercially available.",
       "awardCode": "R42",
       "fundingMechanism": "SBIR/STTR",
       "id": 16,
       "label": "Grant",
       "name": "A SARS-CoV-2 Breathalyzer for Direct Virus Detection",
       "narrative": "Aerosol transmission of SARS-CoV-2 is a likely contributor to the rapid spread of COVID-19. Tools\nare urgently needed for rapidly and inexpensively screening out contagious individuals before they\ncan enter schools, hospitals, office buildings, assisted living facilities, military installations and other\nlarge venues in order to protect vulnerable populations and mitigate the pandemic. We will develop a\nbreathalyzer to detect aerosolized SARS-CoV-2 directly from exhaled breath within minutes by\nmarrying a proven, cutting-edge aerosol sampling technology with a novel and inexpensive virus\ndetector based on magnetic particle spectroscopy.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:A substantial and growing body of evidence has demonstrated that COVID-19 is transmitted by human-emitted\nairborne particles; therefore, it is critical to rapidly screen individuals to determine whether they are at risk of\ntransmitting the disease to others before they enter large venues (e.g., airports, schools) and smaller ones\nwhere extended exposure or close proximity is expected (e.g., dental offices, hair salons). Given the large\nnumber of asymptomatic cases of the disease, the infrared thermometers and health questionnaires frequently\nused to screen individuals are plainly inadequate. Existing SARS-CoV-2 detection technology is time consum-\ning and complicated to use, expensive and not portable and therefore ill-suited to use as point of care (POC)\nscreening tools. Tests recently approved by the FDA under the Emergency Use Authorization face some of\nthe same challenges.\nThe goal of this project is to develop and test a novel breathalyzer for detecting aerosolized SARS-CoV-2 di-\nrectly from exhaled breath in near real-time by marrying a proven, cutting-edge aerosol sampling technology\nwith a novel and inexpensive virus detector. The innovation is directly detecting virus in the breath, while other\nbreathalyzers depend on indirect detection (VOCs and AI algorithms) to infer the presence of the virus.\nIn this Fast-track STTR project, Aersol Devices Inc (ADev) will modify its commercial bioaerosol collector,\nwhich is used to sample from the ambient environment, to enable it to collect viruses from breath samples into\na concentrated liquid sample. The University of Minnesota (UMN) will modify its Magnetic Particle Spectrome-\nter (MPS), a version of which has previously been used to detect Influenza A H1N1 virus, so that the liquid\nsamples from the collector can be analyzed to detect SARS-CoV-2.\nSpecific aims include developing the hardware for transforming an ambient sampler into a breath sampler, de-\nsigning a rapid means of decontaminating the collector between tests, integrating the collector and the detector\ninto a robust package, functionalizing magnetic nanoparticles with SARS-CoV-2 antibodies, increasing the sig-\nnal/noise ratio of the MPS electronics, reducing the assay time, improving the analytical sensitivity/specificity,\nmeasuring the clinical sensitivity/specificity and comparing to RT-qPCR in pre-clinical testing.\nThe technology platform proposed is flexible and extensible and could be tailored to detect other pathogens\n(e.g., rhinoviruses, respiratory syncytial virus, parainfluenza virus other coronaviruses, etc.). This flexibility is\nvaluable since (1) this will not be the last pandemic (new pathogens in the future) and (2) development could\npivot to a different pathogen if a vaccine or other control measures bring the current COVID-19 pandemic un-\nder control before this SARS-CoV-2 breathalyzer is commercially available.\nid:R42DE030832\nnarrative:Aerosol transmission of SARS-CoV-2 is a likely contributor to the rapid spread of COVID-19. Tools\nare urgently needed for rapidly and inexpensively screening out contagious individuals before they\ncan enter schools, hospitals, office buildings, assisted living facilities, military installations and other\nlarge venues in order to protect vulnerable populations and mitigate the pandemic. We will develop a\nbreathalyzer to detect aerosolized SARS-CoV-2 directly from exhaled breath within minutes by\nmarrying a proven, cutting-edge aerosol sampling technology with a novel and inexpensive virus\ndetector based on magnetic particle spectroscopy.\nname:A SARS-CoV-2 Breathalyzer for Direct Virus Detection\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:SBIR/STTR\nawardCode:R42"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c049a979b5ef498e8b9105de81567c33": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Michael",
       "fullName": "Michael A Lynes",
       "id": 701,
       "label": "Researcher",
       "lastName": "Lynes",
       "middleName": "A",
       "name": "Lynes MA",
       "orcid": "orcid:0000-0003-0085-5394",
       "profileId": "profileid:2431709",
       "tooltip": "Researcher\nmiddleName:A\nid:profileid:2431709\nlastName:Lynes\norcid:orcid:0000-0003-0085-5394\nprofileId:profileid:2431709\nname:Lynes MA\nfullName:Michael A Lynes\nfirstName:Michael"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c0afd95bb3d3423bafe5b64a376dba38": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 630,
       "target": 47
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c0ee0f2337334a32b4cc86167e099308": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "awardCode": "U18",
       "fundingMechanism": "Other Research-Related",
       "id": 8,
       "label": "Grant",
       "name": "Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2",
       "narrative": "The urgent need to curb the spread of SARS-CoV-2 demands availability of diagnostics that are more rapid,\naccurate, sensitive and affordable than qPCR and antibody tests. Current qPCR tests are specific and sensitive,\nbut lengthy turnaround times limit interventions against disease spread. Antibody testing is faster, but false-\npositive/negative rates are high. Here, we propose to repurpose extracellular vesicle (EV) separation and\ncharacterization technologies into a fully automated SARS-CoV-2 testing platform that is low-cost, accurate,\nsensitive, rapid (within 3 h), and practical. The device will be optimized to analyze blood, saliva, and\nnasopharyngeal (NP) swabs collected at home, without risking transmission to healthcare workers. The sample\nis processed with an automated device developed with Sognef, and data are transferred to the Sognef servers\nfor analysis through an app that can be downloaded to any smart device. This technology is similar to Abbott's\nrecently launched BinaxNOW COVID-19 Ag Card, but has the advantage of multiparametric detection of viral\nRNA (vRNA), including Spike (S) and Nucleocapsid (N) protein-coding regions, plus a panel of host EV\nmicroRNAs (exomiRs) that reveals infection even when viral loads are below detectable limits. This approach\nwill decrease false-positives/negatives, the major limitation of antigen/antibody tests. Examine relationships of\nmiRNA panels with characteristics such as: symptomatic vs asymptomatic, qPCR-determined viral load,\nbiological sex, age (including pediatric populations), and comorbidities.\n We will optimize a COVID-19 device that uses simple bind-elute microfluidics for sample separation\nfollowed by electrical, probe-based detection of i) all validated exomiRs from Aim 1 and ii) our three conserved\nvRNAs. We envision that the device will be used first for either finger-pricked blood or saliva, followed, if positive,\nby an optional confirmatory second test of NP swab viral transport medium (VTM) that could be done with the\nsame device. We will then test the device in multiple centers worldwide in two phases: Phase 1 – every center\nwill perform a double-blinded validation using their biorepository specimen, and Phase 2 – in a β-testing phase,\nwe will provide a large number of devices to healthcare providers for regular testing of workers.",
       "researchInitiative": "RADx-rad",
       "subProject": "Exosome",
       "tooltip": "Grant\nid:U18TR003780\nnarrative:The urgent need to curb the spread of SARS-CoV-2 demands availability of diagnostics that are more rapid,\naccurate, sensitive and affordable than qPCR and antibody tests. Current qPCR tests are specific and sensitive,\nbut lengthy turnaround times limit interventions against disease spread. Antibody testing is faster, but false-\npositive/negative rates are high. Here, we propose to repurpose extracellular vesicle (EV) separation and\ncharacterization technologies into a fully automated SARS-CoV-2 testing platform that is low-cost, accurate,\nsensitive, rapid (within 3 h), and practical. The device will be optimized to analyze blood, saliva, and\nnasopharyngeal (NP) swabs collected at home, without risking transmission to healthcare workers. The sample\nis processed with an automated device developed with Sognef, and data are transferred to the Sognef servers\nfor analysis through an app that can be downloaded to any smart device. This technology is similar to Abbott's\nrecently launched BinaxNOW COVID-19 Ag Card, but has the advantage of multiparametric detection of viral\nRNA (vRNA), including Spike (S) and Nucleocapsid (N) protein-coding regions, plus a panel of host EV\nmicroRNAs (exomiRs) that reveals infection even when viral loads are below detectable limits. This approach\nwill decrease false-positives/negatives, the major limitation of antigen/antibody tests. Examine relationships of\nmiRNA panels with characteristics such as: symptomatic vs asymptomatic, qPCR-determined viral load,\nbiological sex, age (including pediatric populations), and comorbidities.\n We will optimize a COVID-19 device that uses simple bind-elute microfluidics for sample separation\nfollowed by electrical, probe-based detection of i) all validated exomiRs from Aim 1 and ii) our three conserved\nvRNAs. We envision that the device will be used first for either finger-pricked blood or saliva, followed, if positive,\nby an optional confirmatory second test of NP swab viral transport medium (VTM) that could be done with the\nsame device. We will then test the device in multiple centers worldwide in two phases: Phase 1 – every center\nwill perform a double-blinded validation using their biorepository specimen, and Phase 2 – in a β-testing phase,\nwe will provide a large number of devices to healthcare providers for regular testing of workers.\nname:Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2\nsubProject:Exosome\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U18"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c1f8c20f720c44a9819f6cd993e82f51": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Xiaohu",
       "fullName": "Xiaohu Yao",
       "id": 617,
       "label": "Researcher",
       "lastName": "Yao",
       "name": "Yao X",
       "profileId": "profileid:77861758",
       "tooltip": "Researcher\nid:profileid:77861758\nlastName:Yao\nprofileId:profileid:77861758\nname:Yao X\nfullName:Xiaohu Yao\nfirstName:Xiaohu"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c20253de64b74f9982386981a4372edb": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": false,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 1091,
       "target": 47
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c23cd1f9602f4dfaa51e0ca2f20da079": {
     "model_module": "@jupyter-widgets/controls",
     "model_module_version": "1.5.0",
     "model_name": "HBoxModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HBoxModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HBoxView",
      "box_style": "",
      "children": [
       "IPY_MODEL_cef1ee8643ec4ed7b1772aa188593d5b",
       "IPY_MODEL_54b07100d4c344acbc0e6e002f8943d3",
       "IPY_MODEL_a9008d164b824628927319617506d950"
      ],
      "layout": "IPY_MODEL_d1f50b0b62bf4a7cbb58b68ee2ff7576"
     }
    },
    "c26592d8201a4d26a08bd45529da6867": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 645,
       "target": 565
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c2c511441595421189d8fce8c87a56fd": {
     "model_module": "@jupyter-widgets/base",
     "model_module_version": "1.2.0",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": "1000px",
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "c30bd8ca75a0426083b475d77caed828": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Available tools for detection of SARS-CoV-2 virus require extensive sample preparation and/or expensive lab-\nbased equipment to obtain accurate results. The objective in this proposal is to build a touch-screen sensor array\nto directly capture, detect, and identify model SARS-CoV-2 virus particles with minimal false alarms. This ambi-\ntious goal will be achieved by the interdisciplinary team of GE Research scientists and engineers and will be a\nsynergistic combination of the proposed innovations and the prior scientific and engineering accomplishments\nof the team.\n Our proposed solution is based on several innovations driven by eliminating a need for a dedicated sam-\npling step and solving the problems of detection and reliable selective recognition of virus particles, performing\ndetection/recognition operation in a two-dimensional (2D) format of biosensors, e.g., as a touch-screen surface,\nand having this technical solution as a low-profile, low power, unobtrusive device that can be adapted to diverse\napplication scenarios.\n Innovations of the proposed proof-of-principle touch-screen detector are in three main areas. For virus\nrecognition, we will create new multifunctional bioreceptors. Our transduction principle will be based on our\nearlier reported transduction with the significantly enhanced performance. Our touch surface design will have a\n2D array of biosensors.\n The proposed proof-of-principle sensor will be developed in five aims. Aim 1 will focus on demonstration of\nnew multifunctional bioreceptors. Aim 2 will focus on validation of the functionality of these multifunctional\nbioreceptors upon their immobilization on sensor surface. Aim 3 will focus on demonstration of sensing of mod-\nel virus particles in a layout of 2D array of biosensors. Aim 4 will focus on demonstration of virus recognition\nwith immobilized multifunctional bioreceptors in variable ambient conditions. Aim 5 will focus on demonstra-\ntion of enhanced detection and recognition of model virus particles in the same layout of 2D array of biosensors\nas in Aim 3, but under variable ambient conditions. The findings in this proposed work will change the state-of-\nthe-art biosensing paradigm and will improve the scientific knowledge, technologies, and workflow practice for\nvirus detection.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 33,
       "label": "Grant",
       "name": "Minimal False-alarm Touch-based Detection of SARS-Cov-2 Virus Particles using Poly-aptamers",
       "narrative": "Reliable real-time detection of SARS-CoV-2 virus represents a considerable challenge, with available tools re-\nquiring extensive sample preparation and/or expensive lab-based equipment to obtain accurate results. The ob-\njective in this proposal is to build a touch-screen sensor array to directly capture, detect, and identify model\nSARS-CoV-2 virus particles with minimal false alarms. This ambitious goal will be achieved by the interdisci-\nplinary team of GE Research scientists and engineers and will be a synergistic combination of the proposed in-\nnovations and the prior scientific and engineering accomplishments of the team.",
       "researchInitiative": "RADx-rad",
       "subProject": "Automatic Detection & Tracing",
       "tooltip": "Grant\nabstract:Available tools for detection of SARS-CoV-2 virus require extensive sample preparation and/or expensive lab-\nbased equipment to obtain accurate results. The objective in this proposal is to build a touch-screen sensor array\nto directly capture, detect, and identify model SARS-CoV-2 virus particles with minimal false alarms. This ambi-\ntious goal will be achieved by the interdisciplinary team of GE Research scientists and engineers and will be a\nsynergistic combination of the proposed innovations and the prior scientific and engineering accomplishments\nof the team.\n Our proposed solution is based on several innovations driven by eliminating a need for a dedicated sam-\npling step and solving the problems of detection and reliable selective recognition of virus particles, performing\ndetection/recognition operation in a two-dimensional (2D) format of biosensors, e.g., as a touch-screen surface,\nand having this technical solution as a low-profile, low power, unobtrusive device that can be adapted to diverse\napplication scenarios.\n Innovations of the proposed proof-of-principle touch-screen detector are in three main areas. For virus\nrecognition, we will create new multifunctional bioreceptors. Our transduction principle will be based on our\nearlier reported transduction with the significantly enhanced performance. Our touch surface design will have a\n2D array of biosensors.\n The proposed proof-of-principle sensor will be developed in five aims. Aim 1 will focus on demonstration of\nnew multifunctional bioreceptors. Aim 2 will focus on validation of the functionality of these multifunctional\nbioreceptors upon their immobilization on sensor surface. Aim 3 will focus on demonstration of sensing of mod-\nel virus particles in a layout of 2D array of biosensors. Aim 4 will focus on demonstration of virus recognition\nwith immobilized multifunctional bioreceptors in variable ambient conditions. Aim 5 will focus on demonstra-\ntion of enhanced detection and recognition of model virus particles in the same layout of 2D array of biosensors\nas in Aim 3, but under variable ambient conditions. The findings in this proposed work will change the state-of-\nthe-art biosensing paradigm and will improve the scientific knowledge, technologies, and workflow practice for\nvirus detection.\nid:U01AA029324\nnarrative:Reliable real-time detection of SARS-CoV-2 virus represents a considerable challenge, with available tools re-\nquiring extensive sample preparation and/or expensive lab-based equipment to obtain accurate results. The ob-\njective in this proposal is to build a touch-screen sensor array to directly capture, detect, and identify model\nSARS-CoV-2 virus particles with minimal false alarms. This ambitious goal will be achieved by the interdisci-\nplinary team of GE Research scientists and engineers and will be a synergistic combination of the proposed in-\nnovations and the prior scientific and engineering accomplishments of the team.\nname:Minimal False-alarm Touch-based Detection of SARS-Cov-2 Virus Particles using Poly-aptamers\nsubProject:Automatic Detection & Tracing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c3842b8a552d4961a3fc6b71cec4438a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The SARS-CoV-2 pandemic has manifested in children with a wide spectrum of clinical presentations ranging\nfrom asymptomatic infection to devastating acute respiratory symptoms, appendicitis (often with rupture), and\nMultisystem Inflammatory Syndrome in Children (MIS-C), a serious inflammatory condition presenting several\nweeks after exposure to or infection with the virus. These presentations overlap in their clinical severity while\nmaintaining distinct clinical profiles. Public health and clinical approaches will benefit from an improved\nunderstanding of the spectrum of illness associated with SARS CoV-2 and from the capacity to integrate data to\nachieve two goals: (i) to identify the clinical, social, and biological variables that predict severe COVID-19 and\nMIS-C, and (ii) to target those populations and individuals at greatest risk for harm from the virus. We propose\nthe COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness\nin Children (CONNECT to Predict SIck Children) comprising eight partners providing access to data on >15\nmillion children. Our network will systematically integrate social, epidemiological, genetic, immunological, and\ncomputational approaches to identify both population- and individual-level risk factors for severe illness. Our\nunderlying hypothesis is that a combination of multidimensional data – clinical, sociodemographic, epidemiologic,\nand biological -- can be integrated to predict which children are at greatest risk to have severe consequences\nfrom SARS-CoV-2 infection. To test our hypothesis, we will develop CONNECT to Predict SIck Children, a\nnetwork of networks that leverages inpatient, outpatient, community, and epidemiological data resources to\nsupport the analysis of large data using machine learning and model-based analyses. For the R61 phase, we\nwill develop and refine predictive models using data from our network of networks (Aim 1). We will also recruit\nparticipants previously diagnosed with either COVID-19 or MIS-C (along with appropriate controls who have had\nmild or asymptomatic infections with SARS-CoV2), who will provide survey data (including social determinants)\nand saliva and blood samples to identify persisting biological factors associated with severe disease (Aim 2). We\nwill iteratively assess our models using a knowledge management framework that considers the marginal value\nof data for improving models' predictive capacity over time. In the R33 phase, we will validate and further refine\npredictive models incorporating data from additional participants recruited throughout our network of networks,\nincluding newly infected children with severe COVID-19 or MIS-C identified through real-time surveillance (Aim\n3). We seek to develop predictive models for children and adolescents that are useful, sensitive to community\nand environmental contexts, and informed by the REASSURED framework specified by the RFA. The models\nand biomarkers developed through our nationwide network of networks will produce generalizable knowledge\nthat will improve our ability to predict which children are at greatest risk for severe complications of SARS-CoV-\n2 infection. This knowledge will facilitate interventions to prevent and treat severe pediatric illness.",
       "awardCode": "R61",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 22,
       "label": "Grant",
       "name": "COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)",
       "narrative": "COVID-19, the disease caused by SARS-CoV-2, is a world-wide public health problem. Pediatric disease has\nbeen particularly difficult to manage since children tend less frequently to get sick from SARS-CoV-2 infection\nas adults but, when they do become ill, can present with life-threatening pulmonary disease or a systemic\ninflammatory condition known as multisystem inflammatory syndrome. The proposed COVID-19 Network of\nNetworks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to\nPredict SIck Children) will develop models and biomarkers that predict risk for severe disease in children and\nadolescents by systematically integrating social science, epidemiological, genetic, biochemical, immunological,\nand computational approaches.",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nabstract:The SARS-CoV-2 pandemic has manifested in children with a wide spectrum of clinical presentations ranging\nfrom asymptomatic infection to devastating acute respiratory symptoms, appendicitis (often with rupture), and\nMultisystem Inflammatory Syndrome in Children (MIS-C), a serious inflammatory condition presenting several\nweeks after exposure to or infection with the virus. These presentations overlap in their clinical severity while\nmaintaining distinct clinical profiles. Public health and clinical approaches will benefit from an improved\nunderstanding of the spectrum of illness associated with SARS CoV-2 and from the capacity to integrate data to\nachieve two goals: (i) to identify the clinical, social, and biological variables that predict severe COVID-19 and\nMIS-C, and (ii) to target those populations and individuals at greatest risk for harm from the virus. We propose\nthe COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness\nin Children (CONNECT to Predict SIck Children) comprising eight partners providing access to data on >15\nmillion children. Our network will systematically integrate social, epidemiological, genetic, immunological, and\ncomputational approaches to identify both population- and individual-level risk factors for severe illness. Our\nunderlying hypothesis is that a combination of multidimensional data – clinical, sociodemographic, epidemiologic,\nand biological -- can be integrated to predict which children are at greatest risk to have severe consequences\nfrom SARS-CoV-2 infection. To test our hypothesis, we will develop CONNECT to Predict SIck Children, a\nnetwork of networks that leverages inpatient, outpatient, community, and epidemiological data resources to\nsupport the analysis of large data using machine learning and model-based analyses. For the R61 phase, we\nwill develop and refine predictive models using data from our network of networks (Aim 1). We will also recruit\nparticipants previously diagnosed with either COVID-19 or MIS-C (along with appropriate controls who have had\nmild or asymptomatic infections with SARS-CoV2), who will provide survey data (including social determinants)\nand saliva and blood samples to identify persisting biological factors associated with severe disease (Aim 2). We\nwill iteratively assess our models using a knowledge management framework that considers the marginal value\nof data for improving models' predictive capacity over time. In the R33 phase, we will validate and further refine\npredictive models incorporating data from additional participants recruited throughout our network of networks,\nincluding newly infected children with severe COVID-19 or MIS-C identified through real-time surveillance (Aim\n3). We seek to develop predictive models for children and adolescents that are useful, sensitive to community\nand environmental contexts, and informed by the REASSURED framework specified by the RFA. The models\nand biomarkers developed through our nationwide network of networks will produce generalizable knowledge\nthat will improve our ability to predict which children are at greatest risk for severe complications of SARS-CoV-\n2 infection. This knowledge will facilitate interventions to prevent and treat severe pediatric illness.\nid:R61HD105619\nnarrative:COVID-19, the disease caused by SARS-CoV-2, is a world-wide public health problem. Pediatric disease has\nbeen particularly difficult to manage since children tend less frequently to get sick from SARS-CoV-2 infection\nas adults but, when they do become ill, can present with life-threatening pulmonary disease or a systemic\ninflammatory condition known as multisystem inflammatory syndrome. The proposed COVID-19 Network of\nNetworks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to\nPredict SIck Children) will develop models and biomarkers that predict risk for severe disease in children and\nadolescents by systematically integrating social science, epidemiological, genetic, biochemical, immunological,\nand computational approaches.\nname:COVID-19 Network of Networks Expanding Clinical and Translational approaches to Predict Severe Illness in Children (CONNECT to Predict SIck Children)\nsubProject:PreVAIL kIds\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R61"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c5717d6f003f4d58a7567e3084270176": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Samarjit",
       "fullName": "Samarjit Das",
       "id": 661,
       "label": "Researcher",
       "lastName": "Das",
       "name": "Das S",
       "profileId": "profileid:10349485",
       "tooltip": "Researcher\nid:profileid:10349485\nlastName:Das\nprofileId:profileid:10349485\nname:Das S\nfullName:Samarjit Das\nfirstName:Samarjit"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c5cc29bfbc3e4da7989e99cdf983f09e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Ly",
       "fullName": "Ly James Lee",
       "id": 711,
       "label": "Researcher",
       "lastName": "Lee",
       "middleName": "James",
       "name": "Lee LJ",
       "orcid": "orcid:0000-0002-3589-0280",
       "profileId": "profileid:8892513",
       "tooltip": "Researcher\nmiddleName:James\nid:profileid:8892513\nlastName:Lee\norcid:orcid:0000-0002-3589-0280\nprofileId:profileid:8892513\nname:Lee LJ\nfullName:Ly James Lee\nfirstName:Ly"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c5f10c29d7814955993ff52237901df1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Since the SARS-CoV-2 pandemic began, the emergence of an associated novel multisystem\ninflammatory syndrome in children (MIS-C) has been reported. Interestingly, patients with MIS-C follow a\npresentation, management and clinical course that are somewhat similar to that of patients with Kawasaki\ndisease (KD). Currently, the reason for such an overlap in clinical features and management is unclear and\nwhether this overlap is the result of a partially shared etiology or pathophysiology is the subject of fierce\ndebates. The degree of overlap implies that some of the clinical prediction tools that we have developed in the\npast for KD could be repurposed to accelerate the development of clinical support decision tools for MIS-C. In\nthis study, we will first (R61 component) systematically address the overlap between KD and MIS-C and create\nsalient machine-learning based prediction models for diagnosis/identification (Aim #1), management (Aim #2),\nand short- and long-term outcomes (Aim #3) of MIS-C based on our previously developed predictive models for\nKD in a process akin to transfer learning. Secondly (R33 component), we will validate and evaluate the\nperformance and clinical utility of these models in a predictive clinical decision support system for the diagnosis\nand management of pediatric patients presenting with features indicative of either MIS-C or KD. In this study we\nwill include 3 groups of patients: 1) patients with SARS-CoV-2 infection with MIS-C (CDC criteria) regardless of\nwhether they have overlapping signs of KD, 2) patients with SARS-CoV-2 infection investigated for but\neventually not diagnosed with MIS-C, and 3) patients with KD but without SARS-CoV-2 infection. Targeted data\nwill be collected from enrolled patients (900 for training and 450 for validation) for deep phenotyping and\nbiomarker measurements. Physician feedback on the predictions generated by the algorithm will be used to\nestablish clinical utility. Data required for model training will be accrued in the first two years of activity (R61\nperiod of the grant); the development of algorithms and their internal validation will occur concurrently. In the\nfollowing 2 years (R33 period of the grant), we will perform external validation, establish clinical utility, add real-\ntime epidemiological surveillance data to the models and finally package, and certify the algorithms for future\ndeployment and for the integration in electronic health records. This project will be a collaboration with the\nInternational Kawasaki Disease Registry (IKDR) Consortium. The IKDR Consortium has an active KD and\npediatric COVID registry in 35 sites across the world and the number of sites is currently expanding to 60+ sites.\nMore than 600 MIS-C patients have already been identified at IKDR centers, making this project clearly feasible\nand perfectly positioning IKDR to perform this study. We strongly believe that the use of emerging data science\nmethods and of our previously developed algorithms in the context of KD, as opposed to focusing on MIS-C\npatients alone, will boost our understanding of the etiology and pathophysiology of both MIS-C and KD and will\nmore rapidly lead to the emergence of data-driven management protocols for patients with MIS-C.",
       "awardCode": "R61",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 12,
       "label": "Grant",
       "name": "A data science approach to identify and manage Multisystem Inflammatory Syndrome in Children (MIS-C) associated with SARS-CoV-2 infection and Kawasaki disease in pediatric patients",
       "narrative": "The primary objective of this study is to design and validate a predictive decision support\nsystem for the identification, treatment and management of SARS-CoV-2 associated with multisystem\ninflammatory syndrome in children (MIS-C). To develop this system, we will adapt and retrain machine learning\nalgorithms which we have previously trained in patients with Kawasaki Disease, a pediatric inflammatory\nvasculopathy with multiple similarities to MIS-C. This study, performed in collaboration with the International\nKawasaki Disease Registry (IKDR) consortium, will consist of two phases, first a large-scale data collection\nand algorithm development effort and second, the prospective evaluation of the performance and clinical utility\nof the algorithm ahead of large-scale deployment.",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nabstract:Since the SARS-CoV-2 pandemic began, the emergence of an associated novel multisystem\ninflammatory syndrome in children (MIS-C) has been reported. Interestingly, patients with MIS-C follow a\npresentation, management and clinical course that are somewhat similar to that of patients with Kawasaki\ndisease (KD). Currently, the reason for such an overlap in clinical features and management is unclear and\nwhether this overlap is the result of a partially shared etiology or pathophysiology is the subject of fierce\ndebates. The degree of overlap implies that some of the clinical prediction tools that we have developed in the\npast for KD could be repurposed to accelerate the development of clinical support decision tools for MIS-C. In\nthis study, we will first (R61 component) systematically address the overlap between KD and MIS-C and create\nsalient machine-learning based prediction models for diagnosis/identification (Aim #1), management (Aim #2),\nand short- and long-term outcomes (Aim #3) of MIS-C based on our previously developed predictive models for\nKD in a process akin to transfer learning. Secondly (R33 component), we will validate and evaluate the\nperformance and clinical utility of these models in a predictive clinical decision support system for the diagnosis\nand management of pediatric patients presenting with features indicative of either MIS-C or KD. In this study we\nwill include 3 groups of patients: 1) patients with SARS-CoV-2 infection with MIS-C (CDC criteria) regardless of\nwhether they have overlapping signs of KD, 2) patients with SARS-CoV-2 infection investigated for but\neventually not diagnosed with MIS-C, and 3) patients with KD but without SARS-CoV-2 infection. Targeted data\nwill be collected from enrolled patients (900 for training and 450 for validation) for deep phenotyping and\nbiomarker measurements. Physician feedback on the predictions generated by the algorithm will be used to\nestablish clinical utility. Data required for model training will be accrued in the first two years of activity (R61\nperiod of the grant); the development of algorithms and their internal validation will occur concurrently. In the\nfollowing 2 years (R33 period of the grant), we will perform external validation, establish clinical utility, add real-\ntime epidemiological surveillance data to the models and finally package, and certify the algorithms for future\ndeployment and for the integration in electronic health records. This project will be a collaboration with the\nInternational Kawasaki Disease Registry (IKDR) Consortium. The IKDR Consortium has an active KD and\npediatric COVID registry in 35 sites across the world and the number of sites is currently expanding to 60+ sites.\nMore than 600 MIS-C patients have already been identified at IKDR centers, making this project clearly feasible\nand perfectly positioning IKDR to perform this study. We strongly believe that the use of emerging data science\nmethods and of our previously developed algorithms in the context of KD, as opposed to focusing on MIS-C\npatients alone, will boost our understanding of the etiology and pathophysiology of both MIS-C and KD and will\nmore rapidly lead to the emergence of data-driven management protocols for patients with MIS-C.\nid:R61HD105591\nnarrative:The primary objective of this study is to design and validate a predictive decision support\nsystem for the identification, treatment and management of SARS-CoV-2 associated with multisystem\ninflammatory syndrome in children (MIS-C). To develop this system, we will adapt and retrain machine learning\nalgorithms which we have previously trained in patients with Kawasaki Disease, a pediatric inflammatory\nvasculopathy with multiple similarities to MIS-C. This study, performed in collaboration with the International\nKawasaki Disease Registry (IKDR) consortium, will consist of two phases, first a large-scale data collection\nand algorithm development effort and second, the prospective evaluation of the performance and clinical utility\nof the algorithm ahead of large-scale deployment.\nname:A data science approach to identify and manage Multisystem Inflammatory Syndrome in Children (MIS-C) associated with SARS-CoV-2 infection and Kawasaki disease in pediatric patients\nsubProject:PreVAIL kIds\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R61"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c610d95235074478acc1312cb717a94f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Renata",
       "fullName": "Renata Pasqualini",
       "id": 632,
       "label": "Researcher",
       "lastName": "Pasqualini",
       "name": "Pasqualini R",
       "orcid": "orcid:0000-0002-4155-9324",
       "profileId": "profileid:6406851",
       "tooltip": "Researcher\nid:profileid:6406851\nlastName:Pasqualini\norcid:orcid:0000-0002-4155-9324\nprofileId:profileid:6406851\nname:Pasqualini R\nfullName:Renata Pasqualini\nfirstName:Renata"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c680918223f84435b44d71eeb833bab2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Roberta",
       "fullName": "Roberta Lynn DeBiasi",
       "id": 694,
       "label": "Researcher",
       "lastName": "DeBiasi",
       "middleName": "Lynn",
       "name": "DeBiasi RL",
       "orcid": "orcid:0000-0002-5854-8875",
       "profileId": "profileid:8717080",
       "tooltip": "Researcher\nmiddleName:Lynn\nid:profileid:8717080\nlastName:DeBiasi\norcid:orcid:0000-0002-5854-8875\nprofileId:profileid:8717080\nname:DeBiasi RL\nfullName:Roberta Lynn DeBiasi\nfirstName:Roberta"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c6ed0f9fd5024080b657d165ab252c5c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Dongxiao",
       "fullName": "Dongxiao Zhu",
       "id": 697,
       "label": "Researcher",
       "lastName": "Zhu",
       "name": "Zhu D",
       "profileId": "profileid:9502968",
       "tooltip": "Researcher\nid:profileid:9502968\nlastName:Zhu\nprofileId:profileid:9502968\nname:Zhu D\nfullName:Dongxiao Zhu\nfirstName:Dongxiao"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c76889d0de584e4b844982ad37083bbc": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Eliah",
       "fullName": "Eliah S Aronoff-Spencer",
       "id": 630,
       "label": "Researcher",
       "lastName": "Aronoff-Spencer",
       "middleName": "S",
       "name": "Aronoff-Spencer ES",
       "orcid": "orcid:0000-0002-6279-5027",
       "profileId": "profileid:10450719",
       "tooltip": "Researcher\nmiddleName:S\nid:profileid:10450719\nlastName:Aronoff-Spencer\norcid:orcid:0000-0002-6279-5027\nprofileId:profileid:10450719\nname:Aronoff-Spencer ES\nfullName:Eliah S Aronoff-Spencer\nfirstName:Eliah"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c77e29d723bc4acc9ae646abdfb1f089": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Usha",
       "fullName": "Usha Sethuraman",
       "id": 682,
       "label": "Researcher",
       "lastName": "Sethuraman",
       "name": "Sethuraman U",
       "orcid": "orcid:0000-0002-5183-0325",
       "profileId": "profileid:9832700",
       "tooltip": "Researcher\nid:profileid:9832700\nlastName:Sethuraman\norcid:orcid:0000-0002-5183-0325\nprofileId:profileid:9832700\nname:Sethuraman U\nfullName:Usha Sethuraman\nfirstName:Usha"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c787ddb5552542368423117788900006": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "awardCode": "U18",
       "fundingMechanism": "Other Research-Related",
       "id": 8,
       "label": "Grant",
       "name": "Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2",
       "narrative": "The urgent need to curb the spread of SARS-CoV-2 demands availability of diagnostics that are more rapid,\naccurate, sensitive and affordable than qPCR and antibody tests. Current qPCR tests are specific and sensitive,\nbut lengthy turnaround times limit interventions against disease spread. Antibody testing is faster, but false-\npositive/negative rates are high. Here, we propose to repurpose extracellular vesicle (EV) separation and\ncharacterization technologies into a fully automated SARS-CoV-2 testing platform that is low-cost, accurate,\nsensitive, rapid (within 3 h), and practical. The device will be optimized to analyze blood, saliva, and\nnasopharyngeal (NP) swabs collected at home, without risking transmission to healthcare workers. The sample\nis processed with an automated device developed with Sognef, and data are transferred to the Sognef servers\nfor analysis through an app that can be downloaded to any smart device. This technology is similar to Abbott's\nrecently launched BinaxNOW COVID-19 Ag Card, but has the advantage of multiparametric detection of viral\nRNA (vRNA), including Spike (S) and Nucleocapsid (N) protein-coding regions, plus a panel of host EV\nmicroRNAs (exomiRs) that reveals infection even when viral loads are below detectable limits. This approach\nwill decrease false-positives/negatives, the major limitation of antigen/antibody tests. Examine relationships of\nmiRNA panels with characteristics such as: symptomatic vs asymptomatic, qPCR-determined viral load,\nbiological sex, age (including pediatric populations), and comorbidities.\n We will optimize a COVID-19 device that uses simple bind-elute microfluidics for sample separation\nfollowed by electrical, probe-based detection of i) all validated exomiRs from Aim 1 and ii) our three conserved\nvRNAs. We envision that the device will be used first for either finger-pricked blood or saliva, followed, if positive,\nby an optional confirmatory second test of NP swab viral transport medium (VTM) that could be done with the\nsame device. We will then test the device in multiple centers worldwide in two phases: Phase 1 – every center\nwill perform a double-blinded validation using their biorepository specimen, and Phase 2 – in a β-testing phase,\nwe will provide a large number of devices to healthcare providers for regular testing of workers.",
       "researchInitiative": "RADx-rad",
       "subProject": "Exosome",
       "tooltip": "Grant\nid:U18TR003780\nnarrative:The urgent need to curb the spread of SARS-CoV-2 demands availability of diagnostics that are more rapid,\naccurate, sensitive and affordable than qPCR and antibody tests. Current qPCR tests are specific and sensitive,\nbut lengthy turnaround times limit interventions against disease spread. Antibody testing is faster, but false-\npositive/negative rates are high. Here, we propose to repurpose extracellular vesicle (EV) separation and\ncharacterization technologies into a fully automated SARS-CoV-2 testing platform that is low-cost, accurate,\nsensitive, rapid (within 3 h), and practical. The device will be optimized to analyze blood, saliva, and\nnasopharyngeal (NP) swabs collected at home, without risking transmission to healthcare workers. The sample\nis processed with an automated device developed with Sognef, and data are transferred to the Sognef servers\nfor analysis through an app that can be downloaded to any smart device. This technology is similar to Abbott's\nrecently launched BinaxNOW COVID-19 Ag Card, but has the advantage of multiparametric detection of viral\nRNA (vRNA), including Spike (S) and Nucleocapsid (N) protein-coding regions, plus a panel of host EV\nmicroRNAs (exomiRs) that reveals infection even when viral loads are below detectable limits. This approach\nwill decrease false-positives/negatives, the major limitation of antigen/antibody tests. Examine relationships of\nmiRNA panels with characteristics such as: symptomatic vs asymptomatic, qPCR-determined viral load,\nbiological sex, age (including pediatric populations), and comorbidities.\n We will optimize a COVID-19 device that uses simple bind-elute microfluidics for sample separation\nfollowed by electrical, probe-based detection of i) all validated exomiRs from Aim 1 and ii) our three conserved\nvRNAs. We envision that the device will be used first for either finger-pricked blood or saliva, followed, if positive,\nby an optional confirmatory second test of NP swab viral transport medium (VTM) that could be done with the\nsame device. We will then test the device in multiple centers worldwide in two phases: Phase 1 – every center\nwill perform a double-blinded validation using their biorepository specimen, and Phase 2 – in a β-testing phase,\nwe will provide a large number of devices to healthcare providers for regular testing of workers.\nname:Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2\nsubProject:Exosome\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U18"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c793bfdfa5354c8aaecdeb62eb00fa55": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2024,
       "name": "EMPLOYED_AT",
       "source": 632,
       "target": 571
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c84c02a00e294c5c8f46ee07c4f01074": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 698,
       "target": 578
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "c8c6784aaa804690be624164a1d3f437": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Usha",
       "fullName": "Usha Sethuraman",
       "id": 682,
       "label": "Researcher",
       "lastName": "Sethuraman",
       "name": "Sethuraman U",
       "orcid": "orcid:0000-0002-5183-0325",
       "profileId": "profileid:9832700",
       "tooltip": "Researcher\nid:profileid:9832700\nlastName:Sethuraman\norcid:orcid:0000-0002-5183-0325\nprofileId:profileid:9832700\nname:Sethuraman U\nfullName:Usha Sethuraman\nfirstName:Usha"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ca27835ac6ef4db2b2f3b9733fe2bfc2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 660,
       "target": 2
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ca6c7af7239a4d3db3fc426e35e9c0bc": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4390,
       "label": "FundingOpportunity",
       "name": "Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)",
       "tooltip": "FundingOpportunity\nname:Emergency Awards: Exosome-based Non-traditional Technologies Towards Multi-Parametric and Integrated Approaches for SARS-CoV-2 (U18 Clinical Trial Not Allowed)\nid:RFA-OD-20-018\nurl:https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-018.html",
       "url": "https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-018.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "caf5ebd4f0ca4b8b97b9719142e2a782": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4393,
       "label": "FundingOpportunity",
       "name": "Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional)",
       "tooltip": "FundingOpportunity\nname:Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional)\nid:RFA-OD-20-016\nurl:https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-016.html",
       "url": "https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-016.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "cb09a57c607d47c98814840b84db5895": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Dishit",
       "fullName": "Dishit P Ghumra",
       "id": 1901,
       "label": "Researcher",
       "lastName": "Ghumra",
       "middleName": "P",
       "name": "Ghumra DP",
       "tooltip": "Researcher\nmiddleName:P\nid:s2authorid:2090227509\nlastName:Ghumra\nname:Ghumra DP\nfullName:Dishit P Ghumra\nfirstName:Dishit"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "cb37789e22c045bdb76667a85656da8f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "A substantial and growing body of evidence has demonstrated that COVID-19 is transmitted by human-emitted\nairborne particles; therefore, it is critical to rapidly screen individuals to determine whether they are at risk of\ntransmitting the disease to others before they enter large venues (e.g., airports, schools) and smaller ones\nwhere extended exposure or close proximity is expected (e.g., dental offices, hair salons). Given the large\nnumber of asymptomatic cases of the disease, the infrared thermometers and health questionnaires frequently\nused to screen individuals are plainly inadequate. Existing SARS-CoV-2 detection technology is time consum-\ning and complicated to use, expensive and not portable and therefore ill-suited to use as point of care (POC)\nscreening tools. Tests recently approved by the FDA under the Emergency Use Authorization face some of\nthe same challenges.\nThe goal of this project is to develop and test a novel breathalyzer for detecting aerosolized SARS-CoV-2 di-\nrectly from exhaled breath in near real-time by marrying a proven, cutting-edge aerosol sampling technology\nwith a novel and inexpensive virus detector. The innovation is directly detecting virus in the breath, while other\nbreathalyzers depend on indirect detection (VOCs and AI algorithms) to infer the presence of the virus.\nIn this Fast-track STTR project, Aersol Devices Inc (ADev) will modify its commercial bioaerosol collector,\nwhich is used to sample from the ambient environment, to enable it to collect viruses from breath samples into\na concentrated liquid sample. The University of Minnesota (UMN) will modify its Magnetic Particle Spectrome-\nter (MPS), a version of which has previously been used to detect Influenza A H1N1 virus, so that the liquid\nsamples from the collector can be analyzed to detect SARS-CoV-2.\nSpecific aims include developing the hardware for transforming an ambient sampler into a breath sampler, de-\nsigning a rapid means of decontaminating the collector between tests, integrating the collector and the detector\ninto a robust package, functionalizing magnetic nanoparticles with SARS-CoV-2 antibodies, increasing the sig-\nnal/noise ratio of the MPS electronics, reducing the assay time, improving the analytical sensitivity/specificity,\nmeasuring the clinical sensitivity/specificity and comparing to RT-qPCR in pre-clinical testing.\nThe technology platform proposed is flexible and extensible and could be tailored to detect other pathogens\n(e.g., rhinoviruses, respiratory syncytial virus, parainfluenza virus other coronaviruses, etc.). This flexibility is\nvaluable since (1) this will not be the last pandemic (new pathogens in the future) and (2) development could\npivot to a different pathogen if a vaccine or other control measures bring the current COVID-19 pandemic un-\nder control before this SARS-CoV-2 breathalyzer is commercially available.",
       "awardCode": "R42",
       "fundingMechanism": "SBIR/STTR",
       "id": 16,
       "label": "Grant",
       "name": "A SARS-CoV-2 Breathalyzer for Direct Virus Detection",
       "narrative": "Aerosol transmission of SARS-CoV-2 is a likely contributor to the rapid spread of COVID-19. Tools\nare urgently needed for rapidly and inexpensively screening out contagious individuals before they\ncan enter schools, hospitals, office buildings, assisted living facilities, military installations and other\nlarge venues in order to protect vulnerable populations and mitigate the pandemic. We will develop a\nbreathalyzer to detect aerosolized SARS-CoV-2 directly from exhaled breath within minutes by\nmarrying a proven, cutting-edge aerosol sampling technology with a novel and inexpensive virus\ndetector based on magnetic particle spectroscopy.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:A substantial and growing body of evidence has demonstrated that COVID-19 is transmitted by human-emitted\nairborne particles; therefore, it is critical to rapidly screen individuals to determine whether they are at risk of\ntransmitting the disease to others before they enter large venues (e.g., airports, schools) and smaller ones\nwhere extended exposure or close proximity is expected (e.g., dental offices, hair salons). Given the large\nnumber of asymptomatic cases of the disease, the infrared thermometers and health questionnaires frequently\nused to screen individuals are plainly inadequate. Existing SARS-CoV-2 detection technology is time consum-\ning and complicated to use, expensive and not portable and therefore ill-suited to use as point of care (POC)\nscreening tools. Tests recently approved by the FDA under the Emergency Use Authorization face some of\nthe same challenges.\nThe goal of this project is to develop and test a novel breathalyzer for detecting aerosolized SARS-CoV-2 di-\nrectly from exhaled breath in near real-time by marrying a proven, cutting-edge aerosol sampling technology\nwith a novel and inexpensive virus detector. The innovation is directly detecting virus in the breath, while other\nbreathalyzers depend on indirect detection (VOCs and AI algorithms) to infer the presence of the virus.\nIn this Fast-track STTR project, Aersol Devices Inc (ADev) will modify its commercial bioaerosol collector,\nwhich is used to sample from the ambient environment, to enable it to collect viruses from breath samples into\na concentrated liquid sample. The University of Minnesota (UMN) will modify its Magnetic Particle Spectrome-\nter (MPS), a version of which has previously been used to detect Influenza A H1N1 virus, so that the liquid\nsamples from the collector can be analyzed to detect SARS-CoV-2.\nSpecific aims include developing the hardware for transforming an ambient sampler into a breath sampler, de-\nsigning a rapid means of decontaminating the collector between tests, integrating the collector and the detector\ninto a robust package, functionalizing magnetic nanoparticles with SARS-CoV-2 antibodies, increasing the sig-\nnal/noise ratio of the MPS electronics, reducing the assay time, improving the analytical sensitivity/specificity,\nmeasuring the clinical sensitivity/specificity and comparing to RT-qPCR in pre-clinical testing.\nThe technology platform proposed is flexible and extensible and could be tailored to detect other pathogens\n(e.g., rhinoviruses, respiratory syncytial virus, parainfluenza virus other coronaviruses, etc.). This flexibility is\nvaluable since (1) this will not be the last pandemic (new pathogens in the future) and (2) development could\npivot to a different pathogen if a vaccine or other control measures bring the current COVID-19 pandemic un-\nder control before this SARS-CoV-2 breathalyzer is commercially available.\nid:R42DE030832\nnarrative:Aerosol transmission of SARS-CoV-2 is a likely contributor to the rapid spread of COVID-19. Tools\nare urgently needed for rapidly and inexpensively screening out contagious individuals before they\ncan enter schools, hospitals, office buildings, assisted living facilities, military installations and other\nlarge venues in order to protect vulnerable populations and mitigate the pandemic. We will develop a\nbreathalyzer to detect aerosolized SARS-CoV-2 directly from exhaled breath within minutes by\nmarrying a proven, cutting-edge aerosol sampling technology with a novel and inexpensive virus\ndetector based on magnetic particle spectroscopy.\nname:A SARS-CoV-2 Breathalyzer for Direct Virus Detection\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:SBIR/STTR\nawardCode:R42"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "cb39a338672847069ae38ceff479a83e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4386,
       "target": 25
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "cbad7eca01984ba9a415a43247d87394": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "BOSTON",
       "country": "UNITED STATES",
       "duns": "duns:047006379",
       "geonames": "geonames:4930956",
       "id": 552,
       "label": "Organization",
       "name": "Harvard Medical School",
       "ror": "ror:03wevmz92",
       "state": "MA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4930956\nror:ror:03wevmz92\ncity:BOSTON\nname:Harvard Medical School\nuei:uei:JDLVAVGYJQ21\nduns:duns:047006379\nstate:MA\nid:ror:03wevmz92\nurl:https://ror.org/03wevmz92",
       "uei": "uei:JDLVAVGYJQ21",
       "url": "https://ror.org/03wevmz92"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "cbb72e96d5f342d4911c3709112e1ad5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 708,
       "target": 21
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "cc94147b60cd4b158068bf04c5d31e30": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Xing",
       "fullName": "Xing Wang",
       "id": 689,
       "label": "Researcher",
       "lastName": "Wang",
       "name": "Wang X",
       "orcid": "orcid:0000-0001-9930-3287",
       "profileId": "profileid:12225947",
       "tooltip": "Researcher\nid:profileid:12225947\nlastName:Wang\norcid:orcid:0000-0001-9930-3287\nprofileId:profileid:12225947\nname:Wang X\nfullName:Xing Wang\nfirstName:Xing"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "cd5a52304460488d9c02b1a7b1375d9b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 675,
       "target": 607
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "cdc5e150ec0340cf9a8248b409b2ce13": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "A Novel Saliva-Based Aptamer Detection Assay for SARS-CoV-2 Infection\n(RFA-OD-20-021 STTR Application)\nAutomated, rapid diagnostics with little sample collection and preparation are needed to identify\nand trace affected persons in times when hyper-infectious pathogens cause pandemics. Frequent,\nlow cost and highly scalable testing is the only way to gain visibility on the magnitude of the\npandemic and ultimately control the spread of the disease. We propose the development of a\nunique system that can cheaply and readily detect SARS-CoV-2 in saliva samples. The\ndevelopment of a system that uses saliva present an opportunity to readily test patients using a\nsample that is easily collected and harbors high concentration of viral particles.\nThe SARS-CoV-2 pandemic has predominantly affected individuals with pre-existing conditions\nsuch as clotting disorders, diabetes, hypertension or other chronic diseases. Patients with these\npre-existing conditions who then are infected have exacerbated symptoms and complications that\ncan lead to death. For example, many patients that have succumbed to SARS-CoV-2 infection\nhave developed blood clots that have impaired pulmonary or cardiac function and ultimately\ncardiac failure. A rapid diagnostic using easily collected samples (e.g. saliva) would allow for\ninfections to be identified sooner, therapies to be administered quicker, treatment to be monitored,\nand ultimately leading to fewer individuals that succumb to the infection.\nWe outline a novel DNA Star biosensing approach based on the fact that viruses, such as SARS-\nCoV-2, express unique spatial patterns of antigens on their surfaces, facilitating multivalent\nbinding to host cells for infection. These configurations of epitopes drive the high sensitivity and\nspecificity of our assay. Based on this naturally occurring binding mechanism, we developed a\nrational design approach producing pattern matching designer DNA architecture for viral sensing.\nA proof-of-concept Dengue virus (DENV) rapid diagnostics was developed to demonstrate its\npower: DENV surface antigens present the most complex geometric pattern among all known\npathogens, a DNA star linked 10-aptamers nanostructure that offers polyvalent, spatial DENV-\nepitope pattern matching interactions has provided high DENV-binding avidity and specificity,\nincreasing affinity by ~1,000× compared to the conventional aptamer approach which relies on\nmonovalent aptamer-epitope interactions. Our POCT diagnostics detected intact DENV virions in\npatient samples with PCR equivalent sensitivity in <2 mins at a cost <$0.15.\nCurrent RT-PCR molecular test are suited to large, centralized laboratories, and difficult to scale\nfor rapid testing of samples and delivery of results to clinicians and patients. Immunoassay tests\nhave lower sensitivity, and patients need to develop a response to the virus in order to detect the\nantibody response. Our “DNA star” biosensor-based rapid diagnostics will provide the\ninfrastructure for real time SARS-CoV-2 diagnostics that is easy to use (instrument-free), faster\n(sample to results in minutes) and cost effective (~$3 per test).",
       "awardCode": "R44",
       "fundingMechanism": "SBIR/STTR",
       "id": 7,
       "label": "Grant",
       "name": "Designer DNA Nanostructure Based Biosensing for Rapid COVID19 Detection and Monitoring using Saliva Sample",
       "narrative": "Direct detection of viral pathogens is needed to help limit the spread of extremely contagious and lethal infectious\nagents. Our aptamer-based detection assay and instrument will provide a mechanism to detect low levels of the\nSARS-CoV-2 viral pathogen with an automatic system requiring minimal effort for sample collection and no\nsample preparation and the system will be built to analyze at least 7 other sample types (plasma, whole blood,\nurine, nasopharyngeal samples, etc.) and the detection modalities will have additional detection aptamers in\norder to detect additional viral pathogens. This assay system can be deployed to monitor people not only in\nhospital and senior living facilities, but in schools, airports and other locations so that infected and asymptomatic\nindividuals can be identified, quarantined, and treated to limit the spread of the pathogen.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nresearchInitiative:RADx-rad\nnarrative:Direct detection of viral pathogens is needed to help limit the spread of extremely contagious and lethal infectious\nagents. Our aptamer-based detection assay and instrument will provide a mechanism to detect low levels of the\nSARS-CoV-2 viral pathogen with an automatic system requiring minimal effort for sample collection and no\nsample preparation and the system will be built to analyze at least 7 other sample types (plasma, whole blood,\nurine, nasopharyngeal samples, etc.) and the detection modalities will have additional detection aptamers in\norder to detect additional viral pathogens. This assay system can be deployed to monitor people not only in\nhospital and senior living facilities, but in schools, airports and other locations so that infected and asymptomatic\nindividuals can be identified, quarantined, and treated to limit the spread of the pathogen.\nname:Designer DNA Nanostructure Based Biosensing for Rapid COVID19 Detection and Monitoring using Saliva Sample\nsubProject:Novel Biosensing and VOC\nfundingMechanism:SBIR/STTR\nawardCode:R44\nabstract:A Novel Saliva-Based Aptamer Detection Assay for SARS-CoV-2 Infection\n(RFA-OD-20-021 STTR Application)\nAutomated, rapid diagnostics with little sample collection and preparation are needed to identify\nand trace affected persons in times when hyper-infectious pathogens cause pandemics. Frequent,\nlow cost and highly scalable testing is the only way to gain visibility on the magnitude of the\npandemic and ultimately control the spread of the disease. We propose the development of a\nunique system that can cheaply and readily detect SARS-CoV-2 in saliva samples. The\ndevelopment of a system that uses saliva present an opportunity to readily test patients using a\nsample that is easily collected and harbors high concentration of viral particles.\nThe SARS-CoV-2 pandemic has predominantly affected individuals with pre-existing conditions\nsuch as clotting disorders, diabetes, hypertension or other chronic diseases. Patients with these\npre-existing conditions who then are infected have exacerbated symptoms and complications that\ncan lead to death. For example, many patients that have succumbed to SARS-CoV-2 infection\nhave developed blood clots that have impaired pulmonary or cardiac function and ultimately\ncardiac failure. A rapid diagnostic using easily collected samples (e.g. saliva) would allow for\ninfections to be identified sooner, therapies to be administered quicker, treatment to be monitored,\nand ultimately leading to fewer individuals that succumb to the infection.\nWe outline a novel DNA Star biosensing approach based on the fact that viruses, such as SARS-\nCoV-2, express unique spatial patterns of antigens on their surfaces, facilitating multivalent\nbinding to host cells for infection. These configurations of epitopes drive the high sensitivity and\nspecificity of our assay. Based on this naturally occurring binding mechanism, we developed a\nrational design approach producing pattern matching designer DNA architecture for viral sensing.\nA proof-of-concept Dengue virus (DENV) rapid diagnostics was developed to demonstrate its\npower: DENV surface antigens present the most complex geometric pattern among all known\npathogens, a DNA star linked 10-aptamers nanostructure that offers polyvalent, spatial DENV-\nepitope pattern matching interactions has provided high DENV-binding avidity and specificity,\nincreasing affinity by ~1,000× compared to the conventional aptamer approach which relies on\nmonovalent aptamer-epitope interactions. Our POCT diagnostics detected intact DENV virions in\npatient samples with PCR equivalent sensitivity in <2 mins at a cost <$0.15.\nCurrent RT-PCR molecular test are suited to large, centralized laboratories, and difficult to scale\nfor rapid testing of samples and delivery of results to clinicians and patients. Immunoassay tests\nhave lower sensitivity, and patients need to develop a response to the virus in order to detect the\nantibody response. Our “DNA star” biosensor-based rapid diagnostics will provide the\ninfrastructure for real time SARS-CoV-2 diagnostics that is easy to use (instrument-free), faster\n(sample to results in minutes) and cost effective (~$3 per test).\nid:R44DE030852"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "cdf0ad068d1f4ffdbdadd842fd64ae6d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "David",
       "fullName": "David E Golan",
       "id": 650,
       "label": "Researcher",
       "lastName": "Golan",
       "middleName": "E",
       "name": "Golan DE",
       "profileId": "profileid:1858811",
       "tooltip": "Researcher\nmiddleName:E\nid:profileid:1858811\nlastName:Golan\nprofileId:profileid:1858811\nname:Golan DE\nfullName:David E Golan\nfirstName:David"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ce291557b0714708a96813d20128c922": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Thomas",
       "fullName": "Thomas J Esparza",
       "id": 1800,
       "label": "Researcher",
       "lastName": "Esparza",
       "middleName": "J",
       "name": "Esparza TJ",
       "tooltip": "Researcher\nmiddleName:J\nid:s2authorid:4231565\nlastName:Esparza\nname:Esparza TJ\nfullName:Thomas J Esparza\nfirstName:Thomas"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ce755e7a9ed941f99e2f2b791370f4c0": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "NEW YORK",
       "country": "UNITED STATES",
       "duns": "duns:081250499",
       "geonames": "geonames:5128581",
       "id": 603,
       "label": "Organization",
       "name": "Quicksilver Biosciences, Inc.",
       "state": "NY",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5128581\ncity:NEW YORK\nname:Quicksilver Biosciences, Inc.\nuei:uei:ZMEHBJ39DWK1\nduns:duns:081250499\nstate:NY\nid:uei:ZMEHBJ39DWK1",
       "uei": "uei:ZMEHBJ39DWK1"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ceafb536e4504d91a8429e6c1d0477a1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Presently, the application of molecular technology such as RT-qPCR and digital PCR (dPCR) to quantify\nSARS-CoV-2 and related targets in wastewater is cumbersome, time consuming, and costly. While\nprogress has been made on the development of methods and the interpretation of data, much remains to\nbe improved for the technology to be used as a public health management tool. A major drawback in the\ncurrent approaches are 1) the lack of streamlined and consistent pre-analytical processing steps, 2)\ncoverage across the relevant targets requires a high number of reactions (>20) from any single sample to\nprovide quantitative information, and 3) a lack of vision on the development of a pathogen/marker panel,\nmuch like those used in clinical arenas, for interpretation of the data across different states, regions and\nnations. The goal of this project will be to successfully navigate these three limitations toward\ndevelopment of a public health warning system that is not dependent on clinical testing and has the ability\nto rapidly address novel pathogen threats in the future.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 9,
       "label": "Grant",
       "name": "Improved scalability, sensitivity, and interpretability of pathogen detection, including SARS-CoV-2, in wastewater using high-throughput, highly multiplexed digital array PCR technology",
       "narrative": "The proposed research will enhance the usefulness of wastewater monitoring for pathogens to address\npublic health responses to the COVID-19 pandemic as well as future pandemics. We will demonstrate\nhighly multiplexed digital PCR assays on wastewater collected from multiple diverse geographical regions\nthat will be comprehensive, rapid, low cost, and quantitative for monitoring the circulation of disease.\nMoreover, the assay system will be able to address novel pathogens by allowing rapid aggregation of\ngenetic tests for these new targets.",
       "researchInitiative": "RADx-rad",
       "subProject": "Wastewater",
       "tooltip": "Grant\nabstract:Presently, the application of molecular technology such as RT-qPCR and digital PCR (dPCR) to quantify\nSARS-CoV-2 and related targets in wastewater is cumbersome, time consuming, and costly. While\nprogress has been made on the development of methods and the interpretation of data, much remains to\nbe improved for the technology to be used as a public health management tool. A major drawback in the\ncurrent approaches are 1) the lack of streamlined and consistent pre-analytical processing steps, 2)\ncoverage across the relevant targets requires a high number of reactions (>20) from any single sample to\nprovide quantitative information, and 3) a lack of vision on the development of a pathogen/marker panel,\nmuch like those used in clinical arenas, for interpretation of the data across different states, regions and\nnations. The goal of this project will be to successfully navigate these three limitations toward\ndevelopment of a public health warning system that is not dependent on clinical testing and has the ability\nto rapidly address novel pathogen threats in the future.\nid:U01DA053899\nnarrative:The proposed research will enhance the usefulness of wastewater monitoring for pathogens to address\npublic health responses to the COVID-19 pandemic as well as future pandemics. We will demonstrate\nhighly multiplexed digital PCR assays on wastewater collected from multiple diverse geographical regions\nthat will be comprehensive, rapid, low cost, and quantitative for monitoring the circulation of disease.\nMoreover, the assay system will be able to address novel pathogens by allowing rapid aggregation of\ngenetic tests for these new targets.\nname:Improved scalability, sensitivity, and interpretability of pathogen detection, including SARS-CoV-2, in wastewater using high-throughput, highly multiplexed digital array PCR technology\nsubProject:Wastewater\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "cef1ee8643ec4ed7b1772aa188593d5b": {
     "model_module": "@jupyter-widgets/controls",
     "model_module_version": "1.5.0",
     "model_name": "HTMLModel",
     "state": {
      "_dom_classes": [],
      "_model_module": "@jupyter-widgets/controls",
      "_model_module_version": "1.5.0",
      "_model_name": "HTMLModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/controls",
      "_view_module_version": "1.5.0",
      "_view_name": "HTMLView",
      "description": "",
      "description_tooltip": null,
      "layout": "IPY_MODEL_17397a8947894dc29c5ca2081c86e26e",
      "placeholder": "​",
      "style": "IPY_MODEL_9eee0c072fc944f9b984557a1e30b844",
      "value": "Executing: 100%"
     }
    },
    "cf3732029b3c4b838cbef7e3e25df749": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4386,
       "target": 42
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "cf63ef9549844ad494816d6ccc8a250f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 315,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "cfece3ed91c944c3be43f5a490828782": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "John",
       "fullName": "John A Parrish",
       "id": 649,
       "label": "Researcher",
       "lastName": "Parrish",
       "middleName": "A",
       "name": "Parrish JA",
       "profileId": "profileid:8614812",
       "tooltip": "Researcher\nmiddleName:A\nid:profileid:8614812\nlastName:Parrish\nprofileId:profileid:8614812\nname:Parrish JA\nfullName:John A Parrish\nfirstName:John"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d03e84a2edb241189e25c19a5398aa58": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "John",
       "fullName": "John R Cirrito",
       "id": 677,
       "label": "Researcher",
       "lastName": "Cirrito",
       "middleName": "R",
       "name": "Cirrito JR",
       "orcid": "orcid:0000-0002-7196-8786",
       "profileId": "profileid:8553912",
       "tooltip": "Researcher\nmiddleName:R\nid:profileid:8553912\nlastName:Cirrito\norcid:orcid:0000-0002-7196-8786\nprofileId:profileid:8553912\nname:Cirrito JR\nfullName:John R Cirrito\nfirstName:John"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d18d4e1e926445f697e97575a83593ad": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4392,
       "target": 21
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d1c30c898b7a4765b3959d68795d245c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Khalid",
       "fullName": "Khalid S Salaita",
       "id": 610,
       "label": "Researcher",
       "lastName": "Salaita",
       "middleName": "S",
       "name": "Salaita KS",
       "orcid": "orcid:0000-0003-4138-3477",
       "profileId": "profileid:8668731",
       "tooltip": "Researcher\nmiddleName:S\nid:profileid:8668731\nlastName:Salaita\norcid:orcid:0000-0003-4138-3477\nprofileId:profileid:8668731\nname:Salaita KS\nfullName:Khalid S Salaita\nfirstName:Khalid"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d1f50b0b62bf4a7cbb58b68ee2ff7576": {
     "model_module": "@jupyter-widgets/base",
     "model_module_version": "1.2.0",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "d264a8369dd74f20915941672773088c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "IS_INVENTOR",
       "source": 2347,
       "target": 2409
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d31693c77441460bb19ef4cccf7bf451": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4385,
       "target": 45
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d3fe9b262fb94a159482691002b3e662": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 632,
       "target": 3
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d400ad1471474656964038013f39ad88": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Cristina",
       "fullName": "Cristina Elizabeth Davis",
       "id": 678,
       "label": "Researcher",
       "lastName": "Davis",
       "middleName": "Elizabeth",
       "name": "Davis CE",
       "profileId": "profileid:2050145",
       "tooltip": "Researcher\nmiddleName:Elizabeth\nid:profileid:2050145\nlastName:Davis\nprofileId:profileid:2050145\nname:Davis CE\nfullName:Cristina Elizabeth Davis\nfirstName:Cristina"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d41b9de92987458ba057ea46f9ccbd9f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 713,
       "target": 571
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d4d3fb0b1f2b4925981e889193ae5985": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 715,
       "target": 38
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d54e55fd859147bbad7fb0c3e8863a4e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Reynold",
       "fullName": "Reynold Alexander Panettieri",
       "id": 631,
       "label": "Researcher",
       "lastName": "Panettieri",
       "middleName": "Alexander",
       "name": "Panettieri RA",
       "orcid": "orcid:0000-0003-0834-4636",
       "profileId": "profileid:1891108",
       "tooltip": "Researcher\nmiddleName:Alexander\nid:profileid:1891108\nlastName:Panettieri\norcid:orcid:0000-0003-0834-4636\nprofileId:profileid:1891108\nname:Panettieri RA\nfullName:Reynold Alexander Panettieri\nfirstName:Reynold"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d5618f50fb5a4128a398340d3db76e65": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "BOSTON",
       "country": "UNITED STATES",
       "duns": "duns:073130411",
       "geonames": "geonames:4930956",
       "id": 554,
       "label": "Organization",
       "name": "Massachusetts General Hospital",
       "ror": "ror:002pd6e78",
       "state": "MA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4930956\nror:ror:002pd6e78\ncity:BOSTON\nname:Massachusetts General Hospital\nuei:uei:FLJ7DQKLL226\nduns:duns:073130411\nstate:MA\nid:ror:002pd6e78\nurl:https://ror.org/002pd6e78",
       "uei": "uei:FLJ7DQKLL226",
       "url": "https://ror.org/002pd6e78"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d61077757ab8431196de3b93d611623a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 618,
       "target": 10
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d6287c5f6928425aa5bed3c3216b4b0f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 698,
       "target": 40
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d66284811ba748c2bd7d879b1d7dbc71": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Enabling access to comprehensive biomedical information is central to the mission of the National Library of\nMedicine and key to disease prevention for better health outcomes nationally and globally. In the area of\ninfectious disease prevention, real time and non-biased sequence data are essential for early detection of\nthreats to mitigate outbreaks, epidemics and pandemics. This proposed research project aims to innovate in\nthe creation and accessibility of metagenomic sequence data relating to infectious agents by leveraging the\npotentially transformative tool of wastewater-based epidemiology (WBE). The WBE approach employs analysis\nof community wastewater from large populations to enable non-invasive, near real-time monitoring of both\nsymptomatic and asymptomatic individuals. When combined with high-throughput metagenomic sequencing\n(HTS), the resulting WBE-HTS approach is promising for detecting a broad spectrum of infectious agents\nsimultaneously without any a priori assumptions about virus identity or presence. This project will test the\nhypothesis that the processing of aggregated metagenomic sequence data on viruses detectable in U.S.\nwastewater can serve to identify vulnerabilities, outbreaks and epidemics early, thereby creating a novel and\npotentially life-saving diagnostic approach for protecting public health.\n For hypothesis testing, the team will leverage Arizona State University's Human Health Observatory (HHO),\nthe largest sewage monitoring network and largest archive of sewage and sludge samples worldwide,\nrepresenting more than 200 U.S. cities and over 300 cities globally.\n The overall goal of this work is to develop a broadly applicable online bioinformatics framework and to\ndemonstrate its utility in a case study employing WBE and HTS.\n The three specific aims are to: (i) inventory viruses extant in the U.S. in a comprehensive database, using\nexisting database sources and WBE; (ii) generate a knowledge repository and online portal of metagenomic\ndata to support near real-time surveillance of the human–associated virome, and (iii) evaluate the utility of the\nWBE bioinformatics framework for tracking viral outbreaks and epidemics.\n Successful completion of this project will provide the U.S. with an early warning system for pathogen\ndetection and outbreak tracking that can serve to prevent epidemics, thereby reducing morbidity and mortality\nin the U.S. from contagious pathogens, first for viruses and potentially in the future for pathogenic bacteria and\nother biohazards.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 19,
       "label": "Grant",
       "name": "Bioinformatics Framework for Wastewater-based Surveillance of Infectious Diseases",
       "narrative": "This biomedical informatics project will leverage high-throughput sequencing (HTS) data from U.S. wastewater\nprocess flows collected over the past two decades to create an innovative early warning system for virus\nsurveillance and public health protection. It will furnish significantly expanded virome databases and an online\ntool enabling public health practitioners and researchers to rapidly detect characteristic sequences of\npathogenic human viruses in DNA and RNA sequence data from environmental and clinical specimens.",
       "researchInitiative": "RADx-rad",
       "subProject": "Wastewater",
       "tooltip": "Grant\nabstract:Enabling access to comprehensive biomedical information is central to the mission of the National Library of\nMedicine and key to disease prevention for better health outcomes nationally and globally. In the area of\ninfectious disease prevention, real time and non-biased sequence data are essential for early detection of\nthreats to mitigate outbreaks, epidemics and pandemics. This proposed research project aims to innovate in\nthe creation and accessibility of metagenomic sequence data relating to infectious agents by leveraging the\npotentially transformative tool of wastewater-based epidemiology (WBE). The WBE approach employs analysis\nof community wastewater from large populations to enable non-invasive, near real-time monitoring of both\nsymptomatic and asymptomatic individuals. When combined with high-throughput metagenomic sequencing\n(HTS), the resulting WBE-HTS approach is promising for detecting a broad spectrum of infectious agents\nsimultaneously without any a priori assumptions about virus identity or presence. This project will test the\nhypothesis that the processing of aggregated metagenomic sequence data on viruses detectable in U.S.\nwastewater can serve to identify vulnerabilities, outbreaks and epidemics early, thereby creating a novel and\npotentially life-saving diagnostic approach for protecting public health.\n For hypothesis testing, the team will leverage Arizona State University's Human Health Observatory (HHO),\nthe largest sewage monitoring network and largest archive of sewage and sludge samples worldwide,\nrepresenting more than 200 U.S. cities and over 300 cities globally.\n The overall goal of this work is to develop a broadly applicable online bioinformatics framework and to\ndemonstrate its utility in a case study employing WBE and HTS.\n The three specific aims are to: (i) inventory viruses extant in the U.S. in a comprehensive database, using\nexisting database sources and WBE; (ii) generate a knowledge repository and online portal of metagenomic\ndata to support near real-time surveillance of the human–associated virome, and (iii) evaluate the utility of the\nWBE bioinformatics framework for tracking viral outbreaks and epidemics.\n Successful completion of this project will provide the U.S. with an early warning system for pathogen\ndetection and outbreak tracking that can serve to prevent epidemics, thereby reducing morbidity and mortality\nin the U.S. from contagious pathogens, first for viruses and potentially in the future for pathogenic bacteria and\nother biohazards.\nid:U01LM013129\nnarrative:This biomedical informatics project will leverage high-throughput sequencing (HTS) data from U.S. wastewater\nprocess flows collected over the past two decades to create an innovative early warning system for virus\nsurveillance and public health protection. It will furnish significantly expanded virome databases and an online\ntool enabling public health practitioners and researchers to rapidly detect characteristic sequences of\npathogenic human viruses in DNA and RNA sequence data from environmental and clinical specimens.\nname:Bioinformatics Framework for Wastewater-based Surveillance of Infectious Diseases\nsubProject:Wastewater\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d66e68fb3b97441b84d85ba8cbdbff8d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "CITES",
       "source": 2767,
       "target": 2820
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d6aef18847f247f8a37cac9450879e76": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4391,
       "target": 14
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d7454e8d661841ffbf5693af760cd1f0": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 707,
       "target": 598
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d776794e85f84e118a7760f98e2b5c45": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1888,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d7844c6096f74218a755bc39bc7a5594": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The SARS-CoV-2 coronavirus, the cause of the COVID-19 global pandemic, is efficiently spread\nand has reached over 27 million confirmed cases as of September 8, 2020. There is therefore an\nurgent need for new technologies that can provide early detection of virus, reducing the\ntransmission and infection rate. The goal of this proposal is to develop an integrated biosensor-\ntouchscreen that sensitivity reports surface contact with SARS-CoV-2. In our preliminary work,\nwe have identified several aptamers that bind specifically to the envelope-anchored trimeric spike\n(S) protein of SARS-CoV-2, but not of SARS-CoV or MERS. In comparison to antibodies,\naptamers are synthetic molecules that more thermally stable and lower cost while providing\nsimilar specificity and affinity of target binding. In this application, we propose to integrate\naptamer-based biosensing of SARS-CoV-2 into a touchscreen device. Our main objectives are to\n1) engineer conformation switching aptamers for electrochemical sensing of SARS-CoV-2\nbinding, 2) develop nanogap capacitive sensors as a uniquely complementary approach to\ncapacitive touchscreen technology and 3) build and test an integrated biosensor and touchscreen\narray that can detect SARS-CoV-2 from patient samples. Successful completion of these aims\nwill result in a novel automatic sensing platform for SARS-CoV-2. This technology could transform\npersonal device touchscreens as well as to multi-user touchscreen devices in hospitals, airports,\nlibraries, restaurants, for early detection, curbing transmission rates from secondary exposure.\nImportantly, the developed technology could be adapted for other electronic sensing platforms,\nand easily applied for future pathogen detection.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 42,
       "label": "Grant",
       "name": "Touchscreen-compatible, real-time electrochemical sensing of SARS-CoV-2",
       "narrative": "There is an urgent need for new and rapidly translatable technologies that can reduce SARS-CoV-2\ntransmission. The main goal of this proposal is to develop an integrated biosensor-touchscreen that sensitively\nreports surface contact with SARS-CoV-2. Successful completion of these aims will result in a novel automatic\nsensing platform for SARS-CoV-2 that could also applied to multi-user touchscreen devices such as those found\nin hospitals, airports, and restaurants, as well as single-user touchscreen such as mobile phones.",
       "researchInitiative": "RADx-rad",
       "subProject": "Automatic Detection & Tracing",
       "tooltip": "Grant\nabstract:The SARS-CoV-2 coronavirus, the cause of the COVID-19 global pandemic, is efficiently spread\nand has reached over 27 million confirmed cases as of September 8, 2020. There is therefore an\nurgent need for new technologies that can provide early detection of virus, reducing the\ntransmission and infection rate. The goal of this proposal is to develop an integrated biosensor-\ntouchscreen that sensitivity reports surface contact with SARS-CoV-2. In our preliminary work,\nwe have identified several aptamers that bind specifically to the envelope-anchored trimeric spike\n(S) protein of SARS-CoV-2, but not of SARS-CoV or MERS. In comparison to antibodies,\naptamers are synthetic molecules that more thermally stable and lower cost while providing\nsimilar specificity and affinity of target binding. In this application, we propose to integrate\naptamer-based biosensing of SARS-CoV-2 into a touchscreen device. Our main objectives are to\n1) engineer conformation switching aptamers for electrochemical sensing of SARS-CoV-2\nbinding, 2) develop nanogap capacitive sensors as a uniquely complementary approach to\ncapacitive touchscreen technology and 3) build and test an integrated biosensor and touchscreen\narray that can detect SARS-CoV-2 from patient samples. Successful completion of these aims\nwill result in a novel automatic sensing platform for SARS-CoV-2. This technology could transform\npersonal device touchscreens as well as to multi-user touchscreen devices in hospitals, airports,\nlibraries, restaurants, for early detection, curbing transmission rates from secondary exposure.\nImportantly, the developed technology could be adapted for other electronic sensing platforms,\nand easily applied for future pathogen detection.\nid:U01AA029316\nnarrative:There is an urgent need for new and rapidly translatable technologies that can reduce SARS-CoV-2\ntransmission. The main goal of this proposal is to develop an integrated biosensor-touchscreen that sensitively\nreports surface contact with SARS-CoV-2. Successful completion of these aims will result in a novel automatic\nsensing platform for SARS-CoV-2 that could also applied to multi-user touchscreen devices such as those found\nin hospitals, airports, and restaurants, as well as single-user touchscreen such as mobile phones.\nname:Touchscreen-compatible, real-time electrochemical sensing of SARS-CoV-2\nsubProject:Automatic Detection & Tracing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d7c2ac80b1194a2ea747c91b43ae4b6f": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 629,
       "target": 31
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d7c851a9284a41c2a8426cdee0986bf6": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2007,
       "name": "EMPLOYED_AT",
       "source": 701,
       "target": 592
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d87069a9ece54df99d708684a3567458": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "IS_INVENTOR",
       "source": 677,
       "target": 2409
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d89ec995cdb148c88524e2599a8da049": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Robust, efficient and reliable testing for SARS-CoV-2 is extraordinarily challenging due to our lack of ultra-\nsensitive assays and ever evolving knowledge of the virus. Standard PCR based assays still result in very high\nfalse negative rates in the earliest days of infection. Microfluidic processing of clinical samples is low cost and\nshows great promise for translating most liquid biopsy assay to the clinic. Our laboratory was one of the first to\napply microfluidic technologies for the isolation of both circulating tumor cells and exosomes in the blood of\npatients with cancer. For SARS-CoV-2 patients, saliva, stool, and plasma are all thought to be potential resources\nfor both virus detection as well as other clinical biomarkers that might inform us of infection. Thus, for this U18,\nwe will optimize our exosome capture technology, the EVHB-Chip, for the isolation of intact SARS-CoV-2 virus,\ntesting its utility for each of these biofluids. To complete this work, we will complete a full clinical validation and\nbenchmarking of the assay. Once fully optimized, our detection assay will be compared against existing EUA\nSARS-CoV-2 detection assay to determine detection sensitivity and specificity. Further, we plan to demonstrate\nthat the increased sensitivity and specificity enabled by our microfluidic device will result in earlier detection of\nSARS-CoV-2, reducing false negatives in this testing window. At the completion of this work, we will have\ncollected the data training sets and submitted a full EUA plan that would enable the FDA’s authorization of our\ntest to be used in the clinic.",
       "awardCode": "U18",
       "fundingMechanism": "Other Research-Related",
       "id": 1,
       "label": "Grant",
       "name": "Microfluidic Isolation and Characterization of SARS-CoV-2 and Virus Related Exosomes",
       "narrative": "We will develop a SARS-CoV-2 detection assay using our existing microfluidic exosome isolation technology,\nthe EVHB-Chip. The high sensitivity and specificity of our technology allows for the isolation of rare nanoscale\nvesicles from complex biofluids. Based on our early data, we believe it is ideally suited for the isolation of SARS-\nCoV-2 virus particles and have established a strong team of collaborators to rapidly and efficiently lead us\nthrough assay development, validation, and clinical integration.",
       "researchInitiative": "RADx-rad",
       "subProject": "Exosome",
       "tooltip": "Grant\nabstract:Robust, efficient and reliable testing for SARS-CoV-2 is extraordinarily challenging due to our lack of ultra-\nsensitive assays and ever evolving knowledge of the virus. Standard PCR based assays still result in very high\nfalse negative rates in the earliest days of infection. Microfluidic processing of clinical samples is low cost and\nshows great promise for translating most liquid biopsy assay to the clinic. Our laboratory was one of the first to\napply microfluidic technologies for the isolation of both circulating tumor cells and exosomes in the blood of\npatients with cancer. For SARS-CoV-2 patients, saliva, stool, and plasma are all thought to be potential resources\nfor both virus detection as well as other clinical biomarkers that might inform us of infection. Thus, for this U18,\nwe will optimize our exosome capture technology, the EVHB-Chip, for the isolation of intact SARS-CoV-2 virus,\ntesting its utility for each of these biofluids. To complete this work, we will complete a full clinical validation and\nbenchmarking of the assay. Once fully optimized, our detection assay will be compared against existing EUA\nSARS-CoV-2 detection assay to determine detection sensitivity and specificity. Further, we plan to demonstrate\nthat the increased sensitivity and specificity enabled by our microfluidic device will result in earlier detection of\nSARS-CoV-2, reducing false negatives in this testing window. At the completion of this work, we will have\ncollected the data training sets and submitted a full EUA plan that would enable the FDA’s authorization of our\ntest to be used in the clinic.\nid:U18TR003793\nnarrative:We will develop a SARS-CoV-2 detection assay using our existing microfluidic exosome isolation technology,\nthe EVHB-Chip. The high sensitivity and specificity of our technology allows for the isolation of rare nanoscale\nvesicles from complex biofluids. Based on our early data, we believe it is ideally suited for the isolation of SARS-\nCoV-2 virus particles and have established a strong team of collaborators to rapidly and efficiently lead us\nthrough assay development, validation, and clinical integration.\nname:Microfluidic Isolation and Characterization of SARS-CoV-2 and Virus Related Exosomes\nsubProject:Exosome\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U18"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d8d03169bd74488c84491f8f09e12fab": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "Fort Collins",
       "country": "UNITED STATES",
       "duns": "duns:079527397",
       "geonames": "geonames:7173444",
       "id": 604,
       "label": "Organization",
       "name": "Aerosol Devices, Inc.",
       "state": "CO",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:7173444\ncity:Fort Collins\nname:Aerosol Devices, Inc.\nuei:uei:KV6XHGACM3Z5\nduns:duns:079527397\nstate:CO\nid:uei:KV6XHGACM3Z5",
       "uei": "uei:KV6XHGACM3Z5"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d95e75ad59e44e1882a2947fe4716f5a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 693,
       "target": 41
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d9816999e5db48e3bcda9e5a97907a53": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1800,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "d9891ffaf3094fdeb79b322d46d19002": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 680,
       "target": 572
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "da0085b114b748ce97ed5f009493773e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4393,
       "target": 34
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "da3e500fe98d4ded89851a01662a0c03": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Matthew",
       "fullName": "Matthew Scotch",
       "id": 666,
       "label": "Researcher",
       "lastName": "Scotch",
       "name": "Scotch M",
       "orcid": "orcid:0000-0001-5100-9724",
       "profileId": "profileid:8952899",
       "tooltip": "Researcher\nid:profileid:8952899\nlastName:Scotch\norcid:orcid:0000-0001-5100-9724\nprofileId:profileid:8952899\nname:Scotch M\nfullName:Matthew Scotch\nfirstName:Matthew"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "da3e7c28cb864b4387d273d4e554a244": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 627,
       "target": 32
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "da7de2b2d1bb42bf8a79f666d8f782d9": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Lawrence",
       "fullName": "Lawrence C Kleinman",
       "id": 668,
       "label": "Researcher",
       "lastName": "Kleinman",
       "middleName": "C",
       "name": "Kleinman LC",
       "orcid": "orcid:0000-0002-4024-2229",
       "profileId": "profileid:6601712",
       "tooltip": "Researcher\nmiddleName:C\nid:profileid:6601712\nlastName:Kleinman\norcid:orcid:0000-0002-4024-2229\nprofileId:profileid:6601712\nname:Kleinman LC\nfullName:Lawrence C Kleinman\nfirstName:Lawrence"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "db58fcc3b28d45f694fcfa7e2918f805": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 631,
       "target": 3
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "dbd00dab449540c2a704be82cff4a1a6": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Michael",
       "fullName": "Michael H Nantz",
       "id": 704,
       "label": "Researcher",
       "lastName": "Nantz",
       "middleName": "H",
       "name": "Nantz MH",
       "orcid": "orcid:0000-0003-1301-3399",
       "profileId": "profileid:9972311",
       "tooltip": "Researcher\nmiddleName:H\nid:profileid:9972311\nlastName:Nantz\norcid:orcid:0000-0003-1301-3399\nprofileId:profileid:9972311\nname:Nantz MH\nfullName:Michael H Nantz\nfirstName:Michael"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "dbfd555cb5b64e85a8adc4c61118c74b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 925,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "dc72fa2b9359468faea89397a6c1fa67": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 682,
       "target": 41
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "dd0dfc06a1f74d8db5ae7e14de227535": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 701,
       "target": 30
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "dda49b6d522345d380226bb5338e275e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 680,
       "target": 39
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "dde39af3e6814c86b610d7ed97ff3e2d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 691,
       "target": 567
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "de39e48f80f6480d926d2473b17a2540": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "B",
       "fullName": "B Sumlin",
       "id": 1513,
       "label": "Researcher",
       "lastName": "Sumlin",
       "name": "Sumlin B",
       "tooltip": "Researcher\nid:s2authorid:36049431\nlastName:Sumlin\nname:Sumlin B\nfullName:B Sumlin\nfirstName:B"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "de6841351305438fb8a46da9fd6171e4": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Shannon",
       "fullName": "Shannon L Stott",
       "id": 611,
       "label": "Researcher",
       "lastName": "Stott",
       "middleName": "L",
       "name": "Stott SL",
       "orcid": "orcid:0000-0002-0349-0522",
       "profileId": "profileid:8956784",
       "tooltip": "Researcher\nmiddleName:L\nid:profileid:8956784\nlastName:Stott\norcid:orcid:0000-0002-0349-0522\nprofileId:profileid:8956784\nname:Stott SL\nfullName:Shannon L Stott\nfirstName:Shannon"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "de8272ebb0404ebbab3c03a8658ca93a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Stephan",
       "fullName": "Stephan C Schurer",
       "id": 698,
       "label": "Researcher",
       "lastName": "Schurer",
       "middleName": "C",
       "name": "Schurer SC",
       "orcid": "orcid:0000-0002-5522-3389",
       "profileId": "profileid:9136437",
       "tooltip": "Researcher\nmiddleName:C\nid:profileid:9136437\nlastName:Schurer\norcid:orcid:0000-0002-5522-3389\nprofileId:profileid:9136437\nname:Schurer SC\nfullName:Stephan C Schurer\nfirstName:Stephan"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ded7d45f6e6641989eb46c379fe1dfe0": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 668,
       "target": 571
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "df8fbee325c741c98d6bfefe7cc3df85": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4393,
       "target": 28
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "dfd9f3fac6b74747bcb75dc96fc9f3bb": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 650,
       "target": 15
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e02bdd20b233481e80d2dd89a3c95c08": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4395,
       "target": 3
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e0344b8805b541ff9cda6a5b65e92153": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "BATON ROUGE",
       "country": "UNITED STATES",
       "duns": "duns:075050765",
       "geonames": "geonames:4315588",
       "id": 583,
       "label": "Organization",
       "name": "Louisiana State University",
       "ror": "ror:05ect4e57",
       "state": "LA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4315588\nror:ror:05ect4e57\ncity:BATON ROUGE\nname:Louisiana State University\nuei:uei:ECQEYCHRNKJ4\nduns:duns:075050765\nstate:LA\nid:ror:05ect4e57\nurl:https://ror.org/05ect4e57",
       "uei": "uei:ECQEYCHRNKJ4",
       "url": "https://ror.org/05ect4e57"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e045bb78855c415a984de28a9ecb7f60": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 615,
       "target": 5
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e078648af27b42fe9b63502c5fc8eefe": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 617,
       "target": 7
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e0e8ac190c3743e3a94a77caaeac7f1e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The rapid onset of the COVID-19 pandemic left many across the world unprepared to test, treat, and plan for\ncoronavirus morbidity and mortality. This was true for Tribal nations, whose sovereign status enabled swift and\npreventative measures such as lock-downs and border closures, yet whose culture contributed to additional\nunique risk factors. Among those are testing disparities, underlying health factors, and community infrastructure.\nHowever, clinical testing doesn’t capture the extent of positive cases, and without the collective efforts of this\nproject, Tribes will likely not be included in wastewater-based epidemiology (WBE) analysis, which has garnered\nwide-spread interest due to its ability to generate data in advance of community infectivity. In this project, we will\nshow that WBE is a non-invasive, culturally appropriate biomonitoring strategy that can be adopted and\nimplemented by Tribal communities to empower them with a practical, yet technologically advanced health\nsurveillance tool. Building upon a rigorous methodology of Tribal consultation and community-based participatory\nresearch, assessment of wastewater and community infrastructure, and training of Tribal wastewater operators\nand health administrators on WBE, we will form the WBE Tribal Coordination Center. Tribes will be recruited\nthrough the InterTribal Council of Arizona’s National Tribal Water and Wastewater Operator Training Program\nnetwork. We will measure coronavirus in wastewater across U.S. reservations using established RT-qPCR\ntechniques and a novel protein quantification method, and we will sequence viral RNA extracts to assess SARS-\nCoV-2 variants in Tribal communities. Risk factors contributing to elevated COVID-19 in Tribal communities will\nbe quantified with integration of geospatial analysis. Frameworks for risks from numerous environmentally-\ntransmitted pathogens have been developed by our team, setting a foundation to incorporate variability and\nuncertainty for Tribal settings with qualitative information from Tribes in order to appropriately scope our modeling\nefforts. Simulation results will help to target resources efficiently for monitoring and public health interventions\nby identifying specific sampling locations where it is most likely to detect SARS-CoV-2 given other community\nand scientific constraints. Information from the RADx Data Coordination Center will be used to the fullest extent\nto compare Tribal communities with their non-Tribal counterparts. Through the coronavirus pandemic and\nbeyond, Tribes will be better informed of their ability to use WBE to measure community health, thereby\nprotecting community health and building capacity for future applications and research translation.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 44,
       "label": "Grant",
       "name": "Wastewater Analysis of SARS CoV-2 in Tribal Communities",
       "narrative": "SARS-CoV-2 wastewater-based epidemiology is particularly applicable for Tribal communities who wish to\nimprove testing rates, are managing operational plans, or want to observe temporal trends within a defined\nsewershed. Our approach of analyzing wastewater for human metabolites and pathogens addresses known and\nwell-documented concerns of violation of cultural norms by avoiding the collection and analysis biospecimens of\nindividuals. By effectively working with Tribes, these efforts will culminate in a robust data stream to inform\nleadership, health administrators and wastewater utilities of coronavirus trends reflective of the population from\nwhich samples are collected.",
       "researchInitiative": "RADx-rad",
       "subProject": "Wastewater",
       "tooltip": "Grant\nabstract:The rapid onset of the COVID-19 pandemic left many across the world unprepared to test, treat, and plan for\ncoronavirus morbidity and mortality. This was true for Tribal nations, whose sovereign status enabled swift and\npreventative measures such as lock-downs and border closures, yet whose culture contributed to additional\nunique risk factors. Among those are testing disparities, underlying health factors, and community infrastructure.\nHowever, clinical testing doesn’t capture the extent of positive cases, and without the collective efforts of this\nproject, Tribes will likely not be included in wastewater-based epidemiology (WBE) analysis, which has garnered\nwide-spread interest due to its ability to generate data in advance of community infectivity. In this project, we will\nshow that WBE is a non-invasive, culturally appropriate biomonitoring strategy that can be adopted and\nimplemented by Tribal communities to empower them with a practical, yet technologically advanced health\nsurveillance tool. Building upon a rigorous methodology of Tribal consultation and community-based participatory\nresearch, assessment of wastewater and community infrastructure, and training of Tribal wastewater operators\nand health administrators on WBE, we will form the WBE Tribal Coordination Center. Tribes will be recruited\nthrough the InterTribal Council of Arizona’s National Tribal Water and Wastewater Operator Training Program\nnetwork. We will measure coronavirus in wastewater across U.S. reservations using established RT-qPCR\ntechniques and a novel protein quantification method, and we will sequence viral RNA extracts to assess SARS-\nCoV-2 variants in Tribal communities. Risk factors contributing to elevated COVID-19 in Tribal communities will\nbe quantified with integration of geospatial analysis. Frameworks for risks from numerous environmentally-\ntransmitted pathogens have been developed by our team, setting a foundation to incorporate variability and\nuncertainty for Tribal settings with qualitative information from Tribes in order to appropriately scope our modeling\nefforts. Simulation results will help to target resources efficiently for monitoring and public health interventions\nby identifying specific sampling locations where it is most likely to detect SARS-CoV-2 given other community\nand scientific constraints. Information from the RADx Data Coordination Center will be used to the fullest extent\nto compare Tribal communities with their non-Tribal counterparts. Through the coronavirus pandemic and\nbeyond, Tribes will be better informed of their ability to use WBE to measure community health, thereby\nprotecting community health and building capacity for future applications and research translation.\nid:U01DA053976\nnarrative:SARS-CoV-2 wastewater-based epidemiology is particularly applicable for Tribal communities who wish to\nimprove testing rates, are managing operational plans, or want to observe temporal trends within a defined\nsewershed. Our approach of analyzing wastewater for human metabolites and pathogens addresses known and\nwell-documented concerns of violation of cultural norms by avoiding the collection and analysis biospecimens of\nindividuals. By effectively working with Tribes, these efforts will culminate in a robust data stream to inform\nleadership, health administrators and wastewater utilities of coronavirus trends reflective of the population from\nwhich samples are collected.\nname:Wastewater Analysis of SARS CoV-2 in Tribal Communities\nsubProject:Wastewater\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e0f6d0dd8cf44185a320d996428c864b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The COVID-19 pandemic has caused unprecedented societal suffering and economic disruption. In the\nUnited States, more than six million people have contracted COVID-19 and more than one hundred ninety\nthousand patients have died of this disease to date. Although current COVID-19 diagnostic testing technologies\nare critical for slowing the spread of the virus and preventing future outbreaks, they are not practical for field use.\nCurrent diagnostic tests are cumbersome to perform because they use aqueous solutions, require multiple steps,\nand hours-to-days to obtain results. Since the US began to reopen the economy in May, there has been a\nsignificant increase in the number of COVID-19 cases. Therefore, there is an urgent need to develop a diagnostic\napproach that is non-invasive, portable, and can rapidly provide test results.\n The overall goal of the project is to develop a mobile breath analysis technology for rapid screening for\nCOVID-19 using a handheld breath collection tool and a portable GC with a photoionization detector (PID). The\nhandheld tool will be a closed system for trapping select volatile organic compounds (VOCs) on a microfabricated\nchip. The captured VOCs will be eluted with ethanol and then analyzed using a commercially available, portable\nGC-PID instrument. Artificial intelligence (AI) and machine learning algorithms will be applied to recognize the\nVOC pattern that correlates with COVID-19 infection. The central innovation is the microfabricated chip that\ncaptures carbonyl compounds in exhaled breath and thus serves as a preconcentrator, which enables analysis\nof carbonyl VOCs by the portable GC-PID. The hypothesis is that the carbonyl metabolome in exhaled breath is\ndirectly related to the body’s reaction to the novel coronavirus infection, and changes in the carbonyl VOC\ncomposition in exhaled breath relative to healthy controls can be used to detect both symptomatic and\nasymptomatic COVID-19 patients.\n Three specific aims are proposed to fulfill the overall goal. Aim 1 is to build a disposable handheld breath\nanalyzer tool for concentrating carbonyl VOCs. Aim 2 is to identify VOC patterns in the breath of COVID-19\npatients by machine learning algorithms. Aim 3 is to integrate portable GC technology with the breath sampling\ntool for COVID-19 screening guided by an AI system. The University of Louisville is uniquely suited to rapidly\ntransition the microchip technology to field use because of the PI and Co-PI’s experience in breath analysis and\ntranslational research, and the project team’s experience in virology, infectious diseases, biostatistics, and\nartificial intelligence as well as the state-of-the-art facilities that include a MicroNano Technology Center,\nBiosafety Level 3 Regional Biocontainment Lab, and an NIH-funded REACH program.",
       "awardCode": "U18",
       "fundingMechanism": "Other Research-Related",
       "id": 13,
       "label": "Grant",
       "name": "A Handheld Microchip for GC analysis of breath to screen for COVID-19",
       "narrative": "8. Project Narrative\n This project will develop a mobile breath analysis technology for rapid screening for COVID-19 using a\nhandheld breath collection tool and a portable GC with a photoionization detector (PID). Artificial intelligence and\nmachine learning algorithms will be used to analyze the detected signals of volatile organic compounds (VOCs)\nin exhaled breath by the portable GC for detection of COVID-19 patients. UofL is uniquely suited to develop this\napproach because of the PI’s expertise in breath analysis for detection of Tuberculosis and lung cancer and the\nteam’s experience in virology, infectious diseases, biostatistics, and artificial intelligence.",
       "researchInitiative": "RADx-rad",
       "subProject": "SCENT",
       "tooltip": "Grant\nabstract:The COVID-19 pandemic has caused unprecedented societal suffering and economic disruption. In the\nUnited States, more than six million people have contracted COVID-19 and more than one hundred ninety\nthousand patients have died of this disease to date. Although current COVID-19 diagnostic testing technologies\nare critical for slowing the spread of the virus and preventing future outbreaks, they are not practical for field use.\nCurrent diagnostic tests are cumbersome to perform because they use aqueous solutions, require multiple steps,\nand hours-to-days to obtain results. Since the US began to reopen the economy in May, there has been a\nsignificant increase in the number of COVID-19 cases. Therefore, there is an urgent need to develop a diagnostic\napproach that is non-invasive, portable, and can rapidly provide test results.\n The overall goal of the project is to develop a mobile breath analysis technology for rapid screening for\nCOVID-19 using a handheld breath collection tool and a portable GC with a photoionization detector (PID). The\nhandheld tool will be a closed system for trapping select volatile organic compounds (VOCs) on a microfabricated\nchip. The captured VOCs will be eluted with ethanol and then analyzed using a commercially available, portable\nGC-PID instrument. Artificial intelligence (AI) and machine learning algorithms will be applied to recognize the\nVOC pattern that correlates with COVID-19 infection. The central innovation is the microfabricated chip that\ncaptures carbonyl compounds in exhaled breath and thus serves as a preconcentrator, which enables analysis\nof carbonyl VOCs by the portable GC-PID. The hypothesis is that the carbonyl metabolome in exhaled breath is\ndirectly related to the body’s reaction to the novel coronavirus infection, and changes in the carbonyl VOC\ncomposition in exhaled breath relative to healthy controls can be used to detect both symptomatic and\nasymptomatic COVID-19 patients.\n Three specific aims are proposed to fulfill the overall goal. Aim 1 is to build a disposable handheld breath\nanalyzer tool for concentrating carbonyl VOCs. Aim 2 is to identify VOC patterns in the breath of COVID-19\npatients by machine learning algorithms. Aim 3 is to integrate portable GC technology with the breath sampling\ntool for COVID-19 screening guided by an AI system. The University of Louisville is uniquely suited to rapidly\ntransition the microchip technology to field use because of the PI and Co-PI’s experience in breath analysis and\ntranslational research, and the project team’s experience in virology, infectious diseases, biostatistics, and\nartificial intelligence as well as the state-of-the-art facilities that include a MicroNano Technology Center,\nBiosafety Level 3 Regional Biocontainment Lab, and an NIH-funded REACH program.\nid:U18TR003787\nnarrative:8. Project Narrative\n This project will develop a mobile breath analysis technology for rapid screening for COVID-19 using a\nhandheld breath collection tool and a portable GC with a photoionization detector (PID). Artificial intelligence and\nmachine learning algorithms will be used to analyze the detected signals of volatile organic compounds (VOCs)\nin exhaled breath by the portable GC for detection of COVID-19 patients. UofL is uniquely suited to develop this\napproach because of the PI’s expertise in breath analysis for detection of Tuberculosis and lung cancer and the\nteam’s experience in virology, infectious diseases, biostatistics, and artificial intelligence.\nname:A Handheld Microchip for GC analysis of breath to screen for COVID-19\nsubProject:SCENT\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U18"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e1885e9a6f80441eb8ae6bfa410a85b1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "A well-recognized gap exists in the path from biomedical discovery in academia to clinical application and \ncommercialization of therapeutic, device, and diagnostic technologies in cardiovascular, pulmonary, \nhematologic, and sleep disorders. This chasm is the result of inadequate funding for support of proof-of-concept \nor validation studies essential for early stage development; insufficient access to the resources and \nexpertise needed to develop new technologies; and a lack of knowledge and experience among academic \ninvestigators in bringing new ideas to commercial realization. Within the partnering institutions included in \nthis application, the essential elements exist with which to build the infrastructure needed to support and \nsustain the uninterrupted, durable flow of inventions from discovery through development and \ncommercialization. While these institutions have a clear track record of remarkably successful development \nof many biomedical technologies, most of these commercial successes have been achieved by the tenacity \nof individual inventors rather than with the help of committed institutional mechanisms. We proposed to \naddress these key shortcomings by establishing the regional Boston Center for Accelerated Innovation in \nTherapeutics, Devices, and Diagnostics for Heart, Lung, Blood, and Sleep Disorders (B-BIC, or the Boston \nBiomedical Innovation Center). The key objectives of this Center are to: 1) develop an integrated \ninfrastructure that would expand the universe of commercializable technologies for heart, lung, blood, and \nsleep disorders; 2) place these opportunities in the proper evaluative context through an engagement (\"seed \nit\"), solicitation (\"find it\"), and selection (\"pick it\") strategy; 3) efficiently and effectively bring those selected to \nan appropriate exit point from the development process; and 4) provide the educational and mentoring \ninfrastructure necessary for the development of the proper entrepreneurial skills among academic \ninnovators. By achieving these goals, B-BlC would change the culture of our academic environment, as \nwell as the relationship between the public and private sectors in facilitating successful development \nstrategies for technologies in heart, lung, blood, and sleep disorders for the ultimate benefit of patients and society.",
       "awardCode": "U54",
       "fundingMechanism": "Research Centers",
       "id": 15,
       "label": "Grant",
       "name": "Boston Biomedical Innovation Center",
       "narrative": "Translation of basic observations into clinical practice is limited by the resources needed for development, \ninadequate experience of academic investigators, and the discovery-focused academic culture. Building an \nacademic infrastructure that facilitates translation by promoting development is an important goal to ensure \nthe successful translation of research into benefit for patients and society.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:A well-recognized gap exists in the path from biomedical discovery in academia to clinical application and \ncommercialization of therapeutic, device, and diagnostic technologies in cardiovascular, pulmonary, \nhematologic, and sleep disorders. This chasm is the result of inadequate funding for support of proof-of-concept \nor validation studies essential for early stage development; insufficient access to the resources and \nexpertise needed to develop new technologies; and a lack of knowledge and experience among academic \ninvestigators in bringing new ideas to commercial realization. Within the partnering institutions included in \nthis application, the essential elements exist with which to build the infrastructure needed to support and \nsustain the uninterrupted, durable flow of inventions from discovery through development and \ncommercialization. While these institutions have a clear track record of remarkably successful development \nof many biomedical technologies, most of these commercial successes have been achieved by the tenacity \nof individual inventors rather than with the help of committed institutional mechanisms. We proposed to \naddress these key shortcomings by establishing the regional Boston Center for Accelerated Innovation in \nTherapeutics, Devices, and Diagnostics for Heart, Lung, Blood, and Sleep Disorders (B-BIC, or the Boston \nBiomedical Innovation Center). The key objectives of this Center are to: 1) develop an integrated \ninfrastructure that would expand the universe of commercializable technologies for heart, lung, blood, and \nsleep disorders; 2) place these opportunities in the proper evaluative context through an engagement (\"seed \nit\"), solicitation (\"find it\"), and selection (\"pick it\") strategy; 3) efficiently and effectively bring those selected to \nan appropriate exit point from the development process; and 4) provide the educational and mentoring \ninfrastructure necessary for the development of the proper entrepreneurial skills among academic \ninnovators. By achieving these goals, B-BlC would change the culture of our academic environment, as \nwell as the relationship between the public and private sectors in facilitating successful development \nstrategies for technologies in heart, lung, blood, and sleep disorders for the ultimate benefit of patients and society.\nid:U54HL119145\nnarrative:Translation of basic observations into clinical practice is limited by the resources needed for development, \ninadequate experience of academic investigators, and the discovery-focused academic culture. Building an \nacademic infrastructure that facilitates translation by promoting development is an important goal to ensure \nthe successful translation of research into benefit for patients and society.\nname:Boston Biomedical Innovation Center\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:Research Centers\nawardCode:U54"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e1e226c8eb934022b2ab763e29231f7c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4396,
       "target": 14
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e277f7e913394386b7037912d8a49ad8": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Alan",
       "fullName": "Alan T Johnson",
       "id": 673,
       "label": "Researcher",
       "lastName": "Johnson",
       "middleName": "T",
       "name": "Johnson AT",
       "profileId": "profileid:8547915",
       "tooltip": "Researcher\nmiddleName:T\nid:profileid:8547915\nlastName:Johnson\nprofileId:profileid:8547915\nname:Johnson AT\nfullName:Alan T Johnson\nfirstName:Alan"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e2f9c18f7b704a7a9899a67b03de2d07": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "This work is directed at characterizing pediatric COVID-19 and stratifying incoming patients by projected\n(future) disease severity. Such stratification has several implications: immediately improving treatment planning, and\nas disease mechanistic pathways are uncovered, directing treatment. Predicting future severity will inform the risks of\noutpatient treatment; to the patients themselves, their family, other caregivers/cohabitants, and to schools and\nemployers. As varying levels of “reopening” are adopted across the country (and the world), such prognostication will\ninform policy on the handling of pediatric carriers in the community. Based on our preliminary analysis we assert that\na combination of novel assays including quantitative serology inflammatory markers (cytokine/chemokine profiles,\nimmune profiles), transcriptomics, epigenomics, longitudinal physiological monitoring, time series analysis, imaging,\nradiomics and clinical observation including social determinants of health, contains adequate information even at early\nstages of infection to stratify the disease and predict disease severity. We propose an artificial intelligence/machine\nlearning approach to integrate this rich and heterogeneous dataset, characterize the spectrum of disease and identify\nbiosignatures that predict severity in progressive disease. To facilitate translation of the approaches developed in this\nwork to a wide user community, we incorporate a Translational Development function, to oversee the design-control\nprocess and ensure readiness of our methods for regulatory review. Incorporated into our timelines are appropriate\nregulatory milestones intended to conform with the Emergency Use Authorization (EUA) programs in effect for SARS-\nCoV-2 diagnostics.",
       "awardCode": "R61",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 18,
       "label": "Grant",
       "name": "AICORE-kids: Artificial Intelligence COVID-19 Risk AssEssment for kids",
       "narrative": "We propose an artificial intelligence/machine learning approach to integrate a rich and heterogeneous dataset\non COVID-19 in children, characterize the spectrum of disease and identify biosignatures that predict severity in\nprogressive disease. To facilitate translation of the approaches developed in this work to a wide user community, we\nincorporate a Translational Development function, to oversee the design-control process and ensure readiness of our\nmethods for regulatory review. Incorporated into our timelines are appropriate regulatory milestones intended to\nconform with the Emergency Use Authorization (EUA) programs in effect for SARS-CoV-2 diagnostics.",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nabstract:This work is directed at characterizing pediatric COVID-19 and stratifying incoming patients by projected\n(future) disease severity. Such stratification has several implications: immediately improving treatment planning, and\nas disease mechanistic pathways are uncovered, directing treatment. Predicting future severity will inform the risks of\noutpatient treatment; to the patients themselves, their family, other caregivers/cohabitants, and to schools and\nemployers. As varying levels of “reopening” are adopted across the country (and the world), such prognostication will\ninform policy on the handling of pediatric carriers in the community. Based on our preliminary analysis we assert that\na combination of novel assays including quantitative serology inflammatory markers (cytokine/chemokine profiles,\nimmune profiles), transcriptomics, epigenomics, longitudinal physiological monitoring, time series analysis, imaging,\nradiomics and clinical observation including social determinants of health, contains adequate information even at early\nstages of infection to stratify the disease and predict disease severity. We propose an artificial intelligence/machine\nlearning approach to integrate this rich and heterogeneous dataset, characterize the spectrum of disease and identify\nbiosignatures that predict severity in progressive disease. To facilitate translation of the approaches developed in this\nwork to a wide user community, we incorporate a Translational Development function, to oversee the design-control\nprocess and ensure readiness of our methods for regulatory review. Incorporated into our timelines are appropriate\nregulatory milestones intended to conform with the Emergency Use Authorization (EUA) programs in effect for SARS-\nCoV-2 diagnostics.\nid:R61HD105593\nnarrative:We propose an artificial intelligence/machine learning approach to integrate a rich and heterogeneous dataset\non COVID-19 in children, characterize the spectrum of disease and identify biosignatures that predict severity in\nprogressive disease. To facilitate translation of the approaches developed in this work to a wide user community, we\nincorporate a Translational Development function, to oversee the design-control process and ensure readiness of our\nmethods for regulatory review. Incorporated into our timelines are appropriate regulatory milestones intended to\nconform with the Emergency Use Authorization (EUA) programs in effect for SARS-CoV-2 diagnostics.\nname:AICORE-kids: Artificial Intelligence COVID-19 Risk AssEssment for kids\nsubProject:PreVAIL kIds\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R61"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e3036984bde54baebf031c0c1d4d56df": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Na",
       "fullName": "Na Hong",
       "id": 721,
       "label": "Researcher",
       "lastName": "Hong",
       "name": "Hong N",
       "profileId": "s2authorid:2072483999",
       "tooltip": "Researcher\nid:s2authorid:2072483999\nlastName:Hong\nprofileId:s2authorid:2072483999\nname:Hong N\nfullName:Na Hong\nfirstName:Na"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e310e64666b6444d8987a0d56d2d4fc8": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 700,
       "target": 30
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e3be20d7136d458bbfbac134eceec37b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "J",
       "fullName": "J Puthussery",
       "id": 1196,
       "label": "Researcher",
       "lastName": "Puthussery",
       "name": "Puthussery J",
       "tooltip": "Researcher\nid:s2authorid:12172833\nlastName:Puthussery\nname:Puthussery J\nfullName:J Puthussery\nfirstName:J"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e43f215a1b9c4ac09a856034b5a0f51e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4398,
       "label": "FundingOpportunity",
       "name": "NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)",
       "tooltip": "FundingOpportunity\nname:NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)\nid:PA-18-484\nurl:https://grants.nih.gov/grants/guide/pa-files/PA-18-484.html",
       "url": "https://grants.nih.gov/grants/guide/pa-files/PA-18-484.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e44992a9bd664907b594a5267faff114": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The ultimate goal of this proposal is to develop a novel platform technology for automatic surveillance\nand tracing of airborne SARS-CoV-2 virus particles in real time. The centerpiece of this proposal is the\n“Rolosense” technology which leverages a DNA micromotor as the virus sensing and transduction\nmaterial (VSTM) that can be detected by a conventional smart phone camera. This provides both\ngeographical tracing and surveillance. Rolosense motor are comprised a DNA-coated spherical particle\n(5 micrometer diameter) that hybridizes to a surface modified with complementary RNA. The particle\nmoves at speeds of over 1 micron/minute upon the addition of RNase H, which selectively hydrolyses\nhybridized RNA but not single-stranded RNA. DNA motors coated with virus binding ligand (VBL) stall\nin presence of SARS-CoV-2 virus particles. Because motors move autonomously for distances up to\nmillimeters without intervention, the assay is fully automated, and conventional steps such as viral\ninactivation, RNA isolation and amplification are not required. The readout is performed using an\nautomated smart phone app for particle tracking without the need for a spectrophotometer or\nfluorometer. Preliminary data shows realtime SARS-CoV-2 pseudovirus particle sensing. Milestones\ninclude the screening and identification of high affinity and high specificity VBLs. Both aptamers and\nantibody VBLs will be screening and validated. Simulations and experiments will be used to understand\nthe role of temperature and environmental conditions in modulating Rolosense performance.\nMultivalent display of VBLs with DNA origami will enhance avidity. Finally, microfluidic chips with\nairborne droplet capture will be implemented and tested. The work will be performed by a highly\ninterdisciplinary team with complementary expertise and a track-record of co-publications. PI Salaita\ninvented the Rolosense technology and has past experience in developing cell phone diagnostics and\nsynthetic motors. Co-I Melikian is an expert virologist, Co-I Heemstra is an expert at developing\naptamers for novel targets, Co-I Ke has extensive experience in DNA origami structures for avid target\nbinding and has co-authored work on Rolosense, Co-I Rajaraman and Primordia are experts at\nmicrofluidic device development and commercialization. Our solution offers the potential to provide an\nimmediate solution to today’s urgent virus sensing and tracing needs.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 0,
       "label": "Grant",
       "name": "Rolosense: An innovative platform for automatic mobile phone readout of active SARS-CoV-2 particles",
       "narrative": "Public Health Statement/Narrative\nThe aim of this proposal is to help reduce the spread of SARS-CoV-2 virus by\ndeveloping a surveillance technology that allows for realtime and fully automated viral\nsensing. The approach uses a smart phone camera to detect the displacement of\nmotors that are highly sensitive to the SARS-CoV-2 virus.",
       "researchInitiative": "RADx-rad",
       "subProject": "Automatic Detection & Tracing",
       "tooltip": "Grant\nabstract:The ultimate goal of this proposal is to develop a novel platform technology for automatic surveillance\nand tracing of airborne SARS-CoV-2 virus particles in real time. The centerpiece of this proposal is the\n“Rolosense” technology which leverages a DNA micromotor as the virus sensing and transduction\nmaterial (VSTM) that can be detected by a conventional smart phone camera. This provides both\ngeographical tracing and surveillance. Rolosense motor are comprised a DNA-coated spherical particle\n(5 micrometer diameter) that hybridizes to a surface modified with complementary RNA. The particle\nmoves at speeds of over 1 micron/minute upon the addition of RNase H, which selectively hydrolyses\nhybridized RNA but not single-stranded RNA. DNA motors coated with virus binding ligand (VBL) stall\nin presence of SARS-CoV-2 virus particles. Because motors move autonomously for distances up to\nmillimeters without intervention, the assay is fully automated, and conventional steps such as viral\ninactivation, RNA isolation and amplification are not required. The readout is performed using an\nautomated smart phone app for particle tracking without the need for a spectrophotometer or\nfluorometer. Preliminary data shows realtime SARS-CoV-2 pseudovirus particle sensing. Milestones\ninclude the screening and identification of high affinity and high specificity VBLs. Both aptamers and\nantibody VBLs will be screening and validated. Simulations and experiments will be used to understand\nthe role of temperature and environmental conditions in modulating Rolosense performance.\nMultivalent display of VBLs with DNA origami will enhance avidity. Finally, microfluidic chips with\nairborne droplet capture will be implemented and tested. The work will be performed by a highly\ninterdisciplinary team with complementary expertise and a track-record of co-publications. PI Salaita\ninvented the Rolosense technology and has past experience in developing cell phone diagnostics and\nsynthetic motors. Co-I Melikian is an expert virologist, Co-I Heemstra is an expert at developing\naptamers for novel targets, Co-I Ke has extensive experience in DNA origami structures for avid target\nbinding and has co-authored work on Rolosense, Co-I Rajaraman and Primordia are experts at\nmicrofluidic device development and commercialization. Our solution offers the potential to provide an\nimmediate solution to today’s urgent virus sensing and tracing needs.\nid:U01AA029345\nnarrative:Public Health Statement/Narrative\nThe aim of this proposal is to help reduce the spread of SARS-CoV-2 virus by\ndeveloping a surveillance technology that allows for realtime and fully automated viral\nsensing. The approach uses a smart phone camera to detect the displacement of\nmotors that are highly sensitive to the SARS-CoV-2 virus.\nname:Rolosense: An innovative platform for automatic mobile phone readout of active SARS-CoV-2 particles\nsubProject:Automatic Detection & Tracing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e46fb05b8d664c53ab1863ae37d191a9": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "CHAPEL HILL",
       "country": "UNITED STATES",
       "duns": "duns:608195277",
       "geonames": "geonames:4460162",
       "id": 581,
       "label": "Organization",
       "name": "University of North Carolina at Chapel Hill",
       "ror": "ror:0130frc33",
       "state": "NC",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4460162\nror:ror:0130frc33\ncity:CHAPEL HILL\nname:University of North Carolina at Chapel Hill\nuei:uei:D3LHU66KBLD5\nduns:duns:608195277\nstate:NC\nid:ror:0130frc33\nurl:https://ror.org/0130frc33",
       "uei": "uei:D3LHU66KBLD5",
       "url": "https://ror.org/0130frc33"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e5178d1b75d04049977ccbe0d80ab7ab": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1901,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e553469e2cc64fa98f21cc0348bae46a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "CytoscapeModel",
     "state": {
      "_dom_classes": [],
      "_interaction_handlers": {},
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "CytoscapeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "CytoscapeView",
      "auto_ungrabify": false,
      "auto_unselectify": true,
      "autolock": false,
      "box_selection_enabled": false,
      "cytoscape_layout": {
       "name": "cola",
       "nodeDimensionsIncludeLabels": true,
       "nodeSpacing": 40,
       "padding": 0,
       "unconstrIter": 5000
      },
      "cytoscape_style": [
       {
        "selector": "node",
        "style": {
         "background-color": "#A5ABB6",
         "border-color": "#9AA1AC",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "edge",
        "style": {
         "curve-style": "bezier",
         "font-size": "8px",
         "label": "data(name)",
         "line-color": "#A5ABB6",
         "target-arrow-color": "#A5ABB6",
         "target-arrow-shape": "triangle",
         "text-rotation": "autorotate",
         "width": "1px"
        }
       },
       {
        "selector": "node[label=\"*\"]",
        "style": {
         "background-color": "#C990C0",
         "border-color": "#b261a5",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"City\"]",
        "style": {
         "background-color": "#F79767",
         "border-color": "#f36924",
         "border-width": "2px",
         "font-size": "10px",
         "height": "65px",
         "label": "data(name)",
         "text-max-width": "65px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "65px"
        }
       },
       {
        "selector": "node[label=\"Disease\"]",
        "style": {
         "background-color": "#569480",
         "border-color": "#447666",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Symptom\"]",
        "style": {
         "background-color": "#8DCC93",
         "border-color": "#5db665",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"Patient\"]",
        "style": {
         "background-color": "#4C8EDA",
         "border-color": "#2870c2",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(firstName)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"State\"]",
        "style": {
         "background-color": "#FFC454",
         "border-color": "#d7a013",
         "border-width": "2px",
         "font-size": "10px",
         "height": "50px",
         "label": "data(name)",
         "text-max-width": "50px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "50px"
        }
       },
       {
        "selector": "node[label=\"MetaNode\"]",
        "style": {
         "background-color": "#D9C8AE",
         "border-color": "#c0a378",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(nodeName)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Grant\"]",
        "style": {
         "background-color": "#4C8EDA",
         "border-color": "#2870c2",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Researcher\"]",
        "style": {
         "background-color": "#FFC454",
         "border-color": "#d7a013",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"FundingOpportunity\"]",
        "style": {
         "background-color": "#DA7194",
         "border-color": "#cc3c6c",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Organization\"]",
        "style": {
         "background-color": "#569480",
         "border-color": "#447666",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Dataset\"]",
        "style": {
         "background-color": "#F79767",
         "border-color": "#f36924",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"CoordinationCenter\"]",
        "style": {
         "background-color": "#57C7E3",
         "border-color": "#23b3d7",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Event\"]",
        "style": {
         "background-color": "#8DCC93",
         "border-color": "#5db665",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Publication\"]",
        "style": {
         "background-color": "#AA7942",
         "border-color": "#8D6429",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Patent\"]",
        "style": {
         "background-color": "#C990C0",
         "border-color": "#b261a5",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Presentation\"]",
        "style": {
         "background-color": "#F16667",
         "border-color": "#eb2728",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"Software\"]",
        "style": {
         "background-color": "#ECB5C9",
         "border-color": "#da7298",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "node[label=\"ResearchInitiative\"]",
        "style": {
         "background-color": "#57C7E3",
         "border-color": "#23b3d7",
         "border-width": "2px",
         "font-size": "10px",
         "height": "80px",
         "label": "data(name)",
         "text-max-width": "80px",
         "text-valign": "center",
         "text-wrap": "wrap",
         "width": "80px"
        }
       },
       {
        "selector": "edge[name=\"MetaRelationship\"]",
        "style": {
         "curve-style": "bezier",
         "font-size": "8px",
         "label": "data(relationshipName)",
         "line-color": "#A5ABB6",
         "target-arrow-color": "#A5ABB6",
         "target-arrow-shape": "triangle",
         "text-rotation": "autorotate",
         "width": "1px"
        }
       }
      ],
      "desktop_tap_threshold": 4,
      "graph": "IPY_MODEL_b33a688eda9c41cf8df710985e83e18d",
      "headless": false,
      "hide_edges_on_viewport": false,
      "layout": "IPY_MODEL_baf558e380b8456e89873d6427cb3c6d",
      "max_zoom": 1e+50,
      "min_zoom": 1e-50,
      "motion_blur": false,
      "motion_blur_opacity": 0.2,
      "panning_enabled": true,
      "pixel_ratio": "auto",
      "rendered_position": {
       "renderedPosition": {
        "x": 100,
        "y": 100
       }
      },
      "selection_type": "single",
      "style_enabled": true,
      "texture_on_viewport": false,
      "tooltip_source": "tooltip",
      "touch_tap_threshold": 8,
      "user_panning_enabled": true,
      "user_zooming_enabled": true,
      "wheel_sensitivity": 1,
      "zoom": 2,
      "zooming_enabled": true
     }
    },
    "e5c63fa2da76408f814d6f646dcf44fc": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 665,
       "target": 598
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e7449fc4515140c68056a95efd44b3d7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The Rutgers Optimizes Innovation (ROI) Program will provide a vertically integrated mechanism to swiftly\nuncover promising biomedical product discoveries, and seamlessly guide the innovator through the\ncommercialization process with financial and regulatory, IP protection, mentoring, management, and educational\nresources. Drawing on the biomedical/bioengineering sciences across Rutgers and on the solid expertise of the\nOffice of Research Commercialization (ORC), we will integrate our strengths to uncover, develop and\ncommercialize discoveries that improve health and well-being, and train the next generation of innovators. The\nROI Program comprises a cooperative of Rutgers University and affiliates that includes the schools of\nengineering, arts and sciences, schools of medicine, nursing, dental science, public health, and research\ninstitutes and centers, industries, incubators, funders and policymakers.\n All entities provide significant resources to the ROI Program and have contributed to the planning, development,\nand leadership composition of the cooperative. Based in one of the most productive states with respect to\ncommercialization of health-related discoveries (assets), the ROI Program will serve as a platform for translating\nbiomedical discoveries into marketable products. Our REACH Hub will identify innovative health-related\ntechnologies by using the expertise of the NCI-funded Cancer Institute of NJ (CINJ), the Rutgers Institute for\nTranslational Medicine and Science (RITMS, lead of the NCATS-funded CTSA) and the Biomaterials Center,\nfunded by NSF and DOD. These technologies will be evaluated for commercialization feasibility, especially with\nrespect to providing precision therapy to tackle an unmet need created by the heterogeneity of disease\npathogenesis and response to treatment. Addressing such unmet needs will provide assets tailored to patients’\ntherapeutic responses that ultimately improves population health.\n The ROI Program will provide a streamlined and harmonized infrastructure that will enhance commercialization\nof academic discovery. The educational programs embedded in the ROI Program will provide our innovators\nwith hands-on, practical training in product development and start-up requirements, while also training a diverse\nworkforce in biomedical innovation by leveraging, coalescing and repurposing current resources, including I-\nCorps and iJOBS. Implementing a unique project management and mentoring program comprised of industry,\ndisease-state and content experts will also enhance innovators’ opportunity for success. Embracing a Fail Fast\nPhilosophy assures the technology will be developed in a cost-effective and market-conscious manner. Across\nall Aims, the ROI Program will collaborate with the REACH Consortium to build on their advances in platforms for\ncommercialization, technology review, and training, and provide the Consortium with our expertise and commitment to\nserve as an active participating member. Importantly, evaluation milestones and metrics are planned in all aspects\nof the ROI Program to assure continuous quality assessment, improvement and sustainability.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 3,
       "label": "Grant",
       "name": "Rutgers Optimizes Innovation (ROI) Program",
       "narrative": "The Rutgers Optimizes Innovation (ROI) Program will accelerate the transformation of the most promising\nresearch discoveries into marketed products designed to provide the right therapy to the right patient at\nthe right time. By identifying and advancing the most promising and transformative therapeutic and diagnostic\ntechnologies in precision medicine, ROI will impact the health and well-being of a diverse society.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:The Rutgers Optimizes Innovation (ROI) Program will provide a vertically integrated mechanism to swiftly\nuncover promising biomedical product discoveries, and seamlessly guide the innovator through the\ncommercialization process with financial and regulatory, IP protection, mentoring, management, and educational\nresources. Drawing on the biomedical/bioengineering sciences across Rutgers and on the solid expertise of the\nOffice of Research Commercialization (ORC), we will integrate our strengths to uncover, develop and\ncommercialize discoveries that improve health and well-being, and train the next generation of innovators. The\nROI Program comprises a cooperative of Rutgers University and affiliates that includes the schools of\nengineering, arts and sciences, schools of medicine, nursing, dental science, public health, and research\ninstitutes and centers, industries, incubators, funders and policymakers.\n All entities provide significant resources to the ROI Program and have contributed to the planning, development,\nand leadership composition of the cooperative. Based in one of the most productive states with respect to\ncommercialization of health-related discoveries (assets), the ROI Program will serve as a platform for translating\nbiomedical discoveries into marketable products. Our REACH Hub will identify innovative health-related\ntechnologies by using the expertise of the NCI-funded Cancer Institute of NJ (CINJ), the Rutgers Institute for\nTranslational Medicine and Science (RITMS, lead of the NCATS-funded CTSA) and the Biomaterials Center,\nfunded by NSF and DOD. These technologies will be evaluated for commercialization feasibility, especially with\nrespect to providing precision therapy to tackle an unmet need created by the heterogeneity of disease\npathogenesis and response to treatment. Addressing such unmet needs will provide assets tailored to patients’\ntherapeutic responses that ultimately improves population health.\n The ROI Program will provide a streamlined and harmonized infrastructure that will enhance commercialization\nof academic discovery. The educational programs embedded in the ROI Program will provide our innovators\nwith hands-on, practical training in product development and start-up requirements, while also training a diverse\nworkforce in biomedical innovation by leveraging, coalescing and repurposing current resources, including I-\nCorps and iJOBS. Implementing a unique project management and mentoring program comprised of industry,\ndisease-state and content experts will also enhance innovators’ opportunity for success. Embracing a Fail Fast\nPhilosophy assures the technology will be developed in a cost-effective and market-conscious manner. Across\nall Aims, the ROI Program will collaborate with the REACH Consortium to build on their advances in platforms for\ncommercialization, technology review, and training, and provide the Consortium with our expertise and commitment to\nserve as an active participating member. Importantly, evaluation milestones and metrics are planned in all aspects\nof the ROI Program to assure continuous quality assessment, improvement and sustainability.\nid:U01HL150852\nnarrative:The Rutgers Optimizes Innovation (ROI) Program will accelerate the transformation of the most promising\nresearch discoveries into marketed products designed to provide the right therapy to the right patient at\nthe right time. By identifying and advancing the most promising and transformative therapeutic and diagnostic\ntechnologies in precision medicine, ROI will impact the health and well-being of a diverse society.\nname:Rutgers Optimizes Innovation (ROI) Program\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e777c8d0d56048e7a31fbd2d5799d12c": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The World Health Organization has recognized a global pandemic of novel coronavirus pneumonia (COVID-19)\nfrom exposure to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronaviruses (CoVs)\nare membrane-enveloped positive-sense, single-stranded RNA viruses decorated with membrane proteins. The\nspike (S) glycoprotein is implicated in the viral attachment and fusion to host cells via the human angiotensin-\nconverting enzyme 2 (hACE2). There are different assays to test for COVID-19, including nucleic acid, antigen,\nand serological tests that can be used in hospitals, point-of-care, and large-scale population testing. Nucleic acid\ntesting is the standard method for the detection of SARS-CoV-2, which consists of the amplification of viral RNA\nfrom nasopharyngeal swabs (NPS) by quantitative reverse-transcription polymerase chain reaction (qRT-PCR).\nFurthermore, given the invasive nature of NPS, saliva is being considered an alternative for detection. Methods\nthat bypass RNA extraction, as well as isothermal amplification such as loop-mediated isothermal amplification\n(LAMP), have been developed to improve the speed of viral RNA detection. However, viral protein expression\ncannot be detected by qRT-PCR. Serological tests, on the other hand, are based on host antibodies against the\nvirus (IgG/IgM). Although fast, these tests suffer from significant false negative/positive. Besides, they do not\ndetect a current infection. Therefore, to relieve the current healthcare crisis, new technologies capable of\nsimultaneous viral RNA/protein detection at the single virus level and host antibody response detection from a\nbody fluid in an integrated device would be highly valuable for enhanced COVID-19 diagnosis.\nRecently, our group, as part of Phase 2 of the Extracellular RNA Communication Consortium (ERCC2), has\nsuccessfully developed a microfluidics technology capable of capturing individual exosomes from biofluids and\nthen simultaneously quantify both exosomal surface proteins and RNA cargo. Given the resemblance in size\nand other characteristics between exosomes and coronaviruses, our technology can be adapted for COVID-19\ndiagnosis. Therefore, we propose to develop and validate a safe-to-use version of our microfluidics system for\ndirect detection of SARS-CoV-2. The integrated system is capable of multi-parametric detection for enhanced\nCOVID-19 diagnosis. The platform will be engineered to simultaneously quantify both viral protein, viral RNA,\nand host antibodies (IgG/IgM) in the same sample, enabling diagnosis, disease status, and prognostic\nassessment. Model systems, including host IgG/IgM from patient serum, standard synthetic vesicles (SVs), and\nheat-inactivated SARS-CoV-2 viral particles (SVVs), will be designed and spiked in biofluids to validate and\ncalibrate the system. To demonstrate the clinical utility, our biochip technology will be deployed and tested using\ndifferent biofluids from COVID-19 patients at two independent laboratories (Institute of Systems Biology in\nSeattle and The Ohio State University (OSU) Wexner Medical Center in Columbus). Measurements obtained\nfrom the biochips will be compared to standard qRT-PCR and ELISA methods. A transition plan will be prepared\nfor FDA Emergency Use Authorization (EUA) application of the biochip technology through a COVID-19 clinical\ntesting laboratory at OSU Wexner Medical Center. A commercialization plan will also be developed via licensing\nto a biotech company.\nWe have assembled a multi-disciplinary team with extensive knowledge and experience in nanobiotechnology,\nmicrofluidics, micro/nano-fabrication, infectious diseases, and clinical COVID-19 patient sample collection and\ntesting. The proposed aims and milestones are given as follows:\nSpecific Aim 1: Development of an integrated biochip to simultaneously capture, fix, and characterize\nsingle SARS-CoV-2 and IgG/IgM proteins. Milestones. (i) Sorting, capture, and quantitative analysis of\nselected proteins and viral RNA in single virus in spike experiments with >95% repeatability; (ii) A sensitivity of\nsingle virus detection with >90% repeatability and 5-fold better sensitivity than the current qRT-PCR and ELISA\nmethods. Specific Aim 2: Testing of single SARS-CoV-2 virus and associated IgG/IgM in biofluids from\nCOVID-19 patients. Milestones. (i) Quantitative analysis of clinical samples with >95% repeatability; (ii) 95%\nof concordance for the detection of SARS-CoV-2 between the biochip technology and the lab-based qRT-PCR\nand ELISA. Specific Aim 3: Biochip technology transition plan. Milestones. (i) Submission of documentation\nto the FDA Center for Devices and Radiological Health (CDRH) for EUA; (ii) Scale-up commercialization plan for\nGMP chip production.",
       "awardCode": "U18",
       "fundingMechanism": "Other Research-Related",
       "id": 35,
       "label": "Grant",
       "name": "Multi-parametric Integrated Molecular Detection of SARS-CoV-2 from Biofluids by Adapting Single Extracellular Vesicle Characterization Technologies",
       "narrative": "In this project, we propose to repurpose our single exosome-based characterization technology towards the\ndetection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection from biofluids. Our\napproach will enable the simultaneous detection of viral signals and host antibodies, including viral RNA, S-\nprotein, and associated IgG/IgM from the same sample on a single device, thus enabling enhanced diagnosis,\ndisease status, and prognostic assessment of COVID-19.",
       "researchInitiative": "RADx-rad",
       "subProject": "Exosome",
       "tooltip": "Grant\nabstract:The World Health Organization has recognized a global pandemic of novel coronavirus pneumonia (COVID-19)\nfrom exposure to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronaviruses (CoVs)\nare membrane-enveloped positive-sense, single-stranded RNA viruses decorated with membrane proteins. The\nspike (S) glycoprotein is implicated in the viral attachment and fusion to host cells via the human angiotensin-\nconverting enzyme 2 (hACE2). There are different assays to test for COVID-19, including nucleic acid, antigen,\nand serological tests that can be used in hospitals, point-of-care, and large-scale population testing. Nucleic acid\ntesting is the standard method for the detection of SARS-CoV-2, which consists of the amplification of viral RNA\nfrom nasopharyngeal swabs (NPS) by quantitative reverse-transcription polymerase chain reaction (qRT-PCR).\nFurthermore, given the invasive nature of NPS, saliva is being considered an alternative for detection. Methods\nthat bypass RNA extraction, as well as isothermal amplification such as loop-mediated isothermal amplification\n(LAMP), have been developed to improve the speed of viral RNA detection. However, viral protein expression\ncannot be detected by qRT-PCR. Serological tests, on the other hand, are based on host antibodies against the\nvirus (IgG/IgM). Although fast, these tests suffer from significant false negative/positive. Besides, they do not\ndetect a current infection. Therefore, to relieve the current healthcare crisis, new technologies capable of\nsimultaneous viral RNA/protein detection at the single virus level and host antibody response detection from a\nbody fluid in an integrated device would be highly valuable for enhanced COVID-19 diagnosis.\nRecently, our group, as part of Phase 2 of the Extracellular RNA Communication Consortium (ERCC2), has\nsuccessfully developed a microfluidics technology capable of capturing individual exosomes from biofluids and\nthen simultaneously quantify both exosomal surface proteins and RNA cargo. Given the resemblance in size\nand other characteristics between exosomes and coronaviruses, our technology can be adapted for COVID-19\ndiagnosis. Therefore, we propose to develop and validate a safe-to-use version of our microfluidics system for\ndirect detection of SARS-CoV-2. The integrated system is capable of multi-parametric detection for enhanced\nCOVID-19 diagnosis. The platform will be engineered to simultaneously quantify both viral protein, viral RNA,\nand host antibodies (IgG/IgM) in the same sample, enabling diagnosis, disease status, and prognostic\nassessment. Model systems, including host IgG/IgM from patient serum, standard synthetic vesicles (SVs), and\nheat-inactivated SARS-CoV-2 viral particles (SVVs), will be designed and spiked in biofluids to validate and\ncalibrate the system. To demonstrate the clinical utility, our biochip technology will be deployed and tested using\ndifferent biofluids from COVID-19 patients at two independent laboratories (Institute of Systems Biology in\nSeattle and The Ohio State University (OSU) Wexner Medical Center in Columbus). Measurements obtained\nfrom the biochips will be compared to standard qRT-PCR and ELISA methods. A transition plan will be prepared\nfor FDA Emergency Use Authorization (EUA) application of the biochip technology through a COVID-19 clinical\ntesting laboratory at OSU Wexner Medical Center. A commercialization plan will also be developed via licensing\nto a biotech company.\nWe have assembled a multi-disciplinary team with extensive knowledge and experience in nanobiotechnology,\nmicrofluidics, micro/nano-fabrication, infectious diseases, and clinical COVID-19 patient sample collection and\ntesting. The proposed aims and milestones are given as follows:\nSpecific Aim 1: Development of an integrated biochip to simultaneously capture, fix, and characterize\nsingle SARS-CoV-2 and IgG/IgM proteins. Milestones. (i) Sorting, capture, and quantitative analysis of\nselected proteins and viral RNA in single virus in spike experiments with >95% repeatability; (ii) A sensitivity of\nsingle virus detection with >90% repeatability and 5-fold better sensitivity than the current qRT-PCR and ELISA\nmethods. Specific Aim 2: Testing of single SARS-CoV-2 virus and associated IgG/IgM in biofluids from\nCOVID-19 patients. Milestones. (i) Quantitative analysis of clinical samples with >95% repeatability; (ii) 95%\nof concordance for the detection of SARS-CoV-2 between the biochip technology and the lab-based qRT-PCR\nand ELISA. Specific Aim 3: Biochip technology transition plan. Milestones. (i) Submission of documentation\nto the FDA Center for Devices and Radiological Health (CDRH) for EUA; (ii) Scale-up commercialization plan for\nGMP chip production.\nid:U18TR003807\nnarrative:In this project, we propose to repurpose our single exosome-based characterization technology towards the\ndetection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection from biofluids. Our\napproach will enable the simultaneous detection of viral signals and host antibodies, including viral RNA, S-\nprotein, and associated IgG/IgM from the same sample on a single device, thus enabling enhanced diagnosis,\ndisease status, and prognostic assessment of COVID-19.\nname:Multi-parametric Integrated Molecular Detection of SARS-CoV-2 from Biofluids by Adapting Single Extracellular Vesicle Characterization Technologies\nsubProject:Exosome\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U18"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e7fb906f13624acb835d1164f1cea470": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "ATLANTA",
       "country": "UNITED STATES",
       "duns": "duns:066469933",
       "geonames": "geonames:4180439",
       "id": 585,
       "label": "Organization",
       "name": "Emory University",
       "ror": "ror:03czfpz43",
       "state": "GA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4180439\nror:ror:03czfpz43\ncity:ATLANTA\nname:Emory University\nuei:uei:S352L5PJLMP8\nduns:duns:066469933\nstate:GA\nid:ror:03czfpz43\nurl:https://ror.org/03czfpz43",
       "uei": "uei:S352L5PJLMP8",
       "url": "https://ror.org/03czfpz43"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e8a40c87bdea422ba83f5696268e112a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "CLEMSON",
       "country": "UNITED STATES",
       "duns": "duns:042629816",
       "geonames": "geonames:4574989",
       "id": 587,
       "label": "Organization",
       "name": "Clemson University",
       "ror": "ror:037s24f05",
       "state": "SC",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4574989\nror:ror:037s24f05\ncity:CLEMSON\nname:Clemson University\nuei:uei:H2BMNX7DSKU8\nduns:duns:042629816\nstate:SC\nid:ror:037s24f05\nurl:https://ror.org/037s24f05",
       "uei": "uei:H2BMNX7DSKU8",
       "url": "https://ror.org/037s24f05"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e97b072c329d432e988fa52870119524": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "R",
       "fullName": "R Chakrabarty",
       "id": 1022,
       "label": "Researcher",
       "lastName": "Chakrabarty",
       "name": "Chakrabarty R",
       "tooltip": "Researcher\nid:s2authorid:1852772\nlastName:Chakrabarty\nname:Chakrabarty R\nfullName:R Chakrabarty\nfirstName:R"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "e9b6f768fe5147e28dfa700b4dea0e82": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "CITES",
       "source": 4110,
       "target": 2767
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ead7475f011d4f35b12cb77d80e2d0a7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "description": "Description of the research initiative (string)",
       "id": 2762,
       "label": "MetaNode",
       "longName": "Long name for research initiative (string)",
       "name": "Abbreviation of the research initiative (string)",
       "nodeName": "ResearchInitiative",
       "researchInitiativeUrl": "Description of the research initiative that funded the research initiative (string)",
       "tooltip": "MetaNode\nresearchInitiativeUrl:Description of the research initiative that funded the research initiative (string)\nid:Unique id of the research initiative (string)\ndescription:Description of the research initiative (string)\nname:Abbreviation of the research initiative (string)\nnodeName:ResearchInitiative\nlongName:Long name for research initiative (string)\nwebsites:URLs of related websites (string[])\nurl:URL of the research initiative website (string)",
       "url": "URL of the research initiative website (string)",
       "websites": "URLs of related websites (string[])"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "eade7fbd3b9a411a9a89da1d1f62ad4b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 617,
       "target": 7
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "eb51efe97dfa404b9e32ade6e01159e3": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "David",
       "fullName": "David A Lawrence",
       "id": 700,
       "label": "Researcher",
       "lastName": "Lawrence",
       "middleName": "A",
       "name": "Lawrence DA",
       "orcid": "orcid:0000-0002-8940-9640",
       "profileId": "profileid:1861871",
       "tooltip": "Researcher\nmiddleName:A\nid:profileid:1861871\nlastName:Lawrence\norcid:orcid:0000-0002-8940-9640\nprofileId:profileid:1861871\nname:Lawrence DA\nfullName:David A Lawrence\nfirstName:David"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "eb540ecb7c6b4dc88b97c763ae3218f7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "UNIVERSITY PARK",
       "country": "UNITED STATES",
       "duns": "duns:003403953",
       "geonames": "geonames:5213681",
       "id": 575,
       "label": "Organization",
       "name": "Pennsylvania State University",
       "ror": "ror:04p491231",
       "state": "PA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:5213681\nror:ror:04p491231\ncity:UNIVERSITY PARK\nname:Pennsylvania State University\nuei:uei:NPM2J7MSCF61\nduns:duns:003403953\nstate:PA\nid:ror:04p491231\nurl:https://ror.org/04p491231",
       "uei": "uei:NPM2J7MSCF61",
       "url": "https://ror.org/04p491231"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "eb659eed22c04ed794d312f7261a6dd8": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Airborne transmission via virus-laden aerosols is a dominant route for the transmission of respiratory diseases, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Direct, non-invasive screening of respiratory virus aerosols in patients has been a long-standing technical challenge. Here, we introduce a point-of-care testing platform that directly detects SARS-CoV-2 aerosols in as little as two exhaled breaths of patients and provides results in under 60 s. It integrates a hand-held breath aerosol collector and a llama-derived, SARS-CoV-2 spike-protein specific nanobody bound to an ultrasensitive micro-immunoelectrode biosensor, which detects the oxidation of tyrosine amino acids present in SARS-CoV-2 viral particles. Laboratory and clinical trial results were within 20% of those obtained using standard testing methods. Importantly, the electrochemical biosensor directly detects the virus itself, as opposed to a surrogate or signature of the virus, and is sensitive to as little as 10 viral particles in a sample. Our platform holds the potential to be adapted for multiplexed detection of different respiratory viruses. It provides a rapid and non-invasive alternative to conventional viral diagnostics.",
       "doi": "doi:10.1021/acssensors.3c00512",
       "id": 2767,
       "journal": "ACS sensors",
       "label": "Publication",
       "name": "Rapid Direct Detection of SARS-CoV-2 Aerosols in Exhaled Breath at the Point of Care.",
       "pmId": "37498298",
       "pmcId": "PMC10463275",
       "tooltip": "Publication\njournal:ACS sensors\nabstract:Airborne transmission via virus-laden aerosols is a dominant route for the transmission of respiratory diseases, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Direct, non-invasive screening of respiratory virus aerosols in patients has been a long-standing technical challenge. Here, we introduce a point-of-care testing platform that directly detects SARS-CoV-2 aerosols in as little as two exhaled breaths of patients and provides results in under 60 s. It integrates a hand-held breath aerosol collector and a llama-derived, SARS-CoV-2 spike-protein specific nanobody bound to an ultrasensitive micro-immunoelectrode biosensor, which detects the oxidation of tyrosine amino acids present in SARS-CoV-2 viral particles. Laboratory and clinical trial results were within 20% of those obtained using standard testing methods. Importantly, the electrochemical biosensor directly detects the virus itself, as opposed to a surrogate or signature of the virus, and is sensitive to as little as 10 viral particles in a sample. Our platform holds the potential to be adapted for multiplexed detection of different respiratory viruses. It provides a rapid and non-invasive alternative to conventional viral diagnostics.\nid:doi:10.1021/acssensors.3c00512\nname:Rapid Direct Detection of SARS-CoV-2 Aerosols in Exhaled Breath at the Point of Care.\npmId:37498298\nyear:2023\ntype:primary\npmcId:PMC10463275\nurl:https://doi.org/doi:10.1021/acssensors.3c00512\ndoi:doi:10.1021/acssensors.3c00512",
       "type": "primary",
       "url": "https://doi.org/doi:10.1021/acssensors.3c00512",
       "year": 2023
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "eb84494c22fd4edf88e09a58f72ae772": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2017,
       "name": "EMPLOYED_AT",
       "source": 630,
       "target": 556
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ec77499e249d4e679cb3d8a9bf2bf3af": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4387,
       "target": 41
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "eca41e573ede44788ee257c22d36ba48": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 677,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ed5de39f86f4482487c9142812a27fe1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 712,
       "target": 599
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ed6495b4b290422cbfbb4a63976dfb55": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "USED",
       "source": 1290,
       "target": 2741
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "eda9ff5cf17741df89ef7bc63bfc076e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 666,
       "target": 568
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "eec1254869ca4f4a9d106d560cc938aa": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Brian",
       "fullName": "Brian W McCrindle",
       "id": 712,
       "label": "Researcher",
       "lastName": "McCrindle",
       "middleName": "W",
       "name": "McCrindle BW",
       "orcid": "orcid:0000-0001-6485-6551",
       "profileId": "profileid:6763646",
       "tooltip": "Researcher\nmiddleName:W\nid:profileid:6763646\nlastName:McCrindle\norcid:orcid:0000-0001-6485-6551\nprofileId:profileid:6763646\nname:McCrindle BW\nfullName:Brian W McCrindle\nfirstName:Brian"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "eed56dd822d6499e891834ea1eb35d44": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "TORONTO",
       "country": "CANADA",
       "duns": "duns:208511808",
       "geonames": "geonames:6167865",
       "id": 599,
       "label": "Organization",
       "name": "Hospital for Sick Children",
       "ror": "ror:057q4rt57",
       "state": "ON",
       "tooltip": "Organization\ncountry:CANADA\ngeonames:geonames:6167865\nror:ror:057q4rt57\ncity:TORONTO\nname:Hospital for Sick Children\nuei:uei:JGUJNPJSMYT5\nduns:duns:208511808\nstate:ON\nid:ror:057q4rt57\nurl:https://ror.org/057q4rt57",
       "uei": "uei:JGUJNPJSMYT5",
       "url": "https://ror.org/057q4rt57"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ef923a7c7bce4bb28c0e3fee270f9cdf": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 664,
       "target": 563
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "efc631d1ff66437bbb39bcd7c6eb4f75": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4385,
       "target": 40
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "efda262f928d45c3a1812c141244a2b2": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Children have been disproportionately less impacted by the Corona Virus Disease 2019 (COVID-19) caused\nby the Severe Acute Respiratory Syndrome Corona Virus 2 (SAR-CoV-2) compared to adults. However,\nsevere illnesses including Multisystem Inflammatory Syndrome (MIS-C) and respiratory failure have occurred\nin a small proportion of children with SARS-CoV-2 infection. Nearly 80% of children with MIS-C are critically ill\nwith a 2-4% mortality rate. Currently there are no modalities to characterize the spectrum of disease severity\nand predict which child with SARS-CoV-2 exposure will likely develop severe illness including MIS-C. Thus\nthere is an urgent need to develop a diagnostic modality to distinguish the varying phenotypes of disease and\nrisk stratify disease. The epigenetic changes in microRNA (miRNA) profiles that occur due to an infection can\nimpact disease severity by altering immune response and cytokine regulation which may be detected in body\nfluids including saliva. Our long-term goal is to improve outcomes of children with SARS-CoV-2 by early\nidentification and treatment of those at risk for severe illness. Our central hypothesis is that a model that\nintegrates salivary biomarkers with social and clinical determinants of health will predict disease severity in\nchildren with SARS-CoV-2 infection. The central hypothesis will be pursued through phased four specific aims.\nThe first two aims will be pursued during the R61 phase and include: 1) Define and compare the salivary\nmolecular host response in children with varying phenotypes (severe and non severe) SARS-CoV-2 infections\nand 2) Develop and validate a sensitive and specific model to predict severe SARS-CoV-2 illness in children.\nDuring the R33 phase we will pursue the following two aims: 3) Develop a portable, rapid device that quantifies\nsalivary miRNAs with comparable accuracy to predicate technology (qRT-PCR), and 4) Develop an artificial\nintelligence (AI) assisted cloud and mobile system for early recognition of severe SARS-CoV-2 infection in\nchildren. We will pursue the above aims using an innovative combination of salivaomics and bioinformatics,\nanalytic techniques of AI and clinical informatics. The proposed research is significant because development of\na sensitive model to risk stratify disease is expected to improve outcomes of children with severe SARS-CoV-2\ninfection via early recognition and timely intervention. The proximate expected outcome of this proposal is\nbetter understanding of the epigenetic regulation of host immune response to the viral infection which we\nexpect to lead to personalized therapy in the future. The results will have a positive impact immediately as it\nwill lead to the creation of patient profiles based on individual risk factors which can enable early identification\nof severe disease and appropriate resource allocation during the pandemic.",
       "awardCode": "R61",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 41,
       "label": "Grant",
       "name": "Severity Predictors Integrating salivary Transcriptomics and proteomics with Multi neural network Intelligence in SARS-CoV2 infection in Children (SPITS MISC)",
       "narrative": "This project is relevant to public health as development of a predictive model that integrates salivary\nbiomarkers with clinical and social determinants into a bedside tool will enable early identification of\nsevere COVID-19 in children, ensure appropriate resource allocation and aid in targeted treatment.",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nabstract:Children have been disproportionately less impacted by the Corona Virus Disease 2019 (COVID-19) caused\nby the Severe Acute Respiratory Syndrome Corona Virus 2 (SAR-CoV-2) compared to adults. However,\nsevere illnesses including Multisystem Inflammatory Syndrome (MIS-C) and respiratory failure have occurred\nin a small proportion of children with SARS-CoV-2 infection. Nearly 80% of children with MIS-C are critically ill\nwith a 2-4% mortality rate. Currently there are no modalities to characterize the spectrum of disease severity\nand predict which child with SARS-CoV-2 exposure will likely develop severe illness including MIS-C. Thus\nthere is an urgent need to develop a diagnostic modality to distinguish the varying phenotypes of disease and\nrisk stratify disease. The epigenetic changes in microRNA (miRNA) profiles that occur due to an infection can\nimpact disease severity by altering immune response and cytokine regulation which may be detected in body\nfluids including saliva. Our long-term goal is to improve outcomes of children with SARS-CoV-2 by early\nidentification and treatment of those at risk for severe illness. Our central hypothesis is that a model that\nintegrates salivary biomarkers with social and clinical determinants of health will predict disease severity in\nchildren with SARS-CoV-2 infection. The central hypothesis will be pursued through phased four specific aims.\nThe first two aims will be pursued during the R61 phase and include: 1) Define and compare the salivary\nmolecular host response in children with varying phenotypes (severe and non severe) SARS-CoV-2 infections\nand 2) Develop and validate a sensitive and specific model to predict severe SARS-CoV-2 illness in children.\nDuring the R33 phase we will pursue the following two aims: 3) Develop a portable, rapid device that quantifies\nsalivary miRNAs with comparable accuracy to predicate technology (qRT-PCR), and 4) Develop an artificial\nintelligence (AI) assisted cloud and mobile system for early recognition of severe SARS-CoV-2 infection in\nchildren. We will pursue the above aims using an innovative combination of salivaomics and bioinformatics,\nanalytic techniques of AI and clinical informatics. The proposed research is significant because development of\na sensitive model to risk stratify disease is expected to improve outcomes of children with severe SARS-CoV-2\ninfection via early recognition and timely intervention. The proximate expected outcome of this proposal is\nbetter understanding of the epigenetic regulation of host immune response to the viral infection which we\nexpect to lead to personalized therapy in the future. The results will have a positive impact immediately as it\nwill lead to the creation of patient profiles based on individual risk factors which can enable early identification\nof severe disease and appropriate resource allocation during the pandemic.\nid:R61HD105610\nnarrative:This project is relevant to public health as development of a predictive model that integrates salivary\nbiomarkers with clinical and social determinants into a bedside tool will enable early identification of\nsevere COVID-19 in children, ensure appropriate resource allocation and aid in targeted treatment.\nname:Severity Predictors Integrating salivary Transcriptomics and proteomics with Multi neural network Intelligence in SARS-CoV2 infection in Children (SPITS MISC)\nsubProject:PreVAIL kIds\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R61"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f11e723322244aac939cd25cedf3a752": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": false,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 996,
       "target": 47
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f134cc9509c64b5c9a7472d9d7bb745a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4396,
       "target": 7
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f19ad7bd4f054812814f5a2c8571d32e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 636,
       "target": 580
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f1a33c4d2d4a4301aa2cc5f23e56b54b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2020,
       "name": "EMPLOYED_AT",
       "source": 700,
       "target": 594
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f1b603b469de4449a44c79a6cb7fef89": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "LEXINGTON",
       "country": "UNITED STATES",
       "duns": "duns:939017877",
       "geonames": "geonames:4297983",
       "id": 580,
       "label": "Organization",
       "name": "University of Kentucky",
       "ror": "ror:02k3smh20",
       "state": "KY",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4297983\nror:ror:02k3smh20\ncity:LEXINGTON\nname:University of Kentucky\nuei:uei:H1HYA8Z1NTM5\nduns:duns:939017877\nstate:KY\nid:ror:02k3smh20\nurl:https://ror.org/02k3smh20",
       "uei": "uei:H1HYA8Z1NTM5",
       "url": "https://ror.org/02k3smh20"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f212675824ce475395ae3bc34b0c0a3d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "IS_INVENTOR",
       "source": 689,
       "target": 2408
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f2eaee0c45b84e7592c851816e2c0cfe": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2022,
       "name": "EMPLOYED_AT",
       "source": 624,
       "target": 603
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f2fd1f0a71de4179854f923448dfb0e0": {
     "model_module": "@jupyter-widgets/base",
     "model_module_version": "1.2.0",
     "model_name": "LayoutModel",
     "state": {
      "_model_module": "@jupyter-widgets/base",
      "_model_module_version": "1.2.0",
      "_model_name": "LayoutModel",
      "_view_count": null,
      "_view_module": "@jupyter-widgets/base",
      "_view_module_version": "1.2.0",
      "_view_name": "LayoutView",
      "align_content": null,
      "align_items": null,
      "align_self": null,
      "border": null,
      "bottom": null,
      "display": null,
      "flex": null,
      "flex_flow": null,
      "grid_area": null,
      "grid_auto_columns": null,
      "grid_auto_flow": null,
      "grid_auto_rows": null,
      "grid_column": null,
      "grid_gap": null,
      "grid_row": null,
      "grid_template_areas": null,
      "grid_template_columns": null,
      "grid_template_rows": null,
      "height": null,
      "justify_content": null,
      "justify_items": null,
      "left": null,
      "margin": null,
      "max_height": null,
      "max_width": null,
      "min_height": null,
      "min_width": null,
      "object_fit": null,
      "object_position": null,
      "order": null,
      "overflow": null,
      "overflow_x": null,
      "overflow_y": null,
      "padding": null,
      "right": null,
      "top": null,
      "visibility": null,
      "width": null
     }
    },
    "f3e13c14a1d246ceb784929efbb95cb1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4393,
       "target": 43
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f49e98e4331245e9b86a95b849c432b9": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Vulnerable populations do not just need testing—they need surveillance. The ideal surveillance tool would\noperate in the background with minimal involvement of the population to be tested; it would be simple,\naffordable, reliable, and accurate. Unfortunately, no such surveillance system yet exists. Here, we propose\na “smart mask” that changes colors when the wearer has been exposed to biomarkers (proteases) of\nCOVID-19. These proteases are known to be in saliva, and the smart mask will concentrate the proteases\nfrom aerosolized saliva when the subject breathes and speaks through the smart mask. This is a simple\nyet novel approach to surveillance because most people are already wearing masks—especially in high-\nrisk settings. Our first goal is to optimize the reagents that will monitor the proteases. We will customize\nthe peptide sequences such that the reagents change color only when two key SARS proteases are\npresent. After characterizing the colorimetric reagents, Aim 2 will integrate these reagents into an adhesive\nstrip (i.e., a sticker) that can be affixed to any existing cloth or surgical mask. Aim 3 is validation with human\nsubjects. First, we will use biobanked saliva samples that are confirmed to be either COVID-19-positive or\nCOVID-19-negative. Next, we will evaluate how long people infected with SARS-CoV-2 must breathe\nthrough the smart mask before it changes colors. Finally, we will use the smart mask for surveillance of a\npopulation that is concurrently being tested regularly via PCR. We will calculate the sensitivity and\nspecificity of the smart masks through comparison to PCR. We will measure true positives, true negatives,\nfalse positives, and false negatives and estimate needing 800 subjects, which is very feasible at our\ninstitution. Our team is well-suited to conduct this research because of Dr. Jokerst’s training colorimetric\nsensing; Drs. Penny, Knight, and Laurent have decades of human subjects research experience, and Dr.\nTu offers biostatistical experience to confirm study design. This work could have a significant impact on\nthe pandemic because our proposed design combines the simplicity of the home pregnancy test with the\nspecificity of expensive viral-based assays. It is practical because it uses the masks that are already\ncommon in daily life and reports the presence of SARS viruses via a simple color change. While a vaccine\nwill hopefully be deployed during the course of this work, the proteases evaluated here have been\nimplicated in a variety of SARS viruses. Thus, this work will be useful should future pandemics emerge.",
       "awardCode": "R01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 43,
       "label": "Grant",
       "name": "Validation of Smart Masks for Surveillance of COVID-19",
       "narrative": "We propose to build a mask that changes color when the wearer has COVID-19 or has been\nexposed to COVID-19. Mask-wearing is currently widespread and thus adding this colorimetric\nsensing approach is a simple yet innovative way to perform surveillance especially among\nvulnerable groups. After building and characterizing this mask, we will validate it in group of at-risk\nindividuals.",
       "researchInitiative": "RADx-rad",
       "subProject": "Multimodal Surveillance",
       "tooltip": "Grant\nabstract:Vulnerable populations do not just need testing—they need surveillance. The ideal surveillance tool would\noperate in the background with minimal involvement of the population to be tested; it would be simple,\naffordable, reliable, and accurate. Unfortunately, no such surveillance system yet exists. Here, we propose\na “smart mask” that changes colors when the wearer has been exposed to biomarkers (proteases) of\nCOVID-19. These proteases are known to be in saliva, and the smart mask will concentrate the proteases\nfrom aerosolized saliva when the subject breathes and speaks through the smart mask. This is a simple\nyet novel approach to surveillance because most people are already wearing masks—especially in high-\nrisk settings. Our first goal is to optimize the reagents that will monitor the proteases. We will customize\nthe peptide sequences such that the reagents change color only when two key SARS proteases are\npresent. After characterizing the colorimetric reagents, Aim 2 will integrate these reagents into an adhesive\nstrip (i.e., a sticker) that can be affixed to any existing cloth or surgical mask. Aim 3 is validation with human\nsubjects. First, we will use biobanked saliva samples that are confirmed to be either COVID-19-positive or\nCOVID-19-negative. Next, we will evaluate how long people infected with SARS-CoV-2 must breathe\nthrough the smart mask before it changes colors. Finally, we will use the smart mask for surveillance of a\npopulation that is concurrently being tested regularly via PCR. We will calculate the sensitivity and\nspecificity of the smart masks through comparison to PCR. We will measure true positives, true negatives,\nfalse positives, and false negatives and estimate needing 800 subjects, which is very feasible at our\ninstitution. Our team is well-suited to conduct this research because of Dr. Jokerst’s training colorimetric\nsensing; Drs. Penny, Knight, and Laurent have decades of human subjects research experience, and Dr.\nTu offers biostatistical experience to confirm study design. This work could have a significant impact on\nthe pandemic because our proposed design combines the simplicity of the home pregnancy test with the\nspecificity of expensive viral-based assays. It is practical because it uses the masks that are already\ncommon in daily life and reports the presence of SARS viruses via a simple color change. While a vaccine\nwill hopefully be deployed during the course of this work, the proteases evaluated here have been\nimplicated in a variety of SARS viruses. Thus, this work will be useful should future pandemics emerge.\nid:R01DE031114\nnarrative:We propose to build a mask that changes color when the wearer has COVID-19 or has been\nexposed to COVID-19. Mask-wearing is currently widespread and thus adding this colorimetric\nsensing approach is a simple yet innovative way to perform surveillance especially among\nvulnerable groups. After building and characterizing this mask, we will validate it in group of at-risk\nindividuals.\nname:Validation of Smart Masks for Surveillance of COVID-19\nsubProject:Multimodal Surveillance\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f504608a5ff0456f8b26eae0abc21d2a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Area deprivation index (ADI) is associated with the risk of severe COVID-19 in adults. However, this association has not been established in children. Information on ADI, demographics, clinical features, disease severity, and outcomes was analyzed for 3434 children with COVID-19. A multivariate logistic regression revealed that non-Hispanic Asians, extremes of weight, and higher ADI were associated with severe disease.",
       "doi": "doi:10.1097/INF.0000000000003888",
       "id": 2846,
       "journal": "The Pediatric infectious disease journal",
       "label": "Publication",
       "name": "Association of Area Deprivation Index With Severity of COVID-19 in Pediatric Patients: A Multisite Study of Racially and Ethnically Diverse Children.",
       "pmId": "36854096",
       "tooltip": "Publication\njournal:The Pediatric infectious disease journal\nabstract:Area deprivation index (ADI) is associated with the risk of severe COVID-19 in adults. However, this association has not been established in children. Information on ADI, demographics, clinical features, disease severity, and outcomes was analyzed for 3434 children with COVID-19. A multivariate logistic regression revealed that non-Hispanic Asians, extremes of weight, and higher ADI were associated with severe disease.\nid:doi:10.1097/INF.0000000000003888\nname:Association of Area Deprivation Index With Severity of COVID-19 in Pediatric Patients: A Multisite Study of Racially and Ethnically Diverse Children.\npmId:36854096\nyear:2023\ntype:primary\nurl:https://doi.org/doi:10.1097/INF.0000000000003888\ndoi:doi:10.1097/INF.0000000000003888",
       "type": "primary",
       "url": "https://doi.org/doi:10.1097/INF.0000000000003888",
       "year": 2023
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f5430260dcc44d4caab0fa323a6dcda5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "/Abstract: This proposal has two major goals: 1) Define signature exhaled breath volatile\norganic compounds (VOCs) to diagnose SARS-CoV-2 infections, and 2) Develop a portable chemical sensing\ndevice that can capture and detect exhaled VOCs and includes machine learning algorithms for automated\ndata processing and results interpretation. This project will bring a portable sensor forward into clinical use with\nthe aim of supplementing COVID-19 diagnostics with a reagentless alternative. Breath testing of exhaled VOC\nbiomarkers is a relatively new concept that has the potential to transform healthcare in the US and globally.\nOur overarching hypothesis is that a miniature breath analysis device can measure signatures of exhaled\nbreath VOCs in real-time and correlate their profile to viral upper respiratory infections such as SARS-CoV-2,\neven asymptomatically. In Aim #1, we propose a prospective, observational study to analyze breath samples\nfrom COVID-19 positive and negative subjects, solely for the purpose of analysis through gold standard GC-\nMS to define breath VOC biomarkers of infection. We will recruit subjects at two local sites, the UC Davis\nMedical Center (Sacramento, CA) and VA Northern California Health Care System (Mather, CA), where MPI\nDr. Kenyon and Co-Is Drs. Harper and Schivo have joint clinical appointments. Our group has a proven track\nrecord to conduct these types of clinical breath studies. In Aim #2, we will develop a portable breath analysis\ndevice using our novel miniature differential mobility spectrometry (DMS) detector, coupled with chip-based\ngas chromatography. DMS is a subset of ion mobility spectrometry and detects VOCs at ambient temperatures\nand pressures, making it highly appropriate for portable devices. This device would include our custom chip-\nbased preconcentrator, which is packed with a chemical sorbent for extraction of VOCs from breath, and will\ncompare functionality of a compact commercially available GC column to a micro-GC column chip from\nDeviant, a subcontractor in this work. Individual components of this device have already been developed, and\nunder direction of MPI Prof. Davis, Chair of Mechanical and Aerospace Engineering, a team of research\nengineers would integrate these pieces together into a single unit. Collaborator Prof. Chuah would guide\ndevelopment of a custom software package for the device with machine learning and artificial intelligence\ncapabilities for automated data processing and interpretation. The device would be placed in the hands of\nclinicians, who would provide feedback that engineers would immediately incorporate into the device and\nreturn to the clinicians for more testing. Under Aim #3, our team would process the GC-MS and GC-DMS data\ngenerated in this work, identifying a novel VOC profile for COVID-19 diagnostics. Aim #4 would initiate towards\nthe end of this study to develop both a regulatory pathway & contract manufacturing plan for large scale\nproduction and deployment of the device for clinical approval. These efforts are supported by collaborator Dr.\nNam Tran, Director of Clinical Pathology & Clinical Chemistry at the UC Davis Medical Center.",
       "awardCode": "U18",
       "fundingMechanism": "Other Research-Related",
       "id": 37,
       "label": "Grant",
       "name": "Portable GC detector for breath-based COVID diagnostics",
       "narrative": "In the United States and worldwide, public health experts agree that nations must increase\ntheir capacity to test for COVID-19, yet global supplies for testing materials remain scarce. This project would\nlead to the development of an entirely new type of COVID-19 test, one that could diagnose infections with only\na breath sample. Through this proposal, our team would develop a portable device that could identify people\nwith COVID-19 infections by analyzing volatile organic compounds (VOCs) found in exhaled breath.",
       "researchInitiative": "RADx-rad",
       "subProject": "SCENT",
       "tooltip": "Grant\nabstract:/Abstract: This proposal has two major goals: 1) Define signature exhaled breath volatile\norganic compounds (VOCs) to diagnose SARS-CoV-2 infections, and 2) Develop a portable chemical sensing\ndevice that can capture and detect exhaled VOCs and includes machine learning algorithms for automated\ndata processing and results interpretation. This project will bring a portable sensor forward into clinical use with\nthe aim of supplementing COVID-19 diagnostics with a reagentless alternative. Breath testing of exhaled VOC\nbiomarkers is a relatively new concept that has the potential to transform healthcare in the US and globally.\nOur overarching hypothesis is that a miniature breath analysis device can measure signatures of exhaled\nbreath VOCs in real-time and correlate their profile to viral upper respiratory infections such as SARS-CoV-2,\neven asymptomatically. In Aim #1, we propose a prospective, observational study to analyze breath samples\nfrom COVID-19 positive and negative subjects, solely for the purpose of analysis through gold standard GC-\nMS to define breath VOC biomarkers of infection. We will recruit subjects at two local sites, the UC Davis\nMedical Center (Sacramento, CA) and VA Northern California Health Care System (Mather, CA), where MPI\nDr. Kenyon and Co-Is Drs. Harper and Schivo have joint clinical appointments. Our group has a proven track\nrecord to conduct these types of clinical breath studies. In Aim #2, we will develop a portable breath analysis\ndevice using our novel miniature differential mobility spectrometry (DMS) detector, coupled with chip-based\ngas chromatography. DMS is a subset of ion mobility spectrometry and detects VOCs at ambient temperatures\nand pressures, making it highly appropriate for portable devices. This device would include our custom chip-\nbased preconcentrator, which is packed with a chemical sorbent for extraction of VOCs from breath, and will\ncompare functionality of a compact commercially available GC column to a micro-GC column chip from\nDeviant, a subcontractor in this work. Individual components of this device have already been developed, and\nunder direction of MPI Prof. Davis, Chair of Mechanical and Aerospace Engineering, a team of research\nengineers would integrate these pieces together into a single unit. Collaborator Prof. Chuah would guide\ndevelopment of a custom software package for the device with machine learning and artificial intelligence\ncapabilities for automated data processing and interpretation. The device would be placed in the hands of\nclinicians, who would provide feedback that engineers would immediately incorporate into the device and\nreturn to the clinicians for more testing. Under Aim #3, our team would process the GC-MS and GC-DMS data\ngenerated in this work, identifying a novel VOC profile for COVID-19 diagnostics. Aim #4 would initiate towards\nthe end of this study to develop both a regulatory pathway & contract manufacturing plan for large scale\nproduction and deployment of the device for clinical approval. These efforts are supported by collaborator Dr.\nNam Tran, Director of Clinical Pathology & Clinical Chemistry at the UC Davis Medical Center.\nid:U18TR003795\nnarrative:In the United States and worldwide, public health experts agree that nations must increase\ntheir capacity to test for COVID-19, yet global supplies for testing materials remain scarce. This project would\nlead to the development of an entirely new type of COVID-19 test, one that could diagnose infections with only\na breath sample. Through this proposal, our team would develop a portable device that could identify people\nwith COVID-19 infections by analyzing volatile organic compounds (VOCs) found in exhaled breath.\nname:Portable GC detector for breath-based COVID diagnostics\nsubProject:SCENT\nresearchInitiative:RADx-rad\nfundingMechanism:Other Research-Related\nawardCode:U18"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f56721e7678b496791d5f2c685dc87c7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Douglas",
       "fullName": "Douglas Bell",
       "id": 619,
       "label": "Researcher",
       "lastName": "Bell",
       "name": "Bell D",
       "orcid": "orcid:0000-0001-7700-0840",
       "profileId": "profileid:6570860",
       "tooltip": "Researcher\nid:profileid:6570860\nlastName:Bell\norcid:orcid:0000-0001-7700-0840\nprofileId:profileid:6570860\nname:Bell D\nfullName:Douglas Bell\nfirstName:Douglas"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f5fdbc22415e4916a564e679f7c8c17e": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 682,
       "target": 2846
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f69d39fc979a400fa092eda07b91141a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "id": 4386,
       "label": "FundingOpportunity",
       "name": "Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed)",
       "tooltip": "FundingOpportunity\nname:Emergency Awards: Automatic Detection and Tracing of SARS-CoV-2 (U01 Clinical Trial Not Allowed)\nid:RFA-OD-20-014\nurl:https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-014.html",
       "url": "https://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-014.html"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f71ca59245d24c258c08765efde968d0": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Charles",
       "fullName": "Charles Yen Chiu",
       "id": 671,
       "label": "Researcher",
       "lastName": "Chiu",
       "middleName": "Yen",
       "name": "Chiu CY",
       "orcid": "orcid:0000-0003-2915-2094",
       "profileId": "profileid:8667619",
       "tooltip": "Researcher\nmiddleName:Yen\nid:profileid:8667619\nlastName:Chiu\norcid:orcid:0000-0003-2915-2094\nprofileId:profileid:8667619\nname:Chiu CY\nfullName:Charles Yen Chiu\nfirstName:Charles"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f73ce55c934844c4a7902ec953e7078b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Scott",
       "fullName": "Scott M Berry",
       "id": 636,
       "label": "Researcher",
       "lastName": "Berry",
       "middleName": "M",
       "name": "Berry SM",
       "profileId": "profileid:10311819",
       "tooltip": "Researcher\nmiddleName:M\nid:profileid:10311819\nlastName:Berry\nprofileId:profileid:10311819\nname:Berry SM\nfullName:Scott M Berry\nfirstName:Scott"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f799df5e1c22467ab9e0a3f3847b9825": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Smell loss is a predominant symptom of COVID-19, and initial evidence based on self-reports suggests that\nchemosensory loss is a sensitive predictor of COVID-19 in the general population, more so than fever.\nHowever, given the natural lack of awareness of chemosensory changes, self-reports underestimate the true\nprevalence of smell loss in patients with COVID-19 by 20% compared to an objective test. Therefore, we\npropose testing and deploying a rapid and objective measure of smell ability, the SCENTinel test, inspired by\nthe NIH Toolbox® Odor Identification Test that our team previously developed. SCENTinel is an inexpensive,\nand convenient smell test for COVID-19 surveillance of the population that quickly and easily assesses\nthree smell loss factors: odor detection, odor intensity, and odor identification. It is designed for practical use in\nseveral contexts, including high-density areas such as community medical sites, universities, subacute care\nfacilities, and both industrial and nonindustrial workplaces. Our multi-disciplinary team has expertise in\nunderstanding taste and smell, developing and validating chemosensory tests, as well as studying the broad\nsymptomatology of COVID-19. The group is led by MPI Dalton from the Monell Chemical Senses Center, an\nexpert in human olfaction and designing olfactory tests; MPI Parma from Temple University is an expert in\nCOVID-19 smell loss, is the Chair of the Global Consortium for Chemosensory Research, and has expertise in\nconducting research in rapidly changing situations; Dr. Schalet and his team at Northwestern University and\nDr. Chun and his team at Yale University, among the other established and interested partners (Fox subacute\nnursing homes, Hormel Food). Our team also includes the Director of Technology Transfer at the Monell\nCenter, Dr. O’Leary, to explore potential partners and expand SCENTinel deployment nationwide. Dr. Reed\nfrom the Monell Chemical Senses Center will work directly with the Data Coordination Center, drawing on her\nexperience in managing large shared NIH datasets. All will work closely with the NIH Project Scientist. This\nproposal aims to a) fine-tune SCENTinel’s ability to predict a positive COVID-19 diagnostic test; b) examine\nmarginal smell loss as a sign of the earliest phases of COVID-19, before a positive diagnostic test; and c)\nassess the test’s psychometric validity with test-retest reliability measures and validation against the NIH\nToolbox® Odor Identification Test. Together, these aims will establish a standardized protocol for use of\nSCENTinel as a rapid and objective smell test that can easily be incorporated into onsite COVID-19 testing\ncenters, schools, and workplaces nationwide. Furthermore, it will provide key insights into early-onset\nchemosensory symptoms in relation to a confirmed COVID-19 diagnosis, providing a crucially needed means\nto contain the spread of COVID-19.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 39,
       "label": "Grant",
       "name": "SCENTinel: A Rapid Smell Test for COVID-19 Surveillance",
       "narrative": "As COVID-19 continues to spread in concurrence with the reopening of activities and workplaces, there is an\nimmediate need to develop more robust screening tools to ensure everyone’s personal safety. Loss of the\nsense of smell is an early and sensitive predictor of COVID-19 infection. The goal of this project is to develop\nthe SCENTinel test, an inexpensive, rapid, and highly scalable objective smell test to use for COVID-19\nsurveillance.",
       "researchInitiative": "RADx-rad",
       "subProject": "Chemosensory Testing",
       "tooltip": "Grant\nabstract:Smell loss is a predominant symptom of COVID-19, and initial evidence based on self-reports suggests that\nchemosensory loss is a sensitive predictor of COVID-19 in the general population, more so than fever.\nHowever, given the natural lack of awareness of chemosensory changes, self-reports underestimate the true\nprevalence of smell loss in patients with COVID-19 by 20% compared to an objective test. Therefore, we\npropose testing and deploying a rapid and objective measure of smell ability, the SCENTinel test, inspired by\nthe NIH Toolbox® Odor Identification Test that our team previously developed. SCENTinel is an inexpensive,\nand convenient smell test for COVID-19 surveillance of the population that quickly and easily assesses\nthree smell loss factors: odor detection, odor intensity, and odor identification. It is designed for practical use in\nseveral contexts, including high-density areas such as community medical sites, universities, subacute care\nfacilities, and both industrial and nonindustrial workplaces. Our multi-disciplinary team has expertise in\nunderstanding taste and smell, developing and validating chemosensory tests, as well as studying the broad\nsymptomatology of COVID-19. The group is led by MPI Dalton from the Monell Chemical Senses Center, an\nexpert in human olfaction and designing olfactory tests; MPI Parma from Temple University is an expert in\nCOVID-19 smell loss, is the Chair of the Global Consortium for Chemosensory Research, and has expertise in\nconducting research in rapidly changing situations; Dr. Schalet and his team at Northwestern University and\nDr. Chun and his team at Yale University, among the other established and interested partners (Fox subacute\nnursing homes, Hormel Food). Our team also includes the Director of Technology Transfer at the Monell\nCenter, Dr. O’Leary, to explore potential partners and expand SCENTinel deployment nationwide. Dr. Reed\nfrom the Monell Chemical Senses Center will work directly with the Data Coordination Center, drawing on her\nexperience in managing large shared NIH datasets. All will work closely with the NIH Project Scientist. This\nproposal aims to a) fine-tune SCENTinel’s ability to predict a positive COVID-19 diagnostic test; b) examine\nmarginal smell loss as a sign of the earliest phases of COVID-19, before a positive diagnostic test; and c)\nassess the test’s psychometric validity with test-retest reliability measures and validation against the NIH\nToolbox® Odor Identification Test. Together, these aims will establish a standardized protocol for use of\nSCENTinel as a rapid and objective smell test that can easily be incorporated into onsite COVID-19 testing\ncenters, schools, and workplaces nationwide. Furthermore, it will provide key insights into early-onset\nchemosensory symptoms in relation to a confirmed COVID-19 diagnosis, providing a crucially needed means\nto contain the spread of COVID-19.\nid:U01DC019578\nnarrative:As COVID-19 continues to spread in concurrence with the reopening of activities and workplaces, there is an\nimmediate need to develop more robust screening tools to ensure everyone’s personal safety. Loss of the\nsense of smell is an early and sensitive predictor of COVID-19 infection. The goal of this project is to develop\nthe SCENTinel test, an inexpensive, rapid, and highly scalable objective smell test to use for COVID-19\nsurveillance.\nname:SCENTinel: A Rapid Smell Test for COVID-19 Surveillance\nsubProject:Chemosensory Testing\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f7a6637c47454d349f991487540e7417": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The COVID-19 pandemic is a critical global public health emergency and many countries are failing to contain\nthe virus's spread due to slow and insufficient testing. While several diagnostic methods are now available, most\ntests are either reagent-intensive and must be done in CLIA-approved labs, making them expensive and slow to\nreport results, or rapid and inexpensive, but potentially lacking in sensitivity. In the U.S., seriously ill and high-\nrisk patients have been prioritized for testing, causing states to miss mild and asymptomatic cases, some of\nwhich are the most effective spreaders of the virus. However, expanding testing has been a challenge due to\nshortages of sampling swabs and key reagents for nucleic acid amplification-based tests, which are the most\npopular option. Testing capabilities must be expanded exponentially to enable mass population-level testing of\nall patients, healthcare workers and their families, other critical key workers, and the wider community in order\nto bring the pandemic under control. mPOD proposes to expand testing capabilities through a novel biosensor\nthat will use oligonucleotide molecules called aptamers to bind to unique sites on the SARS-CoV-2 virus.\nAptamers have similar binding affinities to antibodies, but due to their smaller size, they are more agile, making\nthem particularly suited for high-specificity binding. To complete the test, a saliva sample will be loaded onto a\ntest strip containing aptamers immobilized onto gold electrodes. The gold-electrode test strip will be inserted into\nthe mPOD DTCT, a proprietary electrochemical test platform where virus-bound aptamers will be detected via\ncyclic voltammetry, triggering a positive result. The result is sent wirelessly via a mobile app, which sends\nencrypted data on to the cloud for storage and to public health agencies for enhanced data collection, tracking,\nand tracing of COVID-19. The app will also include a backend database to help businesses, manufacturers,\nschools, and large institutions track tested individuals' results and tailor specific public health responses. In order\nto further develop this technology and enable rapid deployment for timely COVID-19 intervention, mPOD plans\nto 1) Select SARS-CoV-2-specific aptamers for use in electrode test strips with an optimized signal-to-noise ratio\nperformance, 2) Demonstrate sensitivity and specificity of a low-cost, miniaturized potentiostat test strip for use\nas a COVID-19 POC or OTC diagnostic, 3) Complete and test a fully-fledged digital infrastructure for data\ncollection, tracking, and tracing of COVID-19 test results via the mPOD mobile app. This non-traditional approach\nwill provide new testing capabilities with the potential to report results faster than standard RT-PCR tests and\nwith greater accuracy and sensitivity compared to existing antigen-based diagnostics. Furthermore, once the\nsystem is developed, test strips with customized aptamers can be developed for rapid diagnosis of other\npathogens, including future emerging pandemics, via routine POC and OTC testing.",
       "awardCode": "R44",
       "fundingMechanism": "SBIR/STTR",
       "id": 6,
       "label": "Grant",
       "name": "A scalable aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2 from saliva",
       "narrative": "Worldwide, healthcare systems are struggling to diagnose new COVID-19 cases in a timely manner and to\nperform effective contract tracing to contain the pandemic. New diagnostic methods that are rapid, affordable,\nsensitive, and don't draw from already overtaxed supply chains are necessary to meet the urgent need for point-\nof-care and over-the-counter testing. To help meet this need, mPOD aims to develop a low-cost, aptamer-based\nbiosensor platform to detect the SARS-CoV-2 virus in saliva, complete with an app that will facilitate data\ncollection, tracking, and tracing of COVID-19 cases.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:The COVID-19 pandemic is a critical global public health emergency and many countries are failing to contain\nthe virus's spread due to slow and insufficient testing. While several diagnostic methods are now available, most\ntests are either reagent-intensive and must be done in CLIA-approved labs, making them expensive and slow to\nreport results, or rapid and inexpensive, but potentially lacking in sensitivity. In the U.S., seriously ill and high-\nrisk patients have been prioritized for testing, causing states to miss mild and asymptomatic cases, some of\nwhich are the most effective spreaders of the virus. However, expanding testing has been a challenge due to\nshortages of sampling swabs and key reagents for nucleic acid amplification-based tests, which are the most\npopular option. Testing capabilities must be expanded exponentially to enable mass population-level testing of\nall patients, healthcare workers and their families, other critical key workers, and the wider community in order\nto bring the pandemic under control. mPOD proposes to expand testing capabilities through a novel biosensor\nthat will use oligonucleotide molecules called aptamers to bind to unique sites on the SARS-CoV-2 virus.\nAptamers have similar binding affinities to antibodies, but due to their smaller size, they are more agile, making\nthem particularly suited for high-specificity binding. To complete the test, a saliva sample will be loaded onto a\ntest strip containing aptamers immobilized onto gold electrodes. The gold-electrode test strip will be inserted into\nthe mPOD DTCT, a proprietary electrochemical test platform where virus-bound aptamers will be detected via\ncyclic voltammetry, triggering a positive result. The result is sent wirelessly via a mobile app, which sends\nencrypted data on to the cloud for storage and to public health agencies for enhanced data collection, tracking,\nand tracing of COVID-19. The app will also include a backend database to help businesses, manufacturers,\nschools, and large institutions track tested individuals' results and tailor specific public health responses. In order\nto further develop this technology and enable rapid deployment for timely COVID-19 intervention, mPOD plans\nto 1) Select SARS-CoV-2-specific aptamers for use in electrode test strips with an optimized signal-to-noise ratio\nperformance, 2) Demonstrate sensitivity and specificity of a low-cost, miniaturized potentiostat test strip for use\nas a COVID-19 POC or OTC diagnostic, 3) Complete and test a fully-fledged digital infrastructure for data\ncollection, tracking, and tracing of COVID-19 test results via the mPOD mobile app. This non-traditional approach\nwill provide new testing capabilities with the potential to report results faster than standard RT-PCR tests and\nwith greater accuracy and sensitivity compared to existing antigen-based diagnostics. Furthermore, once the\nsystem is developed, test strips with customized aptamers can be developed for rapid diagnosis of other\npathogens, including future emerging pandemics, via routine POC and OTC testing.\nid:R44DE030842\nnarrative:Worldwide, healthcare systems are struggling to diagnose new COVID-19 cases in a timely manner and to\nperform effective contract tracing to contain the pandemic. New diagnostic methods that are rapid, affordable,\nsensitive, and don't draw from already overtaxed supply chains are necessary to meet the urgent need for point-\nof-care and over-the-counter testing. To help meet this need, mPOD aims to develop a low-cost, aptamer-based\nbiosensor platform to detect the SARS-CoV-2 virus in saliva, complete with an app that will facilitate data\ncollection, tracking, and tracing of COVID-19 cases.\nname:A scalable aptamer-based electrochemical biosensor for rapid detection of SARS-CoV-2 from saliva\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:SBIR/STTR\nawardCode:R44"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f7f97e828f8a4149a8a7818abf7088e3": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "In adults, SARS-CoV-2 infection exhibits a wide range of clinical outcomes, from asymptomatic and mild disease\nto severe viral pneumonia, respiratory distress, acute kidney injury, thrombotic disorders, and serious cardiac,\ncerebrovascular and vascular complications. Severe infection can also occur both in children and young adults\n(< 21), and a significant proportion of children admitted with Covid-19 require ICU support, frequently including\nmechanical ventilation. In addition, children and adolescents with initially asymptomatic SARS-CoV-2 infection\nhave presented with a rare, but very severe multisystem inflammatory syndrome (MIS-C). Epidemiologic, clinical\nand laboratory predictors of progression towards severe forms of acute infection with SARS-CoV-2 and MIS-C\nare thus urgently needed in the fight against Covid-19 in this population. As defined in the NIH Rapid\nAcceleration of Diagnostics (RADx) program, biomarker discovery can enable risk stratification and guide\ninterventional studies to target Covid-19 patients at enhanced risk of developing complications and/or severe\ndisease. To target this discovery initiative, herein we will use a battery of biological, immunological and molecular\ntests, including Grating-Coupled Fluorescence Plasmonic (GCFP) and advanced flow cytometry, to study\nchildren and young adults (<21 years) with mild, moderate or severe SARS-CoV-2 infection. GCFP allows the\nuse of disposable biosensor chips that can be mass-produced at low cost and spotted in microarray format to\ngreatly increase multiplexing capabilities. In addition, we will use a similar biomarker approach for rapid\ndifferentiation of patients with MIS-C versus other pediatric infectious or inflammatory conditions where the\nclinical presentation resembles MIS-C, most importantly Kawasaki disease. A child’s biologic and immunologic\nresponse to SARS-CoV-2 exposure is likely influenced by a variety of factors, including genetics, epigenetics\nand products of the mucosa/gut-brain axis, adipose tissue and neuroendocrine immune network, and further\nmodulated by environmental exposures. With these factors in mind, we hypothesize that a child’s biomarker\nprofile in response to SARS-CoV-2 infection enables a timely and accurate prediction of severity of Covid-19\nand diagnosis of MIS-C, and will help guide treatment strategies, and predict patient outcomes. To test this\nhypothesis, we will use a non-traditional diagnostic and comprehensive biomarker discovery to characterize the\nclinical and laboratory spectrum of children and adolescents with mild, moderate and severe SARS-CoV-2\ninfection, as well as MIS-C. We will then validate our newly developed diagnostic and prognostic algorithm to\ndistinguish MIS-C from other inflammatory disorders with overlapping clinical manifestations, including Kawasaki\ndisease, and predict the longitudinal risk of complications.",
       "awardCode": "R61",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 30,
       "label": "Grant",
       "name": "Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)",
       "narrative": "SARS-CoV-2 infection has harshly impacted health care outcomes in children and young adults. This\ngroundbreaking project will employ multiple state-of-the-art technologies and approaches to evaluate children\nand young adults (<21), enrolled in the United States and Colombia, across the spectrum of clinical\nmanifestations of Covid-19 to identify and validate biomolecules or bacterial signatures with diagnostic and\nprognostic value.",
       "researchInitiative": "RADx-rad",
       "subProject": "PreVAIL kIds",
       "tooltip": "Grant\nabstract:In adults, SARS-CoV-2 infection exhibits a wide range of clinical outcomes, from asymptomatic and mild disease\nto severe viral pneumonia, respiratory distress, acute kidney injury, thrombotic disorders, and serious cardiac,\ncerebrovascular and vascular complications. Severe infection can also occur both in children and young adults\n(< 21), and a significant proportion of children admitted with Covid-19 require ICU support, frequently including\nmechanical ventilation. In addition, children and adolescents with initially asymptomatic SARS-CoV-2 infection\nhave presented with a rare, but very severe multisystem inflammatory syndrome (MIS-C). Epidemiologic, clinical\nand laboratory predictors of progression towards severe forms of acute infection with SARS-CoV-2 and MIS-C\nare thus urgently needed in the fight against Covid-19 in this population. As defined in the NIH Rapid\nAcceleration of Diagnostics (RADx) program, biomarker discovery can enable risk stratification and guide\ninterventional studies to target Covid-19 patients at enhanced risk of developing complications and/or severe\ndisease. To target this discovery initiative, herein we will use a battery of biological, immunological and molecular\ntests, including Grating-Coupled Fluorescence Plasmonic (GCFP) and advanced flow cytometry, to study\nchildren and young adults (<21 years) with mild, moderate or severe SARS-CoV-2 infection. GCFP allows the\nuse of disposable biosensor chips that can be mass-produced at low cost and spotted in microarray format to\ngreatly increase multiplexing capabilities. In addition, we will use a similar biomarker approach for rapid\ndifferentiation of patients with MIS-C versus other pediatric infectious or inflammatory conditions where the\nclinical presentation resembles MIS-C, most importantly Kawasaki disease. A child’s biologic and immunologic\nresponse to SARS-CoV-2 exposure is likely influenced by a variety of factors, including genetics, epigenetics\nand products of the mucosa/gut-brain axis, adipose tissue and neuroendocrine immune network, and further\nmodulated by environmental exposures. With these factors in mind, we hypothesize that a child’s biomarker\nprofile in response to SARS-CoV-2 infection enables a timely and accurate prediction of severity of Covid-19\nand diagnosis of MIS-C, and will help guide treatment strategies, and predict patient outcomes. To test this\nhypothesis, we will use a non-traditional diagnostic and comprehensive biomarker discovery to characterize the\nclinical and laboratory spectrum of children and adolescents with mild, moderate and severe SARS-CoV-2\ninfection, as well as MIS-C. We will then validate our newly developed diagnostic and prognostic algorithm to\ndistinguish MIS-C from other inflammatory disorders with overlapping clinical manifestations, including Kawasaki\ndisease, and predict the longitudinal risk of complications.\nid:R61HD105613\nnarrative:SARS-CoV-2 infection has harshly impacted health care outcomes in children and young adults. This\ngroundbreaking project will employ multiple state-of-the-art technologies and approaches to evaluate children\nand young adults (<21), enrolled in the United States and Colombia, across the spectrum of clinical\nmanifestations of Covid-19 to identify and validate biomolecules or bacterial signatures with diagnostic and\nprognostic value.\nname:Identifying biomarker signatures of prognostic value for Multisystem Inflammatory Syndrome in Children (MIS-C)\nsubProject:PreVAIL kIds\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:R61"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f8c5d315a2254cb69dd728e3ee28d89d": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 620,
       "target": 605
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f965957bbf894308b456294027365e30": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "from": "Unique identifier of the researcher (string)",
       "name": "MetaRelationship",
       "relationshipName": "PRESENTED",
       "source": 2755,
       "target": 2752,
       "to": "Unique identifier of the presentation (string)"
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "f9f16919e10247bfa4c6c1fe04135bf3": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 706,
       "target": 18
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "fa771f2a57eb4582916d612877677820": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "PROVIDES",
       "source": 4386,
       "target": 33
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "fa83d237a3ff4822ae90b2d6a98a5859": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Project abstract (string)",
       "awardCode": "Code of award (string)",
       "fundingMechanism": "The type of award (Thesaurus:C20020) (string)",
       "id": 2760,
       "label": "MetaNode",
       "name": "Title of the project (string)",
       "narrative": "Short description (string)",
       "nodeName": "Grant",
       "researchInitiative": "The initiative or program associated with this grant (string)",
       "subProject": "A group of grants on related research areas (string)",
       "tooltip": "MetaNode\nid:Unique identifier for the grant (Thesaurus:C16644) (string)\nabstract:Project abstract (string)\nnarrative:Short description (string)\nname:Title of the project (string)\nnodeName:Grant\nsubProject:A group of grants on related research areas (string)\nresearchInitiative:The initiative or program associated with this grant (string)\nfundingMechanism:The type of award (Thesaurus:C20020) (string)\nawardCode:Code of award (string)"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "faa0cd4ec2fb48119c2a6f1699eec2b1": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "When faced with a pandemic such as SARS-Coronavirus-2 (SAR-CoV-2), the virus responsible for COVID-19,\ntimely risk assessment and action are required to prevent public health impacts to entire communities.\nBecause infected individuals may not have access to testing or may be asymptomatic and contraction can\nmean death, a proactive approach to detect the virus is needed to develop public health strategy to mitigate\nvirus spread. Recent studies have detected SAR-CoV-2 genetic material in sewage and demonstrate a\npositive correlation between the concentration of viral markers and reported cases1-5. The Coronavirus\nSewershed Surveillance Project (CSSP) is a collaborative effort to monitor sewersheds for genetic indicators of\nCOVID-19 in wastewater to provide additional, population-level information about virus circulation that is not\ncaptured by clinical testing. Untreated wastewater (influent) samples are screened weekly from select\nsewersheds and targeted micro-sewersheds for detection and “true” prevalence. Congregate facilities provide\nunique opportunities for study because they are controlled populations where the precise number and timing of\ninfections can be defined. Our team will utilize detailed monitoring of congregate facilities to define the precise\nper patient contribution and longevity of SARS-COV-2 RNA to wastewater by 1) increasing the number of\nfacilities tested, 2) altering the frequency at which samples are collected, and 3) comparing sewershed data\ncollected to clinical patient case data.\nAlthough SARS-COV-2 contribution/patient varies among communities, there have been clear outlier\ncommunities that produce little or no genetic material in the wastewater despite the presence of known\noutbreaks. The reason for this lost signal is not known, so our team will define factors that contribute to SARS-\nCOV-2 signal suppression in wastewater by 1) defining the physical nature of the genetic material in the\nsewershed to better understand the types of factors that could suppress signal, 2) expanding testing within\nsewersheds with suppressed signal as well as from additional facilities with similar population and industry\ndemographics as those with suppressed signal to narrow the sources of signal suppression, 3) performing\nexhaustive chemical characterization comparing wastewater from locations that are suppressed to those that\nare not to identify candidate compounds that could be causing suppression, and 4) obtaining or generating\ncandidate inhibitors and test their ability to suppress signal from viral genetic material in a controlled\nexperimental setting.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 46,
       "label": "Grant",
       "name": "Wastewater Detection of COVID-19",
       "narrative": "Testing of wastewater for genetic traces of SARS-COV-2, a novel Coronavirus that has\ncaused a destructive worldwide pandemic, has been shown to be an effective method\nfor gaining population-level data about viral prevalence and infectivity trends. However,\nbecause we lack critical knowledge about the factors that contribute to SARS-COV-2\ndetection in wastewater, these measurements currently cannot be used to accurately\npredict how many infected patients exist in a population. With a better understanding of\nthe individual patient contribution and duration of SARS-COV-2 signal in wastewater as\nwell as a better understanding of factors that affect signal detection, it will be possible to\nmore accurately predict the severity of outbreaks in populations using this powerful\ntechnique.",
       "researchInitiative": "RADx-rad",
       "subProject": "Wastewater",
       "tooltip": "Grant\nabstract:When faced with a pandemic such as SARS-Coronavirus-2 (SAR-CoV-2), the virus responsible for COVID-19,\ntimely risk assessment and action are required to prevent public health impacts to entire communities.\nBecause infected individuals may not have access to testing or may be asymptomatic and contraction can\nmean death, a proactive approach to detect the virus is needed to develop public health strategy to mitigate\nvirus spread. Recent studies have detected SAR-CoV-2 genetic material in sewage and demonstrate a\npositive correlation between the concentration of viral markers and reported cases1-5. The Coronavirus\nSewershed Surveillance Project (CSSP) is a collaborative effort to monitor sewersheds for genetic indicators of\nCOVID-19 in wastewater to provide additional, population-level information about virus circulation that is not\ncaptured by clinical testing. Untreated wastewater (influent) samples are screened weekly from select\nsewersheds and targeted micro-sewersheds for detection and “true” prevalence. Congregate facilities provide\nunique opportunities for study because they are controlled populations where the precise number and timing of\ninfections can be defined. Our team will utilize detailed monitoring of congregate facilities to define the precise\nper patient contribution and longevity of SARS-COV-2 RNA to wastewater by 1) increasing the number of\nfacilities tested, 2) altering the frequency at which samples are collected, and 3) comparing sewershed data\ncollected to clinical patient case data.\nAlthough SARS-COV-2 contribution/patient varies among communities, there have been clear outlier\ncommunities that produce little or no genetic material in the wastewater despite the presence of known\noutbreaks. The reason for this lost signal is not known, so our team will define factors that contribute to SARS-\nCOV-2 signal suppression in wastewater by 1) defining the physical nature of the genetic material in the\nsewershed to better understand the types of factors that could suppress signal, 2) expanding testing within\nsewersheds with suppressed signal as well as from additional facilities with similar population and industry\ndemographics as those with suppressed signal to narrow the sources of signal suppression, 3) performing\nexhaustive chemical characterization comparing wastewater from locations that are suppressed to those that\nare not to identify candidate compounds that could be causing suppression, and 4) obtaining or generating\ncandidate inhibitors and test their ability to suppress signal from viral genetic material in a controlled\nexperimental setting.\nid:U01DA053893\nnarrative:Testing of wastewater for genetic traces of SARS-COV-2, a novel Coronavirus that has\ncaused a destructive worldwide pandemic, has been shown to be an effective method\nfor gaining population-level data about viral prevalence and infectivity trends. However,\nbecause we lack critical knowledge about the factors that contribute to SARS-COV-2\ndetection in wastewater, these measurements currently cannot be used to accurately\npredict how many infected patients exist in a population. With a better understanding of\nthe individual patient contribution and duration of SARS-COV-2 signal in wastewater as\nwell as a better understanding of factors that affect signal detection, it will be possible to\nmore accurately predict the severity of outbreaks in populations using this powerful\ntechnique.\nname:Wastewater Detection of COVID-19\nsubProject:Wastewater\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "faaffc2b8baa410dbedaddd2cccf31c5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "applicants": [
        "Washington University"
       ],
       "filingDate": "2023-03-30",
       "id": 2409,
       "inventors": [
        "Benjamin Sumlin",
        "Rajan Charkrabarty",
        "Nishit Jaideep Shetty",
        "John Cirrito",
        "Carla Yuede"
       ],
       "label": "Patent",
       "name": "Rapid, single-use methods and systems for electrochemical analysis of pathogens in exhaled breath \n       ",
       "status": "pending",
       "tooltip": "Patent\nid:WO2023192433\napplicants:['Washington University']\nstatus:pending\nname:Rapid, single-use methods and systems for electrochemical analysis of pathogens in exhaled breath \n       \nfilingDate:2023-03-30\ninventors:['Benjamin Sumlin', 'Rajan Charkrabarty', 'Nishit Jaideep Shetty', 'John Cirrito', 'Carla Yuede']\nurl:https://patents.google.com/patent/WO2023192433A1",
       "url": "https://patents.google.com/patent/WO2023192433A1"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "faeef149db124256ad839a59fc46c4fb": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1022,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "fb134e02e5964bd9a957416eaf8b9116": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "SAINT LOUIS",
       "country": "UNITED STATES",
       "duns": "duns:068552207",
       "geonames": "geonames:4407066",
       "id": 586,
       "label": "Organization",
       "name": "Washington University in St. Louis",
       "ror": "ror:01yc7t268",
       "state": "MO",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4407066\nror:ror:01yc7t268\ncity:SAINT LOUIS\nname:Washington University in St. Louis\nuei:uei:L6NFUM28LQM5\nduns:duns:068552207\nstate:MO\nid:ror:01yc7t268\nurl:https://ror.org/01yc7t268",
       "uei": "uei:L6NFUM28LQM5",
       "url": "https://ror.org/01yc7t268"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "fb310da446fc4125a0773165f2c82a91": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 664,
       "target": 13
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "fbea21b09ac14d5eabb61176bd87d7e5": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "city": "BOSTON",
       "country": "UNITED STATES",
       "duns": "duns:128900562",
       "geonames": "geonames:4930956",
       "id": 605,
       "label": "Organization",
       "name": "InnoTech Precision Medicine, Inc",
       "state": "MA",
       "tooltip": "Organization\ncountry:UNITED STATES\ngeonames:geonames:4930956\ncity:BOSTON\nname:InnoTech Precision Medicine, Inc\nuei:uei:E4LRXHW2EKS5\nduns:duns:128900562\nstate:MA\nid:uei:E4LRXHW2EKS5",
       "uei": "uei:E4LRXHW2EKS5"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "fc12a255026b430db99fb732e8fcf546": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "T",
       "fullName": "T Bricker",
       "id": 951,
       "label": "Researcher",
       "lastName": "Bricker",
       "name": "Bricker T",
       "tooltip": "Researcher\nid:s2authorid:38184485\nlastName:Bricker\nname:Bricker T\nfullName:T Bricker\nfirstName:T"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "fc2aef5ccb7444cd956fc1a1c2c7c0b9": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Maria",
       "fullName": "Maria Laura Gennaro",
       "id": 714,
       "label": "Researcher",
       "lastName": "Gennaro",
       "middleName": "Laura",
       "name": "Gennaro ML",
       "orcid": "orcid:0000-0003-4801-3567",
       "profileId": "profileid:1861255",
       "tooltip": "Researcher\nmiddleName:Laura\nid:profileid:1861255\nlastName:Gennaro\norcid:orcid:0000-0003-4801-3567\nprofileId:profileid:1861255\nname:Gennaro ML\nfullName:Maria Laura Gennaro\nfirstName:Maria"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "fc43c828f1c4421493db965d2739dc5a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "lastUpdated": 2023,
       "name": "EMPLOYED_AT",
       "source": 716,
       "target": 574
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "fd26172ca7c74d469a8da92c32838748": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Existing tools to detect and visualize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suffer from low selectivity, poor cell permeability, and high cytotoxicity. Here we report a novel self-immolative fluorescent probe (MP590) for the highly selective and sensitive detection of the SARS-CoV-2 main protease (Mpro). This fluorescent probe was prepared by connecting a Mpro-cleavable peptide (N-acetyl-Abu-Tle-Leu-Gln) with a fluorophore (i.e., resorufin) via a self-immolative aromatic linker. Fluorescent titration results show that MP590 can detect Mpro with a limit of detection (LoD) of 35 nM and is selective over interferents such as hemoglobin, bovine serum albumin (BSA), thrombin, amylase, SARS-CoV-2 papain-like protease (PLpro), and trypsin. The cell imaging data indicate that this probe can report Mpro in HEK 293T cells transfected with a Mpro expression plasmid as well as in TMPRSS2-VeroE6 cells infected with SARS-CoV-2. Our results suggest that MP590 can both measure and monitor Mpro activity and quantitatively evaluate Mpro inhibition in infected cells, making it an important tool for diagnostic and therapeutic research on SARS-CoV-2.",
       "doi": "doi:10.1021/acs.analchem.2c02381",
       "id": 2816,
       "journal": "Analytical chemistry",
       "label": "Publication",
       "name": "A Self-Immolative Fluorescent Probe for Selective Detection of SARS-CoV-2 Main Protease.",
       "pmId": "35973073",
       "pmcId": "PMC9396966",
       "tooltip": "Publication\njournal:Analytical chemistry\nabstract:Existing tools to detect and visualize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) suffer from low selectivity, poor cell permeability, and high cytotoxicity. Here we report a novel self-immolative fluorescent probe (MP590) for the highly selective and sensitive detection of the SARS-CoV-2 main protease (Mpro). This fluorescent probe was prepared by connecting a Mpro-cleavable peptide (N-acetyl-Abu-Tle-Leu-Gln) with a fluorophore (i.e., resorufin) via a self-immolative aromatic linker. Fluorescent titration results show that MP590 can detect Mpro with a limit of detection (LoD) of 35 nM and is selective over interferents such as hemoglobin, bovine serum albumin (BSA), thrombin, amylase, SARS-CoV-2 papain-like protease (PLpro), and trypsin. The cell imaging data indicate that this probe can report Mpro in HEK 293T cells transfected with a Mpro expression plasmid as well as in TMPRSS2-VeroE6 cells infected with SARS-CoV-2. Our results suggest that MP590 can both measure and monitor Mpro activity and quantitatively evaluate Mpro inhibition in infected cells, making it an important tool for diagnostic and therapeutic research on SARS-CoV-2.\nid:doi:10.1021/acs.analchem.2c02381\nname:A Self-Immolative Fluorescent Probe for Selective Detection of SARS-CoV-2 Main Protease.\npmId:35973073\nyear:2022\ntype:primary\npmcId:PMC9396966\nurl:https://doi.org/doi:10.1021/acs.analchem.2c02381\ndoi:doi:10.1021/acs.analchem.2c02381",
       "type": "primary",
       "url": "https://doi.org/doi:10.1021/acs.analchem.2c02381",
       "year": 2022
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "fd31bbffcb2849fbb7e73801c93f2c2a": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "name": "AUTHORED",
       "source": 1196,
       "target": 2768
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "fd880dc4f3344957bf47d8d46b1b94f6": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Audrey",
       "fullName": "Audrey Ragan Odom John",
       "id": 612,
       "label": "Researcher",
       "lastName": "Odom John",
       "middleName": "Ragan",
       "name": "Odom John AR",
       "profileId": "profileid:9198778",
       "tooltip": "Researcher\nmiddleName:Ragan\nid:profileid:9198778\nlastName:Odom John\nprofileId:profileid:9198778\nname:Odom John AR\nfullName:Audrey Ragan Odom John\nfirstName:Audrey"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "fda404ba1fef4d01be4f42822d09b6cc": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 672,
       "target": 28
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "fdfbe7585dfb40f6a35cd3f70ff47c2b": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "Wastewater Assessment for Coronavirus in Kentucky – Implementing Enhanced Surveillance\nTechnology\nSurveillance for SARS-CoV-2 is hindered by the availability of testing, particularly in remote and rural\nareas. Screening of wastewater for SARS-CoV-2 viral biomarkers offers a viable alternative to individual\ntesting and it can identify communities and facilities that are at risk of becoming hotspots.Wastewater\nsurveillance overcomes several limitations of clinical surveillance, such as the need for robust healthcare\nand laboratory infrastructure and the lack of representative and comprehensive testing within\ncommunities. Conventional wastewater surveillance takes samples from sewer systems or wastewater\ntreatment facilities and uses a series of extraction steps prior to advanced PCR technology to quantitate\nthe viral biomarker (RNA). This approach is time and resource-intensive, which limits its wide-scale\napplication. Developing next generation technology to simplify wastewater RNA extraction and\nquantitation will make it feasible to use more broadly at facilities and in rural communities. The limited\nclinical testing for COVID-19 in rural Southeastern Kentucky hampers disease surveillance and prevents\ninformed public action to mitigate and contain the spread of disease. Wastewater testing for SARS-CoV-\n2 in these communities using field-friendly technology will provide important information to local\nauthorities and citizens about the spread and trend of SARS-CoV-2 infection in their communities. Our\nproject will accomplish two aims: 1) Develop next generation wastewater assessment technology and 2)\nImplement and evaluate the next generation wastewater assay. For Aim 1 we adapt technology invented\nby our team termed exclusion-based sample preparation (ESP) to simplify and improve RNA extraction\nfrom wastewater. We will pair ESP with loop-mediated isothermal amplification (LAMP) technology for\nRNA detection to create a sensitive, robust, and field-friendly platform for testing wastewater for SARS-\nCoV-2 RNA. We will compare the next generation assay with established techniques on metrics of\nsensitivity, specificity, and usability (e.g., assay time, number of assay steps). For Aim 2 we will first\nvalidate the next generation assay in the field at congregate living facilities in a side-by-side comparison\nwith conventional wastewater surveillance. Next, building on existing relationships in Appalachian\nKentucky, we will recruit and train a purposive group of wastewater treatment plant operators, watershed\nwatch citizen scientists, and school science teachers to test wastewater in their communities and schools\nusing the field-friendly next generation wastewater assay. Field results will be validated in the lab. A\nrobust mixed methods evaluation using the RE-AIM framework will assess community perceptions of\nfeasibility, acceptability, and utility of wastewater surveillance for SARS-CoV-2 and identify community\nmeasures taken in response to test results.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 45,
       "label": "Grant",
       "name": "Wastewater Assessment for Coronavirus in Kentucky: Implementing Enhanced Surveillance Technology",
       "narrative": "The goal of this project is to develop a “next generation” assay for the identification of SARS-CoV-2 in\nwastewater, which serves as a biomarker of community infection in contrast to more expensive and labor-\nintensive clinical testing. Existing wastewater assays have several limitations that reduce their accuracy and\nprevent use in remote and rural settings where disease surveillance could inform public action. Thus, we plan to\ndevelop, optimize, and validate a new “point-of-acquisition” SARS-CoV-2 assay that enables us to rapidly\nquantify the amount of coronavirus RNA in a wastewater sample, such that additional precautions (e.g.\nindividual testing, infection prevention measures) can be taken when needed.",
       "researchInitiative": "RADx-rad",
       "subProject": "Wastewater",
       "tooltip": "Grant\nabstract:Wastewater Assessment for Coronavirus in Kentucky – Implementing Enhanced Surveillance\nTechnology\nSurveillance for SARS-CoV-2 is hindered by the availability of testing, particularly in remote and rural\nareas. Screening of wastewater for SARS-CoV-2 viral biomarkers offers a viable alternative to individual\ntesting and it can identify communities and facilities that are at risk of becoming hotspots.Wastewater\nsurveillance overcomes several limitations of clinical surveillance, such as the need for robust healthcare\nand laboratory infrastructure and the lack of representative and comprehensive testing within\ncommunities. Conventional wastewater surveillance takes samples from sewer systems or wastewater\ntreatment facilities and uses a series of extraction steps prior to advanced PCR technology to quantitate\nthe viral biomarker (RNA). This approach is time and resource-intensive, which limits its wide-scale\napplication. Developing next generation technology to simplify wastewater RNA extraction and\nquantitation will make it feasible to use more broadly at facilities and in rural communities. The limited\nclinical testing for COVID-19 in rural Southeastern Kentucky hampers disease surveillance and prevents\ninformed public action to mitigate and contain the spread of disease. Wastewater testing for SARS-CoV-\n2 in these communities using field-friendly technology will provide important information to local\nauthorities and citizens about the spread and trend of SARS-CoV-2 infection in their communities. Our\nproject will accomplish two aims: 1) Develop next generation wastewater assessment technology and 2)\nImplement and evaluate the next generation wastewater assay. For Aim 1 we adapt technology invented\nby our team termed exclusion-based sample preparation (ESP) to simplify and improve RNA extraction\nfrom wastewater. We will pair ESP with loop-mediated isothermal amplification (LAMP) technology for\nRNA detection to create a sensitive, robust, and field-friendly platform for testing wastewater for SARS-\nCoV-2 RNA. We will compare the next generation assay with established techniques on metrics of\nsensitivity, specificity, and usability (e.g., assay time, number of assay steps). For Aim 2 we will first\nvalidate the next generation assay in the field at congregate living facilities in a side-by-side comparison\nwith conventional wastewater surveillance. Next, building on existing relationships in Appalachian\nKentucky, we will recruit and train a purposive group of wastewater treatment plant operators, watershed\nwatch citizen scientists, and school science teachers to test wastewater in their communities and schools\nusing the field-friendly next generation wastewater assay. Field results will be validated in the lab. A\nrobust mixed methods evaluation using the RE-AIM framework will assess community perceptions of\nfeasibility, acceptability, and utility of wastewater surveillance for SARS-CoV-2 and identify community\nmeasures taken in response to test results.\nid:U01DA053903\nnarrative:The goal of this project is to develop a “next generation” assay for the identification of SARS-CoV-2 in\nwastewater, which serves as a biomarker of community infection in contrast to more expensive and labor-\nintensive clinical testing. Existing wastewater assays have several limitations that reduce their accuracy and\nprevent use in remote and rural settings where disease surveillance could inform public action. Thus, we plan to\ndevelop, optimize, and validate a new “point-of-acquisition” SARS-CoV-2 assay that enables us to rapidly\nquantify the amount of coronavirus RNA in a wastewater sample, such that additional precautions (e.g.\nindividual testing, infection prevention measures) can be taken when needed.\nname:Wastewater Assessment for Coronavirus in Kentucky: Implementing Enhanced Surveillance Technology\nsubProject:Wastewater\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "feb605097beb408fae30d4673275b044": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Patricia",
       "fullName": "Patricia Bea Keady",
       "id": 651,
       "label": "Researcher",
       "lastName": "Keady",
       "middleName": "Bea",
       "name": "Keady PB",
       "orcid": "orcid:0000-0001-9612-0960",
       "profileId": "profileid:15312069",
       "tooltip": "Researcher\nmiddleName:Bea\nid:profileid:15312069\nlastName:Keady\norcid:orcid:0000-0001-9612-0960\nprofileId:profileid:15312069\nname:Keady PB\nfullName:Patricia Bea Keady\nfirstName:Patricia"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "fec0627f01804f4fa2be300f78f1ac40": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "abstract": "The University of Washington and the entrepreneurial community seeks to partner with the National Institutes\nof Health to become a Research Evaluation and Commercialization Hub (REACH) to accelerate academic\nbiomedical discoveries into products helping ease the highest U.S. burden of disease and disability.\nThe UW is a powerhouse in health sciences, technology, and innovation in a city known for seeking solutions\nto the most pressing health problems around the world.\nThe University’s long-standing relationship with the entrepreneurial business community has helped in the\nformation of Boeing, Microsoft, Amazon, Immunex, Zymogenetics, Teblos, the Drug Interaction Database, and\nSeattle Genetics. It’s also led to well-recognized recombinant therapeutic and vaccine products such as growth\nhormone, insulin, RecombiVax HB®, and Gardasil®.\nMany of our graduates work at major health organizations in the city, including The Gates Foundation, Path,\nFred Hutchinson Cancer Research Center, the Infectious Disease Research Institute. The University’s Foster\nSchool of Business gathers business leaders to judge and mentor solutions to health problems, and major\nbusiness leaders are part of the governing board of these organizations and the networking hub The\nWashington Global Health Alliance and The Innovation Hub of Life Sciences Washington.\nIn this rich spirt of collaboration, a hub to accelerate promising biomedical discoveries would fit right in. A hub\nis needed to further energize the spirit of discovery and collaboration and overcome barriers in getting products\nto the public. A hub will leverage existing resources for translational research and support the journey to\nfruition to innovative products that change lives. With institutional co-funding commitments, strong support of\ncommunity leaders, and proven leadership in entrepreneurial startups, the four Aims of this proposal are to (1)\nDevelop an integrated infrastructure and implementation system; (2) Identify the most promising technologies,\nand increase their availability using milestone-driven gap funding and mentoring (in business, marketing, and\nnetworking) for market-driven proof-of-product concept and product definition; (3) Fuel the formation of new\nbiotechnology, pharmaceutical, and medical device companies, and assist in pathways to a self-sustaining\nstructure; (4) Train the next generation of biomedical entrepreneurs to lead these ventures.\nWith NIH support, this hub will accelerate the creation of small businesses using biomedical discoveries to\nlaunch products that impact health outcomes. An investment in the Pacific Northwest will amplify the returns\non this funding due to the critical mass of investigators, and the will of our institutions to make this happen.",
       "awardCode": "U01",
       "fundingMechanism": "Non-SBIR/STTR",
       "id": 20,
       "label": "Grant",
       "name": "Washington Entrepreneurial Research Evaluation and Commercialization Hub",
       "narrative": "This proposal plans to create a hub to accelerate academic biomedical discoveries into products\nhelping ease the highest burden of disease and disability in the United States.\nThe University of Washington and the region is a powerhouse in health sciences, technology,\nand collaboration but many promising ideas never get to market because of barriers in funding,\nconnections to industry professionals or product development know-how. The Washington\nEntrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) program will\nbuild on strengths and integration of the entrepreneurial and translational environment in the\nregion to identify and accelerate promising products, foster milestone-driven project plans and\ntranslational teams, and then work with experts to overcome the barriers to create marketable\nhealth products.",
       "researchInitiative": "RADx-rad",
       "subProject": "Novel Biosensing and VOC",
       "tooltip": "Grant\nabstract:The University of Washington and the entrepreneurial community seeks to partner with the National Institutes\nof Health to become a Research Evaluation and Commercialization Hub (REACH) to accelerate academic\nbiomedical discoveries into products helping ease the highest U.S. burden of disease and disability.\nThe UW is a powerhouse in health sciences, technology, and innovation in a city known for seeking solutions\nto the most pressing health problems around the world.\nThe University’s long-standing relationship with the entrepreneurial business community has helped in the\nformation of Boeing, Microsoft, Amazon, Immunex, Zymogenetics, Teblos, the Drug Interaction Database, and\nSeattle Genetics. It’s also led to well-recognized recombinant therapeutic and vaccine products such as growth\nhormone, insulin, RecombiVax HB®, and Gardasil®.\nMany of our graduates work at major health organizations in the city, including The Gates Foundation, Path,\nFred Hutchinson Cancer Research Center, the Infectious Disease Research Institute. The University’s Foster\nSchool of Business gathers business leaders to judge and mentor solutions to health problems, and major\nbusiness leaders are part of the governing board of these organizations and the networking hub The\nWashington Global Health Alliance and The Innovation Hub of Life Sciences Washington.\nIn this rich spirt of collaboration, a hub to accelerate promising biomedical discoveries would fit right in. A hub\nis needed to further energize the spirit of discovery and collaboration and overcome barriers in getting products\nto the public. A hub will leverage existing resources for translational research and support the journey to\nfruition to innovative products that change lives. With institutional co-funding commitments, strong support of\ncommunity leaders, and proven leadership in entrepreneurial startups, the four Aims of this proposal are to (1)\nDevelop an integrated infrastructure and implementation system; (2) Identify the most promising technologies,\nand increase their availability using milestone-driven gap funding and mentoring (in business, marketing, and\nnetworking) for market-driven proof-of-product concept and product definition; (3) Fuel the formation of new\nbiotechnology, pharmaceutical, and medical device companies, and assist in pathways to a self-sustaining\nstructure; (4) Train the next generation of biomedical entrepreneurs to lead these ventures.\nWith NIH support, this hub will accelerate the creation of small businesses using biomedical discoveries to\nlaunch products that impact health outcomes. An investment in the Pacific Northwest will amplify the returns\non this funding due to the critical mass of investigators, and the will of our institutions to make this happen.\nid:U01HL152401\nnarrative:This proposal plans to create a hub to accelerate academic biomedical discoveries into products\nhelping ease the highest burden of disease and disability in the United States.\nThe University of Washington and the region is a powerhouse in health sciences, technology,\nand collaboration but many promising ideas never get to market because of barriers in funding,\nconnections to industry professionals or product development know-how. The Washington\nEntrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) program will\nbuild on strengths and integration of the entrepreneurial and translational environment in the\nregion to identify and accelerate promising products, foster milestone-driven project plans and\ntranslational teams, and then work with experts to overcome the barriers to create marketable\nhealth products.\nname:Washington Entrepreneurial Research Evaluation and Commercialization Hub\nsubProject:Novel Biosensing and VOC\nresearchInitiative:RADx-rad\nfundingMechanism:Non-SBIR/STTR\nawardCode:U01"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "feca05b1593349279a716957b204af18": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 645,
       "target": 17
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ff42b2625fc1478ca707807a4a598e83": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": false,
       "isPi": true,
       "isStudyInvestigator": false,
       "name": "IS_INVESTIGATOR_OF",
       "source": 687,
       "target": 4
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "ff79ae5c1e8f4642a3d57941c5e247d7": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "EdgeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "EdgeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "EdgeView",
      "classes": " directed  multiple_edges ",
      "data": {
       "isContactPi": true,
       "isPi": true,
       "isStudyInvestigator": true,
       "name": "IS_INVESTIGATOR_OF",
       "source": 667,
       "target": 21
      },
      "pannable": true,
      "removed": false,
      "selectable": false,
      "selected": false
     }
    },
    "fff54eaeda7f402aa15ba54112a1cde4": {
     "model_module": "jupyter-cytoscape",
     "model_module_version": "^1.3.3",
     "model_name": "NodeModel",
     "state": {
      "_model_module": "jupyter-cytoscape",
      "_model_module_version": "^1.3.3",
      "_model_name": "NodeModel",
      "_view_count": null,
      "_view_module": "jupyter-cytoscape",
      "_view_module_version": "^1.3.3",
      "_view_name": "NodeView",
      "classes": "",
      "data": {
       "firstName": "Anne-Catrin",
       "fullName": "Anne-Catrin Uhlemann",
       "id": 660,
       "label": "Researcher",
       "lastName": "Uhlemann",
       "name": "Uhlemann A",
       "orcid": "orcid:0000-0002-9798-4768",
       "profileId": "profileid:9733196",
       "tooltip": "Researcher\nid:profileid:9733196\nlastName:Uhlemann\norcid:orcid:0000-0002-9798-4768\nprofileId:profileid:9733196\nname:Uhlemann A\nfullName:Anne-Catrin Uhlemann\nfirstName:Anne-Catrin"
      },
      "grabbable": true,
      "grabbed": false,
      "locked": false,
      "pannable": false,
      "position": {},
      "removed": false,
      "selectable": false,
      "selected": false
     }
    }
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
